
<html lang="en"     class="pb-page"  data-request-id="4b743899-4d98-4912-864e-b6baaa002fb4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2013.56.issue-11;article:article:10.1021/jm3017317;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease" /></meta><meta name="dc.Creator" content="Bruno  Bulic" /></meta><meta name="dc.Creator" content="Marcus  Pickhardt" /></meta><meta name="dc.Creator" content="Eckhard  Mandelkow" /></meta><meta name="dc.Description" content="Pharmacological approaches directed toward Alzheimer disease are diversifying in parallel with a growing number of promising targets. Investigations on the microtubule-associated protein tau yielde..." /></meta><meta name="Description" content="Pharmacological approaches directed toward Alzheimer disease are diversifying in parallel with a growing number of promising targets. Investigations on the microtubule-associated protein tau yielde..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 13, 2013" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3017317" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3017317" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3017317" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3017317" /></link>
        
    
    

<title>Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3017317" /></meta><meta property="og:title" content="Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0017.jpeg" /></meta><meta property="og:description" content="Pharmacological approaches directed toward Alzheimer disease are diversifying in parallel with a growing number of promising targets. Investigations on the microtubule-associated protein tau yielded innovative targets backed by recent findings about the central role of tau in numerous neurodegenerative diseases. In this review, we summarize the recent evolution in the development of nonpeptidic small molecules tau aggregation inhibitors (TAGIs) and their advancement toward clinical trials. The compounds are classified according to their chemical structures, providing correlative insights into their pharmacology. Overall, shared structure–activity traits are emerging, as well as specific binding modes related to their ability to engage in hydrogen bonding. Medicinal chemistry efforts on TAGIs together with encouraging in vivo data argue for successful translation to the clinic." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3017317"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3017317">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3017317&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3017317&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3017317&amp;href=/doi/10.1021/jm3017317" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4135-4155</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm301659n" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruno++Bulic">Bruno Bulic</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marcus++Pickhardt">Marcus Pickhardt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eckhard++Mandelkow">Eckhard Mandelkow</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Laboratory of Organic Synthesis of Functional Systems, Humboldt-Universität zu Berlin, Brook-Taylor-Strasse 2, 12489 Berlin, Germany</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">DZNE (German Center for Neurodegenerative Diseases), Ludwig-Erhard-Allee 2, 53175 Bonn, Germany</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">CAESAR Research Center, Ludwig-Erhard-Allee 2, 53175 Bonn, Germany</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Max-Planck-Institute for Neurological Research, Hamburg Outstation, c/o DESY, Notkestrasse 85, 22607 Hamburg, Germany</span></div><div class="corresp-info"><strong>*</strong>Telephone: +49-30 2093-7464. E-mail: <a href="/cdn-cgi/l/email-protection#bedccccbd0d190dccbd2d7ddfed6cb93dcdbccd2d7d090dadb"><span class="__cf_email__" data-cfemail="d0b2a2a5bebffeb2a5bcb9b390b8a5fdb2b5a2bcb9befeb4b5">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3017317&amp;href=/doi/10.1021%2Fjm3017317" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4135–4155</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 13, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 November 2012</li><li><span class="item_label"><b>Published</b> online</span>13 March 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 June 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3017317" title="DOI URL">https://doi.org/10.1021/jm3017317</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4135%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBruno%2BBulic%252C%2BMarcus%2BPickhardt%252C%2BEckhard%2BMandelkow%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D11%26contentID%3Djm3017317%26title%3DProgress%2Band%2BDevelopments%2Bin%2BTau%2BAggregation%2BInhibitors%2Bfor%2BAlzheimer%2BDisease%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4155%26publicationDate%3DJune%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3017317"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6858</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">73</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3017317" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Bruno&quot;,&quot;last_name&quot;:&quot;Bulic&quot;},{&quot;first_name&quot;:&quot;Marcus&quot;,&quot;last_name&quot;:&quot;Pickhardt&quot;},{&quot;first_name&quot;:&quot;Eckhard&quot;,&quot;last_name&quot;:&quot;Mandelkow&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;4135-4155&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3017317&quot;},&quot;abstract&quot;:&quot;Pharmacological approaches directed toward Alzheimer disease are diversifying in parallel with a growing number of promising targets. Investigations on the microtubule-associated protein tau yielded innovative targets backed by recent findings about the central role of tau in numerous neurodegenerative diseases. In this review, we summarize the recent evolution in the development of nonpeptidic small molecules tau aggregation inhibitors (TAGIs) and their advancement toward clinical trials. The compounds are classified according to their chemical structures, providing correlative insights into their pharmacology. Overall, shared structure–activity traits are emerging, as well as specific binding modes related to their ability to engage in hydrogen bonding. Medicinal chemistry efforts on TAGIs together with encouraging in vivo data argue for successful translation to the clinic.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3017317&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3017317" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3017317&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3017317" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3017317&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3017317" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3017317&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3017317&amp;href=/doi/10.1021/jm3017317" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3017317" /></input><a href="/doi/pdf/10.1021/jm3017317" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3017317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3017317%26sid%3Dliteratum%253Aachs%26pmid%3D23484434%26genre%3Darticle%26aulast%3DBulic%26date%3D2013%26atitle%3DProgress%2Band%2BDevelopments%2Bin%2BTau%2BAggregation%2BInhibitors%2Bfor%2BAlzheimer%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D11%26spage%3D4135%26epage%3D4155%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290645" title="Aggregation">Aggregation</a>,</li><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jmcmar.2013.56.issue-11/production/jmcmar.2013.56.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0017.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Pharmacological approaches directed toward Alzheimer disease are diversifying in parallel with a growing number of promising targets. Investigations on the microtubule-associated protein tau yielded innovative targets backed by recent findings about the central role of tau in numerous neurodegenerative diseases. In this review, we summarize the recent evolution in the development of nonpeptidic small molecules tau aggregation inhibitors (TAGIs) and their advancement toward clinical trials. The compounds are classified according to their chemical structures, providing correlative insights into their pharmacology. Overall, shared structure–activity traits are emerging, as well as specific binding modes related to their ability to engage in hydrogen bonding. Medicinal chemistry efforts on TAGIs together with encouraging in vivo data argue for successful translation to the clinic.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55487" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55487" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer disease (AD, also known commonly as Alzheimer’s disease) is developing into the third most frequent pathology afflicting humans after cancer and cardiovascular diseases, mostly because of the worldwide increase in life expectancy. Symptoms may evolve during the progression of the disease, from the so-called mild cognitive impairments (MCI) at early stages to advanced dementia at later stages, placing patients under gradually increasing stress. Unfortunately, disease-modifying drugs able to stop or cure the disease are not yet available, leaving physicians with only symptom-alleviating medications in hand.</div><div class="NLM_p">To address this issue, investigations on the cause and mechanism of AD have significantly intensified over the past decade, leading to novel concepts in neurobiology. Indeed, most of the recent clinical trials have been based on the amyloid cascade hypothesis, stipulating the occurrence of aggregation-prone Aβ42 proteins and subsequent β-amyloid plaques as the source of the disease.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Strikingly, the very close spatial correlation between neuronal loss and Tau-based neurofibrillary tangles in patient’s brains has been long overlooked. It points to a higher layer of complexity and supports the hypothesis that Tau might play a prominent role in AD neurodegeneration.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Indeed, reducing Tau expression in mouse models that express mutant proaggregation forms of APP (amyloid precursor protein) was found to protect the mice from cognitive deficits normally associated with high cerebral Aβ load.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Moreover, in inducible Tau cell lines, interruption of Tau expression rescued cells from toxic effects. Conversely, mutations in the human Tau gene generating aggregation-prone Tau variants are linked to tauopathies, indicating that Tau aggregation might be neurotoxic per se.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5-8)</a></div><div class="NLM_p">Hypotheses on the molecular interplay between Tau and Aβ leading to the reported neurotoxicity are just starting to emerge and have been extensively reviewed elsewhere.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> The hierarchical position of Aβ in the toxicity cascade, traditionally upstream of Tau, has been also challenged by the observation that pathological Tau might appear in the locus coeruleus at early stages preceding amyloid plaques.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Yet it might become essential to further define the molecular form of Tau that mediates toxicity (monomer, oligomer, polymer, combined with posttranslational modifications), while current models favor a key role for oligomers.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a></div><div class="NLM_p">For future drug development, the recent series of suspended clinical trials on lack of efficacy or safety calls for a revision of the current therapeutic concepts for AD.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> Currently, programs based on the amyloid cascade hypothesis still occupy a predominant place in pharmaceutical product pipelines.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22">(18-22)</a> Among at least 17 small molecules in clinical trial or preclinical development phase, 10 candidates target Aβ production through APP processing by β- and γ-secretases, 6 compounds target Aβ aggregation, and only 1 (Rember)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> targets Tau aggregation.<a onclick="showRef(event, 'ref22 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref24">(22, 24)</a></div><div class="NLM_p">Alternatively, Aβ clearance has been addressed through immunotherapy using either active or passive immunization with Aβ antigens or anti-Aβ antibodies, respectively. These studies were particularly instructive on the impact of Aβ-amyloids at advanced stages of AD. Follow-up studies on the terminated trial with the AN1792<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> antigen indicated no evidence of cognitive efficacy in spite of extensive amyloid plaques clearance and no reduction of NFTs.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Outcomes of trials with passive immunization are now eagerly awaited; however, preliminary results from a phase III trial with bapineuzumab<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> show missed primary end points in 1100 ApoE4 carriers. Thus, it is reasonable to search for innovative therapies aimed at Tau as a complement to the available therapeutic arsenal, in a disease that might appear as an Aβ-linked tauopathy.<a onclick="showRef(event, 'ref6 ref17 ref27 ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref6 ref17 ref27 ref28 ref29 ref30 ref31">(6, 17, 27-31)</a></div><div class="NLM_p">Although Tau-directed immunotherapy approaches did not reach clinical trials yet, active and passive immunization in mouse models appears promising.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Knowledge about abnormally phosphorylated sites in tauopathies allowed the design of disease-specific antigens such as the Tau195–213 (targeting the epitope of antibody AT8, pS202 + pT205) or Tau379–408 (epitope of PHF1, pS396 + pS404).<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> Because mouse models recapitulating a specific abnormal phosphorylation pattern are not yet available, active immunization trials have been mostly performed on mice expressing FTDP-17 mutations such as the P301L or P301S or familial AD hTau/M146L-PS1. Administration of antigens resulted in extensive reduction of Tau tangle load, raising questions about the mode of action.<a onclick="showRef(event, 'ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36">(33-36)</a> Additionally, passive immunization using the PHF-1 antibody appears promising as well.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> This implies that antibodies permeate to some extent the blood–brain barrier (BBB), consistent with results using FITC-labeled antibodies.<a onclick="showRef(event, 'ref34 ref39'); return false;" href="javascript:void(0);" class="ref ref34 ref39">(34, 39)</a></div><div class="NLM_p">As complement to immunotherapy, several original Tau-directed approaches have been explored, from reduction of Tau absolute level to inhibition of Tau aggregation or control of Tau posttranslational modifications such as phosphorylation, acetylation, cleavage, or nitration.<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40-42)</a> Promoting Tau degradation deserves special attention, since cell homeostasis is frequently disturbed upon aging.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Autophagy is the major pathway of Tau clearance, and therefore, up-regulation of autophagy is a promising approach.<a onclick="showRef(event, 'ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46">(44-46)</a> In addition Tau has been identified as a client for molecular chaperones such as Hsp70 and Hsp90, leading to stabilization of misfolded proteins or redirection toward proteasomal degradation. For instance, inhibition of Hsp90 leads to increased proteosomal degradation of Tau, thus providing a valuable therapeutic target.<a onclick="showRef(event, 'ref47 ref48 ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50 ref51">(47-51)</a></div><div class="NLM_p">The best documented function of Tau is the binding to and subsequent stabilization of axonal microtubules, negatively regulated by phosphorylation at several serine, threonine, and tyrosine sites. Therefore, besides the gain of toxic function of aggregated Tau, a possible loss of function has been proposed, leading to destabilization of microtubules and impaired axonal transport.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Thus, microtubule stabilizing agents such as paclitaxel, epothilone D,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and the octapeptide NAPVSIPQ (“NAP peptide”)<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> are all promising disease modifying drugs for AD.</div><div class="NLM_p last">In this review article we focus on the recent evolution in the development of nonpeptidic small molecule Tau aggregation inhibitors (TAGIs), starting with a short overview of the current structural models for their targets in the aggregated state and the advancement stage in clinical trials.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Molecular Models of Tau Aggregates and Oligomers</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Knowledge of the molecular structure of aggregates is invaluable for the understanding of the protein self-assembly mechanisms and for the rational design of aggregation inhibitors. However, this task is complicated by the natively unfolded nature of Tau.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> X-ray scattering, FTIR, CD, and fluorescence spectroscopy revealed a mostly disordered structure but also pointed to a localized folding which brings the N- and C-terminal domains to form a “paper clip”.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Solution NMR studies of full-length Tau (hTau40, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) confirmed the lack of ordered strucuture but also highlighted regions with transient secondary structure, notably the hexapeptide motifs with high β-propensity in the repeat domains, short transient polyproline helices upstream of the repeat domain, and a short α helix near the C-terminus.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> Altogether, only a tiny fraction of the Tau protein, the hexapeptide motifs in repeats R2 and R3, are responsible for the abnormal self-assembly process, and the paper-clip conformation is expected to have a protective effect against Tau aggregation by shielding the hexapeptide motifs.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Diagram of hTau40, the largest Tau isoform in CNS, the fetal Tau isoform hTau23 (lacking exons 2, 3, and 10), and the repeat domain constructs used in the PHF inhibition assay (construct K19, repeat domain with three repeats, R2 absent). (B) PHF6 is the hexapeptide motif (<sup>306</sup>VQIVYK<sup>311</sup>) that nucleates the aggregation of construct K19.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a><a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> In the four repeat construct K18 a second hexapeptide is present (<sup>275</sup>VQIINK<sup>280</sup>) which also contributes to aggregation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to AD, aggregation of Tau is characteristic of several diseases known as tauopathies. These diseases are heterogeneous, with spatio–temporal differences linked not only to brain areas but also to the spliced variants of aggregated Tau.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> This variability translates into various fibril morphologies as seen by electron microscopy and atomic force microscopy (AFM), with different twists and diameters. In AD, Tau filaments have typically a twist repeat of 80 nm and a width varying between 12 and 22 nm. Although the term “paired helical filament”, originally coined by Kidd et al.,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> suggests two filaments wrapped around one another, a better interpretation is that of a single filament with a roughly ellipsoidal cross section, twisted around its longitudinal axis.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> The packing order of Tau subunits in the filaments is not known in detail except that the region around the hexapeptide motifs forms several short parallel β-sheets in a cross-β conformation, as seen by EPR and solid-state NMR,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a><a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> while X-ray diffraction shows two reflections at 4.8 and 10 Å thought to correspond to the longitudinal interstrand and lateral intersheet spacing, respectively.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Strikingly, this reflection pattern is shared by most fibrillar aggregates, irrespective of the amino acid sequence of the constitutive proteins.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> This generic structure provides a rationale for the surprising structural similarities in small molecules targeting amyloids. Indeed, it is known that aggregation inhibitors of a specific amyloidogenic peptide are also potential aggregation inhibitors of a wide variety of other amyloidogenic peptides<a onclick="showRef(event, 'ref64 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref64 ref65 ref66">(64-66)</a> and that histological dyes such as thioflavin S or Congo red<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> bind to aggregates in at least 15 genetically unrelated disorders.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div><div class="NLM_p">Recently, a breakthrough in modeling Tau aggregates has been achieved using the aggregation-prone segment of Tau within its repeat domain. This VQIVYK sequence is located in the PHF6 hexapeptide motif (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) and has been proposed to nucleate the aggregation of Tau via formation of β-sheet interactions. Indeed, β-sheet breaker mutations in the hexapeptide motifs such as prolines render the protein incompetent for assembly, as well as deletion of the positively charged K280 lysine engaged in localized electrostatic interactions hindering Tau self-assembly.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Conversely, mutations within the hexapeptide motif that enhance the β-sheet propensity such as the P301L mutation found in FTDP-17 promote Tau aggregation.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> On the basis of this structural information, aggregation of Tau can be inhibited either by mutations disrupting the β structure with “antiaggregant” mutations, e.g., I308P,<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> or by small molecule compounds interacting with the β-sheet region (Akoury et al.).<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a></div><div class="NLM_p">As developed further below, the identification of hot spots required for Tau self-assembly is supporting the feasibility of chemical Tau aggregation inhibition, as deduced from the development of protein–protein interactions inhibitors.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_p">Remarkably, the short <sup>306</sup>VQIVYK<sup>311</sup> segment, when isolated from the whole protein, has been amenable to microcrystallization and thereby to structure determination at atomic resolution using X-ray microcrystallography.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> The resolved structure confirmed not only in-register β-strands running parallel to the fibril axis but also a novel fold perpendicular to the fibril axis, named steric zipper because of the shape-complementary interdigitations with amino acids side chains, forming a tightly packed dry interface (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a).<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Adding up the hydrogen bonds network to the hydrophobic dry interface provides the driving force leading to extremely stable fibrillar aggregates. Moreover, NMR experiments have highlighted the intermolecular interactions of the nucleating hexapeptide motifs VQIINK and VQIVYK motifs, in line with previous findings showing that mutations within these hexapeptide motifs are sufficient to inhibit or promote aggregation.<a onclick="showRef(event, 'ref57 ref69 ref75'); return false;" href="javascript:void(0);" class="ref ref57 ref69 ref75">(57, 69, 75)</a> The involvement of the VQIVYK motif in PHFs has been recently confirmed using solid state NMR, and most importantly, the method also allowed investigation of PHFs formed by the 99 amino acids K19 Tau construct showing multiple interacting regions besides the nucleating core.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Indeed, 18 amino acids out of 99 appeared involved in the rigid core of the fibrils, encompassing, besides the PHF6 motif V306-K311, the sequences V313-L315 and either K317-C322 or K317-K321. Interestingly, the single cysteine C322 of the K19 sequence can be involved in two distinct disulfide bridges, stabilizing the aggregated conformation, in line with previous finding showing dependency of aggregation on redox conditions.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76, 77)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a, left) VQIVYK steric zipper structure determined by X-ray microcrystallography showing interdigitations at the dry interface. Reprinted by permission from Macmillan Publishers Ltd.:  <cite>Nature</cite> <span class="NLM_year">2007</span>, <em>447</em>, 453–457;<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a><a href="http://www.nature.com/nature/index.html" class="extLink">http://www.nature.com/nature/index.html</a>. Copyright 2007. (b, right) Ribbon representation of the crystal structure of oligomer-like segment of αB-crystallin forming a barrel. From <contrib-group person-group-type="allauthors">Laganowsky, A.; Liu, C.; Sawaya, M. R.; Whitelegge, J. P.; Park, J.; Zhao, M.; Pensalfini, A.; Soriaga, A. B.; Landau, M.; Teng, P. K.; Cascio, D.; Glabe, C.; Eisenberg, D.</contrib-group>Atomic view of a toxic amyloid small oligomer.  <cite>Science</cite> <span class="NLM_year">2012</span>, <em>335</em>, 1228–1231;<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a><a href="http://www.sciencemag.org/content/335/6073/1228.abstract?sid=c6273ec7-53be-4d69-b687-a963c44453f4" class="extLink">http://www.sciencemag.org/content/335/6073/1228.abstract?sid=c6273ec7-53be-4d69-b687-a963c44453f4</a>. Reprinted with permission from AAAS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Besides PHFs, novel oligomeric forms with ill-defined structures appeared following the isolation of nonfibrillar Aβ forms in AD patients. These smaller structures, putatively formed by dimers, trimers, and larger multimers of Aβ, were found to induce strong synaptic toxicity.<a onclick="showRef(event, 'ref7 ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref7 ref79 ref80 ref81">(7, 79-81)</a> Oligomeric Tau species have been characterized and also display strong neurotoxicity through a yet unclear mechanism.<a onclick="showRef(event, 'ref6 ref12'); return false;" href="javascript:void(0);" class="ref ref6 ref12">(6, 12)</a> The peptidic arrangement in oligomers is expected to be distinct from the stacking in fully aggregated fibrillar forms, as indicated by the high resolution model of an hexameric fragment of αB-crystallin recently obtained by X-ray crystallography, showing a β-sheet rich structure forming a barrel (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b), a species presumably branching off-pathway from fiber formation (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">03</a>).<a onclick="showRef(event, 'ref78 ref82'); return false;" href="javascript:void(0);" class="ref ref78 ref82">(78, 82)</a> Noteworthy, this structure was specifically recognized by the anti-Aβ conformational antibody A11, hinting at a generic structure eventually shared with Tau oligomers.<a onclick="showRef(event, 'ref78 ref83'); return false;" href="javascript:void(0);" class="ref ref78 ref83">(78, 83)</a> At the dimer level, Tau has been isolated using photochemical cross-linking with benzophenonemaleimide in order to lock and stabilize the oligomeric structure, showing an antiparallel Tau-Tau conformation.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Further, annular hexamers and higher order oligomers have been reported, also with marked neurotoxicity. In the development of TAGIs, it is therefore becoming increasingly important to document the molecular target, which could be monomeric, oligomeric, or aggregated Tau (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">03</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Tau aggregation pathways and potential therapeutic targets. Aggregation intermediates and mature fibrils or monomeric peptides are possible entry points for drug development (schematic representations, not to scale).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Moreover, the availability of atomic resolution structures of oligomeric and fibrillar Tau opens the door to rational design using chemoinformatic approaches.<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84, 85)</a> In a seminal study, structures of aggregated VQIVYK peptides cocrystallized with several Tau binders such as curcumin and DDNP<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> have been obtained (<b>47</b> and <b>48</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>) paving the way for further in silico developments. In parallel, macrocyclic and all-<span class="smallcaps smallerCapital">d</span>-amino acid peptide inhibitors for Tau aggregation could be obtained using structure-based design.<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86, 87)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Progress toward Clinical Trials: Tau and Aβ Aggregation Inhibition</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17352" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17352" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To date, most of drug development targeting aggregation inhibition has been directed toward Aβ. Because valuable precursors pave the way for TAGIs, their current stage of clinical development is described below. At the forefront of TAGIs that successfully moved from preclinical development to clinical trials are methylene blue<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) and demethylated derivatives such as azure A (<b>6</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref23 ref88'); return false;" href="javascript:void(0);" class="ref ref23 ref88">(23, 88)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Redox cycling of methylene blue and TAGI potencies.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Upper panel (black): Reduced leuco form <b>2</b> and structural overlap with inactive phenothiazines <b>3</b>, <b>4</b>, and <b>5</b>. Lower panel (blue): Structural overlap between oxidized form <b>1</b> and azure A (<b>6</b>), reduced anthraquinone, <b>8</b>, and <b>9</b>, showing the extended π-conjugated system (ND: not determined).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a phase II trial on 321 patients with mild-to-moderate AD, TauRx reported that a compound derived from <b>1</b> may slow or halt the progression of the disease. At 24 weeks, patients treated with <b>1</b> declined 5.4 points less on the ADAS-cog scale than placebo. At 50 weeks, no significant cognitive decline could be detected anymore while the placebo group worsened 6.8 points. With several decades of utilization as a medication for diverse human pathologies, the safety profile of <b>1</b> is abundantly documented.<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89, 90)</a> The long-term administration of <b>1</b> in congenital methemoglobinemia and as antimalarial agent does not induce severe side effects and involves only dizziness or nausea.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Although adverse effects in connection with light exposure are not documented, the photosensitizing properties of <b>1</b> might call for prudence.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> From a chemical point of view, two major forms of the molecule are in equilibrium, depending on the redox potential of the solution: the oxidized cationic form (blue, <b>1</b>) and the reduced colorless form, also called leuco-methylene blue (<b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> In an oxygen rich environment, the equilibrium is largely shifted toward the oxidized form <b>1</b>. Noteworthy, while the leuco form is classified as a phenothiazine, the predominantly oxidized form <b>1</b> is closer to polyaromatics such as <b>8</b>, <b>9</b>, or reduced anthraquinones (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><div class="NLM_p">Phenothiazines such as the antipsychotic drugs <b>5</b> and <b>3</b> are nonaromatic tricyclic structures with two aromatic rings bridged through nitrogen and sulfur atoms, while <b>9</b> is a planar aromatic structure (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Strikingly, true phenothiazines such as <b>3</b>, <b>4</b>, and <b>5</b> are incompetent to inhibit Tau aggregation, while aromatic anthracene-type compounds such as <b>1</b>, <b>6</b>, or even quinacrine mustard were all found to be active with comparable low micromolar potencies (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Therefore, the classification of <b>1</b> in the group of phenothiazines might be inadequate as far as its TAGIs properties are considered.</div><div class="NLM_p">From a pharmacokinetic viewpoint, the ADME data analysis (absorption, distribution, metabolism, excretion) suggests a high oral bioavailability at 72% despite its hydrophilic character, probably because of the dispersion of the positive charge on the molecule by resonance.<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94, 95)</a> Investigations on the pharmacokinetics of <b>1</b>, administrated as prophylaxis of ifosfamide-associated encephalopathy, indicate a 5 h half-life, a high volume distribution, and significant brain penetration.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Nevertheless the bioavailability after oral administration was found to go with significant liver accumulation, as also observed for multiple cyanine dyes described below.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div><div class="NLM_p">Recently the experimental drug LMTX (structure not disclosed), derived from <b>1</b>, has been introduced into a global phase 3 clinical trial against the behavioral-variant of frontotemporal dementia (bvFTD) characterized by early changes in personality, also known as Pick disease. The substance was chemically optimized with regard to tolerability and bioavailability in order to enable the use of higher concentrations compared to <b>1</b> (press release, TauRx Therapeutics). While phase III trials in AD are anticipated, the mode of action of the drug remains enigmatic. In vitro investigations on full length Tau provided variable potencies, with demethylated derivatives such as <b>6</b>, thionine, and tolonium chloride being occasionally more potent than <b>1</b> (IC<sub>50</sub> = 69–108 nM at inhibitor/Tau ratio 5/1 versus IC<sub>50</sub> = 3.4 μM for <b>1</b>) or equally potent (IC<sub>50</sub> = 1.9–2.6 μM). Depending on the assay and Tau isoforms, a potency for <b>1</b> as low as 31 μM could be observed.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Note that because of the optical properties of <b>1</b> and its derivatives, e.g., <b>6</b>, which shows a high light absorption potential at wavelengths below 350 nm and between 620 and 760 nm (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), many assays monitoring fluorescence or absorption effects in vitro or in vivo may fail in the presence of <b>1</b>.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. UV/vis absorption spectra for <b>1</b> and <b>6</b> showing strong absorbance below 350 nm and between 620 and 760 nm pointing at potential interferences in protein aggregation fluorescence assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Moreover, Tau aggregation inhibition with <b>1</b> might be dependent on the model investigated and aggregation stage. For instance, <b>1</b> failed to inhibit prefibrillar Tau-dependent toxicity in Tau-P301L zebrafish or Tau phosphorylation in 3xTg-AD mice;<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(98, 99)</a> however, on the contrary, the Tau level was significantly lowered in organotypic brain slices at nanomolar concentrations of <b>1</b>.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> These differences between in vitro and in vitro systems could be explained by the pleiotropic action of <b>1</b> which binds, for example, to ATP-binding pockets of cellular proteins.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Keeping in mind the moderate TAGI potency of <b>1</b>, it has been proposed that <b>1</b> pleiotropy partly accounts for the reported improvements in behavioral studies in mice, since <b>1</b> is also an MAO inhibitor and NO-synthase inhibitor.<a onclick="showRef(event, 'ref92 ref102'); return false;" href="javascript:void(0);" class="ref ref92 ref102">(92, 102)</a> Most importantly, the redox activity of <b>1</b> was proposed to compensate complex IV deficits in the mitochondrial respiratory chain, thereby promoting cell survival. Noteworthy, the redox properties of <b>1</b> might largely contribute to the Tau aggregation inhibitory effect. Indeed, it has been previously reported that redox oscillators could inhibit Tau aggregation unspecifically through peroxide generation.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> The production of reactive oxygen species might also arise from light exposure of photosensitizers such a <b>1</b> or porphyrines.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Predominantly, in the presence of oxygen and reducing agents typically found in vivo, such as NAD(P)H, thioredoxins, or glutathione, <b>1</b> behaves as a redox oscillator, cycling between the reduced and oxidized forms, thereby producing peroxides (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> This property is shared by most of the anthracene-type compounds and is also pertinent for the evaluation of the anthraquinone-based TAGIs described below (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).</div><div class="NLM_p">One of the major hurdles in the development of aggregation inhibitor is that different “aggregopathies” are based on similar structural principles, namely, the inappropriate assembly of β strands into pathological oligomers and fibers. This makes it difficult to identify specific inhibitors that discriminate between different aggregating proteins and yet do not interfere with physiological β structures. Thus, aggregation inhibitors are often designed and tested in parallel for several neurodegenerative diseases.<a onclick="showRef(event, 'ref84 ref87'); return false;" href="javascript:void(0);" class="ref ref84 ref87">(84, 87)</a> Given that only a single member of the TAGI family reached clinical trials so far, a brief glance at the current stage of development in Aβ-aggregation inhibitors might be relevant for feasibility evaluation.</div><div class="NLM_p">Tramiprosate<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> (<b>10</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) was developed as a GAG mimetic (glycosaminoglycan) following the initial observation that sulfated GAGs such as heparin are abundant in amyloid plaques and NFTs. In retrospect, given the difficulties observed with anti-Aβ immonotherapies, the failure of <b>10</b> in phase III is explainable.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> However, the compound was successful at lowering CSF Aβ42 in mild-to-moderate AD, thus proving target engagement. The inhibitor was found to bind preferentially to the soluble monomeric form of Aβ at the highly charged HHQK motif.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of Aβ-aggregation inhibitors evaluated in current or past clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The next most currently advanced candidate, ELND005<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> (AZD-103, <b>11</b>, a scyllo-inositol<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> analogue, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), developed by Transition Therapeutics in partnership with Elan, completed phase II trials on mild AD after fulfilling safety and tolerability tests and is now expected to enter phase III. According to in vitro investigations, scyllo-inositol,<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> but not its stereoisomers such as myo-, epi-, and chiro-inositols, was found to inhibit Aβ aggregation by selectively binding to the Aβ42 C-terminus for shielding or by redirecting the aggregation toward a nontoxic oligomeric form.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> This mode of action is reminiscent of the polyphenol epi-gallocatechine gallate (EGCG<a onclick="showRef(event, 'ref110 ref111'); return false;" href="javascript:void(0);" class="ref ref110 ref111">(110, 111)</a> or Sunphenon, <b>12</b> Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), currently in phase II, even though this last compound associates with a different segment of the Aβ peptide, the hydrophobic core.<a onclick="showRef(event, 'ref111 ref112 ref113'); return false;" href="javascript:void(0);" class="ref ref111 ref112 ref113">(111-113)</a> For more information on the mode of action and structure–activity relationship for polyphenols-derived TAGIs, see the section on polyphenols below.</div><div class="NLM_p">Metal chelators have been reported to inhibit aggregation of Aβ in vitro. Prana Biotechnology has developed PBT-2 (structure not disclosed), an 8-hydroxyquinoline copper/zinc ionophore derived from clioquinol<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> (<b>13</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref115 ref116'); return false;" href="javascript:void(0);" class="ref ref115 ref116">(115, 116)</a> The phase II trial with the drug candidate showed the ability to reduce Aβ42 CSF levels and adequate BBB permeability. In parallel, the compound was reported to significantly reduce the level of phosphorylated Tau in animal models. While PBT-1 was markedly toxic at high doses, the derived drug candidate successfully passed safety and tolerability tests. Noteworthy, besides aggregation inhibition, the compound is claimed to restore metal homeostasis in the brain.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></div><div class="NLM_p">ProteoTech recently received FDA approval to conduct a phase I clinical trial with Exebryl-1 (structure not disclosed). Interestingly, besides inhibition of Aβ aggregation, the compound was also found to inhibit aggregation of the Tau repeat domain (Tau<sub>RD</sub>) with IC<sub>50</sub> = 10.5 μM at a 1:1 Tau/inhibitor ratio and could disassemble full length Tau with EC<sub>50</sub> = 3.56 μM at a 1:2 Tau/inhibitor ratio. The mode of action was investigated by CD spectroscopy, indicating that the compound might bind to soluble monomers and block the conformational change from random coil to β-sheet structure (press release, retrieved from <a href="http://www.proteotech.com/pdfs/exebryl-1_poster.pdf" class="extLink">http://www.proteotech.com/pdfs/exebryl-1_poster.pdf</a>).</div><div class="NLM_p">Samaritan Pharmaceuticals entered phase I trials with SP-233 or caprospinol<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> (<b>14</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), a neurosteroid found to protect neuronal mitochondria from Aβ42 induced toxicity.<a onclick="showRef(event, 'ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref118 ref119">(118, 119)</a> Although the compound is claimed to be an Aβ oligomerization inhibitor, its potency remains undisclosed. However, a mode of action has been proposed, involving the binding of the molecule to residues 23–42 of Aβ42.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div><div class="NLM_p">The pyridazine scaffold (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) has been identified by Daiichi Sankyo Pharmaceuticals as a weak Aβ42-aggregation inhibitor with IC<sub>50</sub> = 100 μM  at 4:1 compound/Aβ42 ratio.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> It was later found to inhibit Aβ oligomerization.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Derivative SEN1269<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> (15, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), currently owned by BTG Pharma, was further developed by Senexis Pharma, improving the pharmacokinetics and BBB permeability. Evidence of direct binding of these compounds to the monomeric Aβ and to oligomers has been obtained using surface plasmon resonance on N-terminus-biotinylated Aβ, supporting the concept of monomer binders.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></div><div class="NLM_p last">Altogether, the successful advancement of several Aβ aggregation inhibitors in clinical trials paves the way for development of TAGIs. One straightforward strategy for the discovery of new active molecules for Tau aggregation inhibition continues to be the screening of compound libraries containing sufficient structural diversity. Identification of hits generally enables the subsequent medicinal chemistry efforts necessary to reach compounds featuring the desired properties, i.e., optimized inhibitory potencies and pharmacokinetics.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">HTS for Tau Aggregation Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35471" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35471" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Several approaches have been used to perform high or medium throughput screens for Tau aggregation inhibitors. They include fluorescence-based assays of Tau aggregation using thioflavin S as an indicator,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> filter assays to segregate soluble and insoluble protein,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> sarkosyl treatment followed by quantification of sarkosyl-soluble and insoluble Tau protein,<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> quantification of filament length and amount by transmission electron microscopy,<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> and fluorescence depolarization of labeled Tau which distinguishes diffusible from aggregated molecules.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div><div class="NLM_p">In our studies on Tau aggregation inhibitors, the Tau construct K19 was used which comprises the three repeat domains of the fetal human isofom hTau23 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> This construct corresponds to the core of the PHF structure and contains the VQIVYK hexapeptide motif which supports the β-sheet structure that promotes aggregation.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The initial screening for active aggregation inhibitor compounds and validation of the results was accomplished by a thioflavin S<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> fluorescence assay where the emission of thioflavin S fluorescence is highly increased at 521 nm (excitation, 440 nm) in the presence of PHFs (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). This fluorescence increase is proportional to the extent of aggregation.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Thiflavin-S fluorescence assay for TAGIs identification (A) for compounds that inhibit aggregation of Tau into PHFs and (B) for compounds that disaggregate preformed PHFs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A library of 200 000 compounds was screened both for inhibition of Tau aggregation and for induced disassembly of Tau aggregates,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> an additional feature that is rarely considered among commonly screened compounds. The compound set used for the primary screen was selected according to Lipinski’s rules. Tau protein was incubated overnight under proaggregation conditions in the presence of the screened compound (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). After addition of thioflavin S, the aggregation was quantified by measurement at 440 nm excitation and 512 nm emission wavelengths. The secondary screen (disassembly of preformed Tau fibrils) was performed by incubation of PHFs in the presence or absence of compounds overnight at 37 °C followed by measurement of the ThS fluorescence of the remaining fibrils. The obtained <i>Z</i>-factor of 0.81 confirmed the reliability of the assay.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> The results were verified with other assays (electron microscopy, filter/pelleting assay) as well as with other Tau constructs and isoforms.</div><div class="NLM_p">In AD, Tau is not only aggregated but also highly phosphorylated, raising the question of the relationship between these two properties. It is often assumed that phosphorylation is a trigger for aggregation (hence, the search for kinase inhibitors as a means to prevent aggregation).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> However, the evidence remains ambiguous. The properties of phosphorylated Tau with regard to detachment from microtubules and aggregation into fibrils depend on a complex phosphorylation pattern, which might contribute or hinder the aggregation, depending on its extent and localization. The screening was performed with unphosphorylated recombinant Tau which provided fibers highly similar to those purified from brain tissues of Alzheimer patients and whose structure has been previously assessed by electron microscopy and spectroscopic methods, indicating that the in vitro aggregation is a reliable PHF model.<a onclick="showRef(event, 'ref127 ref128'); return false;" href="javascript:void(0);" class="ref ref127 ref128">(127, 128)</a></div><div class="NLM_p">In the primary ThS screen the compounds were tested for their potential self-fluorescence at the given excitation and emission wavelengths. All compounds that showed a higher fluorescence signal in the absence of protein than in the presence were excluded from further testing. To exclude possible quenching or ThS-displacement effects, the substances were also tested in “dye-free” assays such as pelleting and filter assays, intrinsic tryptophan fluorescence, or electron microscopy.</div><div class="NLM_p last">As mentioned above, the ability not only to inhibit Tau aggregation but also to disassemble preformed aggregates was included in the selection parameters for the screening of compounds, leading to the elimination of 99.96% of the library compounds. The identified hits were able to induce a PHF disassembly with up to 80% efficiency at 60 μM compound. These hits were classified in clusters according to their chemical structures. Details on the inhibitory activities obtained from the <i>N</i>-phenylamines, anthraquinones, phenylthiazolylhydrazides (PTHs), and thioxothiazolidinones (rhodanines) were described previously.<a onclick="showRef(event, 'ref72 ref129 ref130 ref131 ref132'); return false;" href="javascript:void(0);" class="ref ref72 ref129 ref130 ref131 ref132">(72, 129-132)</a> The chemistry primarily aimed at elucidating the requirements for improved inhibitory potencies led to the structure–activity relationship (SAR) of the two last mentioned compound clusters (PTHs and rhodanines). The compounds were subsequently tested on a neuronal cell model of Tau aggregation<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> and more recently proved to be effective in <i>C. elegans</i> expressing proaggregant Tau species<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> as well as in organic typical slices.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Polyphenols and Anthraquinones</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> </h3><div class="NLM_p"><b>Polyphenols</b> are characterized by the presence of one or more hydroxyl groups (−OH) bound to an aromatic benzene ring (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). These substances are often biosynthesized by plants, and dietary alimentation supplemented with green tea, chocolate, olive oil, or red wine is highly recommended by dieticians worldwide for their potential antibiotic, antidiabetic, or neuroprotective activities.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Pyrogallol generic substitution pattern commonly found in multiple polyphenolic Tau aggregation inhibitors such as <b>12</b> and <b>19</b>. Note the structural overlap with the inactive pyrocatechol-substituted epicatechin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As a result of HTS screen campaigns for amyloid aggregation inhibition, numerous polyphenols have been identified that inhibit aggregation of a wide variety of amyloidogenic peptides such as α-synuclein, IAPP, Aβ40, PrPsc, and Tau.<a onclick="showRef(event, 'ref65 ref112 ref136 ref137 ref138'); return false;" href="javascript:void(0);" class="ref ref65 ref112 ref136 ref137 ref138">(65, 112, 136-138)</a> For instance, myricetin<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> (<b>19</b>) has IC<sub>50</sub> = 1.2 μM on Tau aggregation inhibition and investigations on the binding mode in vitro clearly indicate that they interfere with the elongation phase in fibril assembly.<a onclick="showRef(event, 'ref66 ref139 ref140'); return false;" href="javascript:void(0);" class="ref ref66 ref139 ref140">(66, 139, 140)</a> In a comparable way, the polyphenol (−)-epi-gallocatechine gallate<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> (<b>12</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) was found to redirect the aggregation pathway of Aβ toward nontoxic spherical oligomers by binding to monomers or fibrillar species and was also found to inhibit the aggregation of a wide variety of other amyloidogenic proteins, such as α-synuclein, Aβ, prion protein PrP, yeast prion sup35, lysozyme, transthyretin, and Tau (IC<sub>50</sub> = 1.8 μM for Tau).<a onclick="showRef(event, 'ref65 ref111 ref112'); return false;" href="javascript:void(0);" class="ref ref65 ref111 ref112">(65, 111, 112)</a> We have performed experiments to determine the effect of <b>12</b> on different variants of Tau. In the case of the three-repeat construct K19, the antiaggregation IC<sub>50</sub> was at 3.9 μM, similar to the value described above. However, with full-length hTau40 the IC<sub>50</sub> value was in excess of >200 μM, i.e., 50-fold higher. This unexpected result can be explained if <b>12</b> has a high affinity to regions of Tau outside the repeat domain, which effectively “dilutes” the concentration of the compound by distributing it over the entire polypeptide chain. Similar “dilution” effects have been observed with a number of different compounds, depending on the distribution of low or high affinity binding sites along the length of the Tau chain (for examples, see ref <a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">141</a>). In this context, it is important to bear in mind that Tau is natively unfolded and thus offers many potential interaction sites for small molecules. These considerations emphasize the importance of defining which Tau construct or isoform and which conditions (concentration, buffer) are used in the assay.</div><div class="NLM_p">Catechins, specifically <b>12</b>, are present in high concentration in green tea leaves and grape seeds, and recent reports also confirmed the ability of grape seeds extracts to inhibit Tau at stoichiometric <b>12</b>/Tau concentration.<a onclick="showRef(event, 'ref142 ref143'); return false;" href="javascript:void(0);" class="ref ref142 ref143">(142, 143)</a> Although the extract is a complex mixture of polyphenols, it is reasonable to attribute this effect to <b>12</b> and pyrogallol (<b>17</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Strikingly, a comparative structure–activity relationship analysis between active and inactive polyphenols indicates that the gallate moiety is required for activity, since the gallate-free catechin itself was found to be inactive (<b>12</b> IC<sub>50</sub> = 1.8 μM, <b>18</b> IC<sub>50</sub> ≥ 200 μM, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> More specifically, trisubstituted phenols, a pattern also known as pyrogallol (red, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), are significantly enriched scaffolds within active polyphenolic aggregation inhibitors. Indeed, studies with <b>12</b> on Aβ aggregation inhibition indicate that the pyrogallol vicinal triols are required for inhibitory activity and that the compound loosely targeted hydrophobic areas in the Aβ peptide at positions 14–24 and 27–37.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Furthermore, epicatechin gallate, <b>12</b>, and gallocatechin gallate, which all contain the gallate moiety, were found to be active, whereas catechin and <b>18</b><a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> were not (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Surprisingly, epigallocatechin appeared inactive, in spite of presenting the pyrogallol moiety, hinting at additional binding determinants. However, this structure–activity relationship is broadly supported upon examination of 48 flavonoids evaluated on α-synuclein aggregation inhibition.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></div><div class="NLM_p">Finally, it is unexpected that the high polarity of flavonoids proves to be compatible with the highly hydrophobic regions in aggregated proteins, raising questions about their molecular interactions with the target. A plausible explanation has been proposed based on molecular dynamics with <b>19</b><a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> using the high resolution structure of Sup-35 obtained by X-ray microcrystallography. The obtained model indeed shows a coordination of the pyrogallol hydroxyl groups in <b>19</b> to the peptide backbone amides of GNNQQNY Sup-35.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div><div class="NLM_p">Lastly, the antiaggregation properties of polyphenols cannot be completely dissociated from their typical antioxidant and radical quenching activities. Pro-oxidant activities have also been reported under specific conditions, and the generation of radicals could also be involved in the observed antiaggregation effect. Issues about the specificity of action should be addressed before proceeding further with clinical investigations in order to avoid potential side effects through unspecific binding. From a clinical point of view, the oral bioavailability of polyphenols is notoriously variable, with the gylcosylated forms being the least absorbed because of their very high polarity, while few aglycone polyphenols proved to be extensively absorbed.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> For instance, the bioavailability of <b>12</b> and its BBB permeability is moderate, and it is not yet clear if <b>12</b> itself or metabolites were detected in the brain.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> However, the physicochemical characteristics of this compound class, especially their low log <i>P</i>, hold promise for lead development. Indeed, hydrophilicity is a valuable property frequently observed among drugs of natural origin but not among synthetic molecules which are typically highly hydrophobic and little specific.<a onclick="showRef(event, 'ref148 ref149 ref150'); return false;" href="javascript:void(0);" class="ref ref148 ref149 ref150">(148-150)</a></div><div class="NLM_p"><b>Anthraquinones</b> are close analogues of polyphenols in their oxidized quinone forms (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>A, red); however, upon reduction by NADP(H) in vivo or in vitro by reducing agents such as DTT, they become comparable to anthracene-type compounds such as <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>A, blue).<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Anthraquinones in oxidized (left, red) and reduced forms (right, blue) showing structural overlap with polyphenols and <b>1</b>. (B) Representative examples of anthraquinones identified as Tau aggregation inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Several anthraquinones display aggregation inhibition abilities on Tau and Aβ40 but are best known as intercalating cytostatics that are successfully used in anticancer therapies.<a onclick="showRef(event, 'ref65 ref139'); return false;" href="javascript:void(0);" class="ref ref65 ref139">(65, 139)</a> Precisely because of their DNA intercalating properties, anthraquinones must be handled with care. Our LDH cytotoxicity data confirm substantial toxicity in vitro.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> The ADME properties (absorption, distribution, metabolism, and excretion) of this compound class have been abundantly documented and also converge on their limited intestinal permeability. For this reason, highly hydrophilic anthracyclines such as <b>24</b><a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> (Adriamycin) equipped with a daunosamine sugar are generally administrated intravenously.<a onclick="showRef(event, 'ref151 ref152'); return false;" href="javascript:void(0);" class="ref ref151 ref152">(151, 152)</a> As mentioned above for parent anthracene compounds and <b>1</b>, the formation of reactive oxygen species (ROS) is well documented and was found to cause false positive hits in Tau aggregation assays in the presence of DTT.<a onclick="showRef(event, 'ref103 ref153'); return false;" href="javascript:void(0);" class="ref ref103 ref153">(103, 153)</a> However, this effect is highly variable, and daunorubicin or doxorubicin<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> appeared DTT insensitive. In our own screen performed without DTT, several anthraquinones indeed appeared as potent TAGIs. The five compounds depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>B were all able to inhibit the aggregation of the K19 Tau construct and to induce the disaggregation of preformed aggregates, with IC<sub>50</sub> values between 1.1 and 2.4 μM and DC<sub>50</sub> values (disassembly inducing half-maxima) between 2.2 and 3.8 μM, irrespective of the molecular substitution pattern.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> Several anthraquinones have been assayed on various Tau constructs, such as wtK19 (three repeat Tau), wtK18 (four repeat), K18ΔK280 (proaggregant four-repeat Tau), as well as full length hTau24 and fetal three-repeat isoform hTau23. As expected from previous studies indicating that the four repeat K18 is less amyloidogenic than the three repeat K19, anthraquinones more potently inhibited the aggregation of wtK18 than wtK19.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Moreover, decreased potency with the proaggregation mutant K18ΔK280 versus wtK18 supports the expected aggregation-promoting effect of the ΔK280 mutation. The overall potencies for inhibition of aggregation with hTau23 and hTau24 were of comparable magnitude with inhibition of the repeat domain constructs except for <b>20</b><a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> and <b>22</b>,<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> which appeared unable to inhibit hTau24 aggregation, suggesting that their mode of action might not be shared by the other anthraquinones. Indeed, their vicinal diols and triols are reminiscent of pyrogallol described above for polyphenols (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Finally, compounds showing potency in Tau aggregation inhibition did not necessarily show activity in Tau depolymerisation, raising questions about the respective mechanisms. Lastly, a pharmacophore mapping with several anthraquinones known as Aβ aggregation inhibitors yielded a three-point model with aromatic rings bound to hydrophobic regions and the sugar moiety supporting hydrogen bond donors and acceptors.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Rhodanine-Based Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81662" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81662" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Rhodanines were identified as TAGIs in our screen, and the scaffold was further explored via the synthesis of a focused library.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> The structure–activity relationship (SAR) was obtained following modifications on the heterocycle core itself. Rhodanines (R<sub>1</sub> = S and R<sub>2</sub> = S, <b>25</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>), thiohydantoin (R<sub>1</sub> = S and R<sub>2</sub> = N), thioxooxazolidine (R<sub>1</sub> = S and R<sub>2</sub> = O), oxazolidinedione (R<sub>1</sub> = O and R<sub>2</sub> = O), and hydantoin (R<sub>1</sub> = O and R<sub>2</sub> = N) were synthesized and assayed for activity on Tau aggregation inhibition and disaggregation of preformed Tau aggregates as described above.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (A) Heterocyclic core with variations on heteroatoms (R<sub>1</sub> and R<sub>2</sub>) and on the flanking substituents (R<sub>3</sub> and R<sub>4</sub>). (B) Representative examples of rhodanine aggregation inhibitors (R<sub>1</sub> = R<sub>2</sub> = S). IC<sub>50</sub> and DC<sub>50</sub> activities were determined on the Tau construct K19.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Rhodanines appeared to be the most potent aggregation inhibitors, while hydantoins were the least active (IC<sub>50</sub> = 22.6 μM).<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> The depolymerization of preformed Tau fibrils was also evaluated, with the objective to obtain compounds having the ability to clear up the cells of their tangle load. Gratifyingly, the disassembly inducing half-maxima (DC<sub>50</sub>) were recorded in the low micromolar range (DC<sub>50</sub> = 0.1 μM). The mode of action of this compound class is, however, still poorly understood. As described above for polyphenols, hydrogen bonds might play a predominant role. Indeed, the rhodanine core is sometimes considered as a carboxylic acid bioisoster, able to engage in hydrogen bond and van der Waals interactions.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Furthermore, the analysis of the substitution pattern on the flanking regions (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) showed preference for hydrogen bond donors and acceptors such as nitro groups, carboxylic acids, phenols, sulfonates/sulfonamides.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Interestingly, modifications of the side chains allowed observation of pronounced sensitivity toward the electron density distribution with, for instance, divergent activities between the furan ring in <b>26</b><a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> and thiophene in <b>27</b><a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). The presence of aromatics on the side chain was also important, suggesting hydrophobic interactions and/or π-stacking.<a onclick="showRef(event, 'ref66 ref155'); return false;" href="javascript:void(0);" class="ref ref66 ref155">(66, 155)</a> Next, we investigated the ADME profile of selected rhodanines in order to obtain compounds suitable for in vivo investigations. The rhodanine scaffold has a fair safety profile, according to numerous reports resulting from their evaluation in multiple assays.<a onclick="showRef(event, 'ref156 ref157 ref158 ref159 ref160 ref161 ref162 ref163 ref164 ref165 ref166'); return false;" href="javascript:void(0);" class="ref ref156 ref157 ref158 ref159 ref160 ref161 ref162 ref163 ref164 ref165 ref166">(156-166)</a> However, the pleiotropism of rhodanines might be linked to undesirable chemical properties such as a susceptibility for covalent binding through conjugate addition to cysteins, calling for caution.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> In an LDH assay, we assessed an acceptable safety profile with low cell toxicity (2–8%, LDH assay in N2A cells, incubation for 24 h at 10 μM compound) and determined the highest inhibitory potency on cells with charge-neutral benzimidazole <b>28</b><a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). Interestingly, the bioavailability and safety of a close structural analogue, epalrestat, have been extensively documented following a clinical study on diabetic neuropathy (3 years, 150 mg/day oral administration).<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> The extracted data support an acceptable pharmacologic profile (100 ± 22% bioavailability<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> and peak plasma concentration at 4.0 ± 0.9 μg/mL at 1.7 h after administration of a 50 mg oral dose, plasma half-life of 102 min).<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Others have reported results from in vitro pharmacokinetic evaluations in line with our own data, showing an overall suitable profile for in vivo investigations.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a></div><div class="NLM_p last">Subsequently, investigations on a cell model of tauopathy allowed evaluation of the protective capabilities of rhodanine-based TAGIs against Tau-aggregation-induced cytotoxicity. Indeed, a major concern with disaggregation or inhibition of aggregation is the potential formation and stabilization of cytotoxic oligomers.<a onclick="showRef(event, 'ref79 ref170'); return false;" href="javascript:void(0);" class="ref ref79 ref170">(79, 170)</a> The compounds were therefore tested on neuroblastoma N2a cell lines expressing the FTDP-17 proaggregation mutation ΔK280. Although the multimeric composition of Tau after incubation with rhodanines was not assessed, incubation of inducible N2a K18ΔK280 cells with compound <b>28</b> resulted in a clear reversal of toxicity caused by Tau aggregation,<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> an observation recently confirmed in vivo on <i>C. elegans</i> expressing proaggregant Tau species<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> as well as in a organotypic slice model derived from inducible Tau-transgenic mice.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Phenylthiazolylhydrazide Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">On the basis of hits obtained in an initial screen of 200 000 compounds, a ligand-based virtual screening yielded phenylthiazolylhydrazides (PTHs).<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> For this, a training set of 21 active compounds was selected in different chemical classes. The obtained pharmacophore model showed two aromatic rings at R<sup>1</sup> and R<sup>3</sup>, a hydrophobic region on the thiazole ring and a hydrogen bond acceptor on the carboxyl amide (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>A).</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) Pharmacophore applied to phenylthiazolylhydrazide (PTH) class of Tau aggregation inhibitors. (B) STD-NMR signals indicating compound–Tau interaction spots on <b>29</b>. (C) Pyrogallo-hybrid PTH <b>30</b> developed as a Tau binder and as a Tau aggregation inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The phenylthiazolylhydrazide scaffold was selected as best fit for further development through chemical modifications at R<sup>1</sup>–R<sup>3</sup>, providing <b>29</b><a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> with gratifying activity at substochiometric inhibitor/Tau concentration (IC<sub>50</sub> = 1.6 μM and DC<sub>50</sub> = 0.7 μM at 10 μM K19). Valuable information about the binding mode of PTHs could be obtained using STD-NMR.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> In this experiment, the saturation of the proton signals of the receptor (K18 Tau) transfers to its ligand (<b>29</b>) upon binding, resulting in the attenuation of the signal intensity of the ligands. The data indicate that <b>29</b> binds directly to monomeric Tau, probably shifting the Tau conformation toward off-pathway species, a mode of action reminiscent of <b>12</b> and Aβ as described above for polyphenols. The observed STD effects with <b>29</b> indicate a direct binding to K18 mediated through the aromatic ring of the imidazole ring, involving hydrophobic interactions reinforced by hydrogen bonding with the nitroaromatic and imidazole amines (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>B).<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> Moreover, the STD-NMR experiments allowed the determination of the dissociation constant for <b>29</b> (<i>K</i><sub>d</sub> = 62 ± 12 μM), and complementary experiments using surface plasmon resonance (SPR) with immobilized K18 showed a fast 3700 M<sup>–1</sup>·s<sup>–1</sup> association rate. Interestingly, the binding of <b>29</b> was found to be incompletely reversible on SPR, suggesting some level of covalent binding, although the PTH scaffold does not present any obvious Michael acceptor site.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a></div><div class="NLM_p">Recently, derivatives combining the hydrazine moiety with the above-described pyrogallol moiety have been reported (<b>30</b>,<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>C). Several derivatives displayed a marked selectivity for Tau versus Aβ aggregation inhibition, thereby providing efficient stains for histochemical studies.</div><div class="NLM_p last">From a pharmacokinetic aspect, numerous bioactive thiazolylhydrazide scaffolds have been reported in the literature because of their analgesic, antibacterial, antifungal, or antiproliferative activities.<a onclick="showRef(event, 'ref173 ref174 ref175'); return false;" href="javascript:void(0);" class="ref ref173 ref174 ref175">(173-175)</a> However, the scaffold might be sensitive to cyp P450-mediated oxidative cleavages on both the thiazole and hydrazine moieties.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> Hydrazine/hydrazides are also potential producers of radical oxidative species (ROS) following oxidative cleavage of the hydrazine N–N bond. The formation of reactive acyl radicals has been reported for the antituberculosis isoniazid and will require further testing.<a onclick="showRef(event, 'ref177 ref178 ref179 ref180 ref181 ref182'); return false;" href="javascript:void(0);" class="ref ref177 ref178 ref179 ref180 ref181 ref182">(177-182)</a></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10"><i>N</i>-Phenylamine Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62816" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62816" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Further TAGIs were identified in the <i>N</i>-phenylamines compound class.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Their structure–activity relationship is reminiscent of the one described above for rhodanines and PTHs, with strong involvement of hydrogen bonds presented by nitro/carboxylic acids combined with hydrophobic interactions provided by the aromatic rings. Structurally comparable compounds such as the carbazole <b>33</b><a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>) have been identified as Aβ aggregation inhibitors, for which an in silico pharmacophore mapping confirmed hydrophobic and hydrogen bond contributions.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Representative examples of <i>N</i>-phenylamine Tau aggregation inhibitors and structural overlap with the Aβ40 aggregation inhibitor <b>33</b> or the nonsteroidal anti-inflammatory drug <b>34</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Chemically, the nonplanar conformation linked to the rotation axis around the carbon–nitrogen bond translates into lower potencies in vitro and in cells compared to the two compound classes discussed above (rhodanines and phenylthiazolylhydrazides). Although the pharmacokinetic properties of this compound class have not been reported, the similarities with anthranilic acids used as nonsteroidal anti-inflammatory drugs (niflumic acid and <b>34</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>) might suggest some level of toxicity at high doses. The presence of anilines might also raise safety issues linked to their liver oxidation by cyp P450.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a></div><div class="NLM_p last">The activities of <i>N</i>-phenylamine TAGIs were investigated on an inducible N2a cell model of tauopathy. Using the aggregation-promoting property of the proaggregant mutation ΔK280, neuroblastoma N2a cells expressing the four repeat Tau repeat domain K18ΔK280 gradually form PHFs. Upon incubation with 10 μM <b>32</b><a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> over 5 days, the ThS signal in cells decreased by 70% compared to untreated control and, most importantly, cell viability returned to normal as assessed by LDH release.</div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Benzothiazoles</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36250" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36250" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Benzothiazoles are heteroaromatic structures with a 1,3-thiazole ring, found in well-known histology dyes such as ThS and ThT<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> or cyanine dyes (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>) and display high affinities for β-sheet structures.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Benzothiazole-based Tau aggregation inhibitors (<b>35</b>, <b>36</b>, and <b>37</b>) and Tau NFT binders (<b>38</b> and <b>39</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Cyanine dyes are characterized by a polymethine chain linking two benzothiazoles, and several have been identified as Aβ and Tau aggregation inhibitors.<a onclick="showRef(event, 'ref65 ref185'); return false;" href="javascript:void(0);" class="ref ref65 ref185">(65, 185)</a> Some benzothiazoles-based TAGIs present a cationic charge on the nitrogen, but this feature might not be essential for activity and probably only contributes to the planarity of the structure. Indeed, a charge-neutral ThT analogue, Pittsburgh compound B<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> (<b>39</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>), has an increased affinity toward Aβ40 compared to parent <b>38</b> (<i>K</i><sub>i</sub>(PiB) = 20 nM vs <i>K</i><sub>i</sub>(ThT) = 890 nM).<a onclick="showRef(event, 'ref184 ref186 ref187 ref188 ref189'); return false;" href="javascript:void(0);" class="ref ref184 ref186 ref187 ref188 ref189">(184, 186-189)</a></div><div class="NLM_p">An interesting structure–activity relationship has been reported for cyanine dyes after the synthesis of <b>35</b><a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> (IC<sub>50</sub> = 300 nM at 4 μM N2R4 hTau, Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>). Several modifications of the structure were found to drastically influence the Tau aggregation inhibitory potency when located at the thiazole heterocyle or at the polymethine bridge.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Therefore, it has been proposed that the potency of benzothiazole-based TAGIs might correlate with the π-electron density distribution on the molecule rather than with classical coordination through hydrophobic interaction or hydrogen bonds. In this context, a push–pull type polarizability might be required for inhibitory activity.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> Unfortunately, this type of architecture often correlates with compounds that self-assemble face-to-face, also known as <i>H</i>-aggregation. A loss of inhibitory activity with <b>35</b> has been reported at high concentrations, caused indeed by the formation of <i>H</i>-aggregates. At low concentrations, <b>35</b> behaves as a TAGI by interfering with the fibril elongation phase, but at ≥30 μM the <b>35</b><i>H</i>-aggregates were observed to enhance Tau aggregation. To confirm the impact of inhibitor self-assembly, <b>35</b> was modified to provide a structure able to readily form a dimer through a closed clamshell structure (<b>36</b><a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> and <b>37</b>,<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>). The dimeric conformation suppressed the activity, consistent with the loss of activity of the <i>H</i>-aggregated form of the compound. This finding has been recently confirmed by changing the length of the linker (in red, Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>). In these experiments, compounds with four methylene units, a linker length known to hinder the closed monomer conformation, appeared more potent than the parent compound <b>36</b> with five methylene units favoring the closed conformation.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a></div><div class="NLM_p last">The pharmacology of benzothiazoles is relatively well documented owing to the use of <b>39</b> as imaging agent for in vivo amyloid deposition<a onclick="showRef(event, 'ref186 ref187 ref188'); return false;" href="javascript:void(0);" class="ref ref186 ref187 ref188">(186-188)</a> or to the prescription of the benzothiazole drug riluzole<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> for amyotrophic lateral sclerosis (NMDA receptor antagonist). Riluzole presents a satisfactory 60% bioavailabilty after oral ingestion with a 2 h peak plasma concentration, and a 12 h half-life supports a good in vivo stability.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> The BBB permeability has been confirmed by HPLC analysis on mice brain extracts; however, the drug was also found to be a substrate for PgP efflux transporters.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> On the other hand, the influence of the polymethine bridge is poorly documented and might be prone to first pass metabolism. Cyanine dyes might also complex to DNA.<a onclick="showRef(event, 'ref194 ref195'); return false;" href="javascript:void(0);" class="ref ref194 ref195">(194, 195)</a> Indeed, numerous cyanine dyes are routinely used in laboratories as molecular probes for staining of nucleic acids and mitochondria.<a onclick="showRef(event, 'ref196 ref197'); return false;" href="javascript:void(0);" class="ref ref196 ref197">(196, 197)</a> Finally, the low reduction potential of cyanine dyes impedes a potential involvement in redox cycling, a desirable characteristic too often neglected in drug development.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a></div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Aminothienopyridazines</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63731" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63731" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Aminothienopyridazines (APTZs) have been recently identified as potent inhibitors of P301L K18 Tau aggregation from the screening of a library of 292 000 compounds.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> The finding was confirmed by complementary assays such as fluorescence polarization (FP), sedimentation, and electron microscopy, leading to the selection of two APTZs as lead candidates (<b>41</b><a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> IC<sub>50</sub> = 5.1 μM and <b>42</b><a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> IC<sub>50</sub> = 6.3 μM at 15 μM K18P301L Tau, Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>).</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Aminothienopyridazines (APTZs) Tau aggregation inhibitors (<i>B</i>/<i>P</i>: blood to plasma ratio).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Besides validating similar kinetics of Tau aggregation with ThT and FP assays, it is expected that FP might help select inhibitors for the initial stage of Tau self-assembly. Analysis by size-exclusion chromatography (SEC) of the supernatant after incubation of hTau40 with APTZs did actually show the presence monomeric Tau but also the presence of stabilized oligomeric forms.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Therefore, the data suggest that APTZ prevent Tau aggregation by sequestering oligomers or more likely by remodeling oligomers toward off-pathway structures devoid of β-sheet structures, comparable to the mode of action reported above for <b>12</b> on Aβ.</div><div class="NLM_p">The further medicinal chemistry efforts in synthesis of a diversity-oriented library of APTZs allowed tracing of their structure–activity relationship, showing an interesting tolerability at the C1 position (<b>40</b>,<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>), which allowed for tuning of the pharmacokinetic properties by introduction of esters, carboxylic acids, and amides.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> By contrast, the thiophene ring and the <i>N</i>-phenylaromatic appeared to be very sensitive to modifications. As for cyanine dyes described above, polarizability through mesomeric effects might be involved, since para-substitutions with mesomeric donors such as −F, −Cl, and −OMe were well tolerated, while mesomeric acceptors such as −COOEt appeared detrimental.<a onclick="showRef(event, 'ref124 ref199'); return false;" href="javascript:void(0);" class="ref ref124 ref199">(124, 199)</a></div><div class="NLM_p last">The APTZs were checked for red flags generally associated with promiscuous inhibitors and successfully passed tests aimed at filtering unspecific interactions mediated through <i>H</i>-aggregation or redox cycling activity. Although the compounds share some minor structural similitudes with hydrazinophtalazines and PTHs, ATPZs were found to be nontoxic up to 100 μM.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Further efforts to improve their use in vivo focused on the BBB permeability, leading to APTZs <b>43</b><a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> and <b>44</b><a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> with IC<sub>50</sub> = 5.9 μM and IC<sub>50</sub> = 8.1 μM, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>).<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> These TAGIs were capable of reaching significant brain concentration in mice after oral or iv administration at 2 mg/kg, and compound <b>44</b> presented an excellent blood/plasma ratio (<i>B</i>/<i>P</i> = 1.6) and a 2.5 h half-life. Unfortunately, the low water solubility of the compound (32 μM) demanded further development, leading to <b>45</b><a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> with improvements in both solubility (≥200 μM) and potency (IC<sub>50</sub> = 2.5 μM at 20 μM K18 P301L, Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>), while the <i>B</i>/<i>P</i> ratio slightly deteriorated (<i>B</i>/<i>P</i> = 1.09).<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> However, lipophilic character generally correlates well with plasma binding, and <b>45</b> was indeed found sequestered at 95.7%. At 50 mg<sup>–1</sup> kg<sup>–1</sup> day<sup>–1</sup> orally, free unbound <b>45</b> concentration in the brain was therefore below Tau stoichiometry (according to the author’s calculations). Yet the calculated concentration equals twice the IC<sub>50</sub> value granting significant target engagement. With all the attractive features described above and only marginal toxicity at a 50 mg<sup>–1</sup> kg<sup>–1</sup> day<sup>–1</sup> dose, the compound might be suitable for proof of concept studies in vivo.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a></div></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46207" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46207" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Inhibition of protein–protein interactions (PPIs) is generally considered particularly challenging. Although some 650 000 PPIs are known to be involved in a cell’s organization, only a minute fraction has been addressed pharmacologically.<a onclick="showRef(event, 'ref30 ref73 ref201 ref202'); return false;" href="javascript:void(0);" class="ref ref30 ref73 ref201 ref202">(30, 73, 201, 202)</a> Yet eminent examples are paving the way, starting with colchicines or paclitaxel, well-known inhibitor and promoter of microtubule assembly, commonly used in cancer chemotherapy. It is anticipated that comparable approaches could succeed in AD.<a onclick="showRef(event, 'ref203 ref204'); return false;" href="javascript:void(0);" class="ref ref203 ref204">(203, 204)</a> However, difficulties in the development of protein–protein interaction inhibitors arise from the unfortunate conjunction of two factors, the first being the inadequate composition of the commercial small molecule libraries for HTS. Indeed, several decades of optimization for inhibitors typically directed toward enzymatic active sites might have biased the current compound libraries toward scaffolds not necessarily adapted for the inhibition of PPIs. The second limiting factor is directly linked to the nature of the PPIs interface. The relatively flat surfaces involved in protein–proteins interactions, averaging 2000 Å<sup>2</sup>, are typically much larger than the 60 Å<sup>2</sup> average surface of small molecules.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> Fortunately, vulnerable areas with high binding free energy, named hot spots, could be occasionally identified at the protein–protein interface, raising hopes about the druggability of such targets.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> Previous investigations on Tau indicated the presence of such hot spots localized within the hexapeptide motif and support the feasibility of Tau aggregation inhibition with small molecules.<a onclick="showRef(event, 'ref57 ref69'); return false;" href="javascript:void(0);" class="ref ref57 ref69">(57, 69)</a> Although the inhibitors reviewed here might target such area at the Tau-Tau interface, further investigations will be required to delineate with high resolution the Tau binding spot for TAGIs.</div><div class="NLM_p">While several compounds redirect the self-assembly toward off-pathway oligomeric forms, compounds binding to and stabilizing monomeric Tau in solution are scarce. With intrinsically disordered proteins such as Tau and Aβ, rational design of suitable binders indeed proves to be very challenging because of lack of epitopes. However, the 1:1 inhibitor/Tau stoichiometry often observed for maximal aggregation inhibition might point at significant binding to monomeric Tau, perhaps by recognition of the paper-clip-like folded state in solution.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> For instance, the binding spots observed by STD-NMR involving a PTH inhibitor and the monomeric Tau peptide, as depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>B, illustrate that a direct interaction between small molecules and soluble monomeric peptides might be common among aggregation inhibitors and disaggregation promoters<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> However, binders from the thioflavin family such as <b>38</b> have been reported to only bind to aggregate forms, showing that multiple binding modes are likely.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a> Thioflavin S stains only fibrillar Tau aggregates but not small Tau oligomers, suggesting that the dye binds to large surfaces with ordered protein motifs (e.g., β sheets).</div><div class="NLM_p">Compounds that bind to soluble monomeric Tau might lock the protein in an aggregation-incompetent state, thus explaining their ability to inhibit aggregation. However, the mode of action for compounds binding to oligomers and fibrils appears more obscure. Moreover, discrepant potencies between Tau aggregation inhibition and disaggregation indicate two different modes of action for inhibition or disaggregation. Studies performed with fluorescently labeled Aβ fibrils in the presence of compound <b>12</b> were particularly instructive in that matter, showing a direct remodeling of the fibril itself, via an undetermined mechanism.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div><div class="NLM_p">To gain further insights into the mode of action of TAGIs, the cocrystallization of inhibitors with their targets for X-ray analysis would provide direct evidence. However, alternative methods must be considered because of difficulties in obtaining crystalline materials with intrinsically disordered proteins such as Tau. A palliative solution circumventing the issue came with the determination of the Tau hexapeptide motifs responsible for aggregation.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Microcrystallization of this segment provided a simplified model for full-length Tau aggregates and allowed elucidation of the binding mode of three amyloid binders at atomic resolution. Among several investigated compounds, <b>46</b>,<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a><b>47</b>,<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> and the dialkylaminonaphthylethylidene (<b>48</b>,<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>) are known to bind to PHFs with high affinity and to also inhibit Tau aggregation at high concentrations,<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> whereas <b>47</b> is a polyphenolic stilbene and <b>48</b> shares the push–pull electronic architecture described above for benzothiazoles or APTZs (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>A).</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. (A) Chemical structures of amyloid binders Orange G, curcumin, and DDNP. (B) Binding mode of depicted compounds to Tau VQIVYK fibers obtained by X-ray microcrystallography (left, <b>46</b>; right, <b>47</b>/<b>48</b>).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">According to X-ray microcrystallography, all three compounds were found positioned with their long axis parallel to the fiber axis. Furthermore the binding modes could be sorted into two classes, depending on the ability of the compounds to engage in hydrogen bonding. While the binding of charged compounds such as <b>46</b> appeared largely mediated through electrostatic interaction between sulfonates on <b>46</b> and Tau lysines, neutral or hydrophobic compounds such as <b>47</b> and <b>48</b> enter a hydrophobic tubelike cavity running parallel to the fiber axis (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>B).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> In line with this model, a comparable binding mode for <b>38</b> has been recently reported on crystallized β2-microglobulin.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> The compound’s arrangement parallel to the fibril axis is also supported by recent NMR investigations and appears consistent with previous investigations using Congo red.<a onclick="showRef(event, 'ref207 ref211 ref212'); return false;" href="javascript:void(0);" class="ref ref207 ref211 ref212">(207, 211, 212)</a> These investigations also predicted electrostatic interactions between positively charged residues on the fibril and the negatively charged sulfonic acids on Congo red. The binding was proposed to span perpendicularly across five peptide chains, based on the 19 Å distance between the Congo red sulfonic acids.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a></div><div class="NLM_p">A powerful approach to analyze Tau–inhibitor interactions on full-length Tau comes from NMR spectroscopy, following the recent assignment of nearly all residues in Tau.<a onclick="showRef(event, 'ref55 ref214'); return false;" href="javascript:void(0);" class="ref ref55 ref214">(55, 214)</a> This permits mapping of the regions of Tau interacting with small molecules, proteins (e.g., microtubules), other interactors,<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a> or Tau itself, embedded in the structure of paired helical filaments.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p last">Altogether, perceptible progress has been achieved after years of collective efforts aimed at deciphering the mode of action of TAGIs, as well as developing compounds with improved pharmacokinetic profiles. With several Aβ-aggregation inhibitors now facing clinical trials, it is about time to promote in vivo proof of concept studies for TAGIs.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm3017317" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84305" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84305" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruno Bulic</span> - <span class="hlFld-Affiliation affiliation">Laboratory of Organic Synthesis of Functional
Systems, Humboldt-Universität zu Berlin, Brook-Taylor-Strasse 2, 12489 Berlin, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5b39292e353475392e3732381b332e76393e29373235753f3e"><span class="__cf_email__" data-cfemail="d6b4a4a3b8b9f8b4a3babfb596bea3fbb4b3a4babfb8f8b2b3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcus Pickhardt</span> - <span class="hlFld-Affiliation affiliation">DZNE (German Center for Neurodegenerative
Diseases), Ludwig-Erhard-Allee 2, 53175 Bonn, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eckhard Mandelkow</span> - <span class="hlFld-Affiliation affiliation">DZNE (German Center for Neurodegenerative
Diseases), Ludwig-Erhard-Allee 2, 53175 Bonn, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">CAESAR Research Center, Ludwig-Erhard-Allee 2, 53175 Bonn, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Max-Planck-Institute for Neurological
Research, Hamburg Outstation, c/o DESY, Notkestrasse
85, 22607 Hamburg, Germany</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12722" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12722" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Bruno Bulic</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=BIO-d7e2113-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Bruno Bulic</b> received his M.Sc. in Chemistry and Bioorganic Chemistry from the Paris VI University while working with Prof. J. P. Genet on the synthesis of ambruticine. Thereafter, he joined the group of Prof. A. Pflatz (Basel, Switzerland) and received his Ph.D. in 2004 on metal-catalyzed asymmetric reactions. He was then awarded a postdoctoral grant from the Max-Planck Society to work with Prof. H. Waldmann (Dortmund, Germany) and Prof. Mandelkow and selected as group leader in 2006 with research focus on the development of Tau aggregation inhibitors for Alzheimer’s disease. In 2009 he established his independent research group “Chemical Biology of Neurodegenerative Diseases” at the CAESAR Institute (Bonn, Germany) and is currently at Humboldt-Universität zu Berlin, Germany.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Marcus Pickhardt</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=BIO-d7e2118-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Marcus Pickhardt</b> received his Diploma in Microbiology from the University Göttingen, Germany, in the group of Professor H. G. Schlegel. He joined the group of Professor R. Thomssen at the Department of Virology at Institute of Medicinal Microbiology  in Göttingen, Germany, and received his Ph.D. on structural analysis of the hepatitis C virus surface proteins. In 1998 he guided a project on high sensitive detection of PML (progressive multifocal leukoencephalopathy) virus in human CSF. Since 2000 he has been a Research Scientist in the group of Prof. E. Mandelkow at the Max-Planck Institute for Structural Molecular Biology, Hamburg, Germany, and at the German Center for Neurodegenerative Disease (DZNE), Bonn, Germany. He is working at the screening and development of protein aggregation inhibitors for Alzheimer’s disease.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Eckhard Mandelkow</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=BIO-d7e2123-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Eckhard Mandelkow</b> studied physics in Braunschweig (Germany), New Orleans (U.S.), and Hamburg (Germany) and received his Ph.D. at the Max-Planck-Institute for Medical Research in Heidelberg, Germany (X-ray structure analysis of viruses). After postdoctoral training at Brandeis University, MA, U.S. (structural studies on cytoskeletal fibers), he received his habilitation at the University of Heidelberg and in 1986 became Director at the Max-Planck-Unit for Structural Molecular Biology at DESY in Hamburg and Professor at Hamburg University. In 2011 he became Principal Investigator at the German Center for Neurodegenerative Diseases (DZNE) at the CAESAR Research Center, Bonn, Germany. His research focusses on the structures and roles of cytoskeletal proteins (notably Tau, motor proteins, protein kinases) in neurodegenerative diseases. He is co-recipient of the Metlife Award and the Potamkin Award for Alzheimer research.</p></figure></div><div class="ack" id="ACK-d7e2128-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73622" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73622" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Eva-Maria Mandelkow (DZNE and CAESAR, Bonn, Germany), Herbert Waldmann (MPI Dortmund, Germany), Hans Boerner (HU Berlin, Germany), and R. Heiner Schirmer (University of Heidelberg, Germany) for valuable suggestions and support. This work was supported by MPG, VW Foundation, and Wellcome Trust/MRC.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i18" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i18"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i19" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i19"> Abbreviations Used</h2><tr><td class="NLM_term">ADAS</td><td class="NLM_def"><p class="first last">Alzheimer disease assessment scale</p></td></tr><tr><td class="NLM_term">APTZ</td><td class="NLM_def"><p class="first last">aminothienopyridazine</p></td></tr><tr><td class="NLM_term">DC<sub>50</sub></td><td class="NLM_def"><p class="first last">disassembly inducing half-maxima</p></td></tr><tr><td class="NLM_term">EGCG</td><td class="NLM_def"><p class="first last">epi-gallocatechine gallate</p></td></tr><tr><td class="NLM_term">EPR</td><td class="NLM_def"><p class="first last">electron paramagnetic resonance</p></td></tr><tr><td class="NLM_term">FITC</td><td class="NLM_def"><p class="first last">fluorescein isothiocyanate</p></td></tr><tr><td class="NLM_term">GAG</td><td class="NLM_def"><p class="first last">glycosaminoglycan</p></td></tr><tr><td class="NLM_term">LDH</td><td class="NLM_def"><p class="first last">lactate dehydrogenase</p></td></tr><tr><td class="NLM_term">MCI</td><td class="NLM_def"><p class="first last">mild cognitive impairment</p></td></tr><tr><td class="NLM_term">ND</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">NFT</td><td class="NLM_def"><p class="first last">neurofibriallary tangle</p></td></tr><tr><td class="NLM_term">PHF</td><td class="NLM_def"><p class="first last">paired helical filament</p></td></tr><tr><td class="NLM_term">PTH</td><td class="NLM_def"><p class="first last">phenylthiazolylhydrazide</p></td></tr><tr><td class="NLM_term">STD</td><td class="NLM_def"><p class="first last">saturation transfer difference</p></td></tr><tr><td class="NLM_term">TAGI</td><td class="NLM_def"><p class="first last">tau aggregation inhibitor</p></td></tr><tr><td class="NLM_term">ThS</td><td class="NLM_def"><p class="first last">thioflavin S</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50413" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50413" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 215 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lilguKEZfB4UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span> </span><span class="NLM_article-title">Neuropathological stageing of Alzheimer-related changes</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1007%2FBF00308809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=1759558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1991&pages=239-259&author=H.+Braakauthor=E.+Braak&title=Neuropathological+stageing+of+Alzheimer-related+changes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathological stageing of Alzheimer-related changes</span></div><div class="casAuthors">Braak H; Braak E</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-59</span>
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    </div><div class="casAbstract">Eighty-three brains obtained at autopsy from nondemented and demented individuals were examined for extracellular amyloid deposits and intraneuronal neurofibrillary changes.  The distribution pattern and packing density of amyloid deposits turned out to be of limited significance for differentiation of neuropathological stages.  Neurofibrillary changes occurred in the form of neuritic plaques, neurofibrillary tangles and neuropil threads.  The distribution of neuritic plaques varied widely not only within architectonic units but also from one individual to another.  Neurofibrillary tangles and neuropil threads, in contrast, exhibited a characteristic distribution pattern permitting the differentiation of six stages.  The first two stages were characterized by an either mild or severe alteration of the transentorhinal layer Pre-alpha (transentorhinal stages I-II).  The two forms of limbic stages (stages III-IV) were marked by a conspicuous affection of layer Pre-alpha in both transentorhinal region and proper entorhinal cortex.  In addition, there was mild involvement of the first Ammon's horn sector.  The hallmark of the two isocortical stages (stages V-VI) was the destruction of virtually all isocortical association areas.  The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIZP19xbDelK_dlEzl_fBafW6udTcc2eb1lSjB0b4n1Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D&md5=b3e2663c943c202f121efeb65527a280</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2FBF00308809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00308809%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DBraak%26aufirst%3DE.%26atitle%3DNeuropathological%2520stageing%2520of%2520Alzheimer-related%2520changes%26jtitle%3DActa%2520Neuropathol.%26date%3D1991%26volume%3D82%26spage%3D239%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Rapoport, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitek, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, A.</span><span> </span><span class="NLM_article-title">Tau is essential to beta-amyloid-induced neurotoxicity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">6364</span><span class="NLM_x">–</span> <span class="NLM_lpage">6369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=6364-6369&author=M.+Rapoportauthor=H.+N.+Dawsonauthor=L.+I.+Binderauthor=M.+P.+Vitekauthor=A.+Ferreira&title=Tau+is+essential+to+beta-amyloid-induced+neurotoxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRapoport%26aufirst%3DM.%26aulast%3DDawson%26aufirst%3DH.%2BN.%26aulast%3DBinder%26aufirst%3DL.%2BI.%26aulast%3DVitek%26aufirst%3DM.%2BP.%26aulast%3DFerreira%26aufirst%3DA.%26atitle%3DTau%2520is%2520essential%2520to%2520beta-amyloid-induced%2520neurotoxicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D6364%26epage%3D6369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Roberson, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palop, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer’s disease mouse model</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">750</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=750-754&author=E.+D.+Robersonauthor=K.+Scearce-Levieauthor=J.+J.+Palopauthor=F.+Yanauthor=I.+H.+Chengauthor=T.+Wuauthor=H.+Gersteinauthor=G.+Q.+Yuauthor=L.+Mucke&title=Reducing+endogenous+tau+ameliorates+amyloid+beta-induced+deficits+in+an+Alzheimer%E2%80%99s+disease+mouse+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoberson%26aufirst%3DE.%2BD.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DPalop%26aufirst%3DJ.%2BJ.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DCheng%26aufirst%3DI.%2BH.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DGerstein%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DG.%2BQ.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DReducing%2520endogenous%2520tau%2520ameliorates%2520amyloid%2520beta-induced%2520deficits%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D750%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hutton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, E.</span><span> </span><span class="NLM_article-title">Analysis of tauopathies with transgenic mice</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=467-470&author=M.+Huttonauthor=J.+Lewisauthor=D.+Dicksonauthor=S.+H.+Yenauthor=E.+McGowan&title=Analysis+of+tauopathies+with+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutton%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DDickson%26aufirst%3DD.%26aulast%3DYen%26aufirst%3DS.%2BH.%26aulast%3DMcGowan%26aufirst%3DE.%26atitle%3DAnalysis%2520of%2520tauopathies%2520with%2520transgenic%2520mice%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2001%26volume%3D7%26spage%3D467%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Crespo-Biel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theunis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Leuven, F.</span><span> </span><span class="NLM_article-title">Protein tau: prime cause of synaptic and neuronal degeneration in Alzheimer’s disease</span> <span class="citation_source-journal">Int. J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">251426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslKmsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=251426&author=N.+Crespo-Bielauthor=C.+Theunisauthor=F.+Van+Leuven&title=Protein+tau%3A+prime+cause+of+synaptic+and+neuronal+degeneration+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Tau: prime cause of synaptic and neuronal degeneration in Alzheimer's disease</span></div><div class="casAuthors">Crespo-Biel, Natalia; Theunis, Clara; Van Leuven, Fred</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">251426, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJADAQ</span>;
        ISSN:<span class="NLM_cas:issn">2090-0252</span>.
    
            (<span class="NLM_cas:orgname">Hindawi Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  The microtubule-assocd. protein Tau (MAPT) is a major component of the pathogenesis of a wide variety of brain-damaging disorders, known as tauopathies.  These include Alzheimer's disease (AD), denoted as secondary tauopathy because of the obligatory combination with amyloid pathol.  In all tauopathies, protein Tau becomes aberrantly phosphorylated, adopts abnormal conformations, and aggregates into fibrils that eventually accumulate as threads in neuropil and as tangles in soma.  The argyrophilic neurofibrillary threads and tangles, together denoted as NFT, provide the postmortem pathol. diagnosis for all tauopathies.  In AD, neurofibrillary threads and tangles (NFTs) are codiagnostic with amyloid depositions but their sepd. and combined contributions to clin. symptoms remain elusive.  Importantly, NFTs are now considered a late event and not directly responsible for early synaptic dysfunctions.  Conversely, the biochem. and pathol. timeline is not exactly known in human tauopathy, but exptl. models point to smaller Tau-aggregates, termed oligomers or multimers, as synaptotoxic in early stages.  The challenge is to molecularly define these Tau-isoforms that cause early cognitive and synaptic impairments.  Here, we discuss relevant studies and data obtained in our mono- and bi-genic validated preclin. models, with the perspective of Tau as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozgjn3h5A7DLVg90H21EOLACvtfcHk0lih8pj-k7tK7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslKmsbc%253D&md5=cbf293593895e434037019c401ae1a66</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrespo-Biel%26aufirst%3DN.%26aulast%3DTheunis%26aufirst%3DC.%26aulast%3DVan%2BLeuven%26aufirst%3DF.%26atitle%3DProtein%2520tau%253A%2520prime%2520cause%2520of%2520synaptic%2520and%2520neuronal%2520degeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26spage%3D251426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Eisenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jucker, M.</span><span> </span><span class="NLM_article-title">The amyloid state of proteins in human diseases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">1188</span><span class="NLM_x">–</span> <span class="NLM_lpage">1203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.cell.2012.02.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22424229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1Ggsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=1188-1203&author=D.+Eisenbergauthor=M.+Jucker&title=The+amyloid+state+of+proteins+in+human+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Amyloid state of proteins in human diseases</span></div><div class="casAuthors">Eisenberg, David; Jucker, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1188-1203</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Amyloid fibers and oligomers are assocd. with a great variety of human diseases including Alzheimer's disease and the prion conditions.  Here we attempt to connect recent discoveries on the mol. properties of proteins in the amyloid state with observations about pathol. tissues and disease states.  We summarize studies of structure and nucleation of amyloid and relate these to observations on amyloid polymorphism, prion strains, coaggregation of pathogenic proteins in tissues, and mechanisms of toxicity and transmissibility.  Mol. studies have also led to numerous strategies for biol. and chem. interventions against amyloid diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaQ6wkkP5ZZrVg90H21EOLACvtfcHk0lih8pj-k7tK7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1Ggsbo%253D&md5=b141512d0e7f84a085bc7433f258d60a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.02.022%26sid%3Dliteratum%253Aachs%26aulast%3DEisenberg%26aufirst%3DD.%26aulast%3DJucker%26aufirst%3DM.%26atitle%3DThe%2520amyloid%2520state%2520of%2520proteins%2520in%2520human%2520diseases%26jtitle%3DCell%26date%3D2012%26volume%3D148%26spage%3D1188%26epage%3D1203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kolarova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Sierra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripova, D.</span><span> </span><span class="NLM_article-title">Structure and pathology of tau protein in Alzheimer disease</span> <span class="citation_source-journal">Int. J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">731526</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XosVensLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=731526&author=M.+Kolarovaauthor=F.+Garcia-Sierraauthor=A.+Bartosauthor=J.+Ricnyauthor=D.+Ripova&title=Structure+and+pathology+of+tau+protein+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and pathology of tau protein in Alzheimer disease</span></div><div class="casAuthors">Kolarova, Michala; Garcia-Sierra, Francisco; Bartos, Ales; Ricny, Jan; Ripova, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">731526, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJADAQ</span>;
        ISSN:<span class="NLM_cas:issn">2090-0252</span>.
    
            (<span class="NLM_cas:orgname">Hindawi Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common type of dementia.  In connection with the global trend of prolonging human life and the increasing no. of elderly in the population, the AD becomes one of the most serious health and socioeconomic problems of the present.  Tau protein promotes assembly and stabilizes microtubules, which contributes to the proper function of neuron.  Alterations in the amt. or the structure of tau protein can affect its role as a stabilizer of microtubules as well as some of the processes in which it is implicated.  The mol. mechanisms governing tau aggregation are mainly represented by several posttranslational modifications that alter its structure and conformational state.  Hence, abnormal phosphorylation and truncation of tau protein have gained attention as key mechanisms that become tau protein in a pathol. entity.  Evidences about the clinicopathol. significance of phosphorylated and truncated tau have been documented during the progression of AD as well as their capacity to exert cytotoxicity when expressed in cell and animal models.  This paper describes the normal structure and function of tau protein and its major alterations during its pathol. aggregation in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0pOuzGFY7-7Vg90H21EOLACvtfcHk0lih8pj-k7tK7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosVensLg%253D&md5=32af79b01fe2aed9c1fe80ebbc0181de</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKolarova%26aufirst%3DM.%26aulast%3DGarcia-Sierra%26aufirst%3DF.%26aulast%3DBartos%26aufirst%3DA.%26aulast%3DRicny%26aufirst%3DJ.%26aulast%3DRipova%26aufirst%3DD.%26atitle%3DStructure%2520and%2520pathology%2520of%2520tau%2520protein%2520in%2520Alzheimer%2520disease%26jtitle%3DInt.%2520J.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26spage%3D731526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ittner, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotz, J.</span><span> </span><span class="NLM_article-title">Amyloid-beta and tau—a toxic pas de deux in Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnrn2967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21193853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFeq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=65-72&author=L.+M.+Ittnerauthor=J.+Gotz&title=Amyloid-beta+and+tau%E2%80%94a+toxic+pas+de+deux+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease</span></div><div class="casAuthors">Ittner, Lars M.; Goetz, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-72</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Amyloid-β and tau are the two hallmark proteins in Alzheimer's disease.  Although both amyloid-β and tau have been extensively studied individually with regard to their sep. modes of toxicity, more recently new light has been shed on their possible interactions and synergistic effects in Alzheimer's disease.  Here, we review novel findings that have shifted our understanding of the role of tau in the pathogenesis of Alzheimer's disease towards being a crucial partner of amyloid-β.  As we gain a deeper understanding of the different cellular functions of tau, the focus shifts from the axon, where tau has a principal role as a microtubule-assocd. protein, to the dendrite, where it mediates amyloid-β toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPL1v0nYjAz7Vg90H21EOLACvtfcHk0ljD4e5yPNaiMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFeq&md5=3eba522187f11cb5e7944dae5a025e55</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrn2967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2967%26sid%3Dliteratum%253Aachs%26aulast%3DIttner%26aufirst%3DL.%2BM.%26aulast%3DGotz%26aufirst%3DJ.%26atitle%3DAmyloid-beta%2520and%2520tau%25E2%2580%2594a%2520toxic%2520pas%2520de%2520deux%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2011%26volume%3D12%26spage%3D65%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Zempel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span> </span><span class="NLM_article-title">Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">11938</span><span class="NLM_x">–</span> <span class="NLM_lpage">11950</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1523%2FJNEUROSCI.2357-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20826658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtF2qsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=11938-11950&author=H.+Zempelauthor=E.+Thiesauthor=E.+Mandelkowauthor=E.+M.+Mandelkow&title=Abeta+oligomers+cause+localized+Ca%282%2B%29+elevation%2C+missorting+of+endogenous+Tau+into+dendrites%2C+Tau+phosphorylation%2C+and+destruction+of+microtubules+and+spines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ oligomers cause localized Ca2+ elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines</span></div><div class="casAuthors">Zempel, Hans; Thies, Edda; Mandelkow, Eckhard; Mandelkow, Eva-Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">11938-11950</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Aggregation of amyloid-β (Aβ) and Tau protein are hallmarks of Alzheimer's disease (AD), and according to the Aβ-cascade hypothesis, Aβ is considered toxic for neurons and Tau a downstream target of Aβ.  We have investigated differentiated primary hippocampal neurons for early localized changes following exposure to Aβ oligomers.  Initial events become evident by missorting of endogenous Tau into the somatodendritic compartment, in contrast to axonal sorting in normal neurons.  In missorted dendritic regions there is a depletion of spines and local increase in Ca2+, and breakdown of microtubules.  Tau in these regions shows elevated phosphorylation at certain sites diagnostic of AD-Tau (e.g., epitope of antibody 12E8, whose phosphorylation causes detachment of Tau from microtubules, and AT8 epitope), and local elevation of certain kinase activities (e.g., MARK/par-1, BRSK/SADK, p70S6K, cdk5, but not GSK3β, JNK, MAPK).  These local effects occur without global changes in Tau, tubulin, or kinase levels.  Somatodendritic missorting occurs not only with Tau, but also with other axonal proteins such as neurofilaments, and correlates with pronounced depletion of microtubules and mitochondria.  The Aβ-induced effects on microtubule and mitochondria depletion, Tau missorting, and loss of spines are prevented by taxol, indicating that Aβ-induced microtubule destabilization and corresponding traffic defects are key factors in incipient degeneration.  By contrast, the rise in Ca2+ levels, kinase activities, and Tau phosphorylation cannot be prevented by taxol.  Incipient and local changes similar to those of Aβ oligomers can be evoked by cell stressors (e.g., H2O2, glutamate, serum deprivation), suggesting some common mechanism of signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIS9RYGK4jMrVg90H21EOLACvtfcHk0ljD4e5yPNaiMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtF2qsLnK&md5=c7f6cf2af311d01c746b16e31be0e4a4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2357-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2357-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DZempel%26aufirst%3DH.%26aulast%3DThies%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DAbeta%2520oligomers%2520cause%2520localized%2520Ca%25282%252B%2529%2520elevation%252C%2520missorting%2520of%2520endogenous%2520Tau%2520into%2520dendrites%252C%2520Tau%2520phosphorylation%252C%2520and%2520destruction%2520of%2520microtubules%2520and%2520spines%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D11938%26epage%3D11950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Tredici, K.</span><span> </span><span class="NLM_article-title">The pathological process underlying Alzheimer’s disease in individuals under thirty</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1007%2Fs00401-010-0789-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21170538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BC3M7jvV2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=171-181&author=H.+Braakauthor=K.+Del+Tredici&title=The+pathological+process+underlying+Alzheimer%E2%80%99s+disease+in+individuals+under+thirty"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The pathological process underlying Alzheimer's disease in individuals under thirty</span></div><div class="casAuthors">Braak Heiko; Del Tredici Kelly</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Brains of 42 individuals between the ages of 4 and 29 were examined with antibodies (AT8, 4G8) and silver stains for the presence of intraneuronal and extracellular protein aggregates associated with Alzheimer's disease.  Thirty-eight of 42 (38/42) cases displayed abnormally phosphorylated tau protein (pretangle material) in nerve cells or in portions of their cellular processes, and 41/42 individuals showed no extracellular amyloid-β protein deposition or neuritic plaques-an individual with Down syndrome was the only exception.  In 16/42 cases abnormal tau was found in the transentorhinal region, and in 3/42 cases this site was Gallyas-positive for isolated NFTs (NFT stage I).  Of 26 cases that lacked abnormal tau in the transentorhinal region, 4 did not show pretangle material at subcortical sites.  The remaining 22 of these same 26 cases, however, had subcortical lesions confined to non-thalamic nuclei with diffuse projections to the cerebral cortex, and, remarkably, in 19/22 individuals the pretangle material was confined to the noradrenergic coeruleus/subcoeruleus complex.  Assuming the pretangle alterations are not transient and do not regress, these findings may indicate that the Alzheimer's disease-related pathological process leading to neurofibrillary tangle formation does not begin in the cerebral cortex but, rather, in select subcortical nuclei, and it may start quite early, i.e., before puberty or in early young adulthood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwm-8zIl3llYMcDoIzZtNkfW6udTcc2eaEUiWkk6l99bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7jvV2gtw%253D%253D&md5=fee9c22eed3f3ed66c22a7aa7215cb9d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00401-010-0789-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-010-0789-4%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DDel%2BTredici%26aufirst%3DK.%26atitle%3DThe%2520pathological%2520process%2520underlying%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520individuals%2520under%2520thirty%26jtitle%3DActa%2520Neuropathol.%26date%3D2011%26volume%3D121%26spage%3D171%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lasagna-Reeves, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo-Carranza, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrero-Muoz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayed, R.</span><span> </span><span class="NLM_article-title">Preparation and characterization of neurotoxic tau oligomers</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">10039</span><span class="NLM_x">–</span> <span class="NLM_lpage">10041</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi1016233" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=10039-10041&author=C.+A.+Lasagna-Reevesauthor=D.+L.+Castillo-Carranzaauthor=M.+J.+Guerrero-Muozauthor=G.+R.+Jacksonauthor=R.+Kayed&title=Preparation+and+characterization+of+neurotoxic+tau+oligomers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fbi1016233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1016233%26sid%3Dliteratum%253Aachs%26aulast%3DLasagna-Reeves%26aufirst%3DC.%2BA.%26aulast%3DCastillo-Carranza%26aufirst%3DD.%2BL.%26aulast%3DGuerrero-Muoz%26aufirst%3DM.%2BJ.%26aulast%3DJackson%26aufirst%3DG.%2BR.%26aulast%3DKayed%26aufirst%3DR.%26atitle%3DPreparation%2520and%2520characterization%2520of%2520neurotoxic%2520tau%2520oligomers%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D10039%26epage%3D10041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Lasagna-Reeves, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo-Carranza, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarmiento, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncoso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayed, R.</span><span> </span><span class="NLM_article-title">Identification of oligomers at early stages of tau aggregation in Alzheimer’s disease</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1946</span><span class="NLM_x">–</span> <span class="NLM_lpage">1959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1946-1959&author=C.+A.+Lasagna-Reevesauthor=D.+L.+Castillo-Carranzaauthor=U.+Senguptaauthor=J.+Sarmientoauthor=J.+Troncosoauthor=G.+R.+Jacksonauthor=R.+Kayed&title=Identification+of+oligomers+at+early+stages+of+tau+aggregation+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLasagna-Reeves%26aufirst%3DC.%2BA.%26aulast%3DCastillo-Carranza%26aufirst%3DD.%2BL.%26aulast%3DSengupta%26aufirst%3DU.%26aulast%3DSarmiento%26aufirst%3DJ.%26aulast%3DTroncoso%26aufirst%3DJ.%26aulast%3DJackson%26aufirst%3DG.%2BR.%26aulast%3DKayed%26aufirst%3DR.%26atitle%3DIdentification%2520of%2520oligomers%2520at%2520early%2520stages%2520of%2520tau%2520aggregation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFASEB%2520J.%26date%3D2012%26volume%3D26%26spage%3D1946%26epage%3D1959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Patterson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remmers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanaan, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vana, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philibert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glucksman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, L. I.</span><span> </span><span class="NLM_article-title">Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">23063</span><span class="NLM_x">–</span> <span class="NLM_lpage">23076</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1074%2Fjbc.M111.237974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21550980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFersr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=23063-23076&author=K.+R.+Pattersonauthor=C.+Remmersauthor=Y.+Fuauthor=S.+Brookerauthor=N.+M.+Kanaanauthor=L.+Vanaauthor=S.+Wardauthor=J.+F.+Reyesauthor=K.+Philibertauthor=M.+J.+Glucksmanauthor=L.+I.+Binder&title=Characterization+of+prefibrillar+Tau+oligomers+in+vitro+and+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer Disease</span></div><div class="casAuthors">Patterson, Kristina R.; Remmers, Christine; Fu, Yifan; Brooker, Sarah; Kanaan, Nicholas M.; Vana, Laurel; Ward, Sarah; Reyes, Juan F.; Philibert, Keith; Glucksman, Marc J.; Binder, Lester I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">23063-23076</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Neurofibrillary tangles, composed of insol. aggregates of the microtubule-assocd. protein Tau, are a pathol. hallmark of Alzheimer disease (AD) and other tauopathies.  However, recent evidence indicates that neuronal dysfunction precedes the formation of these insol. fibrillar deposits, suggesting that earlier prefibrillar Tau aggregates may be neurotoxic.  To det. the compn. of these aggregates, we have employed a photochem. crosslinking technique to examine intermol. interactions of full-length Tau in vitro.  Using this method, we demonstrate that dimerization is an early event in the Tau aggregation process and that these dimers self-assoc. to form larger oligomeric aggregates.  Moreover, using these stabilized Tau aggregates as immunogens, we generated a monoclonal antibody that selectively recognizes Tau dimers and higher order oligomeric aggregates but shows little reactivity to Tau filaments in vitro.  Immunostaining indicates that these dimers/oligomers are markedly elevated in AD, appearing in early pathol. inclusions such as neuropil threads and pretangle neurons as well as colocalizing with other early markers of Tau pathogenesis.  Taken as a whole, the work presented herein demonstrates the existence of alternative Tau aggregates that precede formation of fibrillar Tau pathologies and raises the possibility that these hierarchical oligomeric forms of Tau may contribute to neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGR3uIS5yFVbVg90H21EOLACvtfcHk0lg5YR0NWm88uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFersr0%253D&md5=6baddf052e7c2d7458ae47e9b5391451</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.237974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.237974%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DK.%2BR.%26aulast%3DRemmers%26aufirst%3DC.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DBrooker%26aufirst%3DS.%26aulast%3DKanaan%26aufirst%3DN.%2BM.%26aulast%3DVana%26aufirst%3DL.%26aulast%3DWard%26aufirst%3DS.%26aulast%3DReyes%26aufirst%3DJ.%2BF.%26aulast%3DPhilibert%26aufirst%3DK.%26aulast%3DGlucksman%26aufirst%3DM.%2BJ.%26aulast%3DBinder%26aufirst%3DL.%2BI.%26atitle%3DCharacterization%2520of%2520prefibrillar%2520Tau%2520oligomers%2520in%2520vitro%2520and%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D23063%26epage%3D23076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Green, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beelen, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swabb, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavitz, K. H.</span><span> </span><span class="NLM_article-title">Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">2557</span><span class="NLM_x">–</span> <span class="NLM_lpage">2564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2009&pages=2557-2564&author=R.+C.+Greenauthor=L.+S.+Schneiderauthor=D.+A.+Amatoauthor=A.+P.+Beelenauthor=G.+Wilcockauthor=E.+A.+Swabbauthor=K.+H.+Zavitz&title=Effect+of+tarenflurbil+on+cognitive+decline+and+activities+of+daily+living+in+patients+with+mild+Alzheimer+disease%3A+a+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DR.%2BC.%26aulast%3DSchneider%26aufirst%3DL.%2BS.%26aulast%3DAmato%26aufirst%3DD.%2BA.%26aulast%3DBeelen%26aufirst%3DA.%2BP.%26aulast%3DWilcock%26aufirst%3DG.%26aulast%3DSwabb%26aufirst%3DE.%2BA.%26aulast%3DZavitz%26aufirst%3DK.%2BH.%26atitle%3DEffect%2520of%2520tarenflurbil%2520on%2520cognitive%2520decline%2520and%2520activities%2520of%2520daily%2520living%2520in%2520patients%2520with%2520mild%2520Alzheimer%2520disease%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2009%26volume%3D302%26spage%3D2557%26epage%3D2564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sabbagh, M. N.</span><span> </span><span class="NLM_article-title">Drug development for Alzheimer’s disease: Where are we now and where are we headed?</span> <span class="citation_source-journal">Am. J. Geriatr. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.amjopharm.2009.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=19616185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpslaqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=167-185&author=M.+N.+Sabbagh&title=Drug+development+for+Alzheimer%E2%80%99s+disease%3A+Where+are+we+now+and+where+are+we+headed%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Drug development for Alzheimer's disease: where are we now and where are we headed?</span></div><div class="casAuthors">Sabbagh, Marwan N.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Geriatric Pharmacotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-185</span>CODEN:
                <span class="NLM_cas:coden">AJGPB5</span>;
        ISSN:<span class="NLM_cas:issn">1543-5946</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Objective: The aim of this article was to provide a survey of the clin. development of pharmacotherapy for Alzheimer's disease (AD).  Methods: A search of PubMed to identify pertinent English-language literature was conducted using the terms Alzheimer's disease AND clin. trials (2003-2008), dementia AND prevention AND clin. trials (2003-2008), and the chem. names of all compds. mentioned in articles on new drugs for AD published since 2005.  Www.ClinicalTrials.gov was searched for relevant trials.  Abstrs. of the 2008 International Conference on Alzheimer's Disease (ICAD) were reviewed for relevance, as were pharmaceutical company and AD advocacy Web sites.  Articles selected for review were primary reports of data from preclin. studies and clin. trials.  Results: A large no. of drugs with differing targets and mechanisms of action are under development for the treatment of AD.  Phase III trials of Ginkgo biloba, NSAIDs, phenserine, statins, tarenflurbil, tramiprosate, and xaliproden have been completed, none of them demonstrating adequate efficacy.  Encouraging results from completed Phase II trials of dimebon, huperzine A, i.v. Ig, and methylthioninium chloride were reported at ICAD 2008.  Nineteen compds. are currently in Phase II trials, and 3 compds. (AN1792, lecozotan SR, and SGS742) failed at this stage of development.  Conclusions: Despite disappointing results from recently completed Phase III trials of several novel compds., the extent and breadth of activity at all phases of clin. development suggest that new pharmacotherapeutic options for the treatment of AD will become available within the next decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA46qmUaTUX7Vg90H21EOLACvtfcHk0lg5YR0NWm88uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpslaqu7k%253D&md5=fbf0ab80c77a77ebc44a130309cb9434</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.amjopharm.2009.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjopharm.2009.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26atitle%3DDrug%2520development%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Where%2520are%2520we%2520now%2520and%2520where%2520are%2520we%2520headed%253F%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Pharmacother.%26date%3D2009%26volume%3D7%26spage%3D167%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span> </span><span class="NLM_article-title">Targeting Abeta and tau in Alzheimer’s disease, an early interim report</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">223</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.expneurol.2009.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=19716367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFShsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2010&pages=252-266&author=T.+E.+Goldeauthor=L.+Petrucelliauthor=J.+Lewis&title=Targeting+Abeta+and+tau+in+Alzheimer%E2%80%99s+disease%2C+an+early+interim+report"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Aβ and tau in Alzheimer's disease, an early interim report</span></div><div class="casAuthors">Golde, Todd E.; Petrucelli, Leonard; Lewis, Jada</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">252-266</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The amyloid β (Aβ) and tau proteins, which misfold, aggregate, and accumulate in the Alzheimer's disease (AD) brain, are implicated as central factors in a complex neurodegenerative cascade.  Studies of mutations that cause early onset AD and promote Aβ accumulation in the brain strongly support the notion that inhibiting Aβ aggregation will prevent AD.  Similarly, genetic studies of frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17 MAPT) showing that mutations in the MAPT gene encoding tau lead to abnormal tau accumulation and neurodegeneration.  Such genetic studies clearly show that tau dysfunction and aggregation can be central to neurodegeneration, however, most likely in a secondary fashion in relation to AD.  Addnl. pathol., biochem., and modeling studies further support the concept that Aβ and tau are prime targets for disease modifying therapies in AD.  Treatment strategies aimed at preventing the aggregation and accumulation of Aβ, tau, or both proteins should therefore be theor. possible, assuming that treatment can be initiated before either irreversible damage is present or downstream, self-sustaining, pathol. cascades have been initiated.  Herein, we will review recent advances and also potential setbacks with respect to the myriad of therapeutic strategies that are designed to slow down, prevent, or clear the accumulation of either "pathol." Aβ or tau.  We will also discuss the need for thoughtful prioritization with respect to clin. development of the preclinically validated modifiers of Aβ and tau pathol.  The current no. of candidate therapies targeting Aβ is becoming so large that a triage process is clearly needed to insure that resources are invested in a way such that the best candidates for disease modifying therapy are rapidly moved toward clin. trials.  Finally, we will discuss the challenges for an appropriate "triage" after potential disease modifying therapies targeting tau and Aβ have entered clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom0oGH_CvQYrVg90H21EOLACvtfcHk0ljwhvVe0lBS3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFShsrw%253D&md5=5364e5607732e0888d76cd4565496b30</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2009.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2009.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DPetrucelli%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DJ.%26atitle%3DTargeting%2520Abeta%2520and%2520tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520an%2520early%2520interim%2520report%26jtitle%3DExp.%2520Neurol.%26date%3D2010%26volume%3D223%26spage%3D252%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hamley, I. W.</span><span> </span><span class="NLM_article-title">The amyloid beta peptide: a chemist’s perspective. Role in Alzheimer’s and fibrillization</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">5147</span><span class="NLM_x">–</span> <span class="NLM_lpage">5192</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr3000994" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=5147-5192&author=I.+W.+Hamley&title=The+amyloid+beta+peptide%3A+a+chemist%E2%80%99s+perspective.+Role+in+Alzheimer%E2%80%99s+and+fibrillization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fcr3000994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr3000994%26sid%3Dliteratum%253Aachs%26aulast%3DHamley%26aufirst%3DI.%2BW.%26atitle%3DThe%2520amyloid%2520beta%2520peptide%253A%2520a%2520chemist%25E2%2580%2599s%2520perspective.%2520Role%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520fibrillization%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D5147%26epage%3D5192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Estrada, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, C.</span><span> </span><span class="NLM_article-title">Disrupting beta-amyloid aggregation for Alzheimer disease treatment</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F156802607779318262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17266599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Wjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=115-126&author=L.+D.+Estradaauthor=C.+Soto&title=Disrupting+beta-amyloid+aggregation+for+Alzheimer+disease+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupting β-amyloid aggregation for Alzheimer disease treatment</span></div><div class="casAuthors">Estrada, L. D.; Soto, C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-126</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is a devastating degenerative disorder for which there is no cure or effective treatment.  Although the etiol. of Alzheimer's disease is not fully understood, compelling evidence indicates that deposition of aggregates composed by a misfolded form of the amyloid beta peptide (Aβ) is the central event in the disease pathogenesis.  Therefore, an attractive therapeutic strategy is to prevent or reverse Aβ misfolding and aggregation.  Diverse strategies have been described to identify inhibitors of this process, including screening of libraries of small mols. chem. compds., rational design of synthetic peptides, assessment of natural Aβ-binding proteins and stimulation of the immune system by vaccination.  In this article we describe these different approaches, their principles and their potential strengths and weaknesses.  Overall the available data suggest that the development of drugs to interfere with Aβ misfolding and aggregation is a feasible target that hold great promise for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqaHC31lKaYbVg90H21EOLACvtfcHk0ljwhvVe0lBS3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Wjs7c%253D&md5=0b7d22ef53b075c9cdd9a7ee5c1ece06</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F156802607779318262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607779318262%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DL.%2BD.%26aulast%3DSoto%26aufirst%3DC.%26atitle%3DDisrupting%2520beta-amyloid%2520aggregation%2520for%2520Alzheimer%2520disease%2520treatment%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D115%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Di Carlo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomazza, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Biagio, P. L.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: biological aspects, therapeutic perspectives and diagnostic tools</span> <span class="citation_source-journal">J. Phys.: Condens. Matter</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">244102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1088%2F0953-8984%2F24%2F24%2F244102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22595372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWiu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=244102&author=M.+Di+Carloauthor=D.+Giacomazzaauthor=P.+L.+San+Biagio&title=Alzheimer%E2%80%99s+disease%3A+biological+aspects%2C+therapeutic+perspectives+and+diagnostic+tools"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: biological aspects, therapeutic perspectives and diagnostic tools</span></div><div class="casAuthors">Di Carlo, M.; Giacomazza, D.; San Biagio, P. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physics: Condensed Matter</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">244102/1-244102/17</span>CODEN:
                <span class="NLM_cas:coden">JCOMEL</span>;
        ISSN:<span class="NLM_cas:issn">0953-8984</span>.
    
            (<span class="NLM_cas:orgname">Institute of Physics Publishing</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia among older people.  Dementia is an irreversible brain disorder that seriously affects a person's ability to carry out daily activities.  It is characterized by loss of cognitive functioning and behavioral abilities, to such an extent that it interferes with the daily life and activities of the affected patients.  Although it is still unknown how the disease process begins, it seems that brain damage starts a decade or more before problems become evident.  Scientific data seem to indicate that changes in the generation or the degrdn. of the amyloid-β peptide (Aβ) lead to the formation of aggregated structures that are the triggering mol. events in the pathogenic cascade of AD.  This review summarizes some characteristic features of Aβ misfolding and aggregation and how cell damage and death mechanisms are induced by these supramol. and toxic structures.  Further, some interventions for the early diagnosis of AD are described and in the last part the potential therapeutic strategies adoptable to slow down, or better block, the progression of the pathol. are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYDxwPOzYttbVg90H21EOLACvtfcHk0ljwhvVe0lBS3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWiu7rF&md5=200d6b8e386421a30c3a3ad7cd6f0057</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1088%2F0953-8984%2F24%2F24%2F244102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1088%252F0953-8984%252F24%252F24%252F244102%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCarlo%26aufirst%3DM.%26aulast%3DGiacomazza%26aufirst%3DD.%26aulast%3DSan%2BBiagio%26aufirst%3DP.%2BL.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520biological%2520aspects%252C%2520therapeutic%2520perspectives%2520and%2520diagnostic%2520tools%26jtitle%3DJ.%2520Phys.%253A%2520Condens.%2520Matter%26date%3D2012%26volume%3D24%26spage%3D244102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Mangialasche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mecocci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kivipelto, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: clinical trials and drug development</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2FS1474-4422%2810%2970119-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20610346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFajur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=702-716&author=F.+Mangialascheauthor=A.+Solomonauthor=B.+Winbladauthor=P.+Mecocciauthor=M.+Kivipelto&title=Alzheimer%E2%80%99s+disease%3A+clinical+trials+and+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: clinical trials and drug development</span></div><div class="casAuthors">Mangialasche, Francesca; Solomon, Alina; Winblad, Bengt; Mecocci, Patrizia; Kivipelto, Miia</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">702-716</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is the most common cause of dementia in elderly people.  Research into Alzheimer's disease therapy has been at least partly successful in terms of developing symptomatic treatments, but has also had several failures in terms of developing disease-modifying therapies.  These successes and failures have led to debate about the potential deficiencies in our understanding of the pathogenesis of Alzheimer's disease and potential pitfalls in diagnosis, choice of therapeutic targets, development of drug candidates, and design of clin. trials.  Many clin. and exptl. studies are ongoing, but we need to acknowledge that a single cure for Alzheimer's disease is unlikely to be found and that the approach to drug development for this disorder needs to be reconsidered.  Preclin. research is constantly providing us with new information on pieces of the complex Alzheimer's disease puzzle, and an anal. of this information might reveal patterns of pharmacol. interactions instead of single potential drug targets.  Several promising randomized controlled trials are ongoing, and the increased collaboration between pharmaceutical companies, basic researchers, and clin. researchers has the potential to bring us closer to developing an optimum pharmaceutical approach for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIaQ4TlzK_v7Vg90H21EOLACvtfcHk0li3DjNMV3_SIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFajur8%253D&md5=8641c7a6fdb89aa80a2e35fbd2f369a1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2810%2970119-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252810%252970119-8%26sid%3Dliteratum%253Aachs%26aulast%3DMangialasche%26aufirst%3DF.%26aulast%3DSolomon%26aufirst%3DA.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DMecocci%26aufirst%3DP.%26aulast%3DKivipelto%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520clinical%2520trials%2520and%2520drug%2520development%26jtitle%3DLancet%2520Neurol.%26date%3D2010%26volume%3D9%26spage%3D702%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wischik, C. M.; Rickard, J. E.; Harrington, C. R.; Horsley, D.; Storey, J. M. D.; Marshall, C.; Sinclair, J. P.</span><span> </span><span class="NLM_article-title">Preparation of Phenothiazine Derivatives for Treatment of Tauopathy</span>. PCT Int. Appl. WO 2007110630,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=C.+M.+Wischik&author=J.+E.+Rickard&author=C.+R.+Harrington&author=D.+Horsley&author=J.+M.+D.+Storey&author=C.+Marshall&author=J.+P.+Sinclair&title=Preparation+of+Phenothiazine+Derivatives+for+Treatment+of+Tauopathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWischik%26aufirst%3DC.%2BM.%26atitle%3DPreparation%2520of%2520Phenothiazine%2520Derivatives%2520for%2520Treatment%2520of%2520Tauopathy%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Nie, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M. Y.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of amyloid beta peptide aggregation as a potential therapeutic strategy for Alzheimer’s disease</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Faps.2011.14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21499284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFKgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=545-551&author=Q.+Nieauthor=X.+G.+Duauthor=M.+Y.+Geng&title=Small+molecule+inhibitors+of+amyloid+beta+peptide+aggregation+as+a+potential+therapeutic+strategy+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease</span></div><div class="casAuthors">Nie, Qin; Du, Xiao-guang; Geng, Mei-yu</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">545-551</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Amyloid β (Aβ) peptides have long been viewed as a potential target for Alzheimer's disease (AD).  Aggregation of Aβ peptides in the brain tissue is believed to be an exclusively pathol. process.  Therefore, blocking the initial stages of Aβ peptide aggregation with small mols. could hold considerable promise as the starting point for the development of new therapies for AD.  Recent rapid progresses in our understanding of toxic amyloid assembly provide a fresh impetus for this interesting approach.  Here, we discuss the problems, challenges and new concepts in targeting Aβ peptides.  Acta Pharmacologica Sinica (2011) 32: 545-551; doi: 10.1038/aps.2011.14; published online 18 Apr 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrROzsHwdwhHbVg90H21EOLACvtfcHk0li3DjNMV3_SIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFKgtb4%253D&md5=243954abf169e75b7ed55f3096afb34b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Faps.2011.14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2011.14%26sid%3Dliteratum%253Aachs%26aulast%3DNie%26aufirst%3DQ.%26aulast%3DDu%26aufirst%3DX.%2BG.%26aulast%3DGeng%26aufirst%3DM.%2BY.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520amyloid%2520beta%2520peptide%2520aggregation%2520as%2520a%2520potential%2520therapeutic%2520strategy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2011%26volume%3D32%26spage%3D545%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Holmes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boche, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadegarfar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neal, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zotova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll, J. A.</span><span> </span><span class="NLM_article-title">Long-term effects of Abeta42 immunisation in Alzheimer’s disease: follow-up of a randomised, placebo-controlled phase I trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2008&pages=216-223&author=C.+Holmesauthor=D.+Bocheauthor=D.+Wilkinsonauthor=G.+Yadegarfarauthor=V.+Hopkinsauthor=A.+Bayerauthor=R.+W.+Jonesauthor=R.+Bullockauthor=S.+Loveauthor=J.+W.+Nealauthor=E.+Zotovaauthor=J.+A.+Nicoll&title=Long-term+effects+of+Abeta42+immunisation+in+Alzheimer%E2%80%99s+disease%3A+follow-up+of+a+randomised%2C+placebo-controlled+phase+I+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DC.%26aulast%3DBoche%26aufirst%3DD.%26aulast%3DWilkinson%26aufirst%3DD.%26aulast%3DYadegarfar%26aufirst%3DG.%26aulast%3DHopkins%26aufirst%3DV.%26aulast%3DBayer%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DR.%2BW.%26aulast%3DBullock%26aufirst%3DR.%26aulast%3DLove%26aufirst%3DS.%26aulast%3DNeal%26aufirst%3DJ.%2BW.%26aulast%3DZotova%26aufirst%3DE.%26aulast%3DNicoll%26aufirst%3DJ.%2BA.%26atitle%3DLong-term%2520effects%2520of%2520Abeta42%2520immunisation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520follow-up%2520of%2520a%2520randomised%252C%2520placebo-controlled%2520phase%2520I%2520trial%26jtitle%3DLancet%26date%3D2008%26volume%3D372%26spage%3D216%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellas, B.</span><span> </span><span class="NLM_article-title">Editorial: passive immunotherapy for Alzheimer’s disease: What have we learned, and where are we headed?</span> <span class="citation_source-journal">J. Nutr., Health Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1007%2Fs12603-013-0001-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=23299379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BC3s3nslKjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=49-50&author=P.+S.+Aisenauthor=B.+Vellas&title=Editorial%3A+passive+immunotherapy+for+Alzheimer%E2%80%99s+disease%3A+What+have+we+learned%2C+and+where+are+we+headed%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Passive immunotherapy for Alzheimer's disease: what have we learned, and where are we headed?</span></div><div class="casAuthors">Aisen P S; Vellas B</div><div class="citationInfo"><span class="NLM_cas:title">The journal of nutrition, health & aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-50</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-VXyD7KCpiWmbXvSEQle5fW6udTcc2eY8WqXzXdd6CLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3nslKjuw%253D%253D&md5=d2a2a4e92cf9f75697acea43d00e95ac</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs12603-013-0001-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12603-013-0001-3%26sid%3Dliteratum%253Aachs%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DVellas%26aufirst%3DB.%26atitle%3DEditorial%253A%2520passive%2520immunotherapy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520What%2520have%2520we%2520learned%252C%2520and%2520where%2520are%2520we%2520headed%253F%26jtitle%3DJ.%2520Nutr.%252C%2520Health%2520Aging%26date%3D2013%26volume%3D17%26spage%3D49%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Biochemistry and cell biology of tau protein in neurofibrillary degeneration</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1101%2Fcshperspect.a006247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22762014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlemtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a006247&author=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Biochemistry+and+cell+biology+of+tau+protein+in+neurofibrillary+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry and cell biology of tau protein in neurofibrillary degeneration</span></div><div class="casAuthors">Mandelkow, Eva-Maria; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">a006247/1-a006247/25</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Tau represents the subunit protein of one of the major hallmarks of Alzheimer disease (AD), the neurofibrillary tangles, and is therefore of major interest as an indicator of disease mechanisms.  Many of the unusual properties of Tau can be explained by its nature as a natively unfolded protein.  Examples are the large no. of structural conformations and biochem. modifications (phosphorylation, proteolysis, glycosylation, and others), the multitude of interaction partners (mainly microtubules, but also other cytoskeletal proteins, kinases, and phosphatases, motor proteins, chaperones, and membrane proteins).  The pathol. aggregation of Tau is counterintuitive, given its high soly., but can be rationalized by short hydrophobic motifs forming β structures.  The aggregation of Tau is toxic in cell and animal models, but can be reversed by suppressing expression or by aggregation inhibitors.  This review summarizes some of the structural, biochem., and cell biol. properties of Tau and Tau fibers.  Further aspects of Tau as a diagnostic marker and therapeutic target, its involvement in other Tau-based diseases, and its histopathol. are covered by other chapters in this vol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKzKbGbJg9zrVg90H21EOLACvtfcHk0ljDFEY1ki_o9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlemtb8%253D&md5=d28fa3d4f1b17ec95b53c228c7dd9d25</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006247%26sid%3Dliteratum%253Aachs%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DBiochemistry%2520and%2520cell%2520biology%2520of%2520tau%2520protein%2520in%2520neurofibrillary%2520degeneration%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da006247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Himmelstein, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancia, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, L. I.</span><span> </span><span class="NLM_article-title">Tau as a therapeutic target in neurodegenerative disease</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.pharmthera.2012.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22790092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFahsbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2012&pages=8-22&author=D.+S.+Himmelsteinauthor=S.+M.+Wardauthor=J.+K.+Lanciaauthor=K.+R.+Pattersonauthor=L.+I.+Binder&title=Tau+as+a+therapeutic+target+in+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Tau as a therapeutic target in neurodegenerative disease</span></div><div class="casAuthors">Himmelstein, Diana S.; Ward, Sarah M.; Lancia, Jody K.; Patterson, Kristina R.; Binder, Lester I.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-22</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Tau is a microtubule-assocd. protein thought to help modulate the stability of neuronal microtubules.  In tauopathies, including Alzheimer's disease and several frontotemporal dementias, tau is abnormally modified and misfolded resulting in its disassocn. from microtubules and the generation of pathol. lesions characteristic for each disease.  A recent surge in the population of people with neurodegenerative tauopathies has highlighted the immense need for disease-modifying therapies for these conditions, and new attention has focused on tau as a potential target for intervention.  In the current work we summarize evidence linking tau to disease pathogenesis and review recent therapeutic approaches aimed at ameliorating tau dysfunction.  The primary therapeutic tactics considered include kinase inhibitors and phosphatase activators, immunotherapies, small mol. inhibitors of protein aggregation, and microtubule-stabilizing agents.  Although the evidence for tau-based treatments is encouraging, addnl. work is undoubtedly needed to optimize each treatment strategy for the successful development of safe and effective therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2FtQkgbrvLLVg90H21EOLACvtfcHk0ljDFEY1ki_o9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFahsbjM&md5=6dfd790eccaec71c2baf56a9967eb734</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2012.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2012.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DHimmelstein%26aufirst%3DD.%2BS.%26aulast%3DWard%26aufirst%3DS.%2BM.%26aulast%3DLancia%26aufirst%3DJ.%2BK.%26aulast%3DPatterson%26aufirst%3DK.%2BR.%26aulast%3DBinder%26aufirst%3DL.%2BI.%26atitle%3DTau%2520as%2520a%2520therapeutic%2520target%2520in%2520neurodegenerative%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2012%26volume%3D136%26spage%3D8%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Noble, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pooler, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanger, D. P.</span><span> </span><span class="NLM_article-title">Advances in tau-based drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=797-810&author=W.+Nobleauthor=A.+M.+Poolerauthor=D.+P.+Hanger&title=Advances+in+tau-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoble%26aufirst%3DW.%26aulast%3DPooler%26aufirst%3DA.%2BM.%26aulast%3DHanger%26aufirst%3DD.%2BP.%26atitle%3DAdvances%2520in%2520tau-based%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D797%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D. M.</span><span> </span><span class="NLM_article-title">Modulation of protein–protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F156802611794072605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21320060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslahsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=317-330&author=C.+Ballatoreauthor=K.+R.+Brundenauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=A.+B.+Smithauthor=D.+M.+Huryn&title=Modulation+of+protein%E2%80%93protein+interactions+as+a+therapeutic+strategy+for+the+treatment+of+neurodegenerative+tauopathies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies</span></div><div class="casAuthors">Ballatore, C.; Brunden, K. R.; Trojanowski, J. Q.; Lee, V. M.-Y.; Smith, A. B., III; Huryn, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-330</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The recognition that malfunction of the microtubule (MT) assocd. protein tau is likely to play a defining role in the onset and/or progression of a no. of neurodegenerative diseases, including Alzheimer's disease, has resulted in the initiation of drug discovery programs that target this protein.  Tau is an endogenous MT-stabilizing agent that is highly expressed in the axons of neurons.  The MT-stabilizing function of tau is essential for the axonal transport of proteins, neurotransmitters and other cellular constituents.  Under pathol. conditions, tau misfolding and aggregation results in axonal transport deficits that appear to have deleterious consequences for the affected neurons, leading to synapse dysfunction and, ultimately, neuronal loss.  This review focuses on both progress and unresolved issues surrounding the development of novel therapeutics for the treatment of neurodegenerative tauopathies, which are based on (A) MT-stabilizing agents to compensate for the loss of normal tau function and (B) small mol. inhibitors of tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRv3v9WR9uIrVg90H21EOLACvtfcHk0lgOtjDxdJ3Mgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslahsLk%253D&md5=b35d6ff9dac27b56e59f1e2fd5b8fafd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F156802611794072605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611794072605%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26atitle%3DModulation%2520of%2520protein%25E2%2580%2593protein%2520interactions%2520as%2520a%2520therapeutic%2520strategy%2520for%2520the%2520treatment%2520of%2520neurodegenerative%2520tauopathies%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D317%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Advances in tau-focused drug discovery for Alzheimer’s disease and related tauopathies</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=783-793&author=K.+R.+Brundenauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=Advances+in+tau-focused+drug+discovery+for+Alzheimer%E2%80%99s+disease+and+related+tauopathies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DAdvances%2520in%2520tau-focused%2520drug%2520discovery%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520related%2520tauopathies%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D783%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Rosenmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoriadis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karussis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boimel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Touloumi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovadia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramsky, O.</span><span> </span><span class="NLM_article-title">Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1459</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1001%2Farchneur.63.10.1459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17030663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BD28rpvVenuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2006&pages=1459-1467&author=H.+Rosenmannauthor=N.+Grigoriadisauthor=D.+Karussisauthor=M.+Boimelauthor=O.+Touloumiauthor=H.+Ovadiaauthor=O.+Abramsky&title=Tauopathy-like+abnormalities+and+neurologic+deficits+in+mice+immunized+with+neuronal+tau+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein</span></div><div class="casAuthors">Rosenmann Hanna; Grigoriadis Nikolaos; Karussis Dimitrios; Boimel Moran; Touloumi Olga; Ovadia Haim; Abramsky Oded</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1459-67</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">BACKGROUND:  A possible role of autoimmunity in Alzheimer disease pathogenesis has recently attracted increasing attention.  Vaccination with amyloid-beta peptide was reported to cause marked reduction in amyloid deposition, but it also induced encephalitis.  Not much is known regarding neurofibrillary tangle-related autoimmune effects.  OBJECTIVE:  To use the main component of tangles-microtubule-associated tau protein-to test the feasibility of active induction of a neuroautoimmune disorder in mice.  DESIGN:  Prospective, randomized controlled animal study.  SETTING:  University medical center research laboratory.  Subjects Female C57BL/6 mice.  INTERVENTIONS:  Inoculation with recombinant human tau protein emulsified in complete Freund adjuvant and with pertussis toxin.  MAIN OUTCOME MEASURES:  Clinical, immunologic, pathologic, and behavioral evaluations were performed.  RESULTS:  Vaccination with tau protein induced histopathologic features of Alzheimer disease and tauopathies, indicated by the presence of neurofibrillary tangle-like structures, axonal damage, and gliosis.  Also, mononuclear infiltrates without demyelination in the central nervous system, accompanied by neurologic deficits (such as a limp tail and limb paralysis), were observed.  Anti-tau antibodies were detected in the serum of tau-immunized mice.  CONCLUSIONS:  These results provide a link between tau autoimmunity and tauopathy-like abnormalities and indicate potential dangers of using tau for immunotherapy.  This experimental autoimmune tauopathy-like model is due to a pathogenic immune response against an intraneuronal antigen and is not related to myelin antigens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_SFNfeu3JABJ5E29YNGvQfW6udTcc2eZea-j8WU0-T7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rpvVenuw%253D%253D&md5=ee600b23d1c1bc944bca30f66f53c25e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1001%2Farchneur.63.10.1459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.63.10.1459%26sid%3Dliteratum%253Aachs%26aulast%3DRosenmann%26aufirst%3DH.%26aulast%3DGrigoriadis%26aufirst%3DN.%26aulast%3DKarussis%26aufirst%3DD.%26aulast%3DBoimel%26aufirst%3DM.%26aulast%3DTouloumi%26aufirst%3DO.%26aulast%3DOvadia%26aufirst%3DH.%26aulast%3DAbramsky%26aufirst%3DO.%26atitle%3DTauopathy-like%2520abnormalities%2520and%2520neurologic%2520deficits%2520in%2520mice%2520immunized%2520with%2520neuronal%2520tau%2520protein%26jtitle%3DArch.%2520Neurol.%26date%3D2006%26volume%3D63%26spage%3D1459%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Boimel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoriadis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lourbopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramsky, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenmann, H.</span><span> </span><span class="NLM_article-title">Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">224</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.expneurol.2010.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20546729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFCgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2010&pages=472-485&author=M.+Boimelauthor=N.+Grigoriadisauthor=A.+Lourbopoulosauthor=E.+Haberauthor=O.+Abramskyauthor=H.+Rosenmann&title=Efficacy+and+safety+of+immunization+with+phosphorylated+tau+against+neurofibrillary+tangles+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice</span></div><div class="casAuthors">Boimel, Moran; Grigoriadis, Nikolaos; Lourbopoulos, Athanasios; Haber, Esther; Abramsky, Oded; Rosenmann, Hanna</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">472-485</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As an abnormally folded and aggregated protein, tau composed of neurofibrillary tangles (NFTs) in Alzheimer's disease and other tauopathies seems to be a candidate for immunotherapy.  Yet, the encephalitogenicity of full-length tau protein, recently reported by us in immunized mice, demands to carefully and selectively target pathol. tau and address both efficacy (anti-NFT effect) and safety (free of encephalitis).  We immunized NFT mice with NFT-related phosphorylated (phos) tau peptides, using an immunization protocol aimed to predispose a proinflammatory milieu in CNS as a set up to detect biohazard, an approach we used when the neurotoxicity of full-length tau was detected [use of complete Freund adjuvant (CFA) with pertussis toxin (PT)].  A decrease of about 40% in NFT burden in CNS was demonstrated and was accompanied with an increase in microglial burden.  Anti-phos-tau antibodies were detected in serum and blood vessels in the CNS, while no encephalitogenicity (free of clin. neurol. deficits, of adverse effects on brain inflammatory cells and of axonal damage) was recorded.  The level of the lysosomal proteases, cathepsins D and L, was affected in the immunized mice suggesting the possible involvement of the lysosomal system in the decrease of NFTs.  The robust anti-NFT effect and the lack of encephalitogenicity in NFT mice immunized with phos-tau peptides, even though CFA with PT was included in vaccine, point to their anti-NFT therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPkI0KKjFAo7Vg90H21EOLACvtfcHk0lgOtjDxdJ3Mgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFCgt7s%253D&md5=73c4539303a642b21109966ca35a71c9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2010.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2010.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DBoimel%26aufirst%3DM.%26aulast%3DGrigoriadis%26aufirst%3DN.%26aulast%3DLourbopoulos%26aufirst%3DA.%26aulast%3DHaber%26aufirst%3DE.%26aulast%3DAbramsky%26aufirst%3DO.%26aulast%3DRosenmann%26aufirst%3DH.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520immunization%2520with%2520phosphorylated%2520tau%2520against%2520neurofibrillary%2520tangles%2520in%2520mice%26jtitle%3DExp.%2520Neurol.%26date%3D2010%26volume%3D224%26spage%3D472%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Asuni, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutajangout, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quartermain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdsson, E. M.</span><span> </span><span class="NLM_article-title">Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">9115</span><span class="NLM_x">–</span> <span class="NLM_lpage">9129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1523%2FJNEUROSCI.2361-07.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17715348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSnsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=9115-9129&author=A.+A.+Asuniauthor=A.+Boutajangoutauthor=D.+Quartermainauthor=E.+M.+Sigurdsson&title=Immunotherapy+targeting+pathological+tau+conformers+in+a+tangle+mouse+model+reduces+brain+pathology+with+associated+functional+improvements"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy targeting pathological Tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements</span></div><div class="casAuthors">Asuni, Ayodeji A.; Boutajangout, Allal; Quartermain, David; Sigurdsson, Einar M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">9115-9129</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Immunotherapies for various neurodegenerative diseases have recently emerged as a promising approach for clearing pathol. protein conformers in these disorders.  This type of treatment has not been assessed in models that develop neuronal tau aggregates as obsd. in frontotemporal dementia and Alzheimer's disease.  Here, we present that active immunization with a phosphorylated tau epitope, in P301L tangle model mice, reduces aggregated tau in the brain and slows progression of the tangle-related behavioral phenotype.  Females had more tau pathol. than males but were also more receptive to the immunotherapy.  The tau antibodies generated in these animals recognized pathol. tau on brain sections.  Performance on behavioral assays that require extensive motor coordination correlated with tau pathol. in corresponding brain areas, and antibody levels against the immunogen correlated inversely with tau pathol.  Interestingly, age-dependent autoantibodies that recognized recombinant tau protein but not the immunogen were detected in the P301L mice.  To confirm that anti-tau antibodies could enter the brain and bind to pathol. tau, FITC-tagged antibodies purified from a P301L mouse, with a high antibody titer against the immunogen, were injected into the carotid artery of P301L mice.  These antibodies were subsequently detected within the brain and colocalized with PHF1 and MC1 antibodies that recognize pathol. tau.  Currently, no treatment is available for clearing tau aggregates.  Our present findings may lead to a novel therapy targeting one of the major hallmarks of Alzheimer's disease and frontotemporal dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkAMut_6Cw-7Vg90H21EOLACvtfcHk0ljgttr-bJzoMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSnsLbN&md5=7336ed21cebd455b68db373044bf3797</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2361-07.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2361-07.2007%26sid%3Dliteratum%253Aachs%26aulast%3DAsuni%26aufirst%3DA.%2BA.%26aulast%3DBoutajangout%26aufirst%3DA.%26aulast%3DQuartermain%26aufirst%3DD.%26aulast%3DSigurdsson%26aufirst%3DE.%2BM.%26atitle%3DImmunotherapy%2520targeting%2520pathological%2520tau%2520conformers%2520in%2520a%2520tangle%2520mouse%2520model%2520reduces%2520brain%2520pathology%2520with%2520associated%2520functional%2520improvements%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D9115%26epage%3D9129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Boutajangout, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quartermain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdsson, E. M.</span><span> </span><span class="NLM_article-title">Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">16559</span><span class="NLM_x">–</span> <span class="NLM_lpage">16566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1523%2FJNEUROSCI.4363-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21147995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2nurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=16559-16566&author=A.+Boutajangoutauthor=D.+Quartermainauthor=E.+M.+Sigurdsson&title=Immunotherapy+targeting+pathological+tau+prevents+cognitive+decline+in+a+new+tangle+mouse+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy targeting pathological Tau prevents cognitive decline in a new tangle mouse model</span></div><div class="casAuthors">Boutajangout, Allal; Quartermain, David; Sigurdsson, Einar M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">16559-16566</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Harnessing the immune system to clear protein aggregates is emerging as a promising approach to treat various neurodegenerative diseases.  In Alzheimer's disease (AD), several clin. trials are ongoing using active and passive immunotherapy targeting the amyloid-β (Aβ) peptide.  Limited emphasis has been put into clearing tau/tangle pathol., another major hallmark of the disease.  Recent findings from the first Aβ vaccination trial suggest that this approach has limited effect on tau pathol. and that Aβ plaque clearance may not halt or slow the progression of dementia in individuals with mild-to-moderate AD.  To assess within a reasonable timeframe whether targeting tau pathol. with immunotherapy could prevent cognitive decline, we developed a new model with accelerated tangle development.  It was generated by crossing available strains that express all six human tau isoforms and the M146L presenilin mutation.  Here, we show that this unique approach completely prevents severe cognitive impairment in three different tests.  This remarkable effect correlated well with extensive clearance of abnormal tau within the brain.  Overall, our findings indicate that immunotherapy targeting pathol. tau is very feasible for tauopathies, and should be assessed in clin. trials in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcNSh5qcUrb7Vg90H21EOLACvtfcHk0ljgttr-bJzoMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2nurjI&md5=54d56cb56f1981982c781c2c8b86a07e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4363-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4363-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DBoutajangout%26aufirst%3DA.%26aulast%3DQuartermain%26aufirst%3DD.%26aulast%3DSigurdsson%26aufirst%3DE.%2BM.%26atitle%3DImmunotherapy%2520targeting%2520pathological%2520tau%2520prevents%2520cognitive%2520decline%2520in%2520a%2520new%2520tangle%2520mouse%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D16559%26epage%3D16566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Troquier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caillierez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnouf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Gomez, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosjean, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zommer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sergeant, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schraen-Maschke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buee, L.</span><span> </span><span class="NLM_article-title">Targeting phospho-Ser422 by active Tau immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F156720512800492503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22272619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BC38vhtVOhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=397-405&author=L.+Troquierauthor=R.+Caillierezauthor=S.+Burnoufauthor=F.+J.+Fernandez-Gomezauthor=M.+E.+Grosjeanauthor=N.+Zommerauthor=N.+Sergeantauthor=S.+Schraen-Maschkeauthor=D.+Blumauthor=L.+Buee&title=Targeting+phospho-Ser422+by+active+Tau+immunotherapy+in+the+THYTau22+mouse+model%3A+a+suitable+therapeutic+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach</span></div><div class="casAuthors">Troquier Laetitia; Caillierez Raphaelle; Burnouf Sylvie; Fernandez-Gomez Francisco J; Grosjean Marie-Eve; Zommer Nadege; Sergeant Nicolas; Schraen-Maschke Susanna; Blum David; Buee Luc</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">397-405</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recent data indicate that Tau immunotherapy may be relevant for interfering with neurofibrillary degeneration in Alzheimer disease and related disorders referred to as Tauopathies.  The key question for immunotherapy is the choice of the epitope to target.  Abnormal phosphorylation is a well-described post-translational modification of Tau proteins and may be a good target.  In the present study, we investigated the effects of active immunization against the pathological epitope phospho-Ser422 in the THY-Tau22 transgenic mouse model.  Starting from 3-6 months of age, THY-Tau22 mice develop hippocampal neurofibrillary tangle-like inclusions and exhibit phosphorylation of Tau on several AD-relevant Tau epitopes.  Three month-old THY-Tau22 mice were immunized with a peptide including the phosphoserine 422 residue while control mice received the adjuvant alone.  A specific antibody response against the phospho-Ser422 epitope was observed.  We noticed a decrease in insoluble Tau species (AT100- and pS422 immunoreactive) by both biochemical and immunohistochemical means correlated with a significant cognitive improvement using the Y-maze.  This Tau immunotherapy may facilitate Tau clearance from the brain toward the periphery since, following immunization, an increase in Tau concentrations was observed in blood.  Overall, the present work is, to our knowledge, the first one to demonstrate that active immunotherapy targeting a real pathological epitope such as phospho-Ser422 epitope is efficient.  This immunotherapy allows for Tau clearance and improves cognitive deficits promoted by Tau pathology in a well-defined Tau transgenic model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTgT9V41xcvEiA3UY9EwTNrfW6udTcc2eafEa7XyBX9V7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vhtVOhsA%253D%253D&md5=a235e28d9582ae33719f29f15ce68c86</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F156720512800492503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720512800492503%26sid%3Dliteratum%253Aachs%26aulast%3DTroquier%26aufirst%3DL.%26aulast%3DCaillierez%26aufirst%3DR.%26aulast%3DBurnouf%26aufirst%3DS.%26aulast%3DFernandez-Gomez%26aufirst%3DF.%2BJ.%26aulast%3DGrosjean%26aufirst%3DM.%2BE.%26aulast%3DZommer%26aufirst%3DN.%26aulast%3DSergeant%26aufirst%3DN.%26aulast%3DSchraen-Maschke%26aufirst%3DS.%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DBuee%26aufirst%3DL.%26atitle%3DTargeting%2520phospho-Ser422%2520by%2520active%2520Tau%2520immunotherapy%2520in%2520the%2520THYTau22%2520mouse%2520model%253A%2520a%2520suitable%2520therapeutic%2520approach%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2012%26volume%3D9%26spage%3D397%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Boutajangout, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingadottir, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdsson, E. M.</span><span> </span><span class="NLM_article-title">Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1471-4159.2011.07337.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21644996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVSit7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=658-667&author=A.+Boutajangoutauthor=J.+Ingadottirauthor=P.+Daviesauthor=E.+M.+Sigurdsson&title=Passive+immunization+targeting+pathological+phospho-tau+protein+in+a+mouse+model+reduces+functional+decline+and+clears+tau+aggregates+from+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain</span></div><div class="casAuthors">Boutajangout, Allal; Ingadottir, Johanna; Davies, Peter; Sigurdsson, Einar M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3 & 4</span>),
    <span class="NLM_cas:pages">658-667</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Targeting hyperphosphorylated tau by immunotherapy is emerging as a promising approach to treat tauopathies such as Alzheimer's disease and frontotemporal dementia.  The authors have previously reported that active tau immunization clears tau aggregates from the brain and attenuates or prevents functional impairments in two different tangle mouse models.  Here, the authors assessed the efficacy of passive immunization with the PHF1 antibody, which targets a phospho-epitope within one of the authors' active immunogens.  Homozygous female tangle mice (JNPL3, 2-3 mo) were injected i.p. once per wk with PHF1 or pooled mouse IgG (250 μg/125 μL; per group) for a total of 13 injections.  Their behavior was assessed at 5-6 mo of age and brain tissue was subsequently harvested for analyses of treatment efficacy.  The treated mice performed better than controls on the traverse beam task, and had 58% less tau pathol. in the dentate gyrus of the hippocampus.  As assessed by western blots, the antibody therapy reduced the levels of insol. pathol. tau by 14-27% (PHF1,; PHF1/total tau) and 34-45% (CP13 or CP13/total tau).  Levels of sol. tau and sarkosyl sol. tau were unchanged, compared with controls, as well as total tau levels in all the fractions.  Plasma levels of PHF1 correlated inversely with tau pathol. in the brainstem, with a strong trend in the motor cortex as well as with insol. total tau levels, indicating that higher dose of antibodies may have a greater therapeutic effect.  Significant correlation was also obsd. between performance on the traverse beam task and PHF1 immunoreactivity in the dentate gyrus as well as with insol. PHF1/total tau ratio on western blots.  These results show that passive immunization with tau antibodies can decrease tau pathol. and functional impairments in the JNPL3 model.  Future studies will det. the feasibility of this approach with other monoclonals and in different tangle models in which thorough cognitive assessment can be performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZcfYAUWLolLVg90H21EOLACvtfcHk0lglfAyezmWFfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVSit7bM&md5=cf6d19f67cf7400b2aa3cdf78460251f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07337.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07337.x%26sid%3Dliteratum%253Aachs%26aulast%3DBoutajangout%26aufirst%3DA.%26aulast%3DIngadottir%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DSigurdsson%26aufirst%3DE.%2BM.%26atitle%3DPassive%2520immunization%2520targeting%2520pathological%2520phospho-tau%2520protein%2520in%2520a%2520mouse%2520model%2520reduces%2520functional%2520decline%2520and%2520clears%2520tau%2520aggregates%2520from%2520the%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D2011%26volume%3D118%26spage%3D658%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Chai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cella, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanmer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">34457</span><span class="NLM_x">–</span> <span class="NLM_lpage">34467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=34457-34467&author=X.+Chaiauthor=S.+Wuauthor=T.+K.+Murrayauthor=R.+Kinleyauthor=C.+V.+Cellaauthor=H.+Simsauthor=N.+Bucknerauthor=J.+Hanmerauthor=P.+Daviesauthor=M.+J.+O%E2%80%99Neillauthor=M.+L.+Huttonauthor=M.+Citron&title=Passive+immunization+with+anti-Tau+antibodies+in+two+transgenic+models%3A+reduction+of+Tau+pathology+and+delay+of+disease+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DT.%2BK.%26aulast%3DKinley%26aufirst%3DR.%26aulast%3DCella%26aufirst%3DC.%2BV.%26aulast%3DSims%26aufirst%3DH.%26aulast%3DBuckner%26aufirst%3DN.%26aulast%3DHanmer%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DHutton%26aufirst%3DM.%2BL.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DPassive%2520immunization%2520with%2520anti-Tau%2520antibodies%2520in%2520two%2520transgenic%2520models%253A%2520reduction%2520of%2520Tau%2520pathology%2520and%2520delay%2520of%2520disease%2520progression%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D34457%26epage%3D34467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Krishnamurthy, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdsson, E. M.</span><span> </span><span class="NLM_article-title">Mechanistic studies of antibody-mediated clearance of Tau aggregates using an ex vivo brain slice model</span> <span class="citation_source-journal">Front. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.3389%2Ffpsyt.2011.00059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BC3MbjvVaisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=59&author=P.+K.+Krishnamurthyauthor=Y.+Dengauthor=E.+M.+Sigurdsson&title=Mechanistic+studies+of+antibody-mediated+clearance+of+Tau+aggregates+using+an+ex+vivo+brain+slice+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic Studies of Antibody-Mediated Clearance of Tau Aggregates Using an ex vivo Brain Slice Model</span></div><div class="casAuthors">Krishnamurthy Pavan K; Deng Yan; Sigurdsson Einar M</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in psychiatry / Frontiers Research Foundation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recent studies have shown that immunotherapy clears amyloid beta (Aβ) plaques and reduces Aβ levels in mouse models of Alzheimer's disease (AD), as well as in AD patients.  Tangle pathology is also relevant for the neurodegeneration in AD, and our studies have shown that active immunization with an AD related phospho-tau peptide reduces aggregated tau within the brain and slows the progression of tauopathy-induced behavioral impairments.  Thus, clearance of neurofibrillary tangles and/or their precursors may reduce synaptic and neuronal loss associated with AD and other tauopathies.  So far the mechanisms involved in antibody-mediated clearance of tau pathology are yet to be elucidated.  In this study we have used a mouse brain slice model to examine the uptake and localization of FITC labeled anti-tau antibodies.  Confocal microscopy analysis showed that the FITC labeled anti-tau antibody co-stained with phosphorylated tau, had a perinuclear appearance and co-localized with markers of the endosomal/lysosomal pathway.  Additionally, tau and FITC-IgG were found together in an enriched lysosome fraction.  In summary, antibody-mediated clearance of intracellular tau aggregates appears to occur via the lysosomal pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTPw3xVJ6b_IkFb3mqPUYDfW6udTcc2eY8i0Wf5cq8f7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbjvVaisw%253D%253D&md5=2dd9b2f7f86770907d5608bf73546bea</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3389%2Ffpsyt.2011.00059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffpsyt.2011.00059%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnamurthy%26aufirst%3DP.%2BK.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DSigurdsson%26aufirst%3DE.%2BM.%26atitle%3DMechanistic%2520studies%2520of%2520antibody-mediated%2520clearance%2520of%2520Tau%2520aggregates%2520using%2520an%2520ex%2520vivo%2520brain%2520slice%2520model%26jtitle%3DFront.%2520Psychiatry%26date%3D2011%26volume%3D2%26spage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latypova, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terro, F.</span><span> </span><span class="NLM_article-title">Post-translational modifications of tau protein: implications for Alzheimer’s disease</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.neuint.2010.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21215781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFGnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2011&pages=458-471&author=L.+Martinauthor=X.+Latypovaauthor=F.+Terro&title=Post-translational+modifications+of+tau+protein%3A+implications+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Post-translational modifications of tau protein: Implications for Alzheimer's disease</span></div><div class="casAuthors">Martin, Ludovic; Latypova, Xenia; Terro, Faraj</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-471</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) belongs to a group of neurodegenerative diseases collectively designated as "tauopathies", because they are characterized by the aggregation of abnormally phosphorylated tau protein.  The mechanisms responsible for tau aggregation and its contribution to neurodegeneration are still unknown.  Thereby, understanding the modes of regulation of tau is of high interest in the detn. of the possible causes at the origin of the formation of tau aggregates and to elaborate protection strategies to cope with these pathol. lesions.  The regulation of tau takes place predominantly through post-translational modifications.  Extensive reports have been published about tau phosphorylation; however, the other tau post-translational modifications have received much less attention.  Here, we review the different types of post-translational modifications of tau including phosphorylation, glycosylation, glycation, prolyl-isomerization, cleavage or truncation, nitration, polyamination, ubiquitination, sumoylation, oxidn. and aggregation, with a particular interest towards their relevance in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsG774y8lsNrVg90H21EOLACvtfcHk0lglfAyezmWFfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFGnsLo%253D&md5=dde6742c84b61e90575c394bbe05c55a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2010.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2010.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLatypova%26aufirst%3DX.%26aulast%3DTerro%26aufirst%3DF.%26atitle%3DPost-translational%2520modifications%2520of%2520tau%2520protein%253A%2520implications%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurochem.%2520Int.%26date%3D2011%26volume%3D58%26spage%3D458%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hanger, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderton, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, W.</span><span> </span><span class="NLM_article-title">Tau phosphorylation: the therapeutic challenge for neurodegenerative disease</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.molmed.2009.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=19246243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1ahu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=112-119&author=D.+P.+Hangerauthor=B.+H.+Andertonauthor=W.+Noble&title=Tau+phosphorylation%3A+the+therapeutic+challenge+for+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Tau phosphorylation: the therapeutic challenge for neurodegenerative disease</span></div><div class="casAuthors">Hanger, Diane P.; Anderton, Brian H.; Noble, Wendy</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">112-119</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The microtubule-assocd. protein tau is integral to the pathogenesis of Alzheimer's disease (AD), as well as several related disorders, termed tauopathies, in which tau is deposited in affected brain regions.  In the tauopathies, pathol. tau is in an elevated state of phosphorylation and is aberrantly cleaved.  It also exhibits abnormal conformations and becomes aggregated, resulting in neurofibrillary tau pathol.  Recent evidence suggests that relatively early disease-assocd. changes in sol. tau proteins, including phosphorylation, are involved in the induction of neuronal death.  Here, we summarize recent developments that suggest new therapeutic strategies to prevent or reduce the progression of pathol. in the tauopathies.  A list of tau phosphorylation sites identified in the tauopathies and in controls accompanies this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8l3EQ3bznVLVg90H21EOLACvtfcHk0lj8V0bnwFLpKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1ahu7w%253D&md5=116159eeaae25800a22b687f36df70e2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2009.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2009.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DHanger%26aufirst%3DD.%2BP.%26aulast%3DAnderton%26aufirst%3DB.%2BH.%26aulast%3DNoble%26aufirst%3DW.%26atitle%3DTau%2520phosphorylation%253A%2520the%2520therapeutic%2520challenge%2520for%2520neurodegenerative%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2009%26volume%3D15%26spage%3D112%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Min, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haroutunian, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeley, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, L.</span><span> </span><span class="NLM_article-title">Acetylation of tau inhibits its degradation and contributes to tauopathy</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.neuron.2010.08.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20869593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Wisr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=953-966&author=S.+W.+Minauthor=S.+H.+Choauthor=Y.+Zhouauthor=S.+Schroederauthor=V.+Haroutunianauthor=W.+W.+Seeleyauthor=E.+J.+Huangauthor=Y.+Shenauthor=E.+Masliahauthor=C.+Mukherjeeauthor=D.+Meyersauthor=P.+A.+Coleauthor=M.+Ottauthor=L.+Gan&title=Acetylation+of+tau+inhibits+its+degradation+and+contributes+to+tauopathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy</span></div><div class="casAuthors">Min, Sang-Won; Cho, Seo-Hyun; Zhou, Yungui; Schroeder, Sebastian; Haroutunian, Vahram; Seeley, William W.; Huang, Eric J.; Shen, Yong; Masliah, Eliezer; Mukherjee, Chandrani; Meyers, David; Cole, Philip A.; Ott, Melanie; Gan, Li</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">953-966</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Neurodegenerative tauopathies characterized by hyperphosphorylated tau include frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17) and Alzheimer's disease (AD).  Reducing tau levels improves cognitive function in mouse models of AD and FTDP-17, but the mechanisms regulating the turnover of pathogenic tau are unknown.  We found that tau is acetylated and that tau acetylation prevents degrdn. of phosphorylated tau (p-tau).  We generated 2 antibodies specific for acetylated tau and showed that tau acetylation is elevated in patients at early and moderate Braak stages of tauopathy.  Histone acetyltransferase p300 was involved in tau acetylation and the class III protein deacetylase SIRT1 in deacetylation.  Deleting SIRT1 enhanced levels of acetylated-tau and pathogenic forms of p-tau, probably by blocking proteasome-mediated degrdn.  Inhibiting p300 with a small mol. promoted tau deacetylation and eliminated p-tau assocd. with tauopathy.  Modulating tau acetylation could be a new therapeutic strategy to reduce tau-mediated neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8new1uGtz27Vg90H21EOLACvtfcHk0lj8V0bnwFLpKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Wisr3K&md5=047a89c3a8d161d4cb24f6590046fd2c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2010.08.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2010.08.044%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DS.%2BW.%26aulast%3DCho%26aufirst%3DS.%2BH.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSchroeder%26aufirst%3DS.%26aulast%3DHaroutunian%26aufirst%3DV.%26aulast%3DSeeley%26aufirst%3DW.%2BW.%26aulast%3DHuang%26aufirst%3DE.%2BJ.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DMukherjee%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DD.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DOtt%26aufirst%3DM.%26aulast%3DGan%26aufirst%3DL.%26atitle%3DAcetylation%2520of%2520tau%2520inhibits%2520its%2520degradation%2520and%2520contributes%2520to%2520tauopathy%26jtitle%3DNeuron%26date%3D2010%26volume%3D67%26spage%3D953%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Jana, N. R.</span><span> </span><span class="NLM_article-title">Protein homeostasis and aging: role of ubiquitin protein ligases</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.neuint.2012.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22353631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkslejs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=443-447&author=N.+R.+Jana&title=Protein+homeostasis+and+aging%3A+role+of+ubiquitin+protein+ligases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Protein homeostasis and aging: Role of ubiquitin protein ligases</span></div><div class="casAuthors">Jana, Nihar Ranjan</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">443-447</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein homeostasis is fundamental in normal cellular function and cell survival.  The ubiquitin-proteasome system (UPS) plays a central role in maintaining the protein homeostasis network through selective elimination of misfolded and damaged proteins.  Impaired function of UPS is implicated in normal aging process and also in several age-related neurodegenerative disorders that are characterized by increased accumulation oxidatively modified proteins and protein aggregates.  Growing literature also indicate the potential role of various ubiquitin protein ligases in the regulation of aging process by enhancing the degrdn. of either central lifespan regulators or abnormally folded and damaged proteins.  This review mainly focuses on our current understanding of the importance of UPS function in the regulation of normal aging process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY2AxLRE_y07Vg90H21EOLACvtfcHk0ljrBxisoTFf4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkslejs7c%253D&md5=8fa96e8d3d6d0af79a876948b899ebb4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2012.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2012.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DJana%26aufirst%3DN.%2BR.%26atitle%3DProtein%2520homeostasis%2520and%2520aging%253A%2520role%2520of%2520ubiquitin%2520protein%2520ligases%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D60%26spage%3D443%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Vicente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaushik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuervo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4153</span><span class="NLM_x">–</span> <span class="NLM_lpage">4170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1093%2Fhmg%2Fddp367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=19654187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1CrtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=4153-4170&author=Y.+Wangauthor=M.+Martinez-Vicenteauthor=U.+Krugerauthor=S.+Kaushikauthor=E.+Wongauthor=E.+M.+Mandelkowauthor=A.+M.+Cuervoauthor=E.+Mandelkow&title=Tau+fragmentation%2C+aggregation+and+clearance%3A+the+dual+role+of+lysosomal+processing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Tau fragmentation, aggregation and clearance: The dual role of lysosomal processing</span></div><div class="casAuthors">Wang, Yipeng; Martinez-Vicente, Marta; Krueger, Ulrike; Kaushik, Susmita; Wong, Esther; Mandelkow, Eva-Maria; Cuervo, Ana Maria; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4153-4170</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aggregation and cleavage are two hallmarks of Tau pathol. in Alzheimer disease (AD), and abnormal fragmentation of Tau is thought to contribute to the nucleation of Tau paired helical filaments.  Clearance of the abnormally modified protein could occur by the ubiquitin-proteasome and autophagy-lysosomal pathways, the two major routes for protein degrdn. in cells.  There is a debate on which of these pathways contributes to clearance of Tau protein and of the abnormal Tau aggregates formed in AD.  Here, we demonstrate in an inducible neuronal cell model of tauopathy that the autophagy-lysosomal system contributes to both Tau fragmentation into pro-aggregating forms and to clearance of Tau aggregates.  Inhibition of macroautophagy enhances Tau aggregation and cytotoxicity.  The Tau repeat domain can be cleaved near the N terminus by a cytosolic protease to generate the fragment F1.  Addnl. cleavage near the C terminus by the lysosomal protease cathepsin L is required to generate Tau fragments F2 and F3 that are highly amyloidogenic and capable of seeding the aggregation of Tau.  We identify in this work that components of a selective form of autophagy, chaperone-mediated autophagy, are involved in the delivery of cytosolic Tau to lysosomes for this limited cleavage.  However, F1 does not fully enter the lysosome but remains assocd. with the lysosomal membrane.  Inefficient translocation of the Tau fragments across the lysosomal membrane seems to promote formation of Tau oligomers at the surface of these organelles which may act as precursors of aggregation and interfere with lysosomal functioning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyBU3e86nzELVg90H21EOLACvtfcHk0ljrBxisoTFf4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1CrtrrI&md5=1445a4552030dbcab3dc2c90e39606f7</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddp367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddp367%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMartinez-Vicente%26aufirst%3DM.%26aulast%3DKruger%26aufirst%3DU.%26aulast%3DKaushik%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DCuervo%26aufirst%3DA.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DTau%2520fragmentation%252C%2520aggregation%2520and%2520clearance%253A%2520the%2520dual%2520role%2520of%2520lysosomal%2520processing%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2009%26volume%3D18%26spage%3D4153%26epage%3D4170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ravikumar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinsztein, D. C.</span><span> </span><span class="NLM_article-title">Can autophagy protect against neurodegeneration caused by aggregate-prone proteins?</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2443</span><span class="NLM_x">–</span> <span class="NLM_lpage">2445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=2443-2445&author=B.+Ravikumarauthor=D.+C.+Rubinsztein&title=Can+autophagy+protect+against+neurodegeneration+caused+by+aggregate-prone+proteins%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRavikumar%26aufirst%3DB.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26atitle%3DCan%2520autophagy%2520protect%2520against%2520neurodegeneration%2520caused%2520by%2520aggregate-prone%2520proteins%253F%26jtitle%3DNeuroReport%26date%3D2004%26volume%3D15%26spage%3D2443%26epage%3D2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Kruger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span> </span><span class="NLM_article-title">Autophagic degradation of tau in primary neurons and its enhancement by trehalose</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2291</span><span class="NLM_x">–</span> <span class="NLM_lpage">2305</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=2291-2305&author=U.+Krugerauthor=Y.+Wangauthor=S.+Kumarauthor=E.+M.+Mandelkow&title=Autophagic+degradation+of+tau+in+primary+neurons+and+its+enhancement+by+trehalose"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKruger%26aufirst%3DU.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DAutophagic%2520degradation%2520of%2520tau%2520in%2520primary%2520neurons%2520and%2520its%2520enhancement%2520by%2520trehalose%26jtitle%3DNeurobiol.%2520Aging%26date%3D2012%26volume%3D33%26spage%3D2291%26epage%3D2305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Luo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chip, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">9511</span><span class="NLM_x">–</span> <span class="NLM_lpage">9516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.0701055104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17517623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtlGqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=9511-9516&author=W.+Luoauthor=F.+Douauthor=A.+Rodinaauthor=S.+Chipauthor=J.+Kimauthor=Q.+Zhaoauthor=K.+Moulickauthor=J.+Aguirreauthor=N.+Wuauthor=P.+Greengardauthor=G.+Chiosis&title=Roles+of+heat-shock+protein+90+in+maintaining+and+facilitating+the+neurodegenerative+phenotype+in+tauopathies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies</span></div><div class="casAuthors">Luo, Wenjie; Dou, Fei; Rodina, Anna; Chip, Sophorn; Kim, Joungnam; Zhao, Qi; Moulick, Kamalika; Aguirre, Julia; Wu, Nian; Greengard, Paul; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9511-9516</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Neurodegeneration, a result of multiple dysregulatory events, is a lengthy multistep process manifested by accrual of mutant variants and abnormal expression, posttranslational modification, and processing of certain proteins.  Accumulation of these dysregulated processes requires a mechanism that maintains their functional stability and allows the evolution of the neurodegenerative phenotype.  In malignant cells, the capacity to buffer transformation has been attributed to heat-shock protein 90 (Hsp90).  Although normal proteins seem to require limited assistance from the chaperone, their aberrant counterparts seem to be highly dependent on Hsp90.  Whereas enhanced Hsp90 affinity for mutated or functionally deregulated client proteins has been obsd. for several oncoproteins, it is unknown whether Hsp90 plays a similar role for neuronal proteins and thus maintains and facilitates the transformed phenotype in neurodegenerative diseases.  Tauopathies are neurodegenerative diseases characterized by aberrant phosphorylation and/or expression of Tau protein, leading to a time-dependent accumulation of Tau aggregates and subsequent neuronal death.  Here, we show that the stability of p35, a neuronal protein that activates cyclin-dependent protein kinase 5 through complex formation leading to aberrant Tau phosphorylation, and that of mutant but not WT Tau protein is maintained in tauopathies by Hsp90.  Inhibition of Hsp90 in cellular and mouse models of tauopathies leads to a redn. of the pathogenic activity of these proteins and results in elimination of aggregated Tau.  The results identify important roles played by Hsp90 in maintaining and facilitating the degenerative phenotype in these diseases and provide a common principle governing cancer and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcCkJP_DiSK7Vg90H21EOLACvtfcHk0ljrBxisoTFf4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtlGqsr4%253D&md5=232a72b98067db9340561258ebb6fcb8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0701055104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0701055104%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DDou%26aufirst%3DF.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DChip%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DGreengard%26aufirst%3DP.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DRoles%2520of%2520heat-shock%2520protein%252090%2520in%2520maintaining%2520and%2520facilitating%2520the%2520neurodegenerative%2520phenotype%2520in%2520tauopathies%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D9511%26epage%3D9516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Dickey, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klosak, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunmore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ash, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoraka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlatkovic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahman, N. S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span> </span><span class="NLM_article-title">The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=648-658&author=C.+A.+Dickeyauthor=A.+Kamalauthor=K.+Lundgrenauthor=N.+Klosakauthor=R.+M.+Baileyauthor=J.+Dunmoreauthor=P.+Ashauthor=S.+Shorakaauthor=J.+Zlatkovicauthor=C.+B.+Eckmanauthor=C.+Pattersonauthor=D.+W.+Dicksonauthor=N.+S.+Nahmanauthor=M.+Huttonauthor=F.+Burrowsauthor=L.+Petrucelli&title=The+high-affinity+HSP90-CHIP+complex+recognizes+and+selectively+degrades+phosphorylated+tau+client+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DKlosak%26aufirst%3DN.%26aulast%3DBailey%26aufirst%3DR.%2BM.%26aulast%3DDunmore%26aufirst%3DJ.%26aulast%3DAsh%26aufirst%3DP.%26aulast%3DShoraka%26aufirst%3DS.%26aulast%3DZlatkovic%26aufirst%3DJ.%26aulast%3DEckman%26aufirst%3DC.%2BB.%26aulast%3DPatterson%26aufirst%3DC.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DNahman%26aufirst%3DN.%2BS.%26aulast%3DHutton%26aufirst%3DM.%26aulast%3DBurrows%26aufirst%3DF.%26aulast%3DPetrucelli%26aufirst%3DL.%26atitle%3DThe%2520high-affinity%2520HSP90-CHIP%2520complex%2520recognizes%2520and%2520selectively%2520degrades%2520phosphorylated%2520tau%2520client%2520proteins%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D648%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Dickey, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunmore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span> </span><span class="NLM_article-title">HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=753-755&author=C.+A.+Dickeyauthor=J.+Dunmoreauthor=B.+Luauthor=J.+W.+Wangauthor=W.+C.+Leeauthor=A.+Kamalauthor=F.+Burrowsauthor=C.+Eckmanauthor=M.+Huttonauthor=L.+Petrucelli&title=HSP+induction+mediates+selective+clearance+of+tau+phosphorylated+at+proline-directed+Ser%2FThr+sites+but+not+KXGS+%28MARK%29+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DDunmore%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DW.%2BC.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DBurrows%26aufirst%3DF.%26aulast%3DEckman%26aufirst%3DC.%26aulast%3DHutton%26aufirst%3DM.%26aulast%3DPetrucelli%26aufirst%3DL.%26atitle%3DHSP%2520induction%2520mediates%2520selective%2520clearance%2520of%2520tau%2520phosphorylated%2520at%2520proline-directed%2520Ser%252FThr%2520sites%2520but%2520not%2520KXGS%2520%2528MARK%2529%2520sites%26jtitle%3DFASEB%2520J.%26date%3D2006%26volume%3D20%26spage%3D753%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Salminen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojala, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaarniranta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiltunen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soininen, H.</span><span> </span><span class="NLM_article-title">Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer’s disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.pneurobio.2010.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21056617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BC3M7mvFSitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2011&pages=99-110&author=A.+Salminenauthor=J.+Ojalaauthor=K.+Kaarnirantaauthor=M.+Hiltunenauthor=H.+Soininen&title=Hsp90+regulates+tau+pathology+through+co-chaperone+complexes+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease</span></div><div class="casAuthors">Salminen Antero; Ojala Johanna; Kaarniranta Kai; Hiltunen Mikko; Soininen Hilkka</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neurobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-110</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease is a tauopathy which involves the deposition of microtubule-associated tau proteins into neurofibrillary tangles.  Post-translational modifications, in particular site-specific phosphorylations, affect the conformation of tau protein which is an intrinsically disordered protein.  These structural changes significantly increase the affinity of tau protein for certain molecular chaperones.  Hsp90 is a major cellular chaperone which assembles large complexes with a variety of co-chaperones.  The main function of Hsp90 complexes is to maintain protein quality control and assist in protein degradation via proteasomal and autophagic-lysosomal pathways.  Tau protein is a client protein for these Hsp90 complexes.  If the tau protein is in an abnormal or modified form, then it can trigger the recruitment of CHIP protein, a co-chaperone with E3 activity, to the complex which induces the ubiquitination of tau protein and activates its downstream degradation processes.  Large immunophilins, FKBP51 and FKBP52 are also co-chaperones of Hsp90-tau complexes.  These proteins contain peptidylprolyl cis/trans isomerase activity which catalyzes phosphorylation-dependent rotation in pSer/Thr-Pro peptide bond.  The proline switch in the tau conformation triggers dephosphorylation of Ser/Thr residues phosphorylated, e.g. by two well-known tau kinases Cdk5 and GSK-3β.  Binding of PP5 protein phosphatase to Hsp90 complex, can also dephosphorylate tau protein.  Subsequently, dephosphorylated tau protein can be shuttled back to the microtubules.  It seems that high-affinity binding of abnormal tau to Hsp90 complexes may have some counteracting effects on the aggregation process, since Hsp90 inhibitors can ameliorate the aggregation process in several neurodegenerative diseases.  We will review the role of Hsp90 chaperone network in the regulation of tau biology and pathology in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIGys_IlOfaRe4jJGKT5N0fW6udTcc2eak3QoRWRpzRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7mvFSitw%253D%253D&md5=92c5535c5b5bc12c8c0807ea338310d4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2010.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2010.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DOjala%26aufirst%3DJ.%26aulast%3DKaarniranta%26aufirst%3DK.%26aulast%3DHiltunen%26aufirst%3DM.%26aulast%3DSoininen%26aufirst%3DH.%26atitle%3DHsp90%2520regulates%2520tau%2520pathology%2520through%2520co-chaperone%2520complexes%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2011%26volume%3D93%26spage%3D99%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Shimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gygi, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosik, K. S.</span><span> </span><span class="NLM_article-title">CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">4869</span><span class="NLM_x">–</span> <span class="NLM_lpage">4876</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=4869-4876&author=H.+Shimuraauthor=D.+Schwartzauthor=S.+P.+Gygiauthor=K.+S.+Kosik&title=CHIP-Hsc70+complex+ubiquitinates+phosphorylated+tau+and+enhances+cell+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimura%26aufirst%3DH.%26aulast%3DSchwartz%26aufirst%3DD.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26aulast%3DKosik%26aufirst%3DK.%2BS.%26atitle%3DCHIP-Hsc70%2520complex%2520ubiquitinates%2520phosphorylated%2520tau%2520and%2520enhances%2520cell%2520survival%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D4869%26epage%3D4876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Jeganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">10526</span><span class="NLM_x">–</span> <span class="NLM_lpage">10539</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi800783d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=10526-10539&author=S.+Jeganathanauthor=M.+von+Bergenauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=The+natively+unfolded+character+of+tau+and+its+aggregation+to+Alzheimer-like+paired+helical+filaments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fbi800783d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi800783d%26sid%3Dliteratum%253Aachs%26aulast%3DJeganathan%26aufirst%3DS.%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DThe%2520natively%2520unfolded%2520character%2520of%2520tau%2520and%2520its%2520aggregation%2520to%2520Alzheimer-like%2520paired%2520helical%2520filaments%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D10526%26epage%3D10539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Schweers, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn-Hanebeck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">24290</span><span class="NLM_x">–</span> <span class="NLM_lpage">24297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2FS0021-9258%2819%2951080-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=7929085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK2cXmtVagurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=24290-24297&author=O.+Schweersauthor=E.+Schonbrunn-Hanebeckauthor=A.+Marxauthor=E.+Mandelkow&title=Structural+studies+of+tau+protein+and+Alzheimer+paired+helical+filaments+show+no+evidence+for+beta-structure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for β-structure</span></div><div class="casAuthors">Schweers, Olaf; Schoenbrunn-Hanebeck, Ernst; Marx, Alexander; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">24290-7</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The authors have studied the conformation of tau protein and Alzheimer paired helical filaments (PHF) by several spectroscopic, scattering, and imaging methods revealing the overall shape and the conformation of the polypeptide backbone.  Tau protein behaves in soln. as if it were denatured; no evidence for compact folding was detected.  The protein is highly extended, there is no defined radius of gyration, and the scattering is best described by that of a random ("Gaussian") polymer.  CD and Fourier transform IR spectroscopy show only a minimal content of ordered secondary structure (α-helix or β-sheet).  Similarly, PHFs from Alzheimer brain tissue show no detectable secondary structure by x-ray diffraction or spectroscopy.  It is thus unlikely that the aggregation of tau into Alzheimer PHFs is based on interactions between strands of β-sheets (a model currently favored for other disease-related polymers such as β-amyloid fibers of Alzheimer's disease).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkQACRJIok1LVg90H21EOLACvtfcHk0lgV7nl3ODg_hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmtVagurY%253D&md5=6df9f656b2d3f66617becb2b4afc9b8a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2819%2951080-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252819%252951080-8%26sid%3Dliteratum%253Aachs%26aulast%3DSchweers%26aufirst%3DO.%26aulast%3DSchonbrunn-Hanebeck%26aufirst%3DE.%26aulast%3DMarx%26aufirst%3DA.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DStructural%2520studies%2520of%2520tau%2520protein%2520and%2520Alzheimer%2520paired%2520helical%2520filaments%2520show%2520no%2520evidence%2520for%2520beta-structure%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D24290%26epage%3D24297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Jeganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hascher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnathambi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">32066</span><span class="NLM_x">–</span> <span class="NLM_lpage">32076</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=32066-32076&author=S.+Jeganathanauthor=A.+Hascherauthor=S.+Chinnathambiauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Proline-directed+pseudo-phosphorylation+at+AT8+and+PHF1+epitopes+induces+a+compaction+of+the+paperclip+folding+of+Tau+and+generates+a+pathological+%28MC-1%29+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeganathan%26aufirst%3DS.%26aulast%3DHascher%26aufirst%3DA.%26aulast%3DChinnathambi%26aufirst%3DS.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DProline-directed%2520pseudo-phosphorylation%2520at%2520AT8%2520and%2520PHF1%2520epitopes%2520induces%2520a%2520compaction%2520of%2520the%2520paperclip%2520folding%2520of%2520Tau%2520and%2520generates%2520a%2520pathological%2520%2528MC-1%2529%2520conformation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D32066%26epage%3D32076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Mukrasch, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korukottu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweckstetter, M.</span><span> </span><span class="NLM_article-title">Structural polymorphism of 441-residue tau at single residue resolution</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=e34&author=M.+D.+Mukraschauthor=S.+Bibowauthor=J.+Korukottuauthor=S.+Jeganathanauthor=J.+Biernatauthor=C.+Griesingerauthor=E.+Mandelkowauthor=M.+Zweckstetter&title=Structural+polymorphism+of+441-residue+tau+at+single+residue+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukrasch%26aufirst%3DM.%2BD.%26aulast%3DBibow%26aufirst%3DS.%26aulast%3DKorukottu%26aufirst%3DJ.%26aulast%3DJeganathan%26aufirst%3DS.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DGriesinger%26aufirst%3DC.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DZweckstetter%26aufirst%3DM.%26atitle%3DStructural%2520polymorphism%2520of%2520441-residue%2520tau%2520at%2520single%2520residue%2520resolution%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3De34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Mukrasch, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweckstetter, M.</span><span> </span><span class="NLM_article-title">The “jaws” of the tau–microtubule interaction</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">12230</span><span class="NLM_x">–</span> <span class="NLM_lpage">12239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=12230-12239&author=M.+D.+Mukraschauthor=M.+von+Bergenauthor=J.+Biernatauthor=D.+Fischerauthor=C.+Griesingerauthor=E.+Mandelkowauthor=M.+Zweckstetter&title=The+%E2%80%9Cjaws%E2%80%9D+of+the+tau%E2%80%93microtubule+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukrasch%26aufirst%3DM.%2BD.%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DD.%26aulast%3DGriesinger%26aufirst%3DC.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DZweckstetter%26aufirst%3DM.%26atitle%3DThe%2520%25E2%2580%259Cjaws%25E2%2580%259D%2520of%2520the%2520tau%25E2%2580%2593microtubule%2520interaction%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D12230%26epage%3D12239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedhoff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heberle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">5129</span><span class="NLM_x">–</span> <span class="NLM_lpage">5134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.97.10.5129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=10805776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsVWntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=5129-5134&author=M.+von+Bergenauthor=P.+Friedhoffauthor=J.+Biernatauthor=J.+Heberleauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Assembly+of+tau+protein+into+Alzheimer+paired+helical+filaments+depends+on+a+local+sequence+motif+%28%28306%29VQIVYK%28311%29%29+forming+beta+structure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure</span></div><div class="casAuthors">Von Bergen, M.; Friedhoff, P.; Biernat, J.; Heberle, J.; Mandelkow, E.-M.; Mandelkow, E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5129-5134</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We have searched for a minimal interaction motif in τ protein that supports the aggregation into Alzheimer-like paired helical filaments.  Digestion of the repeat domain with different proteases yields a GluC-induced fragment comprising 43 residues (termed PHF43), which represents the third repeat of τ plus some flanking residues.  This fragment self assembles readily into thin filaments without a paired helical appearance, but these filaments are highly competent to nucleate bona fide PHFs from full-length τ.  Probing the interactions of PHF43 with overlapping peptides derived from the full τ sequence yields a minimal hexapeptide interaction motif of 306VQIVYK311 at the beginning of the third internal repeat.  This motif coincides with the highest predicted β-structure potential in τ.  CD and Fourier transform IR spectroscopy shows that PHF43 acquires pronounced β structure in conditions of self assembly.  Point mutations in the hexapeptide region by proline-scanning mutagenesis prevent the aggregation.  The data indicate that PHF assembly is initiated by a short fragment contg. the minimal interaction motif forming a local β structure embedded in a largely random-coil protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGJW3qEQJRQ7Vg90H21EOLACvtfcHk0lg5io9TCtky_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsVWntrg%253D&md5=11be2a14e779315fcb88dac3afb22ed9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.10.5129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.10.5129%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DFriedhoff%26aufirst%3DP.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DHeberle%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DAssembly%2520of%2520tau%2520protein%2520into%2520Alzheimer%2520paired%2520helical%2520filaments%2520depends%2520on%2520a%2520local%2520sequence%2520motif%2520%2528%2528306%2529VQIVYK%2528311%2529%2529%2520forming%2520beta%2520structure%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D5129%26epage%3D5134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Daebel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnathambi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwalbe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habenstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akoury, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tepper, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweckstetter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijayan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, A.</span><span> </span><span class="NLM_article-title">beta-Sheet core of tau paired helical filaments revealed by solid-state NMR</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">13982</span><span class="NLM_x">–</span> <span class="NLM_lpage">13989</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja305470p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFChtL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=13982-13989&author=V.+Daebelauthor=S.+Chinnathambiauthor=J.+Biernatauthor=M.+Schwalbeauthor=B.+Habensteinauthor=A.+Loquetauthor=E.+Akouryauthor=K.+Tepperauthor=H.+Mullerauthor=M.+Baldusauthor=C.+Griesingerauthor=M.+Zweckstetterauthor=E.+Mandelkowauthor=V.+Vijayanauthor=A.+Lange&title=beta-Sheet+core+of+tau+paired+helical+filaments+revealed+by+solid-state+NMR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">β-Sheet Core of Tau Paired Helical Filaments Revealed by Solid-State NMR</span></div><div class="casAuthors">Daebel, Venita; Chinnathambi, Subashchandrabose; Biernat, Jacek; Schwalbe, Martin; Habenstein, Birgit; Loquet, Antoine; Akoury, Elias; Tepper, Katharina; Mueller, Henrik; Baldus, Marc; Griesinger, Christian; Zweckstetter, Markus; Mandelkow, Eckhard; Vijayan, Vinesh; Lange, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">13982-13989</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the hallmarks of Alzheimer's disease is the self-assembly of the microtubule-assocd. protein tau into fibers termed "paired helical filaments" (PHFs).  However, the structural basis of PHF assembly at at. detail is largely unknown.  Here, we applied solid-state NMR (ssNMR) spectroscopy to investigate in vitro assembled PHFs from a truncated three-repeat tau isoform (K19) that represents the core of PHFs.  We found that the rigid core of the fibrils is formed by amino acids V306 to S324, only 18 out of 99 residues, and comprises three β-strands connected by two short kinks.  The first β-strand is formed by the well-studied hexapeptide motif VQIVYK that is known to self-aggregate in a steric zipper arrangement.  Results on mixed [15N:13C]-labeled K19 fibrils show that β-strands are stacked in a parallel, in-register manner.  Disulfide bridges formed between C322 residues of different mols. lead to a disturbance of the β-sheet structure, and polymorphism in ssNMR spectra is obsd.  In particular, residues K321-S324 exhibit two sets of resonances.  Expts. on K19 C322A PHFs further confirm the influence of disulfide bond formation on the core structure.  Our structural data are supported by H/D exchange NMR measurements on K19 as well as a truncated four-repeat isoform of tau (K18).  Site-directed mutagenesis studies show that single-point mutations within the three different β-strands result in a significant loss of PHF aggregation efficiency, highlighting the importance of the β-structure-rich regions for tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIrCwqfFqN-LVg90H21EOLACvtfcHk0lhENWB-U80KZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFChtL%252FP&md5=4200e54ea1d875990eab6ecfe7056b64</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fja305470p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja305470p%26sid%3Dliteratum%253Aachs%26aulast%3DDaebel%26aufirst%3DV.%26aulast%3DChinnathambi%26aufirst%3DS.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DSchwalbe%26aufirst%3DM.%26aulast%3DHabenstein%26aufirst%3DB.%26aulast%3DLoquet%26aufirst%3DA.%26aulast%3DAkoury%26aufirst%3DE.%26aulast%3DTepper%26aufirst%3DK.%26aulast%3DMuller%26aufirst%3DH.%26aulast%3DBaldus%26aufirst%3DM.%26aulast%3DGriesinger%26aufirst%3DC.%26aulast%3DZweckstetter%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DVijayan%26aufirst%3DV.%26aulast%3DLange%26aufirst%3DA.%26atitle%3Dbeta-Sheet%2520core%2520of%2520tau%2520paired%2520helical%2520filaments%2520revealed%2520by%2520solid-state%2520NMR%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D13982%26epage%3D13989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Delacourte, A.</span><span> </span><span class="NLM_article-title">Tauopathies: recent insights into old diseases</span> <span class="citation_source-journal">Folia Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16416389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFGjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2005&pages=244-257&author=A.+Delacourte&title=Tauopathies%3A+recent+insights+into+old+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Tauopathies: recent insights into old diseases</span></div><div class="casAuthors">Delacourte, Andre</div><div class="citationInfo"><span class="NLM_cas:title">Folia Neuropathologica</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">244-257</span>CODEN:
                <span class="NLM_cas:coden">FONEEW</span>;
        ISSN:<span class="NLM_cas:issn">1641-4640</span>.
    
            (<span class="NLM_cas:orgname">Termedia Publishing House</span>)
        </div><div class="casAbstract">A review.  Neurofibrillary tangles are brain lesions that have been discovered at the beginning of the 20th century, using histol. silver staining.  Tangles are intra-neuronal hallmarks of a degenerating process: neurofibrillary degeneration (NFD).  The basic component involved in tangle formation is tau protein.  Tangles are found in more than 20 different neurodegenerative disorders, suggesting that NFD is a unique consequence to different types of etiol. factors.  However, tangles have a morphol. and biochem. signature which is disease-specific.  They are made up of different types of filaments such as paired helical filaments (PHFs) in Alzheimer's disease or straight filaments in progressive supranuclear palsy.  Tau aggregates have a disease-specific biochem. bar-code due to the aggregation of specific sets of tau isoforms.  Tau lesions have also a disease-specific pattern of spatio-temporal progression in the human brain which is well correlated to cognitive impairment.  At last, pathol. tau mutations are at the origin of familial fronto-temporal diseases with parkinsonism (FTDP-17).  Together, these observations have generated the concept of tauopathies.  Indeed, each tauopathy is defined by a combination of clin., neuropathol., biochem. and genetic features.  Most of them have a specific defect on tau (mutation, aberrant splicing, abnormal phosphorylation, abnormal processing, neuronal or genotypic vulnerability), suggesting that, in fact, the etiol. of most tauopathies is directly linked to tau dysfunction.  In conclusion, we observe that most dementing disorders are tauopathies and that most demented patients have a tauopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH8dNcgb5ZdLVg90H21EOLACvtfcHk0lhENWB-U80KZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFGjsbg%253D&md5=ff66eb6cc2827a1e46ee8413dc2ce8de</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelacourte%26aufirst%3DA.%26atitle%3DTauopathies%253A%2520recent%2520insights%2520into%2520old%2520diseases%26jtitle%3DFolia%2520Neuropathol.%26date%3D2005%26volume%3D43%26spage%3D244%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Kidd, M.</span><span> </span><span class="NLM_article-title">Paired helical filaments in electron microscopy of Alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=1963&pages=192-193&author=M.+Kidd&title=Paired+helical+filaments+in+electron+microscopy+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKidd%26aufirst%3DM.%26atitle%3DPaired%2520helical%2520filaments%2520in%2520electron%2520microscopy%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D1963%26volume%3D197%26spage%3D192%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Wegmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnathambi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, D. J.</span><span> </span><span class="NLM_article-title">Human Tau isoforms assemble into ribbon-like fibrils that display polymorphic structure and stability</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">27302</span><span class="NLM_x">–</span> <span class="NLM_lpage">27313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=27302-27313&author=S.+Wegmannauthor=Y.+J.+Jungauthor=S.+Chinnathambiauthor=E.+M.+Mandelkowauthor=E.+Mandelkowauthor=D.+J.+Muller&title=Human+Tau+isoforms+assemble+into+ribbon-like+fibrils+that+display+polymorphic+structure+and+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWegmann%26aufirst%3DS.%26aulast%3DJung%26aufirst%3DY.%2BJ.%26aulast%3DChinnathambi%26aufirst%3DS.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMuller%26aufirst%3DD.%2BJ.%26atitle%3DHuman%2520Tau%2520isoforms%2520assemble%2520into%2520ribbon-like%2520fibrils%2520that%2520display%2520polymorphic%2520structure%2520and%2520stability%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D27302%26epage%3D27313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Margittai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langen, R.</span><span> </span><span class="NLM_article-title">Template-assisted filament growth by parallel stacking of tau</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">10278</span><span class="NLM_x">–</span> <span class="NLM_lpage">10283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.0401911101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15240881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVyku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=10278-10283&author=M.+Margittaiauthor=R.+Langen&title=Template-assisted+filament+growth+by+parallel+stacking+of+tau"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Template-assisted filament growth by parallel stacking of tau</span></div><div class="casAuthors">Margittai, Martin; Langen, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">10278-10283</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tau Filaments are found in >20 neurodegenerative diseases.  Yet, because of their enormous mol. wts. and poor tendency to form highly ordered 3D crystal lattices, they have evaded high-resoln. structure detn.  Here, we studied 25 derivatized tau mutants by using ESR and fluorescence spectroscopy to report structural details of tau filaments.  Based on strong spin exchange and pyrene excimer formation of core residues, we find that individual tau proteins form single mol. layers along the fiber axis that perfectly stack on top of each other by in-register, parallel alignment of β-strands.  We suggest a model of filament growth wherein the existing filament serves as a template for the incoming, unfolded tau mol., resulting in a new structured layer with maximized hydrogen-bonded contact surface and side-chain stacking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBxmfhcAUYSbVg90H21EOLACvtfcHk0lhENWB-U80KZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVyku7o%253D&md5=cae2e8d1606d8fbb73adcaefdf4cc6f2</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0401911101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0401911101%26sid%3Dliteratum%253Aachs%26aulast%3DMargittai%26aufirst%3DM.%26aulast%3DLangen%26aufirst%3DR.%26atitle%3DTemplate-assisted%2520filament%2520growth%2520by%2520parallel%2520stacking%2520of%2520tau%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D10278%26epage%3D10283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barghorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Tau aggregation is driven by a transition from random coil to beta sheet structure</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1739</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1739&publication_year=2005&pages=158-166&author=M.+von+Bergenauthor=S.+Barghornauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Tau+aggregation+is+driven+by+a+transition+from+random+coil+to+beta+sheet+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DBarghorn%26aufirst%3DS.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DTau%2520aggregation%2520is%2520driven%2520by%2520a%2520transition%2520from%2520random%2520coil%2520to%2520beta%2520sheet%2520structure%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2005%26volume%3D1739%26spage%3D158%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Heiser, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engemann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunkel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeddrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waelter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordhoff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lurz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schugardt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rautenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herhaus, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnickel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottcher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehrach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanker, E. E.</span><span> </span><span class="NLM_article-title">Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington’s disease by using an automated filter retardation assay</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">16400</span><span class="NLM_x">–</span> <span class="NLM_lpage">16406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=16400-16406&issue=Suppl.+4&author=V.+Heiserauthor=S.+Engemannauthor=W.+Brockerauthor=I.+Dunkelauthor=A.+Boeddrichauthor=S.+Waelterauthor=E.+Nordhoffauthor=R.+Lurzauthor=N.+Schugardtauthor=S.+Rautenbergauthor=C.+Herhausauthor=G.+Barnickelauthor=H.+Bottcherauthor=H.+Lehrachauthor=E.+E.+Wanker&title=Identification+of+benzothiazoles+as+potential+polyglutamine+aggregation+inhibitors+of+Huntington%E2%80%99s+disease+by+using+an+automated+filter+retardation+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeiser%26aufirst%3DV.%26aulast%3DEngemann%26aufirst%3DS.%26aulast%3DBrocker%26aufirst%3DW.%26aulast%3DDunkel%26aufirst%3DI.%26aulast%3DBoeddrich%26aufirst%3DA.%26aulast%3DWaelter%26aufirst%3DS.%26aulast%3DNordhoff%26aufirst%3DE.%26aulast%3DLurz%26aufirst%3DR.%26aulast%3DSchugardt%26aufirst%3DN.%26aulast%3DRautenberg%26aufirst%3DS.%26aulast%3DHerhaus%26aufirst%3DC.%26aulast%3DBarnickel%26aufirst%3DG.%26aulast%3DBottcher%26aufirst%3DH.%26aulast%3DLehrach%26aufirst%3DH.%26aulast%3DWanker%26aufirst%3DE.%2BE.%26atitle%3DIdentification%2520of%2520benzothiazoles%2520as%2520potential%2520polyglutamine%2520aggregation%2520inhibitors%2520of%2520Huntington%25E2%2580%2599s%2520disease%2520by%2520using%2520an%2520automated%2520filter%2520retardation%2520assay%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26issue%3DSuppl.%25204%26spage%3D16400%26epage%3D16406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Taniguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hisanaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span> </span><span class="NLM_article-title">Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">7614</span><span class="NLM_x">–</span> <span class="NLM_lpage">7623</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=7614-7623&author=S.+Taniguchiauthor=N.+Suzukiauthor=M.+Masudaauthor=S.+Hisanagaauthor=T.+Iwatsuboauthor=M.+Goedertauthor=M.+Hasegawa&title=Inhibition+of+heparin-induced+tau+filament+formation+by+phenothiazines%2C+polyphenols%2C+and+porphyrins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaniguchi%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMasuda%26aufirst%3DM.%26aulast%3DHisanaga%26aufirst%3DS.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DHasegawa%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520heparin-induced%2520tau%2520filament%2520formation%2520by%2520phenothiazines%252C%2520polyphenols%252C%2520and%2520porphyrins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D7614%26epage%3D7623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Porat, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramowitz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazit, E.</span><span> </span><span class="NLM_article-title">Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1747-0285.2005.00318.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16492146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=27-37&author=Y.+Poratauthor=A.+Abramowitzauthor=E.+Gazit&title=Inhibition+of+amyloid+fibril+formation+by+polyphenols%3A+structural+similarity+and+aromatic+interactions+as+a+common+inhibition+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism</span></div><div class="casAuthors">Porat, Yair; Abramowitz, Adel; Gazit, Ehud</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-37</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The formation of well-ordered fibrillar protein deposits is common to a large group of amyloid-assocd. disorders.  This group consists of several major human diseases such as Alzheimer's disease, Parkinson's disease, prion diseases, and type II diabetes.  Currently, there is no approved therapeutic agent directed towards the formation of fibrillar assemblies, which have been recently shown to have a key role in the cytotoxic nature of amyloidogenic proteins.  One important approach in the development of therapeutic agents is the use of small mols. that specifically and efficiently inhibit the aggregation process.  Several small polyphenol mols. have been demonstrated to remarkably inhibit the formation of fibrillar assemblies in vitro and their assocd. cytotoxicity.  Yet, the inhibition mechanism was mostly attributed to the antioxidative properties of these polyphenol compds.  Based on several observations demonstrating that polyphenols are capable of inhibiting amyloid fibril formation in vitro, regardless of oxidative conditions, and in view of their structural similarities, we suggest an addnl. mechanism of action.  This mechanism is assuming structural constraints and specific arom. interactions, which direct polyphenol inhibitors to the amyloidogenic core.  This proposed mechanism is highly relevant for future de novo inhibitors' design as therapeutic agents for the treatment of amyloid-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJuuqfGHMQs7Vg90H21EOLACvtfcHk0lh1RmwsxLiDTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7g%253D&md5=700c4ba4939fe1153fe825906981e628</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2005.00318.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2005.00318.x%26sid%3Dliteratum%253Aachs%26aulast%3DPorat%26aufirst%3DY.%26aulast%3DAbramowitz%26aufirst%3DA.%26aulast%3DGazit%26aufirst%3DE.%26atitle%3DInhibition%2520of%2520amyloid%2520fibril%2520formation%2520by%2520polyphenols%253A%2520structural%2520similarity%2520and%2520aromatic%2520interactions%2520as%2520a%2520common%2520inhibition%2520mechanism%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D27%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Reinke, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span> </span><span class="NLM_article-title">Insight into amyloid structure using chemical probes</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1747-0285.2011.01110.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21457473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslWqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2011&pages=399-411&author=A.+A.+Reinkeauthor=J.+E.+Gestwicki&title=Insight+into+amyloid+structure+using+chemical+probes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into amyloid structure using chemical probes</span></div><div class="casAuthors">Reinke, Ashley A.; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">399-411</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a common neurodegenerative disorder characterized by the deposition of amyloids in the brain.  One prominent form of amyloid is composed of repeating units of the amyloid-β (Aβ) peptide.  Over the past decade, it has become clear that these Aβ amyloids are not homogeneous; rather, they are composed of a series of structures varying in their overall size and shape and the no. of Aβ peptides they contain.  Recent theories suggest that these different amyloid conformations may play distinct roles in disease, although their relative contributions are still being discovered.  Here, we review how chem. probes, such as Congo red, thioflavin T and their derivs., have been powerful tools for the better understanding of amyloid structure and function.  Moreover, we discuss how design and deployment of conformationally selective probes might be used to test emerging models of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1MeycFDiwGLVg90H21EOLACvtfcHk0lh1RmwsxLiDTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslWqsb0%253D&md5=52a8815e569523bd2b05e7a5e7c70d00</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2011.01110.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2011.01110.x%26sid%3Dliteratum%253Aachs%26aulast%3DReinke%26aufirst%3DA.%2BA.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DInsight%2520into%2520amyloid%2520structure%2520using%2520chemical%2520probes%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2011%26volume%3D77%26spage%3D399%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Kelly, J. W.</span><span> </span><span class="NLM_article-title">Alternative conformations of amyloidogenic proteins govern their behavior</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2FS0959-440X%2896%2980089-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=8696966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK28Xhtlamtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=11-17&author=J.+W.+Kelly&title=Alternative+conformations+of+amyloidogenic+proteins+govern+their+behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative conformations of amyloidogenic proteins govern their behavior</span></div><div class="casAuthors">Kelly, Jeffery W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-17</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review, with 44 refs.  Recent publications strongly support the hypothesis that conformational changes in amyloidogenic proteins lead to amyloid fibril formation and cause disease.  Biophys. studies on several amyloidogenic proteins provide insights into the conformational changes required for fibrillogenesis.  In addn., newly available moderate to high resoln. structural studies are bringing the authors' closer to understanding the structure of amyloid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVdwMwZU44ILVg90H21EOLACvtfcHk0lgsTE4JhOOv1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xhtlamtrk%253D&md5=fcb4a97155070d54f28b170572f827eb</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2FS0959-440X%2896%2980089-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-440X%252896%252980089-3%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DAlternative%2520conformations%2520of%2520amyloidogenic%2520proteins%2520govern%2520their%2520behavior%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D1996%26volume%3D6%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barghorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">48165</span><span class="NLM_x">–</span> <span class="NLM_lpage">48174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=48165-48174&author=M.+von+Bergenauthor=S.+Barghornauthor=L.+Liauthor=A.+Marxauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Mutations+of+tau+protein+in+frontotemporal+dementia+promote+aggregation+of+paired+helical+filaments+by+enhancing+local+beta-structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DBarghorn%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMarx%26aufirst%3DA.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DMutations%2520of%2520tau%2520protein%2520in%2520frontotemporal%2520dementia%2520promote%2520aggregation%2520of%2520paired%2520helical%2520filaments%2520by%2520enhancing%2520local%2520beta-structure%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D48165%26epage%3D48174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melrose, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacharaju, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Slegtenhorst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwinn-Hardy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul Murphy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corral, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, M.</span><span> </span><span class="NLM_article-title">Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2F78078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=10932182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvVertbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2000&pages=402-405&author=J.+Lewisauthor=E.+McGowanauthor=J.+Rockwoodauthor=H.+Melroseauthor=P.+Nacharajuauthor=M.+Van+Slegtenhorstauthor=K.+Gwinn-Hardyauthor=M.+Paul+Murphyauthor=M.+Bakerauthor=X.+Yuauthor=K.+Duffauthor=J.+Hardyauthor=A.+Corralauthor=W.+L.+Linauthor=S.+H.+Yenauthor=D.+W.+Dicksonauthor=P.+Daviesauthor=M.+Hutton&title=Neurofibrillary+tangles%2C+amyotrophy+and+progressive+motor+disturbance+in+mice+expressing+mutant+%28P301L%29+tau+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein</span></div><div class="casAuthors">Lewis, Jada; McGowan, Eileen; Rockwood, Julia; Melrose, Heather; Nacharaju, Parimala; Van Slegtenhorst, Marjon; Gwinn-Hardy, Katrina; Murphy, M. Paul; Baker, Matt; Yu, Xin; Duff, Karen; Hardy, John; Corral, Anthony; Lin, Wen-Lang; Yen, Shu-Hui; Dickson, Dennis W.; Davies, Peter; Hutton, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">402-405</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Neurofibrillary tangles (NFT) composed of the microtubule-assocd. protein tau are prominent in Alzheimer disease (AD), Pick disease, progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).  Mutations in the gene (Mtapt) encoding tau protein cause frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), thereby proving that tau dysfunction can directly result in neurodegeneration.  Expression of human tau contg. the most common FTDP-17 mutation (P301L) results in motor and behavioral deficits in transgenic mice, with age- and gene-dose-dependent development of NFT.  This phenotype occurred as early as 6.5 mo in hemizygous and 4.5 mo in homozygous animals.  NFT and Pick-body-like neuronal lesions occurred in the amygdala, septal nuclei, pre-optic nuclei, hypothalamus, midbrain, pons, medulla, deep cerebellar nuclei and spinal cord, with tau-immunoreactive pre-tangles in the cortex, hippocampus and basal ganglia.  Areas with the most NFT had reactive gliosis.  Spinal cord had axonal spheroids, anterior horn cell loss and axonal degeneration in anterior spinal roots.  The authors also saw peripheral neuropathy and skeletal muscle with neurogenic atrophy.  Brain and spinal cord contained insol. tau that co-migrated with insol. tau from AD and FTDP-17 brains.  The phenotype of mice expressing P301L mutant tau mimics features of human tauopathies and provides a model for investigating the pathogenesis of diseases with NFT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowupSUQH41jLVg90H21EOLACvtfcHk0lgsTE4JhOOv1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvVertbc%253D&md5=9719b5e58a3ad82f509662e39fe5b647</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2F78078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F78078%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DMcGowan%26aufirst%3DE.%26aulast%3DRockwood%26aufirst%3DJ.%26aulast%3DMelrose%26aufirst%3DH.%26aulast%3DNacharaju%26aufirst%3DP.%26aulast%3DVan%2BSlegtenhorst%26aufirst%3DM.%26aulast%3DGwinn-Hardy%26aufirst%3DK.%26aulast%3DPaul%2BMurphy%26aufirst%3DM.%26aulast%3DBaker%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DDuff%26aufirst%3DK.%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DCorral%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DW.%2BL.%26aulast%3DYen%26aufirst%3DS.%2BH.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DHutton%26aufirst%3DM.%26atitle%3DNeurofibrillary%2520tangles%252C%2520amyotrophy%2520and%2520progressive%2520motor%2520disturbance%2520in%2520mice%2520expressing%2520mutant%2520%2528P301L%2529%2520tau%2520protein%26jtitle%3DNat.%2520Genet.%26date%3D2000%26volume%3D25%26spage%3D402%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Khlistunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span> </span><span class="NLM_article-title">Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">1205</span><span class="NLM_x">–</span> <span class="NLM_lpage">1214</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=1205-1214&author=I.+Khlistunovaauthor=J.+Biernatauthor=Y.+Wangauthor=M.+Pickhardtauthor=M.+von+Bergenauthor=Z.+Gazovaauthor=E.+Mandelkowauthor=E.+M.+Mandelkow&title=Inducible+expression+of+Tau+repeat+domain+in+cell+models+of+tauopathy%3A+aggregation+is+toxic+to+cells+but+can+be+reversed+by+inhibitor+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DGazova%26aufirst%3DZ.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DInducible%2520expression%2520of%2520Tau%2520repeat%2520domain%2520in%2520cell%2520models%2520of%2520tauopathy%253A%2520aggregation%2520is%2520toxic%2520to%2520cells%2520but%2520can%2520be%2520reversed%2520by%2520inhibitor%2520drugs%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D1205%26epage%3D1214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hascher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Screening for inhibitors of tau polymerization</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F1567205053585891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15974921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVant7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=219-226&author=M.+Pickhardtauthor=M.+von+Bergenauthor=Z.+Gazovaauthor=A.+Hascherauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Screening+for+inhibitors+of+tau+polymerization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Screening for inhibitors of tau polymerization</span></div><div class="casAuthors">Pickhardt, Marcus; von Bergen, Martin; Gazova, Zuzana; Hascher, Antje; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-226</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The histopathol. diagnosis of Alzheimer's disease relies on two kinds of proteinaceous aggregates: the extracellular plaques built from filaments of the Aβ-peptide and the intracellular tangles consisting of tau polymd. into Paired Helical Filaments (PHFs).  The order of aggregation events is still under debate, but it is well accepted that tau related changes have an important impact on the viability of neurons.  In neurons, early morphol. changes are seen in axons which begin to loose and retract synapses.  This process is accompanied by an increase of aggregated tau protein.  Thus the prevention of tau aggregation seems to be a valuable target for therapy of Alzheimer's disease.  Here we present a screening procedure by which we identified inhibitors of tau polymn.  In the primary screen we used a thioflavin-S based assay which detects PHF formation in soln.  These initial hits were further analyzed for their capacity to depolymerize preformed PHFs.  These results were confirmed by several secondary assays (tryptophan fluorescence, pelleting, filter trapping and electron microscopy).  By this approach it is possible to identify small mol. compds. which prevent or reverse the aggregation of tau and thereby might improve the viability of neurons in a therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy03P_HSMU9rVg90H21EOLACvtfcHk0lgrVVfelAmo5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVant7o%253D&md5=fed74b4c33a839506b840019402e6abf</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.2174%2F1567205053585891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205053585891%26sid%3Dliteratum%253Aachs%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DGazova%26aufirst%3DZ.%26aulast%3DHascher%26aufirst%3DA.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DScreening%2520for%2520inhibitors%2520of%2520tau%2520polymerization%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2005%26volume%3D2%26spage%3D219%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Morelli, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, P.</span><span> </span><span class="NLM_article-title">Chemical and structural lessons from recent successes in protein–protein interaction inhibition (2P2I)</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.cbpa.2011.05.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21684802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFCltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=475-481&author=X.+Morelliauthor=R.+Bourgeasauthor=P.+Roche&title=Chemical+and+structural+lessons+from+recent+successes+in+protein%E2%80%93protein+interaction+inhibition+%282P2I%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I)</span></div><div class="casAuthors">Morelli, Xavier; Bourgeas, Raphael; Roche, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">475-481</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Worldwide research efforts have driven recent pharmaceutical successes, and consequently, the emerging role of Protein-Protein Interactions (PPIs) as drug targets has finally been widely embraced by the scientific community.  Inhibitors of these Protein-Protein Interactions (2P2Is or i-PPIs) are likely to represent the next generation of highly innovative drugs that will reach the market over the next decade.  This review describes up-to-date knowledge on this particular chem. space, with a specific emphasis on a subset of this ensemble.  We also address current structural knowledge regarding both protein-protein and protein-inhibitor complexes, i.e., the 2P2I database.  Finally, ligand efficiency analyses permit us to relate potency to size and polarity and to discuss the need to co-develop nanoparticle drug delivery systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW7NByutY_QLVg90H21EOLACvtfcHk0lgrVVfelAmo5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFCltro%253D&md5=efe168c18c73e16044583471b7927751</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2011.05.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2011.05.024%26sid%3Dliteratum%253Aachs%26aulast%3DMorelli%26aufirst%3DX.%26aulast%3DBourgeas%26aufirst%3DR.%26aulast%3DRoche%26aufirst%3DP.%26atitle%3DChemical%2520and%2520structural%2520lessons%2520from%2520recent%2520successes%2520in%2520protein%25E2%2580%2593protein%2520interaction%2520inhibition%2520%25282P2I%2529%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D15%26spage%3D475%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Sawaya, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambashivan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanova, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sievers, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apostol, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balbirnie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltzius, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarlane, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riekel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span> </span><span class="NLM_article-title">Atomic structures of amyloid cross-beta spines reveal varied steric zippers</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnature05695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17468747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFOhu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2007&pages=453-457&author=M.+R.+Sawayaauthor=S.+Sambashivanauthor=R.+Nelsonauthor=M.+I.+Ivanovaauthor=S.+A.+Sieversauthor=M.+I.+Apostolauthor=M.+J.+Thompsonauthor=M.+Balbirnieauthor=J.+J.+Wiltziusauthor=H.+T.+McFarlaneauthor=A.+O.+Madsenauthor=C.+Riekelauthor=D.+Eisenberg&title=Atomic+structures+of+amyloid+cross-beta+spines+reveal+varied+steric+zippers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic structures of amyloid cross-β spines reveal varied steric zippers</span></div><div class="casAuthors">Sawaya, Michael R.; Sambashivan, Shilpa; Nelson, Rebecca; Ivanova, Magdalena I.; Sievers, Stuart A.; Apostol, Marcin I.; Thompson, Michael J.; Balbirnie, Melinda; Wiltzius, Jed J. W.; McFarlane, Heather T.; Madsen, Anders O.; Riekel, Christian; Eisenberg, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">7143</span>),
    <span class="NLM_cas:pages">453-457</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Amyloid fibrils formed from different proteins, each assocd. with a particular disease, contain a common cross-β spine.  The at. architecture of a spine, from the fibril-forming segment GNNQQNY of the yeast prion protein Sup35, was recently revealed by x-ray microcrystallog.  It is a pair of β-sheets, with the facing side chains of the two sheets interdigitated in a dry 'steric zipper'.  Here we report some 30 other segments from fibril-forming proteins that form amyloid-like fibrils, microcrystals, or usually both.  These include segments from the Alzheimer's amyloid-β and tau proteins, the PrP prion protein, insulin, islet amyloid polypeptide (IAPP), lysozyme, myoglobin, α-synuclein and β2-microglobulin, suggesting that common structural features are shared by amyloid diseases at the mol. level.  Structures of 13 of these microcrystals all reveal steric zippers, but with variations that expand the range of at. architectures for amyloid-like fibrils and offer an at.-level hypothesis for the basis of prion strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpui5BhVRryrVg90H21EOLACvtfcHk0lgrVVfelAmo5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFOhu7o%253D&md5=be66c8d19b944e484fc13f0037ab043f</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fnature05695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05695%26sid%3Dliteratum%253Aachs%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DSambashivan%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DR.%26aulast%3DIvanova%26aufirst%3DM.%2BI.%26aulast%3DSievers%26aufirst%3DS.%2BA.%26aulast%3DApostol%26aufirst%3DM.%2BI.%26aulast%3DThompson%26aufirst%3DM.%2BJ.%26aulast%3DBalbirnie%26aufirst%3DM.%26aulast%3DWiltzius%26aufirst%3DJ.%2BJ.%26aulast%3DMcFarlane%26aufirst%3DH.%2BT.%26aulast%3DMadsen%26aufirst%3DA.%2BO.%26aulast%3DRiekel%26aufirst%3DC.%26aulast%3DEisenberg%26aufirst%3DD.%26atitle%3DAtomic%2520structures%2520of%2520amyloid%2520cross-beta%2520spines%2520reveal%2520varied%2520steric%2520zippers%26jtitle%3DNature%26date%3D2007%26volume%3D447%26spage%3D453%26epage%3D457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Peterson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlquist, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lew, J.</span><span> </span><span class="NLM_article-title">A soluble oligomer of tau associated with fiber formation analyzed by NMR</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">7393</span><span class="NLM_x">–</span> <span class="NLM_lpage">7404</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi702466a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntlKrtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=7393-7404&author=D.+W.+Petersonauthor=H.+Zhouauthor=F.+W.+Dahlquistauthor=J.+Lew&title=A+soluble+oligomer+of+tau+associated+with+fiber+formation+analyzed+by+NMR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A Soluble Oligomer of Tau Associated with Fiber Formation Analyzed by NMR</span></div><div class="casAuthors">Peterson, Dylan W.; Zhou, Hongjun; Dahlquist, Frederick W.; Lew, John</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">7393-7404</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by the intracellular accumulation of the neurofibrillary tangles comprised mainly of the microtubule-assocd. protein, tau.  A crit. aspect of understanding tangle formation is to understand the transition of sol. monomeric tau into mature fibrils by characterizing the structure of intermediates along the aggregation pathway.  We have carried out multidimensional NMR studies on a C-terminal fragment of human tau (tau187) to gain structural insight into the aggregation process.  To specifically monitor intermol. interaction between tau mols. in soln., we combined 15N- and 14N-labeled tau, the latter of which was modified with a paramagnetic nitroxide spin label (MTSL).  Paramagnetic relaxation enhancement (PRE) of 15N-tau by interaction with MTSL-14N-tau allowed identification of low mol. wt. oligomers of tau187 that formed in response to heparin-induced aggregation.  Two regions, VQIINK280 and VQIVYK311, were exclusively broadened by MTSL located at varied positions in the tau mol.  We propose that sol. oligomers of tau187 are generated via intermol. interactions at these motifs triggered by heparin addn.  However, the assocd. line broadening at these motifs cannot be due to interaction between tau187 and heparin directly.  Instead, these specific interactions necessarily occur between tau mols. and are intermol. in nature.  Our data support the idea that VQIINK280 and VQIVYK311 are the major, if not sole, crit. regions that directly mediate intermol. contact between tau mols. during the early phases of aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWg8wkfVZp37Vg90H21EOLACvtfcHk0lgQ0upan_MOsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntlKrtrk%253D&md5=19e34dbd9d994fd40cbadf8224623e8a</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fbi702466a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi702466a%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DD.%2BW.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DDahlquist%26aufirst%3DF.%2BW.%26aulast%3DLew%26aufirst%3DJ.%26atitle%3DA%2520soluble%2520oligomer%2520of%2520tau%2520associated%2520with%2520fiber%2520formation%2520analyzed%2520by%2520NMR%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D7393%26epage%3D7404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Barghorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">14885</span><span class="NLM_x">–</span> <span class="NLM_lpage">14896</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi026469j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD38XoslOgtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=14885-14896&author=S.+Barghornauthor=E.+Mandelkow&title=Toward+a+unified+scheme+for+the+aggregation+of+tau+into+Alzheimer+paired+helical+filaments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Toward a Unified Scheme for the Aggregation of Tau into Alzheimer Paired Helical Filaments</span></div><div class="casAuthors">Barghorn, S.; Mandelkow, E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">14885-14896</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease is characterized by aggregates of tau protein.  Attempts to study the conditions for aggregation in vitro have led to different exptl. systems, some of which appear mutually exclusive (e.g., oxidative vs. reductive conditions, induction by polyanions vs. fatty acids).  The authors show here that different approaches and pathways can be viewed in a common framework, and that apparent differences can be explained by variations in the kinetics of subreactions.  A unified view of PHF aggregation should help to analyze the causes of PHF aggregation and devise methods to prevent it.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXAWNAtsEARLVg90H21EOLACvtfcHk0lgQ0upan_MOsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XoslOgtbY%253D&md5=3fce6c2c87cd012067603dd9fb7aac04</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fbi026469j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi026469j%26sid%3Dliteratum%253Aachs%26aulast%3DBarghorn%26aufirst%3DS.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DToward%2520a%2520unified%2520scheme%2520for%2520the%2520aggregation%2520of%2520tau%2520into%2520Alzheimer%2520paired%2520helical%2520filaments%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D14885%26epage%3D14896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Schweers, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">8463</span><span class="NLM_x">–</span> <span class="NLM_lpage">8467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.92.18.8463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=7667312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK2MXnvVymu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=8463-8467&author=O.+Schweersauthor=E.+M.+Mandelkowauthor=J.+Biernatauthor=E.+Mandelkow&title=Oxidation+of+cysteine-322+in+the+repeat+domain+of+microtubule-associated+protein+tau+controls+the+in+vitro+assembly+of+paired+helical+filaments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein τ controls the in vitro assembly of paired helical filaments</span></div><div class="casAuthors">Schweers, Olaf; Mandelkow, Eva-Maria; Biernat, Jacek; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8463-7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">One of the hallmarks of Alzheimer disease is the pathol. aggregation of τ protein into paired helical filaments (PHFs) and neurofibrillary tangles.  Here the authors describe the in vitro assembly of recombinant τ protein and constructs derived from it into PHFs.  Though whole τ assembled poorly, constructs contg. three internal repeats (corresponding to the fetal τ isoform) formed PHFs reproducibility.  This ability depended on intermol. disulfide bridges formed by the single Cys-322.  Blocking the SH group, mutating Cys for Ala, or keeping τ in a reducing environment all inhibited assembly.  With constructs derived from four-repeat τ (having the addnl. repeat no. 2 and a second Cys-291), PHF assembly was blocked because Cys-291 and Cys-322 interact within the mol.  PHF assembly was enabled again by mutating Cys-291 for Ala.  The synthetic PHFs bound the dye thioflavin S used in Alzheimer disease diagnostics.  The data imply that the redox potential in the neuron is crucial for PHF assembly, independently or in addn. to pathol. phosphorylation reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoc1u_viDgB7Vg90H21EOLACvtfcHk0lgQ0upan_MOsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvVymu7c%253D&md5=ceac2390a6e7024570a5d64102376660</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.18.8463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.18.8463%26sid%3Dliteratum%253Aachs%26aulast%3DSchweers%26aufirst%3DO.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DOxidation%2520of%2520cysteine-322%2520in%2520the%2520repeat%2520domain%2520of%2520microtubule-associated%2520protein%2520tau%2520controls%2520the%2520in%2520vitro%2520assembly%2520of%2520paired%2520helical%2520filaments%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D8463%26epage%3D8467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Laganowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitelegge, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pensalfini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriaga, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span> </span><span class="NLM_article-title">Atomic view of a toxic amyloid small oligomer</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">1228</span><span class="NLM_x">–</span> <span class="NLM_lpage">1231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1126%2Fscience.1213151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22403391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlKjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2012&pages=1228-1231&author=A.+Laganowskyauthor=C.+Liuauthor=M.+R.+Sawayaauthor=J.+P.+Whiteleggeauthor=J.+Parkauthor=M.+Zhaoauthor=A.+Pensalfiniauthor=A.+B.+Soriagaauthor=M.+Landauauthor=P.+K.+Tengauthor=D.+Cascioauthor=C.+Glabeauthor=D.+Eisenberg&title=Atomic+view+of+a+toxic+amyloid+small+oligomer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic View of a Toxic Amyloid Small Oligomer</span></div><div class="casAuthors">Laganowsky, Arthur; Liu, Cong; Sawaya, Michael R.; Whitelegge, Julian P.; Park, Jiyong; Zhao, Minglei; Pensalfini, Anna; Soriaga, Angela B.; Landau, Meytal; Teng, Poh K.; Cascio, Duilio; Glabe, Charles; Eisenberg, David</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">6073</span>),
    <span class="NLM_cas:pages">1228-1231</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Amyloid diseases, including Alzheimer's, Parkinson's, and the prion conditions, are each assocd. with a particular protein in fibrillar form.  These amyloid fibrils were long suspected to be the disease agents, but evidence suggests that smaller, often transient and polymorphic oligomers are the toxic entities.  Here, we identify a segment of the amyloid-forming protein αB crystallin, which forms an oligomeric complex exhibiting properties of other amyloid oligomers: β-sheet-rich structure, cytotoxicity, and recognition by an oligomer-specific antibody.  The x-ray-derived at. structure of the oligomer reveals a cylindrical barrel, formed from six antiparallel protein strands, that we term a cylindrin.  The cylindrin structure is compatible with a sequence segment from the β-amyloid protein of Alzheimer's disease.  Cylindrins offer models for the hitherto elusive structures of amyloid oligomers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZJv8jyRJtyLVg90H21EOLACvtfcHk0lgQ0upan_MOsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlKjt74%253D&md5=d48078bd840f79a3f049ce72750a6dfa</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1126%2Fscience.1213151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1213151%26sid%3Dliteratum%253Aachs%26aulast%3DLaganowsky%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DWhitelegge%26aufirst%3DJ.%2BP.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DPensalfini%26aufirst%3DA.%26aulast%3DSoriaga%26aufirst%3DA.%2BB.%26aulast%3DLandau%26aufirst%3DM.%26aulast%3DTeng%26aufirst%3DP.%2BK.%26aulast%3DCascio%26aufirst%3DD.%26aulast%3DGlabe%26aufirst%3DC.%26aulast%3DEisenberg%26aufirst%3DD.%26atitle%3DAtomic%2520view%2520of%2520a%2520toxic%2520amyloid%2520small%2520oligomer%26jtitle%3DScience%26date%3D2012%26volume%3D335%26spage%3D1228%26epage%3D1231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">A beta oligomers—a decade of discovery</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1172</span><span class="NLM_x">–</span> <span class="NLM_lpage">1184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1471-4159.2006.04426.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17286590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=1172-1184&author=D.+M.+Walshauthor=D.+J.+Selkoe&title=A+beta+oligomers%E2%80%94a+decade+of+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ oligomers - a decade of discovery</span></div><div class="casAuthors">Walsh, Dominic M.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1172-1184</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Converging lines of evidence suggest that progressive accumulation of the amyloid β-protein (Aβ) plays a central role in the genesis of Alzheimer's disease, but it was long assumed that Aβ had to be assembled into extracellular amyloid fibrils to exert its cytotoxic effects.  Over the past decade, data have emerged from the use of synthetic Aβ peptides, cell culture models, β-amyloid precursor protein transgenic mice and human brain to suggest that pre-fibrillar, diffusible assemblies of Aβ are also deleterious.  Although the precise mol. identity of these sol. toxins remains unsettled, accumulating evidence suggests that sol. forms of Aβ are indeed the proximate effectors of synapse loss and neuronal injury.  Here the authors review recent progress in understanding the role of sol. oligomers in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrWrluV1aL7Vg90H21EOLACvtfcHk0lgSwuT-fccLTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D&md5=263855754364d2ab520e6fd705b9f5f7</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04426.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DA%2520beta%2520oligomers%25E2%2580%2594a%2520decade%2520of%2520discovery%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D1172%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Podlisny, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostaszewski, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squazzo, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">9564</span><span class="NLM_x">–</span> <span class="NLM_lpage">9570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=9564-9570&author=M.+B.+Podlisnyauthor=B.+L.+Ostaszewskiauthor=S.+L.+Squazzoauthor=E.+H.+Kooauthor=R.+E.+Rydellauthor=D.+B.+Teplowauthor=D.+J.+Selkoe&title=Aggregation+of+secreted+amyloid+beta-protein+into+sodium+dodecyl+sulfate-stable+oligomers+in+cell+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPodlisny%26aufirst%3DM.%2BB.%26aulast%3DOstaszewski%26aufirst%3DB.%2BL.%26aulast%3DSquazzo%26aufirst%3DS.%2BL.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DRydell%26aufirst%3DR.%2BE.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DAggregation%2520of%2520secreted%2520amyloid%2520beta-protein%2520into%2520sodium%2520dodecyl%2520sulfate-stable%2520oligomers%2520in%2520cell%2520culture%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D9564%26epage%3D9570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Campioni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampagni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pensalfini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evangelisti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Relini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiti, F.</span><span> </span><span class="NLM_article-title">A causative link between the structure of aberrant protein oligomers and their toxicity</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnchembio.283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20081829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFGqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=140-147&author=S.+Campioniauthor=B.+Manniniauthor=M.+Zampagniauthor=A.+Pensalfiniauthor=C.+Parriniauthor=E.+Evangelistiauthor=A.+Reliniauthor=M.+Stefaniauthor=C.+M.+Dobsonauthor=C.+Cecchiauthor=F.+Chiti&title=A+causative+link+between+the+structure+of+aberrant+protein+oligomers+and+their+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">A causative link between the structure of aberrant protein oligomers and their toxicity</span></div><div class="casAuthors">Campioni, Silvia; Mannini, Benedetta; Zampagni, Mariagioia; Pensalfini, Anna; Parrini, Claudia; Evangelisti, Elisa; Relini, Annalisa; Stefani, Massimo; Dobson, Christopher M.; Cecchi, Cristina; Chiti, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-147</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The aberrant assembly of peptides and proteins into fibrillar aggregates proceeds through oligomeric intermediates that are thought to be the primary pathogenic species in many protein deposition diseases.  We describe two types of oligomers formed by the HypF-N protein that are morphol. and tinctorially similar, as detected with at. force microscopy (AFM) and thioflavin T (ThT) assays, though one is benign when added to cell cultures whereas the other is toxic.  Structural investigation at a residue-specific level using site-directed labeling with pyrene indicated differences in the hydrophobic packing between adjacent protein mols. in the oligomers.  A lower degree of hydrophobic packing was found to correlate with a higher ability to penetrate the cell membrane and cause an influx of Ca2+ ions.  Our findings suggest that structural flexibility and hydrophobic exposure are primary determinants of the ability of oligomeric assemblies to cause cellular dysfunction and its consequences, such as neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9jKW3yYrOd7Vg90H21EOLACvtfcHk0lgSwuT-fccLTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFGqtg%253D%253D&md5=80714f81c8c6d23af2f8bd6d7d45365e</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.283%26sid%3Dliteratum%253Aachs%26aulast%3DCampioni%26aufirst%3DS.%26aulast%3DMannini%26aufirst%3DB.%26aulast%3DZampagni%26aufirst%3DM.%26aulast%3DPensalfini%26aufirst%3DA.%26aulast%3DParrini%26aufirst%3DC.%26aulast%3DEvangelisti%26aufirst%3DE.%26aulast%3DRelini%26aufirst%3DA.%26aulast%3DStefani%26aufirst%3DM.%26aulast%3DDobson%26aufirst%3DC.%2BM.%26aulast%3DCecchi%26aufirst%3DC.%26aulast%3DChiti%26aufirst%3DF.%26atitle%3DA%2520causative%2520link%2520between%2520the%2520structure%2520of%2520aberrant%2520protein%2520oligomers%2520and%2520their%2520toxicity%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D140%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Braun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharias, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peschek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastenmuller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanzlik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haslbeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappsilber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinkauf, S.</span><span> </span><span class="NLM_article-title">Multiple molecular architectures of the eye lens chaperone alphaB-crystallin elucidated by a triple hybrid approach</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">20491</span><span class="NLM_x">–</span> <span class="NLM_lpage">20496</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=20491-20496&author=N.+Braunauthor=M.+Zachariasauthor=J.+Peschekauthor=A.+Kastenmullerauthor=J.+Zouauthor=M.+Hanzlikauthor=M.+Haslbeckauthor=J.+Rappsilberauthor=J.+Buchnerauthor=S.+Weinkauf&title=Multiple+molecular+architectures+of+the+eye+lens+chaperone+alphaB-crystallin+elucidated+by+a+triple+hybrid+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBraun%26aufirst%3DN.%26aulast%3DZacharias%26aufirst%3DM.%26aulast%3DPeschek%26aufirst%3DJ.%26aulast%3DKastenmuller%26aufirst%3DA.%26aulast%3DZou%26aufirst%3DJ.%26aulast%3DHanzlik%26aufirst%3DM.%26aulast%3DHaslbeck%26aufirst%3DM.%26aulast%3DRappsilber%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26aulast%3DWeinkauf%26aufirst%3DS.%26atitle%3DMultiple%2520molecular%2520architectures%2520of%2520the%2520eye%2520lens%2520chaperone%2520alphaB-crystallin%2520elucidated%2520by%2520a%2520triple%2520hybrid%2520approach%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D20491%26epage%3D20496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Shafrir, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anishkin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, H. R.</span><span> </span><span class="NLM_article-title">Beta-barrel models of soluble amyloid beta oligomers and annular protofibrils</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">3458</span><span class="NLM_x">–</span> <span class="NLM_lpage">3472</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1002%2Fprot.22832" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20830782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2jsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=3458-3472&author=Y.+Shafrirauthor=S.+R.+Durellauthor=A.+Anishkinauthor=H.+R.+Guy&title=Beta-barrel+models+of+soluble+amyloid+beta+oligomers+and+annular+protofibrils"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-barrel models of soluble amyloid beta oligomers and annular protofibrils</span></div><div class="casAuthors">Shafrir, Yinon; Durell, Stewart R.; Anishkin, Andriy; Guy, H. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3458-3472</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Both sol. and membrane-bound prefibrillar assemblies of Abeta (Aβ) peptides have been assocd. with Alzheimer's disease (AD).  The size and nature of these assemblies vary greatly and are affected by many factors.  Here, we present models of sol. hexameric assemblies of Aβ42 and suggest how they can lead to larger assemblies and eventually to fibrils.  The common element in most of these assemblies is a six-stranded β-barrel formed by the last third of Aβ42, which is composed of hydrophobic residues and glycines.  The hydrophobic core β-barrels of the hexameric models are shielded from water by the N-terminus and central segments.  These more hydrophilic segments were modeled to have either predominantly β or predominantly α secondary structure.  Mol. dynamics simulations were performed to analyze stabilities of the models.  The hexameric models were used as starting points from which larger sol. assemblies of 12 and 36 subunits were modeled.  These models were developed to be consistent with numerous exptl. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1LQxO1gkTkrVg90H21EOLACvtfcHk0ljCsgBJGvBWLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2jsrbP&md5=2de226fd95abf54fd2c4d82fb3e0cb6c</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fprot.22832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.22832%26sid%3Dliteratum%253Aachs%26aulast%3DShafrir%26aufirst%3DY.%26aulast%3DDurell%26aufirst%3DS.%2BR.%26aulast%3DAnishkin%26aufirst%3DA.%26aulast%3DGuy%26aufirst%3DH.%2BR.%26atitle%3DBeta-barrel%2520models%2520of%2520soluble%2520amyloid%2520beta%2520oligomers%2520and%2520annular%2520protofibrils%26jtitle%3DProteins%26date%3D2010%26volume%3D78%26spage%3D3458%26epage%3D3472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Cheng, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowick, J. S.</span><span> </span><span class="NLM_article-title">Amyloid beta-sheet mimics that antagonize protein aggregation and reduce amyloid toxicity</span> <span class="citation_source-journal">Nat. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnchem.1433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=23089868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlWnsrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=927-933&author=P.+N.+Chengauthor=C.+Liuauthor=M.+Zhaoauthor=D.+Eisenbergauthor=J.+S.+Nowick&title=Amyloid+beta-sheet+mimics+that+antagonize+protein+aggregation+and+reduce+amyloid+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β-sheet mimics that antagonize protein aggregation and reduce amyloid toxicity</span></div><div class="casAuthors">Cheng, Pin-Nan; Liu, Cong; Zhao, Minglei; Eisenberg, David; Nowick, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">927-933</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The amyloid protein aggregation assocd. with diseases such as Alzheimer's, Parkinson's and type II diabetes (among many others) features a bewildering variety of β-sheet-rich structures in transition from native proteins to ordered oligomers and fibers.  The variation in the amino-acid sequences of the β-structures presents a challenge to developing a model system of β-sheets for the study of various amyloid aggregates.  Here, we introduce a family of robust β-sheet macrocycles that can serve as a platform to display a variety of heptapeptide sequences from different amyloid proteins.  We have tailored these amyloid β-sheet mimics (ABSMs) to antagonize the aggregation of various amyloid proteins, thereby reducing the toxicity of amyloid aggregates.  We describe the structures and inhibitory properties of ABSMs contg. amyloidogenic peptides from the amyloid-β peptide assocd. with Alzheimer's disease, β2-microglobulin assocd. with dialysis-related amyloidosis, α-synuclein assocd. with Parkinson's disease, islet amyloid polypeptide assocd. with type II diabetes, human and yeast prion proteins, and Tau, which forms neurofibrillary tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYZtzUX4piIrVg90H21EOLACvtfcHk0ljCsgBJGvBWLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlWnsrjI&md5=a2e1200698caabb0702ddf5c1b7d523e</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1433%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DP.%2BN.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DEisenberg%26aufirst%3DD.%26aulast%3DNowick%26aufirst%3DJ.%2BS.%26atitle%3DAmyloid%2520beta-sheet%2520mimics%2520that%2520antagonize%2520protein%2520aggregation%2520and%2520reduce%2520amyloid%2520toxicity%26jtitle%3DNat.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D927%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Landau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faull, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laganowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sievers, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span> </span><span class="NLM_article-title">Towards a pharmacophore for amyloid</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1001080</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1371%2Fjournal.pbio.1001080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21695112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFegtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=e1001080&author=M.+Landauauthor=M.+R.+Sawayaauthor=K.+F.+Faullauthor=A.+Laganowskyauthor=L.+Jiangauthor=S.+A.+Sieversauthor=J.+Liuauthor=J.+R.+Barrioauthor=D.+Eisenberg&title=Towards+a+pharmacophore+for+amyloid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a pharmacophore for amyloid</span></div><div class="casAuthors">Landau, Meytal; Sawaya, Michael R.; Faull, Kym F.; Laganowsky, Arthur; Jiang, Lin; Sievers, Stuart A.; Liu, Jie; Barrio, Jorge R.; Eisenberg, David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1001080</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Diagnosing and treating Alzheimer's and other diseases assocd. with amyloid fibers remains a great challenge despite intensive research.  To aid in this effort, we present at. structures of fiber-forming segments of proteins involved in Alzheimer's disease in complex with small mol. binders, detd. by X-ray microcrystallog.  The fiber-like complexes consist of pairs of β-sheets, with small mols. binding between the sheets, roughly parallel to the fiber axis.  The structures suggest that apolar mols. drift along the fiber, consistent with the observation of nonspecific binding to a variety of amyloid proteins.  In contrast, neg. charged orange-G binds specifically to lysine side chains of adjacent sheets.  These structures provide mol. frameworks for the design of diagnostics and drugs for protein aggregation diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHJDf_wPbESrVg90H21EOLACvtfcHk0ljCsgBJGvBWLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFegtbs%253D&md5=6fedd1729b59ee89733ea5f127fc0b1d</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1001080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1001080%26sid%3Dliteratum%253Aachs%26aulast%3DLandau%26aufirst%3DM.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DFaull%26aufirst%3DK.%2BF.%26aulast%3DLaganowsky%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DSievers%26aufirst%3DS.%2BA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26aulast%3DEisenberg%26aufirst%3DD.%26atitle%3DTowards%2520a%2520pharmacophore%2520for%2520amyloid%26jtitle%3DPLoS%2520Biol.%26date%3D2011%26volume%3D9%26spage%3De1001080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Sievers, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanicolas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zirafi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span> </span><span class="NLM_article-title">Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">475</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnature10154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21677644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsFOrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=96-100&author=S.+A.+Sieversauthor=J.+Karanicolasauthor=H.+W.+Changauthor=A.+Zhaoauthor=L.+Jiangauthor=O.+Zirafiauthor=J.+T.+Stevensauthor=J.+Munchauthor=D.+Bakerauthor=D.+Eisenberg&title=Structure-based+design+of+non-natural+amino-acid+inhibitors+of+amyloid+fibril+formation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation</span></div><div class="casAuthors">Sievers, Stuart A.; Karanicolas, John; Chang, Howard W.; Zhao, Anni; Jiang, Lin; Zirafi, Onofrio; Stevens, Jason T.; Muench, Jan; Baker, David; Eisenberg, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7354</span>),
    <span class="NLM_cas:pages">96-100</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Many globular and natively disordered proteins can convert into amyloid fibrils.  These fibrils are assocd. with numerous pathologies as well as with normal cellular functions, and frequently form during protein denaturation.  Inhibitors of pathol. amyloid fibril formation could be useful in the development of therapeutics, provided that the inhibitors were specific enough to avoid interfering with normal processes.  Computer-aided, structure-based design can yield highly specific peptide inhibitors of amyloid formation.  Using known at. structures of segments of amyloid fibrils as templates, the authors have designed and characterized an all-d-amino-acid inhibitor of the fibril formation of the tau protein assocd. with Alzheimer's disease, and a non-natural l-amino-acid inhibitor of an amyloid fibril that enhances sexual transmission of human immunodeficiency virus.  The authors' results indicate that peptides from structure-based designs can disrupt the fibril formation of full-length proteins, including those, such as tau protein, that lack fully ordered native structures.  Because the inhibiting peptides have been designed on structures of dual-β-sheet 'steric zippers', the successful inhibition of amyloid fibril formation strengthens the hypothesis that amyloid spines contain steric zippers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAFy-0fm-GobVg90H21EOLACvtfcHk0ljCsgBJGvBWLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsFOrs7s%253D&md5=75a55d1238691e18683583b1f9d093d5</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fnature10154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10154%26sid%3Dliteratum%253Aachs%26aulast%3DSievers%26aufirst%3DS.%2BA.%26aulast%3DKaranicolas%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DH.%2BW.%26aulast%3DZhao%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DZirafi%26aufirst%3DO.%26aulast%3DStevens%26aufirst%3DJ.%2BT.%26aulast%3DMunch%26aufirst%3DJ.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DEisenberg%26aufirst%3DD.%26atitle%3DStructure-based%2520design%2520of%2520non-natural%2520amino-acid%2520inhibitors%2520of%2520amyloid%2520fibril%2520formation%26jtitle%3DNature%26date%3D2011%26volume%3D475%26spage%3D96%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Zheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vadla, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goux, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowick, J. S.</span><span> </span><span class="NLM_article-title">Macrocyclic beta-sheet peptides that inhibit the aggregation of a tau-protein-derived hexapeptide</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">3144</span><span class="NLM_x">–</span> <span class="NLM_lpage">3157</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja110545h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFeis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=3144-3157&author=J.+Zhengauthor=C.+Liuauthor=M.+R.+Sawayaauthor=B.+Vadlaauthor=S.+Khanauthor=R.+J.+Woodsauthor=D.+Eisenbergauthor=W.+J.+Gouxauthor=J.+S.+Nowick&title=Macrocyclic+beta-sheet+peptides+that+inhibit+the+aggregation+of+a+tau-protein-derived+hexapeptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic β-sheet peptides that inhibit the aggregation of a tau-protein-derived hexapeptide</span></div><div class="casAuthors">Zheng, Jing; Liu, Cong; Sawaya, Michael R.; Vadla, Balraju; Khan, Shafiullah; Woods, R. Jeremy; Eisenberg, David; Goux, Warren J.; Nowick, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3144-3157</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes studies of a series of macrocyclic β-sheet peptides 1 that inhibit the aggregation of a tau-protein-derived peptide.  The macrocyclic β-sheet peptides comprise a pentapeptide "upper" strand, two δ-linked ornithine turn units, and a "lower" strand comprising two addnl. residues and the β-sheet peptidomimetic template "Hao".  The tau-derived peptide Ac-VQIVYK-NH2 (AcPHF6) aggregates in soln. through β-sheet interactions to form straight and twisted filaments similar to those formed by tau protein in Alzheimer's neurofibrillary tangles.  Macrocycles 1 contg. the pentapeptide VQIVY in the "upper" strand delay and suppress the onset of aggregation of the AcPHF6 peptide.  Inhibition is particularly pronounced in other macrocycles in which the two residues in the "lower" strand provide a pattern of hydrophobicity and hydrophilicity that matches that of the pentapeptide "upper" strand.  Inhibition varies strongly with the concn. of these macrocycles, suggesting that it is cooperative.  Another macrocycle contg. the pentapeptide QIVYK shows little inhibition, suggesting the possibility of a preferred direction of growth of AcPHF6 β-sheets.  On the basis of these studies, a model is proposed in which the AcPHF6 amyloid grows as a layered pair of β-sheets and in which growth is blocked by a pair of macrocycles that cap the growing paired hydrogen-bonding edges.  This model provides a provocative and appealing target for future inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUUxfY1h_AurVg90H21EOLACvtfcHk0lggcNM87p7x4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFeis7k%253D&md5=47c5d5dd0864b5e4613bf00baa445ef1</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fja110545h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja110545h%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DVadla%26aufirst%3DB.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DWoods%26aufirst%3DR.%2BJ.%26aulast%3DEisenberg%26aufirst%3DD.%26aulast%3DGoux%26aufirst%3DW.%2BJ.%26aulast%3DNowick%26aufirst%3DJ.%2BS.%26atitle%3DMacrocyclic%2520beta-sheet%2520peptides%2520that%2520inhibit%2520the%2520aggregation%2520of%2520a%2520tau-protein-derived%2520hexapeptide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D3144%26epage%3D3157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Wischik, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, C. R.</span><span> </span><span class="NLM_article-title">Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">11213</span><span class="NLM_x">–</span> <span class="NLM_lpage">11218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.93.20.11213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=8855335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK28XmtVOqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=11213-11218&author=C.+M.+Wischikauthor=P.+C.+Edwardsauthor=R.+Y.+Laiauthor=M.+Rothauthor=C.+R.+Harrington&title=Selective+inhibition+of+Alzheimer+disease-like+tau+aggregation+by+phenothiazines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines</span></div><div class="casAuthors">Wischik, C. M.; Edwards, P. C.; Lai, R. Y.; Roth, M.; Harrington, C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11213-11218</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In Alzheimer disease (AD) the microtubule-assocd. protein tau is redistributed exponentially into paired helical filaments (PHFs) forming neurofibrillary tangles, which correlate with pyramidal cell destruction and dementia.  Amorphous neuronal deposits and PHFs in AD are characterized by aggregation through the repeat domain and C-terminal truncation at Glu-391 by endogenous proteases.  We show that a similar proteolytically stable complex can be generated in vitro following the self-aggregation of tau protein through a high-affinity binding site in the repeat domain.  Once started, tau capture can be propagated by seeding the further accumulation of truncated tau in the presence of proteases.  We have identified a non-neuroleptic phenothiazine previously used in man (methylene blue, MB), which reverses the proteolytic stability of protease-resistant PHFs by blocking the tau-tau binding interaction through the repeat domain.  Although MB is inhibitory at a higher concn. than may be achieved clin., the tau-tau binding assay was used to identify desmethyl derivs. of MB that have Ki values in the nanomolar range.  Neuroleptic phenothiazines are inactive.  Tau aggregation inhibitors do not affect the tau-tubulin interaction, which also occurs through the repeat domain.  Our findings demonstrate that biol. selective pharmaceutical agents could be developed to facilitate the proteolytic degrdn. of tau aggregates and prevent the further propagation of tau capture in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogZyJ57Clqp7Vg90H21EOLACvtfcHk0lggcNM87p7x4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtVOqsLg%253D&md5=d586f688ffc47cc4129ed6407bd15720</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.20.11213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.20.11213%26sid%3Dliteratum%253Aachs%26aulast%3DWischik%26aufirst%3DC.%2BM.%26aulast%3DEdwards%26aufirst%3DP.%2BC.%26aulast%3DLai%26aufirst%3DR.%2BY.%26aulast%3DRoth%26aufirst%3DM.%26aulast%3DHarrington%26aufirst%3DC.%2BR.%26atitle%3DSelective%2520inhibition%2520of%2520Alzheimer%2520disease-like%2520tau%2520aggregation%2520by%2520phenothiazines%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D11213%26epage%3D11218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Wainwright, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaral, L.</span><span> </span><span class="NLM_article-title">The phenothiazinium chromophore and the evolution of antimalarial drugs</span> <span class="citation_source-journal">Trop. Med. Int. Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1365-3156.2005.01417.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15941412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFGrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=501-511&author=M.+Wainwrightauthor=L.+Amaral&title=The+phenothiazinium+chromophore+and+the+evolution+of+antimalarial+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">The phenothiazinium chromophore and the evolution of antimalarial drugs</span></div><div class="casAuthors">Wainwright, Mark; Amaral, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Tropical Medicine & International Health</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">501-511</span>CODEN:
                <span class="NLM_cas:coden">TMIHFL</span>;
        ISSN:<span class="NLM_cas:issn">1360-2276</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The phenothiazinium salt methylene blue [3, 7-bis(dimethylamino)phenothiazinium chloride] is the oldest known synthetic antimalarial drug, its clin. efficacy having been reported in 1891.  The role of methylene blue in the evolution of the modern antimalarial armoury is often unappreciated, yet it can be linked directly to std. drugs such as chloroquine and its congeners.  Also, in the face of increasing plasmodial resistance to modern antimalarials, phenothiazinium derivs. have again featured as lead compds. in drug research.  The precise mode of action of methylene blue and its com. analogs against Plasmodium spp remains a cause for conjecture, having been variously described as nucleic acid intercalation, food vacuole basification, parasite redox cycle interference and haem polymn. inhibition.  That the activity of the series may be due to more than one route - i.e. a multifactorial activity - underlines the utility of these compds. in antimalarial research either as single drugs or as adjuvants (partners in a drug combination), particularly in the face of resistant parasitic strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3A1-361mIZrVg90H21EOLACvtfcHk0lggcNM87p7x4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFGrs7c%253D&md5=873f7cc2d4da96fc19842f83af937028</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-3156.2005.01417.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-3156.2005.01417.x%26sid%3Dliteratum%253Aachs%26aulast%3DWainwright%26aufirst%3DM.%26aulast%3DAmaral%26aufirst%3DL.%26atitle%3DThe%2520phenothiazinium%2520chromophore%2520and%2520the%2520evolution%2520of%2520antimalarial%2520drugs%26jtitle%3DTrop.%2520Med.%2520Int.%2520Health%26date%3D2005%26volume%3D10%26spage%3D501%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Schirmer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Lest we forget you—methylene blue..</span> <span class="citation_source-journal">Neurobiol Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2325 e2327</span><span class="NLM_x">–</span> <span class="NLM_lpage">e2316</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.neurobiolaging.2010.12.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=2325+e2327-e2316&author=R.+H.+Schirmerauthor=H.+Adlerauthor=M.+Pickhardtauthor=E.+Mandelkow&title=Lest+we+forget+you%E2%80%94methylene+blue.."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2010.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2010.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DSchirmer%26aufirst%3DR.%2BH.%26aulast%3DAdler%26aufirst%3DH.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DLest%2520we%2520forget%2520you%25E2%2580%2594methylene%2520blue..%26jtitle%3DNeurobiol%2520Aging%26date%3D2011%26volume%3D32%26spage%3D2325%2520e2327%26epage%3De2316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Josefsen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, R. W.</span><span> </span><span class="NLM_article-title">Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics</span> <span class="citation_source-journal">Theranostics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">916</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=916-966&author=L.+B.+Josefsenauthor=R.+W.+Boyle&title=Unique+diagnostic+and+therapeutic+roles+of+porphyrins+and+phthalocyanines+in+photodynamic+therapy%2C+imaging+and+theranostics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJosefsen%26aufirst%3DL.%2BB.%26aulast%3DBoyle%26aufirst%3DR.%2BW.%26atitle%3DUnique%2520diagnostic%2520and%2520therapeutic%2520roles%2520of%2520porphyrins%2520and%2520phthalocyanines%2520in%2520photodynamic%2520therapy%252C%2520imaging%2520and%2520theranostics%26jtitle%3DTheranostics%26date%3D2012%26volume%3D2%26spage%3D916%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Bruchey, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Lima, F.</span><span> </span><span class="NLM_article-title">Behavioral, physiological and biochemical hormetic responses to the autoxidizable dye methylene blue</span> <span class="citation_source-journal">Am. J. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.3844%2Fajptsp.2008.72.79" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFOqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=72-79&author=A.+K.+Brucheyauthor=F.+Gonzalez-Lima&title=Behavioral%2C+physiological+and+biochemical+hormetic+responses+to+the+autoxidizable+dye+methylene+blue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral, physiological and biochemical hormetic responses to the autoxidizable dye methylene blue</span></div><div class="casAuthors">Bruchey, Aleksandra K.; Gonzalez-Lima, F.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-79</span>CODEN:
                <span class="NLM_cas:coden">AJPTCT</span>;
        ISSN:<span class="NLM_cas:issn">1557-4962</span>.
    
            (<span class="NLM_cas:orgname">Science Publications</span>)
        </div><div class="casAbstract">The goals of this review were to identify methylene blue (MB) as a compd. that follows hormetic behavior for a wide range of effects and to address the question of what is unique about MB that could account for its wide applicability and hormetic behavior as a drug.  The MB hormetic dose-response relationship is exemplified by an increase in various behavioral, physiol. and biochem. responses with increasing dose, followed by a decrease in the same responses with an even higher dose, until the responses are equal to control responses.  With MB doses increasing beyond the hormetic zone, the responses decrease even further, until they are below the control responses.  At doses spanning its hormetic zone, MB can increase select responses until they are 130-160% of control.  For example, low doses of MB produce max. behavioral and biochem. responses with avs. of approx. 140% of control.  As MB dose is raised outside the hormetic zone the response decreases below the control response, as exemplified by MB's ability to increase cytochrome oxidase activity at intermediate doses, while decreasing cytochrome oxidase activity at higher doses.  It is proposed that MB's autoxidizable chem. property may be responsible for its unique biol. action as both a metabolic energy enhancer and antioxidant that is frequently characterized by hormetic dose-response relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBEKHL_yDpYrVg90H21EOLACvtfcHk0lgCmvajwyJgXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFOqt7s%253D&md5=cae396bd6725339a0c87647e9774c28c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.3844%2Fajptsp.2008.72.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3844%252Fajptsp.2008.72.79%26sid%3Dliteratum%253Aachs%26aulast%3DBruchey%26aufirst%3DA.%2BK.%26aulast%3DGonzalez-Lima%26aufirst%3DF.%26atitle%3DBehavioral%252C%2520physiological%2520and%2520biochemical%2520hormetic%2520responses%2520to%2520the%2520autoxidizable%2520dye%2520methylene%2520blue%26jtitle%3DAm.%2520J.%2520Pharmacol.%2520Toxicol.%26date%3D2008%26volume%3D3%26spage%3D72%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Ohlow, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moosmann, B.</span><span> </span><span class="NLM_article-title">Phenothiazine: the seven lives of pharmacology’s first lead structure</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=119-131&author=M.+J.+Ohlowauthor=B.+Moosmann&title=Phenothiazine%3A+the+seven+lives+of+pharmacology%E2%80%99s+first+lead+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhlow%26aufirst%3DM.%2BJ.%26aulast%3DMoosmann%26aufirst%3DB.%26atitle%3DPhenothiazine%253A%2520the%2520seven%2520lives%2520of%2520pharmacology%25E2%2580%2599s%2520first%2520lead%2520structure%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D119%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">DiSanto, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. G.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of highly ionized drugs. II. Methylene blue—absorption, metabolism, and excretion in man and dog after oral administration</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1090</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1972&pages=1086-1090&author=A.+R.+DiSantoauthor=J.+G.+Wagner&title=Pharmacokinetics+of+highly+ionized+drugs.+II.+Methylene+blue%E2%80%94absorption%2C+metabolism%2C+and+excretion+in+man+and+dog+after+oral+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiSanto%26aufirst%3DA.%2BR.%26aulast%3DWagner%26aufirst%3DJ.%2BG.%26atitle%3DPharmacokinetics%2520of%2520highly%2520ionized%2520drugs.%2520II.%2520Methylene%2520blue%25E2%2580%2594absorption%252C%2520metabolism%252C%2520and%2520excretion%2520in%2520man%2520and%2520dog%2520after%2520oral%2520administration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1972%26volume%3D61%26spage%3D1086%26epage%3D1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Walter-Sack, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rengelshausen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberwittler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burhenne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meissner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikus, G.</span><span> </span><span class="NLM_article-title">High absolute bioavailability of methylene blue given as an aqueous oral formulation</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=179-189&author=I.+Walter-Sackauthor=J.+Rengelshausenauthor=H.+Oberwittlerauthor=J.+Burhenneauthor=O.+Muellerauthor=P.+Meissnerauthor=G.+Mikus&title=High+absolute+bioavailability+of+methylene+blue+given+as+an+aqueous+oral+formulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalter-Sack%26aufirst%3DI.%26aulast%3DRengelshausen%26aufirst%3DJ.%26aulast%3DOberwittler%26aufirst%3DH.%26aulast%3DBurhenne%26aufirst%3DJ.%26aulast%3DMueller%26aufirst%3DO.%26aulast%3DMeissner%26aufirst%3DP.%26aulast%3DMikus%26aufirst%3DG.%26atitle%3DHigh%2520absolute%2520bioavailability%2520of%2520methylene%2520blue%2520given%2520as%2520an%2520aqueous%2520oral%2520formulation%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D65%26spage%3D179%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Peter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hongwan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupfer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauterburg, B. H.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and organ distribution of intravenous and oral methylene blue</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2000&pages=247-250&author=C.+Peterauthor=D.+Hongwanauthor=A.+Kupferauthor=B.+H.+Lauterburg&title=Pharmacokinetics+and+organ+distribution+of+intravenous+and+oral+methylene+blue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeter%26aufirst%3DC.%26aulast%3DHongwan%26aufirst%3DD.%26aulast%3DKupfer%26aufirst%3DA.%26aulast%3DLauterburg%26aufirst%3DB.%2BH.%26atitle%3DPharmacokinetics%2520and%2520organ%2520distribution%2520of%2520intravenous%2520and%2520oral%2520methylene%2520blue%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2000%26volume%3D56%26spage%3D247%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Meijer, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeer, G. A.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of biliary excretion in man. VI. Indocyanine green</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1007%2FBF00558268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=3181282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADyaL1M%252FjtV2msg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1988&pages=295-303&author=D.+K.+Meijerauthor=B.+Weertauthor=G.+A.+Vermeer&title=Pharmacokinetics+of+biliary+excretion+in+man.+VI.+Indocyanine+green"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of biliary excretion in man. VI. Indocyanine green</span></div><div class="casAuthors">Meijer D K; Weert B; Vermeer G A</div><div class="citationInfo"><span class="NLM_cas:title">European journal of clinical pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">295-303</span>
        ISSN:<span class="NLM_cas:issn">0031-6970</span>.
    </div><div class="casAbstract">The pharmacokinetics of Indocyanine Green (ICG) has been studied in 15 patients given 0.5, 1.0 and 2.0 mg.kg-1.  The plasma disappearance and biliary excretion rate were measured in patients with tightly fitting catheters under slight negative pressure in order to achieve complete collection of bile.  Recovery of unchanged ICG in bile over 18 h after the i.v. injection was 80% of the dose in all three dose groups.  Plasma disappearance in all 3 groups was biphasic, showing an initial phase with a t1/2 of 3-4 min and a secondary phase with a dose-dependent apparent t1/2 of 67.6, 72.5 and 88.7 min, respectively.  After 0.5 and 1.0 mg.kg-1 the biliary excretion rate curves showed an ascending phase with a mean t1/2 of 5 min and a descending phase with a mean t1/2 of 72 min.  It was inferred that the secondary component of the plasma-decay mainly reflected the biliary excretion rate.  After 2.0 mg.kg-1 in some patients the biliary excretion curve showed features of saturation; the t1/2 of the descending phase ranged from 73 to 440 min, and the time of maximal excretion was increased from 1.3 to 2.7 h after injection, whilst the mean maximal excretion rate was in the same range as the excretion rate after the 1.0 mg.kg-1 dose.  The non-linear pharmacokinetics was only moderately reflected in the measured plasma disappearance patterns.  Two compartment analysis of the plasma levels indicated a clearance of 230-260 ml.min-1, whereas the clearance conventionally calculated from the initial t1/2 was 475 ml.min-1.(ABSTRACT TRUNCATED AT 250 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQv2Sjh9FVNNEwlCcfExbvbfW6udTcc2eaPmWiS5Bw8krntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M%252FjtV2msg%253D%253D&md5=80c143aafcc153d7f21dcfae5953c772</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1007%2FBF00558268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00558268%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DD.%2BK.%26aulast%3DWeert%26aufirst%3DB.%26aulast%3DVermeer%26aufirst%3DG.%2BA.%26atitle%3DPharmacokinetics%2520of%2520biliary%2520excretion%2520in%2520man.%2520VI.%2520Indocyanine%2520green%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1988%26volume%3D35%26spage%3D295%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Medina, D. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccamo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oddo, S.</span><span> </span><span class="NLM_article-title">Methylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity</span> <span class="citation_source-journal">Brain Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1750-3639.2010.00430.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20731659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Cis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=140-149&author=D.+X.+Medinaauthor=A.+Caccamoauthor=S.+Oddo&title=Methylene+blue+reduces+abeta+levels+and+rescues+early+cognitive+deficit+by+increasing+proteasome+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Methylene blue reduces Aβ levels and rescues early cognitive deficit by increasing proteasome activity</span></div><div class="casAuthors">Medina, David X.; Caccamo, Antonella; Oddo, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-149</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Promising results have emerged from a phase II clin. trial testing methylene blue (MB) as a potential therapeutic for Alzheimer disease (AD), where improvements in cognitive functions of AD patients after 6 mo of MB administration have been reported.  Despite these reports, no preclin. testing of MB in mammals has been published, and thus its mechanism of action in relation to AD pathol. remains unknown.  In order to elucidate the effects of MB on AD pathol. and to det. its mechanism of action, we used a mouse model (3xTg-AD) that develops age-dependent accumulation of Aβ and tau and cognitive decline.  Here, we report that chronic dietary MB treatment reduces Aβ levels and improves learning and memory deficits in the 3xTg-AD mice.  The mechanisms underlying the effects of MB on Aβ pathol. appears to be mediated by an increase in Aβ clearance as we show that MB increases the chymotrypsin- and trypsin-like activities of the proteasome in the brain.  To our knowledge, this is the first report showing that MB increases proteasome function and ameliorates AD-like pathol. in vivo.  Overall, the data presented here support the use of MB for the treatment of AD and offer a possible mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWODYX7uLwdbVg90H21EOLACvtfcHk0lh5Gq7zJDhXig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Cis74%253D&md5=d26eb29cec29fd8477fd189019643ab5</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1111%2Fj.1750-3639.2010.00430.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1750-3639.2010.00430.x%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DD.%2BX.%26aulast%3DCaccamo%26aufirst%3DA.%26aulast%3DOddo%26aufirst%3DS.%26atitle%3DMethylene%2520blue%2520reduces%2520abeta%2520levels%2520and%2520rescues%2520early%2520cognitive%2520deficit%2520by%2520increasing%2520proteasome%2520activity%26jtitle%3DBrain%2520Pathol.%26date%3D2011%26volume%3D21%26spage%3D140%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">van Bebber, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruscha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.nbd.2010.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20381619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt12nur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=265-271&author=F.+van+Bebberauthor=D.+Paquetauthor=A.+Hruschaauthor=B.+Schmidauthor=C.+Haass&title=Methylene+blue+fails+to+inhibit+Tau+and+polyglutamine+protein+dependent+toxicity+in+zebrafish"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish</span></div><div class="casAuthors">van Bebber, Frauke; Paquet, Dominik; Hruscha, Alexander; Schmid, Bettina; Haass, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-271</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Methylene blue is an FDA approved compd. with a variety of pharmacol. activities.  It inhibits aggregation of several amyloidogenic proteins known to be deposited in neurodegenerative diseases.  Recently, it has been proposed that methylene blue shows significant beneficial effects in a phase 2 clin. trial by slowing cognitive decline in Alzheimer's disease patients.  To analyze its therapeutic potential, we investigated the effect of methylene blue on neurotoxicity in a zebrafish model for tauopathies.  Transgenic expression of the frontotemporal dementia assocd. Tau-P301L mutation recapitulates a no. of the pathol. features obsd. in humans including abnormal phosphorylation and folding of Tau, tangle formation and Tau dependent neuronal loss.  Upon incubation of zebrafish larvae with methylene blue, neither abnormal phosphorylation nor neuronal cell loss, reduced neurite outgrowth or a swimming defect were rescued.  Methylene blue is biol. active in zebrafish since it reduced aggregation of a huntingtin variant contg. a stretch of 102 glutamine residues.  However, although huntingtin aggregation was largely prevented by methylene blue, huntingtin-dependent toxicity was unaffected.  Our findings are consistent with the hypothesis that toxicity is not necessarily assocd. with deposition of insol. amyloid proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog0EKGS9I8E7Vg90H21EOLACvtfcHk0li8_6_9DU2Vag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt12nur0%253D&md5=c4a5333ea90d770a5fc27496ff626c6e</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2010.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2010.03.023%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BBebber%26aufirst%3DF.%26aulast%3DPaquet%26aufirst%3DD.%26aulast%3DHruscha%26aufirst%3DA.%26aulast%3DSchmid%26aufirst%3DB.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DMethylene%2520blue%2520fails%2520to%2520inhibit%2520Tau%2520and%2520polyglutamine%2520protein%2520dependent%2520toxicity%2520in%2520zebrafish%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2010%26volume%3D39%26spage%3D265%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Congdon, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myeku, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinec, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickey, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duff, K. E.</span><span> </span><span class="NLM_article-title">Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=609-622&author=E.+E.+Congdonauthor=J.+W.+Wuauthor=N.+Myekuauthor=Y.+H.+Figueroaauthor=M.+Hermanauthor=P.+S.+Marinecauthor=J.+E.+Gestwickiauthor=C.+A.+Dickeyauthor=W.+H.+Yuauthor=K.+E.+Duff&title=Methylthioninium+chloride+%28methylene+blue%29+induces+autophagy+and+attenuates+tauopathy+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCongdon%26aufirst%3DE.%2BE.%26aulast%3DWu%26aufirst%3DJ.%2BW.%26aulast%3DMyeku%26aufirst%3DN.%26aulast%3DFigueroa%26aufirst%3DY.%2BH.%26aulast%3DHerman%26aufirst%3DM.%26aulast%3DMarinec%26aufirst%3DP.%2BS.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DYu%26aufirst%3DW.%2BH.%26aulast%3DDuff%26aufirst%3DK.%2BE.%26atitle%3DMethylthioninium%2520chloride%2520%2528methylene%2520blue%2529%2520induces%2520autophagy%2520and%2520attenuates%2520tauopathy%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAutophagy%26date%3D2012%26volume%3D8%26spage%3D609%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Buchholz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comini, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissenbach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirmer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauth-Siegel, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gromer, S.</span><span> </span><span class="NLM_article-title">Cytotoxic interactions of methylene blue with trypanosomatid-specific disulfide reductases and their dithiol products</span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.molbiopara.2008.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18448175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVamsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2008&pages=65-69&author=K.+Buchholzauthor=M.+A.+Cominiauthor=D.+Wissenbachauthor=R.+H.+Schirmerauthor=R.+L.+Krauth-Siegelauthor=S.+Gromer&title=Cytotoxic+interactions+of+methylene+blue+with+trypanosomatid-specific+disulfide+reductases+and+their+dithiol+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic interactions of methylene blue with trypanosomatid-specific disulfide reductases and their dithiol products</span></div><div class="casAuthors">Buchholz, Kathrin; Comini, Marcelo A.; Wissenbach, Dirk; Schirmer, R. Heiner; Krauth-Siegel, R. Luise; Gromer, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-69</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Methylene blue (MB) is known to have trypanocidal activity.  We tested the interactions of MB with a no. of trypanosomatid-specific mols. of the antioxidant metab.  At pH 7, trypanothione and other (di)thiols were oxidized to disulfides by the phenothiazine drug.  MB inhibited Trypanosoma cruzi trypanothione reductase (TR) (Ki = 1.9 μM), and served as a significant subversive substrate of this enzyme (KM = 30 μM, kcat = 4.9 s-1).  With lipoamide dehydrogenase, the second thiol-generating flavoenzyme of T. cruzi, the catalytic efficiency for MB redn. was found to be almost 106 M-1 s-1.  When the system MB-enzyme-mol. oxygen acts as a NAD(P)H-driven redox cycler, a reactive oxygen species, H2O2 or superoxide, is produced in each cycle.  Since MB is an affordable, available, and accessible drug it might be tested - alone or in drug combinations - against trypanosomatid-caused diseases of animal and man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3BOsO53izELVg90H21EOLACvtfcHk0li8_6_9DU2Vag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVamsbg%253D&md5=734fc267a95fdc2bcd9e7b56c69e5584</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2008.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2008.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DK.%26aulast%3DComini%26aufirst%3DM.%2BA.%26aulast%3DWissenbach%26aufirst%3DD.%26aulast%3DSchirmer%26aufirst%3DR.%2BH.%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26aulast%3DGromer%26aufirst%3DS.%26atitle%3DCytotoxic%2520interactions%2520of%2520methylene%2520blue%2520with%2520trypanosomatid-specific%2520disulfide%2520reductases%2520and%2520their%2520dithiol%2520products%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2008%26volume%3D160%26spage%3D65%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Atamna, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newberry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, B. N.</span><span> </span><span class="NLM_article-title">Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=703-712&author=H.+Atamnaauthor=A.+Nguyenauthor=C.+Schultzauthor=K.+Boyleauthor=J.+Newberryauthor=H.+Katoauthor=B.+N.+Ames&title=Methylene+blue+delays+cellular+senescence+and+enhances+key+mitochondrial+biochemical+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtamna%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DA.%26aulast%3DSchultz%26aufirst%3DC.%26aulast%3DBoyle%26aufirst%3DK.%26aulast%3DNewberry%26aufirst%3DJ.%26aulast%3DKato%26aufirst%3DH.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DMethylene%2520blue%2520delays%2520cellular%2520senescence%2520and%2520enhances%2520key%2520mitochondrial%2520biochemical%2520pathways%26jtitle%3DFASEB%2520J.%26date%3D2008%26volume%3D22%26spage%3D703%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2007&pages=1-6&author=A.+Croweauthor=C.+Ballatoreauthor=E.+Hydeauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=High+throughput+screening+for+small+molecule+inhibitors+of+heparin-induced+tau+fibril+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DHyde%26aufirst%3DE.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DHigh%2520throughput%2520screening%2520for%2520small%2520molecule%2520inhibitors%2520of%2520heparin-induced%2520tau%2520fibril%2520formation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2007%26volume%3D358%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Buchholz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirmer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eubel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akoachere, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dandekar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gromer, S.</span><span> </span><span class="NLM_article-title">Interactions of methylene blue with human disulfide reductases and their orthologues from <i>Plasmodium falciparum</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=183-191&author=K.+Buchholzauthor=R.+H.+Schirmerauthor=J.+K.+Eubelauthor=M.+B.+Akoachereauthor=T.+Dandekarauthor=K.+Beckerauthor=S.+Gromer&title=Interactions+of+methylene+blue+with+human+disulfide+reductases+and+their+orthologues+from+Plasmodium+falciparum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DK.%26aulast%3DSchirmer%26aufirst%3DR.%2BH.%26aulast%3DEubel%26aufirst%3DJ.%2BK.%26aulast%3DAkoachere%26aufirst%3DM.%2BB.%26aulast%3DDandekar%26aufirst%3DT.%26aulast%3DBecker%26aufirst%3DK.%26aulast%3DGromer%26aufirst%3DS.%26atitle%3DInteractions%2520of%2520methylene%2520blue%2520with%2520human%2520disulfide%2520reductases%2520and%2520their%2520orthologues%2520from%2520Plasmodium%2520falciparum%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D183%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saumier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garceau, D.</span><span> </span><span class="NLM_article-title">Alzhemed: a potential treatment for Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F156720507781788882" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17908052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSitLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=473-478&author=P.+S.+Aisenauthor=S.+Gauthierauthor=B.+Vellasauthor=R.+Briandauthor=D.+Saumierauthor=J.+Laurinauthor=D.+Garceau&title=Alzhemed%3A+a+potential+treatment+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Alzhemed: a potential treatment for Alzheimer's disease</span></div><div class="casAuthors">Aisen, Paul S.; Gauthier, Serge; Vellas, Bruno; Briand, Richard; Saumier, Daniel; Laurin, Julie; Garceau, Denis</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">473-478</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  As a potential disease-modifying treatment for AD, Alzhemed (tramiprosate) is a compd. that binds to sol. amyloid-beta peptide (Aβ) and inhibits the formation of neurotoxic aggregates that lead to amyloid plaque deposition in the brain.  The safety, tolerability, and pharmacodynamic effects of Alzhemed were assessed in a double-blind study in which 58 individuals with mild-to-moderate AD (MMSE 13-25) were randomized to receive placebo or Alzhemed 50, 100 or 150 mg BID for 3 mo.  At the end of the double-blind phase, 42 of these subjects entered a 36-mo openlabel (OL) phase in which they received Alzhemed 150 mg BID.  Assessments included plasma and cerebrospinal fluid (CSF) Alzhemed concns., CSF levels of Aβ, as well as cognitive (Alzheimer's Disease Assessment Scale-cognitive subscale, Mini-Mental State Examn.) and clin. performance (Clin. Dementia Rating scale, Sum-of-Boxes) measures.  Alzhemed was safe and well tolerated, crossed the blood-brain barrier, and dose-dependently reduced CSF Aβ42 levels after 3 mo of treatment.  Mild AD subjects (MMSE 19-25 at entry) displayed greater redn. of CSF Aβ42 levels than moderate AD participants (MMSE 13-18 at entry).  There was no effect of Alzhemed on the cognitive or clin. measures after 3 mo of treatment.  The OL follow-up suggested a stabilization of cognitive function esp. in mild AD subjects over the 36-mo study period.  Alzhemed thus appears to be well tolerated with long-term exposure and reduces CSF Aβ42 levels in mild-to-moderate AD subjects.  These findings will be discussed in the context of two large-scale randomized, double-blind, placebo-controlled Phase III clin. trials that are currently being conducted to test the long-term safety and efficacy of Alzhemed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUc83sp13UN7Vg90H21EOLACvtfcHk0lgj9-lGOGMysQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSitLzN&md5=42ad3c5746bdeca812c1036083ee1167</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.2174%2F156720507781788882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720507781788882%26sid%3Dliteratum%253Aachs%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DBriand%26aufirst%3DR.%26aulast%3DSaumier%26aufirst%3DD.%26aulast%3DLaurin%26aufirst%3DJ.%26aulast%3DGarceau%26aufirst%3DD.%26atitle%3DAlzhemed%253A%2520a%2520potential%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2007%26volume%3D4%26spage%3D473%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Gervais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morissette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krzywkowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szarek, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, P.</span><span> </span><span class="NLM_article-title">Targeting soluble Abeta peptide with tramiprosate for the treatment of brain amyloidosis</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.neurobiolaging.2006.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16675063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitFyks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=537-547&author=F.+Gervaisauthor=J.+Paquetteauthor=C.+Morissetteauthor=P.+Krzywkowskiauthor=M.+Yuauthor=M.+Azziauthor=D.+Lacombeauthor=X.+Kongauthor=A.+Amanauthor=J.+Laurinauthor=W.+A.+Szarekauthor=P.+Tremblay&title=Targeting+soluble+Abeta+peptide+with+tramiprosate+for+the+treatment+of+brain+amyloidosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis</span></div><div class="casAuthors">Gervais, Francine; Paquette, Julie; Morissette, Celine; Krzywkowski, Pascale; Yu, Mathilde; Azzi, Mounia; Lacombe, Diane; Kong, Xianqi; Aman, Ahmed; Laurin, Julie; Szarek, Walter A.; Tremblay, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">537-547</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Amyloid β-peptide (Aβ) is a major constituent of senile plaques in Alzheimer's disease (AD).  Neurotoxicity results from the conformational transition of Aβ from random-coil to β-sheet and its oligomerization.  Among a series of ionic compds. able to interact with sol. Aβ, Tramiprosate (3-amino-1-propanesulfonic acid; 3APS; Alzhemed) was found to maintain Aβ in a non-fibrillar form, to decrease Aβ42-induced cell death in neuronal cell cultures, and to inhibit amyloid deposition.  Tramiprosate crosses the murine blood-brain barrier (BBB) to exert its activity.  Treatment of TgCRND8 mice with Tramiprosate resulted in significant redn. (∼30%) in the brain amyloid plaque load and a significant decrease in the cerebral levels of sol. and insol. Aβ40 and Aβ42 (∼20-30%).  A dose-dependent redn. (up to 60%) of plasma Aβ levels was also obsd., suggesting that Tramiprosate influences the central pool of Aβ, changing either its efflux or its metab. in the brain.  We propose that Tramiprosate, which targets sol. Aβ, represents a new and promising therapeutic class of drugs for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLqWabGttsm7Vg90H21EOLACvtfcHk0lgj9-lGOGMysQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitFyks74%253D&md5=f871b841546682e832b666dc875a68ef</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2006.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2006.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DGervais%26aufirst%3DF.%26aulast%3DPaquette%26aufirst%3DJ.%26aulast%3DMorissette%26aufirst%3DC.%26aulast%3DKrzywkowski%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DAzzi%26aufirst%3DM.%26aulast%3DLacombe%26aufirst%3DD.%26aulast%3DKong%26aufirst%3DX.%26aulast%3DAman%26aufirst%3DA.%26aulast%3DLaurin%26aufirst%3DJ.%26aulast%3DSzarek%26aufirst%3DW.%2BA.%26aulast%3DTremblay%26aufirst%3DP.%26atitle%3DTargeting%2520soluble%2520Abeta%2520peptide%2520with%2520tramiprosate%2520for%2520the%2520treatment%2520of%2520brain%2520amyloidosis%26jtitle%3DNeurobiol.%2520Aging%26date%3D2007%26volume%3D28%26spage%3D537%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keren, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porsteinsson, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dyck, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tariot, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abushakra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bairu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastrak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cedarbaum, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Investigators, E. A.</span><span> </span><span class="NLM_article-title">A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1253</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2011&pages=1253-1262&author=S.+Sallowayauthor=R.+Sperlingauthor=R.+Kerenauthor=A.+P.+Porsteinssonauthor=C.+H.+van+Dyckauthor=P.+N.+Tariotauthor=S.+Gilmanauthor=D.+Arnoldauthor=S.+Abushakraauthor=C.+Hernandezauthor=G.+Cransauthor=E.+Liangauthor=G.+Quinnauthor=M.+Bairuauthor=A.+Pastrakauthor=J.+M.+Cedarbaumauthor=E.+A.+Investigators&title=A+phase+2+randomized+trial+of+ELND005%2C+scyllo-inositol%2C+in+mild+to+moderate+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DSperling%26aufirst%3DR.%26aulast%3DKeren%26aufirst%3DR.%26aulast%3DPorsteinsson%26aufirst%3DA.%2BP.%26aulast%3Dvan%2BDyck%26aufirst%3DC.%2BH.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DGilman%26aufirst%3DS.%26aulast%3DArnold%26aufirst%3DD.%26aulast%3DAbushakra%26aufirst%3DS.%26aulast%3DHernandez%26aufirst%3DC.%26aulast%3DCrans%26aufirst%3DG.%26aulast%3DLiang%26aufirst%3DE.%26aulast%3DQuinn%26aufirst%3DG.%26aulast%3DBairu%26aufirst%3DM.%26aulast%3DPastrak%26aufirst%3DA.%26aulast%3DCedarbaum%26aufirst%3DJ.%2BM.%26aulast%3DInvestigators%26aufirst%3DE.%2BA.%26atitle%3DA%2520phase%25202%2520randomized%2520trial%2520of%2520ELND005%252C%2520scyllo-inositol%252C%2520in%2520mild%2520to%2520moderate%2520Alzheimer%2520disease%26jtitle%3DNeurology%26date%3D2011%26volume%3D77%26spage%3D1253%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">McLaurin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kierstead, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkes, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambermon, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phinney, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darabie, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cousins, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mount, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westaway, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St George-Hyslop, P.</span><span> </span><span class="NLM_article-title">Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnm1423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16767098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1eksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=801-808&author=J.+McLaurinauthor=M.+E.+Kiersteadauthor=M.+E.+Brownauthor=C.+A.+Hawkesauthor=M.+H.+Lambermonauthor=A.+L.+Phinneyauthor=A.+A.+Darabieauthor=J.+E.+Cousinsauthor=J.+E.+Frenchauthor=M.+F.+Lanauthor=F.+Chenauthor=S.+S.+Wongauthor=H.+T.+Mountauthor=P.+E.+Fraserauthor=D.+Westawayauthor=P.+St+George-Hyslop&title=Cyclohexanehexol+inhibitors+of+Abeta+aggregation+prevent+and+reverse+Alzheimer+phenotype+in+a+mouse+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse model</span></div><div class="casAuthors">McLaurin, JoAnne; Kierstead, Meredith E.; Brown, Mary E.; Hawkes, Cheryl A.; Lambermon, Mark H. L.; Phinney, Amie L.; Darabie, Audrey A.; Cousins, Julian E.; French, Janet E.; Lan, Melissa F.; Chen, Fusheng; Wong, Sydney S. N.; Mount, Howard T. J.; Fraser, Paul E.; Westaway, David; St. George-Hyslop, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">801-808</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">When given orally to a transgenic mouse model of Alzheimer disease, cyclohexanehexol stereoisomers inhibit aggregation of amyloid β peptide (Aβ) into high-mol.-wt. oligomers in the brain and ameliorate several Alzheimer disease-like phenotypes in these mice, including impaired cognition, altered synaptic physiol., cerebral Aβ pathol. and accelerated mortality.  These therapeutic effects, which occur regardless of whether the compds. are given before or well after the onset of the Alzheimer disease-like phenotype, support the idea that the accumulation of Aβ oligomers has a central role in the pathogenesis of Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFtzDe5YKoj7Vg90H21EOLACvtfcHk0lh8BL06q4_C8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1eksLw%253D&md5=d1c366440d6831a9486fde66d410f4c1</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1038%2Fnm1423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1423%26sid%3Dliteratum%253Aachs%26aulast%3DMcLaurin%26aufirst%3DJ.%26aulast%3DKierstead%26aufirst%3DM.%2BE.%26aulast%3DBrown%26aufirst%3DM.%2BE.%26aulast%3DHawkes%26aufirst%3DC.%2BA.%26aulast%3DLambermon%26aufirst%3DM.%2BH.%26aulast%3DPhinney%26aufirst%3DA.%2BL.%26aulast%3DDarabie%26aufirst%3DA.%2BA.%26aulast%3DCousins%26aufirst%3DJ.%2BE.%26aulast%3DFrench%26aufirst%3DJ.%2BE.%26aulast%3DLan%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DWong%26aufirst%3DS.%2BS.%26aulast%3DMount%26aufirst%3DH.%2BT.%26aulast%3DFraser%26aufirst%3DP.%2BE.%26aulast%3DWestaway%26aufirst%3DD.%26aulast%3DSt%2BGeorge-Hyslop%26aufirst%3DP.%26atitle%3DCyclohexanehexol%2520inhibitors%2520of%2520Abeta%2520aggregation%2520prevent%2520and%2520reverse%2520Alzheimer%2520phenotype%2520in%2520a%2520mouse%2520model%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D801%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">McLaurin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golomb, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurewicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P. E.</span><span> </span><span class="NLM_article-title">Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">18495</span><span class="NLM_x">–</span> <span class="NLM_lpage">18502</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1074%2Fjbc.M906994199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=10764800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlylsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=18495-18502&author=J.+McLaurinauthor=R.+Golombauthor=A.+Jurewiczauthor=J.+P.+Antelauthor=P.+E.+Fraser&title=Inositol+stereoisomers+stabilize+an+oligomeric+aggregate+of+Alzheimer+amyloid+beta+peptide+and+inhibit+abeta+-induced+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid β peptide and inhibit Aβ-induced toxicity</span></div><div class="casAuthors">McLaurin, JoAnne; Golomb, Rivka; Jurewicz, Anna; Antel, Jack P.; Fraser, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">18495-18502</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Inositol has 8 stereoisomers, four of which are physiol. active.  Myo-Inositol is the most abundant isomer in the brain and more recently shown that epi- and scyllo-inositol are also present.  Myo-Inositol complexes with Aβ42 in vitro to form a small stable micelle.  The ability of inositol stereoisomers to interact with and stabilize small Aβ complexes was addressed.  CD spectroscopy demonstrated that epi- and scyllo- but not chiro-inositol were able to induce a structural transition from random to β-structure in Aβ42.  Alternatively, none of the stereoisomers were able to induce a structural transition in Aβ40.  Electron microscopy demonstrated that inositol stabilizes small aggregates of Aβ42.  We demonstrate that inositol-Aβ interactions result in a complex that is non-toxic to nerve growth factor-differentiated PC-12 cells and primary human neuronal cultures.  The attenuation of toxicity is the result of Aβ-inositol interaction, as inositol uptake inhibitors had no effect on neuronal survival.  The use of inositol stereoisomers allowed us to elucidate an important structure-activity relationship between Aβ and inositol.  Inositol stereoisomers are naturally occurring mols. that readily cross the blood-brain barrier and may represent a viable treatment for AD through the complexation of Aβ and attenuation of Aβ neurotoxic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrkjUUlOx_4rVg90H21EOLACvtfcHk0lh8BL06q4_C8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlylsrc%253D&md5=a384d0003a0409a3494dff0a6a8bc6cc</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M906994199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M906994199%26sid%3Dliteratum%253Aachs%26aulast%3DMcLaurin%26aufirst%3DJ.%26aulast%3DGolomb%26aufirst%3DR.%26aulast%3DJurewicz%26aufirst%3DA.%26aulast%3DAntel%26aufirst%3DJ.%2BP.%26aulast%3DFraser%26aufirst%3DP.%2BE.%26atitle%3DInositol%2520stereoisomers%2520stabilize%2520an%2520oligomeric%2520aggregate%2520of%2520Alzheimer%2520amyloid%2520beta%2520peptide%2520and%2520inhibit%2520abeta%2520-induced%2520toxicity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D18495%26epage%3D18502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Rezai-Zadeh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shytle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanniton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrhart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Town, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span> </span><span class="NLM_article-title">Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">8807</span><span class="NLM_x">–</span> <span class="NLM_lpage">8814</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1523%2FJNEUROSCI.1521-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16177050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGls73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=8807-8814&author=K.+Rezai-Zadehauthor=D.+Shytleauthor=N.+Sunauthor=T.+Moriauthor=H.+Houauthor=D.+Jeannitonauthor=J.+Ehrhartauthor=K.+Townsendauthor=J.+Zengauthor=D.+Morganauthor=J.+Hardyauthor=T.+Townauthor=J.+Tan&title=Green+tea+epigallocatechin-3-gallate+%28EGCG%29+modulates+amyloid+precursor+protein+cleavage+and+reduces+cerebral+amyloidosis+in+Alzheimer+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice</span></div><div class="casAuthors">Rezai-Zadeh, Kavon; Shytle, Doug; Sun, Nan; Mori, Takashi; Hou, Huayan; Jeanniton, Deborah; Ehrhart, Jared; Townsend, Kirk; Zeng, Jin; Morgan, David; Hardy, John; Town, Terrence; Tan, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">8807-8814</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disorder pathol. characterized by deposition of β-amyloid (Aβ) peptides as senile plaques in the brain.  Recent studies suggest that green tea flavonoids may be used for the prevention and treatment of a variety of neurodegenerative diseases.  Here, we report that (-)-epigallocatechin-3-gallate (EGCG), the main polyphenolic constituent of green tea, reduces Aβ generation in both murine neuron-like cells (N2a) transfected with the human "Swedish" mutant amyloid precursor protein (APP) and in primary neurons derived from Swedish mutant APP-overexpressing mice (Tg APPsw line 2576).  In concert with these observations, we find that EGCG markedly promotes cleavage of the α-C-terminal fragment of APP and elevates the N-terminal APP cleavage product, sol. APP-α.  These cleavage events are assocd. with elevated α-secretase activity and enhanced hydrolysis of tumor necrosis factor α-converting enzyme, a primary candidate α-secretase.  As a validation of these findings in vivo, we treated Tg APPsw transgenic mice overproducing Aβ with EGCG and found decreased Aβ levels and plaques assocd. with promotion of the nonamyloidogenic α-secretase proteolytic pathway.  These data raise the possibility that EGCG dietary supplementation may provide effective prophylaxis for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAwCf6nx6QU7Vg90H21EOLACvtfcHk0lhWWbhSP_qO_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGls73F&md5=7bedc52129ea6eeed557f242a5afe639</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1521-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1521-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DRezai-Zadeh%26aufirst%3DK.%26aulast%3DShytle%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DN.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DHou%26aufirst%3DH.%26aulast%3DJeanniton%26aufirst%3DD.%26aulast%3DEhrhart%26aufirst%3DJ.%26aulast%3DTownsend%26aufirst%3DK.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DTown%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DJ.%26atitle%3DGreen%2520tea%2520epigallocatechin-3-gallate%2520%2528EGCG%2529%2520modulates%2520amyloid%2520precursor%2520protein%2520cleavage%2520and%2520reduces%2520cerebral%2520amyloidosis%2520in%2520Alzheimer%2520transgenic%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D8807%26epage%3D8814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Ehrnhoefer, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieschke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeddrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lurz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engemann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanker, E. E.</span><span> </span><span class="NLM_article-title">EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnsmb.1437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18511942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=558-566&author=D.+E.+Ehrnhoeferauthor=J.+Bieschkeauthor=A.+Boeddrichauthor=M.+Herbstauthor=L.+Masinoauthor=R.+Lurzauthor=S.+Engemannauthor=A.+Pastoreauthor=E.+E.+Wanker&title=EGCG+redirects+amyloidogenic+polypeptides+into+unstructured%2C+off-pathway+oligomers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers</span></div><div class="casAuthors">Ehrnhoefer, Dagmar E.; Bieschke, Jan; Boeddrich, Annett; Herbst, Martin; Masino, Laura; Lurz, Rudi; Engemann, Sabine; Pastore, Annalisa; Wanker, Erich E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">558-566</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The accumulation of β-sheet-rich amyloid fibrils or aggregates is a complex, multistep process that is assocd. with cellular toxicity in a no. of human protein misfolding disorders, including Parkinson's and Alzheimer's diseases.  It involves the formation of various transient and intransient, on- and off-pathway aggregate species, whose structure, size and cellular toxicity are largely unclear.  Here we demonstrate redirection of amyloid fibril formation through the action of a small mol., resulting in off-pathway, highly stable oligomers.  The polyphenol (-)-epigallocatechin gallate efficiently inhibits the fibrillogenesis of both α-synuclein and amyloid-β by directly binding to the natively unfolded polypeptides and preventing their conversion into toxic, on-pathway aggregation intermediates.  Instead of β-sheet-rich amyloid, the formation of unstructured, nontoxic α-synuclein and amyloid-β oligomers of a new type is promoted, suggesting a generic effect on aggregation pathways in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzZB-LENNWJ7Vg90H21EOLACvtfcHk0lhWWbhSP_qO_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWgsbg%253D&md5=ad713b3e1a769dfb64afe70690b94bee</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1437%26sid%3Dliteratum%253Aachs%26aulast%3DEhrnhoefer%26aufirst%3DD.%2BE.%26aulast%3DBieschke%26aufirst%3DJ.%26aulast%3DBoeddrich%26aufirst%3DA.%26aulast%3DHerbst%26aufirst%3DM.%26aulast%3DMasino%26aufirst%3DL.%26aulast%3DLurz%26aufirst%3DR.%26aulast%3DEngemann%26aufirst%3DS.%26aulast%3DPastore%26aufirst%3DA.%26aulast%3DWanker%26aufirst%3DE.%2BE.%26atitle%3DEGCG%2520redirects%2520amyloidogenic%2520polypeptides%2520into%2520unstructured%252C%2520off-pathway%2520oligomers%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D558%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Bieschke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russ, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrnhoefer, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wobst, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neugebauer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanker, E. E.</span><span> </span><span class="NLM_article-title">EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">7710</span><span class="NLM_x">–</span> <span class="NLM_lpage">7715</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.0910723107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20385841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXls1amtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=7710-7715&author=J.+Bieschkeauthor=J.+Russauthor=R.+P.+Friedrichauthor=D.+E.+Ehrnhoeferauthor=H.+Wobstauthor=K.+Neugebauerauthor=E.+E.+Wanker&title=EGCG+remodels+mature+alpha-synuclein+and+amyloid-beta+fibrils+and+reduces+cellular+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity</span></div><div class="casAuthors">Bieschke, Jan; Russ, Jenny; Friedrich, Ralf P.; Ehrnhoefer, Dagmar E.; Wobst, Heike; Neugebauer, Katja; Wanker, Erich E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7710-7715, S7710/1-S7710/13</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Protein misfolding and formation of β-sheet-rich amyloid fibrils or aggregates is related to cellular toxicity and decay in various human disorders including Alzheimer's and Parkinson's disease.  Recently, we demonstrated that the polyphenol(-)-epi-gallocatechine gallate (EGCG) inhibits α-synuclein and amyloid-β fibrillogenesis.  It assocs. with natively unfolded polypeptides and promotes the self-assembly of unstructured oligomers of a new type.  Whether EGCG disassembles preformed amyloid fibrils, however, remained unclear.  Here, we show that EGCG has the ability to convert large, mature α-synuclein and amyloid-β fibrils into smaller, amorphous protein aggregates that are nontoxic to mammalian cells.  Mechanistic studies revealed that the compd. directly binds to β-sheet-rich aggregates and mediates the conformational change without their disassembly into monomers or small diffusible oligomers.  These findings suggest that EGCG is a potent remodeling agent of mature amyloid fibrils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrduWIRUxO1x7Vg90H21EOLACvtfcHk0lhWWbhSP_qO_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXls1amtrw%253D&md5=f1fd226e013a67c2f2de00efad51533e</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0910723107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0910723107%26sid%3Dliteratum%253Aachs%26aulast%3DBieschke%26aufirst%3DJ.%26aulast%3DRuss%26aufirst%3DJ.%26aulast%3DFriedrich%26aufirst%3DR.%2BP.%26aulast%3DEhrnhoefer%26aufirst%3DD.%2BE.%26aulast%3DWobst%26aufirst%3DH.%26aulast%3DNeugebauer%26aufirst%3DK.%26aulast%3DWanker%26aufirst%3DE.%2BE.%26atitle%3DEGCG%2520remodels%2520mature%2520alpha-synuclein%2520and%2520amyloid-beta%2520fibrils%2520and%2520reduces%2520cellular%2520toxicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D7710%26epage%3D7715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Bieschke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiglenda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeddrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiele, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleckers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez del Amo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruning, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lurz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwyl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnoegl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reif, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunther, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanker, E. E.</span><span> </span><span class="NLM_article-title">Small-molecule conversion of toxic oligomers to nontoxic beta-sheet-rich amyloid fibrils</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnchembio.719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2gtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=93-101&author=J.+Bieschkeauthor=M.+Herbstauthor=T.+Wiglendaauthor=R.+P.+Friedrichauthor=A.+Boeddrichauthor=F.+Schieleauthor=D.+Kleckersauthor=J.+M.+Lopez+del+Amoauthor=B.+A.+Gruningauthor=Q.+Wangauthor=M.+R.+Schmidtauthor=R.+Lurzauthor=R.+Anwylauthor=S.+Schnoeglauthor=M.+Fandrichauthor=R.+F.+Frankauthor=B.+Reifauthor=S.+Guntherauthor=D.+M.+Walshauthor=E.+E.+Wanker&title=Small-molecule+conversion+of+toxic+oligomers+to+nontoxic+beta-sheet-rich+amyloid+fibrils"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils</span></div><div class="casAuthors">Bieschke, Jan; Herbst, Martin; Wiglenda, Thomas; Friedrich, Ralf P.; Boeddrich, Annett; Schiele, Franziska; Kleckers, Daniela; Lopez del Amo, Juan Miguel; Gruening, Bjoern A.; Wang, Qinwen; Schmidt, Michael R.; Lurz, Rudi; Anwyl, Roger; Schnoegl, Sigrid; Faendrich, Marcus; Frank, Ronald F.; Reif, Bernd; Guenther, Stefan; Walsh, Dominic M.; Wanker, Erich E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-101</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Several lines of evidence indicate that prefibrillar assemblies of amyloid-β (Aβ) polypeptides, such as sol. oligomers or protofibrils, rather than mature, end-stage amyloid fibrils cause neuronal dysfunction and memory impairment in Alzheimer's disease.  These findings suggest that reducing the prevalence of transient intermediates by small mol.-mediated stimulation of amyloid polymn. might decrease toxicity.  Here we demonstrate the acceleration of Aβ fibrillogenesis through the action of the orcein-related small mol. O4, which directly binds to hydrophobic amino acid residues in Aβ peptides and stabilizes the self-assembly of seeding-competent, β-sheet-rich protofibrils and fibrils.  Notably, the O4-mediated acceleration of amyloid fibril formation efficiently decreases the concn. of small, toxic Aβ oligomers in complex, heterogeneous aggregation reactions.  In addn., O4 treatment suppresses inhibition of long-term potentiation by Aβ oligomers in hippocampal brain slices.  These results support the hypothesis that small, diffusible prefibrillar amyloid species rather than mature fibrillar aggregates are toxic for mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZXPTy8dSfjLVg90H21EOLACvtfcHk0ljizIBY6zdXDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2gtrvL&md5=28dd2adecd2d1ea3dbb1387dfbd415f9</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.719%26sid%3Dliteratum%253Aachs%26aulast%3DBieschke%26aufirst%3DJ.%26aulast%3DHerbst%26aufirst%3DM.%26aulast%3DWiglenda%26aufirst%3DT.%26aulast%3DFriedrich%26aufirst%3DR.%2BP.%26aulast%3DBoeddrich%26aufirst%3DA.%26aulast%3DSchiele%26aufirst%3DF.%26aulast%3DKleckers%26aufirst%3DD.%26aulast%3DLopez%2Bdel%2BAmo%26aufirst%3DJ.%2BM.%26aulast%3DGruning%26aufirst%3DB.%2BA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DSchmidt%26aufirst%3DM.%2BR.%26aulast%3DLurz%26aufirst%3DR.%26aulast%3DAnwyl%26aufirst%3DR.%26aulast%3DSchnoegl%26aufirst%3DS.%26aulast%3DFandrich%26aufirst%3DM.%26aulast%3DFrank%26aufirst%3DR.%2BF.%26aulast%3DReif%26aufirst%3DB.%26aulast%3DGunther%26aufirst%3DS.%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DWanker%26aufirst%3DE.%2BE.%26atitle%3DSmall-molecule%2520conversion%2520of%2520toxic%2520oligomers%2520to%2520nontoxic%2520beta-sheet-rich%2520amyloid%2520fibrils%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D93%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">The metallobiology of Alzheimer’s disease</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=207-214&author=A.+I.+Bush&title=The+metallobiology+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DThe%2520metallobiology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Neurosci.%26date%3D2003%26volume%3D26%26spage%3D207%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Jenagaratnam, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McShane, R.</span><span> </span><span class="NLM_article-title">Clioquinol for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD005380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=CD005380&author=L.+Jenagaratnamauthor=R.+McShane&title=Clioquinol+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJenagaratnam%26aufirst%3DL.%26aulast%3DMcShane%26aufirst%3DR.%26atitle%3DClioquinol%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2006%26spage%3DCD005380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Sampson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenagaratnam, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McShane, R.</span><span> </span><span class="NLM_article-title">Metal protein attenuating compounds for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD005380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=CD005380&author=E.+Sampsonauthor=L.+Jenagaratnamauthor=R.+McShane&title=Metal+protein+attenuating+compounds+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSampson%26aufirst%3DE.%26aulast%3DJenagaratnam%26aufirst%3DL.%26aulast%3DMcShane%26aufirst%3DR.%26atitle%3DMetal%2520protein%2520attenuating%2520compounds%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2008%26spage%3DCD005380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Lei, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spoerri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccotosto, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adlard, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volitakis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duce, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnm.2613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22286308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlOlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=291-295&author=P.+Leiauthor=S.+Aytonauthor=D.+I.+Finkelsteinauthor=L.+Spoerriauthor=G.+D.+Ciccotostoauthor=D.+K.+Wrightauthor=B.+X.+Wongauthor=P.+A.+Adlardauthor=R.+A.+Chernyauthor=L.+Q.+Lamauthor=B.+R.+Robertsauthor=I.+Volitakisauthor=G.+F.+Eganauthor=C.+A.+McLeanauthor=R.+Cappaiauthor=J.+A.+Duceauthor=A.+I.+Bush&title=Tau+deficiency+induces+parkinsonism+with+dementia+by+impairing+APP-mediated+iron+export"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export</span></div><div class="casAuthors">Lei, Peng; Ayton, Scott; Finkelstein, David I.; Spoerri, Loredana; Ciccotosto, Giuseppe D.; Wright, David K.; Wong, Bruce X. W.; Adlard, Paul A.; Cherny, Robert A.; Lam, Linh Q.; Roberts, Blaine R.; Volitakis, Irene; Egan, Gary F.; McLean, Catriona A.; Cappai, Roberto; Duce, James A.; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">291-295</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The microtubule-assocd. protein tau has risk alleles for both Alzheimer's disease and Parkinson's disease and mutations that cause brain degenerative diseases termed tauopathies.  Aggregated tau forms neurofibrillary tangles in these pathologies, but little is certain about the function of tau or its mode of involvement in pathogenesis.  Neuronal iron accumulation has been obsd. pathol. in the cortex in Alzheimer's disease, the substantia nigra (SN) in Parkinson's disease and various brain regions in the tauopathies.  Here we report that tau-knockout mice develop age-dependent brain atrophy, iron accumulation and SN neuronal loss, with concomitant cognitive deficits and parkinsonism.  These changes are prevented by oral treatment with a moderate iron chelator, clioquinol.  Amyloid precursor protein (APP) ferroxidase activity couples with surface ferroportin to export iron, but its activity is inhibited in Alzheimer's disease, thereby causing neuronal iron accumulation.  In primary neuronal culture, we found loss of tau also causes iron retention, by decreasing surface trafficking of APP.  Sol. tau levels fall in affected brain regions in Alzheimer's disease and tauopathies, and we found a similar decrease of sol. tau in the SN in both Parkinson's disease and the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model.  These data suggest that the loss of sol. tau could contribute to toxic neuronal iron accumulation in Alzheimer's disease, Parkinson's disease and tauopathies, and that it can be rescued pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsDxfEAJe0CbVg90H21EOLACvtfcHk0ljizIBY6zdXDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlOlsbg%253D&md5=154d24d4d4bfa181c490cdb1c146e721</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1038%2Fnm.2613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2613%26sid%3Dliteratum%253Aachs%26aulast%3DLei%26aufirst%3DP.%26aulast%3DAyton%26aufirst%3DS.%26aulast%3DFinkelstein%26aufirst%3DD.%2BI.%26aulast%3DSpoerri%26aufirst%3DL.%26aulast%3DCiccotosto%26aufirst%3DG.%2BD.%26aulast%3DWright%26aufirst%3DD.%2BK.%26aulast%3DWong%26aufirst%3DB.%2BX.%26aulast%3DAdlard%26aufirst%3DP.%2BA.%26aulast%3DCherny%26aufirst%3DR.%2BA.%26aulast%3DLam%26aufirst%3DL.%2BQ.%26aulast%3DRoberts%26aufirst%3DB.%2BR.%26aulast%3DVolitakis%26aufirst%3DI.%26aulast%3DEgan%26aufirst%3DG.%2BF.%26aulast%3DMcLean%26aufirst%3DC.%2BA.%26aulast%3DCappai%26aufirst%3DR.%26aulast%3DDuce%26aufirst%3DJ.%2BA.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DTau%2520deficiency%2520induces%2520parkinsonism%2520with%2520dementia%2520by%2520impairing%2520APP-mediated%2520iron%2520export%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D291%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Lecanu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teper, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greeson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, V.</span><span> </span><span class="NLM_article-title">Identification of naturally occurring spirostenols preventing beta-amyloid-induced neurotoxicity</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=1-16&author=L.+Lecanuauthor=W.+Yaoauthor=G.+L.+Teperauthor=Z.+X.+Yaoauthor=J.+Greesonauthor=V.+Papadopoulos&title=Identification+of+naturally+occurring+spirostenols+preventing+beta-amyloid-induced+neurotoxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLecanu%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DTeper%26aufirst%3DG.%2BL.%26aulast%3DYao%26aufirst%3DZ.%2BX.%26aulast%3DGreeson%26aufirst%3DJ.%26aulast%3DPapadopoulos%26aufirst%3DV.%26atitle%3DIdentification%2520of%2520naturally%2520occurring%2520spirostenols%2520preventing%2520beta-amyloid-induced%2520neurotoxicity%26jtitle%3DSteroids%26date%3D2004%26volume%3D69%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Papadopoulos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecanu, L.</span><span> </span><span class="NLM_article-title">Caprospinol: discovery of a steroid drug candidate to treat Alzheimer’s disease based on 22<i>R</i>-hydroxycholesterol structure and properties</span> <span class="citation_source-journal">J. Neuroendocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1365-2826.2011.02167.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21623958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlslyisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=93-101&author=V.+Papadopoulosauthor=L.+Lecanu&title=Caprospinol%3A+discovery+of+a+steroid+drug+candidate+to+treat+Alzheimer%E2%80%99s+disease+based+on+22R-hydroxycholesterol+structure+and+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Caprospinol: discovery of a steroid drug candidate to treat Alzheimer's disease based on 22R-hydroxycholesterol structure and properties</span></div><div class="casAuthors">Papadopoulos, V.; Lecanu, L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroendocrinology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-101</span>CODEN:
                <span class="NLM_cas:coden">JOUNE2</span>;
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The overall ability of the brain to synthesize neuroactive steroids led us to the identification of compds. that would reproduce aspects of neurosteroid pharmacol.  The rate-detg. step in neurosteroid biosynthesis is the import of the substrate cholesterol into the mitochondria, where it is metabolized into pregnenolone via the intermediate 22R-hydroxycholesterol.  The levels of translocator protein 18-kDa, mediating the import of cholesterol into mitochondria, correlated with increased pregnenolone formation and reduced levels of 22R-hydroxycholesterol in biopsies from Alzheimer's disease (AD), but not age-matched control, brains.  22R-hydroxycholesterol was shown to protect against β-amyloid (Aβ42)-induced neurotoxicity.  In search of 22R-hydroxycholesterol stable analogs, we identified the naturally occurring heterospirostenol, (22R,25R)-20α-spirost-5-en-3β-yl hexanoate (caprospinol) and derivs. that protect neuronal cells against Aβ1-42 neurotoxicity.  The neuroprotective effect of caprospinol is the result of a combination of overlapping properties, including: (i) the ability to bind to Aβ42 and reduce plaque formation in the brain in vivo; (ii) interaction with components of the mitochondria respiratory chain resulting in an anti-uncoupling effect; (iii) the capacity to scavenge Aβ42 monomers present in mitochondria; and (iv) the property of being a sigma-1 receptor ligand.  In vivo, caprospinol crosses the blood-brain barrier, accumulates in the brain, and restores cognitive impairment in a pharmacol. rat model of AD.  Caprospinol is stable, does not bind to known steroid receptors, is devoid of mutagenic and genotoxic properties, and is devoid of acute toxicity in rodents.  The pharmacokinetics and pharmacodynamics of caprospinol were studied, and long-term toxicity studies are under investigation, aiming to develop this compd. as a disease-modifying drug for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFN_NfoFDcrVg90H21EOLACvtfcHk0lipqziCLzF-OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlslyisw%253D%253D&md5=15e9d7ea67bb8f6b665cd78a35f5882b</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2826.2011.02167.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2826.2011.02167.x%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulos%26aufirst%3DV.%26aulast%3DLecanu%26aufirst%3DL.%26atitle%3DCaprospinol%253A%2520discovery%2520of%2520a%2520steroid%2520drug%2520candidate%2520to%2520treat%2520Alzheimer%25E2%2580%2599s%2520disease%2520based%2520on%252022R-hydroxycholesterol%2520structure%2520and%2520properties%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D2012%26volume%3D24%26spage%3D93%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Nakagami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murasugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meguro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, T.</span><span> </span><span class="NLM_article-title">A novel beta-sheet breaker, RS-0406, reverses amyloid beta-induced cytotoxicity and impairment of long-term potentiation in vitro</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">676</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fsj.bjp.0704911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=12381681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD38XosF2ht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2002&pages=676-682&author=Y.+Nakagamiauthor=S.+Nishimuraauthor=T.+Murasugiauthor=I.+Kanekoauthor=M.+Meguroauthor=S.+Marumotoauthor=H.+Kogenauthor=K.+Koyamaauthor=T.+Oda&title=A+novel+beta-sheet+breaker%2C+RS-0406%2C+reverses+amyloid+beta-induced+cytotoxicity+and+impairment+of+long-term+potentiation+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">A novel β-sheet breaker, RS-0406, reverses amyloid β-induced cytotoxicity and impairment of long-term potentiation in vitro</span></div><div class="casAuthors">Nakagami, Yasuhiro; Nishimura, Satoko; Murasugi, Takako; Kaneko, Isao; Meguro, Masaki; Marumoto, Shinji; Kogen, Hiroshi; Koyama, Kazuo; Oda, Tomiichiro</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">676-682</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fibril formation of amyloid β peptide (Aβ) is considered to be responsible for the pathol. of Alzheimer's disease (AD).  The Aβ fibril is formed by a protein misfolding process in which intermol. β-sheet interactions become stabilized abnormally.  Thus, to develop potential anti-AD drugs, we screened an inhouse library to find compds. which have a profile as a β-sheet breaker.  We searched for a β-sheet breaker profile in an inhouse library of approx. 113,000 compds.  From among the screening hits, we focused on N,N'-bis(3-hydroxyphenyl)pyridazine-3,6-diamine (named RS-0406), which had been newly synthesized in our lab.  This compd. (10 - 100 μg ml-1) was found to be capable of significantly inhibiting 25 μM Aβ1-42 fibrillogenesis and, furthermore, disassembling preformed Aβ1-42 fibrils in vitro.  We then investigated the effect of RS-0406 on 111 nM Aβ1-42-induced cytotoxicity in primary hippocampal neurons, and found that 0.3 - 3 μg ml-1 RS-0406 ameliorates the cytotoxicity.  Moreover, 3 μg ml-1 RS-0406 reversed 1 μM Aβ1-42-induced impairment of long-term potentiation in hippocampal slices.  In this study, we have succeeded in identifying RS-0406 which has potential to inhibit Aβ1-42 fibrillogenesis, and to protect neurons against Aβ1-42-induced biol. toxicity in vitro.  These results suggest that RS-0406 or one of the derivs. could become a therapeutic agent for AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf90pJU6VsSLVg90H21EOLACvtfcHk0lipqziCLzF-OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosF2ht7g%253D&md5=49f5933b6b49aa972eb77a14882dd4fe</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704911%26sid%3Dliteratum%253Aachs%26aulast%3DNakagami%26aufirst%3DY.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DMurasugi%26aufirst%3DT.%26aulast%3DKaneko%26aufirst%3DI.%26aulast%3DMeguro%26aufirst%3DM.%26aulast%3DMarumoto%26aufirst%3DS.%26aulast%3DKogen%26aufirst%3DH.%26aulast%3DKoyama%26aufirst%3DK.%26aulast%3DOda%26aufirst%3DT.%26atitle%3DA%2520novel%2520beta-sheet%2520breaker%252C%2520RS-0406%252C%2520reverses%2520amyloid%2520beta-induced%2520cytotoxicity%2520and%2520impairment%2520of%2520long-term%2520potentiation%2520in%2520vitro%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D137%26spage%3D676%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlisny, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankar, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadeeva, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Agnaf, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2455</span><span class="NLM_x">–</span> <span class="NLM_lpage">2462</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1523%2FJNEUROSCI.4391-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15758153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1ygsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=2455-2462&author=D.+M.+Walshauthor=M.+Townsendauthor=M.+B.+Podlisnyauthor=G.+M.+Shankarauthor=J.+V.+Fadeevaauthor=O.+El+Agnafauthor=D.+M.+Hartleyauthor=D.+J.+Selkoe&title=Certain+inhibitors+of+synthetic+amyloid+beta-peptide+%28Abeta%29+fibrillogenesis+block+oligomerization+of+natural+Abeta+and+thereby+rescue+long-term+potentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Certain inhibitors of synthetic amyloid β-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation</span></div><div class="casAuthors">Walsh, Dominic M.; Townsend, Matthew; Podlisny, Marcia B.; Shankar, Ganesh M.; Fadeeva, Julia V.; El Agnaf, Omar; Hartley, Dean M.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2455-2462</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent studies support the hypothesis that sol. oligomers of amyloid β-peptide (Aβ) rather than mature amyloid fibrils are the earliest effectors of synaptic compromise in Alzheimer's disease.  We took advantage of an amyloid precursor protein-overexpressing cell line that secretes SDS-stable Aβ oligomers to search for inhibitors of the pathobiol. effects of natural human Aβ oligomers.  Here, we identify small mols. that inhibit formation of sol. Aβ oligomers and thus abrogate their block of long-term potentiation (LTP).  Furthermore, we show that cell-derived Aβ oligomers can be sepd. from monomers by size exclusion chromatog. under nondenaturing conditions and that the isolated, sol. oligomers, but not monomers, block LTP.  The identification of small mols. that inhibit early Aβ oligomer formation and rescue LTP inhibition offers a rational approach for therapeutic intervention in Alzheimer's disease and highlights the utility of our cell-culture paradigm as a useful secondary screen for compds. designed to inhibit early steps in Aβ oligomerization under biol. relevant conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpntJTiDtBHv7Vg90H21EOLACvtfcHk0lipqziCLzF-OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1ygsr8%253D&md5=638707df43af1dda17cd36d730bc47c8</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4391-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4391-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DTownsend%26aufirst%3DM.%26aulast%3DPodlisny%26aufirst%3DM.%2BB.%26aulast%3DShankar%26aufirst%3DG.%2BM.%26aulast%3DFadeeva%26aufirst%3DJ.%2BV.%26aulast%3DEl%2BAgnaf%26aufirst%3DO.%26aulast%3DHartley%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DCertain%2520inhibitors%2520of%2520synthetic%2520amyloid%2520beta-peptide%2520%2528Abeta%2529%2520fibrillogenesis%2520block%2520oligomerization%2520of%2520natural%2520Abeta%2520and%2520thereby%2520rescue%2520long-term%2520potentiation%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D2455%26epage%3D2462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Scopes, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Hare, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeggo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyment, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanswick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gannon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amijee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treherne, J. M.</span><span> </span><span class="NLM_article-title">Abeta oligomer toxicity inhibitor protects memory in models of synaptic toxicity</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1476-5381.2012.01973.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22913627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=383-392&author=D.+I.+Scopesauthor=E.+O%E2%80%99Hareauthor=R.+Jeggoauthor=A.+D.+Whymentauthor=D.+Spanswickauthor=E.+M.+Kimauthor=J.+Gannonauthor=H.+Amijeeauthor=J.+M.+Treherne&title=Abeta+oligomer+toxicity+inhibitor+protects+memory+in+models+of+synaptic+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ oligomer toxicity inhibitor protects memory in models of synaptic toxicity</span></div><div class="casAuthors">Scopes, D. I. C.; O'Hare, E.; Jeggo, R.; Whyment, A. D.; Spanswick, D.; Kim, E.-M.; Gannon, J.; Amijee, H.; Treherne, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">383-392</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ) aggregation into synaptotoxic, prefibrillar oligomers is a major pathogenic event underlying the neuropathol. of Alzheimer's disease (AD).  The pharmacol. and neuroprotective properties of a novel Aβ aggregation inhibitor, SEN1269, were investigated on aggregation and cell viability and in test systems relevant to synaptic function and memory, using both synthetic Aβ1-42 and cell-derived Aβ oligomers.  Surface plasmon resonance studies measured binding of SEN1269 to Aβ1-42.  Thioflavin-T fluorescence and MTT assays were used to measure its ability to block Aβ1-42-induced aggregation and redn. in cell viability.  In vitro and in vivo long-term potentiation (LTP) expts. measured the effect of SEN1269 on deficits induced by synthetic Aβ1-42 and cell-derived Aβ oligomers.  Following i.c.v. administration of the latter, a complex (alternating-lever cyclic ratio) schedule of operant responding measured effects on memory in freely moving rats.  SEN1269 demonstrated direct binding to monomeric Aβ1-42, produced a concn.-related blockade of Aβ1-42 aggregation and protected neuronal cell lines exposed to Aβ1-42.  In vitro, SEN1269 alleviated deficits in hippocampal LTP induced by Aβ1-42 and cell-derived Aβ oligomers.  In vivo, SEN1269 reduced the deficits in LTP and memory induced by i.c.v. administration of cell-derived Aβ oligomers.  SEN1269 protected cells exposed to Aβ1-42, displayed central activity with respect to reducing Aβ-induced neurotoxicity and was neuroprotective in electrophysiol. and behavioral models of memory relevant to Aβ-induced neurodegeneration.  It represents a promising lead for designing inhibitors of Aβ-mediated synaptic toxicity as potential neuroprotective agents for treating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0YHqYYKmz7Vg90H21EOLACvtfcHk0lixH2_CjnIKPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShurfF&md5=bdc5de632ac7d72b62ded1dc2eb8d3e8</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01973.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01973.x%26sid%3Dliteratum%253Aachs%26aulast%3DScopes%26aufirst%3DD.%2BI.%26aulast%3DO%25E2%2580%2599Hare%26aufirst%3DE.%26aulast%3DJeggo%26aufirst%3DR.%26aulast%3DWhyment%26aufirst%3DA.%2BD.%26aulast%3DSpanswick%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DE.%2BM.%26aulast%3DGannon%26aufirst%3DJ.%26aulast%3DAmijee%26aufirst%3DH.%26aulast%3DTreherne%26aufirst%3DJ.%2BM.%26atitle%3DAbeta%2520oligomer%2520toxicity%2520inhibitor%2520protects%2520memory%2520in%2520models%2520of%2520synaptic%2520toxicity%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D383%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Congdon, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Necula, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackstone, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuret, J.</span><span> </span><span class="NLM_article-title">Potency of a tau fibrillization inhibitor is influenced by its aggregation state</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2007&pages=127-135&author=E.+E.+Congdonauthor=M.+Neculaauthor=R.+D.+Blackstoneauthor=J.+Kuret&title=Potency+of+a+tau+fibrillization+inhibitor+is+influenced+by+its+aggregation+state"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCongdon%26aufirst%3DE.%2BE.%26aulast%3DNecula%26aufirst%3DM.%26aulast%3DBlackstone%26aufirst%3DR.%2BD.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DPotency%2520of%2520a%2520tau%2520fibrillization%2520inhibitor%2520is%2520influenced%2520by%2520its%2520aggregation%2520state%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2007%26volume%3D465%26spage%3D127%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichterman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auld, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7732</span><span class="NLM_x">–</span> <span class="NLM_lpage">7745</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi9006435" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7732-7745&author=A.+Croweauthor=W.+Huangauthor=C.+Ballatoreauthor=R.+L.+Johnsonauthor=A.+M.+Hoganauthor=R.+Huangauthor=J.+Wichtermanauthor=J.+McCoyauthor=D.+Hurynauthor=D.+S.+Auldauthor=A.+B.+Smithauthor=J.+Ingleseauthor=J.+Q.+Trojanowskiauthor=C.+P.+Austinauthor=K.+R.+Brundenauthor=V.+M.+Lee&title=Identification+of+aminothienopyridazine+inhibitors+of+tau+assembly+by+quantitative+high-throughput+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fbi9006435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9006435%26sid%3Dliteratum%253Aachs%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DHogan%26aufirst%3DA.%2BM.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DWichterman%26aufirst%3DJ.%26aulast%3DMcCoy%26aufirst%3DJ.%26aulast%3DHuryn%26aufirst%3DD.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DIdentification%2520of%2520aminothienopyridazine%2520inhibitors%2520of%2520tau%2520assembly%2520by%2520quantitative%2520high-throughput%2520screening%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D7732%26epage%3D7745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Friedhoff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">10223</span><span class="NLM_x">–</span> <span class="NLM_lpage">10230</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi980537d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=10223-10230&author=P.+Friedhoffauthor=A.+Schneiderauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Rapid+assembly+of+Alzheimer-like+paired+helical+filaments+from+microtubule-associated+protein+tau+monitored+by+fluorescence+in+solution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fbi980537d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi980537d%26sid%3Dliteratum%253Aachs%26aulast%3DFriedhoff%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DRapid%2520assembly%2520of%2520Alzheimer-like%2520paired%2520helical%2520filaments%2520from%2520microtubule-associated%2520protein%2520tau%2520monitored%2520by%2520fluorescence%2520in%2520solution%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D10223%26epage%3D10230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Zhang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldenburg, K. R.</span><span> </span><span class="NLM_article-title">A simple statistical parameter for use in evaluation and validation of high throughput screening assays</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1177%2F108705719900400206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=10838414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=67-73&author=J.+H.+Zhangauthor=T.+D.+Chungauthor=K.+R.+Oldenburg&title=A+simple+statistical+parameter+for+use+in+evaluation+and+validation+of+high+throughput+screening+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span></div><div class="casAuthors">Zhang; Chung; Oldenburg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The ability to identify active compounds (3hits2) from large chemical libraries accurately and rapidly has been the ultimate goal in developing high-throughput screening (HTS) assays.  The ability to identify hits from a particular HTS assay depends largely on the suitability or quality of the assay used in the screening.  The criteria or parameters for evaluating the 3suitability2 of an HTS assay for hit identification are not well defined and hence it still remains difficult to compare the quality of assays directly.  In this report, a screening window coefficient, called 3Z-factor,2 is defined.  This coefficient is reflective of both the assay signal dynamic range and the data variation associated with the signal measurements, and therefore is suitable for assay quality assessment.  The Z-factor is a dimensionless, simple statistical characteristic for each HTS assay.  The Z-factor provides a useful tool for comparison and evaluation of the quality of assays, and can be utilized in assay optimization and validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkwW5JDdXnbsNIRw0GKUoEfW6udTcc2eapf2OZ1dQJ0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D&md5=0ec4ed2ccdd3b4a16521567a0975d31f</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1177%2F108705719900400206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719900400206%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BH.%26aulast%3DChung%26aufirst%3DT.%2BD.%26aulast%3DOldenburg%26aufirst%3DK.%2BR.%26atitle%3DA%2520simple%2520statistical%2520parameter%2520for%2520use%2520in%2520evaluation%2520and%2520validation%2520of%2520high%2520throughput%2520screening%2520assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1999%26volume%3D4%26spage%3D67%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Barghorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Tau paired helical filaments from Alzheimer’s disease brain and assembled in vitro are based on beta-structure in the core domain</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1694</span><span class="NLM_x">–</span> <span class="NLM_lpage">1703</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0357006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=1694-1703&author=S.+Barghornauthor=P.+Daviesauthor=E.+Mandelkow&title=Tau+paired+helical+filaments+from+Alzheimer%E2%80%99s+disease+brain+and+assembled+in+vitro+are+based+on+beta-structure+in+the+core+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fbi0357006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0357006%26sid%3Dliteratum%253Aachs%26aulast%3DBarghorn%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DTau%2520paired%2520helical%2520filaments%2520from%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain%2520and%2520assembled%2520in%2520vitro%2520are%2520based%2520on%2520beta-structure%2520in%2520the%2520core%2520domain%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D1694%26epage%3D1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Schneider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span> </span><span class="NLM_article-title">Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3549</span><span class="NLM_x">–</span> <span class="NLM_lpage">3558</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi981874p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=3549-3558&author=A.+Schneiderauthor=J.+Biernatauthor=M.+von+Bergenauthor=E.+Mandelkowauthor=E.+M.+Mandelkow&title=Phosphorylation+that+detaches+tau+protein+from+microtubules+%28Ser262%2C+Ser214%29+also+protects+it+against+aggregation+into+Alzheimer+paired+helical+filaments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fbi981874p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi981874p%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DPhosphorylation%2520that%2520detaches%2520tau%2520protein%2520from%2520microtubules%2520%2528Ser262%252C%2520Ser214%2529%2520also%2520protects%2520it%2520against%2520aggregation%2520into%2520Alzheimer%2520paired%2520helical%2520filaments%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D3549%26epage%3D3558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Bulic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khlistunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span> </span><span class="NLM_article-title">Rhodanine-based tau aggregation inhibitors in cell models of tauopathy</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">9215</span><span class="NLM_x">–</span> <span class="NLM_lpage">9219</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=9215-9219&author=B.+Bulicauthor=M.+Pickhardtauthor=I.+Khlistunovaauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkowauthor=H.+Waldmann&title=Rhodanine-based+tau+aggregation+inhibitors+in+cell+models+of+tauopathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DRhodanine-based%2520tau%2520aggregation%2520inhibitors%2520in%2520cell%2520models%2520of%2520tauopathy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D9215%26epage%3D9219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Larbig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Screening for inhibitors of tau protein aggregation into Alzheimer paired helical filaments: a ligand based approach results in successful scaffold hopping</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F156720507781077250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17627489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntlCqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=315-323&author=G.+Larbigauthor=M.+Pickhardtauthor=D.+G.+Lloydauthor=B.+Schmidtauthor=E.+Mandelkow&title=Screening+for+inhibitors+of+tau+protein+aggregation+into+Alzheimer+paired+helical+filaments%3A+a+ligand+based+approach+results+in+successful+scaffold+hopping"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Screening for inhibitors of tau protein aggregation into Alzheimer paired helical filaments: a ligand based approach results in successful scaffold hopping</span></div><div class="casAuthors">Larbig, Gregor; Pickhardt, Marcus; Lloyd, David G.; Schmidt, Boris; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-323</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The aggregation of tau protein into paired helical filaments is one of the hallmarks of Alzheimer's disease and related dementias.  We therefore continue our search for non-toxic, cell penetrating inhibitors of tau aggregation, which hold potential for brain penetration.  A previous study reported a high throughput screen for tau aggregation inhibitors, which resulted in the identification of several hit classes.  Here we report the identification of novel inhibitors which were not present in the initial high throughput assay.  This was achieved by transformation of the high throughput screen data into the 3D relationships of virtual pharmacophores.  The pharmacophore models were utilized in a virtual screen of a Maybridge database.  The virtual screen provided 136 hits; 19 representative hits were selected and assayed, this resulted in two novel leads with an IC50 < 13 μM.  These two leads feature a novel scaffold for tau aggregation inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeGtPvnJwCNrVg90H21EOLACvtfcHk0ljXXgkmmMD0Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntlCqtb0%253D&md5=daa891bbad0610400372a56b42d5fa08</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.2174%2F156720507781077250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720507781077250%26sid%3Dliteratum%253Aachs%26aulast%3DLarbig%26aufirst%3DG.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DLloyd%26aufirst%3DD.%2BG.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DScreening%2520for%2520inhibitors%2520of%2520tau%2520protein%2520aggregation%2520into%2520Alzheimer%2520paired%2520helical%2520filaments%253A%2520a%2520ligand%2520based%2520approach%2520results%2520in%2520successful%2520scaffold%2520hopping%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2007%26volume%3D4%26spage%3D315%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khlistunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title"><i>N</i>-Phenylamine derivatives as aggregation inhibitors in cell models of tauopathy</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F156720507781788765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17908042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSitL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=397-402&author=M.+Pickhardtauthor=J.+Biernatauthor=I.+Khlistunovaauthor=Y.+P.+Wangauthor=Z.+Gazovaauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=N-Phenylamine+derivatives+as+aggregation+inhibitors+in+cell+models+of+tauopathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">N-phenylamine derivatives as aggregation inhibitors in cell models of tauopathy</span></div><div class="casAuthors">Pickhardt, M.; Biernat, J.; Khlistunova, I.; Wang, Y.-P.; Gazova, Z.; Mandelkow, E.-M.; Mandelkow, E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">397-402</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Cell models of tauopathy were generated in order to study mechanisms of neurodegeneration involving abnormal changes of tau.  They are based on neuroblastoma cell lines (N2a) that inducibly express different forms of the repeat domain of tau (tauRD), e.g. the 4-repeat domain of tau with the wild-type sequence, the repeat domain with the ΔK280 mutation ("pro-aggregation mutant"), or the repeat domain with ΔK280 and two proline point mutations ("anti-aggregation mutant").  The data indicate that the aggregation of tauRD is toxic, and that aggregation and toxicity can be prevented by low mol. wt. compds., notably compds. based on the N-phenylamine core.  Thus the cell models are suitable for developing aggregation inhibitor drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq782rmh_p5sbVg90H21EOLACvtfcHk0ljXXgkmmMD0Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSitL%252FM&md5=f2f9991a8a38f9c065e254a9e272a3ba</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.2174%2F156720507781788765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720507781788765%26sid%3Dliteratum%253Aachs%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DY.%2BP.%26aulast%3DGazova%26aufirst%3DZ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DN-Phenylamine%2520derivatives%2520as%2520aggregation%2520inhibitors%2520in%2520cell%2520models%2520of%2520tauopathy%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2007%26volume%3D4%26spage%3D397%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Khlistunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Inhibition of tau aggregation in cell models of tauopathy</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">544</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F156720507783018307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18220518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVGqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=544-546&author=I.+Khlistunovaauthor=M.+Pickhardtauthor=J.+Biernatauthor=Y.+Wangauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Inhibition+of+tau+aggregation+in+cell+models+of+tauopathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tau aggregation in cell models of tauopathy</span></div><div class="casAuthors">Khlistunova, Inna; Pickhardt, Marcus; Biernat, Jacek; Wang, Yipeng; Mandelkow, Eva-Maria; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">544-546</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The pathol. aggregation of tau into paired helical filaments is a hallmark of several neurodegenerative diseases, including Alzheimer's disease.  We have generated cell models of tau aggregation in order to study mechanisms involving abnormal changes of tau.  In the cell models the repeat domain of tau (tauRD) and some of its variants are expressed in a regulated fashion, e.g. the 4-repeat domain of tau with the wild-type sequence, the repeat domain with the ΔK280 mutation ("pro-aggregation mutant"), or the repeat domain with addnl. proline mutations ("anti-aggregation mutant").  The aggregation of tauRD is toxic to the cells, but aggregation and toxicity can be prevented by low mol. wt. compds. identified by a screen for inhibitors.  Thus the cell models are suitable for developing aggregation inhibitor drugs and testing their cellular roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPRuLFD4hE0rVg90H21EOLACvtfcHk0ljXXgkmmMD0Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVGqsA%253D%253D&md5=aa96875370b22e54ada7fc96edceca1d</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.2174%2F156720507783018307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720507783018307%26sid%3Dliteratum%253Aachs%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DInhibition%2520of%2520tau%2520aggregation%2520in%2520cell%2520models%2520of%2520tauopathy%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2007%26volume%3D4%26spage%3D544%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Fatouros, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pir, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koushika, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumeister, R.</span><span> </span><span class="NLM_article-title">Inhibition of tau aggregation in a novel <i>Caenorhabditis elegans</i> model of tauopathy mitigates proteotoxicity</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3587</span><span class="NLM_x">–</span> <span class="NLM_lpage">3603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1093%2Fhmg%2Fdds190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22611162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSrtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=3587-3603&author=C.+Fatourosauthor=G.+J.+Pirauthor=J.+Biernatauthor=S.+P.+Koushikaauthor=E.+Mandelkowauthor=E.+M.+Mandelkowauthor=E.+Schmidtauthor=R.+Baumeister&title=Inhibition+of+tau+aggregation+in+a+novel+Caenorhabditis+elegans+model+of+tauopathy+mitigates+proteotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity</span></div><div class="casAuthors">Fatouros, Chronis; Pir, Ghulam Jeelani; Biernat, Jacek; Koushika, Sandhya Padmanabhan; Mandelkow, Eckhard; Mandelkow, Eva-Maria; Schmidt, Enrico; Baumeister, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3587-3603</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Increased Tau protein amyloidogenicity has been causatively implicated in several neurodegenerative diseases, collectively called tauopathies.  In pathol. conditions, Tau becomes hyperphosphorylated and forms intracellular aggregates.  The deletion of K280, which is a mutation that commonly appears in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17, enhances Tau aggregation propensity (pro-aggregation).  In contrast, introduction of the I277P and I308P mutations prevents β-sheet formation and subsequent aggregation (anti-aggregation).  In this study, the authors created a tauopathy model by expressing pro- or anti-aggregant Tau species in the nervous system of Caenorhabditis elegans.  Animals expressing the highly amyloidogenic Tau species showed accelerated Tau aggregation and pathol. manifested by severely impaired motility and evident neuronal dysfunction.  In addn., the authors obsd. that the axonal transport of mitochondria was perturbed in these animals.  Control animals expressing the anti-aggregant combination had rather mild phenotype.  The authors subsequently tested several Tau aggregation inhibitor compds. and obsd. a mitigation of Tau proteotoxicity.  In particular, a novel compd. that crosses the blood-brain barrier of mammals proved effective in ameliorating the motility as well as delaying the accumulation of neuronal defects.  This study establishes a new C. elegans model of Tau aggregation-mediated toxicity and supports the emerging notion that inhibiting the nucleation of Tau aggregation can be neuroprotective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbYmwP2dGra7Vg90H21EOLACvtfcHk0lh6Zkod0cyrSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSrtLfE&md5=cbd8192c50dbceee7907ac7ea3ba6a9f</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fdds190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fdds190%26sid%3Dliteratum%253Aachs%26aulast%3DFatouros%26aufirst%3DC.%26aulast%3DPir%26aufirst%3DG.%2BJ.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DKoushika%26aufirst%3DS.%2BP.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DBaumeister%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520tau%2520aggregation%2520in%2520a%2520novel%2520Caenorhabditis%2520elegans%2520model%2520of%2520tauopathy%2520mitigates%2520proteotoxicity%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2012%26volume%3D21%26spage%3D3587%26epage%3D3603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Messing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span> </span><span class="NLM_article-title">Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1343</span><span class="NLM_x">–</span> <span class="NLM_lpage">1354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.neurobiolaging.2012.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=23158765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSmu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1343-1354&author=L.+Messingauthor=J.+M.+Deckerauthor=M.+Josephauthor=E.+Mandelkowauthor=E.+M.+Mandelkow&title=Cascade+of+tau+toxicity+in+inducible+hippocampal+brain+slices+and+prevention+by+aggregation+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors</span></div><div class="casAuthors">Messing, Lars; Decker, Jochen Martin; Joseph, Maria; Mandelkow, Eckhard; Mandelkow, Eva-Maria</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1343-1354</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mislocalization and aggregation of the axonal protein tau are hallmarks of Alzheimer's disease and other tauopathies.  Here, we studied the relationship between tau aggregation, loss of spines and neurons, and reversibility by aggregation inhibitors.  To this end we established an in vitro model of tauopathy based on regulatable transgenic hippocampal organotypic slice cultures prepd. from mice expressing proaggregant Tau repeat domain with mutation ΔK280 (TauRDΔK).  Transgene expression was monitored by a bioluminescence reporter assay.  We obsd. abnormal tau phosphorylation and mislocalization of exogenous and endogenous tau into the somatodendritic compartment.  This was paralleled by a redn. of dendritic spines, altered dendritic spine morphol., dysregulation of Ca++ dynamics and elevated activation of microglia.  Neurotoxicity was mediated by Caspase-3 activation and correlated with the expression level of proaggregant TauRDΔK.  Finally, tau aggregates appeared in areas CA1 and CA3 after three weeks in vitro.  Neurodegeneration was relieved by aggregation inhibitors or by switching off transgene expression.  Thus the slice culture model is suitable for monitoring the development of tauopathy and the therapeutic benefit of antiaggregation drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC_PnWs0hCu7Vg90H21EOLACvtfcHk0lh6Zkod0cyrSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSmu7rO&md5=795880e4fc8b1dd1f21f4d5fd0c09d59</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2012.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2012.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DMessing%26aufirst%3DL.%26aulast%3DDecker%26aufirst%3DJ.%2BM.%26aulast%3DJoseph%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DCascade%2520of%2520tau%2520toxicity%2520in%2520inducible%2520hippocampal%2520brain%2520slices%2520and%2520prevention%2520by%2520aggregation%2520inhibitors%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D1343%26epage%3D1354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Quideau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deffieux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douat-Casassus, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouysegu, L.</span><span> </span><span class="NLM_article-title">Plant polyphenols: chemical properties, biological activities, and synthesis</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1002%2Fanie.201000044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFGjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=586-621&author=S.+Quideauauthor=D.+Deffieuxauthor=C.+Douat-Casassusauthor=L.+Pouysegu&title=Plant+polyphenols%3A+chemical+properties%2C+biological+activities%2C+and+synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Plant polyphenols: Chemical properties, biological activities, and synthesis</span></div><div class="casAuthors">Quideau, Stephane; Deffieux, Denis; Douat-Casassus, Celine; Pouysegu, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">586-621</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Eating five servings of fruits and vegetables per day!!This is what is highly recommended and heavily advertised nowadays to the general public to stay fit and healthy! Drinking green tea on a regular basis, eating chocolate from time to time, as well as savoring a couple of glasses of red wine per day have been claimed to increase life expectancy even further! Why The answer is in fact still under scientific scrutiny, but a particular class of compds. naturally occurring in fruits and vegetables is considered to be crucial for the expression of such human health benefits: the polyphenols! What are these plant products really What are their physicochem. properties How do they express their biol. activity Are they really valuable for disease prevention Can they be used to develop new pharmaceutical drugs What recent progress has been made toward their prepn. by org. synthesis This Review gives answers from a chem. perspective, summarizes the state of the art, and highlights the most significant advances in the field of polyphenol research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6yStrEg5Z0rVg90H21EOLACvtfcHk0lh6Zkod0cyrSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFGjsw%253D%253D&md5=e1469df2ccba3b121680dff0b43b696a</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1002%2Fanie.201000044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201000044%26sid%3Dliteratum%253Aachs%26aulast%3DQuideau%26aufirst%3DS.%26aulast%3DDeffieux%26aufirst%3DD.%26aulast%3DDouat-Casassus%26aufirst%3DC.%26aulast%3DPouysegu%26aufirst%3DL.%26atitle%3DPlant%2520polyphenols%253A%2520chemical%2520properties%252C%2520biological%2520activities%252C%2520and%2520synthesis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D586%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Meng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munishkina, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uversky, V. N.</span><span> </span><span class="NLM_article-title">Effects of various flavonoids on the alpha-synuclein fibrillation process</span> <span class="citation_source-journal">Parkinson’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">650794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BC3cbitF2qtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=650794&author=X.+Mengauthor=L.+A.+Munishkinaauthor=A.+L.+Finkauthor=V.+N.+Uversky&title=Effects+of+various+flavonoids+on+the+alpha-synuclein+fibrillation+process"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Various Flavonoids on the α-Synuclein Fibrillation Process</span></div><div class="casAuthors">Meng Xiaoyun; Munishkina Larissa A; Fink Anthony L; Uversky Vladimir N</div><div class="citationInfo"><span class="NLM_cas:title">Parkinson's disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2010</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">650794</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">α-Synuclein aggregation and fibrillation are closely associated with the formation of Lewy bodies in neurons and are implicated in the causative pathogenesis of Parkinson's disease and other synucleinopathies.  Currently, there is no approved therapeutic agent directed toward preventing the protein aggregation, which has been recently shown to have a key role in the cytotoxic nature of amyloidogenic proteins.  Flavonoids, known as plant pigments, belong to a broad family of polyphenolic compounds.  Over 4,000 flavonoids have been identified from various plants and foodstuffs derived from plants and have been demonstrated as potential neuroprotective agents.  In this study 48 flavonoids belonging to several classes with structures differing in the position of double bonds and ring substituents were tested for their ability to inhibit the fibrillation of α-synuclein in vitro.  A variety of flavonoids inhibited α-synuclein fibrillation, and most of the strong inhibitory flavonoids were also found to disaggregate preformed fibrils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNPfTLo6kQ4kNoizSOkG_FfW6udTcc2eaSjj3hlnU2WLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbitF2qtA%253D%253D&md5=09ab4fca663e2a7b31c58f078610e922</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DMunishkina%26aufirst%3DL.%2BA.%26aulast%3DFink%26aufirst%3DA.%2BL.%26aulast%3DUversky%26aufirst%3DV.%2BN.%26atitle%3DEffects%2520of%2520various%2520flavonoids%2520on%2520the%2520alpha-synuclein%2520fibrillation%2520process%26jtitle%3DParkinson%25E2%2580%2599s%2520Dis.%26date%3D2010%26volume%3D2010%26spage%3D650794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Berhanu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masunov, A. E.</span><span> </span><span class="NLM_article-title">Natural polyphenols as inhibitors of amyloid aggregation. Molecular dynamics study of GNNQQNY heptapeptide decamer</span> <span class="citation_source-journal">Biophys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2010&pages=12-21&author=W.+M.+Berhanuauthor=A.+E.+Masunov&title=Natural+polyphenols+as+inhibitors+of+amyloid+aggregation.+Molecular+dynamics+study+of+GNNQQNY+heptapeptide+decamer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerhanu%26aufirst%3DW.%2BM.%26aulast%3DMasunov%26aufirst%3DA.%2BE.%26atitle%3DNatural%2520polyphenols%2520as%2520inhibitors%2520of%2520amyloid%2520aggregation.%2520Molecular%2520dynamics%2520study%2520of%2520GNNQQNY%2520heptapeptide%2520decamer%26jtitle%3DBiophys.%2520Chem.%26date%3D2010%26volume%3D149%26spage%3D12%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Bolander, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyny-von Haussen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetschy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czech, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knust, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herms, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilger, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title">Bis(arylvinyl)pyrazines, -pyrimidines, and -pyridazines as imaging agents for Tau fibrils and beta-amyloid plaques in Alzheimer’s disease models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9170</span><span class="NLM_x">–</span> <span class="NLM_lpage">9180</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300653b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9170-9180&author=A.+Bolanderauthor=D.+Kieserauthor=C.+Vossauthor=S.+Bauerauthor=C.+Schonauthor=S.+Burgoldauthor=T.+Bittnerauthor=J.+Holzerauthor=R.+Heyny-von+Haussenauthor=G.+Mallauthor=V.+Goetschyauthor=C.+Czechauthor=H.+Knustauthor=R.+Bergerauthor=J.+Hermsauthor=I.+Hilgerauthor=B.+Schmidt&title=Bis%28arylvinyl%29pyrazines%2C+-pyrimidines%2C+and+-pyridazines+as+imaging+agents+for+Tau+fibrils+and+beta-amyloid+plaques+in+Alzheimer%E2%80%99s+disease+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm300653b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300653b%26sid%3Dliteratum%253Aachs%26aulast%3DBolander%26aufirst%3DA.%26aulast%3DKieser%26aufirst%3DD.%26aulast%3DVoss%26aufirst%3DC.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DSchon%26aufirst%3DC.%26aulast%3DBurgold%26aufirst%3DS.%26aulast%3DBittner%26aufirst%3DT.%26aulast%3DHolzer%26aufirst%3DJ.%26aulast%3DHeyny-von%2BHaussen%26aufirst%3DR.%26aulast%3DMall%26aufirst%3DG.%26aulast%3DGoetschy%26aufirst%3DV.%26aulast%3DCzech%26aufirst%3DC.%26aulast%3DKnust%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DHerms%26aufirst%3DJ.%26aulast%3DHilger%26aufirst%3DI.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DBis%2528arylvinyl%2529pyrazines%252C%2520-pyrimidines%252C%2520and%2520-pyridazines%2520as%2520imaging%2520agents%2520for%2520Tau%2520fibrils%2520and%2520beta-amyloid%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9170%26epage%3D9180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markwell, R. E.</span><span> </span><span class="NLM_article-title">Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x"> (</span><span class="NLM_issue">Part 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=1999&pages=419-423&issue=Part+2&author=D.+R.+Howlettauthor=A.+R.+Georgeauthor=D.+E.+Owenauthor=R.+V.+Wardauthor=R.+E.+Markwell&title=Common+structural+features+determine+the+effectiveness+of+carvedilol%2C+daunomycin+and+rolitetracycline+as+inhibitors+of+Alzheimer+beta-amyloid+fibril+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DGeorge%26aufirst%3DA.%2BR.%26aulast%3DOwen%26aufirst%3DD.%2BE.%26aulast%3DWard%26aufirst%3DR.%2BV.%26aulast%3DMarkwell%26aufirst%3DR.%2BE.%26atitle%3DCommon%2520structural%2520features%2520determine%2520the%2520effectiveness%2520of%2520carvedilol%252C%2520daunomycin%2520and%2520rolitetracycline%2520as%2520inhibitors%2520of%2520Alzheimer%2520beta-amyloid%2520fibril%2520formation%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D343%26issue%3DPart%25202%26spage%3D419%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begum, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubeda, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambegaokar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frautschy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, G. M.</span><span> </span><span class="NLM_article-title">Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">5892</span><span class="NLM_x">–</span> <span class="NLM_lpage">5901</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1074%2Fjbc.M404751200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15590663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlClt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=5892-5901&author=F.+Yangauthor=G.+P.+Limauthor=A.+N.+Begumauthor=O.+J.+Ubedaauthor=M.+R.+Simmonsauthor=S.+S.+Ambegaokarauthor=P.+P.+Chenauthor=R.+Kayedauthor=C.+G.+Glabeauthor=S.+A.+Frautschyauthor=G.+M.+Cole&title=Curcumin+inhibits+formation+of+amyloid+beta+oligomers+and+fibrils%2C+binds+plaques%2C+and+reduces+amyloid+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo</span></div><div class="casAuthors">Yang, Fusheng; Lim, Giselle P.; Begum, Aynun N.; Ubeda, Oliver J.; Simmons, Mychica R.; Ambegaokar, Surendra S.; Chen, Pingping P.; Kayed, Rakez; Glabe, Charles G.; Frautschy, Sally A.; Cole, Gregory M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5892-5901</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) involves amyloid β (Aβ) accumulation, oxidative damage, and inflammation, and risk is reduced with increased antioxidant and anti-inflammatory consumption.  The phenolic yellow curry pigment curcumin has potent anti-inflammatory and antioxidant activities and can suppress oxidative damage, inflammation, cognitive deficits, and amyloid accumulation.  Since the mol. structure of curcumin suggested potential Aβ binding, we investigated whether its efficacy in AD models could be explained by effects on Aβ aggregation.  Under aggregating conditions in vitro, curcumin inhibited aggregation (IC50 = 0.8 μM) as well as disaggregated fibrillar Aβ40 (IC50 = 1 μM), indicating favorable stoichiometry for inhibition.  Curcumin was a better Aβ40 aggregation inhibitor than ibuprofen and naproxen, and prevented Aβ42 oligomer formation and toxicity between 0.1 and 1.0 μM.  Under EM, curcumin decreased dose dependently Aβ fibril formation beginning with 0.125 μM.  The effects of curcumin did not depend on Aβ sequence but on fibril-related conformation.  AD and Tg2576 mice brain sections incubated with curcumin revealed preferential labeling of amyloid plaques.  In vivo studies showed that curcumin injected peripherally into aged Tg mice crossed the blood-brain barrier and bound plaques.  When fed to aged Tg2576 mice with advanced amyloid accumulation, curcumin labeled plaques and reduced amyloid levels and plaque burden.  Hence, curcumin directly binds small β-amyloid species to block aggregation and fibril formation in vitro and in vivo.  These data suggest that low dose curcumin effectively disaggregates Aβ as well as prevents fibril and oligomer formation, supporting the rationale for curcumin use in clin. trials preventing or treating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohTY2O8WLUVrVg90H21EOLACvtfcHk0lhSFHAtpl0hhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlClt7w%253D&md5=5f8f6fb0c3529ba9dbeae5f8af096250</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M404751200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M404751200%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DF.%26aulast%3DLim%26aufirst%3DG.%2BP.%26aulast%3DBegum%26aufirst%3DA.%2BN.%26aulast%3DUbeda%26aufirst%3DO.%2BJ.%26aulast%3DSimmons%26aufirst%3DM.%2BR.%26aulast%3DAmbegaokar%26aufirst%3DS.%2BS.%26aulast%3DChen%26aufirst%3DP.%2BP.%26aulast%3DKayed%26aufirst%3DR.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26aulast%3DFrautschy%26aufirst%3DS.%2BA.%26aulast%3DCole%26aufirst%3DG.%2BM.%26atitle%3DCurcumin%2520inhibits%2520formation%2520of%2520amyloid%2520beta%2520oligomers%2520and%2520fibrils%252C%2520binds%2520plaques%252C%2520and%2520reduces%2520amyloid%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D5892%26epage%3D5901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khlistunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hascher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Anthraquinones inhibit tau aggregation and dissolve Alzheimer’s paired helical filaments in vitro and in cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">3628</span><span class="NLM_x">–</span> <span class="NLM_lpage">3635</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=3628-3635&author=M.+Pickhardtauthor=Z.+Gazovaauthor=M.+von+Bergenauthor=I.+Khlistunovaauthor=Y.+Wangauthor=A.+Hascherauthor=E.+M.+Mandelkowauthor=J.+Biernatauthor=E.+Mandelkow&title=Anthraquinones+inhibit+tau+aggregation+and+dissolve+Alzheimer%E2%80%99s+paired+helical+filaments+in+vitro+and+in+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DGazova%26aufirst%3DZ.%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHascher%26aufirst%3DA.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DAnthraquinones%2520inhibit%2520tau%2520aggregation%2520and%2520dissolve%2520Alzheimer%25E2%2580%2599s%2520paired%2520helical%2520filaments%2520in%2520vitro%2520and%2520in%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D3628%26epage%3D3635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Ho, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yemul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasinetti, G. M.</span><span> </span><span class="NLM_article-title">Grape seed polyphenolic extract as a potential novel therapeutic agent in tauopathies</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=19221432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=433-439&author=L.+Hoauthor=S.+Yemulauthor=J.+Wangauthor=G.+M.+Pasinetti&title=Grape+seed+polyphenolic+extract+as+a+potential+novel+therapeutic+agent+in+tauopathies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Grape Seed Polyphenolic Extract as a Potential Novel Therapeutic Agent in Tauopathies</span></div><div class="casAuthors">Ho, Lap; Yemul, Shrishailam; Wang, Jun; Pasinetti, Giulio Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">433-439</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Abnormal misfoldings of the microtubule-assocd. protein tau, leading to the aggregation of tau into paired helical filaments that are ultimately deposited as neurofibrillary tangles, is a key neuropathol. feature of a no. of neurodegenerative disorders collectively referred to as tauopathies.  We recently obsd. that a particular grape seed polyphenolic ext. (GSPE), namely, Meganatural-Az may attenuate the generation and stability of misfolded proteins.  We hypothesized that Meganatural-Az GSPE might also attenuate tau protein misfolding that leads to the generation of tau filamentary aggregates that are crit. for the initiation and progression of neurodegeneration and/or cognitive dysfunctions in tauopathies.  In this study, we used in vitro aggregations of synthetic Ac-306VQIVYK311 tau peptide as a model system to explore whether Meganatural-Az GSPE might modulate aggregations of tau protein.  We demonstrate that this GSPE is capable of inhibiting tau peptide aggregations, as well as dissocg. preformed tau peptide aggregates.  Results from this study suggest that this GSPE might provide beneficial disease-modifying bioactivities in tau-assocd. neurodegenerative disorders by modulating tau-mediated neuropathol. mechanisms.  Our observation, in conjunction with the demonstrated bioavailability, as well as safety and tolerability, of this GSPE, supports the development of Meganatural-Az GSPE for the prevention and/or treatment of tau-assocd. neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQHKVTkzoxULVg90H21EOLACvtfcHk0ljJnhpZiuvRBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCrsrY%253D&md5=47bd7a41d9e4103492db3a8e0c5eaff7</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DL.%26aulast%3DYemul%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPasinetti%26aufirst%3DG.%2BM.%26atitle%3DGrape%2520seed%2520polyphenolic%2520extract%2520as%2520a%2520potential%2520novel%2520therapeutic%2520agent%2520in%2520tauopathies%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2009%26volume%3D16%26spage%3D433%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Ksiezak-Reding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santa-Maria, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasinetti, G. M.</span><span> </span><span class="NLM_article-title">Ultrastructural alterations of Alzheimer’s disease paired helical filaments by grape seed-derived polyphenols</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1427</span><span class="NLM_x">–</span> <span class="NLM_lpage">1439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.neurobiolaging.2010.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21196065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1KltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=1427-1439&author=H.+Ksiezak-Redingauthor=L.+Hoauthor=I.+Santa-Mariaauthor=C.+Diaz-Ruizauthor=J.+Wangauthor=G.+M.+Pasinetti&title=Ultrastructural+alterations+of+Alzheimer%E2%80%99s+disease+paired+helical+filaments+by+grape+seed-derived+polyphenols"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Ultrastructural alterations of Alzheimer's disease paired helical filaments by grape seed-derived polyphenols</span></div><div class="casAuthors">Ksiezak-Reding, Hanna; Ho, Lap; Santa-Maria, Ismael; Diaz-Ruiz, Carmen; Wang, Jun; Pasinetti, Giulio Maria</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1427-1439</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Abnormal folding of the microtubule-assocd. protein tau leads to aggregation of tau into paired helical filaments (PHFs) and neurofibrillary tangles, the major hallmark of Alzheimer's disease (AD).  We have recently shown that grape seed polyphenol ext. (GSPE) reduces tau pathol. in the TMHT mouse model of tauopathy (Wang et al., 2010).  In the present studies we assessed the impact of GSPE exposure on the ultrastructure of PHFs isolated from Alzheimer's disease brain.  Transmission electron microscopy revealed that GSPE induced profound dose- and time-dependent alterations in the morphol. of PHFs with partial disintegration of filaments.  Filaments showed ∼2-fold enlargement in width and displayed numerous protrusions and splayed ends consistent with unfolding of tau and diminished structural stability.  In addn., GSPE induced a redn. in immunogold labeling with antibodies against the C-terminal half (12E8, PHF-1) and the middle region of tau (AT8, Tau5, pSer214 tau, and AT180) but not the C-terminal end (Tau46).  In comparison, labeling of N-terminus (Alz50) was enhanced.  It is unlikely that alterations in immunogold labeling were due to biochem. alterations, e.g., protein phosphatase or proteolytic activities potentially stimulated by GSPE, because western blotting studies have shown the preservation of full length polypeptides of tau and their phospho-epitopes in GSPE-treated samples.  The GSPE mechanism may include a noncovalent interaction of polyphenols with proline residues in the proline-rich domain of tau, with Pin1 sites at P213 and P232 most seriously affected as judged by suppression of labeling.  Collectively, our results suggest that GSPE has a significant potential for therapeutic development by neutralizing phospho-epitopes and disrupting fibrillary conformation leading to disintegration of PHFs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlYdLrU4JfHLVg90H21EOLACvtfcHk0ljJnhpZiuvRBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1KltL0%253D&md5=d7ace7d1e5c347cccd8ff735343bc362</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2010.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2010.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DKsiezak-Reding%26aufirst%3DH.%26aulast%3DHo%26aufirst%3DL.%26aulast%3DSanta-Maria%26aufirst%3DI.%26aulast%3DDiaz-Ruiz%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPasinetti%26aufirst%3DG.%2BM.%26atitle%3DUltrastructural%2520alterations%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520paired%2520helical%2520filaments%2520by%2520grape%2520seed-derived%2520polyphenols%26jtitle%3DNeurobiol.%2520Aging%26date%3D2012%26volume%3D33%26spage%3D1427%26epage%3D1439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Ferruzzi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobo, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janle, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasinetti, G. M.</span><span> </span><span class="NLM_article-title">Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=19625746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVygtbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=113-124&author=M.+G.+Ferruzziauthor=J.+K.+Loboauthor=E.+M.+Janleauthor=B.+Cooperauthor=J.+E.+Simonauthor=Q.+L.+Wuauthor=C.+Welchauthor=L.+Hoauthor=C.+Weaverauthor=G.+M.+Pasinetti&title=Bioavailability+of+gallic+acid+and+catechins+from+grape+seed+polyphenol+extract+is+improved+by+repeated+dosing+in+rats%3A+implications+for+treatment+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Bioavailability of Gallic Acid and Catechins from Grape Seed Polyphenol Extract is Improved by Repeated Dosing in Rats: Implications for Treatment in Alzheimer's Disease</span></div><div class="casAuthors">Ferruzzi, Mario G.; Lobo, Jessica K.; Janle, Elsa M.; Cooper, Bruce; Simon, James E.; Wu, Qing-Li; Welch, Cara; Ho, Lap; Weaver, Connie; Pasinetti, Giulio M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-124</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The present study explored the bioavailability and brain deposition of a grape seed polyphenolic ext. (GSPE) previously found to attenuate cognitive deterioration in a mouse model of Alzheimer's disease (AD).  Plasma pharmacokinetic response of major GSPE phenolic components was measured following intragastric gavage of 50, 100, and 150 mg GSPE per kg body wt.  Liq. chromatog.-mass spectrometry (LC-MS) anal. identified gallic acid (GA), catechin (C), and epicatechin (EC) in plasma of rats gavaged acutely with GSPE. Addnl., 4-methylgallic acid (4-OMeGA), 3'-methylcatechin (3'-OMeC), and 3'-methylepicatechin (3'-OMeEC) were identified as circulating metabolites of GSPE phenolic constituents.  Cmax for individual GSPE constituents and their metabolites increased in a dose-dependent fashion (with increasing GSPE oral dose).  Repeated daily exposure to GSPE was found to significantly increase bioavailability (defined as plasma AUC0-8h) of GA, C, and EC by 198, 253, and 282% relative to animals receiving only a single acute GSPE dose.  EC and C were not detectable in brain tissues of rats receiving a single GSPE dose but reached levels of 290.7 ± 45.9 and 576.7 ± 227.7 pg/g in brain tissues from rats administered GSPE for 10 days.  This study suggests that brain deposition of GA, C, and EC is affected by repeated dosing of GSPE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0ZrFD5MA_KbVg90H21EOLACvtfcHk0ljJnhpZiuvRBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVygtbfP&md5=a5d0e7046eb5ded50bb055888791d7b2</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerruzzi%26aufirst%3DM.%2BG.%26aulast%3DLobo%26aufirst%3DJ.%2BK.%26aulast%3DJanle%26aufirst%3DE.%2BM.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DSimon%26aufirst%3DJ.%2BE.%26aulast%3DWu%26aufirst%3DQ.%2BL.%26aulast%3DWelch%26aufirst%3DC.%26aulast%3DHo%26aufirst%3DL.%26aulast%3DWeaver%26aufirst%3DC.%26aulast%3DPasinetti%26aufirst%3DG.%2BM.%26atitle%3DBioavailability%2520of%2520gallic%2520acid%2520and%2520catechins%2520from%2520grape%2520seed%2520polyphenol%2520extract%2520is%2520improved%2520by%2520repeated%2520dosing%2520in%2520rats%253A%2520implications%2520for%2520treatment%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2009%26volume%3D18%26spage%3D113%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Lopez Del Amo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grelle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanker, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieschke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reif, B.</span><span> </span><span class="NLM_article-title">Structural properties of EGCG-induced, nontoxic Alzheimer’s disease Abeta oligomers</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">524</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2012&pages=517-524&author=J.+M.+Lopez+Del+Amoauthor=U.+Finkauthor=M.+Dasariauthor=G.+Grelleauthor=E.+E.+Wankerauthor=J.+Bieschkeauthor=B.+Reif&title=Structural+properties+of+EGCG-induced%2C+nontoxic+Alzheimer%E2%80%99s+disease+Abeta+oligomers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%2BDel%2BAmo%26aufirst%3DJ.%2BM.%26aulast%3DFink%26aufirst%3DU.%26aulast%3DDasari%26aufirst%3DM.%26aulast%3DGrelle%26aufirst%3DG.%26aulast%3DWanker%26aufirst%3DE.%2BE.%26aulast%3DBieschke%26aufirst%3DJ.%26aulast%3DReif%26aufirst%3DB.%26atitle%3DStructural%2520properties%2520of%2520EGCG-induced%252C%2520nontoxic%2520Alzheimer%25E2%2580%2599s%2520disease%2520Abeta%2520oligomers%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D421%26spage%3D517%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Hu, M.</span><span> </span><span class="NLM_article-title">Commentary: bioavailability of flavonoids and polyphenols: call to arms</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">806</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp7001363" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKqtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=803-806&author=M.+Hu&title=Commentary%3A+bioavailability+of+flavonoids+and+polyphenols%3A+call+to+arms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Commentary: Bioavailability of Flavonoids and Polyphenols: Call to Arms</span></div><div class="casAuthors">Hu, Ming</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">803-806</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In this special issue of Mol. Pharmaceutics, the authors have assembled a group of active and experienced researchers.  They each provided their own research results or surveyed current research landscape in the form of review articles.  Taken together, the collection serves to make a broad assessment of the current knowledge base and state-of-the-art techniques.  Addnl. papers represent current or new methodologies that can be used to assess the bioavailability of flavonoids and polyphenols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSrxx0P3yBfrVg90H21EOLACvtfcHk0lgS1kiXlWuQvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKqtb3L&md5=cfdf903072c9550028118e4e638c4fe5</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fmp7001363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp7001363%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DM.%26atitle%3DCommentary%253A%2520bioavailability%2520of%2520flavonoids%2520and%2520polyphenols%253A%2520call%2520to%2520arms%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2007%26volume%3D4%26spage%3D803%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Mereles, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunstein, W.</span><span> </span><span class="NLM_article-title">Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5592</span><span class="NLM_x">–</span> <span class="NLM_lpage">5603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.3390%2Fijms12095592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22016611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1entbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=5592-5603&author=D.+Merelesauthor=W.+Hunstein&title=Epigallocatechin-3-gallate+%28EGCG%29+for+clinical+trials%3A+more+pitfalls+than+promises%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?</span></div><div class="casAuthors">Mereles, Derliz; Hunstein, Werner</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5592-5603</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Epigallocatechin-3-gallate (EGCG), the main and most significant polyphenol in green tea, has shown numerous health promoting effects acting through different pathways, as antioxidant, anti-inflammatory and anti-atherogenic agent, showing gene expression activity, functioning through growth factor-mediated pathways, the mitogen-activated protein kinase-dependent pathway, the ubiquitin/proteasome degrdn. pathway, as well as eliciting an amyloid protein remodeling activity.  However, epidemiol. inferences are sometimes conflicting and in vitro and in vivo studies may seem discrepant.  Current knowledge on how to enhance bioavailability could be the answer to some of these issues.  Furthermore, dose levels, administration frequency and potential side effects remain to be examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkeQ8unXUZr7Vg90H21EOLACvtfcHk0lgS1kiXlWuQvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1entbzP&md5=37533e07e8edd850e6d064bfbb6c0de7</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.3390%2Fijms12095592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms12095592%26sid%3Dliteratum%253Aachs%26aulast%3DMereles%26aufirst%3DD.%26aulast%3DHunstein%26aufirst%3DW.%26atitle%3DEpigallocatechin-3-gallate%2520%2528EGCG%2529%2520for%2520clinical%2520trials%253A%2520more%2520pitfalls%2520than%2520promises%253F%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2011%26volume%3D12%26spage%3D5592%26epage%3D5603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Wasan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocks, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs-Barrable, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, S. J.</span><span> </span><span class="NLM_article-title">Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=84-99&author=K.+M.+Wasanauthor=D.+R.+Brocksauthor=S.+D.+Leeauthor=K.+Sachs-Barrableauthor=S.+J.+Thornton&title=Impact+of+lipoproteins+on+the+biological+activity+and+disposition+of+hydrophobic+drugs%3A+implications+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWasan%26aufirst%3DK.%2BM.%26aulast%3DBrocks%26aufirst%3DD.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BD.%26aulast%3DSachs-Barrable%26aufirst%3DK.%26aulast%3DThornton%26aufirst%3DS.%2BJ.%26atitle%3DImpact%2520of%2520lipoproteins%2520on%2520the%2520biological%2520activity%2520and%2520disposition%2520of%2520hydrophobic%2520drugs%253A%2520implications%2520for%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D84%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roggo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuffenhauer, A.</span><span> </span><span class="NLM_article-title">Natural product-likeness score and its application for prioritization of compound libraries</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci700286x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlCqtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=68-74&author=P.+Ertlauthor=S.+Roggoauthor=A.+Schuffenhauer&title=Natural+product-likeness+score+and+its+application+for+prioritization+of+compound+libraries"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries</span></div><div class="casAuthors">Ertl, Peter; Roggo, Silvio; Schuffenhauer, Ansgar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-74</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Natural products (NPs) have been optimized in a very long natural selection process for optimal interactions with biol. macromols.  NPs are therefore an excellent source of validated substructures for the design of novel bioactive mols.  Various cheminformatics techniques can provide useful help in analyzing NPs, and the results of such studies may be used with advantage in the drug discovery process.  In the present study we describe a method to calc. the natural product-likeness score-a Bayesian measure which allows for the detn. of how mols. are similar to the structural space covered by natural products.  This score is shown to efficiently sep. NPs from synthetic mols. in a cross-validation expt.  Possible applications of the NP-likeness score are discussed and illustrated on several examples including virtual screening, prioritization of compd. libraries toward NP-likeness, and design of building blocks for the synthesis of NP-like libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre4QzdpRURjbVg90H21EOLACvtfcHk0lgS1kiXlWuQvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlCqtLfP&md5=0ecfc66d9cd731fcd5c131cd246d7dcf</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Fci700286x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700286x%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRoggo%26aufirst%3DS.%26aulast%3DSchuffenhauer%26aufirst%3DA.%26atitle%3DNatural%2520product-likeness%2520score%2520and%2520its%2520application%2520for%2520prioritization%2520of%2520compound%2520libraries%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D68%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Ganesan, A.</span><span> </span><span class="NLM_article-title">The impact of natural products upon modern drug discovery</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.cbpa.2008.03.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18423384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1ersrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=306-317&author=A.+Ganesan&title=The+impact+of+natural+products+upon+modern+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of natural products upon modern drug discovery</span></div><div class="casAuthors">Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-317</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the period 1970-2006, a total of 24 unique natural products were discovered that led to an approved drug.  We analyze these successful leads in terms of drug-like properties, and show that they can be divided into two equal subsets.  The first falls in the Lipinski universe' and complies with the Rule of Five.  The second is a parallel universe' that violates the rules.  Nevertheless, the latter compds. remain largely compliant in terms of log P and H-bond donors, highlighting the importance of these two metrics in predicting bioavailability.  Natural products are often cited as an exception to Lipinski's rules.  We believe this is because nature has learned to maintain low hydrophobicity and intermol. H-bond donating potential when it needs to make biol. active compds. with high mol. wt. and large nos. of rotatable bonds.  In addn., natural products are more likely than purely synthetic compds. to resemble biosynthetic intermediates or endogenous metabolites, and hence take advantage of active transport mechanisms.  Interestingly, the natural product leads in the Lipinski and parallel universe had an identical success rate (50%) in delivering an oral drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXd8x0Vy0yerVg90H21EOLACvtfcHk0lh_uRpj5FFimA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1ersrk%253D&md5=8cdde276c59d84071ea2d6f572d10088</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2008.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2008.03.016%26sid%3Dliteratum%253Aachs%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DThe%2520impact%2520of%2520natural%2520products%2520upon%2520modern%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D12%26spage%3D306%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Teng, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, Q. B.</span><span> </span><span class="NLM_article-title">Quantitation assay for absorption and first-pass metabolism of emodin in isolated rat small intestine using liquid chromatography-tandem mass spectrometry</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1628</span><span class="NLM_x">–</span> <span class="NLM_lpage">1633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1248%2Fbpb.30.1628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17827711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFelsrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=1628-1633&author=Z.+H.+Tengauthor=S.+Y.+Zhouauthor=R.+T.+Yangauthor=X.+Y.+Liuauthor=R.+W.+Liuauthor=X.+Yangauthor=B.+L.+Zhangauthor=J.+Y.+Yangauthor=D.+Y.+Caoauthor=Q.+B.+Mei&title=Quantitation+assay+for+absorption+and+first-pass+metabolism+of+emodin+in+isolated+rat+small+intestine+using+liquid+chromatography-tandem+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitation assay for absorption and first-pass metabolism of emodin in isolated rat small intestine using liquid chromatography-tandem mass spectrometry</span></div><div class="casAuthors">Teng, Zeng-Hui; Zhou, Si-Yuan; Yang, Run-Tao; Liu, Xin-You; Liu, Ren-Wang; Yang, Xi; Zhang, Bang-Le; Yang, Jing-Yue; Cao, Da-Yong; Mei, Qi-Bing</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1628-1633</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Emodin has numerous biochem. and pharmacol. activities, though information about its intestinal absorption and first-pass metab. is scarce.  The purpose of this study was to evaluate intestinal absorption and metab. of luminally administered emodin in an isolated rat small intestine using the method of LC/MS/MS.  About 22.55% of the administered emodin appeared at the vascular side, chiefly as free emodin (12.01%), but some emodin glucuronide (8.69%) and sulfate (1.84%) were also detected.  Free glucuronide (5.23%) and sulfate (1.08%) moieties were found in the luminal perfusate.  This model serves as a valuable tool for understanding intestinal handling of emodin, and our results confirm absorption and first-pass metab. of emodin in the rat small intestine.  Phase II metabolic enzymes such as glucuronyl transferase or sulfate transferase may also play an important role in the first-pass metab. of emodin in the small intestine, which may ultimately reduce the bioavailability (and thus the efficacy) of orally administered emodin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5ygzDixacVrVg90H21EOLACvtfcHk0lh_uRpj5FFimA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFelsrfL&md5=ceed3a8dc21523efcb652f5087cc1310</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1248%2Fbpb.30.1628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.30.1628%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DZ.%2BH.%26aulast%3DZhou%26aufirst%3DS.%2BY.%26aulast%3DYang%26aufirst%3DR.%2BT.%26aulast%3DLiu%26aufirst%3DX.%2BY.%26aulast%3DLiu%26aufirst%3DR.%2BW.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DB.%2BL.%26aulast%3DYang%26aufirst%3DJ.%2BY.%26aulast%3DCao%26aufirst%3DD.%2BY.%26aulast%3DMei%26aufirst%3DQ.%2BB.%26atitle%3DQuantitation%2520assay%2520for%2520absorption%2520and%2520first-pass%2520metabolism%2520of%2520emodin%2520in%2520isolated%2520rat%2520small%2520intestine%2520using%2520liquid%2520chromatography-tandem%2520mass%2520spectrometry%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2007%26volume%3D30%26spage%3D1628%26epage%3D1633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Mueller, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stopper, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlatter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, W. K.</span><span> </span><span class="NLM_article-title">Occurrence of emodin, chrysophanol and physcion in vegetables, herbs and liquors. Genotoxicity and anti-genotoxicity of the anthraquinones and of the whole plants</span> <span class="citation_source-journal">Food Chem. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2FS0278-6915%2899%2900027-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=10456676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK1MXltVChu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1999&pages=481-491&author=S.+O.+Muellerauthor=M.+Schmittauthor=W.+Dekantauthor=H.+Stopperauthor=J.+Schlatterauthor=P.+Schreierauthor=W.+K.+Lutz&title=Occurrence+of+emodin%2C+chrysophanol+and+physcion+in+vegetables%2C+herbs+and+liquors.+Genotoxicity+and+anti-genotoxicity+of+the+anthraquinones+and+of+the+whole+plants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Occurrence of emodin, chrysophanol and physcion in vegetables, herbs and liquors. Genotoxicity and anti-genotoxicity of the anthraquinones and of the whole plants</span></div><div class="casAuthors">Mueller, S. O.; Schmitt, M.; Dekant, W.; Stopper, H.; Schlatter, J.; Schreier, P.; Lutz, W. K.</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">481-491</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">1,8-Dihydroxyanthraquinones, present in laxatives, fungi imperfecti, Chinese herbs and possibly vegetables, are in debate as human carcinogens.  We screened a variety of vegetables (cabbage lettuce, beans, peas), some herbs and herbal-flavored liquors for their content of the "free" anthraquinones emodin, chrysophanol and physcion.  For qual. and quant. anal., reversed-phase HPLC (RP-LC), gas chromatog.-mass spectrometry (GC-MS) and RP-LC-MS were used.  The vegetables showed a large batch-to-batch variability, from 0.04 to 3.6, 5.9 and 36 mg total anthraquinone per kg fresh wt. in peas, cabbage lettuce, and beans, resp.  Physcion predominated in all vegetables.  In the herbs grape vine leaves, couch grass root and plantain herb, anthraquinones were above the limit of detection.  Contents ranged below 1 mg/kg (dry wt.).  All three anthraquinones were also found in seven of 11 herbal-flavored liquors, in a range of 0.05 mg/kg to 7.6 mg/kg.  The genotoxicity of the analyzed anthraquinones was investigated in the comet assay, the micronucleus test and the mutation assay in mouse lymphoma L5178Ytk+/- cells.  Emodin was genotoxic, whereas chrysophanol and physcion showed no effects.  Complete vegetable ext. on its own did not show any effect in the micronucleus test.  A lettuce ext. completely abolished the induction of micronuclei by the genotoxic anthraquinone danthron.  Taking into consideration the measured concns. of anthraquinones, estd. daily intakes, the genotoxic potency, as well as protective effects of the food matrix, the analyzed constituents do not represent a high priority genotoxic risk in a balanced human diet.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwesuX1dAslrVg90H21EOLACvtfcHk0lh_uRpj5FFimA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVChu7s%253D&md5=35ba83255c87c03f942d834f3344f426</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2FS0278-6915%2899%2900027-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0278-6915%252899%252900027-7%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DS.%2BO.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DDekant%26aufirst%3DW.%26aulast%3DStopper%26aufirst%3DH.%26aulast%3DSchlatter%26aufirst%3DJ.%26aulast%3DSchreier%26aufirst%3DP.%26aulast%3DLutz%26aufirst%3DW.%2BK.%26atitle%3DOccurrence%2520of%2520emodin%252C%2520chrysophanol%2520and%2520physcion%2520in%2520vegetables%252C%2520herbs%2520and%2520liquors.%2520Genotoxicity%2520and%2520anti-genotoxicity%2520of%2520the%2520anthraquinones%2520and%2520of%2520the%2520whole%2520plants%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D1999%26volume%3D37%26spage%3D481%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. R.</span><span> </span><span class="NLM_article-title">Molecular pharmacology of the interaction of anthracyclines with iron</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=261-271&author=X.+Xuauthor=H.+L.+Perssonauthor=D.+R.+Richardson&title=Molecular+pharmacology+of+the+interaction+of+anthracyclines+with+iron"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DPersson%26aufirst%3DH.%2BL.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DMolecular%2520pharmacology%2520of%2520the%2520interaction%2520of%2520anthracyclines%2520with%2520iron%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D261%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Patani, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVoie, E. J.</span><span> </span><span class="NLM_article-title">Bioisosterism: a rational approach in drug design</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3147</span><span class="NLM_x">–</span> <span class="NLM_lpage">3176</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr950066q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1996&pages=3147-3176&author=G.+A.+Pataniauthor=E.+J.+LaVoie&title=Bioisosterism%3A+a+rational+approach+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosterism: A rational approach in drug design</span></div><div class="casAuthors">Patani, George A.; LaVoie, Edmond J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3147-3176</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with 191 refs., on bioisosteres that incorporates sufficient detail to enable the reader to understand the concepts being delineated.  Classical bioisosteres, such as monovalent atoms and groups, divalent isosteres, trivalent atoms and groups, tetra substituted atoms, and ring equiv., and non-classical bioisosteres, such as cyclic vs. non-cyclic non-classical bioisosteric replacements and non-classical bioisosteric replacements of functional groups, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrADeNoRGbU9LVg90H21EOLACvtfcHk0lgunoc5n2t7qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D&md5=4b3ec55087feabc53e0490ebd5a3ddcd</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fcr950066q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr950066q%26sid%3Dliteratum%253Aachs%26aulast%3DPatani%26aufirst%3DG.%2BA.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26atitle%3DBioisosterism%253A%2520a%2520rational%2520approach%2520in%2520drug%2520design%26jtitle%3DChem.%2520Rev.%26date%3D1996%26volume%3D96%26spage%3D3147%26epage%3D3176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Waters, M. L.</span><span> </span><span class="NLM_article-title">Aromatic interactions in model systems</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2FS1367-5931%2802%2900359-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=12470725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD38XptFequ74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=736-741&author=M.+L.+Waters&title=Aromatic+interactions+in+model+systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatic interactions in model systems</span></div><div class="casAuthors">Waters, Marcey L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">736-741</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  A thorough knowledge of noncovalent interactions is crucial to the understanding of biol. complexity.  One of the less well understood but significant weak interactions in nature is the arom. interaction.  Recent studies have provided new insight into the driving force, stability and selectivity of these interactions.  The contribution of solvophobic and electrostatic interactions have been shown to be inextricably linked.  Moreover, the influence of electrostatic and solvophobic components on the selectivity of arom. interactions has been demonstrated.  Recent studies of arom. interactions have provided new insight into the nature of these biol. important noncovalent interactions in terms of their driving force, stability, and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxRG8RP5BTlLVg90H21EOLACvtfcHk0lgunoc5n2t7qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptFequ74%253D&md5=41ce2df6f1baa0cbf508bfab6cbe9083</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2FS1367-5931%2802%2900359-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1367-5931%252802%252900359-9%26sid%3Dliteratum%253Aachs%26aulast%3DWaters%26aufirst%3DM.%2BL.%26atitle%3DAromatic%2520interactions%2520in%2520model%2520systems%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2002%26volume%3D6%26spage%3D736%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. K.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2996</span><span class="NLM_x">–</span> <span class="NLM_lpage">2999</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2996-2999&author=J.+H.+Ahnauthor=S.+J.+Kimauthor=W.+S.+Parkauthor=S.+Y.+Choauthor=J.+D.+Haauthor=S.+S.+Kimauthor=S.+K.+Kangauthor=D.+G.+Jeongauthor=S.+K.+Jungauthor=S.+H.+Leeauthor=H.+M.+Kimauthor=S.+K.+Parkauthor=K.+H.+Leeauthor=C.+W.+Leeauthor=S.+E.+Ryuauthor=J.+K.+Choi&title=Synthesis+and+biological+evaluation+of+rhodanine+derivatives+as+PRL-3+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DPark%26aufirst%3DW.%2BS.%26aulast%3DCho%26aufirst%3DS.%2BY.%26aulast%3DHa%26aufirst%3DJ.%2BD.%26aulast%3DKim%26aufirst%3DS.%2BS.%26aulast%3DKang%26aufirst%3DS.%2BK.%26aulast%3DJeong%26aufirst%3DD.%2BG.%26aulast%3DJung%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DRyu%26aufirst%3DS.%2BE.%26aulast%3DChoi%26aufirst%3DJ.%2BK.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520rhodanine%2520derivatives%2520as%2520PRL-3%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2996%26epage%3D2999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Cutshall, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Day, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezhdo, M.</span><span> </span><span class="NLM_article-title">Rhodanine derivatives as inhibitors of JSP-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3374</span><span class="NLM_x">–</span> <span class="NLM_lpage">3379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3374-3379&author=N.+S.+Cutshallauthor=C.+O%E2%80%99Dayauthor=M.+Prezhdo&title=Rhodanine+derivatives+as+inhibitors+of+JSP-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCutshall%26aufirst%3DN.%2BS.%26aulast%3DO%25E2%2580%2599Day%26aufirst%3DC.%26aulast%3DPrezhdo%26aufirst%3DM.%26atitle%3DRhodanine%2520derivatives%2520as%2520inhibitors%2520of%2520JSP-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3374%26epage%3D3379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Gualtieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastide, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villain-Guillot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaux-Charachon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latouche, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, J. P.</span><span> </span><span class="NLM_article-title">In vitro activity of a new antibacterial rhodanine derivative against <i>Staphylococcus epidermidis</i> biofilms</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1093%2Fjac%2Fdkl314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16880176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1yjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=778-783&author=M.+Gualtieriauthor=L.+Bastideauthor=P.+Villain-Guillotauthor=S.+Michaux-Charachonauthor=J.+Latoucheauthor=J.+P.+Leonetti&title=In+vitro+activity+of+a+new+antibacterial+rhodanine+derivative+against+Staphylococcus+epidermidis+biofilms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms</span></div><div class="casAuthors">Gualtieri, Maxime; Bastide, Lionel; Villain-Guillot, Philippe; Michaux-Charachon, Sylvie; Latouche, Jaqueline; Leonetti, Jean-Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">778-783</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Staphylococcus epidermidis biofilms form at the surface of implants and prostheses and are responsible for the failure of many antibiotic therapies.  Only a few antibiotics are relatively active against biofilms, and rifampicin, a transcription inhibitor, is among the most effective mols. for treating biofilm-related infections.  Having recently selected a new potential transcription inhibitor, the authors attempted to evaluate its efficacy against S. epidermidis biofilms.  Biofilm-forming S. epidermidis strains were grown planktonically or as biofilms and their susceptibility to this transcription inhibitor was compared with ref. antibiotics with different mechanisms of action.  These results demonstrate that this new mol. is active; its effects are fast and kinetically related to those of rifampicin, but unlike rifampicin it does not select for resistant bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTpWNPN_05S7Vg90H21EOLACvtfcHk0li6sjxY9RTjHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1yjsb4%253D&md5=40e13bdcf90673171a4dd6cf38ee1976</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkl314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkl314%26sid%3Dliteratum%253Aachs%26aulast%3DGualtieri%26aufirst%3DM.%26aulast%3DBastide%26aufirst%3DL.%26aulast%3DVillain-Guillot%26aufirst%3DP.%26aulast%3DMichaux-Charachon%26aufirst%3DS.%26aulast%3DLatouche%26aufirst%3DJ.%26aulast%3DLeonetti%26aufirst%3DJ.%2BP.%26atitle%3DIn%2520vitro%2520activity%2520of%2520a%2520new%2520antibacterial%2520rhodanine%2520derivative%2520against%2520Staphylococcus%2520epidermidis%2520biofilms%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2006%26volume%3D58%26spage%3D778%26epage%3D783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Hu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S. Q.</span><span> </span><span class="NLM_article-title">In situ “click” assembly of small molecule matrix metalloprotease inhibitors containing zinc-chelating groups</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">5529</span><span class="NLM_x">–</span> <span class="NLM_lpage">5531</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol802286g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=5529-5531&author=M.+Huauthor=J.+Liauthor=S.+Q.+Yao&title=In+situ+%E2%80%9Cclick%E2%80%9D+assembly+of+small+molecule+matrix+metalloprotease+inhibitors+containing+zinc-chelating+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fol802286g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol802286g%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DS.%2BQ.%26atitle%3DIn%2520situ%2520%25E2%2580%259Cclick%25E2%2580%259D%2520assembly%2520of%2520small%2520molecule%2520matrix%2520metalloprotease%2520inhibitors%2520containing%2520zinc-chelating%2520groups%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D5529%26epage%3D5531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Irvine, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kewney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastings, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKenzie, S. J.</span><span> </span><span class="NLM_article-title">Rhodanine derivatives as novel inhibitors of PDE4</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2032</span><span class="NLM_x">–</span> <span class="NLM_lpage">2037</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2032-2037&author=M.+W.+Irvineauthor=G.+L.+Patrickauthor=J.+Kewneyauthor=S.+F.+Hastingsauthor=S.+J.+MacKenzie&title=Rhodanine+derivatives+as+novel+inhibitors+of+PDE4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DPatrick%26aufirst%3DG.%2BL.%26aulast%3DKewney%26aufirst%3DJ.%26aulast%3DHastings%26aufirst%3DS.%2BF.%26aulast%3DMacKenzie%26aufirst%3DS.%2BJ.%26atitle%3DRhodanine%2520derivatives%2520as%2520novel%2520inhibitors%2520of%2520PDE4%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2032%26epage%3D2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Johnson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbach, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savinov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strongin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiney, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellecchia, M.</span><span> </span><span class="NLM_article-title">Rhodanine derivatives as selective protease inhibitors against bacterial toxins</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1747-0285.2007.00617.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18221310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFSntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=131-139&author=S.+L.+Johnsonauthor=L.+H.+Chenauthor=R.+Harbachauthor=M.+Sabetauthor=A.+Savinovauthor=N.+J.+Cottonauthor=A.+Stronginauthor=D.+Guineyauthor=M.+Pellecchia&title=Rhodanine+derivatives+as+selective+protease+inhibitors+against+bacterial+toxins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodanine derivatives as selective protease inhibitors against bacterial toxins</span></div><div class="casAuthors">Johnson, Sherida L.; Chen, Li-Hsing; Harbach, Rebecca; Sabet, Mojgan; Savinov, Alexei; Cotton, Naomi J. H.; Strongin, Alex; Guiney, Donald; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-139</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A series of rhodanine derivs. were analyzed as potential inhibitors of bacterial toxins, namely the proteases anthrax lethal factor and the botulinum neurotoxin type A.  An extensive structure-activity relation study on rhodanine derivs. was conducted and selectivity was profiled against the two bacterial toxins and two related human metalloproteases using in vitro assays.  In addn., initial in vitro ADME-Tox properties of selected compds. and their ability to protect lethal factor-induced cell death of macrophages were examd.  These data allowed the selection of one addnl. drug candidate for which preliminary in vivo efficacy studies against anthrax spores were conducted.  Integration of these results with structure-activity relation studies provides a framework for the development of potential drug candidates against anthrax and botulinum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozA5v4ZIgxNbVg90H21EOLACvtfcHk0li6sjxY9RTjHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFSntbc%253D&md5=a067d72fa74e517cfbd9f7220a68f5ee</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00617.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00617.x%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DL.%2BH.%26aulast%3DHarbach%26aufirst%3DR.%26aulast%3DSabet%26aufirst%3DM.%26aulast%3DSavinov%26aufirst%3DA.%26aulast%3DCotton%26aufirst%3DN.%2BJ.%26aulast%3DStrongin%26aufirst%3DA.%26aulast%3DGuiney%26aufirst%3DD.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DRhodanine%2520derivatives%2520as%2520selective%2520protease%2520inhibitors%2520against%2520bacterial%2520toxins%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2008%26volume%3D71%26spage%3D131%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Kumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parasuraman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karmodiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surolia, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surolia, A.</span><span> </span><span class="NLM_article-title">Discovery of a rhodanine class of compounds as inhibitors of <i>Plasmodium falciparum</i> enoyl-acyl carrier protein reductase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2665</span><span class="NLM_x">–</span> <span class="NLM_lpage">2675</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061257w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2665-2675&author=G.+Kumarauthor=P.+Parasuramanauthor=S.+K.+Sharmaauthor=T.+Banerjeeauthor=K.+Karmodiyaauthor=N.+Suroliaauthor=A.+Surolia&title=Discovery+of+a+rhodanine+class+of+compounds+as+inhibitors+of+Plasmodium+falciparum+enoyl-acyl+carrier+protein+reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fjm061257w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061257w%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DG.%26aulast%3DParasuraman%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DBanerjee%26aufirst%3DT.%26aulast%3DKarmodiya%26aufirst%3DK.%26aulast%3DSurolia%26aufirst%3DN.%26aulast%3DSurolia%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520rhodanine%2520class%2520of%2520compounds%2520as%2520inhibitors%2520of%2520Plasmodium%2520falciparum%2520enoyl-acyl%2520carrier%2520protein%2520reductase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2665%26epage%3D2675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorronsoro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelpi, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. J.</span><span> </span><span class="NLM_article-title">SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7103</span><span class="NLM_x">–</span> <span class="NLM_lpage">7112</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040895g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyjt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7103-7112&author=A.+Martinezauthor=M.+Alonsoauthor=A.+Castroauthor=I.+Dorronsoroauthor=J.+L.+Gelpiauthor=F.+J.+Luqueauthor=C.+Perezauthor=F.+J.+Moreno&title=SAR+and+3D-QSAR+studies+on+thiadiazolidinone+derivatives%3A+exploration+of+structural+requirements+for+glycogen+synthase+kinase+3+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">SAR and 3D-QSAR Studies on Thiadiazolidinone Derivatives: Exploration of Structural Requirements for Glycogen Synthase Kinase 3 Inhibitors</span></div><div class="casAuthors">Martinez, Ana; Alonso, Mercedes; Castro, Ana; Dorronsoro, Isabel; Gelpi, J. Luis; Luque, F. Javier; Perez, Concepcion; Moreno, Francisco J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7103-7112</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 2,4-disubstituted thiadiazolidinones (TDZD) are described as the first ATP-noncompetitive GSK-3 inhibitors.  Following an SAR study about TDZD, different structural modifications in the heterocyclic ring aimed to test the influence of each heteroatom on the biol. study are here reported here.  Various compds. such as hydantoins, dithiazolidindiones, rhodanines, maleimides, and triazoles were synthesized and screened as GSK-3 inhibitors.  After an extensive SAR study among these different heterocyclic families, TDZDs have been revealed as a privileged scaffold for the selective inhibition of GSK-3.  A Co-MFA anal. was also performed highlighting the mol. electrostatic field interaction in the interaction of TDZDs with GSK-3.  Moreover, first mapping studies indicate two binding modes which in turn might imply relevant differences in the mechanism that underly the inhibitory activity of TDZDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUQ6m_G-n_WLVg90H21EOLACvtfcHk0ljXoF-UqxzONA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyjt73O&md5=35b315178d5e518a64b7a2670d41d27b</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fjm040895g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040895g%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DDorronsoro%26aufirst%3DI.%26aulast%3DGelpi%26aufirst%3DJ.%2BL.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMoreno%26aufirst%3DF.%2BJ.%26atitle%3DSAR%2520and%25203D-QSAR%2520studies%2520on%2520thiadiazolidinone%2520derivatives%253A%2520exploration%2520of%2520structural%2520requirements%2520for%2520glycogen%2520synthase%2520kinase%25203%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7103%26epage%3D7112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Russell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redfield, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurieri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, E.</span><span> </span><span class="NLM_article-title">Selective small molecule inhibitors of the potential breast cancer marker, human arylamine <i>N</i>-acetyltransferase 1, and its murine homologue, mouse arylamine <i>N</i>-acetyltransferase 2</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=905-918&author=A.+J.+Russellauthor=I.+M.+Westwoodauthor=M.+H.+Crawfordauthor=J.+Robinsonauthor=A.+Kawamuraauthor=C.+Redfieldauthor=N.+Laurieriauthor=E.+D.+Loweauthor=S.+G.+Daviesauthor=E.+Sim&title=Selective+small+molecule+inhibitors+of+the+potential+breast+cancer+marker%2C+human+arylamine+N-acetyltransferase+1%2C+and+its+murine+homologue%2C+mouse+arylamine+N-acetyltransferase+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DCrawford%26aufirst%3DM.%2BH.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DRedfield%26aufirst%3DC.%26aulast%3DLaurieri%26aufirst%3DN.%26aulast%3DLowe%26aufirst%3DE.%2BD.%26aulast%3DDavies%26aufirst%3DS.%2BG.%26aulast%3DSim%26aufirst%3DE.%26atitle%3DSelective%2520small%2520molecule%2520inhibitors%2520of%2520the%2520potential%2520breast%2520cancer%2520marker%252C%2520human%2520arylamine%2520N-acetyltransferase%25201%252C%2520and%2520its%2520murine%2520homologue%252C%2520mouse%2520arylamine%2520N-acetyltransferase%25202%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D905%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Villain-Guillot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastide, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roquet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amblard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pugniere, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, J. P.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4195</span><span class="NLM_x">–</span> <span class="NLM_lpage">4204</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0703183" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4195-4204&author=P.+Villain-Guillotauthor=M.+Gualtieriauthor=L.+Bastideauthor=F.+Roquetauthor=J.+Martinezauthor=M.+Amblardauthor=M.+Pugniereauthor=J.+P.+Leonetti&title=Structure%E2%80%93activity+relationships+of+phenyl-furanyl-rhodanines+as+inhibitors+of+RNA+polymerase+with+antibacterial+activity+on+biofilms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1021%2Fjm0703183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703183%26sid%3Dliteratum%253Aachs%26aulast%3DVillain-Guillot%26aufirst%3DP.%26aulast%3DGualtieri%26aufirst%3DM.%26aulast%3DBastide%26aufirst%3DL.%26aulast%3DRoquet%26aufirst%3DF.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DAmblard%26aufirst%3DM.%26aulast%3DPugniere%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DJ.%2BP.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520phenyl-furanyl-rhodanines%2520as%2520inhibitors%2520of%2520RNA%2520polymerase%2520with%2520antibacterial%2520activity%2520on%2520biofilms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4195%26epage%3D4204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Zervosen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, T. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frere, J. M.</span><span> </span><span class="NLM_article-title">Interactions between penicillin-binding proteins (PBPs) and two novel classes of PBP inhibitors, arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-ones</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1128%2FAAC.48.3.961-969.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=14982790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitVGhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=961-969&author=A.+Zervosenauthor=W.+P.+Luauthor=Z.+Chenauthor=R.+E.+Whiteauthor=T.+P.+Demuthauthor=J.+M.+Frere&title=Interactions+between+penicillin-binding+proteins+%28PBPs%29+and+two+novel+classes+of+PBP+inhibitors%2C+arylalkylidene+rhodanines+and+arylalkylidene+iminothiazolidin-4-ones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions between penicillin-binding proteins (PBPs) and two novel classes of PBP inhibitors, arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-ones</span></div><div class="casAuthors">Zervosen, Astrid; Lu, Wei-Ping; Chen, Zhouliang; White, Ronald E.; Demuth, Thomas P., Jr.; Frere, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">961-969</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Several non-β-lactam compds. were active against various gram-pos. and gram-neg. bacterial strains.  The MICs of arylalkylidene rhodanines, e.g. I and II, and arylalkylidene iminothiazolidin-4-ones, e.g. III and IV, were lower than those of ampicillin and cefotaxime for methicillin-resistant Staphylococcus aureus MI339 and vancomycin-resistant Enterococcus faecium EF12.  Several compds. were found to inhibit the cell wall synthesis of S. aureus and the last two steps of peptidoglycan biosynthesis catalyzed by ether-treated cells of Escherichia coli or cell wall membrane prepns. of Bacillus megaterium.  The effects of the arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-one derivs. on E. coli PBP 3 and PBP 5, Streptococcus pneumoniae PBP 2xS (PBP 2x from a penicillin-sensitive strain) and PBP 2xR (PBP 2x from a penicillin-resistant strain), low-affinity PBP 2a of S. aureus, and the Actinomadura sp. strain R39 and Streptomyces sp. strain R61 DD-peptidases were studied.  Some of the compds. exhibited inhibitory activities in the 10 to 100 μM concn. range.  The inhibition of PBP 2xS by several of them appeared to be noncompetitive.  The dissocn. const. for the best inhibitor (Ki = 10 μM) was not influenced by the presence of the substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY1OMwCnBRtrVg90H21EOLACvtfcHk0ljXoF-UqxzONA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitVGhtL0%253D&md5=28a82402adeeb97c9e56fd92625d457e</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.3.961-969.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.3.961-969.2004%26sid%3Dliteratum%253Aachs%26aulast%3DZervosen%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DW.%2BP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWhite%26aufirst%3DR.%2BE.%26aulast%3DDemuth%26aufirst%3DT.%2BP.%26aulast%3DFrere%26aufirst%3DJ.%2BM.%26atitle%3DInteractions%2520between%2520penicillin-binding%2520proteins%2520%2528PBPs%2529%2520and%2520two%2520novel%2520classes%2520of%2520PBP%2520inhibitors%252C%2520arylalkylidene%2520rhodanines%2520and%2520arylalkylidene%2520iminothiazolidin-4-ones%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D961%26epage%3D969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Carlson, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiessling, L. L.</span><span> </span><span class="NLM_article-title">Chemical probes of UDP-galactopyranose mutase</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.chembiol.2006.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16931332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD28XoslOhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=825-837&author=E.+E.+Carlsonauthor=J.+F.+Mayauthor=L.+L.+Kiessling&title=Chemical+probes+of+UDP-galactopyranose+mutase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Probes of UDP-Galactopyranose Mutase</span></div><div class="casAuthors">Carlson, Erin E.; May, John F.; Kiessling, Laura L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">825-837</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Many pathogenic prokaryotes and eukaryotes possess the machinery required to assemble galactofuranose (Galf)-contg. glycoconjugates; these glycoconjugates can be crit. for virulence or viability.  Accordingly, compds. that block Galf incorporation may serve as therapeutic leads or as probes of the function of Galf-contg. glycoconjugates.  The enzyme UDP-galactopyranose mutase (UGM) is the only known generator of UDP-galactofuranose, the precursor to Galf residues.  We previously employed a high-throughput fluorescence polarization assay to investigate the Klebsiella pneumoniae UGM.  We demonstrate the generality of this assay by extending it to UGM from Mycobacterium tuberculosis.  To identify factors influencing binding, we synthesized a directed library contg. a 5-arylidene-2-thioxo-4-thiazolidinone core, a structure possessing features common to ligands for both homologs.  Our studies offer a blueprint for identifying inhibitors of the growing family of UGM homologs and provide insight into UGM inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8RQO7mDu8VrVg90H21EOLACvtfcHk0ljXoF-UqxzONA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XoslOhurc%253D&md5=e2bcbf65928d3d4ddaa15975a6d7639c</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2006.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2006.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26aulast%3DMay%26aufirst%3DJ.%2BF.%26aulast%3DKiessling%26aufirst%3DL.%2BL.%26atitle%3DChemical%2520probes%2520of%2520UDP-galactopyranose%2520mutase%26jtitle%3DChem.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D825%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Hotta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akanuma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shichiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeta, Y.</span><span> </span><span class="NLM_article-title">Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative aldose reductase inhibitor-diabetes complications trial</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1538</span><span class="NLM_x">–</span> <span class="NLM_lpage">1544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=1538-1544&author=N.+Hottaauthor=Y.+Akanumaauthor=R.+Kawamoriauthor=K.+Matsuokaauthor=Y.+Okaauthor=M.+Shichiriauthor=T.+Toyotaauthor=M.+Nakashimaauthor=I.+Yoshimuraauthor=N.+Sakamotoauthor=Y.+Shigeta&title=Long-term+clinical+effects+of+epalrestat%2C+an+aldose+reductase+inhibitor%2C+on+diabetic+peripheral+neuropathy%3A+the+3-year%2C+multicenter%2C+comparative+aldose+reductase+inhibitor-diabetes+complications+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHotta%26aufirst%3DN.%26aulast%3DAkanuma%26aufirst%3DY.%26aulast%3DKawamori%26aufirst%3DR.%26aulast%3DMatsuoka%26aufirst%3DK.%26aulast%3DOka%26aufirst%3DY.%26aulast%3DShichiri%26aufirst%3DM.%26aulast%3DToyota%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DM.%26aulast%3DYoshimura%26aufirst%3DI.%26aulast%3DSakamoto%26aufirst%3DN.%26aulast%3DShigeta%26aufirst%3DY.%26atitle%3DLong-term%2520clinical%2520effects%2520of%2520epalrestat%252C%2520an%2520aldose%2520reductase%2520inhibitor%252C%2520on%2520diabetic%2520peripheral%2520neuropathy%253A%2520the%25203-year%252C%2520multicenter%252C%2520comparative%2520aldose%2520reductase%2520inhibitor-diabetes%2520complications%2520trial%26jtitle%3DDiabetes%2520Care%26date%3D2006%26volume%3D29%26spage%3D1538%26epage%3D1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Sturm, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levstik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristl, A.</span><span> </span><span class="NLM_article-title">Permeability characteristics of novel aldose reductase inhibitors using rat jejunum in vitro</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.ejps.2006.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16497491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ChtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2006&pages=128-133&author=K.+Sturmauthor=L.+Levstikauthor=V.+J.+Demopoulosauthor=A.+Kristl&title=Permeability+characteristics+of+novel+aldose+reductase+inhibitors+using+rat+jejunum+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Permeability characteristics of novel aldose reductase inhibitors using rat jejunum in vitro</span></div><div class="casAuthors">Sturm, Katja; Levstik, Lea; Demopoulos, Vassilis J.; Kristl, Albin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">128-133</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The aim of this study was to est. in vivo permeability and bioavailability of epalrestat and newly synthesized compds. with possible therapeutic activity as aldose enzyme inhibitors (ARIs).  For this purpose permeability in vitro using rat jejunum mounted in side-by-side diffusion cells was detd.  Tested substances were found to be low and moderately permeable and some of them were also substrates for efflux transporters.  It was shown, that the higher efflux for some derivs. was due to MRP-2, but not Pgp involvement.  Tested ARIs do not share the same efflux transporter with epalrestat, the only ARI currently on the market in Japan.  The most permeable compd., a 2,6-difluoro-4-pyrrol-1ylphenol deriv., is not a substrate for efflux transporters and would therefore be the most promising lead compd. for further investigation of potent ARIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3QgzqMrZmXbVg90H21EOLACvtfcHk0lhUE9BsHY2Vqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ChtLo%253D&md5=7feaf11b668fb9877d7aa6419cb25c42</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2006.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2006.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DSturm%26aufirst%3DK.%26aulast%3DLevstik%26aufirst%3DL.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26aulast%3DKristl%26aufirst%3DA.%26atitle%3DPermeability%2520characteristics%2520of%2520novel%2520aldose%2520reductase%2520inhibitors%2520using%2520rat%2520jejunum%2520in%2520vitro%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D28%26spage%3D128%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Necula, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C. G.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">10311</span><span class="NLM_x">–</span> <span class="NLM_lpage">10324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1074%2Fjbc.M608207200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17284452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs1Sitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=10311-10324&author=M.+Neculaauthor=R.+Kayedauthor=S.+Miltonauthor=C.+G.+Glabe&title=Small+molecule+inhibitors+of+aggregation+indicate+that+amyloid+beta+oligomerization+and+fibrillization+pathways+are+independent+and+distinct"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct</span></div><div class="casAuthors">Necula, Mihaela; Kayed, Rakez; Milton, Saskia; Glabe, Charles G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">10311-10324</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Alzheimer disease is characterized by the abnormal aggregation of amyloid β peptide into extracellular fibrillar deposits known as amyloid plaques.  Sol. oligomers have been obsd. at early time points preceding fibril formation, and these oligomers have been implicated as the primary pathol. species rather than the mature fibrils.  A significant issue that remains to be resolved is whether amyloid oligomers are an obligate intermediate on the pathway to fibril formation or represent an alternate assembly pathway that may or may not lead to fiber formation.  To det. whether amyloid β oligomers are obligate intermediates in the fibrillization pathway, we characterized the mechanism of action of amyloid β aggregation inhibitors in terms of oligomer and fibril formation.  Based on their effects, the small mols. segregated into three distinct classes: compds. that inhibit oligomerization but not fibrillization, compds. that inhibit fibrillization but not oligomerization, and compds. that inhibit both.  Several compds. selectively inhibited oligomerization at substoichiometric concns. relative to amyloid β monomer, with some active in the low nanomolar range.  These results indicate that oligomers are not an obligate intermediate in the fibril formation pathway.  In addn., these data suggest that small mol. inhibitors are useful for clarifying the mechanisms underlying protein aggregation and may represent potential therapeutic agents that target fundamental disease mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1wCvf_-f5QLVg90H21EOLACvtfcHk0lhUE9BsHY2Vqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs1Sitb4%253D&md5=094771ea07dedf90832f09fce28cca7d</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M608207200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M608207200%26sid%3Dliteratum%253Aachs%26aulast%3DNecula%26aufirst%3DM.%26aulast%3DKayed%26aufirst%3DR.%26aulast%3DMilton%26aufirst%3DS.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520aggregation%2520indicate%2520that%2520amyloid%2520beta%2520oligomerization%2520and%2520fibrillization%2520pathways%2520are%2520independent%2520and%2520distinct%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D10311%26epage%3D10324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larbig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khlistunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coksezen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">10016</span><span class="NLM_x">–</span> <span class="NLM_lpage">10023</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi700878g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=10016-10023&author=M.+Pickhardtauthor=G.+Larbigauthor=I.+Khlistunovaauthor=A.+Coksezenauthor=B.+Meyerauthor=E.+M.+Mandelkowauthor=B.+Schmidtauthor=E.+Mandelkow&title=Phenylthiazolyl-hydrazide+and+its+derivatives+are+potent+inhibitors+of+tau+aggregation+and+toxicity+in+vitro+and+in+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fbi700878g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi700878g%26sid%3Dliteratum%253Aachs%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DLarbig%26aufirst%3DG.%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DCoksezen%26aufirst%3DA.%26aulast%3DMeyer%26aufirst%3DB.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DPhenylthiazolyl-hydrazide%2520and%2520its%2520derivatives%2520are%2520potent%2520inhibitors%2520of%2520tau%2520aggregation%2520and%2520toxicity%2520in%2520vitro%2520and%2520in%2520cells%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D10016%26epage%3D10023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Taghavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyny-von Haussen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title"><i>N</i>′-Benzylidene-benzohydrazides as novel and selective tau-PHF ligands</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21891864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Sls7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2011&pages=835-843&author=A.+Taghaviauthor=S.+Nasirauthor=M.+Pickhardtauthor=R.+Heyny-von+Haussenauthor=G.+Mallauthor=E.+Mandelkowauthor=E.+M.+Mandelkowauthor=B.+Schmidt&title=N%E2%80%B2-Benzylidene-benzohydrazides+as+novel+and+selective+tau-PHF+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">N'-Benzylidene-Benzohydrazides as Novel and Selective Tau-PHF Ligands</span></div><div class="casAuthors">Taghavi, Ali; Nasir, Samir; Pickhardt, Marcus; Heyny-von Haussen, Roland; Mall, Gerhard; Mandelkow, Eckhard; Mandelkow, Eva-Maria; Schmidt, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">835-843</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The structure activity relationship of N'-benzylidene-benzohydrazide (NBB) binding to tau and paired helical filament (PHF) proteins as well as amyloid-β1-42 fibrils indicate differential selectivity for these protein aggregates.  The ability of the compds. to stain neurofibrillary tangles and senile plaques isolated from human AD brain was investigated histochem.  These studies resulted in several tau-PHF and amyloid-β1-42 fibril selective ligands resp.  Supported by these results, we rationalized a model for the design of selective ligands for tau, PHF, and amyloid-β1-42 fibrils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmUckFrrYIfbVg90H21EOLACvtfcHk0ljDmJXGuXpKPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Sls7bF&md5=6a91548633b7d72a0c439f32bcc3af5a</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaghavi%26aufirst%3DA.%26aulast%3DNasir%26aufirst%3DS.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DHeyny-von%2BHaussen%26aufirst%3DR.%26aulast%3DMall%26aufirst%3DG.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DN%25E2%2580%25B2-Benzylidene-benzohydrazides%2520as%2520novel%2520and%2520selective%2520tau-PHF%2520ligands%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D27%26spage%3D835%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Vijaya Raj, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayana, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashalatha, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchetha Kumari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarojini, B. K.</span><span> </span><span class="NLM_article-title">Synthesis of some bioactive 2-bromo-5-methoxy-<i>N</i>′-[4-(aryl)-1,3-thiazol-2-yl]benzohydrazide derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=425-429&author=K.+K.+Vijaya+Rajauthor=B.+Narayanaauthor=B.+V.+Ashalathaauthor=N.+Suchetha+Kumariauthor=B.+K.+Sarojini&title=Synthesis+of+some+bioactive+2-bromo-5-methoxy-N%E2%80%B2-%5B4-%28aryl%29-1%2C3-thiazol-2-yl%5Dbenzohydrazide+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVijaya%2BRaj%26aufirst%3DK.%2BK.%26aulast%3DNarayana%26aufirst%3DB.%26aulast%3DAshalatha%26aufirst%3DB.%2BV.%26aulast%3DSuchetha%2BKumari%26aufirst%3DN.%26aulast%3DSarojini%26aufirst%3DB.%2BK.%26atitle%3DSynthesis%2520of%2520some%2520bioactive%25202-bromo-5-methoxy-N%25E2%2580%25B2-%255B4-%2528aryl%2529-1%252C3-thiazol-2-yl%255Dbenzohydrazide%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D425%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Sonar, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P. A.</span><span> </span><span class="NLM_article-title">Synthesis and antitubercular activity of a series of hydrazone and nitrovinyl analogs derived from heterocyclic aldehydes</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1080%2F14756360801915526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18629678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=117-124&author=V.+N.+Sonarauthor=P.+A.+Crooks&title=Synthesis+and+antitubercular+activity+of+a+series+of+hydrazone+and+nitrovinyl+analogs+derived+from+heterocyclic+aldehydes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antitubercular activity of a series of hydrazone and nitrovinyl analogs derived from heterocyclic aldehydes</span></div><div class="casAuthors">Sonar, Vijayakumar N.; Crooks, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A series of hydrazone and 3-nitrovinyl analogs of indole-3-carboxaldehydes and related compds. were synthesized and screened for antitubercular activity against Mycobacterium tuberculosis H37RV in BACTEC 12B medium using the Microplate Alamar Blue Assay (MABA).  Several compds. showed inhibitory activity against M. tuberculosis in primary screening assays at a concn. of 6.25 μg/mL; subsequent dose-response studies indicated that the most active compds., 3d, 3e & 8b, had IC50 values of 5.96, 5.4 & 1.6 μg/mL, resp.  These compds. represent potential leads for the further development of novel antitubercular agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyruFNE4xxHbVg90H21EOLACvtfcHk0ljDmJXGuXpKPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSqu74%253D&md5=ce808ff81ae509ba5e18c86f9bd70818</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1080%2F14756360801915526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756360801915526%26sid%3Dliteratum%253Aachs%26aulast%3DSonar%26aufirst%3DV.%2BN.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26atitle%3DSynthesis%2520and%2520antitubercular%2520activity%2520of%2520a%2520series%2520of%2520hydrazone%2520and%2520nitrovinyl%2520analogs%2520derived%2520from%2520heterocyclic%2520aldehydes%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2009%26volume%3D24%26spage%3D117%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Hafez, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Gazzar, A. B.</span><span> </span><span class="NLM_article-title">Design and synthesis of 3-pyrazolyl-thiophene, thieno[2,3-<i>d</i>]pyrimidines as new bioactive and pharmacological activities</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5222</span><span class="NLM_x">–</span> <span class="NLM_lpage">5227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5222-5227&author=H.+N.+Hafezauthor=A.+B.+El-Gazzar&title=Design+and+synthesis+of+3-pyrazolyl-thiophene%2C+thieno%5B2%2C3-d%5Dpyrimidines+as+new+bioactive+and+pharmacological+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHafez%26aufirst%3DH.%2BN.%26aulast%3DEl-Gazzar%26aufirst%3DA.%2BB.%26atitle%3DDesign%2520and%2520synthesis%2520of%25203-pyrazolyl-thiophene%252C%2520thieno%255B2%252C3-d%255Dpyrimidines%2520as%2520new%2520bioactive%2520and%2520pharmacological%2520activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5222%26epage%3D5227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. S.</span><span> </span><span class="NLM_article-title">In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1890</span><span class="NLM_x">–</span> <span class="NLM_lpage">1899</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800185b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvFSls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1890-1899&author=R.+S.+Obachauthor=A.+S.+Kalgutkarauthor=T.+F.+Ryderauthor=G.+S.+Walker&title=In+vitro+metabolism+and+covalent+binding+of+enol-carboxamide+derivatives+and+anti-inflammatory+agents+sudoxicam+and+meloxicam%3A+insights+into+the+hepatotoxicity+of+sudoxicam"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Metabolism and Covalent Binding of Enol-Carboxamide Derivatives and Anti-Inflammatory Agents Sudoxicam and Meloxicam: Insights into the Hepatotoxicity of Sudoxicam</span></div><div class="casAuthors">Obach, R. Scott; Kalgutkar, Amit S.; Ryder, Tim F.; Walker, Gregory S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1890-1899</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sudoxicam and meloxicam are nonsteroidal anti-inflammatory drugs (NSAIDs) from the enol-carboxamide class.  While the only structural difference between the two NSAIDs is the presence of a Me group on the C5-position of the 2-carboxamidothiazole motif in meloxicam, a marked difference in their toxicol. profile in humans has been discerned.  In clin. trials, sudoxicam was assocd. with several cases of severe hepatotoxicity that led to its discontinuation, while meloxicam has been in the market for over a decade and is devoid of hepatotoxicity.  In an attempt to understand the biochem. basis for the differences in safety profile, an in vitro investigation of the metabolic pathways and covalent binding of the two NSAIDs was conducted in NADPH-supplemented human liver microsomes.  Both compds. demonstrated NADPH-dependent covalent binding to human liver microsomes; however, the extent of binding of [14C]-meloxicam was ∼2-fold greater than that of [14C]-sudoxicam.  While inclusion of glutathione (GSH) in microsomal incubations resulted in a decrease in covalent binding for both NSAIDs, the redn. in binding was more pronounced for meloxicam.  Metabolite identification studies on [14C]-sudoxicam in NADPH-supplemented human liver microsomes indicated that the primary route of metab. involved a P 450-mediated thiazole ring scission to the corresponding acylthiourea metabolite (S3), a well-established pro-toxin.  The mechanism of formation of S3 presumably proceeds via (a) epoxidn. of the C4-C5-thiazole ring double bond, (b) epoxide hydrolysis to the corresponding thiazole-4,5-dihydrodiol deriv., which was obsd. as a stable metabolite (S2), (c) ring opening of the thiazole-4,5-dihydrodiol to an 2-oxoethylidene thiourea intermediate, and (d) hydrolysis of the imine bond within this intermediate to yield S3.  In the case of meloxicam, the corresponding acylthiourea metabolite M3 was also obsd., but to a lesser extent; the main route of meloxicam metab. involved hydroxylation of the 5'-Me group, a finding that is consistent with the known metabolic fate of this NSAID.  Inclusion of GSH led to a decrease in the formation of M3 with the concomitant formation of an unusual two-electron redn. product (metabolite M7).  The formation of M7 is proposed to arise via redn. of the imine bond in 2-oxopropylidene thiourea, an intermediate in the thiazole ring scission pathway in meloxicam.  In conclusion, the results of our anal. suggest that if the covalent binding of the two NSAIDs is important to the overall hepatotoxicity risk, the differences in metab. (differential preponderance of formation of the acylthiourea relative to total metab.), differential effects of GSH on covalent binding, and finally differences in daily doses of the two NSAIDs may serve as a plausible explanation for the marked differences in toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr41ErheTuDvLVg90H21EOLACvtfcHk0ljDmJXGuXpKPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvFSls7o%253D&md5=af142bb2df6107277dcbbb82b0907c21</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1021%2Ftx800185b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800185b%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DRyder%26aufirst%3DT.%2BF.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26atitle%3DIn%2520vitro%2520metabolism%2520and%2520covalent%2520binding%2520of%2520enol-carboxamide%2520derivatives%2520and%2520anti-inflammatory%2520agents%2520sudoxicam%2520and%2520meloxicam%253A%2520insights%2520into%2520the%2520hepatotoxicity%2520of%2520sudoxicam%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1890%26epage%3D1899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Preziosi, P.</span><span> </span><span class="NLM_article-title">Isoniazid: metabolic aspects and toxicological correlates</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F138920007782798216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18220565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVahtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=839-851&author=P.+Preziosi&title=Isoniazid%3A+metabolic+aspects+and+toxicological+correlates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Isoniazid: metabolic aspects and toxicological correlates</span></div><div class="casAuthors">Preziosi, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">839-851</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For over half a century, pyridine-4-carboxy hydrazide (isonicotinyl hydrazide; isoniazid - INH) has been a front-line weapon in the battle against tuberculosis.  Its metab. has been the subject of important research, much of which has focused on the pharmacodynamic and toxicol. aspects of certain INH metabolites.  Since 1952, when the drug was first introduced, multiple INH metabolites have been identified, including hydrazine (HZ), isonicotinic acid (INA), ammonia, the acetylated deriv. N1-acetyl-N2-isonicotinylhydrazide (AcINH), hydrazones with pyruvic and ketoglutaric acids (INH-PA and INH-KA, resp.), monoacetylhydrazine (AcHZ), diacetylhydrazine (DiAcHZ), and oxidizing free radicals.  Their formation is the result of hydrolysis (INA, HZ), cytochrome P 450 (CYP)-dependent oxidn. (HZ, NH3, oxidizing free radicals), and N-acetyltransferase (NAT) activity (AcINH, AcHZ, DiAcHZ).  Doubts remain about isonicotinamide (INAAM) as an INH metabolite in mammals.  Quant. speaking, one of the major metabolites is AcINH, which is produced by the enzyme NAT.  It has virtually no antitubercular activity and is far less toxic than INH.  Its formation and elimination are genetically controlled, and its elimination profile is trimodal (rapid, intermediate, and slow acetylation).  Slow acetylation, which is transmitted as an autosomal recessive trait, increases the risk for peripheral neurotoxicity and hepatotoxicity in INH users.  Thus far, there is no conclusive pharmacogenetic evidence that the formation of HZ and oxidizing radicals are linked to CYP polymorphisms.  This article examines INH, HZ and its mono- and diacetylated metabolites, and ammonia (which in vitro and in vivo studies indicate as another deriv. of HZ) in terms of their potential to cause neurotoxic and hepatotoxic effects (the two major forms of INH toxicity obsd. in animals and humans).  INH hepatotoxicity seems to be related mainly to HZ, AcHZ, and other HZ metabolites that are capable of generating free radicals.  The pathol. aspects of slow INH acetylation will be discussed in relation to the drug's hepato- and neurotoxic effects.  The mechanism underlying INH neurotoxicity has yet to be fully defined.  The metabolite(s) involved in this phenomenon remain obscure although a major role is clearly played by HZ (and possibly also by the ammonia it releases).  There is some evidence of the involvement of γ-glutamyl HZ and of a chem. analog of a Schiff base formed by INH and pyridoxal-phosphate.  Recent findings have also revealed important interactions between INH and the various isoforms of CYP, and these may play a role in clin. relevant interactions between INH and several other drugs.  All of these aspects of INH will be covered in the review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPwlruMxT4sbVg90H21EOLACvtfcHk0lguTjoKiRQWBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVahtrrJ&md5=e567918ae0ed2b1f527a243c87883f37</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.2174%2F138920007782798216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920007782798216%26sid%3Dliteratum%253Aachs%26aulast%3DPreziosi%26aufirst%3DP.%26atitle%3DIsoniazid%253A%2520metabolic%2520aspects%2520and%2520toxicological%2520correlates%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2007%26volume%3D8%26spage%3D839%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Timmins, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deretic, V.</span><span> </span><span class="NLM_article-title">Mechanisms of action of isoniazid</span> <span class="citation_source-journal">Mol. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1220</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1365-2958.2006.05467.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17074073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlenu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=1220-1227&author=G.+S.+Timminsauthor=V.+Deretic&title=Mechanisms+of+action+of+isoniazid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of action of isoniazid</span></div><div class="casAuthors">Timmins, Graham S.; Deretic, Vojo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1220-1227</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  For decades after its introduction, the mechanisms of action of the front-line antituberculosis therapeutic agent isoniazid (INH) remained unclear.  Recent developments have shown that peroxidative activation of isoniazid by the mycobacterial enzyme KatG generates reactive species that form adducts with NAD+ and NADP+ that are potent inhibitors of lipid and nucleic acid biosynthetic enzymes.  A direct role for some isoniazid-derived reactive species, such as nitric oxide, in inhibiting mycobacterial metabolic enzymes has also been shown.  The concerted effects of these activities - inhibition of cell wall lipid synthesis, depletion of nucleic acid pools and metabolic depression - drive the exquisite potency and selectivity of this agent.  To understand INH action and resistance fully, a synthesis of knowledge is required from multiple sep. lines of research - including mol. genetic approaches, in vitro biochem. studies and free radical chem. - which is the intent of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq9OybVddk-rVg90H21EOLACvtfcHk0lguTjoKiRQWBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlenu7jE&md5=fbc095f0f79cd443b55d54c19b36f932</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2006.05467.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2006.05467.x%26sid%3Dliteratum%253Aachs%26aulast%3DTimmins%26aufirst%3DG.%2BS.%26aulast%3DDeretic%26aufirst%3DV.%26atitle%3DMechanisms%2520of%2520action%2520of%2520isoniazid%26jtitle%3DMol.%2520Microbiol.%26date%3D2006%26volume%3D62%26spage%3D1220%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Pessayre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Saint-Louvent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degott, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernuau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueff, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, J. P.</span><span> </span><span class="NLM_article-title">Iproclozide fulminant hepatitis. Possible role of enzyme induction</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1978&pages=492-496&author=D.+Pessayreauthor=P.+de+Saint-Louventauthor=C.+Degottauthor=J.+Bernuauauthor=B.+Rueffauthor=J.+P.+Benhamou&title=Iproclozide+fulminant+hepatitis.+Possible+role+of+enzyme+induction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPessayre%26aufirst%3DD.%26aulast%3Dde%2BSaint-Louvent%26aufirst%3DP.%26aulast%3DDegott%26aufirst%3DC.%26aulast%3DBernuau%26aufirst%3DJ.%26aulast%3DRueff%26aufirst%3DB.%26aulast%3DBenhamou%26aufirst%3DJ.%2BP.%26atitle%3DIproclozide%2520fulminant%2520hepatitis.%2520Possible%2520role%2520of%2520enzyme%2520induction%26jtitle%3DGastroenterology%26date%3D1978%26volume%3D75%26spage%3D492%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Fagervall, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S. B.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1986&pages=1381-1387&author=I.+Fagervallauthor=S.+B.+Ross&title=Inhibition+of+monoamine+oxidase+in+monoaminergic+neurones+in+the+rat+brain+by+irreversible+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFagervall%26aufirst%3DI.%26aulast%3DRoss%26aufirst%3DS.%2BB.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520in%2520monoaminergic%2520neurones%2520in%2520the%2520rat%2520brain%2520by%2520irreversible%2520inhibitors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1986%26volume%3D35%26spage%3D1381%26epage%3D1387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">Park, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitteringham, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirmohamed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. P.</span><span> </span><span class="NLM_article-title">The role of metabolic activation in drug-induced hepatotoxicity</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1146%2Fannurev.pharmtox.45.120403.100058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15822174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVWjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=177-202&author=B.+K.+Parkauthor=N.+R.+Kitteringhamauthor=J.+L.+Maggsauthor=M.+Pirmohamedauthor=D.+P.+Williams&title=The+role+of+metabolic+activation+in+drug-induced+hepatotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">The role of metabolic activation in drug-induced hepatotoxicity</span></div><div class="casAuthors">Park, B. Kevin; Kitteringham, Neil R.; Maggs, James L.; Pirmohamed, Munir; Williams, Dominic P.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">177-202</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The importance of reactive metabolites in the pathogenesis of drug-induced toxicity was a focus of research interest since pioneering investigations in the 1950s revealed the link between toxic metabolites and chem. carcinogenesis.  There is now a great deal of evidence that shows that reactive metabolites are formed from drugs known to cause hepatotoxicity, but how these toxic species initiate and propagate tissue damage is still poorly understood.  This review summarizes the evidence for reactive metabolite formation from hepatotoxic drugs, such as acetaminophen, tamoxifen, diclofenac, and troglitazone, and the current hypotheses of how this leads to liver injury.  Several hepatic proteins can be modified by reactive metabolites, but this in general equates poorly with the extent of toxicity.  Much more important may be the identification of the crit. proteins modified by these toxic species and how this alters their function.  It is also important to note that the toxicity of reactive metabolites may be mediated by noncovalent binding mechanisms, which may also have profound effects on normal liver physiol.  Technol. developments in the wake of the genomic revolution now provide unprecedented power to characterize and quantify covalent modification of individual target proteins and their functional consequences; such information should dramatically improve the authors' understanding of drug-induced hepatotoxic reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNxj1QZaR8MbVg90H21EOLACvtfcHk0lguTjoKiRQWBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVWjt78%253D&md5=0e7f16ec0deb3e1da4be3f7f2a68df5b</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.45.120403.100058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.45.120403.100058%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DB.%2BK.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26atitle%3DThe%2520role%2520of%2520metabolic%2520activation%2520in%2520drug-induced%2520hepatotoxicity%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2005%26volume%3D45%26spage%3D177%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group">Koechlin, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberhaensli, W. E.</span><span> </span><span class="NLM_article-title">Metabolism of C-14-iproniazid and C-14-isocarboxazid in man</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=14034092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaF3sXhs1KqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1962&pages=11-20&author=B.+A.+Koechlinauthor=M.+A.+Schwartzauthor=W.+E.+Oberhaensli&title=Metabolism+of+C-14-iproniazid+and+C-14-isocarboxazid+in+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of C14-iproniazid and C14-isocarboxazid in man</span></div><div class="casAuthors">Koechlin, , Bernard A.; Schwartz, , Morton A.; Oberhaensli, Wilhelm E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1962</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-20</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">cf. CA 56, 10846e.  The metabolic fate of iproniazid (I), labeled in the iso-Pr group, and isocarboxazid (II), labeled in the benzyl group, was investigated in humans and compared with results previously obtained in rats.  Both drugs were rapidly absorbed after ingestion.  I was metabolized by oxidn. of the labeled iso-Pr substituent with elimination of 50-60% of the radioactivity as pulmonary CO2 within 24 hrs.  The oxidn. rates differed markedly with the individual subjects as did the patterns of the radioactive urinary excretion products.  II was metabolized in an analogous manner by oxidn. of the labeled benzyl moiety to C14-benzoic acid which was excreted as urinary hippurate and accounted for 56% of the dose in 24 hrs.  The pathways of oxidative degradation of both drugs was the same in man and rat but with differences in the rates of degradation.  In both species II seemed to be oxidized faster than I, and both I and II were oxidized faster in rats than in man</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrozI3SD1fXQbVg90H21EOLACvtfcHk0lich_7iPCkxbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3sXhs1KqtA%253D%253D&md5=a3688b760222f1fb01e1e826f8ed258b</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoechlin%26aufirst%3DB.%2BA.%26aulast%3DSchwartz%26aufirst%3DM.%2BA.%26aulast%3DOberhaensli%26aufirst%3DW.%2BE.%26atitle%3DMetabolism%2520of%2520C-14-iproniazid%2520and%2520C-14-isocarboxazid%2520in%2520man%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1962%26volume%3D138%26spage%3D11%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group">Shimada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, H.</span><span> </span><span class="NLM_article-title">Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans</span> <span class="citation_source-journal">Arch. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1007%2Fs002040050403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=9195021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK2sXjsVCnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1997&pages=401-408&author=T.+Shimadaauthor=M.+Mimuraauthor=K.+Inoueauthor=S.+Nakamuraauthor=H.+Odaauthor=S.+Ohmoriauthor=H.+Yamazaki&title=Cytochrome+P450-dependent+drug+oxidation+activities+in+liver+microsomes+of+various+animal+species+including+rats%2C+guinea+pigs%2C+dogs%2C+monkeys%2C+and+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans</span></div><div class="casAuthors">Shimada, Tsutomu; Mimura, Mayumi; Inoue, Kiyoshi; Nakamura, Seiichi; Oda, Hajime; Ohmori, Shigeru; Yamazaki, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-408</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Levels of cytochrome P 450 (P 450 or CYP) proteins immunoreactive to antibodies raised against human CYP1A2, 2A6, 2C9, 2E1, and 3A4, monkey CYP2B17, and rat CYP2D1 were detd. in liver microsomes of rats, guinea pigs, dogs, monkeys, and humans.  Several drug oxidn. activities were also examd. catalyzed by liver microsomes of these animal species using eleven P 450 substrates such as phenacetin, coumarin, pentoxyresorufin, phenytoin, S-mephenytoin, bufuralol, aniline, benzphetamine, ethylmorphine, erythromycin, and nifedipine; the activities were compared with the levels of individual P 450 enzymes.  Monkey liver P 450 proteins had relatively similar immunochem. properties by immunoblotting anal. to the human enzymes, which belong to the same P 450 gene families.  Mean catalytic activities (on basis of mg microsomal protein) of P 450-dependent drug oxidns. with eleven substrates were higher in liver microsomes of monkeys than of humans, except that humans showed much higher activities for aniline p-hydroxylation than those catalyzed by monkeys.  When the catalytic activities of liver microsomes of monkeys and humans were compared on the basis of nmol of P 450, both species gave relatively similar rates towards the oxidn. of phenacetin, coumarin, pentoxyresorufin, phenytoin, mephenytoin, benzphetamine, ethylmorphine, erythromycin, and nifedipine, while the aniline p-hydroxylation was higher and bufuralol 1°-hydroxylation was lower in humans than monkeys.  The immunochem. properties of P 450 proteins and the activities of P 450-dependent drug oxidn. reactions in dogs, guinea pigs, and rats were somewhat different from those of monkeys and humans; the differences in these animal species varied with the P 450 enzymes examd. and the substrates used.  The results provide useful information towards species-related differences in susceptibilities of various animal species regarding actions and toxicities of drugs and xenobiotic chems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfEheVlvaHFLVg90H21EOLACvtfcHk0lich_7iPCkxbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsVCnsr0%253D&md5=0837537dd86ce2c75a5f22971366697a</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1007%2Fs002040050403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002040050403%26sid%3Dliteratum%253Aachs%26aulast%3DShimada%26aufirst%3DT.%26aulast%3DMimura%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DOda%26aufirst%3DH.%26aulast%3DOhmori%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DH.%26atitle%3DCytochrome%2520P450-dependent%2520drug%2520oxidation%2520activities%2520in%2520liver%2520microsomes%2520of%2520various%2520animal%2520species%2520including%2520rats%252C%2520guinea%2520pigs%252C%2520dogs%252C%2520monkeys%252C%2520and%2520humans%26jtitle%3DArch.%2520Toxicol.%26date%3D1997%26volume%3D71%26spage%3D401%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span> </span><span class="NLM_article-title">Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1471</span><span class="NLM_x">–</span> <span class="NLM_lpage">1484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2FS0024-3205%2801%2901232-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=11554609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtFantrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=1471-1484&author=W.+E.+Klunkauthor=Y.+Wangauthor=G.+F.+Huangauthor=M.+L.+Debnathauthor=D.+P.+Holtauthor=C.+A.+Mathis&title=Uncharged+thioflavin-T+derivatives+bind+to+amyloid-beta+protein+with+high+affinity+and+readily+enter+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain</span></div><div class="casAuthors">Klunk, William E.; Wang, Yanming; Huang, Guo-Feng; Debnath, Manik L.; Holt, Daniel P.; Mathis, Chester A.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1471-1484</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">In vivo assessment of the beta-sheet proteins deposited in amyloid plaques (Aβ peptide) or neurofibrillary tangles (tau protein) presents a target for the development of biol. markers for Alzheimer's disease (AD).  In an effort to develop in vivo beta-sheet imaging probes, derivs. of thioflavin-T (ThT) were synthesized and evaluated.  These compds. lack the pos. charged quaternary heterocyclic nitrogen of ThT and are therefore uncharged at physiol. pH.  They are 600-fold more lipophilic than ThT.  These ThT derivs. bind to Aβ(1-40) fibrils with higher affinity (Ki = 20.2 nM) than ThT (Ki = 890 nM).  The uncharged ThT derivs. stained both plaques and neurofibrillary tangles in post-mortem AD brain, showing some preference for plaque staining.  A carbon-11 labeled compd., [N-methyl-11C]6-Me-BTA-1, was prepd., and its brain entry and clearance were studied in Swiss-Webster mice.  This compd. entered the brain at levels comparable to commonly used neuroreceptor imaging agents (0.223% ID-kg/g or 7.61% ID/g at 2 min post-injection) and showed good clearance of free and non-specifically bound radioactivity in normal rodent brain tissue (brain clearance t1/2 = 20 min).  The combination of relatively high affinity for amyloid, specificity for staining plaques and neurofibrillary tangles in post-mortem AD brain, and good brain entry and clearance makes [N-methyl-11C]6-Me-BTA-1 a promising candidate as an in vivo positron emission tomog. (PET) beta-sheet imaging agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5mxuurQ9YN7Vg90H21EOLACvtfcHk0lich_7iPCkxbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtFantrc%253D&md5=13015aac9a380b4827c8bd205a4846ec</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1016%2FS0024-3205%2801%2901232-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0024-3205%252801%252901232-2%26sid%3Dliteratum%253Aachs%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DG.%2BF.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26atitle%3DUncharged%2520thioflavin-T%2520derivatives%2520bind%2520to%2520amyloid-beta%2520protein%2520with%2520high%2520affinity%2520and%2520readily%2520enter%2520the%2520brain%26jtitle%3DLife%2520Sci.%26date%3D2001%26volume%3D69%26spage%3D1471%26epage%3D1484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group">Necula, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirita, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuret, J.</span><span> </span><span class="NLM_article-title">Cyanine dye N744 inhibits tau fibrillization by blocking filament extension: implications for the treatment of tauopathic neurodegenerative diseases</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">10227</span><span class="NLM_x">–</span> <span class="NLM_lpage">10237</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi050387o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=10227-10237&author=M.+Neculaauthor=C.+N.+Chiritaauthor=J.+Kuret&title=Cyanine+dye+N744+inhibits+tau+fibrillization+by+blocking+filament+extension%3A+implications+for+the+treatment+of+tauopathic+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1021%2Fbi050387o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi050387o%26sid%3Dliteratum%253Aachs%26aulast%3DNecula%26aufirst%3DM.%26aulast%3DChirita%26aufirst%3DC.%2BN.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DCyanine%2520dye%2520N744%2520inhibits%2520tau%2520fibrillization%2520by%2520blocking%2520filament%2520extension%253A%2520implications%2520for%2520the%2520treatment%2520of%2520tauopathic%2520neurodegenerative%2520diseases%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D10227%26epage%3D10237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikonomovic, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefterov, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koldamova, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamson, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span> </span><span class="NLM_article-title">Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer’s disease brain but not in transgenic mouse brain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">10598</span><span class="NLM_x">–</span> <span class="NLM_lpage">10606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1523%2FJNEUROSCI.2990-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16291932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Kqsb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10598-10606&author=W.+E.+Klunkauthor=B.+J.+Loprestiauthor=M.+D.+Ikonomovicauthor=I.+M.+Lefterovauthor=R.+P.+Koldamovaauthor=E.+E.+Abrahamsonauthor=M.+L.+Debnathauthor=D.+P.+Holtauthor=G.+F.+Huangauthor=L.+Shaoauthor=S.+T.+DeKoskyauthor=J.+C.+Priceauthor=C.+A.+Mathis&title=Binding+of+the+positron+emission+tomography+tracer+Pittsburgh+compound-B+reflects+the+amount+of+amyloid-beta+in+Alzheimer%E2%80%99s+disease+brain+but+not+in+transgenic+mouse+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of the positron emission tomography tracer pittsburgh compound-B reflects the amount of amyloid-β in Alzheimer's disease brain but not in transgenic mouse brain</span></div><div class="casAuthors">Klunk, William E.; Lopresti, Brian J.; Ikonomovic, Milos D.; Lefterov, Iliya M.; Koldamova, Radosveta P.; Abrahamson, Eric E.; Debnath, Manik L.; Holt, Daniel P.; Huang, Guo-feng; Shao, Li; DeKosky, Steven T.; Price, Julie C.; Mathis, Chester A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">10598-10606</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">During the development of in vivo amyloid imaging agents, an effort was made to use micro-positron emission tomog. (PET) imaging in the presenilin-1 (PS1)/amyloid precursor protein (APP) transgenic mouse model of CNS amyloid deposition to screen new compds. and further study Pittsburgh Compd.-B (PIB), a PET tracer that has been shown to be retained well in amyloid-contg. areas of Alzheimer's disease (AD) brain.  Unexpectedly, we saw no significant retention of PIB in this model even at 12 mo of age when amyloid deposition in the PS1/APP mouse typically exceeds that seen in AD.  This study describes a series of ex vivo and postmortem in vitro studies designed to explain this low retention.  Ex vivo brain pharmacokinetic studies confirmed the low in vivo PIB retention obsd. in micro-PET expts.  In vitro binding studies showed that PS1/APP brain tissue contained less than one high-affinity (Kd = 1-2 nM) PIB binding site per 1000 mols. of amyloid-β (Aβ), whereas AD brain contained >500 PIB binding sites per 1000 mols. of Aβ.  Synthetic Aβ closely resembled PS1/APP brain in having less than one high-affinity PIB binding site per 1000 mols. of Aβ, although the characteristics of the few high-affinity PIB binding sites found on synthetic Aβ were very similar to those found in AD brain.  We hypothesize that differences in the time course of deposition or tissue factors present during deposition lead to differences in secondary structure between Aβ deposited in AD brain and either synthetic Aβ or Aβ deposited in PS1/APP brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwwhX6rXFA5LVg90H21EOLACvtfcHk0ljOIreTODTsmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Kqsb%252FP&md5=55732aca5ee5b47d4ce985edf014c6a9</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2990-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2990-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DIkonomovic%26aufirst%3DM.%2BD.%26aulast%3DLefterov%26aufirst%3DI.%2BM.%26aulast%3DKoldamova%26aufirst%3DR.%2BP.%26aulast%3DAbrahamson%26aufirst%3DE.%2BE.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DHuang%26aufirst%3DG.%2BF.%26aulast%3DShao%26aufirst%3DL.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DPrice%26aufirst%3DJ.%2BC.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26atitle%3DBinding%2520of%2520the%2520positron%2520emission%2520tomography%2520tracer%2520Pittsburgh%2520compound-B%2520reflects%2520the%2520amount%2520of%2520amyloid-beta%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain%2520but%2520not%2520in%2520transgenic%2520mouse%2520brain%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D10598%26epage%3D10606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacskai, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajdasz, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLellan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frosch, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2FS0960-894X%2801%2900734-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=11814781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslKmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=295-298&author=C.+A.+Mathisauthor=B.+J.+Bacskaiauthor=S.+T.+Kajdaszauthor=M.+E.+McLellanauthor=M.+P.+Froschauthor=B.+T.+Hymanauthor=D.+P.+Holtauthor=Y.+Wangauthor=G.+F.+Huangauthor=M.+L.+Debnathauthor=W.+E.+Klunk&title=A+lipophilic+thioflavin-T+derivative+for+positron+emission+tomography+%28PET%29+imaging+of+amyloid+in+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain</span></div><div class="casAuthors">Mathis, Chester A.; Bacskai, Brian J.; Kajdasz, Stephen T.; McLellan, Megan E.; Frosch, Matthew P.; Hyman, Bradley T.; Holt, Daniel P.; Wang, Yanming; Huang, Guo-Feng; Debnath, Manik L.; Klunk, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">295-298</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The synthesis of a new lipophilic thioflavin-T analog, 2-[4-(methylamino)phenyl]benzothiazole (I), with high affinity for amyloid is reported.  I.v. injection of [11C]-labeled I into control mice resulted in high brain uptake.  Amyloid deposits were imaged with multiphoton microscopy in the brains of living transgenic mice following the systemic injection of unlabeled I.  [11C]-I is a promising amyloid imaging agent for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsNt35PExWgrVg90H21EOLACvtfcHk0ljOIreTODTsmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslKmtQ%253D%253D&md5=c761b7a60b9ec39bdf615c28983a89e0</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900734-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900734-X%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DBacskai%26aufirst%3DB.%2BJ.%26aulast%3DKajdasz%26aufirst%3DS.%2BT.%26aulast%3DMcLellan%26aufirst%3DM.%2BE.%26aulast%3DFrosch%26aufirst%3DM.%2BP.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DG.%2BF.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DA%2520lipophilic%2520thioflavin-T%2520derivative%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%2520of%2520amyloid%2520in%2520brain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D295%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Impact of amyloid imaging on drug development in Alzheimer’s disease</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">822</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.nucmedbio.2007.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17921032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFeiu7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=809-822&author=C.+A.+Mathisauthor=B.+J.+Loprestiauthor=W.+E.+Klunk&title=Impact+of+amyloid+imaging+on+drug+development+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of amyloid imaging on drug development in Alzheimer's disease</span></div><div class="casAuthors">Mathis, Chester A.; Lopresti, Brian J.; Klunk, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">809-822</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Imaging agents capable of assessing amyloid-beta (Aβ) content in vivo in the brains of Alzheimer's disease (AD) subjects likely will be important as diagnostic agents to detect Aβ plaques in the brain as well as to help test the amyloid cascade hypothesis of AD and as an aid to assess the efficacy of anti-amyloid therapeutics currently under development and in clin. trials.  Positron emission tomog. (PET) imaging studies of amyloid deposition in human subjects with several Aβ imaging agents are currently underway.  We reported the first PET studies of the carbon 11-labeled thioflavin-T deriv. Pittsburgh Compd. B in 2004, and this work has subsequently been extended to include a variety of subject groups, including AD patients, mild cognitive impairment patients and healthy controls.  The ability to quantify regional Aβ plaque load in the brains of living human subjects has provided a means to begin to apply this technol. as a diagnostic agent to detect regional concns. of Aβ plaques and as a surrogate marker of therapeutic efficacy in anti-amyloid drug trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCxDzRikl-aLVg90H21EOLACvtfcHk0ljOIreTODTsmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFeiu7%252FM&md5=48130f4a7b66e7fc0ffa34a8460b5749</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2007.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2007.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DImpact%2520of%2520amyloid%2520imaging%2520on%2520drug%2520development%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2007%26volume%3D34%26spage%3D809%26epage%3D822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group">Ikonomovic, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamson, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsopelas, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziolko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paljug, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hope, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isanski, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S. T.</span><span> </span><span class="NLM_article-title">Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1645</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2008&pages=1630-1645&author=M.+D.+Ikonomovicauthor=W.+E.+Klunkauthor=E.+E.+Abrahamsonauthor=C.+A.+Mathisauthor=J.+C.+Priceauthor=N.+D.+Tsopelasauthor=B.+J.+Loprestiauthor=S.+Ziolkoauthor=W.+Biauthor=W.+R.+Paljugauthor=M.+L.+Debnathauthor=C.+E.+Hopeauthor=B.+A.+Isanskiauthor=R.+L.+Hamiltonauthor=S.+T.+DeKosky&title=Post-mortem+correlates+of+in+vivo+PiB-PET+amyloid+imaging+in+a+typical+case+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIkonomovic%26aufirst%3DM.%2BD.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DAbrahamson%26aufirst%3DE.%2BE.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DPrice%26aufirst%3DJ.%2BC.%26aulast%3DTsopelas%26aufirst%3DN.%2BD.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DZiolko%26aufirst%3DS.%26aulast%3DBi%26aufirst%3DW.%26aulast%3DPaljug%26aufirst%3DW.%2BR.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DHope%26aufirst%3DC.%2BE.%26aulast%3DIsanski%26aufirst%3DB.%2BA.%26aulast%3DHamilton%26aufirst%3DR.%2BL.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26atitle%3DPost-mortem%2520correlates%2520of%2520in%2520vivo%2520PiB-PET%2520amyloid%2520imaging%2520in%2520a%2520typical%2520case%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2008%26volume%3D131%26spage%3D1630%26epage%3D1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group">Chang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congdon, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honson, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duff, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuret, J.</span><span> </span><span class="NLM_article-title">Structure–activity relationship of cyanine tau aggregation inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3539</span><span class="NLM_x">–</span> <span class="NLM_lpage">3547</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900116d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3539-3547&author=E.+Changauthor=E.+E.+Congdonauthor=N.+S.+Honsonauthor=K.+E.+Duffauthor=J.+Kuret&title=Structure%E2%80%93activity+relationship+of+cyanine+tau+aggregation+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Fjm900116d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900116d%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DE.%26aulast%3DCongdon%26aufirst%3DE.%2BE.%26aulast%3DHonson%26aufirst%3DN.%2BS.%26aulast%3DDuff%26aufirst%3DK.%2BE.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520of%2520cyanine%2520tau%2520aggregation%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3539%26epage%3D3547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group">Schafer, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murale, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cisek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuret, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, D. G.</span><span> </span><span class="NLM_article-title">Structure–activity relationship of cyclic thiacarbocyanine tau aggregation inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3273</span><span class="NLM_x">–</span> <span class="NLM_lpage">3276</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3273-3276&author=K.+N.+Schaferauthor=D.+P.+Muraleauthor=K.+Kimauthor=K.+Cisekauthor=J.+Kuretauthor=D.+G.+Churchill&title=Structure%E2%80%93activity+relationship+of+cyclic+thiacarbocyanine+tau+aggregation+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchafer%26aufirst%3DK.%2BN.%26aulast%3DMurale%26aufirst%3DD.%2BP.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DCisek%26aufirst%3DK.%26aulast%3DKuret%26aufirst%3DJ.%26aulast%3DChurchill%26aufirst%3DD.%2BG.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520of%2520cyclic%2520thiacarbocyanine%2520tau%2520aggregation%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3273%26epage%3D3276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group">van Kan, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groeneveld, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalmijn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spieksma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Berg, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guchelaar, H. J.</span><span> </span><span class="NLM_article-title">Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1365-2125.2004.02233.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15752377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtVOgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2005&pages=310-313&author=H.+J.+van+Kanauthor=G.+J.+Groeneveldauthor=S.+Kalmijnauthor=M.+Spieksmaauthor=L.+H.+van+den+Bergauthor=H.+J.+Guchelaar&title=Association+between+CYP1A2+activity+and+riluzole+clearance+in+patients+with+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis</span></div><div class="casAuthors">van Kan, H. J. M.; Groeneveld, G. J.; Kalmijn, S.; Spieksma, M.; van den Berg, L. H.; Guchelaar, H. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">310-313</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Riluzole is used in a fixed dosing schedule of 50 mg twice daily to treat patients with amyotropic lateral sclerosis (ALS), one form of motor neuron disease.  The large variability in the pharmacokinetics of riluzole may be a factor contributing to its limited therapeutic benefit.  Riluzole is assumed to be mainly metabolized by the cytochrome P 450 enzyme 1A2 (CYP1A2).  The aim of the study was to investigate the relationship between CYP1A2 activity and riluzole clearance with a view to optimize drug treatment.  A group of 30 ALS patients participated in the study.  In each patient the CYP1A2 activity was detd. using caffeine as a metabolic probe.  Riluzole clearance was estd. from serum drug concn. measurements followed by Bayesian fitting.  Riluzole clearance and the serum paraxanthine : caffeine (P/C) ratio showed a pos. correlation (r=0.693; P=0.0002).  Linear regression anal. identified the P/C ratio (beta: 1.16) and height (beta: 0.027) as independent predictors of riluzole clearance (adjusted r2 = 0.369).  The P/C ratio, used as measure of CYP1A2 activity, significantly correlated with the riluzole clearance, although only 37% of the obsd. variability could be explained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlVb82AN0ZuLVg90H21EOLACvtfcHk0lijTSNo7aV4Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtVOgu7c%253D&md5=7f565cd36addbad20483911f2b18a644</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2004.02233.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2004.02233.x%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BKan%26aufirst%3DH.%2BJ.%26aulast%3DGroeneveld%26aufirst%3DG.%2BJ.%26aulast%3DKalmijn%26aufirst%3DS.%26aulast%3DSpieksma%26aufirst%3DM.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DL.%2BH.%26aulast%3DGuchelaar%26aufirst%3DH.%2BJ.%26atitle%3DAssociation%2520between%2520CYP1A2%2520activity%2520and%2520riluzole%2520clearance%2520in%2520patients%2520with%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2005%26volume%3D59%26spage%3D310%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group">Milane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vautier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensimon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meininger, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farinotti, R.</span><span> </span><span class="NLM_article-title">Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood–brain barrier</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17635670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2qu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2007&pages=164-173&author=A.+Milaneauthor=C.+Fernandezauthor=S.+Vautierauthor=G.+Bensimonauthor=V.+Meiningerauthor=R.+Farinotti&title=Minocycline+and+riluzole+brain+disposition%3A+interactions+with+p-glycoprotein+at+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier</span></div><div class="casAuthors">Milane, Aline; Fernandez, Christine; Vautier, Sarah; Bensimon, Gilbert; Meininger, Vincent; Farinotti, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">164-173</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis is a neurodegenerative fatal disease.  The only drug recognized to increase the survival time is riluzole (RLZ).  In animal models, minocycline (MNC) delayed the onset of the disease and increased the survival time (in combination with RLZ).  The objective of our work was to study the interactions between RLZ, MNC and the efflux pump p-glycoprotein (p-gp) at the blood-brain barrier.  We investigated these two drugs as:.  (i) p-gp substrates by comparing their brain uptake in CF1 mdr1a (-/-) and mdr1a (+/+) mice,.  (ii) p-gp modulators by studying their effect on the cerebral uptake of digoxin.  Mdr1a (-/-) mice showed higher brain uptake of MNC and RLZ than mdr1a (+/+) (in a 1.6- and 1.4-fold, resp.); and in mdr1a (+/+) mice pre-treated with repeated doses of MNC, brain uptake of digoxin was increased.  When both drugs were administered to mdr1a (+/+) mice, MNC increased the brain uptake of RLZ in a 2.1-fold.  In conclusion, MNC and RLZ are both p-gp substrates.  MNC is also a p-gp inhibitor and increases the brain diffusion of RLZ.  In vitro expts. with the GPNT cell line confirmed these results.  These interactions should be taken into account in the design of future clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobRSJaLIIDDLVg90H21EOLACvtfcHk0lijTSNo7aV4Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2qu7bP&md5=7044004383a0848d24edbd65491a0dce</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMilane%26aufirst%3DA.%26aulast%3DFernandez%26aufirst%3DC.%26aulast%3DVautier%26aufirst%3DS.%26aulast%3DBensimon%26aufirst%3DG.%26aulast%3DMeininger%26aufirst%3DV.%26aulast%3DFarinotti%26aufirst%3DR.%26atitle%3DMinocycline%2520and%2520riluzole%2520brain%2520disposition%253A%2520interactions%2520with%2520p-glycoprotein%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D103%26spage%3D164%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group">Hilal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. A.</span><span> </span><span class="NLM_article-title">Cyanine dyes for the detection of double stranded DNA</span> <span class="citation_source-journal">J. Biochem. Biophys. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.jprot.2007.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18304645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVOgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2008&pages=1104-1108&author=H.+Hilalauthor=J.+A.+Taylor&title=Cyanine+dyes+for+the+detection+of+double+stranded+DNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Cyanine dyes for the detection of double stranded DNA</span></div><div class="casAuthors">Hilal, H.; Taylor, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemical and Biophysical Methods</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1104-1108</span>CODEN:
                <span class="NLM_cas:coden">JBBMDG</span>;
        ISSN:<span class="NLM_cas:issn">0165-022X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Twenty three novel cyanine dyes have been applied as fluorescent stains for the detection of nucleic acids in agarose gel electrophoresis.  Significant fluorescence enhancement of these dyes in the presence of double stranded DNA was obsd.  Five dyes offered superior sensitivity in the detection and quantification of DNA, over Ethidium Bromide, the most commonly used nucleic acid stain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVc0Yp_0rdurVg90H21EOLACvtfcHk0lhGgkt9WSigOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVOgtro%253D&md5=ae0e889fca1568962bb2020ae0f8b18d</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2Fj.jprot.2007.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jprot.2007.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DHilal%26aufirst%3DH.%26aulast%3DTaylor%26aufirst%3DJ.%2BA.%26atitle%3DCyanine%2520dyes%2520for%2520the%2520detection%2520of%2520double%2520stranded%2520DNA%26jtitle%3DJ.%2520Biochem.%2520Biophys.%2520Methods%26date%3D2008%26volume%3D70%26spage%3D1104%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group">Clifton, J.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leikin, J. B.</span><span> </span><span class="NLM_article-title">Methylene blue</span> <span class="citation_source-journal">Am. J. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1097%2F00045391-200307000-00009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=12845393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BD3szhsFeqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=289-291&author=J.+Cliftonauthor=J.+B.+Leikin&title=Methylene+blue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Methylene blue</span></div><div class="casAuthors">Clifton Jack 2nd; Leikin Jerrold B</div><div class="citationInfo"><span class="NLM_cas:title">American journal of therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">289-91</span>
        ISSN:<span class="NLM_cas:issn">1075-2765</span>.
    </div><div class="casAbstract">Methylene blue finds its major utilization in toxicology in the treatment of methemoglobinemia at a dose of 1 to 2 mg/kg intravenously.  By interacting with methemoglobin and the erythrocyte's enzyme systems to reduce back to hemoglobin, methylene blue is a generally safe drug with dose-related hemolytic effects.  People with G-6-PD deficiency, along with patients exposed to aniline dyes and dapsone, may present with special risks in the treatment of methemoglobinemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTsV_YxfWgvkny-c-E1v-fmfW6udTcc2ea_Ll8PpRCWf7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szhsFeqtA%253D%253D&md5=d1a99d86f55a591ec32273ef6b7dafb2</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1097%2F00045391-200307000-00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00045391-200307000-00009%26sid%3Dliteratum%253Aachs%26aulast%3DClifton%26aufirst%3DJ.%26aulast%3DLeikin%26aufirst%3DJ.%2BB.%26atitle%3DMethylene%2520blue%26jtitle%3DAm.%2520J.%2520Ther.%26date%3D2003%26volume%3D10%26spage%3D289%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group">Johnson, I. D.</span><span> </span><span class="NLM_article-title">Cellular Function Probes</span>. In  <span class="citation_source-book">Current Protocols in Cytometry</span>; <span class="NLM_publisher-name">Wiley Online Library</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">; </span>Chapter 4, Unit 4 4.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=I.+D.+Johnson&title=Current+Protocols+in+Cytometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DI.%2BD.%26atitle%3DCellular%2520Function%2520Probes%26btitle%3DCurrent%2520Protocols%2520in%2520Cytometry%26pub%3DWiley%2520Online%2520Library%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group">Hassan, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridovich, I.</span><span> </span><span class="NLM_article-title">Intracellular production of superoxide radical and of hydrogen peroxide by redox active compounds</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=1979&pages=385-395&author=H.+M.+Hassanauthor=I.+Fridovich&title=Intracellular+production+of+superoxide+radical+and+of+hydrogen+peroxide+by+redox+active+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHassan%26aufirst%3DH.%2BM.%26aulast%3DFridovich%26aufirst%3DI.%26atitle%3DIntracellular%2520production%2520of%2520superoxide%2520radical%2520and%2520of%2520hydrogen%2520peroxide%2520by%2520redox%2520active%2520compounds%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1979%26volume%3D196%26spage%3D385%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group">Zigman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilman, P.,  Jr.</span><span> </span><span class="NLM_article-title">Inhibition of cell division and growth by a redox series of cyanine dyes</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">208</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=208&publication_year=1980&pages=188-191&author=S.+Zigmanauthor=P.+Gilman&title=Inhibition+of+cell+division+and+growth+by+a+redox+series+of+cyanine+dyes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZigman%26aufirst%3DS.%26aulast%3DGilman%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520cell%2520division%2520and%2520growth%2520by%2520a%2520redox%2520series%2520of%2520cyanine%2520dyes%26jtitle%3DScience%26date%3D1980%26volume%3D208%26spage%3D188%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd.</span><span> </span><span class="NLM_article-title">Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3739</span><span class="NLM_x">–</span> <span class="NLM_lpage">3747</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100138f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3739-3747&author=C.+Ballatoreauthor=K.+R.+Brundenauthor=F.+Piscitelliauthor=M.+J.+Jamesauthor=A.+Croweauthor=Y.+Yaoauthor=E.+Hydeauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=A.+B.+Smith&title=Discovery+of+brain-penetrant%2C+orally+bioavailable+aminothienopyridazine+inhibitors+of+tau+aggregation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1021%2Fjm100138f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100138f%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DPiscitelli%26aufirst%3DF.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DHyde%26aufirst%3DE.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DDiscovery%2520of%2520brain-penetrant%252C%2520orally%2520bioavailable%2520aminothienopyridazine%2520inhibitors%2520of%2520tau%2520aggregation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3739%26epage%3D3747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossidivito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd.</span><span> </span><span class="NLM_article-title">Aminothienopyridazine inhibitors of tau aggregation: evaluation of structure–activity relationship leads to selection of candidates with desirable in vivo properties</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4451</span><span class="NLM_x">–</span> <span class="NLM_lpage">4461</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=4451-4461&author=C.+Ballatoreauthor=A.+Croweauthor=F.+Piscitelliauthor=M.+Jamesauthor=K.+Louauthor=G.+Rossidivitoauthor=Y.+Yaoauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=K.+R.+Brundenauthor=A.+B.+Smith&title=Aminothienopyridazine+inhibitors+of+tau+aggregation%3A+evaluation+of+structure%E2%80%93activity+relationship+leads+to+selection+of+candidates+with+desirable+in+vivo+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DPiscitelli%26aufirst%3DF.%26aulast%3DJames%26aufirst%3DM.%26aulast%3DLou%26aufirst%3DK.%26aulast%3DRossidivito%26aufirst%3DG.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DAminothienopyridazine%2520inhibitors%2520of%2520tau%2520aggregation%253A%2520evaluation%2520of%2520structure%25E2%2580%2593activity%2520relationship%2520leads%2520to%2520selection%2520of%2520candidates%2520with%2520desirable%2520in%2520vivo%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D4451%26epage%3D4461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group">Buchwald, P.</span><span> </span><span class="NLM_article-title">Small-molecule protein–protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations</span> <span class="citation_source-journal">IUBMB Life</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">724</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=724-731&author=P.+Buchwald&title=Small-molecule+protein%E2%80%93protein+interaction+inhibitors%3A+therapeutic+potential+in+light+of+molecular+size%2C+chemical+space%2C+and+ligand+binding+efficiency+considerations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuchwald%26aufirst%3DP.%26atitle%3DSmall-molecule%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitors%253A%2520therapeutic%2520potential%2520in%2520light%2520of%2520molecular%2520size%252C%2520chemical%2520space%252C%2520and%2520ligand%2520binding%2520efficiency%2520considerations%26jtitle%3DIUBMB%2520Life%26date%3D2010%26volume%3D62%26spage%3D724%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group">Arkin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. A.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of protein–protein interactions: progressing towards the dream</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=301-317&author=M.+R.+Arkinauthor=J.+A.+Wells&title=Small-molecule+inhibitors+of+protein%E2%80%93protein+interactions%3A+progressing+towards+the+dream"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520protein%25E2%2580%2593protein%2520interactions%253A%2520progressing%2520towards%2520the%2520dream%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D301%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group">Thiel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottmann, C.</span><span> </span><span class="NLM_article-title">Small-molecule stabilization of protein–protein interactions: an underestimated concept in drug discovery?</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2012</span><span class="NLM_x">–</span> <span class="NLM_lpage">2018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=2012-2018&author=P.+Thielauthor=M.+Kaiserauthor=C.+Ottmann&title=Small-molecule+stabilization+of+protein%E2%80%93protein+interactions%3A+an+underestimated+concept+in+drug+discovery%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThiel%26aufirst%3DP.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DOttmann%26aufirst%3DC.%26atitle%3DSmall-molecule%2520stabilization%2520of%2520protein%25E2%2580%2593protein%2520interactions%253A%2520an%2520underestimated%2520concept%2520in%2520drug%2520discovery%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D2012%26epage%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shively, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald-Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toleikis, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.0406361102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15615853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtlemtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=227-231&author=B.+Zhangauthor=A.+Maitiauthor=S.+Shivelyauthor=F.+Lakhaniauthor=G.+McDonald-Jonesauthor=J.+Bruceauthor=E.+B.+Leeauthor=S.+X.+Xieauthor=S.+Joyceauthor=C.+Liauthor=P.+M.+Toleikisauthor=V.+M.+Leeauthor=J.+Q.+Trojanowski&title=Microtubule-binding+drugs+offset+tau+sequestration+by+stabilizing+microtubules+and+reversing+fast+axonal+transport+deficits+in+a+tauopathy+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model</span></div><div class="casAuthors">Zhang, Bin; Maiti, Arpita; Shively, Sharon; Lakhani, Fara; McDonald-Jones, Gaye; Bruce, Jennifer; Lee, Edward B.; Xie, Sharon X.; Joyce, Sonali; Li, Chi; Toleikis, Philip M.; Lee, Virginia M.-Y.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">227-231</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We tested the hypothesis that microtubule (MT)-binding drugs could be therapeutically beneficial in tauopathies by functionally substituting for the MT-binding protein tau, which is sequestered into inclusions of human tauopathies and transgenic mouse models thereof.  Transgenic mice were treated for 12 wk with weekly i.p. injections of 10 or 25 mg/m2 paclitaxel (Paxceed).  Both doses restored fast axonal transport in spinal axons, wherein MT nos. and stable (detyrosinated) tubulins were increased, compared with sham treatment, and only Paxceed ameliorated motor impairments in tau transgenic mice.  Thus, MT-stabilizing drugs could have therapeutic potential for treating neurodegenerative tauopathies by offsetting losses of tau function that result from the sequestration of this MT-stabilizing protein into filamentous inclusions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Xfh_fgcZrLVg90H21EOLACvtfcHk0lhVjbgFFqGMjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtlemtA%253D%253D&md5=bf2746acbdcf115ac7fc9042232c9c36</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0406361102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0406361102%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DMaiti%26aufirst%3DA.%26aulast%3DShively%26aufirst%3DS.%26aulast%3DLakhani%26aufirst%3DF.%26aulast%3DMcDonald-Jones%26aufirst%3DG.%26aulast%3DBruce%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DE.%2BB.%26aulast%3DXie%26aufirst%3DS.%2BX.%26aulast%3DJoyce%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DToleikis%26aufirst%3DP.%2BM.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DMicrotubule-binding%2520drugs%2520offset%2520tau%2520sequestration%2520by%2520stabilizing%2520microtubules%2520and%2520reversing%2520fast%2520axonal%2520transport%2520deficits%2520in%2520a%2520tauopathy%2520model%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D227%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group">Lo Conte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chothia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janin, J.</span><span> </span><span class="NLM_article-title">The atomic structure of protein–protein recognition sites</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=2177-2198&author=L.+Lo+Conteauthor=C.+Chothiaauthor=J.+Janin&title=The+atomic+structure+of+protein%E2%80%93protein+recognition+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLo%2BConte%26aufirst%3DL.%26aulast%3DChothia%26aufirst%3DC.%26aulast%3DJanin%26aufirst%3DJ.%26atitle%3DThe%2520atomic%2520structure%2520of%2520protein%25E2%2580%2593protein%2520recognition%2520sites%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D285%26spage%3D2177%26epage%3D2198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group">LeVine, H.,  3rd.</span><span> </span><span class="NLM_article-title">Thioflavine T interaction with synthetic Alzheimer’s disease beta-amyloid peptides: detection of amyloid aggregation in solution</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">404</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1002%2Fpro.5560020312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=8453378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK3sXksVCntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1993&pages=404-410&author=H.+LeVine&title=Thioflavine+T+interaction+with+synthetic+Alzheimer%E2%80%99s+disease+beta-amyloid+peptides%3A+detection+of+amyloid+aggregation+in+solution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Thioflavin T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution</span></div><div class="casAuthors">LeVine, Harry, III</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">404-10</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    </div><div class="casAbstract">Thioflavine T (ThT) assocs. rapidly with aggregated fibrils of the synthetic β/A4-derived peptides β(1-28) and β(1-40), giving rise to a new excitation (ex) (absorption) max. at 450 nm and enhanced emission (em) at 482 nm, as opposed to the 385 nm (ex) and 445 nm (em) of the free dye.  This change is dependent on the aggregated state as monomeric or dimeric peptides do not react, and guanidine dissocn. of aggregates destroys the signal.  There was no effect of high salt concns.  Binding to the β(1-40) is of lower affinity, Kd 2 μM, while it sats. with a Kd of 0.54 μM for β(1-28).  Insulin fibrils converted to a β-sheet conformation fluoresce intensely with ThT.  A variety of polyhydroxy, polyanionic, or polycationic materials fail to interact or impede interaction with the amyloid peptides.  This fluorometric technique should allow the kinetic elucidation of the amyloid fibril assembly process as well as the testing of agents that might modulate their assembly or disassembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGqSauseHbKrVg90H21EOLACvtfcHk0lhVjbgFFqGMjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVCntLo%253D&md5=d4bfff1cedf68a3c9379a87d88c3f97a</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560020312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560020312%26sid%3Dliteratum%253Aachs%26aulast%3DLeVine%26aufirst%3DH.%26atitle%3DThioflavine%2520T%2520interaction%2520with%2520synthetic%2520Alzheimer%25E2%2580%2599s%2520disease%2520beta-amyloid%2520peptides%253A%2520detection%2520of%2520amyloid%2520aggregation%2520in%2520solution%26jtitle%3DProtein%2520Sci.%26date%3D1993%26volume%3D2%26spage%3D404%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettegrew, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, D. J.</span><span> </span><span class="NLM_article-title">Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1273</span><span class="NLM_x">–</span> <span class="NLM_lpage">1281</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1177%2F37.8.2666510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=2666510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaL1MXlt12ht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1989&pages=1273-1281&author=W.+E.+Klunkauthor=J.+W.+Pettegrewauthor=D.+J.+Abraham&title=Quantitative+evaluation+of+Congo+red+binding+to+amyloid-like+proteins+with+a+beta-pleated+sheet+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation</span></div><div class="casAuthors">Klunk, William E.; Pettegrew, Jay W.; Abraham, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1273-81</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    </div><div class="casAbstract">The binding of Congo Red to several purified amyloid-like peptides having a β-pleated sheet conformation was quant. examd.  Congo Red binds preferentially to the β-pleated sheet conformation of both insulin fibrils and poly-L-lysine.  Congo Red does not bind nearly so well to poly-L-serine or polyglycine, despite the fact that these peptides also have a β-pleated sheet conformation.  Binding to insulin fibrils was saturable with an apparent Bmax of 2 mol Congo Red/mol insulin fibrils and an apparent KD of 1.75 × 10-7M.  Binding to β-poly-L-lysine was similar but had a much higher apparent Bmax of 43.  Binding of Congo Red to β-poly-L-lysine was pH dependent and appeared to be detd. by the no. of protonated lysine residues in the 250 amino acid peptide.  A new hypothesis is presented in which Congo Red binds to amyloid-like proteins via bonds between the 2 neg. charged sulfonic acid groups of Congo Red and 2 pos. charged amino acid residues of 2 sep. protein mols. which are properly oriented by virtue of the β-pleated sheet conformation of the peptide backbone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqB2vRbQvcVLVg90H21EOLACvtfcHk0lh63_on_xv0yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlt12ht7k%253D&md5=dbf3a9182aa87171b7a13a0e1dd529fd</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1177%2F37.8.2666510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F37.8.2666510%26sid%3Dliteratum%253Aachs%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DPettegrew%26aufirst%3DJ.%2BW.%26aulast%3DAbraham%26aufirst%3DD.%2BJ.%26atitle%3DQuantitative%2520evaluation%2520of%2520Congo%2520red%2520binding%2520to%2520amyloid-like%2520proteins%2520with%2520a%2520beta-pleated%2520sheet%2520conformation%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D1989%26volume%3D37%26spage%3D1273%26epage%3D1281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group">Petric, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golobic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agdeppa, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timbol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keum, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyamurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houk, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span> </span><span class="NLM_article-title">Dicyanovinylnaphthalenes for neuroimaging of amyloids and relationships of electronic structures and geometries to binding affinities</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">16492</span><span class="NLM_x">–</span> <span class="NLM_lpage">16497</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.1214134109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=23012452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKltrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=16492-16497&author=A.+Petricauthor=S.+A.+Johnsonauthor=H.+V.+Phamauthor=Y.+Liauthor=S.+Cehauthor=A.+Golobicauthor=E.+D.+Agdeppaauthor=G.+Timbolauthor=J.+Liuauthor=G.+Keumauthor=N.+Satyamurthyauthor=V.+Kepeauthor=K.+N.+Houkauthor=J.+R.+Barrio&title=Dicyanovinylnaphthalenes+for+neuroimaging+of+amyloids+and+relationships+of+electronic+structures+and+geometries+to+binding+affinities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Dicyanovinylnaphthalenes for neuroimaging of amyloids and relationships of electronic structures and geometries to binding affinities</span></div><div class="casAuthors">Petric, Andrej; Johnson, Scott A.; Pham, Hung V.; Li, Ying; Ceh, Simon; Golobic, Amalija; Agdeppa, Eric D.; Timbol, Gerald; Liu, Jie; Keum, Gyochang; Satyamurthy, Nagichettiar; Kepe, Vladimir; Houk, Kendall N.; Barrio, Jorge R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">16492-16497, S16492/1-S16492/47</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The positron-emission tomog. (PET) probe 2-(1-[6-[(2-fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene) (FDDNP) is used for the noninvasive brain imaging of amyloid-β (Aβ) and other amyloid aggregates present in Alzheimer's disease and other neurodegenerative diseases.  A series of FDDNP analogs has been synthesized and characterized using spectroscopic and computational methods.  The binding affinities of these mols. have been measured exptl. and explained through the use of a computational model.  The analogs were created by systematically modifying the donor and the acceptor sides of FDDNP to learn the structural requirements for optimal binding to Aβ aggregates.  FDDNP and its analogs are neutral, environmentally sensitive, fluorescent mols. with high dipole moments, as evidenced by their spectroscopic properties and dipole moment calcns.  The preferred soln.-state conformation of these compds. is directly related to the binding affinities.  The extreme cases were a nonplanar analog t-butyl-FDDNP, which shows low binding affinity for Aβ aggregates (520 nM Ki) in vitro and a nearly planar tricyclic analog cDDNP, which displayed the highest binding affinity (10 pM Ki).  Using a previously published x-ray crystallog. model of 1,1-dicyano-2-[6-(dimethylamino)naphthalen-2-yl]propene (DDNP) bound to an amyloidogenic Aβ peptide model, the binding affinity is inversely related to the distortion energy necessary to avoid steric clashes along the internal surface of the binding channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPwwHtPvSJpbVg90H21EOLACvtfcHk0lh63_on_xv0yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKltrrK&md5=a2d4875f1ad3219e50d3c205c8fd5cfb</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1214134109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1214134109%26sid%3Dliteratum%253Aachs%26aulast%3DPetric%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DS.%2BA.%26aulast%3DPham%26aufirst%3DH.%2BV.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCeh%26aufirst%3DS.%26aulast%3DGolobic%26aufirst%3DA.%26aulast%3DAgdeppa%26aufirst%3DE.%2BD.%26aulast%3DTimbol%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DKeum%26aufirst%3DG.%26aulast%3DSatyamurthy%26aufirst%3DN.%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26atitle%3DDicyanovinylnaphthalenes%2520for%2520neuroimaging%2520of%2520amyloids%2520and%2520relationships%2520of%2520electronic%2520structures%2520and%2520geometries%2520to%2520binding%2520affinities%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D16492%26epage%3D16497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group">Reinke, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1747-0285.2007.00557.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17718715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVels7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=206-215&author=A.+A.+Reinkeauthor=J.+E.+Gestwicki&title=Structure%E2%80%93activity+relationships+of+amyloid+beta-aggregation+inhibitors+based+on+curcumin%3A+influence+of+linker+length+and+flexibility"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility</span></div><div class="casAuthors">Reinke, Ashley A.; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-215</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Self-assembly of amyloid beta into fibrillar plaques is characteristic of Alzheimer's disease, and oligomers of this peptide are believed to be involved in neurodegeneration.  Natural org. dyes, such as congo red and curcumin, bind tightly to amyloid beta and, at higher concns., block its self-assembly.  The ability of these mols. to prevent amyloid accumulation has generated interest in understanding which of their structural features contribute to inhibitory potency.  In general, amyloid beta ligands tend to be flat, planar mols. with substituted arom. end groups; however, a comprehensive structure-activity study has not been reported.  To better understand these ligands, the authors surveyed the effect of three prominent features on inhibition of amyloid aggregation: the presence of two arom. end groups, the substitution pattern of these aroms., and the length and flexibility of the linker region.  The authors found that modification of any one of the modules has profound effects on activity.  Further, the authors report that the optimal length of the linker lies within a surprisingly narrow regime (6-19 Å).  These results offer insight into the key chem. features required for inhibiting amyloid beta aggregation.  In turn, these findings help define the nature of the docking site for small mols. on the amyloid beta surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK9vZhehk5I7Vg90H21EOLACvtfcHk0lh63_on_xv0yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVels7rO&md5=9fb830c8d1dda285aa6d50c88a03ff27</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00557.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00557.x%26sid%3Dliteratum%253Aachs%26aulast%3DReinke%26aufirst%3DA.%2BA.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520amyloid%2520beta-aggregation%2520inhibitors%2520based%2520on%2520curcumin%253A%2520influence%2520of%2520linker%2520length%2520and%2520flexibility%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2007%26volume%3D70%26spage%3D206%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group">Wolfe, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaho, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranker, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span> </span><span class="NLM_article-title">Protein-induced photophysical changes to the amyloid indicator dye thioflavin T</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">16863</span><span class="NLM_x">–</span> <span class="NLM_lpage">16868</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.1002867107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20826442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1OlsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=16863-16868&author=L.+S.+Wolfeauthor=M.+F.+Calabreseauthor=A.+Nathauthor=D.+V.+Blahoauthor=A.+D.+Mirankerauthor=Y.+Xiong&title=Protein-induced+photophysical+changes+to+the+amyloid+indicator+dye+thioflavin+T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-induced photophysical changes to the amyloid indicator dye thioflavin T</span></div><div class="casAuthors">Wolfe, Leslie S.; Calabrese, Matthew F.; Nath, Abhinav; Blaho, Dorottya V.; Miranker, Andrew D.; Xiong, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">16863-16868, S16863/1-S16863/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The small mol. thioflavin T (ThT) is a defining probe for the identification and mechanistic study of amyloid fiber formation.  As such, ThT is fundamental to investigations of serious diseases such as Alzheimer's disease, Parkinson disease, and type II diabetes.  For each disease, a different protein undergoes conformational conversion to a β-sheet rich fiber.  The fluorescence of ThT exhibits an increase in quantum yield upon binding these fibers.  Despite its widespread use, the structural basis for binding specificity and for the changes to the photophys. properties of ThT remain poorly understood.  Here, we report the co-crystal structures of ThT with two alternative states of β-2 microglobulin (β2m); one monomeric, the other an amyloid-like oligomer.  In the latter, the dye intercalates between β-sheets orthogonal to the β-strands.  Importantly, the fluorophore is bound in such a manner that a photophys. relevant torsion is limited to a range of angles generally assocd. with low, not high, quantum yield.  Quantum mech. assessment of the fluorophore shows the electronic distribution to be strongly stabilized by arom. interactions with the protein.  Monomeric β2m gives little increase in ThT fluorescence despite showing three fluorophores, at two binding sites, in configurations generally assocd. with high quantum yield.  Our efforts fundamentally extend existing understanding about the origins of amyloid-induced photophys. changes.  Specifically, the β-sheet interface that characterizes amyloid acts both sterically and electronically to stabilize the fluorophore's ground state electronic distribution.  By preventing the fluorophore from adopting its preferred excited state configuration, nonradiative relaxation pathways are minimized and quantum yield is increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppmHF0DIrtwbVg90H21EOLACvtfcHk0lhufxfaGlQyog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1OlsLfJ&md5=cee6125bc69a3965da8db55138c002fa</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1002867107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1002867107%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DL.%2BS.%26aulast%3DCalabrese%26aufirst%3DM.%2BF.%26aulast%3DNath%26aufirst%3DA.%26aulast%3DBlaho%26aufirst%3DD.%2BV.%26aulast%3DMiranker%26aufirst%3DA.%2BD.%26aulast%3DXiong%26aufirst%3DY.%26atitle%3DProtein-induced%2520photophysical%2520changes%2520to%2520the%2520amyloid%2520indicator%2520dye%2520thioflavin%2520T%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D16863%26epage%3D16868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group">Krebs, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromley, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donald, A. M.</span><span> </span><span class="NLM_article-title">The binding of thioflavin-T to amyloid fibrils: localisation and implications</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.jsb.2004.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15629655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFGj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2005&pages=30-37&author=M.+R.+Krebsauthor=E.+H.+Bromleyauthor=A.+M.+Donald&title=The+binding+of+thioflavin-T+to+amyloid+fibrils%3A+localisation+and+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">The binding of thioflavin-T to amyloid fibrils: localisation and implications</span></div><div class="casAuthors">Krebs, M. R. H.; Bromley, E. H. C.; Donald, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Structural Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-37</span>CODEN:
                <span class="NLM_cas:coden">JSBIEM</span>;
        ISSN:<span class="NLM_cas:issn">1047-8477</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Amyloid fibrils are a polymeric form of protein, involving a continuous β-sheet with the strands perpendicular to the long axis of the fibril.  Although typically implicated in diseases such as Alzheimer's disease and the transmissible spongiform encephalopathies, non disease-assocd. protein can also be converted into amyloid fibrils.  Traditionally, amyloid fibrils are identified via the use of specific dyes such as Congo red and thioflavin-T, although their specificity is ill understood.  Recently, solns. of bovine insulin and bovine β-lactoglobulin have been found to form spherulites, micron-sized spherical structures contg. radially arranged amyloid fibrils.  When studied by confocal microscopy using polarized laser light and thioflavin-T, a consistent pattern of emission, rather than a uniform disk, was obsd.  This suggests the dye binds in a specific, regular fashion to amyloid fibrils.  Confocal microscopy studies of thioflavin-T aligned in stretched poly-vinyl alc. films showed that the dye dipole excitation axis lies parallel to the long mol. axis.  Therefore, thioflavin-T binds to amyloid fibrils such that their long axes are parallel.  We propose binding occurs in channels' that run along the length of the β-sheet.  Steric interactions between dye mols. and side chains indicate why thioflavin-T fluoresces more intensely when bound to amyloid fibrils and can explain why this interaction with amyloid fibrils is specific, but with varying efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqly9uW7UlHI7Vg90H21EOLACvtfcHk0lhufxfaGlQyog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFGj&md5=c3110e632f450a1e2287df4fbc014c3e</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1016%2Fj.jsb.2004.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsb.2004.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DKrebs%26aufirst%3DM.%2BR.%26aulast%3DBromley%26aufirst%3DE.%2BH.%26aulast%3DDonald%26aufirst%3DA.%2BM.%26atitle%3DThe%2520binding%2520of%2520thioflavin-T%2520to%2520amyloid%2520fibrils%253A%2520localisation%2520and%2520implications%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2005%26volume%3D149%26spage%3D30%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettegrew, J. W.</span><span> </span><span class="NLM_article-title">Development of small molecule probes for the beta-amyloid protein of Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2F0197-4580%2894%2990050-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=7891823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK2MXis1Crur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1994&pages=691-698&author=W.+E.+Klunkauthor=M.+L.+Debnathauthor=J.+W.+Pettegrew&title=Development+of+small+molecule+probes+for+the+beta-amyloid+protein+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Development of small molecule probes for the beta-amyloid protein of Alzheimer's disease</span></div><div class="casAuthors">Klunk, William E.; Debnath, Manik L.; Pettegrew, Jay W.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">691-8</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    </div><div class="casAbstract">This study describes the synthesis and in vitro testing of small mol. probes that may eventually prove useful as markers of amyloid deposition in living patients.  The prototype agent, Chrysamine G (CG), is a deriv. of Congo red.  CG binds synthetic beta-amyloid well in vitro, as does a fluorinated deriv.  The mechanism of binding appears to be the same as Congo red-through a bidentate attachment spanning several amyloid peptide chains.  CG is much more lipophilic than Congo red and crosses the blood-brain barrier in normal mice, achieving a brain/blood ratio over 10/1.  There was no acute toxicity in mice at doses 10 times those used in the distribution studies.  CG appears to be a relatively high affinity probe for beta-amyloid that appears to have low toxicity and can cross the blood-brain barrier.  These characteristics are promising for development of in vivo amyloid probes similar to CG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph72RMRngsGLVg90H21EOLACvtfcHk0lhufxfaGlQyog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXis1Crur0%253D&md5=39b76e039c4831218445956e2eee3c9e</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1016%2F0197-4580%2894%2990050-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0197-4580%252894%252990050-7%26sid%3Dliteratum%253Aachs%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DPettegrew%26aufirst%3DJ.%2BW.%26atitle%3DDevelopment%2520of%2520small%2520molecule%2520probes%2520for%2520the%2520beta-amyloid%2520protein%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D1994%26volume%3D15%26spage%3D691%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group">Inouye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschner, D. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s beta-amyloid: insights into fibril formation and structure from Congo red binding</span> <span class="citation_source-journal">Subcell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1007%2F0-387-23226-5_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15709480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotFaktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2005&pages=203-224&author=H.+Inouyeauthor=D.+A.+Kirschner&title=Alzheimer%E2%80%99s+beta-amyloid%3A+insights+into+fibril+formation+and+structure+from+Congo+red+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's β-amyloid: Insights into fibril formation and structure from congo red binding</span></div><div class="casAuthors">Inouye, Hideyo; Kirschner, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Subcellular Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid β</span>),
    <span class="NLM_cas:pages">203-224</span>CODEN:
                <span class="NLM_cas:coden">SBCBAG</span>;
        ISSN:<span class="NLM_cas:issn">0306-0225</span>.
    
            (<span class="NLM_cas:orgname">Springer Science+Business Media, Inc.</span>)
        </div><div class="casAbstract">A review.  We consider here the chem. of Congo red (CR), its binding equil. to Alzheimer's β-amyloid, and the kinetics of β-amyloid formation.  Spectroscopic UV/Vis measurements for the pH- and time-dependence binding of CR to Aβ analogs are analyzed by Scatchard binding and the theory of nucleation-dependent fibril formation.  CR likely binds electrostatically to the imidazolium sidechains of histidine residues that are exposed at the surface of amyloid fibrils.  As revealed by at. models of the Aβ protofilament, such as the nanotube β-helix and parallel β-sheet, the regular arrangement of histidines likely acts as a template for the end-to-end J-aggregation of CR mols., which produces a red shift in UV/Vis absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA60Stf-PA6bVg90H21EOLACvtfcHk0lhufxfaGlQyog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotFaktrs%253D&md5=09488750b42cdd5a496c599433b1a391</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1007%2F0-387-23226-5_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F0-387-23226-5_10%26sid%3Dliteratum%253Aachs%26aulast%3DInouye%26aufirst%3DH.%26aulast%3DKirschner%26aufirst%3DD.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520beta-amyloid%253A%2520insights%2520into%2520fibril%2520formation%2520and%2520structure%2520from%2520Congo%2520red%2520binding%26jtitle%3DSubcell.%2520Biochem.%26date%3D2005%26volume%3D38%26spage%3D203%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group">Mukrasch, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweckstetter, M.</span><span> </span><span class="NLM_article-title">Sites of tau important for aggregation populate {beta}-structure and bind to microtubules and polyanions</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">24978</span><span class="NLM_x">–</span> <span class="NLM_lpage">24986</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=24978-24986&author=M.+D.+Mukraschauthor=J.+Biernatauthor=M.+von+Bergenauthor=C.+Griesingerauthor=E.+Mandelkowauthor=M.+Zweckstetter&title=Sites+of+tau+important+for+aggregation+populate+%7Bbeta%7D-structure+and+bind+to+microtubules+and+polyanions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukrasch%26aufirst%3DM.%2BD.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DGriesinger%26aufirst%3DC.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DZweckstetter%26aufirst%3DM.%26atitle%3DSites%2520of%2520tau%2520important%2520for%2520aggregation%2520populate%2520%257Bbeta%257D-structure%2520and%2520bind%2520to%2520microtubules%2520and%2520polyanions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D24978%26epage%3D24986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group">Akoury, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soraya, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweckstetter, M.</span><span> </span><span class="NLM_article-title">Inhibition of tau filament formation by conformational modulation</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">2853</span><span class="NLM_x">–</span> <span class="NLM_lpage">2862</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja312471h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=2853-2862&author=E.+Akouryauthor=M.+Gajdaauthor=M.+Pickhardtauthor=J.+Biernatauthor=P.+Sorayaauthor=C.+Griesingerauthor=E.+Mandelkowauthor=M.+Zweckstetter&title=Inhibition+of+tau+filament+formation+by+conformational+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1021%2Fja312471h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja312471h%26sid%3Dliteratum%253Aachs%26aulast%3DAkoury%26aufirst%3DE.%26aulast%3DGajda%26aufirst%3DM.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DSoraya%26aufirst%3DP.%26aulast%3DGriesinger%26aufirst%3DC.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DZweckstetter%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520tau%2520filament%2520formation%2520by%2520conformational%2520modulation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D2853%26epage%3D2862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 73 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Arpan Pradhan, Satyendra Mishra, Avadhesha Surolia, <span class="NLM_string-name hlFld-ContribAuthor">Dulal Panda</span>. </span><span class="cited-content_cbyCitation_article-title">C1 Inhibits Liquid–Liquid Phase Separation and Oligomerization of Tau and Protects Neuroblastoma Cells against Toxic Tau Oligomers. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (11)
                                     , 1989-2002. <a href="https://doi.org/10.1021/acschemneuro.1c00098" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00098%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DC1%252BInhibits%252BLiquid%2525E2%252580%252593Liquid%252BPhase%252BSeparation%252Band%252BOligomerization%252Bof%252BTau%252Band%252BProtects%252BNeuroblastoma%252BCells%252Bagainst%252BToxic%252BTau%252BOligomers%26aulast%3DPradhan%26aufirst%3DArpan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D20022021%26date%3D05052021%26date%3D19052021%26volume%3D12%26issue%3D11%26spage%3D1989%26epage%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">David J. Ingham, Bryce R. Blankenfeld, Shibin Chacko, Chamani Perera, Berl R. Oakley, <span class="NLM_string-name hlFld-ContribAuthor">Truman Christopher Gamblin</span>. </span><span class="cited-content_cbyCitation_article-title">Fungally Derived Isoquinoline Demonstrates Inducer-Specific Tau Aggregation Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2021,</strong> <em>60 </em>
                                    (21)
                                     , 1658-1669. <a href="https://doi.org/10.1021/acs.biochem.1c00111" title="DOI URL">https://doi.org/10.1021/acs.biochem.1c00111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.1c00111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.1c00111%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DFungally%252BDerived%252BIsoquinoline%252BDemonstrates%252BInducer-Specific%252BTau%252BAggregation%252BInhibition%26aulast%3DIngham%26aufirst%3DDavid%2BJ.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12022021%26date%3D10052021%26date%3D19052021%26volume%3D60%26issue%3D21%26spage%3D1658%26epage%3D1669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lin Zhu, Linlin Xu, Xiaohui Wu, Fei Deng, Rujiang Ma, Yang Liu, Fan Huang, <span class="NLM_string-name hlFld-ContribAuthor">Linqi Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Tau-Targeted Multifunctional Nanoinhibitor for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2021,</strong> <em>13 </em>
                                    (20)
                                     , 23328-23338. <a href="https://doi.org/10.1021/acsami.1c00257" title="DOI URL">https://doi.org/10.1021/acsami.1c00257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.1c00257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.1c00257%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DTau-Targeted%252BMultifunctional%252BNanoinhibitor%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DZhu%26aufirst%3DLin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D05012021%26date%3D05052021%26date%3D17052021%26volume%3D13%26issue%3D20%26spage%3D23328%26epage%3D23338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Angela De Simone, Vincenzo Tumiatti, Vincenza Andrisano, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Milelli</span>. </span><span class="cited-content_cbyCitation_article-title">Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 26-41. <a href="https://doi.org/10.1021/acs.jmedchem.0c00931" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00931</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00931%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%25253A%252BA%252BNew%252BGold%252BRush%252Bin%252BAnti-Alzheimer%2525E2%252580%252599s%252BDisease%252BMultitarget%252BDrug%252BDiscovery%25253F%26aulast%3DDe%2BSimone%26aufirst%3DAngela%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D01062020%26date%3D21122020%26volume%3D64%26issue%3D1%26spage%3D26%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shweta Kishor Sonawane, Absar Ahmad, <span class="NLM_string-name hlFld-ContribAuthor">Subashchandrabose Chinnathambi</span>. </span><span class="cited-content_cbyCitation_article-title">Protein-Capped Metal Nanoparticles Inhibit Tau Aggregation in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (7)
                                     , 12833-12840. <a href="https://doi.org/10.1021/acsomega.9b01411" title="DOI URL">https://doi.org/10.1021/acsomega.9b01411</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b01411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b01411%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DProtein-Capped%252BMetal%252BNanoparticles%252BInhibit%252BTau%252BAggregation%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DSonawane%26aufirst%3DShweta%2BKishor%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15052019%26date%3D24062019%26volume%3D4%26issue%3D7%26spage%3D12833%26epage%3D12840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Florent Alix, Vincent Gembus, Laurent Coquet, Marie Hubert-Roux, Philippe Chan, Lina Truong, Muriel Sebban, Gaël Coadou, Hassan Oulyadi, Cyril Papamicaël, <span class="NLM_string-name hlFld-ContribAuthor">Vincent Levacher</span>. </span><span class="cited-content_cbyCitation_article-title">Dihydroquinoline Carbamate DQS1-02 as a Prodrug of a Potent Acetylcholinesterase Inhibitor for Alzheimer’s Disease Therapy: Multigram-Scale Synthesis, Mechanism Investigations, in Vitro Safety Pharmacology, and Preliminary in Vivo Toxicology Profile. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (12)
                                     , 18387-18397. <a href="https://doi.org/10.1021/acsomega.8b02121" title="DOI URL">https://doi.org/10.1021/acsomega.8b02121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b02121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b02121%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DDihydroquinoline%252BCarbamate%252BDQS1-02%252Bas%252Ba%252BProdrug%252Bof%252Ba%252BPotent%252BAcetylcholinesterase%252BInhibitor%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTherapy%25253A%252BMultigram-Scale%252BSynthesis%25252C%252BMechanism%252BInvestigations%25252C%252Bin%252BVitro%252BSafety%252BPharmacology%25252C%252Band%252BPreliminary%252Bin%252BVivo%252BToxicology%252BProfile%26aulast%3DAlix%26aufirst%3DFlorent%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21082018%26date%3D14112018%26volume%3D3%26issue%3D12%26spage%3D18387%26epage%3D18397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Annachiara Gandini, Manuela Bartolini, Daniele Tedesco, Loreto Martinez-Gonzalez, Carlos Roca, Nuria E. Campillo, Josefa Zaldivar-Diez, Concepción Perez, Giampaolo Zuccheri, Andrea Miti, Alessandra Feoli, Sabrina Castellano, Sabrina Petralla, Barbara Monti, Martina Rossi, Fabio Moda, Giuseppe Legname, Ana Martinez, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (17)
                                     , 7640-7656. <a href="https://doi.org/10.1021/acs.jmedchem.8b00610" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00610%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTau-Centric%252BMultitarget%252BApproach%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BDevelopment%252Bof%252BFirst-in-Class%252BDual%252BGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%252Band%252BTau-Aggregation%252BInhibitors%26aulast%3DGandini%26aufirst%3DAnnachiara%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D17042018%26date%3D24082018%26date%3D04082018%26volume%3D61%26issue%3D17%26spage%3D7640%26epage%3D7656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dawid Panek, Anna Więckowska, Jakub Jończyk, Justyna Godyń, Marek Bajda, Tomasz Wichur, Anna Pasieka, Damijan Knez, Anja Pišlar, Jan Korabecny, Ondrej Soukup, Vendula Sepsova, Raimon Sabaté, Janko Kos, Stanislav Gobec, <span class="NLM_string-name hlFld-ContribAuthor">Barbara Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer’s Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 1074-1094. <a href="https://doi.org/10.1021/acschemneuro.7b00461" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00461%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252B1-Benzylamino-2-hydroxyalkyl%252BDerivatives%252Bas%252BNew%252BPotential%252BDisease-Modifying%252BMultifunctional%252BAnti-Alzheimer%2525E2%252580%252599s%252BAgents%26aulast%3DPanek%26aufirst%3DDawid%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D20112017%26date%3D18012018%26date%3D01022018%26date%3D18012018%26volume%3D9%26issue%3D5%26spage%3D1074%26epage%3D1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dirk  Matthes</span>, <span class="hlFld-ContribAuthor ">Vytautas  Gapsys</span>, <span class="hlFld-ContribAuthor ">Christian  Griesinger</span>, and <span class="hlFld-ContribAuthor ">Bert L.  de Groot</span>  . </span><span class="cited-content_cbyCitation_article-title">Resolving the Atomistic Modes of Anle138b Inhibitory Action on Peptide Oligomer Formation. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (12)
                                     , 2791-2808. <a href="https://doi.org/10.1021/acschemneuro.7b00325" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00325%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DResolving%252Bthe%252BAtomistic%252BModes%252Bof%252BAnle138b%252BInhibitory%252BAction%252Bon%252BPeptide%252BOligomer%252BFormation%26aulast%3DMatthes%26aufirst%3DDirk%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D24082017%26date%3D14092017%26date%3D28092017%26date%3D20122017%26date%3D14092017%26volume%3D8%26issue%3D12%26spage%3D2791%26epage%3D2808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonas  Schartner</span>, <span class="hlFld-ContribAuthor ">Andreas  Nabers</span>, <span class="hlFld-ContribAuthor ">Brian  Budde</span>, <span class="hlFld-ContribAuthor ">Julia  Lange</span>, <span class="hlFld-ContribAuthor ">Nina  Hoeck</span>, <span class="hlFld-ContribAuthor ">Jens  Wiltfang</span>, <span class="hlFld-ContribAuthor ">Carsten  Kötting</span>, and <span class="hlFld-ContribAuthor ">Klaus  Gerwert</span>  . </span><span class="cited-content_cbyCitation_article-title">An ATR–FTIR Sensor Unraveling the Drug Intervention of Methylene Blue, Congo Red, and Berberine on Human Tau and Aβ. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (7)
                                     , 710-714. <a href="https://doi.org/10.1021/acsmedchemlett.7b00079" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00079%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAn%252BATR%2525E2%252580%252593FTIR%252BSensor%252BUnraveling%252Bthe%252BDrug%252BIntervention%252Bof%252BMethylene%252BBlue%25252C%252BCongo%252BRed%25252C%252Band%252BBerberine%252Bon%252BHuman%252BTau%252Band%252BA%2525CE%2525B2%26aulast%3DSchartner%26aufirst%3DJonas%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D22022017%26date%3D09062017%26date%3D23062017%26date%3D13072017%26date%3D11062017%26volume%3D8%26issue%3D7%26spage%3D710%26epage%3D714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent  Lunven</span>, <span class="hlFld-ContribAuthor ">Hugues  Bonnet</span>, <span class="hlFld-ContribAuthor ">Samir  Yahiaoui</span>, <span class="hlFld-ContribAuthor ">Wei  Yi</span>, <span class="hlFld-ContribAuthor ">Laurène  Da Costa</span>, <span class="hlFld-ContribAuthor ">Marine  Peuchmaur</span>, <span class="hlFld-ContribAuthor ">Ahcène  Boumendjel</span>, and <span class="hlFld-ContribAuthor ">Sabine  Chierici</span>  . </span><span class="cited-content_cbyCitation_article-title">Disruption of Fibers from the Tau Model AcPHF6 by Naturally Occurring Aurones and Synthetic Analogues. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2016,</strong> <em>7 </em>
                                    (7)
                                     , 995-1003. <a href="https://doi.org/10.1021/acschemneuro.6b00102" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00102%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDisruption%252Bof%252BFibers%252Bfrom%252Bthe%252BTau%252BModel%252BAcPHF6%252Bby%252BNaturally%252BOccurring%252BAurones%252Band%252BSynthetic%252BAnalogues%26aulast%3DLunven%26aufirst%3DLaurent%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D06042016%26date%3D25052016%26date%3D06062016%26date%3D20072016%26date%3D25052016%26volume%3D7%26issue%3D7%26spage%3D995%26epage%3D1003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuela  Ariza</span>, <span class="hlFld-ContribAuthor ">Hartmuth C.  Kolb</span>, <span class="hlFld-ContribAuthor ">Dieder  Moechars</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, and <span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>  . </span><span class="cited-content_cbyCitation_article-title">Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (11)
                                     , 4365-4382. <a href="https://doi.org/10.1021/jm5017544" title="DOI URL">https://doi.org/10.1021/jm5017544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5017544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5017544%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTau%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BImaging%25253A%252BPast%25252C%252BPresent%25252C%252Band%252BFuture%26aulast%3DAriza%26aufirst%3DManuela%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D12112014%26date%3D25022015%26date%3D11062015%26date%3D11022015%26volume%3D58%26issue%3D11%26spage%3D4365%26epage%3D4382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashim  Paul</span>, <span class="hlFld-ContribAuthor ">Guru KrishnaKumar  Viswanathan</span>, <span class="hlFld-ContribAuthor ">Adi  Huber</span>, <span class="hlFld-ContribAuthor ">Elad  Arad</span>, <span class="hlFld-ContribAuthor ">Hamutal  Engel</span>, <span class="hlFld-ContribAuthor ">Raz  Jelinek</span>, <span class="hlFld-ContribAuthor ">Ehud  Gazit</span>, <span class="hlFld-ContribAuthor ">Daniel  Segal</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone–Dopamine hybrid. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2021,</strong> <em>288 </em>
                                    (14)
                                     , 4267-4290. <a href="https://doi.org/10.1111/febs.15741" title="DOI URL">https://doi.org/10.1111/febs.15741</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.15741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.15741%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DInhibition%252Bof%252Btau%252Bamyloid%252Bformation%252Band%252Bdisruption%252Bof%252Bits%252Bpreformed%252Bfibrils%252Bby%252BNaphthoquinone%2525E2%252580%252593Dopamine%252Bhybrid%26aulast%3DPaul%26aufirst%3DAshim%26date%3D2021%26date%3D2021%26volume%3D288%26issue%3D14%26spage%3D4267%26epage%3D4290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Sanna</span>, <span class="hlFld-ContribAuthor ">Margarida  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Steven G.  Fagan</span>, <span class="hlFld-ContribAuthor ">Timothy S.  Chisholm</span>, <span class="hlFld-ContribAuthor ">Klara  Kulenkampff</span>, <span class="hlFld-ContribAuthor ">David  Klenerman</span>, <span class="hlFld-ContribAuthor ">Maria Grazia  Spillantini</span>, <span class="hlFld-ContribAuthor ">Franklin I.  Aigbirhio</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Hunter</span>. </span><span class="cited-content_cbyCitation_article-title">Mapping the binding site topology of amyloid protein aggregates using multivalent ligands. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>12 </em>
                                    (25)
                                     , 8892-8899. <a href="https://doi.org/10.1039/D1SC01263K" title="DOI URL">https://doi.org/10.1039/D1SC01263K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1SC01263K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1SC01263K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DMapping%252Bthe%252Bbinding%252Bsite%252Btopology%252Bof%252Bamyloid%252Bprotein%252Baggregates%252Busing%252Bmultivalent%252Bligands%26aulast%3DSanna%26aufirst%3DElena%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D25%26spage%3D8892%26epage%3D8899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Malafaia</span>, <span class="hlFld-ContribAuthor ">Hélio M.T.  Albuquerque</span>, <span class="hlFld-ContribAuthor ">Artur M.S.  Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113209. <a href="https://doi.org/10.1016/j.ejmech.2021.113209" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113209%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAmyloid-%2525CE%2525B2%252Band%252Btau%252Baggregation%252Bdual-inhibitors%25253A%252BA%252Bsynthetic%252Band%252Bstructure-activity%252Brelationship%252Bfocused%252Breview%26aulast%3DMalafaia%26aufirst%3DDaniela%26date%3D2021%26volume%3D214%26spage%3D113209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehrdad  Mehrazar</span>, <span class="hlFld-ContribAuthor ">Mahdi  Hassankalhori</span>, <span class="hlFld-ContribAuthor ">Mahsa  Toolabi</span>, <span class="hlFld-ContribAuthor ">Fereshteh  Goli</span>, <span class="hlFld-ContribAuthor ">Setareh  Moghimi</span>, <span class="hlFld-ContribAuthor ">Hamid  Nadri</span>, <span class="hlFld-ContribAuthor ">Syed Nasir Abbas  Bukhari</span>, <span class="hlFld-ContribAuthor ">Loghman  Firoozpour</span>, <span class="hlFld-ContribAuthor ">Alireza  Foroumadi</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of benzodiazepine-1,2,3-triazole hybrid derivatives as selective butyrylcholinesterase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2020,</strong> <em>24 </em>
                                    (4)
                                     , 997-1013. <a href="https://doi.org/10.1007/s11030-019-10008-x" title="DOI URL">https://doi.org/10.1007/s11030-019-10008-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-019-10008-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-019-10008-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bbenzodiazepine-1%25252C2%25252C3-triazole%252Bhybrid%252Bderivatives%252Bas%252Bselective%252Bbutyrylcholinesterase%252Binhibitors%26aulast%3DMehrazar%26aufirst%3DMehrdad%26date%3D2020%26date%3D2019%26volume%3D24%26issue%3D4%26spage%3D997%26epage%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Dominguez-Meijide</span>, <span class="hlFld-ContribAuthor ">Eftychia  Vasili</span>, <span class="hlFld-ContribAuthor ">Tiago Fleming  Outeiro</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological Modulators of Tau Aggregation and Spreading. </span><span class="cited-content_cbyCitation_journal-name">Brain Sciences</span><span> <strong>2020,</strong> <em>10 </em>
                                    (11)
                                     , 858. <a href="https://doi.org/10.3390/brainsci10110858" title="DOI URL">https://doi.org/10.3390/brainsci10110858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/brainsci10110858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbrainsci10110858%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Sciences%26atitle%3DPharmacological%252BModulators%252Bof%252BTau%252BAggregation%252Band%252BSpreading%26aulast%3DDominguez-Meijide%26aufirst%3DAntonio%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D11%26spage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danira  Toral-Rios</span>, <span class="hlFld-ContribAuthor ">Genaro  Patiño-López</span>, <span class="hlFld-ContribAuthor ">Gisela  Gómez-Lira</span>, <span class="hlFld-ContribAuthor ">Rafael  Gutiérrez</span>, <span class="hlFld-ContribAuthor ">Fernando  Becerril-Pérez</span>, <span class="hlFld-ContribAuthor ">Aldebarán  Rosales-Córdova</span>, <span class="hlFld-ContribAuthor ">Juan Carlos  León-Contreras</span>, <span class="hlFld-ContribAuthor ">Rogelio  Hernández-Pando</span>, <span class="hlFld-ContribAuthor ">Ismael  León-Rivera</span>, <span class="hlFld-ContribAuthor ">Isabel  Soto-Cruz</span>, <span class="hlFld-ContribAuthor ">Benjamín  Florán-Garduño</span>, <span class="hlFld-ContribAuthor ">Victoria  Campos-Peña</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of STAT3 Regulates Reactive Astrogliosis and Neuronal Death Induced by AβO Neurotoxicity. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (20)
                                     , 7458. <a href="https://doi.org/10.3390/ijms21207458" title="DOI URL">https://doi.org/10.3390/ijms21207458</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21207458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21207458%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DActivation%252Bof%252BSTAT3%252BRegulates%252BReactive%252BAstrogliosis%252Band%252BNeuronal%252BDeath%252BInduced%252Bby%252BA%2525CE%2525B2O%252BNeurotoxicity%26aulast%3DToral-Rios%26aufirst%3DDanira%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D20%26spage%3D7458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Darius  Vagrys</span>, <span class="hlFld-ContribAuthor ">James  Davidson</span>, <span class="hlFld-ContribAuthor ">Ijen  Chen</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>, <span class="hlFld-ContribAuthor ">Ben  Davis</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring IDP–Ligand Interactions: Tau K18 as a Test Case. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (15)
                                     , 5257. <a href="https://doi.org/10.3390/ijms21155257" title="DOI URL">https://doi.org/10.3390/ijms21155257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21155257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21155257%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DExploring%252BIDP%2525E2%252580%252593Ligand%252BInteractions%25253A%252BTau%252BK18%252Bas%252Ba%252BTest%252BCase%26aulast%3DVagrys%26aufirst%3DDarius%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D15%26spage%3D5257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danira  Toral-Rios</span>, <span class="hlFld-ContribAuthor ">Pavel S.  Pichardo-Rojas</span>, <span class="hlFld-ContribAuthor ">Mario  Alonso-Vanegas</span>, <span class="hlFld-ContribAuthor ">Victoria  Campos-Peña</span>. </span><span class="cited-content_cbyCitation_article-title">GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cellular Neuroscience</span><span> <strong>2020,</strong> <em>14 </em><a href="https://doi.org/10.3389/fncel.2020.00019" title="DOI URL">https://doi.org/10.3389/fncel.2020.00019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fncel.2020.00019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffncel.2020.00019%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cellular%2520Neuroscience%26atitle%3DGSK3%2525CE%2525B2%252Band%252BTau%252BProtein%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BEpilepsy%26aulast%3DToral-Rios%26aufirst%3DDanira%26date%3D2020%26date%3D2020%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angelique  Camilleri</span>, <span class="hlFld-ContribAuthor ">Stephanie  Ghio</span>, <span class="hlFld-ContribAuthor ">Mario  Caruana</span>, <span class="hlFld-ContribAuthor ">Daniel  Weckbecker</span>, <span class="hlFld-ContribAuthor ">Felix  Schmidt</span>, <span class="hlFld-ContribAuthor ">Frits  Kamp</span>, <span class="hlFld-ContribAuthor ">Andrei  Leonov</span>, <span class="hlFld-ContribAuthor ">Sergey  Ryazanov</span>, <span class="hlFld-ContribAuthor ">Christian  Griesinger</span>, <span class="hlFld-ContribAuthor ">Armin  Giese</span>, <span class="hlFld-ContribAuthor ">Ruben J.  Cauchi</span>, <span class="hlFld-ContribAuthor ">Neville  Vassallo</span>. </span><span class="cited-content_cbyCitation_article-title">Tau-induced mitochondrial membrane perturbation is dependent upon cardiolipin. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Biomembranes</span><span> <strong>2020,</strong> <em>1862 </em>
                                    (2)
                                     , 183064. <a href="https://doi.org/10.1016/j.bbamem.2019.183064" title="DOI URL">https://doi.org/10.1016/j.bbamem.2019.183064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamem.2019.183064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamem.2019.183064%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Biomembranes%26atitle%3DTau-induced%252Bmitochondrial%252Bmembrane%252Bperturbation%252Bis%252Bdependent%252Bupon%252Bcardiolipin%26aulast%3DCamilleri%26aufirst%3DAngelique%26date%3D2020%26volume%3D1862%26issue%3D2%26spage%3D183064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomasz  Wichur</span>, <span class="hlFld-ContribAuthor ">Anna  Więckowska</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Więckowski</span>, <span class="hlFld-ContribAuthor ">Justyna  Godyń</span>, <span class="hlFld-ContribAuthor ">Jakub  Jończyk</span>, <span class="hlFld-ContribAuthor ">Álvaro del Río  Valdivieso</span>, <span class="hlFld-ContribAuthor ">Dawid  Panek</span>, <span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabaté</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111916. <a href="https://doi.org/10.1016/j.ejmech.2019.111916" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111916</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111916%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1-Benzylpyrrolidine-3-amine-based%252BBuChE%252Binhibitors%252Bwith%252Banti-aggregating%25252C%252Bantioxidant%252Band%252Bmetal-chelating%252Bproperties%252Bas%252Bmultifunctional%252Bagents%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DWichur%26aufirst%3DTomasz%26date%3D2020%26volume%3D187%26spage%3D111916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cun-Jian  Shi</span>, <span class="hlFld-ContribAuthor ">Wan  Peng</span>, <span class="hlFld-ContribAuthor ">Jin-Hua  Zhao</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Yang</span>, <span class="hlFld-ContribAuthor ">Lai-Liang  Qu</span>, <span class="hlFld-ContribAuthor ">Cheng  Wang</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Usnic acid derivatives as tau-aggregation and neuroinflammation inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111961. <a href="https://doi.org/10.1016/j.ejmech.2019.111961" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111961</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111961%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUsnic%252Bacid%252Bderivatives%252Bas%252Btau-aggregation%252Band%252Bneuroinflammation%252Binhibitors%26aulast%3DShi%26aufirst%3DCun-Jian%26date%3D2020%26volume%3D187%26spage%3D111961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hossein  Derakhshankhah</span>, <span class="hlFld-ContribAuthor ">Soraya  Sajadimajd</span>, <span class="hlFld-ContribAuthor ">Samira  Jafari</span>, <span class="hlFld-ContribAuthor ">Zhila  Izadi</span>, <span class="hlFld-ContribAuthor ">Sajad  Sarvari</span>, <span class="hlFld-ContribAuthor ">Majid  Sharifi</span>, <span class="hlFld-ContribAuthor ">Mojtaba  Falahati</span>, <span class="hlFld-ContribAuthor ">Faezeh  Moakedi</span>, <span class="hlFld-ContribAuthor ">Willis Collins Akeyo  Muganda</span>, <span class="hlFld-ContribAuthor ">Mareike  Müller</span>, <span class="hlFld-ContribAuthor ">Mohammad  Raoufi</span>, <span class="hlFld-ContribAuthor ">John F.  Presley</span>. </span><span class="cited-content_cbyCitation_article-title">Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy. </span><span class="cited-content_cbyCitation_journal-name">Nanomedicine: Nanotechnology, Biology and Medicine</span><span> <strong>2020,</strong> <em>24 </em>, 102149. <a href="https://doi.org/10.1016/j.nano.2020.102149" title="DOI URL">https://doi.org/10.1016/j.nano.2020.102149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nano.2020.102149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nano.2020.102149%26sid%3Dliteratum%253Aachs%26jtitle%3DNanomedicine%253A%2520Nanotechnology%252C%2520Biology%2520and%2520Medicine%26atitle%3DNovel%252Btherapeutic%252Bstrategies%252Bfor%252BAlzheimer%252527s%252Bdisease%25253A%252BImplications%252Bfrom%252Bcell-based%252Btherapy%252Band%252Bnanotherapy%26aulast%3DDerakhshankhah%26aufirst%3DHossein%26date%3D2020%26volume%3D24%26spage%3D102149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eliot J.  Davidowitz</span>, <span class="hlFld-ContribAuthor ">Pavan K.  Krishnamurthy</span>, <span class="hlFld-ContribAuthor ">Patricia  Lopez</span>, <span class="hlFld-ContribAuthor ">Heidy  Jimenez</span>, <span class="hlFld-ContribAuthor ">Leslie  Adrien</span>, <span class="hlFld-ContribAuthor ">Peter  Davies</span>, <span class="hlFld-ContribAuthor ">James G.  Moe</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2020,</strong> <em>73 </em>
                                    (1)
                                     , 147-161. <a href="https://doi.org/10.3233/JAD-190465" title="DOI URL">https://doi.org/10.3233/JAD-190465</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-190465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-190465%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DIn%252BVivo%252BValidation%252Bof%252Ba%252BSmall%252BMolecule%252BInhibitor%252Bof%252BTau%252BSelf-Association%252Bin%252Bhtau%252BMice%26aulast%3DDavidowitz%26aufirst%3DEliot%2BJ.%26date%3D2020%26volume%3D73%26issue%3D1%26spage%3D147%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Praveen P.N.  Rao</span>, <span class="hlFld-ContribAuthor ">Amy Trinh  Pham</span>, <span class="hlFld-ContribAuthor ">Arash  Shakeri</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of small molecules for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 289-322. <a href="https://doi.org/10.1016/B978-0-12-818349-6.00011-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-818349-6.00011-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818349-6.00011-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818349-6.00011-X%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252Bsmall%252Bmolecules%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DRao%26aufirst%3DPraveen%2BP.N.%26date%3D2020%26spage%3D289%26epage%3D322%26pub%3DElsevier%26atitle%3DSmall%252BMolecule%252BDrug%252BDiscovery%26date%3D2020%26volume%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fred  Yeboah</span>, <span class="hlFld-ContribAuthor ">Tae-Eun  Kim</span>, <span class="hlFld-ContribAuthor ">Anke  Bill</span>, <span class="hlFld-ContribAuthor ">Ulf  Dettmer</span>. </span><span class="cited-content_cbyCitation_article-title">Dynamic behaviors of α-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Disease</span><span> <strong>2019,</strong> <em>132 </em>, 104543. <a href="https://doi.org/10.1016/j.nbd.2019.104543" title="DOI URL">https://doi.org/10.1016/j.nbd.2019.104543</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nbd.2019.104543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nbd.2019.104543%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Disease%26atitle%3DDynamic%252Bbehaviors%252Bof%252B%2525CE%2525B1-synuclein%252Band%252Btau%252Bin%252Bthe%252Bcellular%252Bcontext%25253A%252BNew%252Bmechanistic%252Binsights%252Band%252Btherapeutic%252Bopportunities%252Bin%252Bneurodegeneration%26aulast%3DYeboah%26aufirst%3DFred%26date%3D2019%26volume%3D132%26spage%3D104543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Filippa  Lo Cascio</span>, <span class="hlFld-ContribAuthor ">Nicha  Puangmalai</span>, <span class="hlFld-ContribAuthor ">Anna  Ellsworth</span>, <span class="hlFld-ContribAuthor ">Fabio  Bucchieri</span>, <span class="hlFld-ContribAuthor ">Andrea  Pace</span>, <span class="hlFld-ContribAuthor ">Antonio  Palumbo Piccionello</span>, <span class="hlFld-ContribAuthor ">Rakez  Kayed</span>. </span><span class="cited-content_cbyCitation_article-title">Toxic Tau Oligomers Modulated by Novel Curcumin Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-55419-w" title="DOI URL">https://doi.org/10.1038/s41598-019-55419-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-55419-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-55419-w%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DToxic%252BTau%252BOligomers%252BModulated%252Bby%252BNovel%252BCurcumin%252BDerivatives%26aulast%3DLo%2BCascio%26aufirst%3DFilippa%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shweta Kishor  Sonawane</span>, <span class="hlFld-ContribAuthor ">Abhishek Ankur  Balmik</span>, <span class="hlFld-ContribAuthor ">Debjyoti  Boral</span>, <span class="hlFld-ContribAuthor ">Sureshkumar  Ramasamy</span>, <span class="hlFld-ContribAuthor ">Subashchandrabose  Chinnathambi</span>. </span><span class="cited-content_cbyCitation_article-title">Baicalein suppresses Repeat Tau fibrillization by sequestering oligomers. </span><span class="cited-content_cbyCitation_journal-name">Archives of Biochemistry and Biophysics</span><span> <strong>2019,</strong> <em>675 </em>, 108119. <a href="https://doi.org/10.1016/j.abb.2019.108119" title="DOI URL">https://doi.org/10.1016/j.abb.2019.108119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.abb.2019.108119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.abb.2019.108119%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Biochemistry%2520and%2520Biophysics%26atitle%3DBaicalein%252Bsuppresses%252BRepeat%252BTau%252Bfibrillization%252Bby%252Bsequestering%252Boligomers%26aulast%3DSonawane%26aufirst%3DShweta%2BKishor%26date%3D2019%26volume%3D675%26spage%3D108119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ghulam Jeelani  Pir</span>, <span class="hlFld-ContribAuthor ">Bikash  Choudhary</span>, <span class="hlFld-ContribAuthor ">Senthilvelrajan  Kaniyappan</span>, <span class="hlFld-ContribAuthor ">Ram Reddy  Chandupatla</span>, <span class="hlFld-ContribAuthor ">Eckhard  Mandelkow</span>, <span class="hlFld-ContribAuthor ">Eva-Maria  Mandelkow</span>, <span class="hlFld-ContribAuthor ">Yipeng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurobiology</span><span> <strong>2019,</strong> <em>56 </em>
                                    (5)
                                     , 3751-3767. <a href="https://doi.org/10.1007/s12035-018-1326-z" title="DOI URL">https://doi.org/10.1007/s12035-018-1326-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12035-018-1326-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12035-018-1326-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurobiology%26atitle%3DSuppressing%252BTau%252BAggregation%252Band%252BToxicity%252Bby%252Ban%252BAnti-Aggregant%252BTau%252BFragment%26aulast%3DPir%26aufirst%3DGhulam%2BJeelani%26date%3D2019%26date%3D2018%26volume%3D56%26issue%3D5%26spage%3D3751%26epage%3D3767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young-Ho  Lee</span>, <span class="hlFld-ContribAuthor ">Yuxi  Lin</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Cox</span>, <span class="hlFld-ContribAuthor ">Misaki  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Bikash R.  Sahoo</span>, <span class="hlFld-ContribAuthor ">Magdalena  Ivanova</span>, <span class="hlFld-ContribAuthor ">Ayyalusamy  Ramamoorthy</span>. </span><span class="cited-content_cbyCitation_article-title">Zinc boosts EGCG's hIAPP amyloid Inhibition both in solution and membrane. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2019,</strong> <em>1867 </em>
                                    (5)
                                     , 529-536. <a href="https://doi.org/10.1016/j.bbapap.2018.11.006" title="DOI URL">https://doi.org/10.1016/j.bbapap.2018.11.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2018.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2018.11.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DZinc%252Bboosts%252BEGCG%252527s%252BhIAPP%252Bamyloid%252BInhibition%252Bboth%252Bin%252Bsolution%252Band%252Bmembrane%26aulast%3DLee%26aufirst%3DYoung-Ho%26date%3D2019%26volume%3D1867%26issue%3D5%26spage%3D529%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcus  Pickhardt</span>, <span class="hlFld-ContribAuthor ">Michele  Tassoni</span>, <span class="hlFld-ContribAuthor ">Philip  Denner</span>, <span class="hlFld-ContribAuthor ">Birgit  Kurkowsky</span>, <span class="hlFld-ContribAuthor ">Ana  Kitanovic</span>, <span class="hlFld-ContribAuthor ">Christoph  Möhl</span>, <span class="hlFld-ContribAuthor ">Eugenio  Fava</span>, <span class="hlFld-ContribAuthor ">Eckhard  Mandelkow</span>. </span><span class="cited-content_cbyCitation_article-title">Screening of a neuronal cell model of tau pathology for therapeutic compounds. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Aging</span><span> <strong>2019,</strong> <em>76 </em>, 24-34. <a href="https://doi.org/10.1016/j.neurobiolaging.2018.11.026" title="DOI URL">https://doi.org/10.1016/j.neurobiolaging.2018.11.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neurobiolaging.2018.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neurobiolaging.2018.11.026%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Aging%26atitle%3DScreening%252Bof%252Ba%252Bneuronal%252Bcell%252Bmodel%252Bof%252Btau%252Bpathology%252Bfor%252Btherapeutic%252Bcompounds%26aulast%3DPickhardt%26aufirst%3DMarcus%26date%3D2019%26volume%3D76%26spage%3D24%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Chi</span>, <span class="hlFld-ContribAuthor ">Tzu-Kang  Sang</span>, <span class="hlFld-ContribAuthor ">Hui-Yun  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Tauopathy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.5772/intechopen.73198" title="DOI URL">https://doi.org/10.5772/intechopen.73198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.73198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.73198%26sid%3Dliteratum%253Aachs%26atitle%3DTauopathy%26aulast%3DChi%26aufirst%3DHao%26date%3D2019%26date%3D2019%26pub%3DIntechOpen%26atitle%3DCognitive%252BDisorders%26aulast%3DFoyaca%2BSibat%26aufirst%3DHumberto%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luc  Buee</span>. </span><span class="cited-content_cbyCitation_article-title">Dementia Therapy Targeting Tau. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 407-416. <a href="https://doi.org/10.1007/978-981-32-9358-8_30" title="DOI URL">https://doi.org/10.1007/978-981-32-9358-8_30</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-32-9358-8_30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-32-9358-8_30%26sid%3Dliteratum%253Aachs%26atitle%3DDementia%252BTherapy%252BTargeting%252BTau%26aulast%3DBuee%26aufirst%3DLuc%26date%3D2019%26date%3D2020%26spage%3D407%26epage%3D416%26pub%3DSpringer%2520Singapore%26atitle%3DTau%252BBiology%26aulast%3DTakashima%26aufirst%3DAkihiko%26date%3D2019%26volume%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ram W.  Sabnis</span>. </span><span class="cited-content_cbyCitation_article-title">Patents on Natural Products for Diagnosing/Preventing/Treating Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 85-141. <a href="https://doi.org/10.1016/B978-0-444-64183-0.00003-8" title="DOI URL">https://doi.org/10.1016/B978-0-444-64183-0.00003-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-64183-0.00003-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-64183-0.00003-8%26sid%3Dliteratum%253Aachs%26atitle%3DPatents%252Bon%252BNatural%252BProducts%252Bfor%252BDiagnosing%25252FPreventing%25252FTreating%252BAlzheimer%252527s%252BDisease%26aulast%3DSabnis%26aufirst%3DRam%2BW.%26date%3D2019%26spage%3D85%26epage%3D141%26pub%3DElsevier%26date%3D2019%26volume%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Merezhko</span>, <span class="hlFld-ContribAuthor ">Cecilia A.  Brunello</span>, <span class="hlFld-ContribAuthor ">Xu  Yan</span>, <span class="hlFld-ContribAuthor ">Helena  Vihinen</span>, <span class="hlFld-ContribAuthor ">Eija  Jokitalo</span>, <span class="hlFld-ContribAuthor ">Riikka-Liisa  Uronen</span>, <span class="hlFld-ContribAuthor ">Henri J.  Huttunen</span>. </span><span class="cited-content_cbyCitation_article-title">Secretion of Tau via an Unconventional Non-vesicular Mechanism. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2018,</strong> <em>25 </em>
                                    (8)
                                     , 2027-2035.e4. <a href="https://doi.org/10.1016/j.celrep.2018.10.078" title="DOI URL">https://doi.org/10.1016/j.celrep.2018.10.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2018.10.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2018.10.078%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DSecretion%252Bof%252BTau%252Bvia%252Ban%252BUnconventional%252BNon-vesicular%252BMechanism%26aulast%3DMerezhko%26aufirst%3DMaria%26date%3D2018%26volume%3D25%26issue%3D8%26spage%3D2027%26epage%3D2035.e4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoya  Takahashi</span>, <span class="hlFld-ContribAuthor ">Satoru  Nagatoishi</span>, <span class="hlFld-ContribAuthor ">Daisuke  Kuroda</span>, <span class="hlFld-ContribAuthor ">Kouhei  Tsumoto</span>, . </span><span class="cited-content_cbyCitation_article-title">Thermodynamic and computational analyses reveal the functional roles of the galloyl group of tea catechins in molecular recognition. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2018,</strong> <em>13 </em>
                                    (10)
                                     , e0204856. <a href="https://doi.org/10.1371/journal.pone.0204856" title="DOI URL">https://doi.org/10.1371/journal.pone.0204856</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0204856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0204856%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DThermodynamic%252Band%252Bcomputational%252Banalyses%252Breveal%252Bthe%252Bfunctional%252Broles%252Bof%252Bthe%252Bgalloyl%252Bgroup%252Bof%252Btea%252Bcatechins%252Bin%252Bmolecular%252Brecognition%26aulast%3DTakahashi%26aufirst%3DTomoya%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D10%26spage%3De0204856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.  Remmler</span>, <span class="hlFld-ContribAuthor ">T.  Schwaar</span>, <span class="hlFld-ContribAuthor ">M.  Pickhardt</span>, <span class="hlFld-ContribAuthor ">C.  Donth</span>, <span class="hlFld-ContribAuthor ">E.  Mandelkow</span>, <span class="hlFld-ContribAuthor ">M.G.  Weller</span>, <span class="hlFld-ContribAuthor ">H.G.  Börner</span>. </span><span class="cited-content_cbyCitation_article-title">On the way to precision formulation additives: 2D-screening to select solubilizers with tailored host and release capabilities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Controlled Release</span><span> <strong>2018,</strong> <em>285 </em>, 96-105. <a href="https://doi.org/10.1016/j.jconrel.2018.06.032" title="DOI URL">https://doi.org/10.1016/j.jconrel.2018.06.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jconrel.2018.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jconrel.2018.06.032%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Controlled%2520Release%26atitle%3DOn%252Bthe%252Bway%252Bto%252Bprecision%252Bformulation%252Badditives%25253A%252B2D-screening%252Bto%252Bselect%252Bsolubilizers%252Bwith%252Btailored%252Bhost%252Band%252Brelease%252Bcapabilities%26aulast%3DRemmler%26aufirst%3DD.%26date%3D2018%26volume%3D285%26spage%3D96%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miguel  Medina</span>. </span><span class="cited-content_cbyCitation_article-title">An Overview on the Clinical Development of Tau-Based Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (4)
                                     , 1160. <a href="https://doi.org/10.3390/ijms19041160" title="DOI URL">https://doi.org/10.3390/ijms19041160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19041160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19041160%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DAn%252BOverview%252Bon%252Bthe%252BClinical%252BDevelopment%252Bof%252BTau-Based%252BTherapeutics%26aulast%3DMedina%26aufirst%3DMiguel%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D4%26spage%3D1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit U.  Joshi</span>, <span class="hlFld-ContribAuthor ">Nay L.  Saw</span>, <span class="hlFld-ContribAuthor ">Mehrdad  Shamloo</span>, <span class="hlFld-ContribAuthor ">Daria  Mochly-Rosen</span>. </span><span class="cited-content_cbyCitation_article-title">Drp1/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 6128-6143. <a href="https://doi.org/10.18632/oncotarget.23640" title="DOI URL">https://doi.org/10.18632/oncotarget.23640</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.23640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.23640%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DDrp1%25252FFis1%252Binteraction%252Bmediates%252Bmitochondrial%252Bdysfunction%25252C%252Bbioenergetic%252Bfailure%252Band%252Bcognitive%252Bdecline%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DJoshi%26aufirst%3DAmit%2BU.%26date%3D2018%26date%3D2017%26volume%3D9%26issue%3D5%26spage%3D6128%26epage%3D6143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sławomir  Wójcik</span>, <span class="hlFld-ContribAuthor ">Melissa  Birol</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Rhoades</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Miranker</span>, <span class="hlFld-ContribAuthor ">Zachary A.  Levine</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Intrinsically Disordered Proteome Using Small-Molecule Ligands. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 703-734. <a href="https://doi.org/10.1016/bs.mie.2018.09.036" title="DOI URL">https://doi.org/10.1016/bs.mie.2018.09.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.mie.2018.09.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.mie.2018.09.036%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252Bthe%252BIntrinsically%252BDisordered%252BProteome%252BUsing%252BSmall-Molecule%252BLigands%26aulast%3DW%25C3%25B3jcik%26aufirst%3DS%25C5%2582awomir%26date%3D2018%26spage%3D703%26epage%3D734%26pub%3DElsevier%26atitle%3DIntrinsically%252BDisordered%252BProteins%26date%3D2018%26volume%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Belostozky</span>, <span class="hlFld-ContribAuthor ">M.  Richman</span>, <span class="hlFld-ContribAuthor ">E.  Lisniansky</span>, <span class="hlFld-ContribAuthor ">A.  Tovchygrechko</span>, <span class="hlFld-ContribAuthor ">J. H.  Chill</span>, <span class="hlFld-ContribAuthor ">S.  Rahimipour</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of tau-derived hexapeptide aggregation and toxicity by a self-assembled cyclic
              d
              ,
              l
              -α-peptide conformational inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2018,</strong> <em>54 </em>
                                    (47)
                                     , 5980-5983. <a href="https://doi.org/10.1039/C8CC01233D" title="DOI URL">https://doi.org/10.1039/C8CC01233D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC01233D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC01233D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DInhibition%252Bof%252Btau-derived%252Bhexapeptide%252Baggregation%252Band%252Btoxicity%252Bby%252Ba%252Bself-assembled%252Bcyclic%252Bd%252B%25252C%252Bl%252B-%2525CE%2525B1-peptide%252Bconformational%252Binhibitor%26aulast%3DBelostozky%26aufirst%3DA.%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D47%26spage%3D5980%26epage%3D5983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcus  Pickhardt</span>, <span class="hlFld-ContribAuthor ">Jacek  Biernat</span>, <span class="hlFld-ContribAuthor ">Sabrina  Hübschmann</span>, <span class="hlFld-ContribAuthor ">Frank J.A.  Dennissen</span>, <span class="hlFld-ContribAuthor ">Thomas  Timm</span>, <span class="hlFld-ContribAuthor ">Annukka  Aho</span>, <span class="hlFld-ContribAuthor ">Eva-Maria  Mandelkow</span>, <span class="hlFld-ContribAuthor ">Eckhard  Mandelkow</span>. </span><span class="cited-content_cbyCitation_article-title">Time course of Tau toxicity and pharmacologic prevention in a cell model of Tauopathy. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Aging</span><span> <strong>2017,</strong> <em>57 </em>, 47-63. <a href="https://doi.org/10.1016/j.neurobiolaging.2017.04.022" title="DOI URL">https://doi.org/10.1016/j.neurobiolaging.2017.04.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neurobiolaging.2017.04.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neurobiolaging.2017.04.022%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Aging%26atitle%3DTime%252Bcourse%252Bof%252BTau%252Btoxicity%252Band%252Bpharmacologic%252Bprevention%252Bin%252Ba%252Bcell%2525C2%2525A0model%252Bof%252BTauopathy%26aulast%3DPickhardt%26aufirst%3DMarcus%26date%3D2017%26volume%3D57%26spage%3D47%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nampally  Sreenivasachary</span>, <span class="hlFld-ContribAuthor ">Heiko  Kroth</span>, <span class="hlFld-ContribAuthor ">Pascal  Benderitter</span>, <span class="hlFld-ContribAuthor ">Anne  Hamel</span>, <span class="hlFld-ContribAuthor ">Yvan  Varisco</span>, <span class="hlFld-ContribAuthor ">David T.  Hickman</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Froestl</span>, <span class="hlFld-ContribAuthor ">Andrea  Pfeifer</span>, <span class="hlFld-ContribAuthor ">Andreas  Muhs</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and characterization of novel indole and 7-azaindole derivatives as inhibitors of β-amyloid-42 aggregation for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (6)
                                     , 1405-1411. <a href="https://doi.org/10.1016/j.bmcl.2017.02.001" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.02.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Bcharacterization%252Bof%252Bnovel%252Bindole%252Band%252B7-azaindole%252Bderivatives%252Bas%252Binhibitors%252Bof%252B%2525CE%2525B2-amyloid-42%252Baggregation%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSreenivasachary%26aufirst%3DNampally%26date%3D2017%26volume%3D27%26issue%3D6%26spage%3D1405%26epage%3D1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michel  Goedert</span>. </span><span class="cited-content_cbyCitation_article-title">Protein Aggregation and Neurodegeneration: Tauopathies and Synucleinopathies. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 12-24. <a href="https://doi.org/10.1002/9781118661895.ch2" title="DOI URL">https://doi.org/10.1002/9781118661895.ch2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118661895.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118661895.ch2%26sid%3Dliteratum%253Aachs%26atitle%3DProtein%252BAggregation%252Band%252BNeurodegeneration%25253A%252BTauopathies%252Band%252BSynucleinopathies%26aulast%3DGoedert%26aufirst%3DMichel%26date%3D2017%26date%3D2017%26spage%3D12%26epage%3D24%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DNeurodegeneration%26aulast%3DSchapira%26aufirst%3DAnthony%26date%3D2017%26volume%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji-Ying  Hu</span>, <span class="hlFld-ContribAuthor ">De-Lin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Ling  Liu</span>, <span class="hlFld-ContribAuthor ">Xue-Shou  Li</span>, <span class="hlFld-ContribAuthor ">Xiao-Qing  Cheng</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Hai-Ning  Du</span>, <span class="hlFld-ContribAuthor ">Yi  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Pathological concentration of zinc dramatically accelerates abnormal aggregation of full-length human Tau and thereby significantly increases Tau toxicity in neuronal cells. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</span><span> <strong>2017,</strong> <em>1863 </em>
                                    (2)
                                     , 414-427. <a href="https://doi.org/10.1016/j.bbadis.2016.11.022" title="DOI URL">https://doi.org/10.1016/j.bbadis.2016.11.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbadis.2016.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbadis.2016.11.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520Basis%2520of%2520Disease%26atitle%3DPathological%252Bconcentration%252Bof%252Bzinc%252Bdramatically%252Baccelerates%252Babnormal%252Baggregation%252Bof%252Bfull-length%252Bhuman%252BTau%252Band%252Bthereby%252Bsignificantly%252Bincreases%252BTau%252Btoxicity%252Bin%252Bneuronal%252Bcells%26aulast%3DHu%26aufirst%3DJi-Ying%26date%3D2017%26volume%3D1863%26issue%3D2%26spage%3D414%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean J.  Martens</span>, <span class="hlFld-ContribAuthor ">David K  Geiger</span>. </span><span class="cited-content_cbyCitation_article-title">Structural characterization of two tetrachloridozincate salts of 4-carboxy-1
              H
              -imidazol-3-ium: a salt hydrate and a co-crystal salt hydrate. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section E Crystallographic Communications</span><span> <strong>2017,</strong> <em>73 </em>
                                    (2)
                                     , 162-167. <a href="https://doi.org/10.1107/S2056989017000317" title="DOI URL">https://doi.org/10.1107/S2056989017000317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2056989017000317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2056989017000317%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520E%2520Crystallographic%2520Communications%26atitle%3DStructural%252Bcharacterization%252Bof%252Btwo%252Btetrachloridozincate%252Bsalts%252Bof%252B4-carboxy-1%252BH%252B-imidazol-3-ium%25253A%252Ba%252Bsalt%252Bhydrate%252Band%252Ba%252Bco-crystal%252Bsalt%252Bhydrate%26aulast%3DMartens%26aufirst%3DSean%2BJ.%26date%3D2017%26date%3D2017%26volume%3D73%26issue%3D2%26spage%3D162%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jai  Malik</span>. </span><span class="cited-content_cbyCitation_article-title">Phytomedicine. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 167-198. <a href="https://doi.org/10.1002/9781119155195.ch8" title="DOI URL">https://doi.org/10.1002/9781119155195.ch8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119155195.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119155195.ch8%26sid%3Dliteratum%253Aachs%26atitle%3DPhytomedicine%26aulast%3DMalik%26aufirst%3DJai%26date%3D2017%26date%3D2017%26spage%3D167%26epage%3D198%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DNeuroprotective%252BEffects%252Bof%252BPhytochemicals%252Bin%252BNeurological%252BDisorders%26aulast%3DFarooqui%26aufirst%3DTahira%26date%3D2017%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janet E.  Rickard</span>, <span class="hlFld-ContribAuthor ">David  Horsley</span>, <span class="hlFld-ContribAuthor ">Claude M.  Wischik</span>, <span class="hlFld-ContribAuthor ">Charles R.  Harrington</span>. </span><span class="cited-content_cbyCitation_article-title">Assays for the Screening and Characterization of Tau Aggregation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 129-140. <a href="https://doi.org/10.1007/978-1-4939-6598-4_8" title="DOI URL">https://doi.org/10.1007/978-1-4939-6598-4_8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-6598-4_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-6598-4_8%26sid%3Dliteratum%253Aachs%26atitle%3DAssays%252Bfor%252Bthe%252BScreening%252Band%252BCharacterization%252Bof%252BTau%252BAggregation%252BInhibitors%26aulast%3DRickard%26aufirst%3DJanet%2BE.%26date%3D2017%26date%3D2016%26spage%3D129%26epage%3D140%26pub%3DSpringer%2520New%2520York%26atitle%3DTau%252BProtein%26aulast%3DSmet-Nocca%26aufirst%3DCaroline%26date%3D2017%26volume%3D1523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. S.  Borodkin</span>, <span class="hlFld-ContribAuthor ">L. Yu.  Ukhin</span>, <span class="hlFld-ContribAuthor ">L. V.  Belousova</span>, <span class="hlFld-ContribAuthor ">E. N.  Shepelenko</span>, <span class="hlFld-ContribAuthor ">A. V.  Alekseenko</span>. </span><span class="cited-content_cbyCitation_article-title">Opianic Acid in the Synthesis of Benzimidazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Natural Compounds</span><span> <strong>2017,</strong> <em>53 </em>
                                    (1)
                                     , 118-120. <a href="https://doi.org/10.1007/s10600-017-1923-5" title="DOI URL">https://doi.org/10.1007/s10600-017-1923-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10600-017-1923-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10600-017-1923-5%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Natural%2520Compounds%26atitle%3DOpianic%252BAcid%252Bin%252Bthe%252BSynthesis%252Bof%252BBenzimidazole%252BDerivatives%26aulast%3DBorodkin%26aufirst%3DG.%2BS.%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D1%26spage%3D118%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.F.  Kazim</span>, <span class="hlFld-ContribAuthor ">K.  Iqbal</span>. </span><span class="cited-content_cbyCitation_article-title">Neural Regeneration as a Disease-Modifying Therapeutic Strategy for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 3-29. <a href="https://doi.org/10.1016/B978-0-12-803690-7.00002-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-803690-7.00002-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803690-7.00002-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803690-7.00002-8%26sid%3Dliteratum%253Aachs%26atitle%3DNeural%252BRegeneration%252Bas%252Ba%252BDisease-Modifying%252BTherapeutic%252BStrategy%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DKazim%26aufirst%3DS.F.%26date%3D2017%26spage%3D3%26epage%3D29%26pub%3DElsevier%26atitle%3DNeuroprotection%252Bin%252BAlzheimer%252527s%252BDisease%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ronald  Melki</span>. </span><span class="cited-content_cbyCitation_article-title">The multitude of therapeutic targets in neurodegenerative proteinopathies. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-20. <a href="https://doi.org/10.1016/B978-0-12-805120-7.00001-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-805120-7.00001-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-805120-7.00001-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-805120-7.00001-4%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252Bmultitude%252Bof%252Btherapeutic%252Btargets%252Bin%252Bneurodegenerative%252Bproteinopathies%26aulast%3DMelki%26aufirst%3DRonald%26date%3D2017%26spage%3D1%26epage%3D20%26pub%3DElsevier%26atitle%3DDisease-Modifying%252BTargets%252Bin%252BNeurodegenerative%252BDisorders%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christina  Dammers</span>, <span class="hlFld-ContribAuthor ">Deniz  Yolcu</span>, <span class="hlFld-ContribAuthor ">Laura  Kukuk</span>, <span class="hlFld-ContribAuthor ">Dieter  Willbold</span>, <span class="hlFld-ContribAuthor ">Marcus  Pickhardt</span>, <span class="hlFld-ContribAuthor ">Eckhard  Mandelkow</span>, <span class="hlFld-ContribAuthor ">Anselm H. C.  Horn</span>, <span class="hlFld-ContribAuthor ">Heinrich  Sticht</span>, <span class="hlFld-ContribAuthor ">Marwa Nidal  Malhis</span>, <span class="hlFld-ContribAuthor ">Nadja  Will</span>, <span class="hlFld-ContribAuthor ">Judith  Schuster</span>, <span class="hlFld-ContribAuthor ">Susanne Aileen  Funke</span>, . </span><span class="cited-content_cbyCitation_article-title">Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (12)
                                     , e0167432. <a href="https://doi.org/10.1371/journal.pone.0167432" title="DOI URL">https://doi.org/10.1371/journal.pone.0167432</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0167432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0167432%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DSelection%252Band%252BCharacterization%252Bof%252BTau%252BBinding%252B%2525E1%2525B4%252585-Enantiomeric%252BPeptides%252Bwith%252BPotential%252Bfor%252BTherapy%252Bof%252BAlzheimer%252BDisease%26aulast%3DDammers%26aufirst%3DChristina%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D12%26spage%3De0167432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frank J. A.  Dennissen</span>, <span class="hlFld-ContribAuthor ">Marta  Anglada-Huguet</span>, <span class="hlFld-ContribAuthor ">Astrid  Sydow</span>, <span class="hlFld-ContribAuthor ">Eckhard  Mandelkow</span>, <span class="hlFld-ContribAuthor ">Eva-Maria  Mandelkow</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine A
              1
              receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2016,</strong> <em>113 </em>
                                    (41)
                                     , 11597-11602. <a href="https://doi.org/10.1073/pnas.1603119113" title="DOI URL">https://doi.org/10.1073/pnas.1603119113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1603119113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1603119113%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DAdenosine%252BA%252B1%252Breceptor%252Bantagonist%252Brolofylline%252Balleviates%252Baxonopathy%252Bcaused%252Bby%252Bhuman%252BTau%252B%2525CE%252594K280%26aulast%3DDennissen%26aufirst%3DFrank%2BJ.%2BA.%26date%3D2016%26date%3D2016%26volume%3D113%26issue%3D41%26spage%3D11597%26epage%3D11602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tetsuro  Tago</span>, <span class="hlFld-ContribAuthor ">Shozo  Furumoto</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Okamura</span>, <span class="hlFld-ContribAuthor ">Ryuichi  Harada</span>, <span class="hlFld-ContribAuthor ">Hajime  Adachi</span>, <span class="hlFld-ContribAuthor ">Yoichi  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Yanai</span>, <span class="hlFld-ContribAuthor ">Ren  Iwata</span>, <span class="hlFld-ContribAuthor ">Yukitsuka  Kudo</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Evaluation of [18F]THK-5105 Enantiomers: Effects of Chirality on Its Effectiveness as a Tau Imaging Radiotracer. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2016,</strong> <em>18 </em>
                                    (2)
                                     , 258-266. <a href="https://doi.org/10.1007/s11307-015-0879-8" title="DOI URL">https://doi.org/10.1007/s11307-015-0879-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-015-0879-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-015-0879-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DPreclinical%252BEvaluation%252Bof%252B%25255B18F%25255DTHK-5105%252BEnantiomers%25253A%252BEffects%252Bof%252BChirality%252Bon%252BIts%252BEffectiveness%252Bas%252Ba%252BTau%252BImaging%252BRadiotracer%26aulast%3DTago%26aufirst%3DTetsuro%26date%3D2016%26date%3D2015%26volume%3D18%26issue%3D2%26spage%3D258%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kanae  Ando</span>, <span class="hlFld-ContribAuthor ">Akiko  Maruko-Otake</span>, <span class="hlFld-ContribAuthor ">Yosuke  Ohtake</span>, <span class="hlFld-ContribAuthor ">Motoki  Hayashishita</span>, <span class="hlFld-ContribAuthor ">Michiko  Sekiya</span>, <span class="hlFld-ContribAuthor ">Koichi M.  Iijima</span>, . </span><span class="cited-content_cbyCitation_article-title">Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity. </span><span class="cited-content_cbyCitation_journal-name">PLOS Genetics</span><span> <strong>2016,</strong> <em>12 </em>
                                    (3)
                                     , e1005917. <a href="https://doi.org/10.1371/journal.pgen.1005917" title="DOI URL">https://doi.org/10.1371/journal.pgen.1005917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pgen.1005917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pgen.1005917%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Genetics%26atitle%3DStabilization%252Bof%252BMicrotubule-Unbound%252BTau%252Bvia%252BTau%252BPhosphorylation%252Bat%252BSer262%25252F356%252Bby%252BPar-1%25252FMARK%252BContributes%252Bto%252BAugmentation%252Bof%252BAD-Related%252BPhosphorylation%252Band%252BA%2525CE%2525B242-Induced%252BTau%252BToxicity%26aulast%3DAndo%26aufirst%3DKanae%26date%3D2016%26date%3D2016%26volume%3D12%26issue%3D3%26spage%3De1005917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Davide  Seripa</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Solfrizzi</span>, <span class="hlFld-ContribAuthor ">Bruno P.  Imbimbo</span>, <span class="hlFld-ContribAuthor ">Antonio  Daniele</span>, <span class="hlFld-ContribAuthor ">Andrea  Santamato</span>, <span class="hlFld-ContribAuthor ">Madia  Lozupone</span>, <span class="hlFld-ContribAuthor ">Giovanni  Zuliani</span>, <span class="hlFld-ContribAuthor ">Antonio  Greco</span>, <span class="hlFld-ContribAuthor ">Giancarlo  Logroscino</span>, <span class="hlFld-ContribAuthor ">Francesco  Panza</span>. </span><span class="cited-content_cbyCitation_article-title">Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Neurotherapeutics</span><span> <strong>2016,</strong> <em>16 </em>
                                    (3)
                                     , 259-277. <a href="https://doi.org/10.1586/14737175.2016.1140039" title="DOI URL">https://doi.org/10.1586/14737175.2016.1140039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/14737175.2016.1140039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F14737175.2016.1140039%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Neurotherapeutics%26atitle%3DTau-directed%252Bapproaches%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Bfocus%252Bon%252Bleuco-methylthioninium%26aulast%3DSeripa%26aufirst%3DDavide%26date%3D2016%26date%3D2016%26volume%3D16%26issue%3D3%26spage%3D259%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Panza</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Solfrizzi</span>, <span class="hlFld-ContribAuthor ">Davide  Seripa</span>, <span class="hlFld-ContribAuthor ">Bruno P.  Imbimbo</span>, <span class="hlFld-ContribAuthor ">Madia  Lozupone</span>, <span class="hlFld-ContribAuthor ">Andrea  Santamato</span>, <span class="hlFld-ContribAuthor ">Chiara  Zecca</span>, <span class="hlFld-ContribAuthor ">Maria Rosaria  Barulli</span>, <span class="hlFld-ContribAuthor ">Antonello  Bellomo</span>, <span class="hlFld-ContribAuthor ">Alberto  Pilotto</span>, <span class="hlFld-ContribAuthor ">Antonio  Daniele</span>, <span class="hlFld-ContribAuthor ">Antonio  Greco</span>, <span class="hlFld-ContribAuthor ">Giancarlo  Logroscino</span>. </span><span class="cited-content_cbyCitation_article-title">Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2016,</strong> <em>2016 </em>, 1-15. <a href="https://doi.org/10.1155/2016/3245935" title="DOI URL">https://doi.org/10.1155/2016/3245935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2016/3245935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2016%2F3245935%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DTau-Centric%252BTargets%252Band%252BDrugs%252Bin%252BClinical%252BDevelopment%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPanza%26aufirst%3DFrancesco%26date%3D2016%26volume%3D2016%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katja  Hochgräfe</span>, <span class="hlFld-ContribAuthor ">Astrid  Sydow</span>, <span class="hlFld-ContribAuthor ">Dorthe  Matenia</span>, <span class="hlFld-ContribAuthor ">Daniela  Cadinu</span>, <span class="hlFld-ContribAuthor ">Stefanie  Könen</span>, <span class="hlFld-ContribAuthor ">Olga  Petrova</span>, <span class="hlFld-ContribAuthor ">Marcus  Pickhardt</span>, <span class="hlFld-ContribAuthor ">Petra  Goll</span>, <span class="hlFld-ContribAuthor ">Fabio  Morellini</span>, <span class="hlFld-ContribAuthor ">Eckhard  Mandelkow</span>, <span class="hlFld-ContribAuthor ">Eva-Maria  Mandelkow</span>. </span><span class="cited-content_cbyCitation_article-title">Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau. </span><span class="cited-content_cbyCitation_journal-name">Acta Neuropathologica Communications</span><span> <strong>2015,</strong> <em>3 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40478-015-0204-4" title="DOI URL">https://doi.org/10.1186/s40478-015-0204-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40478-015-0204-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40478-015-0204-4%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Neuropathologica%2520Communications%26atitle%3DPreventive%252Bmethylene%252Bblue%252Btreatment%252Bpreserves%252Bcognition%252Bin%252Bmice%252Bexpressing%252Bfull-length%252Bpro-aggregant%252Bhuman%252BTau%26aulast%3DHochgr%25C3%25A4fe%26aufirst%3DKatja%26date%3D2015%26date%3D2015%26volume%3D3%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kina  Höglund</span>, <span class="hlFld-ContribAuthor ">Anthony  Fourier</span>, <span class="hlFld-ContribAuthor ">Armand  Perret-Liaudet</span>, <span class="hlFld-ContribAuthor ">Henrik  Zetterberg</span>, <span class="hlFld-ContribAuthor ">Kaj  Blennow</span>, <span class="hlFld-ContribAuthor ">Erik  Portelius</span>. </span><span class="cited-content_cbyCitation_article-title">Alzheimer's disease — Recent biomarker developments in relation to updated diagnostic criteria. </span><span class="cited-content_cbyCitation_journal-name">Clinica Chimica Acta</span><span> <strong>2015,</strong> <em>449 </em>, 3-8. <a href="https://doi.org/10.1016/j.cca.2015.01.041" title="DOI URL">https://doi.org/10.1016/j.cca.2015.01.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cca.2015.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cca.2015.01.041%26sid%3Dliteratum%253Aachs%26jtitle%3DClinica%2520Chimica%2520Acta%26atitle%3DAlzheimer%252527s%252Bdisease%252B%2525E2%252580%252594%252BRecent%252Bbiomarker%252Bdevelopments%252Bin%252Brelation%252Bto%252Bupdated%252Bdiagnostic%252Bcriteria%26aulast%3DH%25C3%25B6glund%26aufirst%3DKina%26date%3D2015%26volume%3D449%26spage%3D3%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurence  Ozmen</span>, <span class="hlFld-ContribAuthor ">Ludovic  Collin</span>. </span><span class="cited-content_cbyCitation_article-title">Prévenir la progression de la pathologie Tau par immunothérapie passive. </span><span class="cited-content_cbyCitation_journal-name">médecine/sciences</span><span> <strong>2015,</strong> <em>31 </em>
                                    (2)
                                     , 132-134. <a href="https://doi.org/10.1051/medsci/20153102006" title="DOI URL">https://doi.org/10.1051/medsci/20153102006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1051/medsci/20153102006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1051%2Fmedsci%2F20153102006%26sid%3Dliteratum%253Aachs%26jtitle%3Dm%25C3%25A9decine%252Fsciences%26atitle%3DPr%2525C3%2525A9venir%252Bla%252Bprogression%252Bde%252Bla%252Bpathologie%252BTau%252Bpar%252Bimmunoth%2525C3%2525A9rapie%252Bpassive%26aulast%3DOzmen%26aufirst%3DLaurence%26date%3D2015%26date%3D2015%26volume%3D31%26issue%3D2%26spage%3D132%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Dujardin</span>, <span class="hlFld-ContribAuthor ">Morvane  Colin</span>, <span class="hlFld-ContribAuthor ">Luc  Buée</span>. </span><span class="cited-content_cbyCitation_article-title">Invited review: Animal models of tauopathies and their implications for research/translation into the clinic. </span><span class="cited-content_cbyCitation_journal-name">Neuropathology and Applied Neurobiology</span><span> <strong>2015,</strong> <em>41 </em>
                                    (1)
                                     , 59-80. <a href="https://doi.org/10.1111/nan.12200" title="DOI URL">https://doi.org/10.1111/nan.12200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/nan.12200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fnan.12200%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropathology%2520and%2520Applied%2520Neurobiology%26atitle%3DInvited%252Breview%25253A%252BAnimal%252Bmodels%252Bof%252Btauopathies%252Band%252Btheir%252Bimplications%252Bfor%252Bresearch%25252Ftranslation%252Binto%252Bthe%252Bclinic%26aulast%3DDujardin%26aufirst%3DSimon%26date%3D2015%26date%3D2015%26volume%3D41%26issue%3D1%26spage%3D59%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Cappello</span>, <span class="hlFld-ContribAuthor ">Antonella  Marino Gammazza</span>, <span class="hlFld-ContribAuthor ">Silvia  Vilasi</span>, <span class="hlFld-ContribAuthor ">Maria Grazia  Ortore</span>, <span class="hlFld-ContribAuthor ">Pier Luigi  San Biagio</span>, <span class="hlFld-ContribAuthor ">Claudia  Campanella</span>, <span class="hlFld-ContribAuthor ">Andrea  Pace</span>, <span class="hlFld-ContribAuthor ">Antonio  Palumbo Piccionello</span>, <span class="hlFld-ContribAuthor ">Giulio  Taglialatela</span>, <span class="hlFld-ContribAuthor ">Everly Conway  De Macario</span>, <span class="hlFld-ContribAuthor ">Alberto J. L.  Macario</span>. </span><span class="cited-content_cbyCitation_article-title">Chaperonotherapy for Alzheimer’s Disease: Focusing on HSP60. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 51-76. <a href="https://doi.org/10.1007/978-3-319-17211-8_4" title="DOI URL">https://doi.org/10.1007/978-3-319-17211-8_4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-17211-8_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-17211-8_4%26sid%3Dliteratum%253Aachs%26atitle%3DChaperonotherapy%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BFocusing%252Bon%252BHSP60%26aulast%3DCappello%26aufirst%3DFrancesco%26date%3D2015%26spage%3D51%26epage%3D76%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeat%252BShock%252BProtein-Based%252BTherapies%26aulast%3DAsea%26aufirst%3DAlexzander%2BA.A.%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierfausto  Seneci</span>. </span><span class="cited-content_cbyCitation_article-title">Assembly and Disassembly of Protein Aggregates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 229-276. <a href="https://doi.org/10.1016/B978-0-12-800186-8.00006-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-800186-8.00006-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-800186-8.00006-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-800186-8.00006-7%26sid%3Dliteratum%253Aachs%26atitle%3DAssembly%252Band%252BDisassembly%252Bof%252BProtein%252BAggregates%26aulast%3DSeneci%26aufirst%3DPierfausto%26date%3D2015%26spage%3D229%26epage%3D276%26pub%3DElsevier%26atitle%3DMolecular%252BTargets%252Bin%252BProtein%252BMisfolding%252Band%252BNeurodegenerative%252BDisease%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierfausto  Seneci</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Assembly and Disassembly of Protein Aggregates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 173-228. <a href="https://doi.org/10.1016/B978-0-12-801944-3.00006-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-801944-3.00006-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-801944-3.00006-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-801944-3.00006-0%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BAssembly%252Band%252BDisassembly%252Bof%252BProtein%252BAggregates%26aulast%3DSeneci%26aufirst%3DPierfausto%26date%3D2015%26spage%3D173%26epage%3D228%26pub%3DElsevier%26atitle%3DChemical%252BModulators%252Bof%252BProtein%252BMisfolding%252Band%252BNeurodegenerative%252BDisease%26date%3D2015%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid I.  Belen'kii</span>, <span class="hlFld-ContribAuthor ">Yu B.  Evdokimenkova</span>. </span><span class="cited-content_cbyCitation_article-title">The Literature of Heterocyclic Chemistry, Part XIII, 2012–2013. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 193-363. <a href="https://doi.org/10.1016/bs.aihch.2015.04.002" title="DOI URL">https://doi.org/10.1016/bs.aihch.2015.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2015.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2015.04.002%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BLiterature%252Bof%252BHeterocyclic%252BChemistry%25252C%252BPart%252BXIII%25252C%252B2012%2525E2%252580%2525932013%26aulast%3DBelen%2527kii%26aufirst%3DLeonid%2BI.%26date%3D2015%26spage%3D193%26epage%3D363%26pub%3DElsevier%26date%3D2015%26volume%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Phuriphong  Songarj</span>, <span class="hlFld-ContribAuthor ">Clara  Luh</span>, <span class="hlFld-ContribAuthor ">Irina  Staib-Lasarzik</span>, <span class="hlFld-ContribAuthor ">Kristin  Engelhard</span>, <span class="hlFld-ContribAuthor ">Bernd  Moosmann</span>, <span class="hlFld-ContribAuthor ">Serge C.  Thal</span>. </span><span class="cited-content_cbyCitation_article-title">The antioxidative, non-psychoactive tricyclic phenothiazine reduces brain damage after experimental traumatic brain injury in mice. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience Letters</span><span> <strong>2015,</strong> <em>584 </em>, 253-258. <a href="https://doi.org/10.1016/j.neulet.2014.10.037" title="DOI URL">https://doi.org/10.1016/j.neulet.2014.10.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neulet.2014.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neulet.2014.10.037%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520Letters%26atitle%3DThe%252Bantioxidative%25252C%252Bnon-psychoactive%252Btricyclic%252Bphenothiazine%252Breduces%252Bbrain%252Bdamage%252Bafter%252Bexperimental%252Btraumatic%252Bbrain%252Binjury%252Bin%252Bmice%26aulast%3DSongarj%26aufirst%3DPhuriphong%26date%3D2015%26volume%3D584%26spage%3D253%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leila  Vahdati</span>, <span class="hlFld-ContribAuthor ">Roberto  Fanelli</span>, <span class="hlFld-ContribAuthor ">Guillaume  Bernadat</span>, <span class="hlFld-ContribAuthor ">Isabelle  Correia</span>, <span class="hlFld-ContribAuthor ">Olivier  Lequin</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ongeri</span>, <span class="hlFld-ContribAuthor ">Umberto  Piarulli</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and conformational studies of a stable peptidomimetic β-hairpin based on a bifunctional diketopiperazine turn inducer. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2015,</strong> <em>39 </em>
                                    (5)
                                     , 3250-3258. <a href="https://doi.org/10.1039/C4NJ01437E" title="DOI URL">https://doi.org/10.1039/C4NJ01437E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4NJ01437E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4NJ01437E%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%252Band%252Bconformational%252Bstudies%252Bof%252Ba%252Bstable%252Bpeptidomimetic%252B%2525CE%2525B2-hairpin%252Bbased%252Bon%252Ba%252Bbifunctional%252Bdiketopiperazine%252Bturn%252Binducer%26aulast%3DVahdati%26aufirst%3DLeila%26date%3D2015%26date%3D2015%26volume%3D39%26issue%3D5%26spage%3D3250%26epage%3D3258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dexin  Sui</span>, <span class="hlFld-ContribAuthor ">Xinjing  Xu</span>, <span class="hlFld-ContribAuthor ">Xuemei  Ye</span>, <span class="hlFld-ContribAuthor ">Mengyu  Liu</span>, <span class="hlFld-ContribAuthor ">Maxwell  Mianecki</span>, <span class="hlFld-ContribAuthor ">Chotirat  Rattanasinchai</span>, <span class="hlFld-ContribAuthor ">Christopher  Buehl</span>, <span class="hlFld-ContribAuthor ">Xiexiong  Deng</span>, <span class="hlFld-ContribAuthor ">Min-Hao  Kuo</span>. </span><span class="cited-content_cbyCitation_article-title">Protein Interaction Module–assisted Function X (PIMAX) Approach to Producing Challenging Proteins Including Hyperphosphorylated Tau and Active CDK5/p25 Kinase Complex. </span><span class="cited-content_cbyCitation_journal-name">Molecular & Cellular Proteomics</span><span> <strong>2015,</strong> <em>14 </em>
                                    (1)
                                     , 251-262. <a href="https://doi.org/10.1074/mcp.O114.044412" title="DOI URL">https://doi.org/10.1074/mcp.O114.044412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/mcp.O114.044412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fmcp.O114.044412%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520%2526%2520Cellular%2520Proteomics%26atitle%3DProtein%252BInteraction%252BModule%2525E2%252580%252593assisted%252BFunction%252BX%252B%252528PIMAX%252529%252BApproach%252Bto%252BProducing%252BChallenging%252BProteins%252BIncluding%252BHyperphosphorylated%252BTau%252Band%252BActive%252BCDK5%25252Fp25%252BKinase%252BComplex%26aulast%3DSui%26aufirst%3DDexin%26date%3D2015%26volume%3D14%26issue%3D1%26spage%3D251%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miguel  Medina</span>, <span class="hlFld-ContribAuthor ">Jesús  Avila</span>. </span><span class="cited-content_cbyCitation_article-title">New perspectives on the role of tau in Alzheimer's disease. Implications for therapy. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2014,</strong> <em>88 </em>
                                    (4)
                                     , 540-547. <a href="https://doi.org/10.1016/j.bcp.2014.01.013" title="DOI URL">https://doi.org/10.1016/j.bcp.2014.01.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2014.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2014.01.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DNew%252Bperspectives%252Bon%252Bthe%252Brole%252Bof%252Btau%252Bin%252BAlzheimer%252527s%252Bdisease.%252BImplications%252Bfor%252Btherapy%26aulast%3DMedina%26aufirst%3DMiguel%26date%3D2014%26volume%3D88%26issue%3D4%26spage%3D540%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haakon B.  Nygaard</span>. </span><span class="cited-content_cbyCitation_article-title">Current and Emerging Therapies for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Clinical Therapeutics</span><span> <strong>2013,</strong> <em>35 </em>
                                    (10)
                                     , 1480-1489. <a href="https://doi.org/10.1016/j.clinthera.2013.09.009" title="DOI URL">https://doi.org/10.1016/j.clinthera.2013.09.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.clinthera.2013.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.clinthera.2013.09.009%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Therapeutics%26atitle%3DCurrent%252Band%252BEmerging%252BTherapies%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DNygaard%26aufirst%3DHaakon%2BB.%26date%3D2013%26volume%3D35%26issue%3D10%26spage%3D1480%26epage%3D1489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy M  Pooler</span>, <span class="hlFld-ContribAuthor ">Manuela  Polydoro</span>, <span class="hlFld-ContribAuthor ">Susanne  Wegmann</span>, <span class="hlFld-ContribAuthor ">Samantha B  Nicholls</span>, <span class="hlFld-ContribAuthor ">Tara L  Spires-Jones</span>, <span class="hlFld-ContribAuthor ">Bradley T  Hyman</span>. </span><span class="cited-content_cbyCitation_article-title">Propagation of tau pathology in Alzheimer’s disease: identification of novel therapeutic targets. </span><span class="cited-content_cbyCitation_journal-name">Alzheimer's Research & Therapy</span><span> <strong>2013,</strong> <em>5 </em>
                                    (5)
                                     , 49. <a href="https://doi.org/10.1186/alzrt214" title="DOI URL">https://doi.org/10.1186/alzrt214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/alzrt214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Falzrt214%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%2527s%2520Research%2520%2526%2520Therapy%26atitle%3DPropagation%252Bof%252Btau%252Bpathology%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Bidentification%252Bof%252Bnovel%252Btherapeutic%252Btargets%26aulast%3DPooler%26aufirst%3DAmy%2BM%26date%3D2013%26volume%3D5%26issue%3D5%26spage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0017.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Diagram of hTau40, the largest Tau isoform in CNS, the fetal Tau isoform hTau23 (lacking exons 2, 3, and 10), and the repeat domain constructs used in the PHF inhibition assay (construct K19, repeat domain with three repeats, R2 absent). (B) PHF6 is the hexapeptide motif (<sup>306</sup>VQIVYK<sup>311</sup>) that nucleates the aggregation of construct K19.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a><a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> In the four repeat construct K18 a second hexapeptide is present (<sup>275</sup>VQIINK<sup>280</sup>) which also contributes to aggregation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a, left) VQIVYK steric zipper structure determined by X-ray microcrystallography showing interdigitations at the dry interface. Reprinted by permission from Macmillan Publishers Ltd.:  <cite>Nature</cite> <span class="NLM_year">2007</span>, <em>447</em>, 453–457;<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a><a href="http://www.nature.com/nature/index.html" class="extLink">http://www.nature.com/nature/index.html</a>. Copyright 2007. (b, right) Ribbon representation of the crystal structure of oligomer-like segment of αB-crystallin forming a barrel. From <contrib-group person-group-type="allauthors">Laganowsky, A.; Liu, C.; Sawaya, M. R.; Whitelegge, J. P.; Park, J.; Zhao, M.; Pensalfini, A.; Soriaga, A. B.; Landau, M.; Teng, P. K.; Cascio, D.; Glabe, C.; Eisenberg, D.</contrib-group>Atomic view of a toxic amyloid small oligomer.  <cite>Science</cite> <span class="NLM_year">2012</span>, <em>335</em>, 1228–1231;<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a><a href="http://www.sciencemag.org/content/335/6073/1228.abstract?sid=c6273ec7-53be-4d69-b687-a963c44453f4" class="extLink">http://www.sciencemag.org/content/335/6073/1228.abstract?sid=c6273ec7-53be-4d69-b687-a963c44453f4</a>. Reprinted with permission from AAAS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Tau aggregation pathways and potential therapeutic targets. Aggregation intermediates and mature fibrils or monomeric peptides are possible entry points for drug development (schematic representations, not to scale).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Redox cycling of methylene blue and TAGI potencies.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Upper panel (black): Reduced leuco form <b>2</b> and structural overlap with inactive phenothiazines <b>3</b>, <b>4</b>, and <b>5</b>. Lower panel (blue): Structural overlap between oxidized form <b>1</b> and azure A (<b>6</b>), reduced anthraquinone, <b>8</b>, and <b>9</b>, showing the extended π-conjugated system (ND: not determined).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. UV/vis absorption spectra for <b>1</b> and <b>6</b> showing strong absorbance below 350 nm and between 620 and 760 nm pointing at potential interferences in protein aggregation fluorescence assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of Aβ-aggregation inhibitors evaluated in current or past clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Thiflavin-S fluorescence assay for TAGIs identification (A) for compounds that inhibit aggregation of Tau into PHFs and (B) for compounds that disaggregate preformed PHFs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Pyrogallol generic substitution pattern commonly found in multiple polyphenolic Tau aggregation inhibitors such as <b>12</b> and <b>19</b>. Note the structural overlap with the inactive pyrocatechol-substituted epicatechin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Anthraquinones in oxidized (left, red) and reduced forms (right, blue) showing structural overlap with polyphenols and <b>1</b>. (B) Representative examples of anthraquinones identified as Tau aggregation inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (A) Heterocyclic core with variations on heteroatoms (R<sub>1</sub> and R<sub>2</sub>) and on the flanking substituents (R<sub>3</sub> and R<sub>4</sub>). (B) Representative examples of rhodanine aggregation inhibitors (R<sub>1</sub> = R<sub>2</sub> = S). IC<sub>50</sub> and DC<sub>50</sub> activities were determined on the Tau construct K19.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) Pharmacophore applied to phenylthiazolylhydrazide (PTH) class of Tau aggregation inhibitors. (B) STD-NMR signals indicating compound–Tau interaction spots on <b>29</b>. (C) Pyrogallo-hybrid PTH <b>30</b> developed as a Tau binder and as a Tau aggregation inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Representative examples of <i>N</i>-phenylamine Tau aggregation inhibitors and structural overlap with the Aβ40 aggregation inhibitor <b>33</b> or the nonsteroidal anti-inflammatory drug <b>34</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Benzothiazole-based Tau aggregation inhibitors (<b>35</b>, <b>36</b>, and <b>37</b>) and Tau NFT binders (<b>38</b> and <b>39</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Aminothienopyridazines (APTZs) Tau aggregation inhibitors (<i>B</i>/<i>P</i>: blood to plasma ratio).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/medium/jm-2012-017317_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. (A) Chemical structures of amyloid binders Orange G, curcumin, and DDNP. (B) Binding mode of depicted compounds to Tau VQIVYK fibers obtained by X-ray microcrystallography (left, <b>46</b>; right, <b>47</b>/<b>48</b>).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3017317/production/images/large/jm-2012-017317_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017317&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43411" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43411" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 215 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lheggg_CUFHfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span> </span><span class="NLM_article-title">Neuropathological stageing of Alzheimer-related changes</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1007%2FBF00308809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=1759558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1991&pages=239-259&author=H.+Braakauthor=E.+Braak&title=Neuropathological+stageing+of+Alzheimer-related+changes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathological stageing of Alzheimer-related changes</span></div><div class="casAuthors">Braak H; Braak E</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-59</span>
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    </div><div class="casAbstract">Eighty-three brains obtained at autopsy from nondemented and demented individuals were examined for extracellular amyloid deposits and intraneuronal neurofibrillary changes.  The distribution pattern and packing density of amyloid deposits turned out to be of limited significance for differentiation of neuropathological stages.  Neurofibrillary changes occurred in the form of neuritic plaques, neurofibrillary tangles and neuropil threads.  The distribution of neuritic plaques varied widely not only within architectonic units but also from one individual to another.  Neurofibrillary tangles and neuropil threads, in contrast, exhibited a characteristic distribution pattern permitting the differentiation of six stages.  The first two stages were characterized by an either mild or severe alteration of the transentorhinal layer Pre-alpha (transentorhinal stages I-II).  The two forms of limbic stages (stages III-IV) were marked by a conspicuous affection of layer Pre-alpha in both transentorhinal region and proper entorhinal cortex.  In addition, there was mild involvement of the first Ammon's horn sector.  The hallmark of the two isocortical stages (stages V-VI) was the destruction of virtually all isocortical association areas.  The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIZP19xbDelK_dlEzl_fBafW6udTcc2eZV51FEID31j7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D&md5=b3e2663c943c202f121efeb65527a280</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2FBF00308809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00308809%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DBraak%26aufirst%3DE.%26atitle%3DNeuropathological%2520stageing%2520of%2520Alzheimer-related%2520changes%26jtitle%3DActa%2520Neuropathol.%26date%3D1991%26volume%3D82%26spage%3D239%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Rapoport, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitek, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, A.</span><span> </span><span class="NLM_article-title">Tau is essential to beta-amyloid-induced neurotoxicity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">6364</span><span class="NLM_x">–</span> <span class="NLM_lpage">6369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=6364-6369&author=M.+Rapoportauthor=H.+N.+Dawsonauthor=L.+I.+Binderauthor=M.+P.+Vitekauthor=A.+Ferreira&title=Tau+is+essential+to+beta-amyloid-induced+neurotoxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRapoport%26aufirst%3DM.%26aulast%3DDawson%26aufirst%3DH.%2BN.%26aulast%3DBinder%26aufirst%3DL.%2BI.%26aulast%3DVitek%26aufirst%3DM.%2BP.%26aulast%3DFerreira%26aufirst%3DA.%26atitle%3DTau%2520is%2520essential%2520to%2520beta-amyloid-induced%2520neurotoxicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D6364%26epage%3D6369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Roberson, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palop, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer’s disease mouse model</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">750</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=750-754&author=E.+D.+Robersonauthor=K.+Scearce-Levieauthor=J.+J.+Palopauthor=F.+Yanauthor=I.+H.+Chengauthor=T.+Wuauthor=H.+Gersteinauthor=G.+Q.+Yuauthor=L.+Mucke&title=Reducing+endogenous+tau+ameliorates+amyloid+beta-induced+deficits+in+an+Alzheimer%E2%80%99s+disease+mouse+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoberson%26aufirst%3DE.%2BD.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DPalop%26aufirst%3DJ.%2BJ.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DCheng%26aufirst%3DI.%2BH.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DGerstein%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DG.%2BQ.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DReducing%2520endogenous%2520tau%2520ameliorates%2520amyloid%2520beta-induced%2520deficits%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D750%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hutton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, E.</span><span> </span><span class="NLM_article-title">Analysis of tauopathies with transgenic mice</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=467-470&author=M.+Huttonauthor=J.+Lewisauthor=D.+Dicksonauthor=S.+H.+Yenauthor=E.+McGowan&title=Analysis+of+tauopathies+with+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutton%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DDickson%26aufirst%3DD.%26aulast%3DYen%26aufirst%3DS.%2BH.%26aulast%3DMcGowan%26aufirst%3DE.%26atitle%3DAnalysis%2520of%2520tauopathies%2520with%2520transgenic%2520mice%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2001%26volume%3D7%26spage%3D467%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Crespo-Biel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theunis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Leuven, F.</span><span> </span><span class="NLM_article-title">Protein tau: prime cause of synaptic and neuronal degeneration in Alzheimer’s disease</span> <span class="citation_source-journal">Int. J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">251426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslKmsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=251426&author=N.+Crespo-Bielauthor=C.+Theunisauthor=F.+Van+Leuven&title=Protein+tau%3A+prime+cause+of+synaptic+and+neuronal+degeneration+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Tau: prime cause of synaptic and neuronal degeneration in Alzheimer's disease</span></div><div class="casAuthors">Crespo-Biel, Natalia; Theunis, Clara; Van Leuven, Fred</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">251426, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJADAQ</span>;
        ISSN:<span class="NLM_cas:issn">2090-0252</span>.
    
            (<span class="NLM_cas:orgname">Hindawi Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  The microtubule-assocd. protein Tau (MAPT) is a major component of the pathogenesis of a wide variety of brain-damaging disorders, known as tauopathies.  These include Alzheimer's disease (AD), denoted as secondary tauopathy because of the obligatory combination with amyloid pathol.  In all tauopathies, protein Tau becomes aberrantly phosphorylated, adopts abnormal conformations, and aggregates into fibrils that eventually accumulate as threads in neuropil and as tangles in soma.  The argyrophilic neurofibrillary threads and tangles, together denoted as NFT, provide the postmortem pathol. diagnosis for all tauopathies.  In AD, neurofibrillary threads and tangles (NFTs) are codiagnostic with amyloid depositions but their sepd. and combined contributions to clin. symptoms remain elusive.  Importantly, NFTs are now considered a late event and not directly responsible for early synaptic dysfunctions.  Conversely, the biochem. and pathol. timeline is not exactly known in human tauopathy, but exptl. models point to smaller Tau-aggregates, termed oligomers or multimers, as synaptotoxic in early stages.  The challenge is to molecularly define these Tau-isoforms that cause early cognitive and synaptic impairments.  Here, we discuss relevant studies and data obtained in our mono- and bi-genic validated preclin. models, with the perspective of Tau as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozgjn3h5A7DLVg90H21EOLACvtfcHk0lhQkZJC2qhk0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslKmsbc%253D&md5=cbf293593895e434037019c401ae1a66</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrespo-Biel%26aufirst%3DN.%26aulast%3DTheunis%26aufirst%3DC.%26aulast%3DVan%2BLeuven%26aufirst%3DF.%26atitle%3DProtein%2520tau%253A%2520prime%2520cause%2520of%2520synaptic%2520and%2520neuronal%2520degeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26spage%3D251426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Eisenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jucker, M.</span><span> </span><span class="NLM_article-title">The amyloid state of proteins in human diseases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">1188</span><span class="NLM_x">–</span> <span class="NLM_lpage">1203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.cell.2012.02.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22424229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1Ggsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=1188-1203&author=D.+Eisenbergauthor=M.+Jucker&title=The+amyloid+state+of+proteins+in+human+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Amyloid state of proteins in human diseases</span></div><div class="casAuthors">Eisenberg, David; Jucker, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1188-1203</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Amyloid fibers and oligomers are assocd. with a great variety of human diseases including Alzheimer's disease and the prion conditions.  Here we attempt to connect recent discoveries on the mol. properties of proteins in the amyloid state with observations about pathol. tissues and disease states.  We summarize studies of structure and nucleation of amyloid and relate these to observations on amyloid polymorphism, prion strains, coaggregation of pathogenic proteins in tissues, and mechanisms of toxicity and transmissibility.  Mol. studies have also led to numerous strategies for biol. and chem. interventions against amyloid diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaQ6wkkP5ZZrVg90H21EOLACvtfcHk0ljMj4bLgvMgyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1Ggsbo%253D&md5=b141512d0e7f84a085bc7433f258d60a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.02.022%26sid%3Dliteratum%253Aachs%26aulast%3DEisenberg%26aufirst%3DD.%26aulast%3DJucker%26aufirst%3DM.%26atitle%3DThe%2520amyloid%2520state%2520of%2520proteins%2520in%2520human%2520diseases%26jtitle%3DCell%26date%3D2012%26volume%3D148%26spage%3D1188%26epage%3D1203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kolarova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Sierra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripova, D.</span><span> </span><span class="NLM_article-title">Structure and pathology of tau protein in Alzheimer disease</span> <span class="citation_source-journal">Int. J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">731526</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XosVensLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=731526&author=M.+Kolarovaauthor=F.+Garcia-Sierraauthor=A.+Bartosauthor=J.+Ricnyauthor=D.+Ripova&title=Structure+and+pathology+of+tau+protein+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and pathology of tau protein in Alzheimer disease</span></div><div class="casAuthors">Kolarova, Michala; Garcia-Sierra, Francisco; Bartos, Ales; Ricny, Jan; Ripova, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">731526, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJADAQ</span>;
        ISSN:<span class="NLM_cas:issn">2090-0252</span>.
    
            (<span class="NLM_cas:orgname">Hindawi Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common type of dementia.  In connection with the global trend of prolonging human life and the increasing no. of elderly in the population, the AD becomes one of the most serious health and socioeconomic problems of the present.  Tau protein promotes assembly and stabilizes microtubules, which contributes to the proper function of neuron.  Alterations in the amt. or the structure of tau protein can affect its role as a stabilizer of microtubules as well as some of the processes in which it is implicated.  The mol. mechanisms governing tau aggregation are mainly represented by several posttranslational modifications that alter its structure and conformational state.  Hence, abnormal phosphorylation and truncation of tau protein have gained attention as key mechanisms that become tau protein in a pathol. entity.  Evidences about the clinicopathol. significance of phosphorylated and truncated tau have been documented during the progression of AD as well as their capacity to exert cytotoxicity when expressed in cell and animal models.  This paper describes the normal structure and function of tau protein and its major alterations during its pathol. aggregation in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0pOuzGFY7-7Vg90H21EOLACvtfcHk0ljMj4bLgvMgyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosVensLg%253D&md5=32af79b01fe2aed9c1fe80ebbc0181de</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKolarova%26aufirst%3DM.%26aulast%3DGarcia-Sierra%26aufirst%3DF.%26aulast%3DBartos%26aufirst%3DA.%26aulast%3DRicny%26aufirst%3DJ.%26aulast%3DRipova%26aufirst%3DD.%26atitle%3DStructure%2520and%2520pathology%2520of%2520tau%2520protein%2520in%2520Alzheimer%2520disease%26jtitle%3DInt.%2520J.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26spage%3D731526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ittner, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotz, J.</span><span> </span><span class="NLM_article-title">Amyloid-beta and tau—a toxic pas de deux in Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnrn2967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21193853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFeq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=65-72&author=L.+M.+Ittnerauthor=J.+Gotz&title=Amyloid-beta+and+tau%E2%80%94a+toxic+pas+de+deux+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease</span></div><div class="casAuthors">Ittner, Lars M.; Goetz, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-72</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Amyloid-β and tau are the two hallmark proteins in Alzheimer's disease.  Although both amyloid-β and tau have been extensively studied individually with regard to their sep. modes of toxicity, more recently new light has been shed on their possible interactions and synergistic effects in Alzheimer's disease.  Here, we review novel findings that have shifted our understanding of the role of tau in the pathogenesis of Alzheimer's disease towards being a crucial partner of amyloid-β.  As we gain a deeper understanding of the different cellular functions of tau, the focus shifts from the axon, where tau has a principal role as a microtubule-assocd. protein, to the dendrite, where it mediates amyloid-β toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPL1v0nYjAz7Vg90H21EOLACvtfcHk0ljMj4bLgvMgyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFeq&md5=3eba522187f11cb5e7944dae5a025e55</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrn2967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2967%26sid%3Dliteratum%253Aachs%26aulast%3DIttner%26aufirst%3DL.%2BM.%26aulast%3DGotz%26aufirst%3DJ.%26atitle%3DAmyloid-beta%2520and%2520tau%25E2%2580%2594a%2520toxic%2520pas%2520de%2520deux%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2011%26volume%3D12%26spage%3D65%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Zempel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span> </span><span class="NLM_article-title">Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">11938</span><span class="NLM_x">–</span> <span class="NLM_lpage">11950</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1523%2FJNEUROSCI.2357-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20826658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtF2qsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=11938-11950&author=H.+Zempelauthor=E.+Thiesauthor=E.+Mandelkowauthor=E.+M.+Mandelkow&title=Abeta+oligomers+cause+localized+Ca%282%2B%29+elevation%2C+missorting+of+endogenous+Tau+into+dendrites%2C+Tau+phosphorylation%2C+and+destruction+of+microtubules+and+spines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ oligomers cause localized Ca2+ elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines</span></div><div class="casAuthors">Zempel, Hans; Thies, Edda; Mandelkow, Eckhard; Mandelkow, Eva-Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">11938-11950</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Aggregation of amyloid-β (Aβ) and Tau protein are hallmarks of Alzheimer's disease (AD), and according to the Aβ-cascade hypothesis, Aβ is considered toxic for neurons and Tau a downstream target of Aβ.  We have investigated differentiated primary hippocampal neurons for early localized changes following exposure to Aβ oligomers.  Initial events become evident by missorting of endogenous Tau into the somatodendritic compartment, in contrast to axonal sorting in normal neurons.  In missorted dendritic regions there is a depletion of spines and local increase in Ca2+, and breakdown of microtubules.  Tau in these regions shows elevated phosphorylation at certain sites diagnostic of AD-Tau (e.g., epitope of antibody 12E8, whose phosphorylation causes detachment of Tau from microtubules, and AT8 epitope), and local elevation of certain kinase activities (e.g., MARK/par-1, BRSK/SADK, p70S6K, cdk5, but not GSK3β, JNK, MAPK).  These local effects occur without global changes in Tau, tubulin, or kinase levels.  Somatodendritic missorting occurs not only with Tau, but also with other axonal proteins such as neurofilaments, and correlates with pronounced depletion of microtubules and mitochondria.  The Aβ-induced effects on microtubule and mitochondria depletion, Tau missorting, and loss of spines are prevented by taxol, indicating that Aβ-induced microtubule destabilization and corresponding traffic defects are key factors in incipient degeneration.  By contrast, the rise in Ca2+ levels, kinase activities, and Tau phosphorylation cannot be prevented by taxol.  Incipient and local changes similar to those of Aβ oligomers can be evoked by cell stressors (e.g., H2O2, glutamate, serum deprivation), suggesting some common mechanism of signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIS9RYGK4jMrVg90H21EOLACvtfcHk0ljMj4bLgvMgyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtF2qsLnK&md5=c7f6cf2af311d01c746b16e31be0e4a4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2357-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2357-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DZempel%26aufirst%3DH.%26aulast%3DThies%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DAbeta%2520oligomers%2520cause%2520localized%2520Ca%25282%252B%2529%2520elevation%252C%2520missorting%2520of%2520endogenous%2520Tau%2520into%2520dendrites%252C%2520Tau%2520phosphorylation%252C%2520and%2520destruction%2520of%2520microtubules%2520and%2520spines%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D11938%26epage%3D11950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Tredici, K.</span><span> </span><span class="NLM_article-title">The pathological process underlying Alzheimer’s disease in individuals under thirty</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1007%2Fs00401-010-0789-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21170538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BC3M7jvV2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=171-181&author=H.+Braakauthor=K.+Del+Tredici&title=The+pathological+process+underlying+Alzheimer%E2%80%99s+disease+in+individuals+under+thirty"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The pathological process underlying Alzheimer's disease in individuals under thirty</span></div><div class="casAuthors">Braak Heiko; Del Tredici Kelly</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Brains of 42 individuals between the ages of 4 and 29 were examined with antibodies (AT8, 4G8) and silver stains for the presence of intraneuronal and extracellular protein aggregates associated with Alzheimer's disease.  Thirty-eight of 42 (38/42) cases displayed abnormally phosphorylated tau protein (pretangle material) in nerve cells or in portions of their cellular processes, and 41/42 individuals showed no extracellular amyloid-β protein deposition or neuritic plaques-an individual with Down syndrome was the only exception.  In 16/42 cases abnormal tau was found in the transentorhinal region, and in 3/42 cases this site was Gallyas-positive for isolated NFTs (NFT stage I).  Of 26 cases that lacked abnormal tau in the transentorhinal region, 4 did not show pretangle material at subcortical sites.  The remaining 22 of these same 26 cases, however, had subcortical lesions confined to non-thalamic nuclei with diffuse projections to the cerebral cortex, and, remarkably, in 19/22 individuals the pretangle material was confined to the noradrenergic coeruleus/subcoeruleus complex.  Assuming the pretangle alterations are not transient and do not regress, these findings may indicate that the Alzheimer's disease-related pathological process leading to neurofibrillary tangle formation does not begin in the cerebral cortex but, rather, in select subcortical nuclei, and it may start quite early, i.e., before puberty or in early young adulthood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwm-8zIl3llYMcDoIzZtNkfW6udTcc2eblVc4sU877zLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7jvV2gtw%253D%253D&md5=fee9c22eed3f3ed66c22a7aa7215cb9d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00401-010-0789-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-010-0789-4%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DDel%2BTredici%26aufirst%3DK.%26atitle%3DThe%2520pathological%2520process%2520underlying%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520individuals%2520under%2520thirty%26jtitle%3DActa%2520Neuropathol.%26date%3D2011%26volume%3D121%26spage%3D171%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lasagna-Reeves, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo-Carranza, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrero-Muoz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayed, R.</span><span> </span><span class="NLM_article-title">Preparation and characterization of neurotoxic tau oligomers</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">10039</span><span class="NLM_x">–</span> <span class="NLM_lpage">10041</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi1016233" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=10039-10041&author=C.+A.+Lasagna-Reevesauthor=D.+L.+Castillo-Carranzaauthor=M.+J.+Guerrero-Muozauthor=G.+R.+Jacksonauthor=R.+Kayed&title=Preparation+and+characterization+of+neurotoxic+tau+oligomers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fbi1016233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1016233%26sid%3Dliteratum%253Aachs%26aulast%3DLasagna-Reeves%26aufirst%3DC.%2BA.%26aulast%3DCastillo-Carranza%26aufirst%3DD.%2BL.%26aulast%3DGuerrero-Muoz%26aufirst%3DM.%2BJ.%26aulast%3DJackson%26aufirst%3DG.%2BR.%26aulast%3DKayed%26aufirst%3DR.%26atitle%3DPreparation%2520and%2520characterization%2520of%2520neurotoxic%2520tau%2520oligomers%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D10039%26epage%3D10041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Lasagna-Reeves, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo-Carranza, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarmiento, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncoso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayed, R.</span><span> </span><span class="NLM_article-title">Identification of oligomers at early stages of tau aggregation in Alzheimer’s disease</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1946</span><span class="NLM_x">–</span> <span class="NLM_lpage">1959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1946-1959&author=C.+A.+Lasagna-Reevesauthor=D.+L.+Castillo-Carranzaauthor=U.+Senguptaauthor=J.+Sarmientoauthor=J.+Troncosoauthor=G.+R.+Jacksonauthor=R.+Kayed&title=Identification+of+oligomers+at+early+stages+of+tau+aggregation+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLasagna-Reeves%26aufirst%3DC.%2BA.%26aulast%3DCastillo-Carranza%26aufirst%3DD.%2BL.%26aulast%3DSengupta%26aufirst%3DU.%26aulast%3DSarmiento%26aufirst%3DJ.%26aulast%3DTroncoso%26aufirst%3DJ.%26aulast%3DJackson%26aufirst%3DG.%2BR.%26aulast%3DKayed%26aufirst%3DR.%26atitle%3DIdentification%2520of%2520oligomers%2520at%2520early%2520stages%2520of%2520tau%2520aggregation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFASEB%2520J.%26date%3D2012%26volume%3D26%26spage%3D1946%26epage%3D1959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Patterson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remmers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanaan, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vana, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philibert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glucksman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, L. I.</span><span> </span><span class="NLM_article-title">Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">23063</span><span class="NLM_x">–</span> <span class="NLM_lpage">23076</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1074%2Fjbc.M111.237974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21550980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFersr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=23063-23076&author=K.+R.+Pattersonauthor=C.+Remmersauthor=Y.+Fuauthor=S.+Brookerauthor=N.+M.+Kanaanauthor=L.+Vanaauthor=S.+Wardauthor=J.+F.+Reyesauthor=K.+Philibertauthor=M.+J.+Glucksmanauthor=L.+I.+Binder&title=Characterization+of+prefibrillar+Tau+oligomers+in+vitro+and+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer Disease</span></div><div class="casAuthors">Patterson, Kristina R.; Remmers, Christine; Fu, Yifan; Brooker, Sarah; Kanaan, Nicholas M.; Vana, Laurel; Ward, Sarah; Reyes, Juan F.; Philibert, Keith; Glucksman, Marc J.; Binder, Lester I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">23063-23076</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Neurofibrillary tangles, composed of insol. aggregates of the microtubule-assocd. protein Tau, are a pathol. hallmark of Alzheimer disease (AD) and other tauopathies.  However, recent evidence indicates that neuronal dysfunction precedes the formation of these insol. fibrillar deposits, suggesting that earlier prefibrillar Tau aggregates may be neurotoxic.  To det. the compn. of these aggregates, we have employed a photochem. crosslinking technique to examine intermol. interactions of full-length Tau in vitro.  Using this method, we demonstrate that dimerization is an early event in the Tau aggregation process and that these dimers self-assoc. to form larger oligomeric aggregates.  Moreover, using these stabilized Tau aggregates as immunogens, we generated a monoclonal antibody that selectively recognizes Tau dimers and higher order oligomeric aggregates but shows little reactivity to Tau filaments in vitro.  Immunostaining indicates that these dimers/oligomers are markedly elevated in AD, appearing in early pathol. inclusions such as neuropil threads and pretangle neurons as well as colocalizing with other early markers of Tau pathogenesis.  Taken as a whole, the work presented herein demonstrates the existence of alternative Tau aggregates that precede formation of fibrillar Tau pathologies and raises the possibility that these hierarchical oligomeric forms of Tau may contribute to neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGR3uIS5yFVbVg90H21EOLACvtfcHk0lh9Y1mpxKccrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFersr0%253D&md5=6baddf052e7c2d7458ae47e9b5391451</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.237974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.237974%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DK.%2BR.%26aulast%3DRemmers%26aufirst%3DC.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DBrooker%26aufirst%3DS.%26aulast%3DKanaan%26aufirst%3DN.%2BM.%26aulast%3DVana%26aufirst%3DL.%26aulast%3DWard%26aufirst%3DS.%26aulast%3DReyes%26aufirst%3DJ.%2BF.%26aulast%3DPhilibert%26aufirst%3DK.%26aulast%3DGlucksman%26aufirst%3DM.%2BJ.%26aulast%3DBinder%26aufirst%3DL.%2BI.%26atitle%3DCharacterization%2520of%2520prefibrillar%2520Tau%2520oligomers%2520in%2520vitro%2520and%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D23063%26epage%3D23076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Green, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beelen, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swabb, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavitz, K. H.</span><span> </span><span class="NLM_article-title">Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">2557</span><span class="NLM_x">–</span> <span class="NLM_lpage">2564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2009&pages=2557-2564&author=R.+C.+Greenauthor=L.+S.+Schneiderauthor=D.+A.+Amatoauthor=A.+P.+Beelenauthor=G.+Wilcockauthor=E.+A.+Swabbauthor=K.+H.+Zavitz&title=Effect+of+tarenflurbil+on+cognitive+decline+and+activities+of+daily+living+in+patients+with+mild+Alzheimer+disease%3A+a+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DR.%2BC.%26aulast%3DSchneider%26aufirst%3DL.%2BS.%26aulast%3DAmato%26aufirst%3DD.%2BA.%26aulast%3DBeelen%26aufirst%3DA.%2BP.%26aulast%3DWilcock%26aufirst%3DG.%26aulast%3DSwabb%26aufirst%3DE.%2BA.%26aulast%3DZavitz%26aufirst%3DK.%2BH.%26atitle%3DEffect%2520of%2520tarenflurbil%2520on%2520cognitive%2520decline%2520and%2520activities%2520of%2520daily%2520living%2520in%2520patients%2520with%2520mild%2520Alzheimer%2520disease%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2009%26volume%3D302%26spage%3D2557%26epage%3D2564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sabbagh, M. N.</span><span> </span><span class="NLM_article-title">Drug development for Alzheimer’s disease: Where are we now and where are we headed?</span> <span class="citation_source-journal">Am. J. Geriatr. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.amjopharm.2009.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=19616185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpslaqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=167-185&author=M.+N.+Sabbagh&title=Drug+development+for+Alzheimer%E2%80%99s+disease%3A+Where+are+we+now+and+where+are+we+headed%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Drug development for Alzheimer's disease: where are we now and where are we headed?</span></div><div class="casAuthors">Sabbagh, Marwan N.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Geriatric Pharmacotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-185</span>CODEN:
                <span class="NLM_cas:coden">AJGPB5</span>;
        ISSN:<span class="NLM_cas:issn">1543-5946</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Objective: The aim of this article was to provide a survey of the clin. development of pharmacotherapy for Alzheimer's disease (AD).  Methods: A search of PubMed to identify pertinent English-language literature was conducted using the terms Alzheimer's disease AND clin. trials (2003-2008), dementia AND prevention AND clin. trials (2003-2008), and the chem. names of all compds. mentioned in articles on new drugs for AD published since 2005.  Www.ClinicalTrials.gov was searched for relevant trials.  Abstrs. of the 2008 International Conference on Alzheimer's Disease (ICAD) were reviewed for relevance, as were pharmaceutical company and AD advocacy Web sites.  Articles selected for review were primary reports of data from preclin. studies and clin. trials.  Results: A large no. of drugs with differing targets and mechanisms of action are under development for the treatment of AD.  Phase III trials of Ginkgo biloba, NSAIDs, phenserine, statins, tarenflurbil, tramiprosate, and xaliproden have been completed, none of them demonstrating adequate efficacy.  Encouraging results from completed Phase II trials of dimebon, huperzine A, i.v. Ig, and methylthioninium chloride were reported at ICAD 2008.  Nineteen compds. are currently in Phase II trials, and 3 compds. (AN1792, lecozotan SR, and SGS742) failed at this stage of development.  Conclusions: Despite disappointing results from recently completed Phase III trials of several novel compds., the extent and breadth of activity at all phases of clin. development suggest that new pharmacotherapeutic options for the treatment of AD will become available within the next decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA46qmUaTUX7Vg90H21EOLACvtfcHk0lhlP3t4AYpMgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpslaqu7k%253D&md5=fbf0ab80c77a77ebc44a130309cb9434</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.amjopharm.2009.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjopharm.2009.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26atitle%3DDrug%2520development%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Where%2520are%2520we%2520now%2520and%2520where%2520are%2520we%2520headed%253F%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Pharmacother.%26date%3D2009%26volume%3D7%26spage%3D167%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span> </span><span class="NLM_article-title">Targeting Abeta and tau in Alzheimer’s disease, an early interim report</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">223</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.expneurol.2009.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=19716367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFShsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2010&pages=252-266&author=T.+E.+Goldeauthor=L.+Petrucelliauthor=J.+Lewis&title=Targeting+Abeta+and+tau+in+Alzheimer%E2%80%99s+disease%2C+an+early+interim+report"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Aβ and tau in Alzheimer's disease, an early interim report</span></div><div class="casAuthors">Golde, Todd E.; Petrucelli, Leonard; Lewis, Jada</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">252-266</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The amyloid β (Aβ) and tau proteins, which misfold, aggregate, and accumulate in the Alzheimer's disease (AD) brain, are implicated as central factors in a complex neurodegenerative cascade.  Studies of mutations that cause early onset AD and promote Aβ accumulation in the brain strongly support the notion that inhibiting Aβ aggregation will prevent AD.  Similarly, genetic studies of frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17 MAPT) showing that mutations in the MAPT gene encoding tau lead to abnormal tau accumulation and neurodegeneration.  Such genetic studies clearly show that tau dysfunction and aggregation can be central to neurodegeneration, however, most likely in a secondary fashion in relation to AD.  Addnl. pathol., biochem., and modeling studies further support the concept that Aβ and tau are prime targets for disease modifying therapies in AD.  Treatment strategies aimed at preventing the aggregation and accumulation of Aβ, tau, or both proteins should therefore be theor. possible, assuming that treatment can be initiated before either irreversible damage is present or downstream, self-sustaining, pathol. cascades have been initiated.  Herein, we will review recent advances and also potential setbacks with respect to the myriad of therapeutic strategies that are designed to slow down, prevent, or clear the accumulation of either "pathol." Aβ or tau.  We will also discuss the need for thoughtful prioritization with respect to clin. development of the preclinically validated modifiers of Aβ and tau pathol.  The current no. of candidate therapies targeting Aβ is becoming so large that a triage process is clearly needed to insure that resources are invested in a way such that the best candidates for disease modifying therapy are rapidly moved toward clin. trials.  Finally, we will discuss the challenges for an appropriate "triage" after potential disease modifying therapies targeting tau and Aβ have entered clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom0oGH_CvQYrVg90H21EOLACvtfcHk0lhlP3t4AYpMgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFShsrw%253D&md5=5364e5607732e0888d76cd4565496b30</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2009.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2009.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DPetrucelli%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DJ.%26atitle%3DTargeting%2520Abeta%2520and%2520tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520an%2520early%2520interim%2520report%26jtitle%3DExp.%2520Neurol.%26date%3D2010%26volume%3D223%26spage%3D252%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hamley, I. W.</span><span> </span><span class="NLM_article-title">The amyloid beta peptide: a chemist’s perspective. Role in Alzheimer’s and fibrillization</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">5147</span><span class="NLM_x">–</span> <span class="NLM_lpage">5192</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr3000994" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=5147-5192&author=I.+W.+Hamley&title=The+amyloid+beta+peptide%3A+a+chemist%E2%80%99s+perspective.+Role+in+Alzheimer%E2%80%99s+and+fibrillization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fcr3000994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr3000994%26sid%3Dliteratum%253Aachs%26aulast%3DHamley%26aufirst%3DI.%2BW.%26atitle%3DThe%2520amyloid%2520beta%2520peptide%253A%2520a%2520chemist%25E2%2580%2599s%2520perspective.%2520Role%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520fibrillization%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D5147%26epage%3D5192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Estrada, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, C.</span><span> </span><span class="NLM_article-title">Disrupting beta-amyloid aggregation for Alzheimer disease treatment</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F156802607779318262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17266599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Wjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=115-126&author=L.+D.+Estradaauthor=C.+Soto&title=Disrupting+beta-amyloid+aggregation+for+Alzheimer+disease+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupting β-amyloid aggregation for Alzheimer disease treatment</span></div><div class="casAuthors">Estrada, L. D.; Soto, C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-126</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is a devastating degenerative disorder for which there is no cure or effective treatment.  Although the etiol. of Alzheimer's disease is not fully understood, compelling evidence indicates that deposition of aggregates composed by a misfolded form of the amyloid beta peptide (Aβ) is the central event in the disease pathogenesis.  Therefore, an attractive therapeutic strategy is to prevent or reverse Aβ misfolding and aggregation.  Diverse strategies have been described to identify inhibitors of this process, including screening of libraries of small mols. chem. compds., rational design of synthetic peptides, assessment of natural Aβ-binding proteins and stimulation of the immune system by vaccination.  In this article we describe these different approaches, their principles and their potential strengths and weaknesses.  Overall the available data suggest that the development of drugs to interfere with Aβ misfolding and aggregation is a feasible target that hold great promise for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqaHC31lKaYbVg90H21EOLACvtfcHk0lgbp9Cs1L_ksA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Wjs7c%253D&md5=0b7d22ef53b075c9cdd9a7ee5c1ece06</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F156802607779318262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607779318262%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DL.%2BD.%26aulast%3DSoto%26aufirst%3DC.%26atitle%3DDisrupting%2520beta-amyloid%2520aggregation%2520for%2520Alzheimer%2520disease%2520treatment%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D115%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Di Carlo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomazza, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Biagio, P. L.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: biological aspects, therapeutic perspectives and diagnostic tools</span> <span class="citation_source-journal">J. Phys.: Condens. Matter</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">244102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1088%2F0953-8984%2F24%2F24%2F244102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22595372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWiu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=244102&author=M.+Di+Carloauthor=D.+Giacomazzaauthor=P.+L.+San+Biagio&title=Alzheimer%E2%80%99s+disease%3A+biological+aspects%2C+therapeutic+perspectives+and+diagnostic+tools"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: biological aspects, therapeutic perspectives and diagnostic tools</span></div><div class="casAuthors">Di Carlo, M.; Giacomazza, D.; San Biagio, P. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physics: Condensed Matter</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">244102/1-244102/17</span>CODEN:
                <span class="NLM_cas:coden">JCOMEL</span>;
        ISSN:<span class="NLM_cas:issn">0953-8984</span>.
    
            (<span class="NLM_cas:orgname">Institute of Physics Publishing</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia among older people.  Dementia is an irreversible brain disorder that seriously affects a person's ability to carry out daily activities.  It is characterized by loss of cognitive functioning and behavioral abilities, to such an extent that it interferes with the daily life and activities of the affected patients.  Although it is still unknown how the disease process begins, it seems that brain damage starts a decade or more before problems become evident.  Scientific data seem to indicate that changes in the generation or the degrdn. of the amyloid-β peptide (Aβ) lead to the formation of aggregated structures that are the triggering mol. events in the pathogenic cascade of AD.  This review summarizes some characteristic features of Aβ misfolding and aggregation and how cell damage and death mechanisms are induced by these supramol. and toxic structures.  Further, some interventions for the early diagnosis of AD are described and in the last part the potential therapeutic strategies adoptable to slow down, or better block, the progression of the pathol. are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYDxwPOzYttbVg90H21EOLACvtfcHk0lgbp9Cs1L_ksA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWiu7rF&md5=200d6b8e386421a30c3a3ad7cd6f0057</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1088%2F0953-8984%2F24%2F24%2F244102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1088%252F0953-8984%252F24%252F24%252F244102%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCarlo%26aufirst%3DM.%26aulast%3DGiacomazza%26aufirst%3DD.%26aulast%3DSan%2BBiagio%26aufirst%3DP.%2BL.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520biological%2520aspects%252C%2520therapeutic%2520perspectives%2520and%2520diagnostic%2520tools%26jtitle%3DJ.%2520Phys.%253A%2520Condens.%2520Matter%26date%3D2012%26volume%3D24%26spage%3D244102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Mangialasche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mecocci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kivipelto, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: clinical trials and drug development</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2FS1474-4422%2810%2970119-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20610346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFajur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=702-716&author=F.+Mangialascheauthor=A.+Solomonauthor=B.+Winbladauthor=P.+Mecocciauthor=M.+Kivipelto&title=Alzheimer%E2%80%99s+disease%3A+clinical+trials+and+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: clinical trials and drug development</span></div><div class="casAuthors">Mangialasche, Francesca; Solomon, Alina; Winblad, Bengt; Mecocci, Patrizia; Kivipelto, Miia</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">702-716</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is the most common cause of dementia in elderly people.  Research into Alzheimer's disease therapy has been at least partly successful in terms of developing symptomatic treatments, but has also had several failures in terms of developing disease-modifying therapies.  These successes and failures have led to debate about the potential deficiencies in our understanding of the pathogenesis of Alzheimer's disease and potential pitfalls in diagnosis, choice of therapeutic targets, development of drug candidates, and design of clin. trials.  Many clin. and exptl. studies are ongoing, but we need to acknowledge that a single cure for Alzheimer's disease is unlikely to be found and that the approach to drug development for this disorder needs to be reconsidered.  Preclin. research is constantly providing us with new information on pieces of the complex Alzheimer's disease puzzle, and an anal. of this information might reveal patterns of pharmacol. interactions instead of single potential drug targets.  Several promising randomized controlled trials are ongoing, and the increased collaboration between pharmaceutical companies, basic researchers, and clin. researchers has the potential to bring us closer to developing an optimum pharmaceutical approach for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIaQ4TlzK_v7Vg90H21EOLACvtfcHk0lgbp9Cs1L_ksA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFajur8%253D&md5=8641c7a6fdb89aa80a2e35fbd2f369a1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2810%2970119-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252810%252970119-8%26sid%3Dliteratum%253Aachs%26aulast%3DMangialasche%26aufirst%3DF.%26aulast%3DSolomon%26aufirst%3DA.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DMecocci%26aufirst%3DP.%26aulast%3DKivipelto%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520clinical%2520trials%2520and%2520drug%2520development%26jtitle%3DLancet%2520Neurol.%26date%3D2010%26volume%3D9%26spage%3D702%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wischik, C. M.; Rickard, J. E.; Harrington, C. R.; Horsley, D.; Storey, J. M. D.; Marshall, C.; Sinclair, J. P.</span><span> </span><span class="NLM_article-title">Preparation of Phenothiazine Derivatives for Treatment of Tauopathy</span>. PCT Int. Appl. WO 2007110630,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=C.+M.+Wischik&author=J.+E.+Rickard&author=C.+R.+Harrington&author=D.+Horsley&author=J.+M.+D.+Storey&author=C.+Marshall&author=J.+P.+Sinclair&title=Preparation+of+Phenothiazine+Derivatives+for+Treatment+of+Tauopathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWischik%26aufirst%3DC.%2BM.%26atitle%3DPreparation%2520of%2520Phenothiazine%2520Derivatives%2520for%2520Treatment%2520of%2520Tauopathy%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Nie, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M. Y.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of amyloid beta peptide aggregation as a potential therapeutic strategy for Alzheimer’s disease</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Faps.2011.14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21499284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFKgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=545-551&author=Q.+Nieauthor=X.+G.+Duauthor=M.+Y.+Geng&title=Small+molecule+inhibitors+of+amyloid+beta+peptide+aggregation+as+a+potential+therapeutic+strategy+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease</span></div><div class="casAuthors">Nie, Qin; Du, Xiao-guang; Geng, Mei-yu</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">545-551</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Amyloid β (Aβ) peptides have long been viewed as a potential target for Alzheimer's disease (AD).  Aggregation of Aβ peptides in the brain tissue is believed to be an exclusively pathol. process.  Therefore, blocking the initial stages of Aβ peptide aggregation with small mols. could hold considerable promise as the starting point for the development of new therapies for AD.  Recent rapid progresses in our understanding of toxic amyloid assembly provide a fresh impetus for this interesting approach.  Here, we discuss the problems, challenges and new concepts in targeting Aβ peptides.  Acta Pharmacologica Sinica (2011) 32: 545-551; doi: 10.1038/aps.2011.14; published online 18 Apr 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrROzsHwdwhHbVg90H21EOLACvtfcHk0limVc75kbko6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFKgtb4%253D&md5=243954abf169e75b7ed55f3096afb34b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Faps.2011.14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2011.14%26sid%3Dliteratum%253Aachs%26aulast%3DNie%26aufirst%3DQ.%26aulast%3DDu%26aufirst%3DX.%2BG.%26aulast%3DGeng%26aufirst%3DM.%2BY.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520amyloid%2520beta%2520peptide%2520aggregation%2520as%2520a%2520potential%2520therapeutic%2520strategy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2011%26volume%3D32%26spage%3D545%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Holmes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boche, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadegarfar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neal, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zotova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll, J. A.</span><span> </span><span class="NLM_article-title">Long-term effects of Abeta42 immunisation in Alzheimer’s disease: follow-up of a randomised, placebo-controlled phase I trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2008&pages=216-223&author=C.+Holmesauthor=D.+Bocheauthor=D.+Wilkinsonauthor=G.+Yadegarfarauthor=V.+Hopkinsauthor=A.+Bayerauthor=R.+W.+Jonesauthor=R.+Bullockauthor=S.+Loveauthor=J.+W.+Nealauthor=E.+Zotovaauthor=J.+A.+Nicoll&title=Long-term+effects+of+Abeta42+immunisation+in+Alzheimer%E2%80%99s+disease%3A+follow-up+of+a+randomised%2C+placebo-controlled+phase+I+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DC.%26aulast%3DBoche%26aufirst%3DD.%26aulast%3DWilkinson%26aufirst%3DD.%26aulast%3DYadegarfar%26aufirst%3DG.%26aulast%3DHopkins%26aufirst%3DV.%26aulast%3DBayer%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DR.%2BW.%26aulast%3DBullock%26aufirst%3DR.%26aulast%3DLove%26aufirst%3DS.%26aulast%3DNeal%26aufirst%3DJ.%2BW.%26aulast%3DZotova%26aufirst%3DE.%26aulast%3DNicoll%26aufirst%3DJ.%2BA.%26atitle%3DLong-term%2520effects%2520of%2520Abeta42%2520immunisation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520follow-up%2520of%2520a%2520randomised%252C%2520placebo-controlled%2520phase%2520I%2520trial%26jtitle%3DLancet%26date%3D2008%26volume%3D372%26spage%3D216%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellas, B.</span><span> </span><span class="NLM_article-title">Editorial: passive immunotherapy for Alzheimer’s disease: What have we learned, and where are we headed?</span> <span class="citation_source-journal">J. Nutr., Health Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1007%2Fs12603-013-0001-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=23299379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BC3s3nslKjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=49-50&author=P.+S.+Aisenauthor=B.+Vellas&title=Editorial%3A+passive+immunotherapy+for+Alzheimer%E2%80%99s+disease%3A+What+have+we+learned%2C+and+where+are+we+headed%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Passive immunotherapy for Alzheimer's disease: what have we learned, and where are we headed?</span></div><div class="casAuthors">Aisen P S; Vellas B</div><div class="citationInfo"><span class="NLM_cas:title">The journal of nutrition, health & aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-50</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-VXyD7KCpiWmbXvSEQle5fW6udTcc2eaCPjaB2drGr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3nslKjuw%253D%253D&md5=d2a2a4e92cf9f75697acea43d00e95ac</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs12603-013-0001-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12603-013-0001-3%26sid%3Dliteratum%253Aachs%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DVellas%26aufirst%3DB.%26atitle%3DEditorial%253A%2520passive%2520immunotherapy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520What%2520have%2520we%2520learned%252C%2520and%2520where%2520are%2520we%2520headed%253F%26jtitle%3DJ.%2520Nutr.%252C%2520Health%2520Aging%26date%3D2013%26volume%3D17%26spage%3D49%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Biochemistry and cell biology of tau protein in neurofibrillary degeneration</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1101%2Fcshperspect.a006247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22762014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlemtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a006247&author=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Biochemistry+and+cell+biology+of+tau+protein+in+neurofibrillary+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry and cell biology of tau protein in neurofibrillary degeneration</span></div><div class="casAuthors">Mandelkow, Eva-Maria; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">a006247/1-a006247/25</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Tau represents the subunit protein of one of the major hallmarks of Alzheimer disease (AD), the neurofibrillary tangles, and is therefore of major interest as an indicator of disease mechanisms.  Many of the unusual properties of Tau can be explained by its nature as a natively unfolded protein.  Examples are the large no. of structural conformations and biochem. modifications (phosphorylation, proteolysis, glycosylation, and others), the multitude of interaction partners (mainly microtubules, but also other cytoskeletal proteins, kinases, and phosphatases, motor proteins, chaperones, and membrane proteins).  The pathol. aggregation of Tau is counterintuitive, given its high soly., but can be rationalized by short hydrophobic motifs forming β structures.  The aggregation of Tau is toxic in cell and animal models, but can be reversed by suppressing expression or by aggregation inhibitors.  This review summarizes some of the structural, biochem., and cell biol. properties of Tau and Tau fibers.  Further aspects of Tau as a diagnostic marker and therapeutic target, its involvement in other Tau-based diseases, and its histopathol. are covered by other chapters in this vol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKzKbGbJg9zrVg90H21EOLACvtfcHk0limVc75kbko6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlemtb8%253D&md5=d28fa3d4f1b17ec95b53c228c7dd9d25</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006247%26sid%3Dliteratum%253Aachs%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DBiochemistry%2520and%2520cell%2520biology%2520of%2520tau%2520protein%2520in%2520neurofibrillary%2520degeneration%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da006247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Himmelstein, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancia, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, L. I.</span><span> </span><span class="NLM_article-title">Tau as a therapeutic target in neurodegenerative disease</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.pharmthera.2012.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22790092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFahsbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2012&pages=8-22&author=D.+S.+Himmelsteinauthor=S.+M.+Wardauthor=J.+K.+Lanciaauthor=K.+R.+Pattersonauthor=L.+I.+Binder&title=Tau+as+a+therapeutic+target+in+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Tau as a therapeutic target in neurodegenerative disease</span></div><div class="casAuthors">Himmelstein, Diana S.; Ward, Sarah M.; Lancia, Jody K.; Patterson, Kristina R.; Binder, Lester I.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-22</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Tau is a microtubule-assocd. protein thought to help modulate the stability of neuronal microtubules.  In tauopathies, including Alzheimer's disease and several frontotemporal dementias, tau is abnormally modified and misfolded resulting in its disassocn. from microtubules and the generation of pathol. lesions characteristic for each disease.  A recent surge in the population of people with neurodegenerative tauopathies has highlighted the immense need for disease-modifying therapies for these conditions, and new attention has focused on tau as a potential target for intervention.  In the current work we summarize evidence linking tau to disease pathogenesis and review recent therapeutic approaches aimed at ameliorating tau dysfunction.  The primary therapeutic tactics considered include kinase inhibitors and phosphatase activators, immunotherapies, small mol. inhibitors of protein aggregation, and microtubule-stabilizing agents.  Although the evidence for tau-based treatments is encouraging, addnl. work is undoubtedly needed to optimize each treatment strategy for the successful development of safe and effective therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2FtQkgbrvLLVg90H21EOLACvtfcHk0lgHxIe62h9qtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFahsbjM&md5=6dfd790eccaec71c2baf56a9967eb734</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2012.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2012.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DHimmelstein%26aufirst%3DD.%2BS.%26aulast%3DWard%26aufirst%3DS.%2BM.%26aulast%3DLancia%26aufirst%3DJ.%2BK.%26aulast%3DPatterson%26aufirst%3DK.%2BR.%26aulast%3DBinder%26aufirst%3DL.%2BI.%26atitle%3DTau%2520as%2520a%2520therapeutic%2520target%2520in%2520neurodegenerative%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2012%26volume%3D136%26spage%3D8%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Noble, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pooler, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanger, D. P.</span><span> </span><span class="NLM_article-title">Advances in tau-based drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=797-810&author=W.+Nobleauthor=A.+M.+Poolerauthor=D.+P.+Hanger&title=Advances+in+tau-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoble%26aufirst%3DW.%26aulast%3DPooler%26aufirst%3DA.%2BM.%26aulast%3DHanger%26aufirst%3DD.%2BP.%26atitle%3DAdvances%2520in%2520tau-based%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D797%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D. M.</span><span> </span><span class="NLM_article-title">Modulation of protein–protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F156802611794072605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21320060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslahsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=317-330&author=C.+Ballatoreauthor=K.+R.+Brundenauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=A.+B.+Smithauthor=D.+M.+Huryn&title=Modulation+of+protein%E2%80%93protein+interactions+as+a+therapeutic+strategy+for+the+treatment+of+neurodegenerative+tauopathies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies</span></div><div class="casAuthors">Ballatore, C.; Brunden, K. R.; Trojanowski, J. Q.; Lee, V. M.-Y.; Smith, A. B., III; Huryn, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-330</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The recognition that malfunction of the microtubule (MT) assocd. protein tau is likely to play a defining role in the onset and/or progression of a no. of neurodegenerative diseases, including Alzheimer's disease, has resulted in the initiation of drug discovery programs that target this protein.  Tau is an endogenous MT-stabilizing agent that is highly expressed in the axons of neurons.  The MT-stabilizing function of tau is essential for the axonal transport of proteins, neurotransmitters and other cellular constituents.  Under pathol. conditions, tau misfolding and aggregation results in axonal transport deficits that appear to have deleterious consequences for the affected neurons, leading to synapse dysfunction and, ultimately, neuronal loss.  This review focuses on both progress and unresolved issues surrounding the development of novel therapeutics for the treatment of neurodegenerative tauopathies, which are based on (A) MT-stabilizing agents to compensate for the loss of normal tau function and (B) small mol. inhibitors of tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRv3v9WR9uIrVg90H21EOLACvtfcHk0lgHxIe62h9qtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslahsLk%253D&md5=b35d6ff9dac27b56e59f1e2fd5b8fafd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F156802611794072605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611794072605%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26atitle%3DModulation%2520of%2520protein%25E2%2580%2593protein%2520interactions%2520as%2520a%2520therapeutic%2520strategy%2520for%2520the%2520treatment%2520of%2520neurodegenerative%2520tauopathies%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D317%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Advances in tau-focused drug discovery for Alzheimer’s disease and related tauopathies</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=783-793&author=K.+R.+Brundenauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=Advances+in+tau-focused+drug+discovery+for+Alzheimer%E2%80%99s+disease+and+related+tauopathies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DAdvances%2520in%2520tau-focused%2520drug%2520discovery%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520related%2520tauopathies%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D783%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Rosenmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoriadis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karussis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boimel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Touloumi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovadia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramsky, O.</span><span> </span><span class="NLM_article-title">Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1459</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1001%2Farchneur.63.10.1459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17030663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BD28rpvVenuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2006&pages=1459-1467&author=H.+Rosenmannauthor=N.+Grigoriadisauthor=D.+Karussisauthor=M.+Boimelauthor=O.+Touloumiauthor=H.+Ovadiaauthor=O.+Abramsky&title=Tauopathy-like+abnormalities+and+neurologic+deficits+in+mice+immunized+with+neuronal+tau+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein</span></div><div class="casAuthors">Rosenmann Hanna; Grigoriadis Nikolaos; Karussis Dimitrios; Boimel Moran; Touloumi Olga; Ovadia Haim; Abramsky Oded</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1459-67</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">BACKGROUND:  A possible role of autoimmunity in Alzheimer disease pathogenesis has recently attracted increasing attention.  Vaccination with amyloid-beta peptide was reported to cause marked reduction in amyloid deposition, but it also induced encephalitis.  Not much is known regarding neurofibrillary tangle-related autoimmune effects.  OBJECTIVE:  To use the main component of tangles-microtubule-associated tau protein-to test the feasibility of active induction of a neuroautoimmune disorder in mice.  DESIGN:  Prospective, randomized controlled animal study.  SETTING:  University medical center research laboratory.  Subjects Female C57BL/6 mice.  INTERVENTIONS:  Inoculation with recombinant human tau protein emulsified in complete Freund adjuvant and with pertussis toxin.  MAIN OUTCOME MEASURES:  Clinical, immunologic, pathologic, and behavioral evaluations were performed.  RESULTS:  Vaccination with tau protein induced histopathologic features of Alzheimer disease and tauopathies, indicated by the presence of neurofibrillary tangle-like structures, axonal damage, and gliosis.  Also, mononuclear infiltrates without demyelination in the central nervous system, accompanied by neurologic deficits (such as a limp tail and limb paralysis), were observed.  Anti-tau antibodies were detected in the serum of tau-immunized mice.  CONCLUSIONS:  These results provide a link between tau autoimmunity and tauopathy-like abnormalities and indicate potential dangers of using tau for immunotherapy.  This experimental autoimmune tauopathy-like model is due to a pathogenic immune response against an intraneuronal antigen and is not related to myelin antigens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_SFNfeu3JABJ5E29YNGvQfW6udTcc2earXwW06oIAtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rpvVenuw%253D%253D&md5=ee600b23d1c1bc944bca30f66f53c25e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1001%2Farchneur.63.10.1459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.63.10.1459%26sid%3Dliteratum%253Aachs%26aulast%3DRosenmann%26aufirst%3DH.%26aulast%3DGrigoriadis%26aufirst%3DN.%26aulast%3DKarussis%26aufirst%3DD.%26aulast%3DBoimel%26aufirst%3DM.%26aulast%3DTouloumi%26aufirst%3DO.%26aulast%3DOvadia%26aufirst%3DH.%26aulast%3DAbramsky%26aufirst%3DO.%26atitle%3DTauopathy-like%2520abnormalities%2520and%2520neurologic%2520deficits%2520in%2520mice%2520immunized%2520with%2520neuronal%2520tau%2520protein%26jtitle%3DArch.%2520Neurol.%26date%3D2006%26volume%3D63%26spage%3D1459%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Boimel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoriadis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lourbopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramsky, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenmann, H.</span><span> </span><span class="NLM_article-title">Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">224</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.expneurol.2010.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20546729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFCgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2010&pages=472-485&author=M.+Boimelauthor=N.+Grigoriadisauthor=A.+Lourbopoulosauthor=E.+Haberauthor=O.+Abramskyauthor=H.+Rosenmann&title=Efficacy+and+safety+of+immunization+with+phosphorylated+tau+against+neurofibrillary+tangles+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice</span></div><div class="casAuthors">Boimel, Moran; Grigoriadis, Nikolaos; Lourbopoulos, Athanasios; Haber, Esther; Abramsky, Oded; Rosenmann, Hanna</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">472-485</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As an abnormally folded and aggregated protein, tau composed of neurofibrillary tangles (NFTs) in Alzheimer's disease and other tauopathies seems to be a candidate for immunotherapy.  Yet, the encephalitogenicity of full-length tau protein, recently reported by us in immunized mice, demands to carefully and selectively target pathol. tau and address both efficacy (anti-NFT effect) and safety (free of encephalitis).  We immunized NFT mice with NFT-related phosphorylated (phos) tau peptides, using an immunization protocol aimed to predispose a proinflammatory milieu in CNS as a set up to detect biohazard, an approach we used when the neurotoxicity of full-length tau was detected [use of complete Freund adjuvant (CFA) with pertussis toxin (PT)].  A decrease of about 40% in NFT burden in CNS was demonstrated and was accompanied with an increase in microglial burden.  Anti-phos-tau antibodies were detected in serum and blood vessels in the CNS, while no encephalitogenicity (free of clin. neurol. deficits, of adverse effects on brain inflammatory cells and of axonal damage) was recorded.  The level of the lysosomal proteases, cathepsins D and L, was affected in the immunized mice suggesting the possible involvement of the lysosomal system in the decrease of NFTs.  The robust anti-NFT effect and the lack of encephalitogenicity in NFT mice immunized with phos-tau peptides, even though CFA with PT was included in vaccine, point to their anti-NFT therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPkI0KKjFAo7Vg90H21EOLACvtfcHk0li4cr_14yhORQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFCgt7s%253D&md5=73c4539303a642b21109966ca35a71c9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2010.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2010.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DBoimel%26aufirst%3DM.%26aulast%3DGrigoriadis%26aufirst%3DN.%26aulast%3DLourbopoulos%26aufirst%3DA.%26aulast%3DHaber%26aufirst%3DE.%26aulast%3DAbramsky%26aufirst%3DO.%26aulast%3DRosenmann%26aufirst%3DH.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520immunization%2520with%2520phosphorylated%2520tau%2520against%2520neurofibrillary%2520tangles%2520in%2520mice%26jtitle%3DExp.%2520Neurol.%26date%3D2010%26volume%3D224%26spage%3D472%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Asuni, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutajangout, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quartermain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdsson, E. M.</span><span> </span><span class="NLM_article-title">Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">9115</span><span class="NLM_x">–</span> <span class="NLM_lpage">9129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1523%2FJNEUROSCI.2361-07.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17715348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSnsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=9115-9129&author=A.+A.+Asuniauthor=A.+Boutajangoutauthor=D.+Quartermainauthor=E.+M.+Sigurdsson&title=Immunotherapy+targeting+pathological+tau+conformers+in+a+tangle+mouse+model+reduces+brain+pathology+with+associated+functional+improvements"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy targeting pathological Tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements</span></div><div class="casAuthors">Asuni, Ayodeji A.; Boutajangout, Allal; Quartermain, David; Sigurdsson, Einar M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">9115-9129</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Immunotherapies for various neurodegenerative diseases have recently emerged as a promising approach for clearing pathol. protein conformers in these disorders.  This type of treatment has not been assessed in models that develop neuronal tau aggregates as obsd. in frontotemporal dementia and Alzheimer's disease.  Here, we present that active immunization with a phosphorylated tau epitope, in P301L tangle model mice, reduces aggregated tau in the brain and slows progression of the tangle-related behavioral phenotype.  Females had more tau pathol. than males but were also more receptive to the immunotherapy.  The tau antibodies generated in these animals recognized pathol. tau on brain sections.  Performance on behavioral assays that require extensive motor coordination correlated with tau pathol. in corresponding brain areas, and antibody levels against the immunogen correlated inversely with tau pathol.  Interestingly, age-dependent autoantibodies that recognized recombinant tau protein but not the immunogen were detected in the P301L mice.  To confirm that anti-tau antibodies could enter the brain and bind to pathol. tau, FITC-tagged antibodies purified from a P301L mouse, with a high antibody titer against the immunogen, were injected into the carotid artery of P301L mice.  These antibodies were subsequently detected within the brain and colocalized with PHF1 and MC1 antibodies that recognize pathol. tau.  Currently, no treatment is available for clearing tau aggregates.  Our present findings may lead to a novel therapy targeting one of the major hallmarks of Alzheimer's disease and frontotemporal dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkAMut_6Cw-7Vg90H21EOLACvtfcHk0li4cr_14yhORQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSnsLbN&md5=7336ed21cebd455b68db373044bf3797</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2361-07.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2361-07.2007%26sid%3Dliteratum%253Aachs%26aulast%3DAsuni%26aufirst%3DA.%2BA.%26aulast%3DBoutajangout%26aufirst%3DA.%26aulast%3DQuartermain%26aufirst%3DD.%26aulast%3DSigurdsson%26aufirst%3DE.%2BM.%26atitle%3DImmunotherapy%2520targeting%2520pathological%2520tau%2520conformers%2520in%2520a%2520tangle%2520mouse%2520model%2520reduces%2520brain%2520pathology%2520with%2520associated%2520functional%2520improvements%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D9115%26epage%3D9129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Boutajangout, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quartermain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdsson, E. M.</span><span> </span><span class="NLM_article-title">Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">16559</span><span class="NLM_x">–</span> <span class="NLM_lpage">16566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1523%2FJNEUROSCI.4363-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21147995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2nurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=16559-16566&author=A.+Boutajangoutauthor=D.+Quartermainauthor=E.+M.+Sigurdsson&title=Immunotherapy+targeting+pathological+tau+prevents+cognitive+decline+in+a+new+tangle+mouse+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy targeting pathological Tau prevents cognitive decline in a new tangle mouse model</span></div><div class="casAuthors">Boutajangout, Allal; Quartermain, David; Sigurdsson, Einar M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">16559-16566</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Harnessing the immune system to clear protein aggregates is emerging as a promising approach to treat various neurodegenerative diseases.  In Alzheimer's disease (AD), several clin. trials are ongoing using active and passive immunotherapy targeting the amyloid-β (Aβ) peptide.  Limited emphasis has been put into clearing tau/tangle pathol., another major hallmark of the disease.  Recent findings from the first Aβ vaccination trial suggest that this approach has limited effect on tau pathol. and that Aβ plaque clearance may not halt or slow the progression of dementia in individuals with mild-to-moderate AD.  To assess within a reasonable timeframe whether targeting tau pathol. with immunotherapy could prevent cognitive decline, we developed a new model with accelerated tangle development.  It was generated by crossing available strains that express all six human tau isoforms and the M146L presenilin mutation.  Here, we show that this unique approach completely prevents severe cognitive impairment in three different tests.  This remarkable effect correlated well with extensive clearance of abnormal tau within the brain.  Overall, our findings indicate that immunotherapy targeting pathol. tau is very feasible for tauopathies, and should be assessed in clin. trials in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcNSh5qcUrb7Vg90H21EOLACvtfcHk0li4cr_14yhORQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2nurjI&md5=54d56cb56f1981982c781c2c8b86a07e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4363-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4363-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DBoutajangout%26aufirst%3DA.%26aulast%3DQuartermain%26aufirst%3DD.%26aulast%3DSigurdsson%26aufirst%3DE.%2BM.%26atitle%3DImmunotherapy%2520targeting%2520pathological%2520tau%2520prevents%2520cognitive%2520decline%2520in%2520a%2520new%2520tangle%2520mouse%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D16559%26epage%3D16566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Troquier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caillierez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnouf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Gomez, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosjean, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zommer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sergeant, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schraen-Maschke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buee, L.</span><span> </span><span class="NLM_article-title">Targeting phospho-Ser422 by active Tau immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F156720512800492503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22272619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BC38vhtVOhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=397-405&author=L.+Troquierauthor=R.+Caillierezauthor=S.+Burnoufauthor=F.+J.+Fernandez-Gomezauthor=M.+E.+Grosjeanauthor=N.+Zommerauthor=N.+Sergeantauthor=S.+Schraen-Maschkeauthor=D.+Blumauthor=L.+Buee&title=Targeting+phospho-Ser422+by+active+Tau+immunotherapy+in+the+THYTau22+mouse+model%3A+a+suitable+therapeutic+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach</span></div><div class="casAuthors">Troquier Laetitia; Caillierez Raphaelle; Burnouf Sylvie; Fernandez-Gomez Francisco J; Grosjean Marie-Eve; Zommer Nadege; Sergeant Nicolas; Schraen-Maschke Susanna; Blum David; Buee Luc</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">397-405</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recent data indicate that Tau immunotherapy may be relevant for interfering with neurofibrillary degeneration in Alzheimer disease and related disorders referred to as Tauopathies.  The key question for immunotherapy is the choice of the epitope to target.  Abnormal phosphorylation is a well-described post-translational modification of Tau proteins and may be a good target.  In the present study, we investigated the effects of active immunization against the pathological epitope phospho-Ser422 in the THY-Tau22 transgenic mouse model.  Starting from 3-6 months of age, THY-Tau22 mice develop hippocampal neurofibrillary tangle-like inclusions and exhibit phosphorylation of Tau on several AD-relevant Tau epitopes.  Three month-old THY-Tau22 mice were immunized with a peptide including the phosphoserine 422 residue while control mice received the adjuvant alone.  A specific antibody response against the phospho-Ser422 epitope was observed.  We noticed a decrease in insoluble Tau species (AT100- and pS422 immunoreactive) by both biochemical and immunohistochemical means correlated with a significant cognitive improvement using the Y-maze.  This Tau immunotherapy may facilitate Tau clearance from the brain toward the periphery since, following immunization, an increase in Tau concentrations was observed in blood.  Overall, the present work is, to our knowledge, the first one to demonstrate that active immunotherapy targeting a real pathological epitope such as phospho-Ser422 epitope is efficient.  This immunotherapy allows for Tau clearance and improves cognitive deficits promoted by Tau pathology in a well-defined Tau transgenic model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTgT9V41xcvEiA3UY9EwTNrfW6udTcc2eZFcrUmMWmdcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vhtVOhsA%253D%253D&md5=a235e28d9582ae33719f29f15ce68c86</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F156720512800492503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720512800492503%26sid%3Dliteratum%253Aachs%26aulast%3DTroquier%26aufirst%3DL.%26aulast%3DCaillierez%26aufirst%3DR.%26aulast%3DBurnouf%26aufirst%3DS.%26aulast%3DFernandez-Gomez%26aufirst%3DF.%2BJ.%26aulast%3DGrosjean%26aufirst%3DM.%2BE.%26aulast%3DZommer%26aufirst%3DN.%26aulast%3DSergeant%26aufirst%3DN.%26aulast%3DSchraen-Maschke%26aufirst%3DS.%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DBuee%26aufirst%3DL.%26atitle%3DTargeting%2520phospho-Ser422%2520by%2520active%2520Tau%2520immunotherapy%2520in%2520the%2520THYTau22%2520mouse%2520model%253A%2520a%2520suitable%2520therapeutic%2520approach%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2012%26volume%3D9%26spage%3D397%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Boutajangout, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingadottir, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdsson, E. M.</span><span> </span><span class="NLM_article-title">Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1471-4159.2011.07337.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21644996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVSit7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=658-667&author=A.+Boutajangoutauthor=J.+Ingadottirauthor=P.+Daviesauthor=E.+M.+Sigurdsson&title=Passive+immunization+targeting+pathological+phospho-tau+protein+in+a+mouse+model+reduces+functional+decline+and+clears+tau+aggregates+from+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain</span></div><div class="casAuthors">Boutajangout, Allal; Ingadottir, Johanna; Davies, Peter; Sigurdsson, Einar M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3 & 4</span>),
    <span class="NLM_cas:pages">658-667</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Targeting hyperphosphorylated tau by immunotherapy is emerging as a promising approach to treat tauopathies such as Alzheimer's disease and frontotemporal dementia.  The authors have previously reported that active tau immunization clears tau aggregates from the brain and attenuates or prevents functional impairments in two different tangle mouse models.  Here, the authors assessed the efficacy of passive immunization with the PHF1 antibody, which targets a phospho-epitope within one of the authors' active immunogens.  Homozygous female tangle mice (JNPL3, 2-3 mo) were injected i.p. once per wk with PHF1 or pooled mouse IgG (250 μg/125 μL; per group) for a total of 13 injections.  Their behavior was assessed at 5-6 mo of age and brain tissue was subsequently harvested for analyses of treatment efficacy.  The treated mice performed better than controls on the traverse beam task, and had 58% less tau pathol. in the dentate gyrus of the hippocampus.  As assessed by western blots, the antibody therapy reduced the levels of insol. pathol. tau by 14-27% (PHF1,; PHF1/total tau) and 34-45% (CP13 or CP13/total tau).  Levels of sol. tau and sarkosyl sol. tau were unchanged, compared with controls, as well as total tau levels in all the fractions.  Plasma levels of PHF1 correlated inversely with tau pathol. in the brainstem, with a strong trend in the motor cortex as well as with insol. total tau levels, indicating that higher dose of antibodies may have a greater therapeutic effect.  Significant correlation was also obsd. between performance on the traverse beam task and PHF1 immunoreactivity in the dentate gyrus as well as with insol. PHF1/total tau ratio on western blots.  These results show that passive immunization with tau antibodies can decrease tau pathol. and functional impairments in the JNPL3 model.  Future studies will det. the feasibility of this approach with other monoclonals and in different tangle models in which thorough cognitive assessment can be performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZcfYAUWLolLVg90H21EOLACvtfcHk0lhEfCo1q0Bt_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVSit7bM&md5=cf6d19f67cf7400b2aa3cdf78460251f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07337.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07337.x%26sid%3Dliteratum%253Aachs%26aulast%3DBoutajangout%26aufirst%3DA.%26aulast%3DIngadottir%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DSigurdsson%26aufirst%3DE.%2BM.%26atitle%3DPassive%2520immunization%2520targeting%2520pathological%2520phospho-tau%2520protein%2520in%2520a%2520mouse%2520model%2520reduces%2520functional%2520decline%2520and%2520clears%2520tau%2520aggregates%2520from%2520the%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D2011%26volume%3D118%26spage%3D658%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Chai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cella, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanmer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">34457</span><span class="NLM_x">–</span> <span class="NLM_lpage">34467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=34457-34467&author=X.+Chaiauthor=S.+Wuauthor=T.+K.+Murrayauthor=R.+Kinleyauthor=C.+V.+Cellaauthor=H.+Simsauthor=N.+Bucknerauthor=J.+Hanmerauthor=P.+Daviesauthor=M.+J.+O%E2%80%99Neillauthor=M.+L.+Huttonauthor=M.+Citron&title=Passive+immunization+with+anti-Tau+antibodies+in+two+transgenic+models%3A+reduction+of+Tau+pathology+and+delay+of+disease+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DT.%2BK.%26aulast%3DKinley%26aufirst%3DR.%26aulast%3DCella%26aufirst%3DC.%2BV.%26aulast%3DSims%26aufirst%3DH.%26aulast%3DBuckner%26aufirst%3DN.%26aulast%3DHanmer%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DHutton%26aufirst%3DM.%2BL.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DPassive%2520immunization%2520with%2520anti-Tau%2520antibodies%2520in%2520two%2520transgenic%2520models%253A%2520reduction%2520of%2520Tau%2520pathology%2520and%2520delay%2520of%2520disease%2520progression%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D34457%26epage%3D34467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Krishnamurthy, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdsson, E. M.</span><span> </span><span class="NLM_article-title">Mechanistic studies of antibody-mediated clearance of Tau aggregates using an ex vivo brain slice model</span> <span class="citation_source-journal">Front. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.3389%2Ffpsyt.2011.00059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BC3MbjvVaisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=59&author=P.+K.+Krishnamurthyauthor=Y.+Dengauthor=E.+M.+Sigurdsson&title=Mechanistic+studies+of+antibody-mediated+clearance+of+Tau+aggregates+using+an+ex+vivo+brain+slice+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic Studies of Antibody-Mediated Clearance of Tau Aggregates Using an ex vivo Brain Slice Model</span></div><div class="casAuthors">Krishnamurthy Pavan K; Deng Yan; Sigurdsson Einar M</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in psychiatry / Frontiers Research Foundation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recent studies have shown that immunotherapy clears amyloid beta (Aβ) plaques and reduces Aβ levels in mouse models of Alzheimer's disease (AD), as well as in AD patients.  Tangle pathology is also relevant for the neurodegeneration in AD, and our studies have shown that active immunization with an AD related phospho-tau peptide reduces aggregated tau within the brain and slows the progression of tauopathy-induced behavioral impairments.  Thus, clearance of neurofibrillary tangles and/or their precursors may reduce synaptic and neuronal loss associated with AD and other tauopathies.  So far the mechanisms involved in antibody-mediated clearance of tau pathology are yet to be elucidated.  In this study we have used a mouse brain slice model to examine the uptake and localization of FITC labeled anti-tau antibodies.  Confocal microscopy analysis showed that the FITC labeled anti-tau antibody co-stained with phosphorylated tau, had a perinuclear appearance and co-localized with markers of the endosomal/lysosomal pathway.  Additionally, tau and FITC-IgG were found together in an enriched lysosome fraction.  In summary, antibody-mediated clearance of intracellular tau aggregates appears to occur via the lysosomal pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTPw3xVJ6b_IkFb3mqPUYDfW6udTcc2eYxqMPrmnWPPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbjvVaisw%253D%253D&md5=2dd9b2f7f86770907d5608bf73546bea</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3389%2Ffpsyt.2011.00059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffpsyt.2011.00059%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnamurthy%26aufirst%3DP.%2BK.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DSigurdsson%26aufirst%3DE.%2BM.%26atitle%3DMechanistic%2520studies%2520of%2520antibody-mediated%2520clearance%2520of%2520Tau%2520aggregates%2520using%2520an%2520ex%2520vivo%2520brain%2520slice%2520model%26jtitle%3DFront.%2520Psychiatry%26date%3D2011%26volume%3D2%26spage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latypova, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terro, F.</span><span> </span><span class="NLM_article-title">Post-translational modifications of tau protein: implications for Alzheimer’s disease</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.neuint.2010.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21215781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFGnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2011&pages=458-471&author=L.+Martinauthor=X.+Latypovaauthor=F.+Terro&title=Post-translational+modifications+of+tau+protein%3A+implications+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Post-translational modifications of tau protein: Implications for Alzheimer's disease</span></div><div class="casAuthors">Martin, Ludovic; Latypova, Xenia; Terro, Faraj</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-471</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) belongs to a group of neurodegenerative diseases collectively designated as "tauopathies", because they are characterized by the aggregation of abnormally phosphorylated tau protein.  The mechanisms responsible for tau aggregation and its contribution to neurodegeneration are still unknown.  Thereby, understanding the modes of regulation of tau is of high interest in the detn. of the possible causes at the origin of the formation of tau aggregates and to elaborate protection strategies to cope with these pathol. lesions.  The regulation of tau takes place predominantly through post-translational modifications.  Extensive reports have been published about tau phosphorylation; however, the other tau post-translational modifications have received much less attention.  Here, we review the different types of post-translational modifications of tau including phosphorylation, glycosylation, glycation, prolyl-isomerization, cleavage or truncation, nitration, polyamination, ubiquitination, sumoylation, oxidn. and aggregation, with a particular interest towards their relevance in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsG774y8lsNrVg90H21EOLACvtfcHk0liU9_mDupu_dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFGnsLo%253D&md5=dde6742c84b61e90575c394bbe05c55a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2010.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2010.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLatypova%26aufirst%3DX.%26aulast%3DTerro%26aufirst%3DF.%26atitle%3DPost-translational%2520modifications%2520of%2520tau%2520protein%253A%2520implications%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurochem.%2520Int.%26date%3D2011%26volume%3D58%26spage%3D458%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hanger, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderton, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, W.</span><span> </span><span class="NLM_article-title">Tau phosphorylation: the therapeutic challenge for neurodegenerative disease</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.molmed.2009.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=19246243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1ahu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=112-119&author=D.+P.+Hangerauthor=B.+H.+Andertonauthor=W.+Noble&title=Tau+phosphorylation%3A+the+therapeutic+challenge+for+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Tau phosphorylation: the therapeutic challenge for neurodegenerative disease</span></div><div class="casAuthors">Hanger, Diane P.; Anderton, Brian H.; Noble, Wendy</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">112-119</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The microtubule-assocd. protein tau is integral to the pathogenesis of Alzheimer's disease (AD), as well as several related disorders, termed tauopathies, in which tau is deposited in affected brain regions.  In the tauopathies, pathol. tau is in an elevated state of phosphorylation and is aberrantly cleaved.  It also exhibits abnormal conformations and becomes aggregated, resulting in neurofibrillary tau pathol.  Recent evidence suggests that relatively early disease-assocd. changes in sol. tau proteins, including phosphorylation, are involved in the induction of neuronal death.  Here, we summarize recent developments that suggest new therapeutic strategies to prevent or reduce the progression of pathol. in the tauopathies.  A list of tau phosphorylation sites identified in the tauopathies and in controls accompanies this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8l3EQ3bznVLVg90H21EOLACvtfcHk0liU9_mDupu_dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1ahu7w%253D&md5=116159eeaae25800a22b687f36df70e2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2009.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2009.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DHanger%26aufirst%3DD.%2BP.%26aulast%3DAnderton%26aufirst%3DB.%2BH.%26aulast%3DNoble%26aufirst%3DW.%26atitle%3DTau%2520phosphorylation%253A%2520the%2520therapeutic%2520challenge%2520for%2520neurodegenerative%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2009%26volume%3D15%26spage%3D112%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Min, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haroutunian, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeley, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, L.</span><span> </span><span class="NLM_article-title">Acetylation of tau inhibits its degradation and contributes to tauopathy</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.neuron.2010.08.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20869593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Wisr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=953-966&author=S.+W.+Minauthor=S.+H.+Choauthor=Y.+Zhouauthor=S.+Schroederauthor=V.+Haroutunianauthor=W.+W.+Seeleyauthor=E.+J.+Huangauthor=Y.+Shenauthor=E.+Masliahauthor=C.+Mukherjeeauthor=D.+Meyersauthor=P.+A.+Coleauthor=M.+Ottauthor=L.+Gan&title=Acetylation+of+tau+inhibits+its+degradation+and+contributes+to+tauopathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy</span></div><div class="casAuthors">Min, Sang-Won; Cho, Seo-Hyun; Zhou, Yungui; Schroeder, Sebastian; Haroutunian, Vahram; Seeley, William W.; Huang, Eric J.; Shen, Yong; Masliah, Eliezer; Mukherjee, Chandrani; Meyers, David; Cole, Philip A.; Ott, Melanie; Gan, Li</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">953-966</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Neurodegenerative tauopathies characterized by hyperphosphorylated tau include frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17) and Alzheimer's disease (AD).  Reducing tau levels improves cognitive function in mouse models of AD and FTDP-17, but the mechanisms regulating the turnover of pathogenic tau are unknown.  We found that tau is acetylated and that tau acetylation prevents degrdn. of phosphorylated tau (p-tau).  We generated 2 antibodies specific for acetylated tau and showed that tau acetylation is elevated in patients at early and moderate Braak stages of tauopathy.  Histone acetyltransferase p300 was involved in tau acetylation and the class III protein deacetylase SIRT1 in deacetylation.  Deleting SIRT1 enhanced levels of acetylated-tau and pathogenic forms of p-tau, probably by blocking proteasome-mediated degrdn.  Inhibiting p300 with a small mol. promoted tau deacetylation and eliminated p-tau assocd. with tauopathy.  Modulating tau acetylation could be a new therapeutic strategy to reduce tau-mediated neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8new1uGtz27Vg90H21EOLACvtfcHk0lj4lDczPTlu1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Wisr3K&md5=047a89c3a8d161d4cb24f6590046fd2c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2010.08.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2010.08.044%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DS.%2BW.%26aulast%3DCho%26aufirst%3DS.%2BH.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSchroeder%26aufirst%3DS.%26aulast%3DHaroutunian%26aufirst%3DV.%26aulast%3DSeeley%26aufirst%3DW.%2BW.%26aulast%3DHuang%26aufirst%3DE.%2BJ.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DMukherjee%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DD.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DOtt%26aufirst%3DM.%26aulast%3DGan%26aufirst%3DL.%26atitle%3DAcetylation%2520of%2520tau%2520inhibits%2520its%2520degradation%2520and%2520contributes%2520to%2520tauopathy%26jtitle%3DNeuron%26date%3D2010%26volume%3D67%26spage%3D953%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Jana, N. R.</span><span> </span><span class="NLM_article-title">Protein homeostasis and aging: role of ubiquitin protein ligases</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.neuint.2012.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22353631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkslejs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=443-447&author=N.+R.+Jana&title=Protein+homeostasis+and+aging%3A+role+of+ubiquitin+protein+ligases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Protein homeostasis and aging: Role of ubiquitin protein ligases</span></div><div class="casAuthors">Jana, Nihar Ranjan</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">443-447</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein homeostasis is fundamental in normal cellular function and cell survival.  The ubiquitin-proteasome system (UPS) plays a central role in maintaining the protein homeostasis network through selective elimination of misfolded and damaged proteins.  Impaired function of UPS is implicated in normal aging process and also in several age-related neurodegenerative disorders that are characterized by increased accumulation oxidatively modified proteins and protein aggregates.  Growing literature also indicate the potential role of various ubiquitin protein ligases in the regulation of aging process by enhancing the degrdn. of either central lifespan regulators or abnormally folded and damaged proteins.  This review mainly focuses on our current understanding of the importance of UPS function in the regulation of normal aging process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY2AxLRE_y07Vg90H21EOLACvtfcHk0lj4lDczPTlu1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkslejs7c%253D&md5=8fa96e8d3d6d0af79a876948b899ebb4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2012.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2012.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DJana%26aufirst%3DN.%2BR.%26atitle%3DProtein%2520homeostasis%2520and%2520aging%253A%2520role%2520of%2520ubiquitin%2520protein%2520ligases%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D60%26spage%3D443%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Vicente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaushik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuervo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4153</span><span class="NLM_x">–</span> <span class="NLM_lpage">4170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1093%2Fhmg%2Fddp367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=19654187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1CrtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=4153-4170&author=Y.+Wangauthor=M.+Martinez-Vicenteauthor=U.+Krugerauthor=S.+Kaushikauthor=E.+Wongauthor=E.+M.+Mandelkowauthor=A.+M.+Cuervoauthor=E.+Mandelkow&title=Tau+fragmentation%2C+aggregation+and+clearance%3A+the+dual+role+of+lysosomal+processing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Tau fragmentation, aggregation and clearance: The dual role of lysosomal processing</span></div><div class="casAuthors">Wang, Yipeng; Martinez-Vicente, Marta; Krueger, Ulrike; Kaushik, Susmita; Wong, Esther; Mandelkow, Eva-Maria; Cuervo, Ana Maria; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4153-4170</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aggregation and cleavage are two hallmarks of Tau pathol. in Alzheimer disease (AD), and abnormal fragmentation of Tau is thought to contribute to the nucleation of Tau paired helical filaments.  Clearance of the abnormally modified protein could occur by the ubiquitin-proteasome and autophagy-lysosomal pathways, the two major routes for protein degrdn. in cells.  There is a debate on which of these pathways contributes to clearance of Tau protein and of the abnormal Tau aggregates formed in AD.  Here, we demonstrate in an inducible neuronal cell model of tauopathy that the autophagy-lysosomal system contributes to both Tau fragmentation into pro-aggregating forms and to clearance of Tau aggregates.  Inhibition of macroautophagy enhances Tau aggregation and cytotoxicity.  The Tau repeat domain can be cleaved near the N terminus by a cytosolic protease to generate the fragment F1.  Addnl. cleavage near the C terminus by the lysosomal protease cathepsin L is required to generate Tau fragments F2 and F3 that are highly amyloidogenic and capable of seeding the aggregation of Tau.  We identify in this work that components of a selective form of autophagy, chaperone-mediated autophagy, are involved in the delivery of cytosolic Tau to lysosomes for this limited cleavage.  However, F1 does not fully enter the lysosome but remains assocd. with the lysosomal membrane.  Inefficient translocation of the Tau fragments across the lysosomal membrane seems to promote formation of Tau oligomers at the surface of these organelles which may act as precursors of aggregation and interfere with lysosomal functioning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyBU3e86nzELVg90H21EOLACvtfcHk0lj4lDczPTlu1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1CrtrrI&md5=1445a4552030dbcab3dc2c90e39606f7</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddp367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddp367%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMartinez-Vicente%26aufirst%3DM.%26aulast%3DKruger%26aufirst%3DU.%26aulast%3DKaushik%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DCuervo%26aufirst%3DA.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DTau%2520fragmentation%252C%2520aggregation%2520and%2520clearance%253A%2520the%2520dual%2520role%2520of%2520lysosomal%2520processing%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2009%26volume%3D18%26spage%3D4153%26epage%3D4170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ravikumar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinsztein, D. C.</span><span> </span><span class="NLM_article-title">Can autophagy protect against neurodegeneration caused by aggregate-prone proteins?</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2443</span><span class="NLM_x">–</span> <span class="NLM_lpage">2445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=2443-2445&author=B.+Ravikumarauthor=D.+C.+Rubinsztein&title=Can+autophagy+protect+against+neurodegeneration+caused+by+aggregate-prone+proteins%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRavikumar%26aufirst%3DB.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26atitle%3DCan%2520autophagy%2520protect%2520against%2520neurodegeneration%2520caused%2520by%2520aggregate-prone%2520proteins%253F%26jtitle%3DNeuroReport%26date%3D2004%26volume%3D15%26spage%3D2443%26epage%3D2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Kruger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span> </span><span class="NLM_article-title">Autophagic degradation of tau in primary neurons and its enhancement by trehalose</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2291</span><span class="NLM_x">–</span> <span class="NLM_lpage">2305</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=2291-2305&author=U.+Krugerauthor=Y.+Wangauthor=S.+Kumarauthor=E.+M.+Mandelkow&title=Autophagic+degradation+of+tau+in+primary+neurons+and+its+enhancement+by+trehalose"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKruger%26aufirst%3DU.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DAutophagic%2520degradation%2520of%2520tau%2520in%2520primary%2520neurons%2520and%2520its%2520enhancement%2520by%2520trehalose%26jtitle%3DNeurobiol.%2520Aging%26date%3D2012%26volume%3D33%26spage%3D2291%26epage%3D2305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Luo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chip, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">9511</span><span class="NLM_x">–</span> <span class="NLM_lpage">9516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.0701055104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17517623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtlGqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=9511-9516&author=W.+Luoauthor=F.+Douauthor=A.+Rodinaauthor=S.+Chipauthor=J.+Kimauthor=Q.+Zhaoauthor=K.+Moulickauthor=J.+Aguirreauthor=N.+Wuauthor=P.+Greengardauthor=G.+Chiosis&title=Roles+of+heat-shock+protein+90+in+maintaining+and+facilitating+the+neurodegenerative+phenotype+in+tauopathies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies</span></div><div class="casAuthors">Luo, Wenjie; Dou, Fei; Rodina, Anna; Chip, Sophorn; Kim, Joungnam; Zhao, Qi; Moulick, Kamalika; Aguirre, Julia; Wu, Nian; Greengard, Paul; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9511-9516</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Neurodegeneration, a result of multiple dysregulatory events, is a lengthy multistep process manifested by accrual of mutant variants and abnormal expression, posttranslational modification, and processing of certain proteins.  Accumulation of these dysregulated processes requires a mechanism that maintains their functional stability and allows the evolution of the neurodegenerative phenotype.  In malignant cells, the capacity to buffer transformation has been attributed to heat-shock protein 90 (Hsp90).  Although normal proteins seem to require limited assistance from the chaperone, their aberrant counterparts seem to be highly dependent on Hsp90.  Whereas enhanced Hsp90 affinity for mutated or functionally deregulated client proteins has been obsd. for several oncoproteins, it is unknown whether Hsp90 plays a similar role for neuronal proteins and thus maintains and facilitates the transformed phenotype in neurodegenerative diseases.  Tauopathies are neurodegenerative diseases characterized by aberrant phosphorylation and/or expression of Tau protein, leading to a time-dependent accumulation of Tau aggregates and subsequent neuronal death.  Here, we show that the stability of p35, a neuronal protein that activates cyclin-dependent protein kinase 5 through complex formation leading to aberrant Tau phosphorylation, and that of mutant but not WT Tau protein is maintained in tauopathies by Hsp90.  Inhibition of Hsp90 in cellular and mouse models of tauopathies leads to a redn. of the pathogenic activity of these proteins and results in elimination of aggregated Tau.  The results identify important roles played by Hsp90 in maintaining and facilitating the degenerative phenotype in these diseases and provide a common principle governing cancer and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcCkJP_DiSK7Vg90H21EOLACvtfcHk0lgWxFFBJmZ0QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtlGqsr4%253D&md5=232a72b98067db9340561258ebb6fcb8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0701055104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0701055104%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DDou%26aufirst%3DF.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DChip%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DGreengard%26aufirst%3DP.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DRoles%2520of%2520heat-shock%2520protein%252090%2520in%2520maintaining%2520and%2520facilitating%2520the%2520neurodegenerative%2520phenotype%2520in%2520tauopathies%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D9511%26epage%3D9516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Dickey, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klosak, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunmore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ash, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoraka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlatkovic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahman, N. S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span> </span><span class="NLM_article-title">The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=648-658&author=C.+A.+Dickeyauthor=A.+Kamalauthor=K.+Lundgrenauthor=N.+Klosakauthor=R.+M.+Baileyauthor=J.+Dunmoreauthor=P.+Ashauthor=S.+Shorakaauthor=J.+Zlatkovicauthor=C.+B.+Eckmanauthor=C.+Pattersonauthor=D.+W.+Dicksonauthor=N.+S.+Nahmanauthor=M.+Huttonauthor=F.+Burrowsauthor=L.+Petrucelli&title=The+high-affinity+HSP90-CHIP+complex+recognizes+and+selectively+degrades+phosphorylated+tau+client+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DKlosak%26aufirst%3DN.%26aulast%3DBailey%26aufirst%3DR.%2BM.%26aulast%3DDunmore%26aufirst%3DJ.%26aulast%3DAsh%26aufirst%3DP.%26aulast%3DShoraka%26aufirst%3DS.%26aulast%3DZlatkovic%26aufirst%3DJ.%26aulast%3DEckman%26aufirst%3DC.%2BB.%26aulast%3DPatterson%26aufirst%3DC.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DNahman%26aufirst%3DN.%2BS.%26aulast%3DHutton%26aufirst%3DM.%26aulast%3DBurrows%26aufirst%3DF.%26aulast%3DPetrucelli%26aufirst%3DL.%26atitle%3DThe%2520high-affinity%2520HSP90-CHIP%2520complex%2520recognizes%2520and%2520selectively%2520degrades%2520phosphorylated%2520tau%2520client%2520proteins%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D648%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Dickey, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunmore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span> </span><span class="NLM_article-title">HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=753-755&author=C.+A.+Dickeyauthor=J.+Dunmoreauthor=B.+Luauthor=J.+W.+Wangauthor=W.+C.+Leeauthor=A.+Kamalauthor=F.+Burrowsauthor=C.+Eckmanauthor=M.+Huttonauthor=L.+Petrucelli&title=HSP+induction+mediates+selective+clearance+of+tau+phosphorylated+at+proline-directed+Ser%2FThr+sites+but+not+KXGS+%28MARK%29+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DDunmore%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DW.%2BC.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DBurrows%26aufirst%3DF.%26aulast%3DEckman%26aufirst%3DC.%26aulast%3DHutton%26aufirst%3DM.%26aulast%3DPetrucelli%26aufirst%3DL.%26atitle%3DHSP%2520induction%2520mediates%2520selective%2520clearance%2520of%2520tau%2520phosphorylated%2520at%2520proline-directed%2520Ser%252FThr%2520sites%2520but%2520not%2520KXGS%2520%2528MARK%2529%2520sites%26jtitle%3DFASEB%2520J.%26date%3D2006%26volume%3D20%26spage%3D753%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Salminen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojala, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaarniranta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiltunen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soininen, H.</span><span> </span><span class="NLM_article-title">Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer’s disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.pneurobio.2010.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21056617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BC3M7mvFSitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2011&pages=99-110&author=A.+Salminenauthor=J.+Ojalaauthor=K.+Kaarnirantaauthor=M.+Hiltunenauthor=H.+Soininen&title=Hsp90+regulates+tau+pathology+through+co-chaperone+complexes+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease</span></div><div class="casAuthors">Salminen Antero; Ojala Johanna; Kaarniranta Kai; Hiltunen Mikko; Soininen Hilkka</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neurobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-110</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease is a tauopathy which involves the deposition of microtubule-associated tau proteins into neurofibrillary tangles.  Post-translational modifications, in particular site-specific phosphorylations, affect the conformation of tau protein which is an intrinsically disordered protein.  These structural changes significantly increase the affinity of tau protein for certain molecular chaperones.  Hsp90 is a major cellular chaperone which assembles large complexes with a variety of co-chaperones.  The main function of Hsp90 complexes is to maintain protein quality control and assist in protein degradation via proteasomal and autophagic-lysosomal pathways.  Tau protein is a client protein for these Hsp90 complexes.  If the tau protein is in an abnormal or modified form, then it can trigger the recruitment of CHIP protein, a co-chaperone with E3 activity, to the complex which induces the ubiquitination of tau protein and activates its downstream degradation processes.  Large immunophilins, FKBP51 and FKBP52 are also co-chaperones of Hsp90-tau complexes.  These proteins contain peptidylprolyl cis/trans isomerase activity which catalyzes phosphorylation-dependent rotation in pSer/Thr-Pro peptide bond.  The proline switch in the tau conformation triggers dephosphorylation of Ser/Thr residues phosphorylated, e.g. by two well-known tau kinases Cdk5 and GSK-3β.  Binding of PP5 protein phosphatase to Hsp90 complex, can also dephosphorylate tau protein.  Subsequently, dephosphorylated tau protein can be shuttled back to the microtubules.  It seems that high-affinity binding of abnormal tau to Hsp90 complexes may have some counteracting effects on the aggregation process, since Hsp90 inhibitors can ameliorate the aggregation process in several neurodegenerative diseases.  We will review the role of Hsp90 chaperone network in the regulation of tau biology and pathology in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIGys_IlOfaRe4jJGKT5N0fW6udTcc2ebfrlE5X76VVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7mvFSitw%253D%253D&md5=92c5535c5b5bc12c8c0807ea338310d4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2010.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2010.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DOjala%26aufirst%3DJ.%26aulast%3DKaarniranta%26aufirst%3DK.%26aulast%3DHiltunen%26aufirst%3DM.%26aulast%3DSoininen%26aufirst%3DH.%26atitle%3DHsp90%2520regulates%2520tau%2520pathology%2520through%2520co-chaperone%2520complexes%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2011%26volume%3D93%26spage%3D99%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Shimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gygi, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosik, K. S.</span><span> </span><span class="NLM_article-title">CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">4869</span><span class="NLM_x">–</span> <span class="NLM_lpage">4876</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=4869-4876&author=H.+Shimuraauthor=D.+Schwartzauthor=S.+P.+Gygiauthor=K.+S.+Kosik&title=CHIP-Hsc70+complex+ubiquitinates+phosphorylated+tau+and+enhances+cell+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimura%26aufirst%3DH.%26aulast%3DSchwartz%26aufirst%3DD.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26aulast%3DKosik%26aufirst%3DK.%2BS.%26atitle%3DCHIP-Hsc70%2520complex%2520ubiquitinates%2520phosphorylated%2520tau%2520and%2520enhances%2520cell%2520survival%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D4869%26epage%3D4876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Jeganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">10526</span><span class="NLM_x">–</span> <span class="NLM_lpage">10539</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi800783d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=10526-10539&author=S.+Jeganathanauthor=M.+von+Bergenauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=The+natively+unfolded+character+of+tau+and+its+aggregation+to+Alzheimer-like+paired+helical+filaments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fbi800783d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi800783d%26sid%3Dliteratum%253Aachs%26aulast%3DJeganathan%26aufirst%3DS.%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DThe%2520natively%2520unfolded%2520character%2520of%2520tau%2520and%2520its%2520aggregation%2520to%2520Alzheimer-like%2520paired%2520helical%2520filaments%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D10526%26epage%3D10539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Schweers, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn-Hanebeck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">24290</span><span class="NLM_x">–</span> <span class="NLM_lpage">24297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2FS0021-9258%2819%2951080-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=7929085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK2cXmtVagurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=24290-24297&author=O.+Schweersauthor=E.+Schonbrunn-Hanebeckauthor=A.+Marxauthor=E.+Mandelkow&title=Structural+studies+of+tau+protein+and+Alzheimer+paired+helical+filaments+show+no+evidence+for+beta-structure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for β-structure</span></div><div class="casAuthors">Schweers, Olaf; Schoenbrunn-Hanebeck, Ernst; Marx, Alexander; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">24290-7</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The authors have studied the conformation of tau protein and Alzheimer paired helical filaments (PHF) by several spectroscopic, scattering, and imaging methods revealing the overall shape and the conformation of the polypeptide backbone.  Tau protein behaves in soln. as if it were denatured; no evidence for compact folding was detected.  The protein is highly extended, there is no defined radius of gyration, and the scattering is best described by that of a random ("Gaussian") polymer.  CD and Fourier transform IR spectroscopy show only a minimal content of ordered secondary structure (α-helix or β-sheet).  Similarly, PHFs from Alzheimer brain tissue show no detectable secondary structure by x-ray diffraction or spectroscopy.  It is thus unlikely that the aggregation of tau into Alzheimer PHFs is based on interactions between strands of β-sheets (a model currently favored for other disease-related polymers such as β-amyloid fibers of Alzheimer's disease).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkQACRJIok1LVg90H21EOLACvtfcHk0limuFm4QYIBUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmtVagurY%253D&md5=6df9f656b2d3f66617becb2b4afc9b8a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2819%2951080-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252819%252951080-8%26sid%3Dliteratum%253Aachs%26aulast%3DSchweers%26aufirst%3DO.%26aulast%3DSchonbrunn-Hanebeck%26aufirst%3DE.%26aulast%3DMarx%26aufirst%3DA.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DStructural%2520studies%2520of%2520tau%2520protein%2520and%2520Alzheimer%2520paired%2520helical%2520filaments%2520show%2520no%2520evidence%2520for%2520beta-structure%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D24290%26epage%3D24297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Jeganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hascher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnathambi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">32066</span><span class="NLM_x">–</span> <span class="NLM_lpage">32076</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=32066-32076&author=S.+Jeganathanauthor=A.+Hascherauthor=S.+Chinnathambiauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Proline-directed+pseudo-phosphorylation+at+AT8+and+PHF1+epitopes+induces+a+compaction+of+the+paperclip+folding+of+Tau+and+generates+a+pathological+%28MC-1%29+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeganathan%26aufirst%3DS.%26aulast%3DHascher%26aufirst%3DA.%26aulast%3DChinnathambi%26aufirst%3DS.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DProline-directed%2520pseudo-phosphorylation%2520at%2520AT8%2520and%2520PHF1%2520epitopes%2520induces%2520a%2520compaction%2520of%2520the%2520paperclip%2520folding%2520of%2520Tau%2520and%2520generates%2520a%2520pathological%2520%2528MC-1%2529%2520conformation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D32066%26epage%3D32076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Mukrasch, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korukottu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweckstetter, M.</span><span> </span><span class="NLM_article-title">Structural polymorphism of 441-residue tau at single residue resolution</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=e34&author=M.+D.+Mukraschauthor=S.+Bibowauthor=J.+Korukottuauthor=S.+Jeganathanauthor=J.+Biernatauthor=C.+Griesingerauthor=E.+Mandelkowauthor=M.+Zweckstetter&title=Structural+polymorphism+of+441-residue+tau+at+single+residue+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukrasch%26aufirst%3DM.%2BD.%26aulast%3DBibow%26aufirst%3DS.%26aulast%3DKorukottu%26aufirst%3DJ.%26aulast%3DJeganathan%26aufirst%3DS.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DGriesinger%26aufirst%3DC.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DZweckstetter%26aufirst%3DM.%26atitle%3DStructural%2520polymorphism%2520of%2520441-residue%2520tau%2520at%2520single%2520residue%2520resolution%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3De34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Mukrasch, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweckstetter, M.</span><span> </span><span class="NLM_article-title">The “jaws” of the tau–microtubule interaction</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">12230</span><span class="NLM_x">–</span> <span class="NLM_lpage">12239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=12230-12239&author=M.+D.+Mukraschauthor=M.+von+Bergenauthor=J.+Biernatauthor=D.+Fischerauthor=C.+Griesingerauthor=E.+Mandelkowauthor=M.+Zweckstetter&title=The+%E2%80%9Cjaws%E2%80%9D+of+the+tau%E2%80%93microtubule+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukrasch%26aufirst%3DM.%2BD.%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DD.%26aulast%3DGriesinger%26aufirst%3DC.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DZweckstetter%26aufirst%3DM.%26atitle%3DThe%2520%25E2%2580%259Cjaws%25E2%2580%259D%2520of%2520the%2520tau%25E2%2580%2593microtubule%2520interaction%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D12230%26epage%3D12239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedhoff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heberle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">5129</span><span class="NLM_x">–</span> <span class="NLM_lpage">5134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.97.10.5129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=10805776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsVWntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=5129-5134&author=M.+von+Bergenauthor=P.+Friedhoffauthor=J.+Biernatauthor=J.+Heberleauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Assembly+of+tau+protein+into+Alzheimer+paired+helical+filaments+depends+on+a+local+sequence+motif+%28%28306%29VQIVYK%28311%29%29+forming+beta+structure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure</span></div><div class="casAuthors">Von Bergen, M.; Friedhoff, P.; Biernat, J.; Heberle, J.; Mandelkow, E.-M.; Mandelkow, E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5129-5134</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We have searched for a minimal interaction motif in τ protein that supports the aggregation into Alzheimer-like paired helical filaments.  Digestion of the repeat domain with different proteases yields a GluC-induced fragment comprising 43 residues (termed PHF43), which represents the third repeat of τ plus some flanking residues.  This fragment self assembles readily into thin filaments without a paired helical appearance, but these filaments are highly competent to nucleate bona fide PHFs from full-length τ.  Probing the interactions of PHF43 with overlapping peptides derived from the full τ sequence yields a minimal hexapeptide interaction motif of 306VQIVYK311 at the beginning of the third internal repeat.  This motif coincides with the highest predicted β-structure potential in τ.  CD and Fourier transform IR spectroscopy shows that PHF43 acquires pronounced β structure in conditions of self assembly.  Point mutations in the hexapeptide region by proline-scanning mutagenesis prevent the aggregation.  The data indicate that PHF assembly is initiated by a short fragment contg. the minimal interaction motif forming a local β structure embedded in a largely random-coil protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGJW3qEQJRQ7Vg90H21EOLACvtfcHk0lhWLH4pfYm0Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsVWntrg%253D&md5=11be2a14e779315fcb88dac3afb22ed9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.10.5129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.10.5129%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DFriedhoff%26aufirst%3DP.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DHeberle%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DAssembly%2520of%2520tau%2520protein%2520into%2520Alzheimer%2520paired%2520helical%2520filaments%2520depends%2520on%2520a%2520local%2520sequence%2520motif%2520%2528%2528306%2529VQIVYK%2528311%2529%2529%2520forming%2520beta%2520structure%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D5129%26epage%3D5134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Daebel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnathambi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwalbe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habenstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akoury, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tepper, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweckstetter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijayan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, A.</span><span> </span><span class="NLM_article-title">beta-Sheet core of tau paired helical filaments revealed by solid-state NMR</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">13982</span><span class="NLM_x">–</span> <span class="NLM_lpage">13989</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja305470p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFChtL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=13982-13989&author=V.+Daebelauthor=S.+Chinnathambiauthor=J.+Biernatauthor=M.+Schwalbeauthor=B.+Habensteinauthor=A.+Loquetauthor=E.+Akouryauthor=K.+Tepperauthor=H.+Mullerauthor=M.+Baldusauthor=C.+Griesingerauthor=M.+Zweckstetterauthor=E.+Mandelkowauthor=V.+Vijayanauthor=A.+Lange&title=beta-Sheet+core+of+tau+paired+helical+filaments+revealed+by+solid-state+NMR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">β-Sheet Core of Tau Paired Helical Filaments Revealed by Solid-State NMR</span></div><div class="casAuthors">Daebel, Venita; Chinnathambi, Subashchandrabose; Biernat, Jacek; Schwalbe, Martin; Habenstein, Birgit; Loquet, Antoine; Akoury, Elias; Tepper, Katharina; Mueller, Henrik; Baldus, Marc; Griesinger, Christian; Zweckstetter, Markus; Mandelkow, Eckhard; Vijayan, Vinesh; Lange, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">13982-13989</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the hallmarks of Alzheimer's disease is the self-assembly of the microtubule-assocd. protein tau into fibers termed "paired helical filaments" (PHFs).  However, the structural basis of PHF assembly at at. detail is largely unknown.  Here, we applied solid-state NMR (ssNMR) spectroscopy to investigate in vitro assembled PHFs from a truncated three-repeat tau isoform (K19) that represents the core of PHFs.  We found that the rigid core of the fibrils is formed by amino acids V306 to S324, only 18 out of 99 residues, and comprises three β-strands connected by two short kinks.  The first β-strand is formed by the well-studied hexapeptide motif VQIVYK that is known to self-aggregate in a steric zipper arrangement.  Results on mixed [15N:13C]-labeled K19 fibrils show that β-strands are stacked in a parallel, in-register manner.  Disulfide bridges formed between C322 residues of different mols. lead to a disturbance of the β-sheet structure, and polymorphism in ssNMR spectra is obsd.  In particular, residues K321-S324 exhibit two sets of resonances.  Expts. on K19 C322A PHFs further confirm the influence of disulfide bond formation on the core structure.  Our structural data are supported by H/D exchange NMR measurements on K19 as well as a truncated four-repeat isoform of tau (K18).  Site-directed mutagenesis studies show that single-point mutations within the three different β-strands result in a significant loss of PHF aggregation efficiency, highlighting the importance of the β-structure-rich regions for tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIrCwqfFqN-LVg90H21EOLACvtfcHk0lhWLH4pfYm0Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFChtL%252FP&md5=4200e54ea1d875990eab6ecfe7056b64</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fja305470p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja305470p%26sid%3Dliteratum%253Aachs%26aulast%3DDaebel%26aufirst%3DV.%26aulast%3DChinnathambi%26aufirst%3DS.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DSchwalbe%26aufirst%3DM.%26aulast%3DHabenstein%26aufirst%3DB.%26aulast%3DLoquet%26aufirst%3DA.%26aulast%3DAkoury%26aufirst%3DE.%26aulast%3DTepper%26aufirst%3DK.%26aulast%3DMuller%26aufirst%3DH.%26aulast%3DBaldus%26aufirst%3DM.%26aulast%3DGriesinger%26aufirst%3DC.%26aulast%3DZweckstetter%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DVijayan%26aufirst%3DV.%26aulast%3DLange%26aufirst%3DA.%26atitle%3Dbeta-Sheet%2520core%2520of%2520tau%2520paired%2520helical%2520filaments%2520revealed%2520by%2520solid-state%2520NMR%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D13982%26epage%3D13989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Delacourte, A.</span><span> </span><span class="NLM_article-title">Tauopathies: recent insights into old diseases</span> <span class="citation_source-journal">Folia Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16416389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFGjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2005&pages=244-257&author=A.+Delacourte&title=Tauopathies%3A+recent+insights+into+old+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Tauopathies: recent insights into old diseases</span></div><div class="casAuthors">Delacourte, Andre</div><div class="citationInfo"><span class="NLM_cas:title">Folia Neuropathologica</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">244-257</span>CODEN:
                <span class="NLM_cas:coden">FONEEW</span>;
        ISSN:<span class="NLM_cas:issn">1641-4640</span>.
    
            (<span class="NLM_cas:orgname">Termedia Publishing House</span>)
        </div><div class="casAbstract">A review.  Neurofibrillary tangles are brain lesions that have been discovered at the beginning of the 20th century, using histol. silver staining.  Tangles are intra-neuronal hallmarks of a degenerating process: neurofibrillary degeneration (NFD).  The basic component involved in tangle formation is tau protein.  Tangles are found in more than 20 different neurodegenerative disorders, suggesting that NFD is a unique consequence to different types of etiol. factors.  However, tangles have a morphol. and biochem. signature which is disease-specific.  They are made up of different types of filaments such as paired helical filaments (PHFs) in Alzheimer's disease or straight filaments in progressive supranuclear palsy.  Tau aggregates have a disease-specific biochem. bar-code due to the aggregation of specific sets of tau isoforms.  Tau lesions have also a disease-specific pattern of spatio-temporal progression in the human brain which is well correlated to cognitive impairment.  At last, pathol. tau mutations are at the origin of familial fronto-temporal diseases with parkinsonism (FTDP-17).  Together, these observations have generated the concept of tauopathies.  Indeed, each tauopathy is defined by a combination of clin., neuropathol., biochem. and genetic features.  Most of them have a specific defect on tau (mutation, aberrant splicing, abnormal phosphorylation, abnormal processing, neuronal or genotypic vulnerability), suggesting that, in fact, the etiol. of most tauopathies is directly linked to tau dysfunction.  In conclusion, we observe that most dementing disorders are tauopathies and that most demented patients have a tauopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH8dNcgb5ZdLVg90H21EOLACvtfcHk0lhWLH4pfYm0Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFGjsbg%253D&md5=ff66eb6cc2827a1e46ee8413dc2ce8de</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelacourte%26aufirst%3DA.%26atitle%3DTauopathies%253A%2520recent%2520insights%2520into%2520old%2520diseases%26jtitle%3DFolia%2520Neuropathol.%26date%3D2005%26volume%3D43%26spage%3D244%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Kidd, M.</span><span> </span><span class="NLM_article-title">Paired helical filaments in electron microscopy of Alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=1963&pages=192-193&author=M.+Kidd&title=Paired+helical+filaments+in+electron+microscopy+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKidd%26aufirst%3DM.%26atitle%3DPaired%2520helical%2520filaments%2520in%2520electron%2520microscopy%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D1963%26volume%3D197%26spage%3D192%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Wegmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnathambi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, D. J.</span><span> </span><span class="NLM_article-title">Human Tau isoforms assemble into ribbon-like fibrils that display polymorphic structure and stability</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">27302</span><span class="NLM_x">–</span> <span class="NLM_lpage">27313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=27302-27313&author=S.+Wegmannauthor=Y.+J.+Jungauthor=S.+Chinnathambiauthor=E.+M.+Mandelkowauthor=E.+Mandelkowauthor=D.+J.+Muller&title=Human+Tau+isoforms+assemble+into+ribbon-like+fibrils+that+display+polymorphic+structure+and+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWegmann%26aufirst%3DS.%26aulast%3DJung%26aufirst%3DY.%2BJ.%26aulast%3DChinnathambi%26aufirst%3DS.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMuller%26aufirst%3DD.%2BJ.%26atitle%3DHuman%2520Tau%2520isoforms%2520assemble%2520into%2520ribbon-like%2520fibrils%2520that%2520display%2520polymorphic%2520structure%2520and%2520stability%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D27302%26epage%3D27313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Margittai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langen, R.</span><span> </span><span class="NLM_article-title">Template-assisted filament growth by parallel stacking of tau</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">10278</span><span class="NLM_x">–</span> <span class="NLM_lpage">10283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.0401911101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15240881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVyku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=10278-10283&author=M.+Margittaiauthor=R.+Langen&title=Template-assisted+filament+growth+by+parallel+stacking+of+tau"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Template-assisted filament growth by parallel stacking of tau</span></div><div class="casAuthors">Margittai, Martin; Langen, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">10278-10283</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tau Filaments are found in >20 neurodegenerative diseases.  Yet, because of their enormous mol. wts. and poor tendency to form highly ordered 3D crystal lattices, they have evaded high-resoln. structure detn.  Here, we studied 25 derivatized tau mutants by using ESR and fluorescence spectroscopy to report structural details of tau filaments.  Based on strong spin exchange and pyrene excimer formation of core residues, we find that individual tau proteins form single mol. layers along the fiber axis that perfectly stack on top of each other by in-register, parallel alignment of β-strands.  We suggest a model of filament growth wherein the existing filament serves as a template for the incoming, unfolded tau mol., resulting in a new structured layer with maximized hydrogen-bonded contact surface and side-chain stacking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBxmfhcAUYSbVg90H21EOLACvtfcHk0litykbZIiQEjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVyku7o%253D&md5=cae2e8d1606d8fbb73adcaefdf4cc6f2</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0401911101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0401911101%26sid%3Dliteratum%253Aachs%26aulast%3DMargittai%26aufirst%3DM.%26aulast%3DLangen%26aufirst%3DR.%26atitle%3DTemplate-assisted%2520filament%2520growth%2520by%2520parallel%2520stacking%2520of%2520tau%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D10278%26epage%3D10283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barghorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Tau aggregation is driven by a transition from random coil to beta sheet structure</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1739</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1739&publication_year=2005&pages=158-166&author=M.+von+Bergenauthor=S.+Barghornauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Tau+aggregation+is+driven+by+a+transition+from+random+coil+to+beta+sheet+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DBarghorn%26aufirst%3DS.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DTau%2520aggregation%2520is%2520driven%2520by%2520a%2520transition%2520from%2520random%2520coil%2520to%2520beta%2520sheet%2520structure%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2005%26volume%3D1739%26spage%3D158%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Heiser, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engemann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunkel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeddrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waelter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordhoff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lurz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schugardt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rautenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herhaus, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnickel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottcher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehrach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanker, E. E.</span><span> </span><span class="NLM_article-title">Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington’s disease by using an automated filter retardation assay</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">16400</span><span class="NLM_x">–</span> <span class="NLM_lpage">16406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=16400-16406&issue=Suppl.+4&author=V.+Heiserauthor=S.+Engemannauthor=W.+Brockerauthor=I.+Dunkelauthor=A.+Boeddrichauthor=S.+Waelterauthor=E.+Nordhoffauthor=R.+Lurzauthor=N.+Schugardtauthor=S.+Rautenbergauthor=C.+Herhausauthor=G.+Barnickelauthor=H.+Bottcherauthor=H.+Lehrachauthor=E.+E.+Wanker&title=Identification+of+benzothiazoles+as+potential+polyglutamine+aggregation+inhibitors+of+Huntington%E2%80%99s+disease+by+using+an+automated+filter+retardation+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeiser%26aufirst%3DV.%26aulast%3DEngemann%26aufirst%3DS.%26aulast%3DBrocker%26aufirst%3DW.%26aulast%3DDunkel%26aufirst%3DI.%26aulast%3DBoeddrich%26aufirst%3DA.%26aulast%3DWaelter%26aufirst%3DS.%26aulast%3DNordhoff%26aufirst%3DE.%26aulast%3DLurz%26aufirst%3DR.%26aulast%3DSchugardt%26aufirst%3DN.%26aulast%3DRautenberg%26aufirst%3DS.%26aulast%3DHerhaus%26aufirst%3DC.%26aulast%3DBarnickel%26aufirst%3DG.%26aulast%3DBottcher%26aufirst%3DH.%26aulast%3DLehrach%26aufirst%3DH.%26aulast%3DWanker%26aufirst%3DE.%2BE.%26atitle%3DIdentification%2520of%2520benzothiazoles%2520as%2520potential%2520polyglutamine%2520aggregation%2520inhibitors%2520of%2520Huntington%25E2%2580%2599s%2520disease%2520by%2520using%2520an%2520automated%2520filter%2520retardation%2520assay%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26issue%3DSuppl.%25204%26spage%3D16400%26epage%3D16406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Taniguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hisanaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span> </span><span class="NLM_article-title">Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">7614</span><span class="NLM_x">–</span> <span class="NLM_lpage">7623</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=7614-7623&author=S.+Taniguchiauthor=N.+Suzukiauthor=M.+Masudaauthor=S.+Hisanagaauthor=T.+Iwatsuboauthor=M.+Goedertauthor=M.+Hasegawa&title=Inhibition+of+heparin-induced+tau+filament+formation+by+phenothiazines%2C+polyphenols%2C+and+porphyrins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaniguchi%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMasuda%26aufirst%3DM.%26aulast%3DHisanaga%26aufirst%3DS.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DHasegawa%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520heparin-induced%2520tau%2520filament%2520formation%2520by%2520phenothiazines%252C%2520polyphenols%252C%2520and%2520porphyrins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D7614%26epage%3D7623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Porat, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramowitz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazit, E.</span><span> </span><span class="NLM_article-title">Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1747-0285.2005.00318.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16492146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=27-37&author=Y.+Poratauthor=A.+Abramowitzauthor=E.+Gazit&title=Inhibition+of+amyloid+fibril+formation+by+polyphenols%3A+structural+similarity+and+aromatic+interactions+as+a+common+inhibition+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism</span></div><div class="casAuthors">Porat, Yair; Abramowitz, Adel; Gazit, Ehud</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-37</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The formation of well-ordered fibrillar protein deposits is common to a large group of amyloid-assocd. disorders.  This group consists of several major human diseases such as Alzheimer's disease, Parkinson's disease, prion diseases, and type II diabetes.  Currently, there is no approved therapeutic agent directed towards the formation of fibrillar assemblies, which have been recently shown to have a key role in the cytotoxic nature of amyloidogenic proteins.  One important approach in the development of therapeutic agents is the use of small mols. that specifically and efficiently inhibit the aggregation process.  Several small polyphenol mols. have been demonstrated to remarkably inhibit the formation of fibrillar assemblies in vitro and their assocd. cytotoxicity.  Yet, the inhibition mechanism was mostly attributed to the antioxidative properties of these polyphenol compds.  Based on several observations demonstrating that polyphenols are capable of inhibiting amyloid fibril formation in vitro, regardless of oxidative conditions, and in view of their structural similarities, we suggest an addnl. mechanism of action.  This mechanism is assuming structural constraints and specific arom. interactions, which direct polyphenol inhibitors to the amyloidogenic core.  This proposed mechanism is highly relevant for future de novo inhibitors' design as therapeutic agents for the treatment of amyloid-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJuuqfGHMQs7Vg90H21EOLACvtfcHk0litykbZIiQEjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7g%253D&md5=700c4ba4939fe1153fe825906981e628</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2005.00318.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2005.00318.x%26sid%3Dliteratum%253Aachs%26aulast%3DPorat%26aufirst%3DY.%26aulast%3DAbramowitz%26aufirst%3DA.%26aulast%3DGazit%26aufirst%3DE.%26atitle%3DInhibition%2520of%2520amyloid%2520fibril%2520formation%2520by%2520polyphenols%253A%2520structural%2520similarity%2520and%2520aromatic%2520interactions%2520as%2520a%2520common%2520inhibition%2520mechanism%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D27%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Reinke, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span> </span><span class="NLM_article-title">Insight into amyloid structure using chemical probes</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1747-0285.2011.01110.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21457473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslWqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2011&pages=399-411&author=A.+A.+Reinkeauthor=J.+E.+Gestwicki&title=Insight+into+amyloid+structure+using+chemical+probes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into amyloid structure using chemical probes</span></div><div class="casAuthors">Reinke, Ashley A.; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">399-411</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a common neurodegenerative disorder characterized by the deposition of amyloids in the brain.  One prominent form of amyloid is composed of repeating units of the amyloid-β (Aβ) peptide.  Over the past decade, it has become clear that these Aβ amyloids are not homogeneous; rather, they are composed of a series of structures varying in their overall size and shape and the no. of Aβ peptides they contain.  Recent theories suggest that these different amyloid conformations may play distinct roles in disease, although their relative contributions are still being discovered.  Here, we review how chem. probes, such as Congo red, thioflavin T and their derivs., have been powerful tools for the better understanding of amyloid structure and function.  Moreover, we discuss how design and deployment of conformationally selective probes might be used to test emerging models of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1MeycFDiwGLVg90H21EOLACvtfcHk0lj8RC7OANAXdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslWqsb0%253D&md5=52a8815e569523bd2b05e7a5e7c70d00</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2011.01110.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2011.01110.x%26sid%3Dliteratum%253Aachs%26aulast%3DReinke%26aufirst%3DA.%2BA.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DInsight%2520into%2520amyloid%2520structure%2520using%2520chemical%2520probes%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2011%26volume%3D77%26spage%3D399%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Kelly, J. W.</span><span> </span><span class="NLM_article-title">Alternative conformations of amyloidogenic proteins govern their behavior</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2FS0959-440X%2896%2980089-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=8696966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK28Xhtlamtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=11-17&author=J.+W.+Kelly&title=Alternative+conformations+of+amyloidogenic+proteins+govern+their+behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative conformations of amyloidogenic proteins govern their behavior</span></div><div class="casAuthors">Kelly, Jeffery W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-17</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review, with 44 refs.  Recent publications strongly support the hypothesis that conformational changes in amyloidogenic proteins lead to amyloid fibril formation and cause disease.  Biophys. studies on several amyloidogenic proteins provide insights into the conformational changes required for fibrillogenesis.  In addn., newly available moderate to high resoln. structural studies are bringing the authors' closer to understanding the structure of amyloid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVdwMwZU44ILVg90H21EOLACvtfcHk0lj8RC7OANAXdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xhtlamtrk%253D&md5=fcb4a97155070d54f28b170572f827eb</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2FS0959-440X%2896%2980089-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-440X%252896%252980089-3%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DAlternative%2520conformations%2520of%2520amyloidogenic%2520proteins%2520govern%2520their%2520behavior%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D1996%26volume%3D6%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barghorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">48165</span><span class="NLM_x">–</span> <span class="NLM_lpage">48174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=48165-48174&author=M.+von+Bergenauthor=S.+Barghornauthor=L.+Liauthor=A.+Marxauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Mutations+of+tau+protein+in+frontotemporal+dementia+promote+aggregation+of+paired+helical+filaments+by+enhancing+local+beta-structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DBarghorn%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMarx%26aufirst%3DA.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DMutations%2520of%2520tau%2520protein%2520in%2520frontotemporal%2520dementia%2520promote%2520aggregation%2520of%2520paired%2520helical%2520filaments%2520by%2520enhancing%2520local%2520beta-structure%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D48165%26epage%3D48174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melrose, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacharaju, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Slegtenhorst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwinn-Hardy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul Murphy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corral, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, M.</span><span> </span><span class="NLM_article-title">Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2F78078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=10932182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvVertbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2000&pages=402-405&author=J.+Lewisauthor=E.+McGowanauthor=J.+Rockwoodauthor=H.+Melroseauthor=P.+Nacharajuauthor=M.+Van+Slegtenhorstauthor=K.+Gwinn-Hardyauthor=M.+Paul+Murphyauthor=M.+Bakerauthor=X.+Yuauthor=K.+Duffauthor=J.+Hardyauthor=A.+Corralauthor=W.+L.+Linauthor=S.+H.+Yenauthor=D.+W.+Dicksonauthor=P.+Daviesauthor=M.+Hutton&title=Neurofibrillary+tangles%2C+amyotrophy+and+progressive+motor+disturbance+in+mice+expressing+mutant+%28P301L%29+tau+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein</span></div><div class="casAuthors">Lewis, Jada; McGowan, Eileen; Rockwood, Julia; Melrose, Heather; Nacharaju, Parimala; Van Slegtenhorst, Marjon; Gwinn-Hardy, Katrina; Murphy, M. Paul; Baker, Matt; Yu, Xin; Duff, Karen; Hardy, John; Corral, Anthony; Lin, Wen-Lang; Yen, Shu-Hui; Dickson, Dennis W.; Davies, Peter; Hutton, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">402-405</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Neurofibrillary tangles (NFT) composed of the microtubule-assocd. protein tau are prominent in Alzheimer disease (AD), Pick disease, progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).  Mutations in the gene (Mtapt) encoding tau protein cause frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), thereby proving that tau dysfunction can directly result in neurodegeneration.  Expression of human tau contg. the most common FTDP-17 mutation (P301L) results in motor and behavioral deficits in transgenic mice, with age- and gene-dose-dependent development of NFT.  This phenotype occurred as early as 6.5 mo in hemizygous and 4.5 mo in homozygous animals.  NFT and Pick-body-like neuronal lesions occurred in the amygdala, septal nuclei, pre-optic nuclei, hypothalamus, midbrain, pons, medulla, deep cerebellar nuclei and spinal cord, with tau-immunoreactive pre-tangles in the cortex, hippocampus and basal ganglia.  Areas with the most NFT had reactive gliosis.  Spinal cord had axonal spheroids, anterior horn cell loss and axonal degeneration in anterior spinal roots.  The authors also saw peripheral neuropathy and skeletal muscle with neurogenic atrophy.  Brain and spinal cord contained insol. tau that co-migrated with insol. tau from AD and FTDP-17 brains.  The phenotype of mice expressing P301L mutant tau mimics features of human tauopathies and provides a model for investigating the pathogenesis of diseases with NFT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowupSUQH41jLVg90H21EOLACvtfcHk0lj8RC7OANAXdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvVertbc%253D&md5=9719b5e58a3ad82f509662e39fe5b647</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2F78078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F78078%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DMcGowan%26aufirst%3DE.%26aulast%3DRockwood%26aufirst%3DJ.%26aulast%3DMelrose%26aufirst%3DH.%26aulast%3DNacharaju%26aufirst%3DP.%26aulast%3DVan%2BSlegtenhorst%26aufirst%3DM.%26aulast%3DGwinn-Hardy%26aufirst%3DK.%26aulast%3DPaul%2BMurphy%26aufirst%3DM.%26aulast%3DBaker%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DDuff%26aufirst%3DK.%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DCorral%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DW.%2BL.%26aulast%3DYen%26aufirst%3DS.%2BH.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DHutton%26aufirst%3DM.%26atitle%3DNeurofibrillary%2520tangles%252C%2520amyotrophy%2520and%2520progressive%2520motor%2520disturbance%2520in%2520mice%2520expressing%2520mutant%2520%2528P301L%2529%2520tau%2520protein%26jtitle%3DNat.%2520Genet.%26date%3D2000%26volume%3D25%26spage%3D402%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Khlistunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span> </span><span class="NLM_article-title">Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">1205</span><span class="NLM_x">–</span> <span class="NLM_lpage">1214</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=1205-1214&author=I.+Khlistunovaauthor=J.+Biernatauthor=Y.+Wangauthor=M.+Pickhardtauthor=M.+von+Bergenauthor=Z.+Gazovaauthor=E.+Mandelkowauthor=E.+M.+Mandelkow&title=Inducible+expression+of+Tau+repeat+domain+in+cell+models+of+tauopathy%3A+aggregation+is+toxic+to+cells+but+can+be+reversed+by+inhibitor+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DGazova%26aufirst%3DZ.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DInducible%2520expression%2520of%2520Tau%2520repeat%2520domain%2520in%2520cell%2520models%2520of%2520tauopathy%253A%2520aggregation%2520is%2520toxic%2520to%2520cells%2520but%2520can%2520be%2520reversed%2520by%2520inhibitor%2520drugs%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D1205%26epage%3D1214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hascher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Screening for inhibitors of tau polymerization</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F1567205053585891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15974921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVant7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=219-226&author=M.+Pickhardtauthor=M.+von+Bergenauthor=Z.+Gazovaauthor=A.+Hascherauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Screening+for+inhibitors+of+tau+polymerization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Screening for inhibitors of tau polymerization</span></div><div class="casAuthors">Pickhardt, Marcus; von Bergen, Martin; Gazova, Zuzana; Hascher, Antje; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-226</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The histopathol. diagnosis of Alzheimer's disease relies on two kinds of proteinaceous aggregates: the extracellular plaques built from filaments of the Aβ-peptide and the intracellular tangles consisting of tau polymd. into Paired Helical Filaments (PHFs).  The order of aggregation events is still under debate, but it is well accepted that tau related changes have an important impact on the viability of neurons.  In neurons, early morphol. changes are seen in axons which begin to loose and retract synapses.  This process is accompanied by an increase of aggregated tau protein.  Thus the prevention of tau aggregation seems to be a valuable target for therapy of Alzheimer's disease.  Here we present a screening procedure by which we identified inhibitors of tau polymn.  In the primary screen we used a thioflavin-S based assay which detects PHF formation in soln.  These initial hits were further analyzed for their capacity to depolymerize preformed PHFs.  These results were confirmed by several secondary assays (tryptophan fluorescence, pelleting, filter trapping and electron microscopy).  By this approach it is possible to identify small mol. compds. which prevent or reverse the aggregation of tau and thereby might improve the viability of neurons in a therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy03P_HSMU9rVg90H21EOLACvtfcHk0liDgnVnRL2MlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVant7o%253D&md5=fed74b4c33a839506b840019402e6abf</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.2174%2F1567205053585891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205053585891%26sid%3Dliteratum%253Aachs%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DGazova%26aufirst%3DZ.%26aulast%3DHascher%26aufirst%3DA.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DScreening%2520for%2520inhibitors%2520of%2520tau%2520polymerization%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2005%26volume%3D2%26spage%3D219%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Morelli, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, P.</span><span> </span><span class="NLM_article-title">Chemical and structural lessons from recent successes in protein–protein interaction inhibition (2P2I)</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.cbpa.2011.05.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21684802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFCltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=475-481&author=X.+Morelliauthor=R.+Bourgeasauthor=P.+Roche&title=Chemical+and+structural+lessons+from+recent+successes+in+protein%E2%80%93protein+interaction+inhibition+%282P2I%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I)</span></div><div class="casAuthors">Morelli, Xavier; Bourgeas, Raphael; Roche, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">475-481</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Worldwide research efforts have driven recent pharmaceutical successes, and consequently, the emerging role of Protein-Protein Interactions (PPIs) as drug targets has finally been widely embraced by the scientific community.  Inhibitors of these Protein-Protein Interactions (2P2Is or i-PPIs) are likely to represent the next generation of highly innovative drugs that will reach the market over the next decade.  This review describes up-to-date knowledge on this particular chem. space, with a specific emphasis on a subset of this ensemble.  We also address current structural knowledge regarding both protein-protein and protein-inhibitor complexes, i.e., the 2P2I database.  Finally, ligand efficiency analyses permit us to relate potency to size and polarity and to discuss the need to co-develop nanoparticle drug delivery systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW7NByutY_QLVg90H21EOLACvtfcHk0liDgnVnRL2MlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFCltro%253D&md5=efe168c18c73e16044583471b7927751</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2011.05.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2011.05.024%26sid%3Dliteratum%253Aachs%26aulast%3DMorelli%26aufirst%3DX.%26aulast%3DBourgeas%26aufirst%3DR.%26aulast%3DRoche%26aufirst%3DP.%26atitle%3DChemical%2520and%2520structural%2520lessons%2520from%2520recent%2520successes%2520in%2520protein%25E2%2580%2593protein%2520interaction%2520inhibition%2520%25282P2I%2529%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D15%26spage%3D475%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Sawaya, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambashivan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanova, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sievers, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apostol, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balbirnie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltzius, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarlane, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riekel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span> </span><span class="NLM_article-title">Atomic structures of amyloid cross-beta spines reveal varied steric zippers</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnature05695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17468747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFOhu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2007&pages=453-457&author=M.+R.+Sawayaauthor=S.+Sambashivanauthor=R.+Nelsonauthor=M.+I.+Ivanovaauthor=S.+A.+Sieversauthor=M.+I.+Apostolauthor=M.+J.+Thompsonauthor=M.+Balbirnieauthor=J.+J.+Wiltziusauthor=H.+T.+McFarlaneauthor=A.+O.+Madsenauthor=C.+Riekelauthor=D.+Eisenberg&title=Atomic+structures+of+amyloid+cross-beta+spines+reveal+varied+steric+zippers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic structures of amyloid cross-β spines reveal varied steric zippers</span></div><div class="casAuthors">Sawaya, Michael R.; Sambashivan, Shilpa; Nelson, Rebecca; Ivanova, Magdalena I.; Sievers, Stuart A.; Apostol, Marcin I.; Thompson, Michael J.; Balbirnie, Melinda; Wiltzius, Jed J. W.; McFarlane, Heather T.; Madsen, Anders O.; Riekel, Christian; Eisenberg, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">7143</span>),
    <span class="NLM_cas:pages">453-457</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Amyloid fibrils formed from different proteins, each assocd. with a particular disease, contain a common cross-β spine.  The at. architecture of a spine, from the fibril-forming segment GNNQQNY of the yeast prion protein Sup35, was recently revealed by x-ray microcrystallog.  It is a pair of β-sheets, with the facing side chains of the two sheets interdigitated in a dry 'steric zipper'.  Here we report some 30 other segments from fibril-forming proteins that form amyloid-like fibrils, microcrystals, or usually both.  These include segments from the Alzheimer's amyloid-β and tau proteins, the PrP prion protein, insulin, islet amyloid polypeptide (IAPP), lysozyme, myoglobin, α-synuclein and β2-microglobulin, suggesting that common structural features are shared by amyloid diseases at the mol. level.  Structures of 13 of these microcrystals all reveal steric zippers, but with variations that expand the range of at. architectures for amyloid-like fibrils and offer an at.-level hypothesis for the basis of prion strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpui5BhVRryrVg90H21EOLACvtfcHk0lh32gz3f7UtRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFOhu7o%253D&md5=be66c8d19b944e484fc13f0037ab043f</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fnature05695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05695%26sid%3Dliteratum%253Aachs%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DSambashivan%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DR.%26aulast%3DIvanova%26aufirst%3DM.%2BI.%26aulast%3DSievers%26aufirst%3DS.%2BA.%26aulast%3DApostol%26aufirst%3DM.%2BI.%26aulast%3DThompson%26aufirst%3DM.%2BJ.%26aulast%3DBalbirnie%26aufirst%3DM.%26aulast%3DWiltzius%26aufirst%3DJ.%2BJ.%26aulast%3DMcFarlane%26aufirst%3DH.%2BT.%26aulast%3DMadsen%26aufirst%3DA.%2BO.%26aulast%3DRiekel%26aufirst%3DC.%26aulast%3DEisenberg%26aufirst%3DD.%26atitle%3DAtomic%2520structures%2520of%2520amyloid%2520cross-beta%2520spines%2520reveal%2520varied%2520steric%2520zippers%26jtitle%3DNature%26date%3D2007%26volume%3D447%26spage%3D453%26epage%3D457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Peterson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlquist, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lew, J.</span><span> </span><span class="NLM_article-title">A soluble oligomer of tau associated with fiber formation analyzed by NMR</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">7393</span><span class="NLM_x">–</span> <span class="NLM_lpage">7404</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi702466a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntlKrtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=7393-7404&author=D.+W.+Petersonauthor=H.+Zhouauthor=F.+W.+Dahlquistauthor=J.+Lew&title=A+soluble+oligomer+of+tau+associated+with+fiber+formation+analyzed+by+NMR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A Soluble Oligomer of Tau Associated with Fiber Formation Analyzed by NMR</span></div><div class="casAuthors">Peterson, Dylan W.; Zhou, Hongjun; Dahlquist, Frederick W.; Lew, John</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">7393-7404</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by the intracellular accumulation of the neurofibrillary tangles comprised mainly of the microtubule-assocd. protein, tau.  A crit. aspect of understanding tangle formation is to understand the transition of sol. monomeric tau into mature fibrils by characterizing the structure of intermediates along the aggregation pathway.  We have carried out multidimensional NMR studies on a C-terminal fragment of human tau (tau187) to gain structural insight into the aggregation process.  To specifically monitor intermol. interaction between tau mols. in soln., we combined 15N- and 14N-labeled tau, the latter of which was modified with a paramagnetic nitroxide spin label (MTSL).  Paramagnetic relaxation enhancement (PRE) of 15N-tau by interaction with MTSL-14N-tau allowed identification of low mol. wt. oligomers of tau187 that formed in response to heparin-induced aggregation.  Two regions, VQIINK280 and VQIVYK311, were exclusively broadened by MTSL located at varied positions in the tau mol.  We propose that sol. oligomers of tau187 are generated via intermol. interactions at these motifs triggered by heparin addn.  However, the assocd. line broadening at these motifs cannot be due to interaction between tau187 and heparin directly.  Instead, these specific interactions necessarily occur between tau mols. and are intermol. in nature.  Our data support the idea that VQIINK280 and VQIVYK311 are the major, if not sole, crit. regions that directly mediate intermol. contact between tau mols. during the early phases of aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWg8wkfVZp37Vg90H21EOLACvtfcHk0lh32gz3f7UtRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntlKrtrk%253D&md5=19e34dbd9d994fd40cbadf8224623e8a</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fbi702466a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi702466a%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DD.%2BW.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DDahlquist%26aufirst%3DF.%2BW.%26aulast%3DLew%26aufirst%3DJ.%26atitle%3DA%2520soluble%2520oligomer%2520of%2520tau%2520associated%2520with%2520fiber%2520formation%2520analyzed%2520by%2520NMR%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D7393%26epage%3D7404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Barghorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">14885</span><span class="NLM_x">–</span> <span class="NLM_lpage">14896</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi026469j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD38XoslOgtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=14885-14896&author=S.+Barghornauthor=E.+Mandelkow&title=Toward+a+unified+scheme+for+the+aggregation+of+tau+into+Alzheimer+paired+helical+filaments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Toward a Unified Scheme for the Aggregation of Tau into Alzheimer Paired Helical Filaments</span></div><div class="casAuthors">Barghorn, S.; Mandelkow, E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">14885-14896</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease is characterized by aggregates of tau protein.  Attempts to study the conditions for aggregation in vitro have led to different exptl. systems, some of which appear mutually exclusive (e.g., oxidative vs. reductive conditions, induction by polyanions vs. fatty acids).  The authors show here that different approaches and pathways can be viewed in a common framework, and that apparent differences can be explained by variations in the kinetics of subreactions.  A unified view of PHF aggregation should help to analyze the causes of PHF aggregation and devise methods to prevent it.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXAWNAtsEARLVg90H21EOLACvtfcHk0lh32gz3f7UtRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XoslOgtbY%253D&md5=3fce6c2c87cd012067603dd9fb7aac04</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fbi026469j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi026469j%26sid%3Dliteratum%253Aachs%26aulast%3DBarghorn%26aufirst%3DS.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DToward%2520a%2520unified%2520scheme%2520for%2520the%2520aggregation%2520of%2520tau%2520into%2520Alzheimer%2520paired%2520helical%2520filaments%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D14885%26epage%3D14896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Schweers, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">8463</span><span class="NLM_x">–</span> <span class="NLM_lpage">8467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.92.18.8463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=7667312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK2MXnvVymu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=8463-8467&author=O.+Schweersauthor=E.+M.+Mandelkowauthor=J.+Biernatauthor=E.+Mandelkow&title=Oxidation+of+cysteine-322+in+the+repeat+domain+of+microtubule-associated+protein+tau+controls+the+in+vitro+assembly+of+paired+helical+filaments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein τ controls the in vitro assembly of paired helical filaments</span></div><div class="casAuthors">Schweers, Olaf; Mandelkow, Eva-Maria; Biernat, Jacek; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8463-7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">One of the hallmarks of Alzheimer disease is the pathol. aggregation of τ protein into paired helical filaments (PHFs) and neurofibrillary tangles.  Here the authors describe the in vitro assembly of recombinant τ protein and constructs derived from it into PHFs.  Though whole τ assembled poorly, constructs contg. three internal repeats (corresponding to the fetal τ isoform) formed PHFs reproducibility.  This ability depended on intermol. disulfide bridges formed by the single Cys-322.  Blocking the SH group, mutating Cys for Ala, or keeping τ in a reducing environment all inhibited assembly.  With constructs derived from four-repeat τ (having the addnl. repeat no. 2 and a second Cys-291), PHF assembly was blocked because Cys-291 and Cys-322 interact within the mol.  PHF assembly was enabled again by mutating Cys-291 for Ala.  The synthetic PHFs bound the dye thioflavin S used in Alzheimer disease diagnostics.  The data imply that the redox potential in the neuron is crucial for PHF assembly, independently or in addn. to pathol. phosphorylation reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoc1u_viDgB7Vg90H21EOLACvtfcHk0lieB8Z9kxA4Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvVymu7c%253D&md5=ceac2390a6e7024570a5d64102376660</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.18.8463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.18.8463%26sid%3Dliteratum%253Aachs%26aulast%3DSchweers%26aufirst%3DO.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DOxidation%2520of%2520cysteine-322%2520in%2520the%2520repeat%2520domain%2520of%2520microtubule-associated%2520protein%2520tau%2520controls%2520the%2520in%2520vitro%2520assembly%2520of%2520paired%2520helical%2520filaments%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D8463%26epage%3D8467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Laganowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitelegge, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pensalfini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriaga, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span> </span><span class="NLM_article-title">Atomic view of a toxic amyloid small oligomer</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">1228</span><span class="NLM_x">–</span> <span class="NLM_lpage">1231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1126%2Fscience.1213151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22403391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlKjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2012&pages=1228-1231&author=A.+Laganowskyauthor=C.+Liuauthor=M.+R.+Sawayaauthor=J.+P.+Whiteleggeauthor=J.+Parkauthor=M.+Zhaoauthor=A.+Pensalfiniauthor=A.+B.+Soriagaauthor=M.+Landauauthor=P.+K.+Tengauthor=D.+Cascioauthor=C.+Glabeauthor=D.+Eisenberg&title=Atomic+view+of+a+toxic+amyloid+small+oligomer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic View of a Toxic Amyloid Small Oligomer</span></div><div class="casAuthors">Laganowsky, Arthur; Liu, Cong; Sawaya, Michael R.; Whitelegge, Julian P.; Park, Jiyong; Zhao, Minglei; Pensalfini, Anna; Soriaga, Angela B.; Landau, Meytal; Teng, Poh K.; Cascio, Duilio; Glabe, Charles; Eisenberg, David</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">6073</span>),
    <span class="NLM_cas:pages">1228-1231</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Amyloid diseases, including Alzheimer's, Parkinson's, and the prion conditions, are each assocd. with a particular protein in fibrillar form.  These amyloid fibrils were long suspected to be the disease agents, but evidence suggests that smaller, often transient and polymorphic oligomers are the toxic entities.  Here, we identify a segment of the amyloid-forming protein αB crystallin, which forms an oligomeric complex exhibiting properties of other amyloid oligomers: β-sheet-rich structure, cytotoxicity, and recognition by an oligomer-specific antibody.  The x-ray-derived at. structure of the oligomer reveals a cylindrical barrel, formed from six antiparallel protein strands, that we term a cylindrin.  The cylindrin structure is compatible with a sequence segment from the β-amyloid protein of Alzheimer's disease.  Cylindrins offer models for the hitherto elusive structures of amyloid oligomers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZJv8jyRJtyLVg90H21EOLACvtfcHk0lieB8Z9kxA4Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlKjt74%253D&md5=d48078bd840f79a3f049ce72750a6dfa</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1126%2Fscience.1213151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1213151%26sid%3Dliteratum%253Aachs%26aulast%3DLaganowsky%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DWhitelegge%26aufirst%3DJ.%2BP.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DPensalfini%26aufirst%3DA.%26aulast%3DSoriaga%26aufirst%3DA.%2BB.%26aulast%3DLandau%26aufirst%3DM.%26aulast%3DTeng%26aufirst%3DP.%2BK.%26aulast%3DCascio%26aufirst%3DD.%26aulast%3DGlabe%26aufirst%3DC.%26aulast%3DEisenberg%26aufirst%3DD.%26atitle%3DAtomic%2520view%2520of%2520a%2520toxic%2520amyloid%2520small%2520oligomer%26jtitle%3DScience%26date%3D2012%26volume%3D335%26spage%3D1228%26epage%3D1231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">A beta oligomers—a decade of discovery</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1172</span><span class="NLM_x">–</span> <span class="NLM_lpage">1184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1471-4159.2006.04426.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17286590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=1172-1184&author=D.+M.+Walshauthor=D.+J.+Selkoe&title=A+beta+oligomers%E2%80%94a+decade+of+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ oligomers - a decade of discovery</span></div><div class="casAuthors">Walsh, Dominic M.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1172-1184</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Converging lines of evidence suggest that progressive accumulation of the amyloid β-protein (Aβ) plays a central role in the genesis of Alzheimer's disease, but it was long assumed that Aβ had to be assembled into extracellular amyloid fibrils to exert its cytotoxic effects.  Over the past decade, data have emerged from the use of synthetic Aβ peptides, cell culture models, β-amyloid precursor protein transgenic mice and human brain to suggest that pre-fibrillar, diffusible assemblies of Aβ are also deleterious.  Although the precise mol. identity of these sol. toxins remains unsettled, accumulating evidence suggests that sol. forms of Aβ are indeed the proximate effectors of synapse loss and neuronal injury.  Here the authors review recent progress in understanding the role of sol. oligomers in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrWrluV1aL7Vg90H21EOLACvtfcHk0lieB8Z9kxA4Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D&md5=263855754364d2ab520e6fd705b9f5f7</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04426.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DA%2520beta%2520oligomers%25E2%2580%2594a%2520decade%2520of%2520discovery%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D1172%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Podlisny, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostaszewski, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squazzo, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">9564</span><span class="NLM_x">–</span> <span class="NLM_lpage">9570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=9564-9570&author=M.+B.+Podlisnyauthor=B.+L.+Ostaszewskiauthor=S.+L.+Squazzoauthor=E.+H.+Kooauthor=R.+E.+Rydellauthor=D.+B.+Teplowauthor=D.+J.+Selkoe&title=Aggregation+of+secreted+amyloid+beta-protein+into+sodium+dodecyl+sulfate-stable+oligomers+in+cell+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPodlisny%26aufirst%3DM.%2BB.%26aulast%3DOstaszewski%26aufirst%3DB.%2BL.%26aulast%3DSquazzo%26aufirst%3DS.%2BL.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DRydell%26aufirst%3DR.%2BE.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DAggregation%2520of%2520secreted%2520amyloid%2520beta-protein%2520into%2520sodium%2520dodecyl%2520sulfate-stable%2520oligomers%2520in%2520cell%2520culture%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D9564%26epage%3D9570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Campioni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampagni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pensalfini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evangelisti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Relini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiti, F.</span><span> </span><span class="NLM_article-title">A causative link between the structure of aberrant protein oligomers and their toxicity</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnchembio.283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20081829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFGqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=140-147&author=S.+Campioniauthor=B.+Manniniauthor=M.+Zampagniauthor=A.+Pensalfiniauthor=C.+Parriniauthor=E.+Evangelistiauthor=A.+Reliniauthor=M.+Stefaniauthor=C.+M.+Dobsonauthor=C.+Cecchiauthor=F.+Chiti&title=A+causative+link+between+the+structure+of+aberrant+protein+oligomers+and+their+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">A causative link between the structure of aberrant protein oligomers and their toxicity</span></div><div class="casAuthors">Campioni, Silvia; Mannini, Benedetta; Zampagni, Mariagioia; Pensalfini, Anna; Parrini, Claudia; Evangelisti, Elisa; Relini, Annalisa; Stefani, Massimo; Dobson, Christopher M.; Cecchi, Cristina; Chiti, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-147</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The aberrant assembly of peptides and proteins into fibrillar aggregates proceeds through oligomeric intermediates that are thought to be the primary pathogenic species in many protein deposition diseases.  We describe two types of oligomers formed by the HypF-N protein that are morphol. and tinctorially similar, as detected with at. force microscopy (AFM) and thioflavin T (ThT) assays, though one is benign when added to cell cultures whereas the other is toxic.  Structural investigation at a residue-specific level using site-directed labeling with pyrene indicated differences in the hydrophobic packing between adjacent protein mols. in the oligomers.  A lower degree of hydrophobic packing was found to correlate with a higher ability to penetrate the cell membrane and cause an influx of Ca2+ ions.  Our findings suggest that structural flexibility and hydrophobic exposure are primary determinants of the ability of oligomeric assemblies to cause cellular dysfunction and its consequences, such as neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9jKW3yYrOd7Vg90H21EOLACvtfcHk0lj77_oODw9_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFGqtg%253D%253D&md5=80714f81c8c6d23af2f8bd6d7d45365e</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.283%26sid%3Dliteratum%253Aachs%26aulast%3DCampioni%26aufirst%3DS.%26aulast%3DMannini%26aufirst%3DB.%26aulast%3DZampagni%26aufirst%3DM.%26aulast%3DPensalfini%26aufirst%3DA.%26aulast%3DParrini%26aufirst%3DC.%26aulast%3DEvangelisti%26aufirst%3DE.%26aulast%3DRelini%26aufirst%3DA.%26aulast%3DStefani%26aufirst%3DM.%26aulast%3DDobson%26aufirst%3DC.%2BM.%26aulast%3DCecchi%26aufirst%3DC.%26aulast%3DChiti%26aufirst%3DF.%26atitle%3DA%2520causative%2520link%2520between%2520the%2520structure%2520of%2520aberrant%2520protein%2520oligomers%2520and%2520their%2520toxicity%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D140%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Braun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharias, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peschek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastenmuller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanzlik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haslbeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappsilber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinkauf, S.</span><span> </span><span class="NLM_article-title">Multiple molecular architectures of the eye lens chaperone alphaB-crystallin elucidated by a triple hybrid approach</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">20491</span><span class="NLM_x">–</span> <span class="NLM_lpage">20496</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=20491-20496&author=N.+Braunauthor=M.+Zachariasauthor=J.+Peschekauthor=A.+Kastenmullerauthor=J.+Zouauthor=M.+Hanzlikauthor=M.+Haslbeckauthor=J.+Rappsilberauthor=J.+Buchnerauthor=S.+Weinkauf&title=Multiple+molecular+architectures+of+the+eye+lens+chaperone+alphaB-crystallin+elucidated+by+a+triple+hybrid+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBraun%26aufirst%3DN.%26aulast%3DZacharias%26aufirst%3DM.%26aulast%3DPeschek%26aufirst%3DJ.%26aulast%3DKastenmuller%26aufirst%3DA.%26aulast%3DZou%26aufirst%3DJ.%26aulast%3DHanzlik%26aufirst%3DM.%26aulast%3DHaslbeck%26aufirst%3DM.%26aulast%3DRappsilber%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26aulast%3DWeinkauf%26aufirst%3DS.%26atitle%3DMultiple%2520molecular%2520architectures%2520of%2520the%2520eye%2520lens%2520chaperone%2520alphaB-crystallin%2520elucidated%2520by%2520a%2520triple%2520hybrid%2520approach%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D20491%26epage%3D20496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Shafrir, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anishkin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, H. R.</span><span> </span><span class="NLM_article-title">Beta-barrel models of soluble amyloid beta oligomers and annular protofibrils</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">3458</span><span class="NLM_x">–</span> <span class="NLM_lpage">3472</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1002%2Fprot.22832" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20830782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2jsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=3458-3472&author=Y.+Shafrirauthor=S.+R.+Durellauthor=A.+Anishkinauthor=H.+R.+Guy&title=Beta-barrel+models+of+soluble+amyloid+beta+oligomers+and+annular+protofibrils"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-barrel models of soluble amyloid beta oligomers and annular protofibrils</span></div><div class="casAuthors">Shafrir, Yinon; Durell, Stewart R.; Anishkin, Andriy; Guy, H. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3458-3472</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Both sol. and membrane-bound prefibrillar assemblies of Abeta (Aβ) peptides have been assocd. with Alzheimer's disease (AD).  The size and nature of these assemblies vary greatly and are affected by many factors.  Here, we present models of sol. hexameric assemblies of Aβ42 and suggest how they can lead to larger assemblies and eventually to fibrils.  The common element in most of these assemblies is a six-stranded β-barrel formed by the last third of Aβ42, which is composed of hydrophobic residues and glycines.  The hydrophobic core β-barrels of the hexameric models are shielded from water by the N-terminus and central segments.  These more hydrophilic segments were modeled to have either predominantly β or predominantly α secondary structure.  Mol. dynamics simulations were performed to analyze stabilities of the models.  The hexameric models were used as starting points from which larger sol. assemblies of 12 and 36 subunits were modeled.  These models were developed to be consistent with numerous exptl. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1LQxO1gkTkrVg90H21EOLACvtfcHk0lj77_oODw9_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2jsrbP&md5=2de226fd95abf54fd2c4d82fb3e0cb6c</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fprot.22832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.22832%26sid%3Dliteratum%253Aachs%26aulast%3DShafrir%26aufirst%3DY.%26aulast%3DDurell%26aufirst%3DS.%2BR.%26aulast%3DAnishkin%26aufirst%3DA.%26aulast%3DGuy%26aufirst%3DH.%2BR.%26atitle%3DBeta-barrel%2520models%2520of%2520soluble%2520amyloid%2520beta%2520oligomers%2520and%2520annular%2520protofibrils%26jtitle%3DProteins%26date%3D2010%26volume%3D78%26spage%3D3458%26epage%3D3472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Cheng, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowick, J. S.</span><span> </span><span class="NLM_article-title">Amyloid beta-sheet mimics that antagonize protein aggregation and reduce amyloid toxicity</span> <span class="citation_source-journal">Nat. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnchem.1433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=23089868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlWnsrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=927-933&author=P.+N.+Chengauthor=C.+Liuauthor=M.+Zhaoauthor=D.+Eisenbergauthor=J.+S.+Nowick&title=Amyloid+beta-sheet+mimics+that+antagonize+protein+aggregation+and+reduce+amyloid+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β-sheet mimics that antagonize protein aggregation and reduce amyloid toxicity</span></div><div class="casAuthors">Cheng, Pin-Nan; Liu, Cong; Zhao, Minglei; Eisenberg, David; Nowick, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">927-933</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The amyloid protein aggregation assocd. with diseases such as Alzheimer's, Parkinson's and type II diabetes (among many others) features a bewildering variety of β-sheet-rich structures in transition from native proteins to ordered oligomers and fibers.  The variation in the amino-acid sequences of the β-structures presents a challenge to developing a model system of β-sheets for the study of various amyloid aggregates.  Here, we introduce a family of robust β-sheet macrocycles that can serve as a platform to display a variety of heptapeptide sequences from different amyloid proteins.  We have tailored these amyloid β-sheet mimics (ABSMs) to antagonize the aggregation of various amyloid proteins, thereby reducing the toxicity of amyloid aggregates.  We describe the structures and inhibitory properties of ABSMs contg. amyloidogenic peptides from the amyloid-β peptide assocd. with Alzheimer's disease, β2-microglobulin assocd. with dialysis-related amyloidosis, α-synuclein assocd. with Parkinson's disease, islet amyloid polypeptide assocd. with type II diabetes, human and yeast prion proteins, and Tau, which forms neurofibrillary tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYZtzUX4piIrVg90H21EOLACvtfcHk0lj77_oODw9_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlWnsrjI&md5=a2e1200698caabb0702ddf5c1b7d523e</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1433%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DP.%2BN.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DEisenberg%26aufirst%3DD.%26aulast%3DNowick%26aufirst%3DJ.%2BS.%26atitle%3DAmyloid%2520beta-sheet%2520mimics%2520that%2520antagonize%2520protein%2520aggregation%2520and%2520reduce%2520amyloid%2520toxicity%26jtitle%3DNat.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D927%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Landau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faull, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laganowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sievers, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span> </span><span class="NLM_article-title">Towards a pharmacophore for amyloid</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1001080</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1371%2Fjournal.pbio.1001080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21695112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFegtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=e1001080&author=M.+Landauauthor=M.+R.+Sawayaauthor=K.+F.+Faullauthor=A.+Laganowskyauthor=L.+Jiangauthor=S.+A.+Sieversauthor=J.+Liuauthor=J.+R.+Barrioauthor=D.+Eisenberg&title=Towards+a+pharmacophore+for+amyloid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a pharmacophore for amyloid</span></div><div class="casAuthors">Landau, Meytal; Sawaya, Michael R.; Faull, Kym F.; Laganowsky, Arthur; Jiang, Lin; Sievers, Stuart A.; Liu, Jie; Barrio, Jorge R.; Eisenberg, David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1001080</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Diagnosing and treating Alzheimer's and other diseases assocd. with amyloid fibers remains a great challenge despite intensive research.  To aid in this effort, we present at. structures of fiber-forming segments of proteins involved in Alzheimer's disease in complex with small mol. binders, detd. by X-ray microcrystallog.  The fiber-like complexes consist of pairs of β-sheets, with small mols. binding between the sheets, roughly parallel to the fiber axis.  The structures suggest that apolar mols. drift along the fiber, consistent with the observation of nonspecific binding to a variety of amyloid proteins.  In contrast, neg. charged orange-G binds specifically to lysine side chains of adjacent sheets.  These structures provide mol. frameworks for the design of diagnostics and drugs for protein aggregation diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHJDf_wPbESrVg90H21EOLACvtfcHk0lik65dD-FLxbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFegtbs%253D&md5=6fedd1729b59ee89733ea5f127fc0b1d</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1001080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1001080%26sid%3Dliteratum%253Aachs%26aulast%3DLandau%26aufirst%3DM.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DFaull%26aufirst%3DK.%2BF.%26aulast%3DLaganowsky%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DSievers%26aufirst%3DS.%2BA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26aulast%3DEisenberg%26aufirst%3DD.%26atitle%3DTowards%2520a%2520pharmacophore%2520for%2520amyloid%26jtitle%3DPLoS%2520Biol.%26date%3D2011%26volume%3D9%26spage%3De1001080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Sievers, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanicolas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zirafi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span> </span><span class="NLM_article-title">Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">475</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnature10154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21677644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsFOrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=96-100&author=S.+A.+Sieversauthor=J.+Karanicolasauthor=H.+W.+Changauthor=A.+Zhaoauthor=L.+Jiangauthor=O.+Zirafiauthor=J.+T.+Stevensauthor=J.+Munchauthor=D.+Bakerauthor=D.+Eisenberg&title=Structure-based+design+of+non-natural+amino-acid+inhibitors+of+amyloid+fibril+formation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation</span></div><div class="casAuthors">Sievers, Stuart A.; Karanicolas, John; Chang, Howard W.; Zhao, Anni; Jiang, Lin; Zirafi, Onofrio; Stevens, Jason T.; Muench, Jan; Baker, David; Eisenberg, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7354</span>),
    <span class="NLM_cas:pages">96-100</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Many globular and natively disordered proteins can convert into amyloid fibrils.  These fibrils are assocd. with numerous pathologies as well as with normal cellular functions, and frequently form during protein denaturation.  Inhibitors of pathol. amyloid fibril formation could be useful in the development of therapeutics, provided that the inhibitors were specific enough to avoid interfering with normal processes.  Computer-aided, structure-based design can yield highly specific peptide inhibitors of amyloid formation.  Using known at. structures of segments of amyloid fibrils as templates, the authors have designed and characterized an all-d-amino-acid inhibitor of the fibril formation of the tau protein assocd. with Alzheimer's disease, and a non-natural l-amino-acid inhibitor of an amyloid fibril that enhances sexual transmission of human immunodeficiency virus.  The authors' results indicate that peptides from structure-based designs can disrupt the fibril formation of full-length proteins, including those, such as tau protein, that lack fully ordered native structures.  Because the inhibiting peptides have been designed on structures of dual-β-sheet 'steric zippers', the successful inhibition of amyloid fibril formation strengthens the hypothesis that amyloid spines contain steric zippers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAFy-0fm-GobVg90H21EOLACvtfcHk0lik65dD-FLxbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsFOrs7s%253D&md5=75a55d1238691e18683583b1f9d093d5</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fnature10154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10154%26sid%3Dliteratum%253Aachs%26aulast%3DSievers%26aufirst%3DS.%2BA.%26aulast%3DKaranicolas%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DH.%2BW.%26aulast%3DZhao%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DZirafi%26aufirst%3DO.%26aulast%3DStevens%26aufirst%3DJ.%2BT.%26aulast%3DMunch%26aufirst%3DJ.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DEisenberg%26aufirst%3DD.%26atitle%3DStructure-based%2520design%2520of%2520non-natural%2520amino-acid%2520inhibitors%2520of%2520amyloid%2520fibril%2520formation%26jtitle%3DNature%26date%3D2011%26volume%3D475%26spage%3D96%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Zheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vadla, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goux, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowick, J. S.</span><span> </span><span class="NLM_article-title">Macrocyclic beta-sheet peptides that inhibit the aggregation of a tau-protein-derived hexapeptide</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">3144</span><span class="NLM_x">–</span> <span class="NLM_lpage">3157</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja110545h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFeis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=3144-3157&author=J.+Zhengauthor=C.+Liuauthor=M.+R.+Sawayaauthor=B.+Vadlaauthor=S.+Khanauthor=R.+J.+Woodsauthor=D.+Eisenbergauthor=W.+J.+Gouxauthor=J.+S.+Nowick&title=Macrocyclic+beta-sheet+peptides+that+inhibit+the+aggregation+of+a+tau-protein-derived+hexapeptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic β-sheet peptides that inhibit the aggregation of a tau-protein-derived hexapeptide</span></div><div class="casAuthors">Zheng, Jing; Liu, Cong; Sawaya, Michael R.; Vadla, Balraju; Khan, Shafiullah; Woods, R. Jeremy; Eisenberg, David; Goux, Warren J.; Nowick, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3144-3157</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes studies of a series of macrocyclic β-sheet peptides 1 that inhibit the aggregation of a tau-protein-derived peptide.  The macrocyclic β-sheet peptides comprise a pentapeptide "upper" strand, two δ-linked ornithine turn units, and a "lower" strand comprising two addnl. residues and the β-sheet peptidomimetic template "Hao".  The tau-derived peptide Ac-VQIVYK-NH2 (AcPHF6) aggregates in soln. through β-sheet interactions to form straight and twisted filaments similar to those formed by tau protein in Alzheimer's neurofibrillary tangles.  Macrocycles 1 contg. the pentapeptide VQIVY in the "upper" strand delay and suppress the onset of aggregation of the AcPHF6 peptide.  Inhibition is particularly pronounced in other macrocycles in which the two residues in the "lower" strand provide a pattern of hydrophobicity and hydrophilicity that matches that of the pentapeptide "upper" strand.  Inhibition varies strongly with the concn. of these macrocycles, suggesting that it is cooperative.  Another macrocycle contg. the pentapeptide QIVYK shows little inhibition, suggesting the possibility of a preferred direction of growth of AcPHF6 β-sheets.  On the basis of these studies, a model is proposed in which the AcPHF6 amyloid grows as a layered pair of β-sheets and in which growth is blocked by a pair of macrocycles that cap the growing paired hydrogen-bonding edges.  This model provides a provocative and appealing target for future inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUUxfY1h_AurVg90H21EOLACvtfcHk0lik65dD-FLxbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFeis7k%253D&md5=47c5d5dd0864b5e4613bf00baa445ef1</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fja110545h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja110545h%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DVadla%26aufirst%3DB.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DWoods%26aufirst%3DR.%2BJ.%26aulast%3DEisenberg%26aufirst%3DD.%26aulast%3DGoux%26aufirst%3DW.%2BJ.%26aulast%3DNowick%26aufirst%3DJ.%2BS.%26atitle%3DMacrocyclic%2520beta-sheet%2520peptides%2520that%2520inhibit%2520the%2520aggregation%2520of%2520a%2520tau-protein-derived%2520hexapeptide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D3144%26epage%3D3157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Wischik, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, C. R.</span><span> </span><span class="NLM_article-title">Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">11213</span><span class="NLM_x">–</span> <span class="NLM_lpage">11218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.93.20.11213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=8855335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK28XmtVOqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=11213-11218&author=C.+M.+Wischikauthor=P.+C.+Edwardsauthor=R.+Y.+Laiauthor=M.+Rothauthor=C.+R.+Harrington&title=Selective+inhibition+of+Alzheimer+disease-like+tau+aggregation+by+phenothiazines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines</span></div><div class="casAuthors">Wischik, C. M.; Edwards, P. C.; Lai, R. Y.; Roth, M.; Harrington, C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11213-11218</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In Alzheimer disease (AD) the microtubule-assocd. protein tau is redistributed exponentially into paired helical filaments (PHFs) forming neurofibrillary tangles, which correlate with pyramidal cell destruction and dementia.  Amorphous neuronal deposits and PHFs in AD are characterized by aggregation through the repeat domain and C-terminal truncation at Glu-391 by endogenous proteases.  We show that a similar proteolytically stable complex can be generated in vitro following the self-aggregation of tau protein through a high-affinity binding site in the repeat domain.  Once started, tau capture can be propagated by seeding the further accumulation of truncated tau in the presence of proteases.  We have identified a non-neuroleptic phenothiazine previously used in man (methylene blue, MB), which reverses the proteolytic stability of protease-resistant PHFs by blocking the tau-tau binding interaction through the repeat domain.  Although MB is inhibitory at a higher concn. than may be achieved clin., the tau-tau binding assay was used to identify desmethyl derivs. of MB that have Ki values in the nanomolar range.  Neuroleptic phenothiazines are inactive.  Tau aggregation inhibitors do not affect the tau-tubulin interaction, which also occurs through the repeat domain.  Our findings demonstrate that biol. selective pharmaceutical agents could be developed to facilitate the proteolytic degrdn. of tau aggregates and prevent the further propagation of tau capture in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogZyJ57Clqp7Vg90H21EOLACvtfcHk0liUMS9PS3mbRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtVOqsLg%253D&md5=d586f688ffc47cc4129ed6407bd15720</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.20.11213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.20.11213%26sid%3Dliteratum%253Aachs%26aulast%3DWischik%26aufirst%3DC.%2BM.%26aulast%3DEdwards%26aufirst%3DP.%2BC.%26aulast%3DLai%26aufirst%3DR.%2BY.%26aulast%3DRoth%26aufirst%3DM.%26aulast%3DHarrington%26aufirst%3DC.%2BR.%26atitle%3DSelective%2520inhibition%2520of%2520Alzheimer%2520disease-like%2520tau%2520aggregation%2520by%2520phenothiazines%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D11213%26epage%3D11218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Wainwright, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaral, L.</span><span> </span><span class="NLM_article-title">The phenothiazinium chromophore and the evolution of antimalarial drugs</span> <span class="citation_source-journal">Trop. Med. Int. Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1365-3156.2005.01417.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15941412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFGrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=501-511&author=M.+Wainwrightauthor=L.+Amaral&title=The+phenothiazinium+chromophore+and+the+evolution+of+antimalarial+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">The phenothiazinium chromophore and the evolution of antimalarial drugs</span></div><div class="casAuthors">Wainwright, Mark; Amaral, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Tropical Medicine & International Health</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">501-511</span>CODEN:
                <span class="NLM_cas:coden">TMIHFL</span>;
        ISSN:<span class="NLM_cas:issn">1360-2276</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The phenothiazinium salt methylene blue [3, 7-bis(dimethylamino)phenothiazinium chloride] is the oldest known synthetic antimalarial drug, its clin. efficacy having been reported in 1891.  The role of methylene blue in the evolution of the modern antimalarial armoury is often unappreciated, yet it can be linked directly to std. drugs such as chloroquine and its congeners.  Also, in the face of increasing plasmodial resistance to modern antimalarials, phenothiazinium derivs. have again featured as lead compds. in drug research.  The precise mode of action of methylene blue and its com. analogs against Plasmodium spp remains a cause for conjecture, having been variously described as nucleic acid intercalation, food vacuole basification, parasite redox cycle interference and haem polymn. inhibition.  That the activity of the series may be due to more than one route - i.e. a multifactorial activity - underlines the utility of these compds. in antimalarial research either as single drugs or as adjuvants (partners in a drug combination), particularly in the face of resistant parasitic strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3A1-361mIZrVg90H21EOLACvtfcHk0liUMS9PS3mbRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFGrs7c%253D&md5=873f7cc2d4da96fc19842f83af937028</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-3156.2005.01417.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-3156.2005.01417.x%26sid%3Dliteratum%253Aachs%26aulast%3DWainwright%26aufirst%3DM.%26aulast%3DAmaral%26aufirst%3DL.%26atitle%3DThe%2520phenothiazinium%2520chromophore%2520and%2520the%2520evolution%2520of%2520antimalarial%2520drugs%26jtitle%3DTrop.%2520Med.%2520Int.%2520Health%26date%3D2005%26volume%3D10%26spage%3D501%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Schirmer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Lest we forget you—methylene blue..</span> <span class="citation_source-journal">Neurobiol Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2325 e2327</span><span class="NLM_x">–</span> <span class="NLM_lpage">e2316</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.neurobiolaging.2010.12.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=2325+e2327-e2316&author=R.+H.+Schirmerauthor=H.+Adlerauthor=M.+Pickhardtauthor=E.+Mandelkow&title=Lest+we+forget+you%E2%80%94methylene+blue.."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2010.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2010.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DSchirmer%26aufirst%3DR.%2BH.%26aulast%3DAdler%26aufirst%3DH.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DLest%2520we%2520forget%2520you%25E2%2580%2594methylene%2520blue..%26jtitle%3DNeurobiol%2520Aging%26date%3D2011%26volume%3D32%26spage%3D2325%2520e2327%26epage%3De2316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Josefsen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, R. W.</span><span> </span><span class="NLM_article-title">Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics</span> <span class="citation_source-journal">Theranostics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">916</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=916-966&author=L.+B.+Josefsenauthor=R.+W.+Boyle&title=Unique+diagnostic+and+therapeutic+roles+of+porphyrins+and+phthalocyanines+in+photodynamic+therapy%2C+imaging+and+theranostics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJosefsen%26aufirst%3DL.%2BB.%26aulast%3DBoyle%26aufirst%3DR.%2BW.%26atitle%3DUnique%2520diagnostic%2520and%2520therapeutic%2520roles%2520of%2520porphyrins%2520and%2520phthalocyanines%2520in%2520photodynamic%2520therapy%252C%2520imaging%2520and%2520theranostics%26jtitle%3DTheranostics%26date%3D2012%26volume%3D2%26spage%3D916%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Bruchey, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Lima, F.</span><span> </span><span class="NLM_article-title">Behavioral, physiological and biochemical hormetic responses to the autoxidizable dye methylene blue</span> <span class="citation_source-journal">Am. J. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.3844%2Fajptsp.2008.72.79" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFOqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=72-79&author=A.+K.+Brucheyauthor=F.+Gonzalez-Lima&title=Behavioral%2C+physiological+and+biochemical+hormetic+responses+to+the+autoxidizable+dye+methylene+blue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral, physiological and biochemical hormetic responses to the autoxidizable dye methylene blue</span></div><div class="casAuthors">Bruchey, Aleksandra K.; Gonzalez-Lima, F.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-79</span>CODEN:
                <span class="NLM_cas:coden">AJPTCT</span>;
        ISSN:<span class="NLM_cas:issn">1557-4962</span>.
    
            (<span class="NLM_cas:orgname">Science Publications</span>)
        </div><div class="casAbstract">The goals of this review were to identify methylene blue (MB) as a compd. that follows hormetic behavior for a wide range of effects and to address the question of what is unique about MB that could account for its wide applicability and hormetic behavior as a drug.  The MB hormetic dose-response relationship is exemplified by an increase in various behavioral, physiol. and biochem. responses with increasing dose, followed by a decrease in the same responses with an even higher dose, until the responses are equal to control responses.  With MB doses increasing beyond the hormetic zone, the responses decrease even further, until they are below the control responses.  At doses spanning its hormetic zone, MB can increase select responses until they are 130-160% of control.  For example, low doses of MB produce max. behavioral and biochem. responses with avs. of approx. 140% of control.  As MB dose is raised outside the hormetic zone the response decreases below the control response, as exemplified by MB's ability to increase cytochrome oxidase activity at intermediate doses, while decreasing cytochrome oxidase activity at higher doses.  It is proposed that MB's autoxidizable chem. property may be responsible for its unique biol. action as both a metabolic energy enhancer and antioxidant that is frequently characterized by hormetic dose-response relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBEKHL_yDpYrVg90H21EOLACvtfcHk0liUMS9PS3mbRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFOqt7s%253D&md5=cae396bd6725339a0c87647e9774c28c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.3844%2Fajptsp.2008.72.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3844%252Fajptsp.2008.72.79%26sid%3Dliteratum%253Aachs%26aulast%3DBruchey%26aufirst%3DA.%2BK.%26aulast%3DGonzalez-Lima%26aufirst%3DF.%26atitle%3DBehavioral%252C%2520physiological%2520and%2520biochemical%2520hormetic%2520responses%2520to%2520the%2520autoxidizable%2520dye%2520methylene%2520blue%26jtitle%3DAm.%2520J.%2520Pharmacol.%2520Toxicol.%26date%3D2008%26volume%3D3%26spage%3D72%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Ohlow, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moosmann, B.</span><span> </span><span class="NLM_article-title">Phenothiazine: the seven lives of pharmacology’s first lead structure</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=119-131&author=M.+J.+Ohlowauthor=B.+Moosmann&title=Phenothiazine%3A+the+seven+lives+of+pharmacology%E2%80%99s+first+lead+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhlow%26aufirst%3DM.%2BJ.%26aulast%3DMoosmann%26aufirst%3DB.%26atitle%3DPhenothiazine%253A%2520the%2520seven%2520lives%2520of%2520pharmacology%25E2%2580%2599s%2520first%2520lead%2520structure%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D119%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">DiSanto, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. G.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of highly ionized drugs. II. Methylene blue—absorption, metabolism, and excretion in man and dog after oral administration</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1090</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1972&pages=1086-1090&author=A.+R.+DiSantoauthor=J.+G.+Wagner&title=Pharmacokinetics+of+highly+ionized+drugs.+II.+Methylene+blue%E2%80%94absorption%2C+metabolism%2C+and+excretion+in+man+and+dog+after+oral+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiSanto%26aufirst%3DA.%2BR.%26aulast%3DWagner%26aufirst%3DJ.%2BG.%26atitle%3DPharmacokinetics%2520of%2520highly%2520ionized%2520drugs.%2520II.%2520Methylene%2520blue%25E2%2580%2594absorption%252C%2520metabolism%252C%2520and%2520excretion%2520in%2520man%2520and%2520dog%2520after%2520oral%2520administration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1972%26volume%3D61%26spage%3D1086%26epage%3D1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Walter-Sack, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rengelshausen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberwittler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burhenne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meissner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikus, G.</span><span> </span><span class="NLM_article-title">High absolute bioavailability of methylene blue given as an aqueous oral formulation</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=179-189&author=I.+Walter-Sackauthor=J.+Rengelshausenauthor=H.+Oberwittlerauthor=J.+Burhenneauthor=O.+Muellerauthor=P.+Meissnerauthor=G.+Mikus&title=High+absolute+bioavailability+of+methylene+blue+given+as+an+aqueous+oral+formulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalter-Sack%26aufirst%3DI.%26aulast%3DRengelshausen%26aufirst%3DJ.%26aulast%3DOberwittler%26aufirst%3DH.%26aulast%3DBurhenne%26aufirst%3DJ.%26aulast%3DMueller%26aufirst%3DO.%26aulast%3DMeissner%26aufirst%3DP.%26aulast%3DMikus%26aufirst%3DG.%26atitle%3DHigh%2520absolute%2520bioavailability%2520of%2520methylene%2520blue%2520given%2520as%2520an%2520aqueous%2520oral%2520formulation%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D65%26spage%3D179%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Peter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hongwan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupfer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauterburg, B. H.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and organ distribution of intravenous and oral methylene blue</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2000&pages=247-250&author=C.+Peterauthor=D.+Hongwanauthor=A.+Kupferauthor=B.+H.+Lauterburg&title=Pharmacokinetics+and+organ+distribution+of+intravenous+and+oral+methylene+blue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeter%26aufirst%3DC.%26aulast%3DHongwan%26aufirst%3DD.%26aulast%3DKupfer%26aufirst%3DA.%26aulast%3DLauterburg%26aufirst%3DB.%2BH.%26atitle%3DPharmacokinetics%2520and%2520organ%2520distribution%2520of%2520intravenous%2520and%2520oral%2520methylene%2520blue%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2000%26volume%3D56%26spage%3D247%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Meijer, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeer, G. A.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of biliary excretion in man. VI. Indocyanine green</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1007%2FBF00558268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=3181282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADyaL1M%252FjtV2msg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1988&pages=295-303&author=D.+K.+Meijerauthor=B.+Weertauthor=G.+A.+Vermeer&title=Pharmacokinetics+of+biliary+excretion+in+man.+VI.+Indocyanine+green"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of biliary excretion in man. VI. Indocyanine green</span></div><div class="casAuthors">Meijer D K; Weert B; Vermeer G A</div><div class="citationInfo"><span class="NLM_cas:title">European journal of clinical pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">295-303</span>
        ISSN:<span class="NLM_cas:issn">0031-6970</span>.
    </div><div class="casAbstract">The pharmacokinetics of Indocyanine Green (ICG) has been studied in 15 patients given 0.5, 1.0 and 2.0 mg.kg-1.  The plasma disappearance and biliary excretion rate were measured in patients with tightly fitting catheters under slight negative pressure in order to achieve complete collection of bile.  Recovery of unchanged ICG in bile over 18 h after the i.v. injection was 80% of the dose in all three dose groups.  Plasma disappearance in all 3 groups was biphasic, showing an initial phase with a t1/2 of 3-4 min and a secondary phase with a dose-dependent apparent t1/2 of 67.6, 72.5 and 88.7 min, respectively.  After 0.5 and 1.0 mg.kg-1 the biliary excretion rate curves showed an ascending phase with a mean t1/2 of 5 min and a descending phase with a mean t1/2 of 72 min.  It was inferred that the secondary component of the plasma-decay mainly reflected the biliary excretion rate.  After 2.0 mg.kg-1 in some patients the biliary excretion curve showed features of saturation; the t1/2 of the descending phase ranged from 73 to 440 min, and the time of maximal excretion was increased from 1.3 to 2.7 h after injection, whilst the mean maximal excretion rate was in the same range as the excretion rate after the 1.0 mg.kg-1 dose.  The non-linear pharmacokinetics was only moderately reflected in the measured plasma disappearance patterns.  Two compartment analysis of the plasma levels indicated a clearance of 230-260 ml.min-1, whereas the clearance conventionally calculated from the initial t1/2 was 475 ml.min-1.(ABSTRACT TRUNCATED AT 250 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQv2Sjh9FVNNEwlCcfExbvbfW6udTcc2eYcYNsgbk76frntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M%252FjtV2msg%253D%253D&md5=80c143aafcc153d7f21dcfae5953c772</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1007%2FBF00558268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00558268%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DD.%2BK.%26aulast%3DWeert%26aufirst%3DB.%26aulast%3DVermeer%26aufirst%3DG.%2BA.%26atitle%3DPharmacokinetics%2520of%2520biliary%2520excretion%2520in%2520man.%2520VI.%2520Indocyanine%2520green%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1988%26volume%3D35%26spage%3D295%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Medina, D. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccamo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oddo, S.</span><span> </span><span class="NLM_article-title">Methylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity</span> <span class="citation_source-journal">Brain Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1750-3639.2010.00430.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20731659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Cis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=140-149&author=D.+X.+Medinaauthor=A.+Caccamoauthor=S.+Oddo&title=Methylene+blue+reduces+abeta+levels+and+rescues+early+cognitive+deficit+by+increasing+proteasome+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Methylene blue reduces Aβ levels and rescues early cognitive deficit by increasing proteasome activity</span></div><div class="casAuthors">Medina, David X.; Caccamo, Antonella; Oddo, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-149</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Promising results have emerged from a phase II clin. trial testing methylene blue (MB) as a potential therapeutic for Alzheimer disease (AD), where improvements in cognitive functions of AD patients after 6 mo of MB administration have been reported.  Despite these reports, no preclin. testing of MB in mammals has been published, and thus its mechanism of action in relation to AD pathol. remains unknown.  In order to elucidate the effects of MB on AD pathol. and to det. its mechanism of action, we used a mouse model (3xTg-AD) that develops age-dependent accumulation of Aβ and tau and cognitive decline.  Here, we report that chronic dietary MB treatment reduces Aβ levels and improves learning and memory deficits in the 3xTg-AD mice.  The mechanisms underlying the effects of MB on Aβ pathol. appears to be mediated by an increase in Aβ clearance as we show that MB increases the chymotrypsin- and trypsin-like activities of the proteasome in the brain.  To our knowledge, this is the first report showing that MB increases proteasome function and ameliorates AD-like pathol. in vivo.  Overall, the data presented here support the use of MB for the treatment of AD and offer a possible mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWODYX7uLwdbVg90H21EOLACvtfcHk0liU08cSIZXwIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Cis74%253D&md5=d26eb29cec29fd8477fd189019643ab5</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1111%2Fj.1750-3639.2010.00430.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1750-3639.2010.00430.x%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DD.%2BX.%26aulast%3DCaccamo%26aufirst%3DA.%26aulast%3DOddo%26aufirst%3DS.%26atitle%3DMethylene%2520blue%2520reduces%2520abeta%2520levels%2520and%2520rescues%2520early%2520cognitive%2520deficit%2520by%2520increasing%2520proteasome%2520activity%26jtitle%3DBrain%2520Pathol.%26date%3D2011%26volume%3D21%26spage%3D140%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">van Bebber, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruscha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.nbd.2010.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20381619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt12nur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=265-271&author=F.+van+Bebberauthor=D.+Paquetauthor=A.+Hruschaauthor=B.+Schmidauthor=C.+Haass&title=Methylene+blue+fails+to+inhibit+Tau+and+polyglutamine+protein+dependent+toxicity+in+zebrafish"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish</span></div><div class="casAuthors">van Bebber, Frauke; Paquet, Dominik; Hruscha, Alexander; Schmid, Bettina; Haass, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-271</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Methylene blue is an FDA approved compd. with a variety of pharmacol. activities.  It inhibits aggregation of several amyloidogenic proteins known to be deposited in neurodegenerative diseases.  Recently, it has been proposed that methylene blue shows significant beneficial effects in a phase 2 clin. trial by slowing cognitive decline in Alzheimer's disease patients.  To analyze its therapeutic potential, we investigated the effect of methylene blue on neurotoxicity in a zebrafish model for tauopathies.  Transgenic expression of the frontotemporal dementia assocd. Tau-P301L mutation recapitulates a no. of the pathol. features obsd. in humans including abnormal phosphorylation and folding of Tau, tangle formation and Tau dependent neuronal loss.  Upon incubation of zebrafish larvae with methylene blue, neither abnormal phosphorylation nor neuronal cell loss, reduced neurite outgrowth or a swimming defect were rescued.  Methylene blue is biol. active in zebrafish since it reduced aggregation of a huntingtin variant contg. a stretch of 102 glutamine residues.  However, although huntingtin aggregation was largely prevented by methylene blue, huntingtin-dependent toxicity was unaffected.  Our findings are consistent with the hypothesis that toxicity is not necessarily assocd. with deposition of insol. amyloid proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog0EKGS9I8E7Vg90H21EOLACvtfcHk0lhX8UPvzfdZYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt12nur0%253D&md5=c4a5333ea90d770a5fc27496ff626c6e</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2010.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2010.03.023%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BBebber%26aufirst%3DF.%26aulast%3DPaquet%26aufirst%3DD.%26aulast%3DHruscha%26aufirst%3DA.%26aulast%3DSchmid%26aufirst%3DB.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DMethylene%2520blue%2520fails%2520to%2520inhibit%2520Tau%2520and%2520polyglutamine%2520protein%2520dependent%2520toxicity%2520in%2520zebrafish%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2010%26volume%3D39%26spage%3D265%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Congdon, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myeku, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinec, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickey, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duff, K. E.</span><span> </span><span class="NLM_article-title">Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=609-622&author=E.+E.+Congdonauthor=J.+W.+Wuauthor=N.+Myekuauthor=Y.+H.+Figueroaauthor=M.+Hermanauthor=P.+S.+Marinecauthor=J.+E.+Gestwickiauthor=C.+A.+Dickeyauthor=W.+H.+Yuauthor=K.+E.+Duff&title=Methylthioninium+chloride+%28methylene+blue%29+induces+autophagy+and+attenuates+tauopathy+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCongdon%26aufirst%3DE.%2BE.%26aulast%3DWu%26aufirst%3DJ.%2BW.%26aulast%3DMyeku%26aufirst%3DN.%26aulast%3DFigueroa%26aufirst%3DY.%2BH.%26aulast%3DHerman%26aufirst%3DM.%26aulast%3DMarinec%26aufirst%3DP.%2BS.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DYu%26aufirst%3DW.%2BH.%26aulast%3DDuff%26aufirst%3DK.%2BE.%26atitle%3DMethylthioninium%2520chloride%2520%2528methylene%2520blue%2529%2520induces%2520autophagy%2520and%2520attenuates%2520tauopathy%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAutophagy%26date%3D2012%26volume%3D8%26spage%3D609%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Buchholz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comini, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissenbach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirmer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauth-Siegel, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gromer, S.</span><span> </span><span class="NLM_article-title">Cytotoxic interactions of methylene blue with trypanosomatid-specific disulfide reductases and their dithiol products</span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.molbiopara.2008.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18448175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVamsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2008&pages=65-69&author=K.+Buchholzauthor=M.+A.+Cominiauthor=D.+Wissenbachauthor=R.+H.+Schirmerauthor=R.+L.+Krauth-Siegelauthor=S.+Gromer&title=Cytotoxic+interactions+of+methylene+blue+with+trypanosomatid-specific+disulfide+reductases+and+their+dithiol+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic interactions of methylene blue with trypanosomatid-specific disulfide reductases and their dithiol products</span></div><div class="casAuthors">Buchholz, Kathrin; Comini, Marcelo A.; Wissenbach, Dirk; Schirmer, R. Heiner; Krauth-Siegel, R. Luise; Gromer, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-69</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Methylene blue (MB) is known to have trypanocidal activity.  We tested the interactions of MB with a no. of trypanosomatid-specific mols. of the antioxidant metab.  At pH 7, trypanothione and other (di)thiols were oxidized to disulfides by the phenothiazine drug.  MB inhibited Trypanosoma cruzi trypanothione reductase (TR) (Ki = 1.9 μM), and served as a significant subversive substrate of this enzyme (KM = 30 μM, kcat = 4.9 s-1).  With lipoamide dehydrogenase, the second thiol-generating flavoenzyme of T. cruzi, the catalytic efficiency for MB redn. was found to be almost 106 M-1 s-1.  When the system MB-enzyme-mol. oxygen acts as a NAD(P)H-driven redox cycler, a reactive oxygen species, H2O2 or superoxide, is produced in each cycle.  Since MB is an affordable, available, and accessible drug it might be tested - alone or in drug combinations - against trypanosomatid-caused diseases of animal and man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3BOsO53izELVg90H21EOLACvtfcHk0lhX8UPvzfdZYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVamsbg%253D&md5=734fc267a95fdc2bcd9e7b56c69e5584</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2008.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2008.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DK.%26aulast%3DComini%26aufirst%3DM.%2BA.%26aulast%3DWissenbach%26aufirst%3DD.%26aulast%3DSchirmer%26aufirst%3DR.%2BH.%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26aulast%3DGromer%26aufirst%3DS.%26atitle%3DCytotoxic%2520interactions%2520of%2520methylene%2520blue%2520with%2520trypanosomatid-specific%2520disulfide%2520reductases%2520and%2520their%2520dithiol%2520products%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2008%26volume%3D160%26spage%3D65%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Atamna, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newberry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, B. N.</span><span> </span><span class="NLM_article-title">Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=703-712&author=H.+Atamnaauthor=A.+Nguyenauthor=C.+Schultzauthor=K.+Boyleauthor=J.+Newberryauthor=H.+Katoauthor=B.+N.+Ames&title=Methylene+blue+delays+cellular+senescence+and+enhances+key+mitochondrial+biochemical+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtamna%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DA.%26aulast%3DSchultz%26aufirst%3DC.%26aulast%3DBoyle%26aufirst%3DK.%26aulast%3DNewberry%26aufirst%3DJ.%26aulast%3DKato%26aufirst%3DH.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DMethylene%2520blue%2520delays%2520cellular%2520senescence%2520and%2520enhances%2520key%2520mitochondrial%2520biochemical%2520pathways%26jtitle%3DFASEB%2520J.%26date%3D2008%26volume%3D22%26spage%3D703%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2007&pages=1-6&author=A.+Croweauthor=C.+Ballatoreauthor=E.+Hydeauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=High+throughput+screening+for+small+molecule+inhibitors+of+heparin-induced+tau+fibril+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DHyde%26aufirst%3DE.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DHigh%2520throughput%2520screening%2520for%2520small%2520molecule%2520inhibitors%2520of%2520heparin-induced%2520tau%2520fibril%2520formation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2007%26volume%3D358%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Buchholz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirmer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eubel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akoachere, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dandekar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gromer, S.</span><span> </span><span class="NLM_article-title">Interactions of methylene blue with human disulfide reductases and their orthologues from <i>Plasmodium falciparum</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=183-191&author=K.+Buchholzauthor=R.+H.+Schirmerauthor=J.+K.+Eubelauthor=M.+B.+Akoachereauthor=T.+Dandekarauthor=K.+Beckerauthor=S.+Gromer&title=Interactions+of+methylene+blue+with+human+disulfide+reductases+and+their+orthologues+from+Plasmodium+falciparum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DK.%26aulast%3DSchirmer%26aufirst%3DR.%2BH.%26aulast%3DEubel%26aufirst%3DJ.%2BK.%26aulast%3DAkoachere%26aufirst%3DM.%2BB.%26aulast%3DDandekar%26aufirst%3DT.%26aulast%3DBecker%26aufirst%3DK.%26aulast%3DGromer%26aufirst%3DS.%26atitle%3DInteractions%2520of%2520methylene%2520blue%2520with%2520human%2520disulfide%2520reductases%2520and%2520their%2520orthologues%2520from%2520Plasmodium%2520falciparum%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D183%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saumier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garceau, D.</span><span> </span><span class="NLM_article-title">Alzhemed: a potential treatment for Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F156720507781788882" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17908052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSitLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=473-478&author=P.+S.+Aisenauthor=S.+Gauthierauthor=B.+Vellasauthor=R.+Briandauthor=D.+Saumierauthor=J.+Laurinauthor=D.+Garceau&title=Alzhemed%3A+a+potential+treatment+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Alzhemed: a potential treatment for Alzheimer's disease</span></div><div class="casAuthors">Aisen, Paul S.; Gauthier, Serge; Vellas, Bruno; Briand, Richard; Saumier, Daniel; Laurin, Julie; Garceau, Denis</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">473-478</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  As a potential disease-modifying treatment for AD, Alzhemed (tramiprosate) is a compd. that binds to sol. amyloid-beta peptide (Aβ) and inhibits the formation of neurotoxic aggregates that lead to amyloid plaque deposition in the brain.  The safety, tolerability, and pharmacodynamic effects of Alzhemed were assessed in a double-blind study in which 58 individuals with mild-to-moderate AD (MMSE 13-25) were randomized to receive placebo or Alzhemed 50, 100 or 150 mg BID for 3 mo.  At the end of the double-blind phase, 42 of these subjects entered a 36-mo openlabel (OL) phase in which they received Alzhemed 150 mg BID.  Assessments included plasma and cerebrospinal fluid (CSF) Alzhemed concns., CSF levels of Aβ, as well as cognitive (Alzheimer's Disease Assessment Scale-cognitive subscale, Mini-Mental State Examn.) and clin. performance (Clin. Dementia Rating scale, Sum-of-Boxes) measures.  Alzhemed was safe and well tolerated, crossed the blood-brain barrier, and dose-dependently reduced CSF Aβ42 levels after 3 mo of treatment.  Mild AD subjects (MMSE 19-25 at entry) displayed greater redn. of CSF Aβ42 levels than moderate AD participants (MMSE 13-18 at entry).  There was no effect of Alzhemed on the cognitive or clin. measures after 3 mo of treatment.  The OL follow-up suggested a stabilization of cognitive function esp. in mild AD subjects over the 36-mo study period.  Alzhemed thus appears to be well tolerated with long-term exposure and reduces CSF Aβ42 levels in mild-to-moderate AD subjects.  These findings will be discussed in the context of two large-scale randomized, double-blind, placebo-controlled Phase III clin. trials that are currently being conducted to test the long-term safety and efficacy of Alzhemed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUc83sp13UN7Vg90H21EOLACvtfcHk0lgjqHL7Bk0yJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSitLzN&md5=42ad3c5746bdeca812c1036083ee1167</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.2174%2F156720507781788882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720507781788882%26sid%3Dliteratum%253Aachs%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DBriand%26aufirst%3DR.%26aulast%3DSaumier%26aufirst%3DD.%26aulast%3DLaurin%26aufirst%3DJ.%26aulast%3DGarceau%26aufirst%3DD.%26atitle%3DAlzhemed%253A%2520a%2520potential%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2007%26volume%3D4%26spage%3D473%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Gervais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morissette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krzywkowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szarek, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, P.</span><span> </span><span class="NLM_article-title">Targeting soluble Abeta peptide with tramiprosate for the treatment of brain amyloidosis</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.neurobiolaging.2006.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16675063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitFyks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=537-547&author=F.+Gervaisauthor=J.+Paquetteauthor=C.+Morissetteauthor=P.+Krzywkowskiauthor=M.+Yuauthor=M.+Azziauthor=D.+Lacombeauthor=X.+Kongauthor=A.+Amanauthor=J.+Laurinauthor=W.+A.+Szarekauthor=P.+Tremblay&title=Targeting+soluble+Abeta+peptide+with+tramiprosate+for+the+treatment+of+brain+amyloidosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis</span></div><div class="casAuthors">Gervais, Francine; Paquette, Julie; Morissette, Celine; Krzywkowski, Pascale; Yu, Mathilde; Azzi, Mounia; Lacombe, Diane; Kong, Xianqi; Aman, Ahmed; Laurin, Julie; Szarek, Walter A.; Tremblay, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">537-547</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Amyloid β-peptide (Aβ) is a major constituent of senile plaques in Alzheimer's disease (AD).  Neurotoxicity results from the conformational transition of Aβ from random-coil to β-sheet and its oligomerization.  Among a series of ionic compds. able to interact with sol. Aβ, Tramiprosate (3-amino-1-propanesulfonic acid; 3APS; Alzhemed) was found to maintain Aβ in a non-fibrillar form, to decrease Aβ42-induced cell death in neuronal cell cultures, and to inhibit amyloid deposition.  Tramiprosate crosses the murine blood-brain barrier (BBB) to exert its activity.  Treatment of TgCRND8 mice with Tramiprosate resulted in significant redn. (∼30%) in the brain amyloid plaque load and a significant decrease in the cerebral levels of sol. and insol. Aβ40 and Aβ42 (∼20-30%).  A dose-dependent redn. (up to 60%) of plasma Aβ levels was also obsd., suggesting that Tramiprosate influences the central pool of Aβ, changing either its efflux or its metab. in the brain.  We propose that Tramiprosate, which targets sol. Aβ, represents a new and promising therapeutic class of drugs for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLqWabGttsm7Vg90H21EOLACvtfcHk0lgjqHL7Bk0yJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitFyks74%253D&md5=f871b841546682e832b666dc875a68ef</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2006.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2006.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DGervais%26aufirst%3DF.%26aulast%3DPaquette%26aufirst%3DJ.%26aulast%3DMorissette%26aufirst%3DC.%26aulast%3DKrzywkowski%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DAzzi%26aufirst%3DM.%26aulast%3DLacombe%26aufirst%3DD.%26aulast%3DKong%26aufirst%3DX.%26aulast%3DAman%26aufirst%3DA.%26aulast%3DLaurin%26aufirst%3DJ.%26aulast%3DSzarek%26aufirst%3DW.%2BA.%26aulast%3DTremblay%26aufirst%3DP.%26atitle%3DTargeting%2520soluble%2520Abeta%2520peptide%2520with%2520tramiprosate%2520for%2520the%2520treatment%2520of%2520brain%2520amyloidosis%26jtitle%3DNeurobiol.%2520Aging%26date%3D2007%26volume%3D28%26spage%3D537%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keren, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porsteinsson, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dyck, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tariot, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abushakra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bairu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastrak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cedarbaum, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Investigators, E. A.</span><span> </span><span class="NLM_article-title">A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1253</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2011&pages=1253-1262&author=S.+Sallowayauthor=R.+Sperlingauthor=R.+Kerenauthor=A.+P.+Porsteinssonauthor=C.+H.+van+Dyckauthor=P.+N.+Tariotauthor=S.+Gilmanauthor=D.+Arnoldauthor=S.+Abushakraauthor=C.+Hernandezauthor=G.+Cransauthor=E.+Liangauthor=G.+Quinnauthor=M.+Bairuauthor=A.+Pastrakauthor=J.+M.+Cedarbaumauthor=E.+A.+Investigators&title=A+phase+2+randomized+trial+of+ELND005%2C+scyllo-inositol%2C+in+mild+to+moderate+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DSperling%26aufirst%3DR.%26aulast%3DKeren%26aufirst%3DR.%26aulast%3DPorsteinsson%26aufirst%3DA.%2BP.%26aulast%3Dvan%2BDyck%26aufirst%3DC.%2BH.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DGilman%26aufirst%3DS.%26aulast%3DArnold%26aufirst%3DD.%26aulast%3DAbushakra%26aufirst%3DS.%26aulast%3DHernandez%26aufirst%3DC.%26aulast%3DCrans%26aufirst%3DG.%26aulast%3DLiang%26aufirst%3DE.%26aulast%3DQuinn%26aufirst%3DG.%26aulast%3DBairu%26aufirst%3DM.%26aulast%3DPastrak%26aufirst%3DA.%26aulast%3DCedarbaum%26aufirst%3DJ.%2BM.%26aulast%3DInvestigators%26aufirst%3DE.%2BA.%26atitle%3DA%2520phase%25202%2520randomized%2520trial%2520of%2520ELND005%252C%2520scyllo-inositol%252C%2520in%2520mild%2520to%2520moderate%2520Alzheimer%2520disease%26jtitle%3DNeurology%26date%3D2011%26volume%3D77%26spage%3D1253%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">McLaurin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kierstead, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkes, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambermon, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phinney, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darabie, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cousins, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mount, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westaway, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St George-Hyslop, P.</span><span> </span><span class="NLM_article-title">Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnm1423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16767098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1eksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=801-808&author=J.+McLaurinauthor=M.+E.+Kiersteadauthor=M.+E.+Brownauthor=C.+A.+Hawkesauthor=M.+H.+Lambermonauthor=A.+L.+Phinneyauthor=A.+A.+Darabieauthor=J.+E.+Cousinsauthor=J.+E.+Frenchauthor=M.+F.+Lanauthor=F.+Chenauthor=S.+S.+Wongauthor=H.+T.+Mountauthor=P.+E.+Fraserauthor=D.+Westawayauthor=P.+St+George-Hyslop&title=Cyclohexanehexol+inhibitors+of+Abeta+aggregation+prevent+and+reverse+Alzheimer+phenotype+in+a+mouse+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse model</span></div><div class="casAuthors">McLaurin, JoAnne; Kierstead, Meredith E.; Brown, Mary E.; Hawkes, Cheryl A.; Lambermon, Mark H. L.; Phinney, Amie L.; Darabie, Audrey A.; Cousins, Julian E.; French, Janet E.; Lan, Melissa F.; Chen, Fusheng; Wong, Sydney S. N.; Mount, Howard T. J.; Fraser, Paul E.; Westaway, David; St. George-Hyslop, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">801-808</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">When given orally to a transgenic mouse model of Alzheimer disease, cyclohexanehexol stereoisomers inhibit aggregation of amyloid β peptide (Aβ) into high-mol.-wt. oligomers in the brain and ameliorate several Alzheimer disease-like phenotypes in these mice, including impaired cognition, altered synaptic physiol., cerebral Aβ pathol. and accelerated mortality.  These therapeutic effects, which occur regardless of whether the compds. are given before or well after the onset of the Alzheimer disease-like phenotype, support the idea that the accumulation of Aβ oligomers has a central role in the pathogenesis of Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFtzDe5YKoj7Vg90H21EOLACvtfcHk0lglDBxkT824xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1eksLw%253D&md5=d1c366440d6831a9486fde66d410f4c1</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1038%2Fnm1423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1423%26sid%3Dliteratum%253Aachs%26aulast%3DMcLaurin%26aufirst%3DJ.%26aulast%3DKierstead%26aufirst%3DM.%2BE.%26aulast%3DBrown%26aufirst%3DM.%2BE.%26aulast%3DHawkes%26aufirst%3DC.%2BA.%26aulast%3DLambermon%26aufirst%3DM.%2BH.%26aulast%3DPhinney%26aufirst%3DA.%2BL.%26aulast%3DDarabie%26aufirst%3DA.%2BA.%26aulast%3DCousins%26aufirst%3DJ.%2BE.%26aulast%3DFrench%26aufirst%3DJ.%2BE.%26aulast%3DLan%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DWong%26aufirst%3DS.%2BS.%26aulast%3DMount%26aufirst%3DH.%2BT.%26aulast%3DFraser%26aufirst%3DP.%2BE.%26aulast%3DWestaway%26aufirst%3DD.%26aulast%3DSt%2BGeorge-Hyslop%26aufirst%3DP.%26atitle%3DCyclohexanehexol%2520inhibitors%2520of%2520Abeta%2520aggregation%2520prevent%2520and%2520reverse%2520Alzheimer%2520phenotype%2520in%2520a%2520mouse%2520model%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D801%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">McLaurin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golomb, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurewicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, P. E.</span><span> </span><span class="NLM_article-title">Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">18495</span><span class="NLM_x">–</span> <span class="NLM_lpage">18502</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1074%2Fjbc.M906994199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=10764800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlylsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=18495-18502&author=J.+McLaurinauthor=R.+Golombauthor=A.+Jurewiczauthor=J.+P.+Antelauthor=P.+E.+Fraser&title=Inositol+stereoisomers+stabilize+an+oligomeric+aggregate+of+Alzheimer+amyloid+beta+peptide+and+inhibit+abeta+-induced+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid β peptide and inhibit Aβ-induced toxicity</span></div><div class="casAuthors">McLaurin, JoAnne; Golomb, Rivka; Jurewicz, Anna; Antel, Jack P.; Fraser, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">18495-18502</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Inositol has 8 stereoisomers, four of which are physiol. active.  Myo-Inositol is the most abundant isomer in the brain and more recently shown that epi- and scyllo-inositol are also present.  Myo-Inositol complexes with Aβ42 in vitro to form a small stable micelle.  The ability of inositol stereoisomers to interact with and stabilize small Aβ complexes was addressed.  CD spectroscopy demonstrated that epi- and scyllo- but not chiro-inositol were able to induce a structural transition from random to β-structure in Aβ42.  Alternatively, none of the stereoisomers were able to induce a structural transition in Aβ40.  Electron microscopy demonstrated that inositol stabilizes small aggregates of Aβ42.  We demonstrate that inositol-Aβ interactions result in a complex that is non-toxic to nerve growth factor-differentiated PC-12 cells and primary human neuronal cultures.  The attenuation of toxicity is the result of Aβ-inositol interaction, as inositol uptake inhibitors had no effect on neuronal survival.  The use of inositol stereoisomers allowed us to elucidate an important structure-activity relationship between Aβ and inositol.  Inositol stereoisomers are naturally occurring mols. that readily cross the blood-brain barrier and may represent a viable treatment for AD through the complexation of Aβ and attenuation of Aβ neurotoxic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrkjUUlOx_4rVg90H21EOLACvtfcHk0lglDBxkT824xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlylsrc%253D&md5=a384d0003a0409a3494dff0a6a8bc6cc</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M906994199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M906994199%26sid%3Dliteratum%253Aachs%26aulast%3DMcLaurin%26aufirst%3DJ.%26aulast%3DGolomb%26aufirst%3DR.%26aulast%3DJurewicz%26aufirst%3DA.%26aulast%3DAntel%26aufirst%3DJ.%2BP.%26aulast%3DFraser%26aufirst%3DP.%2BE.%26atitle%3DInositol%2520stereoisomers%2520stabilize%2520an%2520oligomeric%2520aggregate%2520of%2520Alzheimer%2520amyloid%2520beta%2520peptide%2520and%2520inhibit%2520abeta%2520-induced%2520toxicity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D18495%26epage%3D18502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Rezai-Zadeh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shytle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanniton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrhart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Town, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span> </span><span class="NLM_article-title">Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">8807</span><span class="NLM_x">–</span> <span class="NLM_lpage">8814</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1523%2FJNEUROSCI.1521-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16177050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGls73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=8807-8814&author=K.+Rezai-Zadehauthor=D.+Shytleauthor=N.+Sunauthor=T.+Moriauthor=H.+Houauthor=D.+Jeannitonauthor=J.+Ehrhartauthor=K.+Townsendauthor=J.+Zengauthor=D.+Morganauthor=J.+Hardyauthor=T.+Townauthor=J.+Tan&title=Green+tea+epigallocatechin-3-gallate+%28EGCG%29+modulates+amyloid+precursor+protein+cleavage+and+reduces+cerebral+amyloidosis+in+Alzheimer+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice</span></div><div class="casAuthors">Rezai-Zadeh, Kavon; Shytle, Doug; Sun, Nan; Mori, Takashi; Hou, Huayan; Jeanniton, Deborah; Ehrhart, Jared; Townsend, Kirk; Zeng, Jin; Morgan, David; Hardy, John; Town, Terrence; Tan, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">8807-8814</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disorder pathol. characterized by deposition of β-amyloid (Aβ) peptides as senile plaques in the brain.  Recent studies suggest that green tea flavonoids may be used for the prevention and treatment of a variety of neurodegenerative diseases.  Here, we report that (-)-epigallocatechin-3-gallate (EGCG), the main polyphenolic constituent of green tea, reduces Aβ generation in both murine neuron-like cells (N2a) transfected with the human "Swedish" mutant amyloid precursor protein (APP) and in primary neurons derived from Swedish mutant APP-overexpressing mice (Tg APPsw line 2576).  In concert with these observations, we find that EGCG markedly promotes cleavage of the α-C-terminal fragment of APP and elevates the N-terminal APP cleavage product, sol. APP-α.  These cleavage events are assocd. with elevated α-secretase activity and enhanced hydrolysis of tumor necrosis factor α-converting enzyme, a primary candidate α-secretase.  As a validation of these findings in vivo, we treated Tg APPsw transgenic mice overproducing Aβ with EGCG and found decreased Aβ levels and plaques assocd. with promotion of the nonamyloidogenic α-secretase proteolytic pathway.  These data raise the possibility that EGCG dietary supplementation may provide effective prophylaxis for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAwCf6nx6QU7Vg90H21EOLACvtfcHk0lhVZAMWEda9ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGls73F&md5=7bedc52129ea6eeed557f242a5afe639</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1521-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1521-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DRezai-Zadeh%26aufirst%3DK.%26aulast%3DShytle%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DN.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DHou%26aufirst%3DH.%26aulast%3DJeanniton%26aufirst%3DD.%26aulast%3DEhrhart%26aufirst%3DJ.%26aulast%3DTownsend%26aufirst%3DK.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DTown%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DJ.%26atitle%3DGreen%2520tea%2520epigallocatechin-3-gallate%2520%2528EGCG%2529%2520modulates%2520amyloid%2520precursor%2520protein%2520cleavage%2520and%2520reduces%2520cerebral%2520amyloidosis%2520in%2520Alzheimer%2520transgenic%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D8807%26epage%3D8814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Ehrnhoefer, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieschke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeddrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lurz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engemann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanker, E. E.</span><span> </span><span class="NLM_article-title">EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnsmb.1437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18511942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=558-566&author=D.+E.+Ehrnhoeferauthor=J.+Bieschkeauthor=A.+Boeddrichauthor=M.+Herbstauthor=L.+Masinoauthor=R.+Lurzauthor=S.+Engemannauthor=A.+Pastoreauthor=E.+E.+Wanker&title=EGCG+redirects+amyloidogenic+polypeptides+into+unstructured%2C+off-pathway+oligomers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers</span></div><div class="casAuthors">Ehrnhoefer, Dagmar E.; Bieschke, Jan; Boeddrich, Annett; Herbst, Martin; Masino, Laura; Lurz, Rudi; Engemann, Sabine; Pastore, Annalisa; Wanker, Erich E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">558-566</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The accumulation of β-sheet-rich amyloid fibrils or aggregates is a complex, multistep process that is assocd. with cellular toxicity in a no. of human protein misfolding disorders, including Parkinson's and Alzheimer's diseases.  It involves the formation of various transient and intransient, on- and off-pathway aggregate species, whose structure, size and cellular toxicity are largely unclear.  Here we demonstrate redirection of amyloid fibril formation through the action of a small mol., resulting in off-pathway, highly stable oligomers.  The polyphenol (-)-epigallocatechin gallate efficiently inhibits the fibrillogenesis of both α-synuclein and amyloid-β by directly binding to the natively unfolded polypeptides and preventing their conversion into toxic, on-pathway aggregation intermediates.  Instead of β-sheet-rich amyloid, the formation of unstructured, nontoxic α-synuclein and amyloid-β oligomers of a new type is promoted, suggesting a generic effect on aggregation pathways in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzZB-LENNWJ7Vg90H21EOLACvtfcHk0lhVZAMWEda9ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWgsbg%253D&md5=ad713b3e1a769dfb64afe70690b94bee</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1437%26sid%3Dliteratum%253Aachs%26aulast%3DEhrnhoefer%26aufirst%3DD.%2BE.%26aulast%3DBieschke%26aufirst%3DJ.%26aulast%3DBoeddrich%26aufirst%3DA.%26aulast%3DHerbst%26aufirst%3DM.%26aulast%3DMasino%26aufirst%3DL.%26aulast%3DLurz%26aufirst%3DR.%26aulast%3DEngemann%26aufirst%3DS.%26aulast%3DPastore%26aufirst%3DA.%26aulast%3DWanker%26aufirst%3DE.%2BE.%26atitle%3DEGCG%2520redirects%2520amyloidogenic%2520polypeptides%2520into%2520unstructured%252C%2520off-pathway%2520oligomers%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D558%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Bieschke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russ, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrnhoefer, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wobst, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neugebauer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanker, E. E.</span><span> </span><span class="NLM_article-title">EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">7710</span><span class="NLM_x">–</span> <span class="NLM_lpage">7715</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.0910723107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20385841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXls1amtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=7710-7715&author=J.+Bieschkeauthor=J.+Russauthor=R.+P.+Friedrichauthor=D.+E.+Ehrnhoeferauthor=H.+Wobstauthor=K.+Neugebauerauthor=E.+E.+Wanker&title=EGCG+remodels+mature+alpha-synuclein+and+amyloid-beta+fibrils+and+reduces+cellular+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity</span></div><div class="casAuthors">Bieschke, Jan; Russ, Jenny; Friedrich, Ralf P.; Ehrnhoefer, Dagmar E.; Wobst, Heike; Neugebauer, Katja; Wanker, Erich E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7710-7715, S7710/1-S7710/13</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Protein misfolding and formation of β-sheet-rich amyloid fibrils or aggregates is related to cellular toxicity and decay in various human disorders including Alzheimer's and Parkinson's disease.  Recently, we demonstrated that the polyphenol(-)-epi-gallocatechine gallate (EGCG) inhibits α-synuclein and amyloid-β fibrillogenesis.  It assocs. with natively unfolded polypeptides and promotes the self-assembly of unstructured oligomers of a new type.  Whether EGCG disassembles preformed amyloid fibrils, however, remained unclear.  Here, we show that EGCG has the ability to convert large, mature α-synuclein and amyloid-β fibrils into smaller, amorphous protein aggregates that are nontoxic to mammalian cells.  Mechanistic studies revealed that the compd. directly binds to β-sheet-rich aggregates and mediates the conformational change without their disassembly into monomers or small diffusible oligomers.  These findings suggest that EGCG is a potent remodeling agent of mature amyloid fibrils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrduWIRUxO1x7Vg90H21EOLACvtfcHk0lhVZAMWEda9ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXls1amtrw%253D&md5=f1fd226e013a67c2f2de00efad51533e</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0910723107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0910723107%26sid%3Dliteratum%253Aachs%26aulast%3DBieschke%26aufirst%3DJ.%26aulast%3DRuss%26aufirst%3DJ.%26aulast%3DFriedrich%26aufirst%3DR.%2BP.%26aulast%3DEhrnhoefer%26aufirst%3DD.%2BE.%26aulast%3DWobst%26aufirst%3DH.%26aulast%3DNeugebauer%26aufirst%3DK.%26aulast%3DWanker%26aufirst%3DE.%2BE.%26atitle%3DEGCG%2520remodels%2520mature%2520alpha-synuclein%2520and%2520amyloid-beta%2520fibrils%2520and%2520reduces%2520cellular%2520toxicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D7710%26epage%3D7715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Bieschke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiglenda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeddrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiele, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleckers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez del Amo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruning, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lurz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwyl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnoegl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reif, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunther, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanker, E. E.</span><span> </span><span class="NLM_article-title">Small-molecule conversion of toxic oligomers to nontoxic beta-sheet-rich amyloid fibrils</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnchembio.719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2gtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=93-101&author=J.+Bieschkeauthor=M.+Herbstauthor=T.+Wiglendaauthor=R.+P.+Friedrichauthor=A.+Boeddrichauthor=F.+Schieleauthor=D.+Kleckersauthor=J.+M.+Lopez+del+Amoauthor=B.+A.+Gruningauthor=Q.+Wangauthor=M.+R.+Schmidtauthor=R.+Lurzauthor=R.+Anwylauthor=S.+Schnoeglauthor=M.+Fandrichauthor=R.+F.+Frankauthor=B.+Reifauthor=S.+Guntherauthor=D.+M.+Walshauthor=E.+E.+Wanker&title=Small-molecule+conversion+of+toxic+oligomers+to+nontoxic+beta-sheet-rich+amyloid+fibrils"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils</span></div><div class="casAuthors">Bieschke, Jan; Herbst, Martin; Wiglenda, Thomas; Friedrich, Ralf P.; Boeddrich, Annett; Schiele, Franziska; Kleckers, Daniela; Lopez del Amo, Juan Miguel; Gruening, Bjoern A.; Wang, Qinwen; Schmidt, Michael R.; Lurz, Rudi; Anwyl, Roger; Schnoegl, Sigrid; Faendrich, Marcus; Frank, Ronald F.; Reif, Bernd; Guenther, Stefan; Walsh, Dominic M.; Wanker, Erich E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-101</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Several lines of evidence indicate that prefibrillar assemblies of amyloid-β (Aβ) polypeptides, such as sol. oligomers or protofibrils, rather than mature, end-stage amyloid fibrils cause neuronal dysfunction and memory impairment in Alzheimer's disease.  These findings suggest that reducing the prevalence of transient intermediates by small mol.-mediated stimulation of amyloid polymn. might decrease toxicity.  Here we demonstrate the acceleration of Aβ fibrillogenesis through the action of the orcein-related small mol. O4, which directly binds to hydrophobic amino acid residues in Aβ peptides and stabilizes the self-assembly of seeding-competent, β-sheet-rich protofibrils and fibrils.  Notably, the O4-mediated acceleration of amyloid fibril formation efficiently decreases the concn. of small, toxic Aβ oligomers in complex, heterogeneous aggregation reactions.  In addn., O4 treatment suppresses inhibition of long-term potentiation by Aβ oligomers in hippocampal brain slices.  These results support the hypothesis that small, diffusible prefibrillar amyloid species rather than mature fibrillar aggregates are toxic for mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZXPTy8dSfjLVg90H21EOLACvtfcHk0ljOuQgGE9spQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2gtrvL&md5=28dd2adecd2d1ea3dbb1387dfbd415f9</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.719%26sid%3Dliteratum%253Aachs%26aulast%3DBieschke%26aufirst%3DJ.%26aulast%3DHerbst%26aufirst%3DM.%26aulast%3DWiglenda%26aufirst%3DT.%26aulast%3DFriedrich%26aufirst%3DR.%2BP.%26aulast%3DBoeddrich%26aufirst%3DA.%26aulast%3DSchiele%26aufirst%3DF.%26aulast%3DKleckers%26aufirst%3DD.%26aulast%3DLopez%2Bdel%2BAmo%26aufirst%3DJ.%2BM.%26aulast%3DGruning%26aufirst%3DB.%2BA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DSchmidt%26aufirst%3DM.%2BR.%26aulast%3DLurz%26aufirst%3DR.%26aulast%3DAnwyl%26aufirst%3DR.%26aulast%3DSchnoegl%26aufirst%3DS.%26aulast%3DFandrich%26aufirst%3DM.%26aulast%3DFrank%26aufirst%3DR.%2BF.%26aulast%3DReif%26aufirst%3DB.%26aulast%3DGunther%26aufirst%3DS.%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DWanker%26aufirst%3DE.%2BE.%26atitle%3DSmall-molecule%2520conversion%2520of%2520toxic%2520oligomers%2520to%2520nontoxic%2520beta-sheet-rich%2520amyloid%2520fibrils%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D93%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">The metallobiology of Alzheimer’s disease</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=207-214&author=A.+I.+Bush&title=The+metallobiology+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DThe%2520metallobiology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Neurosci.%26date%3D2003%26volume%3D26%26spage%3D207%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Jenagaratnam, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McShane, R.</span><span> </span><span class="NLM_article-title">Clioquinol for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD005380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=CD005380&author=L.+Jenagaratnamauthor=R.+McShane&title=Clioquinol+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJenagaratnam%26aufirst%3DL.%26aulast%3DMcShane%26aufirst%3DR.%26atitle%3DClioquinol%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2006%26spage%3DCD005380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Sampson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenagaratnam, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McShane, R.</span><span> </span><span class="NLM_article-title">Metal protein attenuating compounds for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD005380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=CD005380&author=E.+Sampsonauthor=L.+Jenagaratnamauthor=R.+McShane&title=Metal+protein+attenuating+compounds+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSampson%26aufirst%3DE.%26aulast%3DJenagaratnam%26aufirst%3DL.%26aulast%3DMcShane%26aufirst%3DR.%26atitle%3DMetal%2520protein%2520attenuating%2520compounds%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2008%26spage%3DCD005380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Lei, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spoerri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccotosto, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adlard, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volitakis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duce, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fnm.2613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22286308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlOlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=291-295&author=P.+Leiauthor=S.+Aytonauthor=D.+I.+Finkelsteinauthor=L.+Spoerriauthor=G.+D.+Ciccotostoauthor=D.+K.+Wrightauthor=B.+X.+Wongauthor=P.+A.+Adlardauthor=R.+A.+Chernyauthor=L.+Q.+Lamauthor=B.+R.+Robertsauthor=I.+Volitakisauthor=G.+F.+Eganauthor=C.+A.+McLeanauthor=R.+Cappaiauthor=J.+A.+Duceauthor=A.+I.+Bush&title=Tau+deficiency+induces+parkinsonism+with+dementia+by+impairing+APP-mediated+iron+export"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export</span></div><div class="casAuthors">Lei, Peng; Ayton, Scott; Finkelstein, David I.; Spoerri, Loredana; Ciccotosto, Giuseppe D.; Wright, David K.; Wong, Bruce X. W.; Adlard, Paul A.; Cherny, Robert A.; Lam, Linh Q.; Roberts, Blaine R.; Volitakis, Irene; Egan, Gary F.; McLean, Catriona A.; Cappai, Roberto; Duce, James A.; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">291-295</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The microtubule-assocd. protein tau has risk alleles for both Alzheimer's disease and Parkinson's disease and mutations that cause brain degenerative diseases termed tauopathies.  Aggregated tau forms neurofibrillary tangles in these pathologies, but little is certain about the function of tau or its mode of involvement in pathogenesis.  Neuronal iron accumulation has been obsd. pathol. in the cortex in Alzheimer's disease, the substantia nigra (SN) in Parkinson's disease and various brain regions in the tauopathies.  Here we report that tau-knockout mice develop age-dependent brain atrophy, iron accumulation and SN neuronal loss, with concomitant cognitive deficits and parkinsonism.  These changes are prevented by oral treatment with a moderate iron chelator, clioquinol.  Amyloid precursor protein (APP) ferroxidase activity couples with surface ferroportin to export iron, but its activity is inhibited in Alzheimer's disease, thereby causing neuronal iron accumulation.  In primary neuronal culture, we found loss of tau also causes iron retention, by decreasing surface trafficking of APP.  Sol. tau levels fall in affected brain regions in Alzheimer's disease and tauopathies, and we found a similar decrease of sol. tau in the SN in both Parkinson's disease and the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model.  These data suggest that the loss of sol. tau could contribute to toxic neuronal iron accumulation in Alzheimer's disease, Parkinson's disease and tauopathies, and that it can be rescued pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsDxfEAJe0CbVg90H21EOLACvtfcHk0ljOuQgGE9spQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlOlsbg%253D&md5=154d24d4d4bfa181c490cdb1c146e721</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1038%2Fnm.2613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2613%26sid%3Dliteratum%253Aachs%26aulast%3DLei%26aufirst%3DP.%26aulast%3DAyton%26aufirst%3DS.%26aulast%3DFinkelstein%26aufirst%3DD.%2BI.%26aulast%3DSpoerri%26aufirst%3DL.%26aulast%3DCiccotosto%26aufirst%3DG.%2BD.%26aulast%3DWright%26aufirst%3DD.%2BK.%26aulast%3DWong%26aufirst%3DB.%2BX.%26aulast%3DAdlard%26aufirst%3DP.%2BA.%26aulast%3DCherny%26aufirst%3DR.%2BA.%26aulast%3DLam%26aufirst%3DL.%2BQ.%26aulast%3DRoberts%26aufirst%3DB.%2BR.%26aulast%3DVolitakis%26aufirst%3DI.%26aulast%3DEgan%26aufirst%3DG.%2BF.%26aulast%3DMcLean%26aufirst%3DC.%2BA.%26aulast%3DCappai%26aufirst%3DR.%26aulast%3DDuce%26aufirst%3DJ.%2BA.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DTau%2520deficiency%2520induces%2520parkinsonism%2520with%2520dementia%2520by%2520impairing%2520APP-mediated%2520iron%2520export%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D291%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Lecanu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teper, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greeson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, V.</span><span> </span><span class="NLM_article-title">Identification of naturally occurring spirostenols preventing beta-amyloid-induced neurotoxicity</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=1-16&author=L.+Lecanuauthor=W.+Yaoauthor=G.+L.+Teperauthor=Z.+X.+Yaoauthor=J.+Greesonauthor=V.+Papadopoulos&title=Identification+of+naturally+occurring+spirostenols+preventing+beta-amyloid-induced+neurotoxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLecanu%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DTeper%26aufirst%3DG.%2BL.%26aulast%3DYao%26aufirst%3DZ.%2BX.%26aulast%3DGreeson%26aufirst%3DJ.%26aulast%3DPapadopoulos%26aufirst%3DV.%26atitle%3DIdentification%2520of%2520naturally%2520occurring%2520spirostenols%2520preventing%2520beta-amyloid-induced%2520neurotoxicity%26jtitle%3DSteroids%26date%3D2004%26volume%3D69%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Papadopoulos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecanu, L.</span><span> </span><span class="NLM_article-title">Caprospinol: discovery of a steroid drug candidate to treat Alzheimer’s disease based on 22<i>R</i>-hydroxycholesterol structure and properties</span> <span class="citation_source-journal">J. Neuroendocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1365-2826.2011.02167.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21623958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlslyisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=93-101&author=V.+Papadopoulosauthor=L.+Lecanu&title=Caprospinol%3A+discovery+of+a+steroid+drug+candidate+to+treat+Alzheimer%E2%80%99s+disease+based+on+22R-hydroxycholesterol+structure+and+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Caprospinol: discovery of a steroid drug candidate to treat Alzheimer's disease based on 22R-hydroxycholesterol structure and properties</span></div><div class="casAuthors">Papadopoulos, V.; Lecanu, L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroendocrinology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-101</span>CODEN:
                <span class="NLM_cas:coden">JOUNE2</span>;
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The overall ability of the brain to synthesize neuroactive steroids led us to the identification of compds. that would reproduce aspects of neurosteroid pharmacol.  The rate-detg. step in neurosteroid biosynthesis is the import of the substrate cholesterol into the mitochondria, where it is metabolized into pregnenolone via the intermediate 22R-hydroxycholesterol.  The levels of translocator protein 18-kDa, mediating the import of cholesterol into mitochondria, correlated with increased pregnenolone formation and reduced levels of 22R-hydroxycholesterol in biopsies from Alzheimer's disease (AD), but not age-matched control, brains.  22R-hydroxycholesterol was shown to protect against β-amyloid (Aβ42)-induced neurotoxicity.  In search of 22R-hydroxycholesterol stable analogs, we identified the naturally occurring heterospirostenol, (22R,25R)-20α-spirost-5-en-3β-yl hexanoate (caprospinol) and derivs. that protect neuronal cells against Aβ1-42 neurotoxicity.  The neuroprotective effect of caprospinol is the result of a combination of overlapping properties, including: (i) the ability to bind to Aβ42 and reduce plaque formation in the brain in vivo; (ii) interaction with components of the mitochondria respiratory chain resulting in an anti-uncoupling effect; (iii) the capacity to scavenge Aβ42 monomers present in mitochondria; and (iv) the property of being a sigma-1 receptor ligand.  In vivo, caprospinol crosses the blood-brain barrier, accumulates in the brain, and restores cognitive impairment in a pharmacol. rat model of AD.  Caprospinol is stable, does not bind to known steroid receptors, is devoid of mutagenic and genotoxic properties, and is devoid of acute toxicity in rodents.  The pharmacokinetics and pharmacodynamics of caprospinol were studied, and long-term toxicity studies are under investigation, aiming to develop this compd. as a disease-modifying drug for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFN_NfoFDcrVg90H21EOLACvtfcHk0lj1nGMFbIAHaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlslyisw%253D%253D&md5=15e9d7ea67bb8f6b665cd78a35f5882b</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2826.2011.02167.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2826.2011.02167.x%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulos%26aufirst%3DV.%26aulast%3DLecanu%26aufirst%3DL.%26atitle%3DCaprospinol%253A%2520discovery%2520of%2520a%2520steroid%2520drug%2520candidate%2520to%2520treat%2520Alzheimer%25E2%2580%2599s%2520disease%2520based%2520on%252022R-hydroxycholesterol%2520structure%2520and%2520properties%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D2012%26volume%3D24%26spage%3D93%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Nakagami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murasugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meguro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, T.</span><span> </span><span class="NLM_article-title">A novel beta-sheet breaker, RS-0406, reverses amyloid beta-induced cytotoxicity and impairment of long-term potentiation in vitro</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">676</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1038%2Fsj.bjp.0704911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=12381681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD38XosF2ht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2002&pages=676-682&author=Y.+Nakagamiauthor=S.+Nishimuraauthor=T.+Murasugiauthor=I.+Kanekoauthor=M.+Meguroauthor=S.+Marumotoauthor=H.+Kogenauthor=K.+Koyamaauthor=T.+Oda&title=A+novel+beta-sheet+breaker%2C+RS-0406%2C+reverses+amyloid+beta-induced+cytotoxicity+and+impairment+of+long-term+potentiation+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">A novel β-sheet breaker, RS-0406, reverses amyloid β-induced cytotoxicity and impairment of long-term potentiation in vitro</span></div><div class="casAuthors">Nakagami, Yasuhiro; Nishimura, Satoko; Murasugi, Takako; Kaneko, Isao; Meguro, Masaki; Marumoto, Shinji; Kogen, Hiroshi; Koyama, Kazuo; Oda, Tomiichiro</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">676-682</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fibril formation of amyloid β peptide (Aβ) is considered to be responsible for the pathol. of Alzheimer's disease (AD).  The Aβ fibril is formed by a protein misfolding process in which intermol. β-sheet interactions become stabilized abnormally.  Thus, to develop potential anti-AD drugs, we screened an inhouse library to find compds. which have a profile as a β-sheet breaker.  We searched for a β-sheet breaker profile in an inhouse library of approx. 113,000 compds.  From among the screening hits, we focused on N,N'-bis(3-hydroxyphenyl)pyridazine-3,6-diamine (named RS-0406), which had been newly synthesized in our lab.  This compd. (10 - 100 μg ml-1) was found to be capable of significantly inhibiting 25 μM Aβ1-42 fibrillogenesis and, furthermore, disassembling preformed Aβ1-42 fibrils in vitro.  We then investigated the effect of RS-0406 on 111 nM Aβ1-42-induced cytotoxicity in primary hippocampal neurons, and found that 0.3 - 3 μg ml-1 RS-0406 ameliorates the cytotoxicity.  Moreover, 3 μg ml-1 RS-0406 reversed 1 μM Aβ1-42-induced impairment of long-term potentiation in hippocampal slices.  In this study, we have succeeded in identifying RS-0406 which has potential to inhibit Aβ1-42 fibrillogenesis, and to protect neurons against Aβ1-42-induced biol. toxicity in vitro.  These results suggest that RS-0406 or one of the derivs. could become a therapeutic agent for AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf90pJU6VsSLVg90H21EOLACvtfcHk0lj1nGMFbIAHaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosF2ht7g%253D&md5=49f5933b6b49aa972eb77a14882dd4fe</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704911%26sid%3Dliteratum%253Aachs%26aulast%3DNakagami%26aufirst%3DY.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DMurasugi%26aufirst%3DT.%26aulast%3DKaneko%26aufirst%3DI.%26aulast%3DMeguro%26aufirst%3DM.%26aulast%3DMarumoto%26aufirst%3DS.%26aulast%3DKogen%26aufirst%3DH.%26aulast%3DKoyama%26aufirst%3DK.%26aulast%3DOda%26aufirst%3DT.%26atitle%3DA%2520novel%2520beta-sheet%2520breaker%252C%2520RS-0406%252C%2520reverses%2520amyloid%2520beta-induced%2520cytotoxicity%2520and%2520impairment%2520of%2520long-term%2520potentiation%2520in%2520vitro%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D137%26spage%3D676%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlisny, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankar, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadeeva, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Agnaf, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2455</span><span class="NLM_x">–</span> <span class="NLM_lpage">2462</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1523%2FJNEUROSCI.4391-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15758153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1ygsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=2455-2462&author=D.+M.+Walshauthor=M.+Townsendauthor=M.+B.+Podlisnyauthor=G.+M.+Shankarauthor=J.+V.+Fadeevaauthor=O.+El+Agnafauthor=D.+M.+Hartleyauthor=D.+J.+Selkoe&title=Certain+inhibitors+of+synthetic+amyloid+beta-peptide+%28Abeta%29+fibrillogenesis+block+oligomerization+of+natural+Abeta+and+thereby+rescue+long-term+potentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Certain inhibitors of synthetic amyloid β-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation</span></div><div class="casAuthors">Walsh, Dominic M.; Townsend, Matthew; Podlisny, Marcia B.; Shankar, Ganesh M.; Fadeeva, Julia V.; El Agnaf, Omar; Hartley, Dean M.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2455-2462</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent studies support the hypothesis that sol. oligomers of amyloid β-peptide (Aβ) rather than mature amyloid fibrils are the earliest effectors of synaptic compromise in Alzheimer's disease.  We took advantage of an amyloid precursor protein-overexpressing cell line that secretes SDS-stable Aβ oligomers to search for inhibitors of the pathobiol. effects of natural human Aβ oligomers.  Here, we identify small mols. that inhibit formation of sol. Aβ oligomers and thus abrogate their block of long-term potentiation (LTP).  Furthermore, we show that cell-derived Aβ oligomers can be sepd. from monomers by size exclusion chromatog. under nondenaturing conditions and that the isolated, sol. oligomers, but not monomers, block LTP.  The identification of small mols. that inhibit early Aβ oligomer formation and rescue LTP inhibition offers a rational approach for therapeutic intervention in Alzheimer's disease and highlights the utility of our cell-culture paradigm as a useful secondary screen for compds. designed to inhibit early steps in Aβ oligomerization under biol. relevant conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpntJTiDtBHv7Vg90H21EOLACvtfcHk0lj1nGMFbIAHaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1ygsr8%253D&md5=638707df43af1dda17cd36d730bc47c8</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4391-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4391-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DTownsend%26aufirst%3DM.%26aulast%3DPodlisny%26aufirst%3DM.%2BB.%26aulast%3DShankar%26aufirst%3DG.%2BM.%26aulast%3DFadeeva%26aufirst%3DJ.%2BV.%26aulast%3DEl%2BAgnaf%26aufirst%3DO.%26aulast%3DHartley%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DCertain%2520inhibitors%2520of%2520synthetic%2520amyloid%2520beta-peptide%2520%2528Abeta%2529%2520fibrillogenesis%2520block%2520oligomerization%2520of%2520natural%2520Abeta%2520and%2520thereby%2520rescue%2520long-term%2520potentiation%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D2455%26epage%3D2462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Scopes, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Hare, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeggo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyment, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spanswick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gannon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amijee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treherne, J. M.</span><span> </span><span class="NLM_article-title">Abeta oligomer toxicity inhibitor protects memory in models of synaptic toxicity</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1476-5381.2012.01973.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22913627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=383-392&author=D.+I.+Scopesauthor=E.+O%E2%80%99Hareauthor=R.+Jeggoauthor=A.+D.+Whymentauthor=D.+Spanswickauthor=E.+M.+Kimauthor=J.+Gannonauthor=H.+Amijeeauthor=J.+M.+Treherne&title=Abeta+oligomer+toxicity+inhibitor+protects+memory+in+models+of+synaptic+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ oligomer toxicity inhibitor protects memory in models of synaptic toxicity</span></div><div class="casAuthors">Scopes, D. I. C.; O'Hare, E.; Jeggo, R.; Whyment, A. D.; Spanswick, D.; Kim, E.-M.; Gannon, J.; Amijee, H.; Treherne, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">383-392</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ) aggregation into synaptotoxic, prefibrillar oligomers is a major pathogenic event underlying the neuropathol. of Alzheimer's disease (AD).  The pharmacol. and neuroprotective properties of a novel Aβ aggregation inhibitor, SEN1269, were investigated on aggregation and cell viability and in test systems relevant to synaptic function and memory, using both synthetic Aβ1-42 and cell-derived Aβ oligomers.  Surface plasmon resonance studies measured binding of SEN1269 to Aβ1-42.  Thioflavin-T fluorescence and MTT assays were used to measure its ability to block Aβ1-42-induced aggregation and redn. in cell viability.  In vitro and in vivo long-term potentiation (LTP) expts. measured the effect of SEN1269 on deficits induced by synthetic Aβ1-42 and cell-derived Aβ oligomers.  Following i.c.v. administration of the latter, a complex (alternating-lever cyclic ratio) schedule of operant responding measured effects on memory in freely moving rats.  SEN1269 demonstrated direct binding to monomeric Aβ1-42, produced a concn.-related blockade of Aβ1-42 aggregation and protected neuronal cell lines exposed to Aβ1-42.  In vitro, SEN1269 alleviated deficits in hippocampal LTP induced by Aβ1-42 and cell-derived Aβ oligomers.  In vivo, SEN1269 reduced the deficits in LTP and memory induced by i.c.v. administration of cell-derived Aβ oligomers.  SEN1269 protected cells exposed to Aβ1-42, displayed central activity with respect to reducing Aβ-induced neurotoxicity and was neuroprotective in electrophysiol. and behavioral models of memory relevant to Aβ-induced neurodegeneration.  It represents a promising lead for designing inhibitors of Aβ-mediated synaptic toxicity as potential neuroprotective agents for treating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0YHqYYKmz7Vg90H21EOLACvtfcHk0lj1mP_klgE6aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShurfF&md5=bdc5de632ac7d72b62ded1dc2eb8d3e8</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01973.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01973.x%26sid%3Dliteratum%253Aachs%26aulast%3DScopes%26aufirst%3DD.%2BI.%26aulast%3DO%25E2%2580%2599Hare%26aufirst%3DE.%26aulast%3DJeggo%26aufirst%3DR.%26aulast%3DWhyment%26aufirst%3DA.%2BD.%26aulast%3DSpanswick%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DE.%2BM.%26aulast%3DGannon%26aufirst%3DJ.%26aulast%3DAmijee%26aufirst%3DH.%26aulast%3DTreherne%26aufirst%3DJ.%2BM.%26atitle%3DAbeta%2520oligomer%2520toxicity%2520inhibitor%2520protects%2520memory%2520in%2520models%2520of%2520synaptic%2520toxicity%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D383%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Congdon, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Necula, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackstone, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuret, J.</span><span> </span><span class="NLM_article-title">Potency of a tau fibrillization inhibitor is influenced by its aggregation state</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2007&pages=127-135&author=E.+E.+Congdonauthor=M.+Neculaauthor=R.+D.+Blackstoneauthor=J.+Kuret&title=Potency+of+a+tau+fibrillization+inhibitor+is+influenced+by+its+aggregation+state"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCongdon%26aufirst%3DE.%2BE.%26aulast%3DNecula%26aufirst%3DM.%26aulast%3DBlackstone%26aufirst%3DR.%2BD.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DPotency%2520of%2520a%2520tau%2520fibrillization%2520inhibitor%2520is%2520influenced%2520by%2520its%2520aggregation%2520state%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2007%26volume%3D465%26spage%3D127%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichterman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auld, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7732</span><span class="NLM_x">–</span> <span class="NLM_lpage">7745</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi9006435" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7732-7745&author=A.+Croweauthor=W.+Huangauthor=C.+Ballatoreauthor=R.+L.+Johnsonauthor=A.+M.+Hoganauthor=R.+Huangauthor=J.+Wichtermanauthor=J.+McCoyauthor=D.+Hurynauthor=D.+S.+Auldauthor=A.+B.+Smithauthor=J.+Ingleseauthor=J.+Q.+Trojanowskiauthor=C.+P.+Austinauthor=K.+R.+Brundenauthor=V.+M.+Lee&title=Identification+of+aminothienopyridazine+inhibitors+of+tau+assembly+by+quantitative+high-throughput+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fbi9006435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9006435%26sid%3Dliteratum%253Aachs%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DHogan%26aufirst%3DA.%2BM.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DWichterman%26aufirst%3DJ.%26aulast%3DMcCoy%26aufirst%3DJ.%26aulast%3DHuryn%26aufirst%3DD.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DIdentification%2520of%2520aminothienopyridazine%2520inhibitors%2520of%2520tau%2520assembly%2520by%2520quantitative%2520high-throughput%2520screening%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D7732%26epage%3D7745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Friedhoff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">10223</span><span class="NLM_x">–</span> <span class="NLM_lpage">10230</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi980537d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=10223-10230&author=P.+Friedhoffauthor=A.+Schneiderauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Rapid+assembly+of+Alzheimer-like+paired+helical+filaments+from+microtubule-associated+protein+tau+monitored+by+fluorescence+in+solution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fbi980537d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi980537d%26sid%3Dliteratum%253Aachs%26aulast%3DFriedhoff%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DRapid%2520assembly%2520of%2520Alzheimer-like%2520paired%2520helical%2520filaments%2520from%2520microtubule-associated%2520protein%2520tau%2520monitored%2520by%2520fluorescence%2520in%2520solution%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D10223%26epage%3D10230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Zhang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldenburg, K. R.</span><span> </span><span class="NLM_article-title">A simple statistical parameter for use in evaluation and validation of high throughput screening assays</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1177%2F108705719900400206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=10838414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=67-73&author=J.+H.+Zhangauthor=T.+D.+Chungauthor=K.+R.+Oldenburg&title=A+simple+statistical+parameter+for+use+in+evaluation+and+validation+of+high+throughput+screening+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span></div><div class="casAuthors">Zhang; Chung; Oldenburg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The ability to identify active compounds (3hits2) from large chemical libraries accurately and rapidly has been the ultimate goal in developing high-throughput screening (HTS) assays.  The ability to identify hits from a particular HTS assay depends largely on the suitability or quality of the assay used in the screening.  The criteria or parameters for evaluating the 3suitability2 of an HTS assay for hit identification are not well defined and hence it still remains difficult to compare the quality of assays directly.  In this report, a screening window coefficient, called 3Z-factor,2 is defined.  This coefficient is reflective of both the assay signal dynamic range and the data variation associated with the signal measurements, and therefore is suitable for assay quality assessment.  The Z-factor is a dimensionless, simple statistical characteristic for each HTS assay.  The Z-factor provides a useful tool for comparison and evaluation of the quality of assays, and can be utilized in assay optimization and validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkwW5JDdXnbsNIRw0GKUoEfW6udTcc2ebiyTPC2HQt97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D&md5=0ec4ed2ccdd3b4a16521567a0975d31f</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1177%2F108705719900400206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719900400206%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BH.%26aulast%3DChung%26aufirst%3DT.%2BD.%26aulast%3DOldenburg%26aufirst%3DK.%2BR.%26atitle%3DA%2520simple%2520statistical%2520parameter%2520for%2520use%2520in%2520evaluation%2520and%2520validation%2520of%2520high%2520throughput%2520screening%2520assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1999%26volume%3D4%26spage%3D67%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Barghorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Tau paired helical filaments from Alzheimer’s disease brain and assembled in vitro are based on beta-structure in the core domain</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1694</span><span class="NLM_x">–</span> <span class="NLM_lpage">1703</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0357006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=1694-1703&author=S.+Barghornauthor=P.+Daviesauthor=E.+Mandelkow&title=Tau+paired+helical+filaments+from+Alzheimer%E2%80%99s+disease+brain+and+assembled+in+vitro+are+based+on+beta-structure+in+the+core+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fbi0357006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0357006%26sid%3Dliteratum%253Aachs%26aulast%3DBarghorn%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DTau%2520paired%2520helical%2520filaments%2520from%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain%2520and%2520assembled%2520in%2520vitro%2520are%2520based%2520on%2520beta-structure%2520in%2520the%2520core%2520domain%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D1694%26epage%3D1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Schneider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span> </span><span class="NLM_article-title">Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3549</span><span class="NLM_x">–</span> <span class="NLM_lpage">3558</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi981874p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=3549-3558&author=A.+Schneiderauthor=J.+Biernatauthor=M.+von+Bergenauthor=E.+Mandelkowauthor=E.+M.+Mandelkow&title=Phosphorylation+that+detaches+tau+protein+from+microtubules+%28Ser262%2C+Ser214%29+also+protects+it+against+aggregation+into+Alzheimer+paired+helical+filaments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fbi981874p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi981874p%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DPhosphorylation%2520that%2520detaches%2520tau%2520protein%2520from%2520microtubules%2520%2528Ser262%252C%2520Ser214%2529%2520also%2520protects%2520it%2520against%2520aggregation%2520into%2520Alzheimer%2520paired%2520helical%2520filaments%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D3549%26epage%3D3558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Bulic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khlistunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span> </span><span class="NLM_article-title">Rhodanine-based tau aggregation inhibitors in cell models of tauopathy</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">9215</span><span class="NLM_x">–</span> <span class="NLM_lpage">9219</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=9215-9219&author=B.+Bulicauthor=M.+Pickhardtauthor=I.+Khlistunovaauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkowauthor=H.+Waldmann&title=Rhodanine-based+tau+aggregation+inhibitors+in+cell+models+of+tauopathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DRhodanine-based%2520tau%2520aggregation%2520inhibitors%2520in%2520cell%2520models%2520of%2520tauopathy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D9215%26epage%3D9219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Larbig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Screening for inhibitors of tau protein aggregation into Alzheimer paired helical filaments: a ligand based approach results in successful scaffold hopping</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F156720507781077250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17627489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntlCqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=315-323&author=G.+Larbigauthor=M.+Pickhardtauthor=D.+G.+Lloydauthor=B.+Schmidtauthor=E.+Mandelkow&title=Screening+for+inhibitors+of+tau+protein+aggregation+into+Alzheimer+paired+helical+filaments%3A+a+ligand+based+approach+results+in+successful+scaffold+hopping"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Screening for inhibitors of tau protein aggregation into Alzheimer paired helical filaments: a ligand based approach results in successful scaffold hopping</span></div><div class="casAuthors">Larbig, Gregor; Pickhardt, Marcus; Lloyd, David G.; Schmidt, Boris; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-323</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The aggregation of tau protein into paired helical filaments is one of the hallmarks of Alzheimer's disease and related dementias.  We therefore continue our search for non-toxic, cell penetrating inhibitors of tau aggregation, which hold potential for brain penetration.  A previous study reported a high throughput screen for tau aggregation inhibitors, which resulted in the identification of several hit classes.  Here we report the identification of novel inhibitors which were not present in the initial high throughput assay.  This was achieved by transformation of the high throughput screen data into the 3D relationships of virtual pharmacophores.  The pharmacophore models were utilized in a virtual screen of a Maybridge database.  The virtual screen provided 136 hits; 19 representative hits were selected and assayed, this resulted in two novel leads with an IC50 < 13 μM.  These two leads feature a novel scaffold for tau aggregation inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeGtPvnJwCNrVg90H21EOLACvtfcHk0lhcdd9aZh_SOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntlCqtb0%253D&md5=daa891bbad0610400372a56b42d5fa08</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.2174%2F156720507781077250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720507781077250%26sid%3Dliteratum%253Aachs%26aulast%3DLarbig%26aufirst%3DG.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DLloyd%26aufirst%3DD.%2BG.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DScreening%2520for%2520inhibitors%2520of%2520tau%2520protein%2520aggregation%2520into%2520Alzheimer%2520paired%2520helical%2520filaments%253A%2520a%2520ligand%2520based%2520approach%2520results%2520in%2520successful%2520scaffold%2520hopping%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2007%26volume%3D4%26spage%3D315%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khlistunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title"><i>N</i>-Phenylamine derivatives as aggregation inhibitors in cell models of tauopathy</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F156720507781788765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17908042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSitL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=397-402&author=M.+Pickhardtauthor=J.+Biernatauthor=I.+Khlistunovaauthor=Y.+P.+Wangauthor=Z.+Gazovaauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=N-Phenylamine+derivatives+as+aggregation+inhibitors+in+cell+models+of+tauopathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">N-phenylamine derivatives as aggregation inhibitors in cell models of tauopathy</span></div><div class="casAuthors">Pickhardt, M.; Biernat, J.; Khlistunova, I.; Wang, Y.-P.; Gazova, Z.; Mandelkow, E.-M.; Mandelkow, E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">397-402</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Cell models of tauopathy were generated in order to study mechanisms of neurodegeneration involving abnormal changes of tau.  They are based on neuroblastoma cell lines (N2a) that inducibly express different forms of the repeat domain of tau (tauRD), e.g. the 4-repeat domain of tau with the wild-type sequence, the repeat domain with the ΔK280 mutation ("pro-aggregation mutant"), or the repeat domain with ΔK280 and two proline point mutations ("anti-aggregation mutant").  The data indicate that the aggregation of tauRD is toxic, and that aggregation and toxicity can be prevented by low mol. wt. compds., notably compds. based on the N-phenylamine core.  Thus the cell models are suitable for developing aggregation inhibitor drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq782rmh_p5sbVg90H21EOLACvtfcHk0lhw6xQeuL9Z3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSitL%252FM&md5=f2f9991a8a38f9c065e254a9e272a3ba</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.2174%2F156720507781788765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720507781788765%26sid%3Dliteratum%253Aachs%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DY.%2BP.%26aulast%3DGazova%26aufirst%3DZ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DN-Phenylamine%2520derivatives%2520as%2520aggregation%2520inhibitors%2520in%2520cell%2520models%2520of%2520tauopathy%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2007%26volume%3D4%26spage%3D397%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Khlistunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Inhibition of tau aggregation in cell models of tauopathy</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">544</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F156720507783018307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18220518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVGqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=544-546&author=I.+Khlistunovaauthor=M.+Pickhardtauthor=J.+Biernatauthor=Y.+Wangauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Inhibition+of+tau+aggregation+in+cell+models+of+tauopathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tau aggregation in cell models of tauopathy</span></div><div class="casAuthors">Khlistunova, Inna; Pickhardt, Marcus; Biernat, Jacek; Wang, Yipeng; Mandelkow, Eva-Maria; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">544-546</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The pathol. aggregation of tau into paired helical filaments is a hallmark of several neurodegenerative diseases, including Alzheimer's disease.  We have generated cell models of tau aggregation in order to study mechanisms involving abnormal changes of tau.  In the cell models the repeat domain of tau (tauRD) and some of its variants are expressed in a regulated fashion, e.g. the 4-repeat domain of tau with the wild-type sequence, the repeat domain with the ΔK280 mutation ("pro-aggregation mutant"), or the repeat domain with addnl. proline mutations ("anti-aggregation mutant").  The aggregation of tauRD is toxic to the cells, but aggregation and toxicity can be prevented by low mol. wt. compds. identified by a screen for inhibitors.  Thus the cell models are suitable for developing aggregation inhibitor drugs and testing their cellular roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPRuLFD4hE0rVg90H21EOLACvtfcHk0lhw6xQeuL9Z3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVGqsA%253D%253D&md5=aa96875370b22e54ada7fc96edceca1d</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.2174%2F156720507783018307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720507783018307%26sid%3Dliteratum%253Aachs%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DInhibition%2520of%2520tau%2520aggregation%2520in%2520cell%2520models%2520of%2520tauopathy%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2007%26volume%3D4%26spage%3D544%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Fatouros, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pir, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koushika, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumeister, R.</span><span> </span><span class="NLM_article-title">Inhibition of tau aggregation in a novel <i>Caenorhabditis elegans</i> model of tauopathy mitigates proteotoxicity</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3587</span><span class="NLM_x">–</span> <span class="NLM_lpage">3603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1093%2Fhmg%2Fdds190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22611162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSrtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=3587-3603&author=C.+Fatourosauthor=G.+J.+Pirauthor=J.+Biernatauthor=S.+P.+Koushikaauthor=E.+Mandelkowauthor=E.+M.+Mandelkowauthor=E.+Schmidtauthor=R.+Baumeister&title=Inhibition+of+tau+aggregation+in+a+novel+Caenorhabditis+elegans+model+of+tauopathy+mitigates+proteotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity</span></div><div class="casAuthors">Fatouros, Chronis; Pir, Ghulam Jeelani; Biernat, Jacek; Koushika, Sandhya Padmanabhan; Mandelkow, Eckhard; Mandelkow, Eva-Maria; Schmidt, Enrico; Baumeister, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3587-3603</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Increased Tau protein amyloidogenicity has been causatively implicated in several neurodegenerative diseases, collectively called tauopathies.  In pathol. conditions, Tau becomes hyperphosphorylated and forms intracellular aggregates.  The deletion of K280, which is a mutation that commonly appears in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17, enhances Tau aggregation propensity (pro-aggregation).  In contrast, introduction of the I277P and I308P mutations prevents β-sheet formation and subsequent aggregation (anti-aggregation).  In this study, the authors created a tauopathy model by expressing pro- or anti-aggregant Tau species in the nervous system of Caenorhabditis elegans.  Animals expressing the highly amyloidogenic Tau species showed accelerated Tau aggregation and pathol. manifested by severely impaired motility and evident neuronal dysfunction.  In addn., the authors obsd. that the axonal transport of mitochondria was perturbed in these animals.  Control animals expressing the anti-aggregant combination had rather mild phenotype.  The authors subsequently tested several Tau aggregation inhibitor compds. and obsd. a mitigation of Tau proteotoxicity.  In particular, a novel compd. that crosses the blood-brain barrier of mammals proved effective in ameliorating the motility as well as delaying the accumulation of neuronal defects.  This study establishes a new C. elegans model of Tau aggregation-mediated toxicity and supports the emerging notion that inhibiting the nucleation of Tau aggregation can be neuroprotective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbYmwP2dGra7Vg90H21EOLACvtfcHk0lhw6xQeuL9Z3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSrtLfE&md5=cbd8192c50dbceee7907ac7ea3ba6a9f</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fdds190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fdds190%26sid%3Dliteratum%253Aachs%26aulast%3DFatouros%26aufirst%3DC.%26aulast%3DPir%26aufirst%3DG.%2BJ.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DKoushika%26aufirst%3DS.%2BP.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DBaumeister%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520tau%2520aggregation%2520in%2520a%2520novel%2520Caenorhabditis%2520elegans%2520model%2520of%2520tauopathy%2520mitigates%2520proteotoxicity%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2012%26volume%3D21%26spage%3D3587%26epage%3D3603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Messing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span> </span><span class="NLM_article-title">Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1343</span><span class="NLM_x">–</span> <span class="NLM_lpage">1354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.neurobiolaging.2012.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=23158765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSmu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1343-1354&author=L.+Messingauthor=J.+M.+Deckerauthor=M.+Josephauthor=E.+Mandelkowauthor=E.+M.+Mandelkow&title=Cascade+of+tau+toxicity+in+inducible+hippocampal+brain+slices+and+prevention+by+aggregation+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors</span></div><div class="casAuthors">Messing, Lars; Decker, Jochen Martin; Joseph, Maria; Mandelkow, Eckhard; Mandelkow, Eva-Maria</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1343-1354</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mislocalization and aggregation of the axonal protein tau are hallmarks of Alzheimer's disease and other tauopathies.  Here, we studied the relationship between tau aggregation, loss of spines and neurons, and reversibility by aggregation inhibitors.  To this end we established an in vitro model of tauopathy based on regulatable transgenic hippocampal organotypic slice cultures prepd. from mice expressing proaggregant Tau repeat domain with mutation ΔK280 (TauRDΔK).  Transgene expression was monitored by a bioluminescence reporter assay.  We obsd. abnormal tau phosphorylation and mislocalization of exogenous and endogenous tau into the somatodendritic compartment.  This was paralleled by a redn. of dendritic spines, altered dendritic spine morphol., dysregulation of Ca++ dynamics and elevated activation of microglia.  Neurotoxicity was mediated by Caspase-3 activation and correlated with the expression level of proaggregant TauRDΔK.  Finally, tau aggregates appeared in areas CA1 and CA3 after three weeks in vitro.  Neurodegeneration was relieved by aggregation inhibitors or by switching off transgene expression.  Thus the slice culture model is suitable for monitoring the development of tauopathy and the therapeutic benefit of antiaggregation drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC_PnWs0hCu7Vg90H21EOLACvtfcHk0lhw6xQeuL9Z3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSmu7rO&md5=795880e4fc8b1dd1f21f4d5fd0c09d59</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2012.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2012.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DMessing%26aufirst%3DL.%26aulast%3DDecker%26aufirst%3DJ.%2BM.%26aulast%3DJoseph%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DCascade%2520of%2520tau%2520toxicity%2520in%2520inducible%2520hippocampal%2520brain%2520slices%2520and%2520prevention%2520by%2520aggregation%2520inhibitors%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D1343%26epage%3D1354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Quideau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deffieux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douat-Casassus, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouysegu, L.</span><span> </span><span class="NLM_article-title">Plant polyphenols: chemical properties, biological activities, and synthesis</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1002%2Fanie.201000044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFGjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=586-621&author=S.+Quideauauthor=D.+Deffieuxauthor=C.+Douat-Casassusauthor=L.+Pouysegu&title=Plant+polyphenols%3A+chemical+properties%2C+biological+activities%2C+and+synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Plant polyphenols: Chemical properties, biological activities, and synthesis</span></div><div class="casAuthors">Quideau, Stephane; Deffieux, Denis; Douat-Casassus, Celine; Pouysegu, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">586-621</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Eating five servings of fruits and vegetables per day!!This is what is highly recommended and heavily advertised nowadays to the general public to stay fit and healthy! Drinking green tea on a regular basis, eating chocolate from time to time, as well as savoring a couple of glasses of red wine per day have been claimed to increase life expectancy even further! Why The answer is in fact still under scientific scrutiny, but a particular class of compds. naturally occurring in fruits and vegetables is considered to be crucial for the expression of such human health benefits: the polyphenols! What are these plant products really What are their physicochem. properties How do they express their biol. activity Are they really valuable for disease prevention Can they be used to develop new pharmaceutical drugs What recent progress has been made toward their prepn. by org. synthesis This Review gives answers from a chem. perspective, summarizes the state of the art, and highlights the most significant advances in the field of polyphenol research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6yStrEg5Z0rVg90H21EOLACvtfcHk0lhxFrG11KVrjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFGjsw%253D%253D&md5=e1469df2ccba3b121680dff0b43b696a</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1002%2Fanie.201000044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201000044%26sid%3Dliteratum%253Aachs%26aulast%3DQuideau%26aufirst%3DS.%26aulast%3DDeffieux%26aufirst%3DD.%26aulast%3DDouat-Casassus%26aufirst%3DC.%26aulast%3DPouysegu%26aufirst%3DL.%26atitle%3DPlant%2520polyphenols%253A%2520chemical%2520properties%252C%2520biological%2520activities%252C%2520and%2520synthesis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D586%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Meng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munishkina, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uversky, V. N.</span><span> </span><span class="NLM_article-title">Effects of various flavonoids on the alpha-synuclein fibrillation process</span> <span class="citation_source-journal">Parkinson’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">650794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BC3cbitF2qtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=650794&author=X.+Mengauthor=L.+A.+Munishkinaauthor=A.+L.+Finkauthor=V.+N.+Uversky&title=Effects+of+various+flavonoids+on+the+alpha-synuclein+fibrillation+process"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Various Flavonoids on the α-Synuclein Fibrillation Process</span></div><div class="casAuthors">Meng Xiaoyun; Munishkina Larissa A; Fink Anthony L; Uversky Vladimir N</div><div class="citationInfo"><span class="NLM_cas:title">Parkinson's disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2010</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">650794</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">α-Synuclein aggregation and fibrillation are closely associated with the formation of Lewy bodies in neurons and are implicated in the causative pathogenesis of Parkinson's disease and other synucleinopathies.  Currently, there is no approved therapeutic agent directed toward preventing the protein aggregation, which has been recently shown to have a key role in the cytotoxic nature of amyloidogenic proteins.  Flavonoids, known as plant pigments, belong to a broad family of polyphenolic compounds.  Over 4,000 flavonoids have been identified from various plants and foodstuffs derived from plants and have been demonstrated as potential neuroprotective agents.  In this study 48 flavonoids belonging to several classes with structures differing in the position of double bonds and ring substituents were tested for their ability to inhibit the fibrillation of α-synuclein in vitro.  A variety of flavonoids inhibited α-synuclein fibrillation, and most of the strong inhibitory flavonoids were also found to disaggregate preformed fibrils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNPfTLo6kQ4kNoizSOkG_FfW6udTcc2eamBSkz-TRxwbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbitF2qtA%253D%253D&md5=09ab4fca663e2a7b31c58f078610e922</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DMunishkina%26aufirst%3DL.%2BA.%26aulast%3DFink%26aufirst%3DA.%2BL.%26aulast%3DUversky%26aufirst%3DV.%2BN.%26atitle%3DEffects%2520of%2520various%2520flavonoids%2520on%2520the%2520alpha-synuclein%2520fibrillation%2520process%26jtitle%3DParkinson%25E2%2580%2599s%2520Dis.%26date%3D2010%26volume%3D2010%26spage%3D650794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Berhanu, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masunov, A. E.</span><span> </span><span class="NLM_article-title">Natural polyphenols as inhibitors of amyloid aggregation. Molecular dynamics study of GNNQQNY heptapeptide decamer</span> <span class="citation_source-journal">Biophys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2010&pages=12-21&author=W.+M.+Berhanuauthor=A.+E.+Masunov&title=Natural+polyphenols+as+inhibitors+of+amyloid+aggregation.+Molecular+dynamics+study+of+GNNQQNY+heptapeptide+decamer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerhanu%26aufirst%3DW.%2BM.%26aulast%3DMasunov%26aufirst%3DA.%2BE.%26atitle%3DNatural%2520polyphenols%2520as%2520inhibitors%2520of%2520amyloid%2520aggregation.%2520Molecular%2520dynamics%2520study%2520of%2520GNNQQNY%2520heptapeptide%2520decamer%26jtitle%3DBiophys.%2520Chem.%26date%3D2010%26volume%3D149%26spage%3D12%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Bolander, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyny-von Haussen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetschy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czech, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knust, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herms, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilger, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title">Bis(arylvinyl)pyrazines, -pyrimidines, and -pyridazines as imaging agents for Tau fibrils and beta-amyloid plaques in Alzheimer’s disease models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9170</span><span class="NLM_x">–</span> <span class="NLM_lpage">9180</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300653b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9170-9180&author=A.+Bolanderauthor=D.+Kieserauthor=C.+Vossauthor=S.+Bauerauthor=C.+Schonauthor=S.+Burgoldauthor=T.+Bittnerauthor=J.+Holzerauthor=R.+Heyny-von+Haussenauthor=G.+Mallauthor=V.+Goetschyauthor=C.+Czechauthor=H.+Knustauthor=R.+Bergerauthor=J.+Hermsauthor=I.+Hilgerauthor=B.+Schmidt&title=Bis%28arylvinyl%29pyrazines%2C+-pyrimidines%2C+and+-pyridazines+as+imaging+agents+for+Tau+fibrils+and+beta-amyloid+plaques+in+Alzheimer%E2%80%99s+disease+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm300653b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300653b%26sid%3Dliteratum%253Aachs%26aulast%3DBolander%26aufirst%3DA.%26aulast%3DKieser%26aufirst%3DD.%26aulast%3DVoss%26aufirst%3DC.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DSchon%26aufirst%3DC.%26aulast%3DBurgold%26aufirst%3DS.%26aulast%3DBittner%26aufirst%3DT.%26aulast%3DHolzer%26aufirst%3DJ.%26aulast%3DHeyny-von%2BHaussen%26aufirst%3DR.%26aulast%3DMall%26aufirst%3DG.%26aulast%3DGoetschy%26aufirst%3DV.%26aulast%3DCzech%26aufirst%3DC.%26aulast%3DKnust%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DHerms%26aufirst%3DJ.%26aulast%3DHilger%26aufirst%3DI.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DBis%2528arylvinyl%2529pyrazines%252C%2520-pyrimidines%252C%2520and%2520-pyridazines%2520as%2520imaging%2520agents%2520for%2520Tau%2520fibrils%2520and%2520beta-amyloid%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9170%26epage%3D9180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markwell, R. E.</span><span> </span><span class="NLM_article-title">Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x"> (</span><span class="NLM_issue">Part 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=1999&pages=419-423&issue=Part+2&author=D.+R.+Howlettauthor=A.+R.+Georgeauthor=D.+E.+Owenauthor=R.+V.+Wardauthor=R.+E.+Markwell&title=Common+structural+features+determine+the+effectiveness+of+carvedilol%2C+daunomycin+and+rolitetracycline+as+inhibitors+of+Alzheimer+beta-amyloid+fibril+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DGeorge%26aufirst%3DA.%2BR.%26aulast%3DOwen%26aufirst%3DD.%2BE.%26aulast%3DWard%26aufirst%3DR.%2BV.%26aulast%3DMarkwell%26aufirst%3DR.%2BE.%26atitle%3DCommon%2520structural%2520features%2520determine%2520the%2520effectiveness%2520of%2520carvedilol%252C%2520daunomycin%2520and%2520rolitetracycline%2520as%2520inhibitors%2520of%2520Alzheimer%2520beta-amyloid%2520fibril%2520formation%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D343%26issue%3DPart%25202%26spage%3D419%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begum, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubeda, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambegaokar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frautschy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, G. M.</span><span> </span><span class="NLM_article-title">Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">5892</span><span class="NLM_x">–</span> <span class="NLM_lpage">5901</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1074%2Fjbc.M404751200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15590663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlClt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=5892-5901&author=F.+Yangauthor=G.+P.+Limauthor=A.+N.+Begumauthor=O.+J.+Ubedaauthor=M.+R.+Simmonsauthor=S.+S.+Ambegaokarauthor=P.+P.+Chenauthor=R.+Kayedauthor=C.+G.+Glabeauthor=S.+A.+Frautschyauthor=G.+M.+Cole&title=Curcumin+inhibits+formation+of+amyloid+beta+oligomers+and+fibrils%2C+binds+plaques%2C+and+reduces+amyloid+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo</span></div><div class="casAuthors">Yang, Fusheng; Lim, Giselle P.; Begum, Aynun N.; Ubeda, Oliver J.; Simmons, Mychica R.; Ambegaokar, Surendra S.; Chen, Pingping P.; Kayed, Rakez; Glabe, Charles G.; Frautschy, Sally A.; Cole, Gregory M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5892-5901</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) involves amyloid β (Aβ) accumulation, oxidative damage, and inflammation, and risk is reduced with increased antioxidant and anti-inflammatory consumption.  The phenolic yellow curry pigment curcumin has potent anti-inflammatory and antioxidant activities and can suppress oxidative damage, inflammation, cognitive deficits, and amyloid accumulation.  Since the mol. structure of curcumin suggested potential Aβ binding, we investigated whether its efficacy in AD models could be explained by effects on Aβ aggregation.  Under aggregating conditions in vitro, curcumin inhibited aggregation (IC50 = 0.8 μM) as well as disaggregated fibrillar Aβ40 (IC50 = 1 μM), indicating favorable stoichiometry for inhibition.  Curcumin was a better Aβ40 aggregation inhibitor than ibuprofen and naproxen, and prevented Aβ42 oligomer formation and toxicity between 0.1 and 1.0 μM.  Under EM, curcumin decreased dose dependently Aβ fibril formation beginning with 0.125 μM.  The effects of curcumin did not depend on Aβ sequence but on fibril-related conformation.  AD and Tg2576 mice brain sections incubated with curcumin revealed preferential labeling of amyloid plaques.  In vivo studies showed that curcumin injected peripherally into aged Tg mice crossed the blood-brain barrier and bound plaques.  When fed to aged Tg2576 mice with advanced amyloid accumulation, curcumin labeled plaques and reduced amyloid levels and plaque burden.  Hence, curcumin directly binds small β-amyloid species to block aggregation and fibril formation in vitro and in vivo.  These data suggest that low dose curcumin effectively disaggregates Aβ as well as prevents fibril and oligomer formation, supporting the rationale for curcumin use in clin. trials preventing or treating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohTY2O8WLUVrVg90H21EOLACvtfcHk0li64K5bYfie4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlClt7w%253D&md5=5f8f6fb0c3529ba9dbeae5f8af096250</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M404751200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M404751200%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DF.%26aulast%3DLim%26aufirst%3DG.%2BP.%26aulast%3DBegum%26aufirst%3DA.%2BN.%26aulast%3DUbeda%26aufirst%3DO.%2BJ.%26aulast%3DSimmons%26aufirst%3DM.%2BR.%26aulast%3DAmbegaokar%26aufirst%3DS.%2BS.%26aulast%3DChen%26aufirst%3DP.%2BP.%26aulast%3DKayed%26aufirst%3DR.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26aulast%3DFrautschy%26aufirst%3DS.%2BA.%26aulast%3DCole%26aufirst%3DG.%2BM.%26atitle%3DCurcumin%2520inhibits%2520formation%2520of%2520amyloid%2520beta%2520oligomers%2520and%2520fibrils%252C%2520binds%2520plaques%252C%2520and%2520reduces%2520amyloid%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D5892%26epage%3D5901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khlistunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hascher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Anthraquinones inhibit tau aggregation and dissolve Alzheimer’s paired helical filaments in vitro and in cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">3628</span><span class="NLM_x">–</span> <span class="NLM_lpage">3635</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=3628-3635&author=M.+Pickhardtauthor=Z.+Gazovaauthor=M.+von+Bergenauthor=I.+Khlistunovaauthor=Y.+Wangauthor=A.+Hascherauthor=E.+M.+Mandelkowauthor=J.+Biernatauthor=E.+Mandelkow&title=Anthraquinones+inhibit+tau+aggregation+and+dissolve+Alzheimer%E2%80%99s+paired+helical+filaments+in+vitro+and+in+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DGazova%26aufirst%3DZ.%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHascher%26aufirst%3DA.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DAnthraquinones%2520inhibit%2520tau%2520aggregation%2520and%2520dissolve%2520Alzheimer%25E2%2580%2599s%2520paired%2520helical%2520filaments%2520in%2520vitro%2520and%2520in%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D3628%26epage%3D3635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Ho, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yemul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasinetti, G. M.</span><span> </span><span class="NLM_article-title">Grape seed polyphenolic extract as a potential novel therapeutic agent in tauopathies</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=19221432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=433-439&author=L.+Hoauthor=S.+Yemulauthor=J.+Wangauthor=G.+M.+Pasinetti&title=Grape+seed+polyphenolic+extract+as+a+potential+novel+therapeutic+agent+in+tauopathies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Grape Seed Polyphenolic Extract as a Potential Novel Therapeutic Agent in Tauopathies</span></div><div class="casAuthors">Ho, Lap; Yemul, Shrishailam; Wang, Jun; Pasinetti, Giulio Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">433-439</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Abnormal misfoldings of the microtubule-assocd. protein tau, leading to the aggregation of tau into paired helical filaments that are ultimately deposited as neurofibrillary tangles, is a key neuropathol. feature of a no. of neurodegenerative disorders collectively referred to as tauopathies.  We recently obsd. that a particular grape seed polyphenolic ext. (GSPE), namely, Meganatural-Az may attenuate the generation and stability of misfolded proteins.  We hypothesized that Meganatural-Az GSPE might also attenuate tau protein misfolding that leads to the generation of tau filamentary aggregates that are crit. for the initiation and progression of neurodegeneration and/or cognitive dysfunctions in tauopathies.  In this study, we used in vitro aggregations of synthetic Ac-306VQIVYK311 tau peptide as a model system to explore whether Meganatural-Az GSPE might modulate aggregations of tau protein.  We demonstrate that this GSPE is capable of inhibiting tau peptide aggregations, as well as dissocg. preformed tau peptide aggregates.  Results from this study suggest that this GSPE might provide beneficial disease-modifying bioactivities in tau-assocd. neurodegenerative disorders by modulating tau-mediated neuropathol. mechanisms.  Our observation, in conjunction with the demonstrated bioavailability, as well as safety and tolerability, of this GSPE, supports the development of Meganatural-Az GSPE for the prevention and/or treatment of tau-assocd. neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQHKVTkzoxULVg90H21EOLACvtfcHk0li64K5bYfie4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCrsrY%253D&md5=47bd7a41d9e4103492db3a8e0c5eaff7</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DL.%26aulast%3DYemul%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPasinetti%26aufirst%3DG.%2BM.%26atitle%3DGrape%2520seed%2520polyphenolic%2520extract%2520as%2520a%2520potential%2520novel%2520therapeutic%2520agent%2520in%2520tauopathies%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2009%26volume%3D16%26spage%3D433%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Ksiezak-Reding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santa-Maria, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasinetti, G. M.</span><span> </span><span class="NLM_article-title">Ultrastructural alterations of Alzheimer’s disease paired helical filaments by grape seed-derived polyphenols</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1427</span><span class="NLM_x">–</span> <span class="NLM_lpage">1439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.neurobiolaging.2010.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21196065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1KltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=1427-1439&author=H.+Ksiezak-Redingauthor=L.+Hoauthor=I.+Santa-Mariaauthor=C.+Diaz-Ruizauthor=J.+Wangauthor=G.+M.+Pasinetti&title=Ultrastructural+alterations+of+Alzheimer%E2%80%99s+disease+paired+helical+filaments+by+grape+seed-derived+polyphenols"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Ultrastructural alterations of Alzheimer's disease paired helical filaments by grape seed-derived polyphenols</span></div><div class="casAuthors">Ksiezak-Reding, Hanna; Ho, Lap; Santa-Maria, Ismael; Diaz-Ruiz, Carmen; Wang, Jun; Pasinetti, Giulio Maria</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1427-1439</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Abnormal folding of the microtubule-assocd. protein tau leads to aggregation of tau into paired helical filaments (PHFs) and neurofibrillary tangles, the major hallmark of Alzheimer's disease (AD).  We have recently shown that grape seed polyphenol ext. (GSPE) reduces tau pathol. in the TMHT mouse model of tauopathy (Wang et al., 2010).  In the present studies we assessed the impact of GSPE exposure on the ultrastructure of PHFs isolated from Alzheimer's disease brain.  Transmission electron microscopy revealed that GSPE induced profound dose- and time-dependent alterations in the morphol. of PHFs with partial disintegration of filaments.  Filaments showed ∼2-fold enlargement in width and displayed numerous protrusions and splayed ends consistent with unfolding of tau and diminished structural stability.  In addn., GSPE induced a redn. in immunogold labeling with antibodies against the C-terminal half (12E8, PHF-1) and the middle region of tau (AT8, Tau5, pSer214 tau, and AT180) but not the C-terminal end (Tau46).  In comparison, labeling of N-terminus (Alz50) was enhanced.  It is unlikely that alterations in immunogold labeling were due to biochem. alterations, e.g., protein phosphatase or proteolytic activities potentially stimulated by GSPE, because western blotting studies have shown the preservation of full length polypeptides of tau and their phospho-epitopes in GSPE-treated samples.  The GSPE mechanism may include a noncovalent interaction of polyphenols with proline residues in the proline-rich domain of tau, with Pin1 sites at P213 and P232 most seriously affected as judged by suppression of labeling.  Collectively, our results suggest that GSPE has a significant potential for therapeutic development by neutralizing phospho-epitopes and disrupting fibrillary conformation leading to disintegration of PHFs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlYdLrU4JfHLVg90H21EOLACvtfcHk0lhOXviQfCgJIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1KltL0%253D&md5=d7ace7d1e5c347cccd8ff735343bc362</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2010.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2010.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DKsiezak-Reding%26aufirst%3DH.%26aulast%3DHo%26aufirst%3DL.%26aulast%3DSanta-Maria%26aufirst%3DI.%26aulast%3DDiaz-Ruiz%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPasinetti%26aufirst%3DG.%2BM.%26atitle%3DUltrastructural%2520alterations%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520paired%2520helical%2520filaments%2520by%2520grape%2520seed-derived%2520polyphenols%26jtitle%3DNeurobiol.%2520Aging%26date%3D2012%26volume%3D33%26spage%3D1427%26epage%3D1439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Ferruzzi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobo, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janle, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasinetti, G. M.</span><span> </span><span class="NLM_article-title">Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=19625746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVygtbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=113-124&author=M.+G.+Ferruzziauthor=J.+K.+Loboauthor=E.+M.+Janleauthor=B.+Cooperauthor=J.+E.+Simonauthor=Q.+L.+Wuauthor=C.+Welchauthor=L.+Hoauthor=C.+Weaverauthor=G.+M.+Pasinetti&title=Bioavailability+of+gallic+acid+and+catechins+from+grape+seed+polyphenol+extract+is+improved+by+repeated+dosing+in+rats%3A+implications+for+treatment+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Bioavailability of Gallic Acid and Catechins from Grape Seed Polyphenol Extract is Improved by Repeated Dosing in Rats: Implications for Treatment in Alzheimer's Disease</span></div><div class="casAuthors">Ferruzzi, Mario G.; Lobo, Jessica K.; Janle, Elsa M.; Cooper, Bruce; Simon, James E.; Wu, Qing-Li; Welch, Cara; Ho, Lap; Weaver, Connie; Pasinetti, Giulio M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-124</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The present study explored the bioavailability and brain deposition of a grape seed polyphenolic ext. (GSPE) previously found to attenuate cognitive deterioration in a mouse model of Alzheimer's disease (AD).  Plasma pharmacokinetic response of major GSPE phenolic components was measured following intragastric gavage of 50, 100, and 150 mg GSPE per kg body wt.  Liq. chromatog.-mass spectrometry (LC-MS) anal. identified gallic acid (GA), catechin (C), and epicatechin (EC) in plasma of rats gavaged acutely with GSPE. Addnl., 4-methylgallic acid (4-OMeGA), 3'-methylcatechin (3'-OMeC), and 3'-methylepicatechin (3'-OMeEC) were identified as circulating metabolites of GSPE phenolic constituents.  Cmax for individual GSPE constituents and their metabolites increased in a dose-dependent fashion (with increasing GSPE oral dose).  Repeated daily exposure to GSPE was found to significantly increase bioavailability (defined as plasma AUC0-8h) of GA, C, and EC by 198, 253, and 282% relative to animals receiving only a single acute GSPE dose.  EC and C were not detectable in brain tissues of rats receiving a single GSPE dose but reached levels of 290.7 ± 45.9 and 576.7 ± 227.7 pg/g in brain tissues from rats administered GSPE for 10 days.  This study suggests that brain deposition of GA, C, and EC is affected by repeated dosing of GSPE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0ZrFD5MA_KbVg90H21EOLACvtfcHk0lhOXviQfCgJIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVygtbfP&md5=a5d0e7046eb5ded50bb055888791d7b2</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerruzzi%26aufirst%3DM.%2BG.%26aulast%3DLobo%26aufirst%3DJ.%2BK.%26aulast%3DJanle%26aufirst%3DE.%2BM.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DSimon%26aufirst%3DJ.%2BE.%26aulast%3DWu%26aufirst%3DQ.%2BL.%26aulast%3DWelch%26aufirst%3DC.%26aulast%3DHo%26aufirst%3DL.%26aulast%3DWeaver%26aufirst%3DC.%26aulast%3DPasinetti%26aufirst%3DG.%2BM.%26atitle%3DBioavailability%2520of%2520gallic%2520acid%2520and%2520catechins%2520from%2520grape%2520seed%2520polyphenol%2520extract%2520is%2520improved%2520by%2520repeated%2520dosing%2520in%2520rats%253A%2520implications%2520for%2520treatment%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2009%26volume%3D18%26spage%3D113%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Lopez Del Amo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grelle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanker, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieschke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reif, B.</span><span> </span><span class="NLM_article-title">Structural properties of EGCG-induced, nontoxic Alzheimer’s disease Abeta oligomers</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">524</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2012&pages=517-524&author=J.+M.+Lopez+Del+Amoauthor=U.+Finkauthor=M.+Dasariauthor=G.+Grelleauthor=E.+E.+Wankerauthor=J.+Bieschkeauthor=B.+Reif&title=Structural+properties+of+EGCG-induced%2C+nontoxic+Alzheimer%E2%80%99s+disease+Abeta+oligomers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%2BDel%2BAmo%26aufirst%3DJ.%2BM.%26aulast%3DFink%26aufirst%3DU.%26aulast%3DDasari%26aufirst%3DM.%26aulast%3DGrelle%26aufirst%3DG.%26aulast%3DWanker%26aufirst%3DE.%2BE.%26aulast%3DBieschke%26aufirst%3DJ.%26aulast%3DReif%26aufirst%3DB.%26atitle%3DStructural%2520properties%2520of%2520EGCG-induced%252C%2520nontoxic%2520Alzheimer%25E2%2580%2599s%2520disease%2520Abeta%2520oligomers%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D421%26spage%3D517%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Hu, M.</span><span> </span><span class="NLM_article-title">Commentary: bioavailability of flavonoids and polyphenols: call to arms</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">806</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp7001363" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKqtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=803-806&author=M.+Hu&title=Commentary%3A+bioavailability+of+flavonoids+and+polyphenols%3A+call+to+arms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Commentary: Bioavailability of Flavonoids and Polyphenols: Call to Arms</span></div><div class="casAuthors">Hu, Ming</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">803-806</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In this special issue of Mol. Pharmaceutics, the authors have assembled a group of active and experienced researchers.  They each provided their own research results or surveyed current research landscape in the form of review articles.  Taken together, the collection serves to make a broad assessment of the current knowledge base and state-of-the-art techniques.  Addnl. papers represent current or new methodologies that can be used to assess the bioavailability of flavonoids and polyphenols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSrxx0P3yBfrVg90H21EOLACvtfcHk0lhOXviQfCgJIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKqtb3L&md5=cfdf903072c9550028118e4e638c4fe5</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fmp7001363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp7001363%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DM.%26atitle%3DCommentary%253A%2520bioavailability%2520of%2520flavonoids%2520and%2520polyphenols%253A%2520call%2520to%2520arms%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2007%26volume%3D4%26spage%3D803%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Mereles, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunstein, W.</span><span> </span><span class="NLM_article-title">Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5592</span><span class="NLM_x">–</span> <span class="NLM_lpage">5603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.3390%2Fijms12095592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=22016611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1entbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=5592-5603&author=D.+Merelesauthor=W.+Hunstein&title=Epigallocatechin-3-gallate+%28EGCG%29+for+clinical+trials%3A+more+pitfalls+than+promises%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?</span></div><div class="casAuthors">Mereles, Derliz; Hunstein, Werner</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5592-5603</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Epigallocatechin-3-gallate (EGCG), the main and most significant polyphenol in green tea, has shown numerous health promoting effects acting through different pathways, as antioxidant, anti-inflammatory and anti-atherogenic agent, showing gene expression activity, functioning through growth factor-mediated pathways, the mitogen-activated protein kinase-dependent pathway, the ubiquitin/proteasome degrdn. pathway, as well as eliciting an amyloid protein remodeling activity.  However, epidemiol. inferences are sometimes conflicting and in vitro and in vivo studies may seem discrepant.  Current knowledge on how to enhance bioavailability could be the answer to some of these issues.  Furthermore, dose levels, administration frequency and potential side effects remain to be examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkeQ8unXUZr7Vg90H21EOLACvtfcHk0lgUYCTDMBz2fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1entbzP&md5=37533e07e8edd850e6d064bfbb6c0de7</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.3390%2Fijms12095592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms12095592%26sid%3Dliteratum%253Aachs%26aulast%3DMereles%26aufirst%3DD.%26aulast%3DHunstein%26aufirst%3DW.%26atitle%3DEpigallocatechin-3-gallate%2520%2528EGCG%2529%2520for%2520clinical%2520trials%253A%2520more%2520pitfalls%2520than%2520promises%253F%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2011%26volume%3D12%26spage%3D5592%26epage%3D5603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Wasan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocks, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs-Barrable, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, S. J.</span><span> </span><span class="NLM_article-title">Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=84-99&author=K.+M.+Wasanauthor=D.+R.+Brocksauthor=S.+D.+Leeauthor=K.+Sachs-Barrableauthor=S.+J.+Thornton&title=Impact+of+lipoproteins+on+the+biological+activity+and+disposition+of+hydrophobic+drugs%3A+implications+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWasan%26aufirst%3DK.%2BM.%26aulast%3DBrocks%26aufirst%3DD.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BD.%26aulast%3DSachs-Barrable%26aufirst%3DK.%26aulast%3DThornton%26aufirst%3DS.%2BJ.%26atitle%3DImpact%2520of%2520lipoproteins%2520on%2520the%2520biological%2520activity%2520and%2520disposition%2520of%2520hydrophobic%2520drugs%253A%2520implications%2520for%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D84%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roggo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuffenhauer, A.</span><span> </span><span class="NLM_article-title">Natural product-likeness score and its application for prioritization of compound libraries</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci700286x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlCqtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=68-74&author=P.+Ertlauthor=S.+Roggoauthor=A.+Schuffenhauer&title=Natural+product-likeness+score+and+its+application+for+prioritization+of+compound+libraries"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries</span></div><div class="casAuthors">Ertl, Peter; Roggo, Silvio; Schuffenhauer, Ansgar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-74</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Natural products (NPs) have been optimized in a very long natural selection process for optimal interactions with biol. macromols.  NPs are therefore an excellent source of validated substructures for the design of novel bioactive mols.  Various cheminformatics techniques can provide useful help in analyzing NPs, and the results of such studies may be used with advantage in the drug discovery process.  In the present study we describe a method to calc. the natural product-likeness score-a Bayesian measure which allows for the detn. of how mols. are similar to the structural space covered by natural products.  This score is shown to efficiently sep. NPs from synthetic mols. in a cross-validation expt.  Possible applications of the NP-likeness score are discussed and illustrated on several examples including virtual screening, prioritization of compd. libraries toward NP-likeness, and design of building blocks for the synthesis of NP-like libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre4QzdpRURjbVg90H21EOLACvtfcHk0lgUYCTDMBz2fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlCqtLfP&md5=0ecfc66d9cd731fcd5c131cd246d7dcf</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Fci700286x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700286x%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRoggo%26aufirst%3DS.%26aulast%3DSchuffenhauer%26aufirst%3DA.%26atitle%3DNatural%2520product-likeness%2520score%2520and%2520its%2520application%2520for%2520prioritization%2520of%2520compound%2520libraries%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D68%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Ganesan, A.</span><span> </span><span class="NLM_article-title">The impact of natural products upon modern drug discovery</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.cbpa.2008.03.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18423384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1ersrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=306-317&author=A.+Ganesan&title=The+impact+of+natural+products+upon+modern+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of natural products upon modern drug discovery</span></div><div class="casAuthors">Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-317</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the period 1970-2006, a total of 24 unique natural products were discovered that led to an approved drug.  We analyze these successful leads in terms of drug-like properties, and show that they can be divided into two equal subsets.  The first falls in the Lipinski universe' and complies with the Rule of Five.  The second is a parallel universe' that violates the rules.  Nevertheless, the latter compds. remain largely compliant in terms of log P and H-bond donors, highlighting the importance of these two metrics in predicting bioavailability.  Natural products are often cited as an exception to Lipinski's rules.  We believe this is because nature has learned to maintain low hydrophobicity and intermol. H-bond donating potential when it needs to make biol. active compds. with high mol. wt. and large nos. of rotatable bonds.  In addn., natural products are more likely than purely synthetic compds. to resemble biosynthetic intermediates or endogenous metabolites, and hence take advantage of active transport mechanisms.  Interestingly, the natural product leads in the Lipinski and parallel universe had an identical success rate (50%) in delivering an oral drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXd8x0Vy0yerVg90H21EOLACvtfcHk0lgUYCTDMBz2fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1ersrk%253D&md5=8cdde276c59d84071ea2d6f572d10088</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2008.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2008.03.016%26sid%3Dliteratum%253Aachs%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DThe%2520impact%2520of%2520natural%2520products%2520upon%2520modern%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D12%26spage%3D306%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Teng, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, Q. B.</span><span> </span><span class="NLM_article-title">Quantitation assay for absorption and first-pass metabolism of emodin in isolated rat small intestine using liquid chromatography-tandem mass spectrometry</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1628</span><span class="NLM_x">–</span> <span class="NLM_lpage">1633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1248%2Fbpb.30.1628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17827711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFelsrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=1628-1633&author=Z.+H.+Tengauthor=S.+Y.+Zhouauthor=R.+T.+Yangauthor=X.+Y.+Liuauthor=R.+W.+Liuauthor=X.+Yangauthor=B.+L.+Zhangauthor=J.+Y.+Yangauthor=D.+Y.+Caoauthor=Q.+B.+Mei&title=Quantitation+assay+for+absorption+and+first-pass+metabolism+of+emodin+in+isolated+rat+small+intestine+using+liquid+chromatography-tandem+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitation assay for absorption and first-pass metabolism of emodin in isolated rat small intestine using liquid chromatography-tandem mass spectrometry</span></div><div class="casAuthors">Teng, Zeng-Hui; Zhou, Si-Yuan; Yang, Run-Tao; Liu, Xin-You; Liu, Ren-Wang; Yang, Xi; Zhang, Bang-Le; Yang, Jing-Yue; Cao, Da-Yong; Mei, Qi-Bing</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1628-1633</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Emodin has numerous biochem. and pharmacol. activities, though information about its intestinal absorption and first-pass metab. is scarce.  The purpose of this study was to evaluate intestinal absorption and metab. of luminally administered emodin in an isolated rat small intestine using the method of LC/MS/MS.  About 22.55% of the administered emodin appeared at the vascular side, chiefly as free emodin (12.01%), but some emodin glucuronide (8.69%) and sulfate (1.84%) were also detected.  Free glucuronide (5.23%) and sulfate (1.08%) moieties were found in the luminal perfusate.  This model serves as a valuable tool for understanding intestinal handling of emodin, and our results confirm absorption and first-pass metab. of emodin in the rat small intestine.  Phase II metabolic enzymes such as glucuronyl transferase or sulfate transferase may also play an important role in the first-pass metab. of emodin in the small intestine, which may ultimately reduce the bioavailability (and thus the efficacy) of orally administered emodin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5ygzDixacVrVg90H21EOLACvtfcHk0lgLZBYp7SZXZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFelsrfL&md5=ceed3a8dc21523efcb652f5087cc1310</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1248%2Fbpb.30.1628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.30.1628%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DZ.%2BH.%26aulast%3DZhou%26aufirst%3DS.%2BY.%26aulast%3DYang%26aufirst%3DR.%2BT.%26aulast%3DLiu%26aufirst%3DX.%2BY.%26aulast%3DLiu%26aufirst%3DR.%2BW.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DB.%2BL.%26aulast%3DYang%26aufirst%3DJ.%2BY.%26aulast%3DCao%26aufirst%3DD.%2BY.%26aulast%3DMei%26aufirst%3DQ.%2BB.%26atitle%3DQuantitation%2520assay%2520for%2520absorption%2520and%2520first-pass%2520metabolism%2520of%2520emodin%2520in%2520isolated%2520rat%2520small%2520intestine%2520using%2520liquid%2520chromatography-tandem%2520mass%2520spectrometry%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2007%26volume%3D30%26spage%3D1628%26epage%3D1633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Mueller, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stopper, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlatter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, W. K.</span><span> </span><span class="NLM_article-title">Occurrence of emodin, chrysophanol and physcion in vegetables, herbs and liquors. Genotoxicity and anti-genotoxicity of the anthraquinones and of the whole plants</span> <span class="citation_source-journal">Food Chem. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2FS0278-6915%2899%2900027-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=10456676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK1MXltVChu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1999&pages=481-491&author=S.+O.+Muellerauthor=M.+Schmittauthor=W.+Dekantauthor=H.+Stopperauthor=J.+Schlatterauthor=P.+Schreierauthor=W.+K.+Lutz&title=Occurrence+of+emodin%2C+chrysophanol+and+physcion+in+vegetables%2C+herbs+and+liquors.+Genotoxicity+and+anti-genotoxicity+of+the+anthraquinones+and+of+the+whole+plants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Occurrence of emodin, chrysophanol and physcion in vegetables, herbs and liquors. Genotoxicity and anti-genotoxicity of the anthraquinones and of the whole plants</span></div><div class="casAuthors">Mueller, S. O.; Schmitt, M.; Dekant, W.; Stopper, H.; Schlatter, J.; Schreier, P.; Lutz, W. K.</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">481-491</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">1,8-Dihydroxyanthraquinones, present in laxatives, fungi imperfecti, Chinese herbs and possibly vegetables, are in debate as human carcinogens.  We screened a variety of vegetables (cabbage lettuce, beans, peas), some herbs and herbal-flavored liquors for their content of the "free" anthraquinones emodin, chrysophanol and physcion.  For qual. and quant. anal., reversed-phase HPLC (RP-LC), gas chromatog.-mass spectrometry (GC-MS) and RP-LC-MS were used.  The vegetables showed a large batch-to-batch variability, from 0.04 to 3.6, 5.9 and 36 mg total anthraquinone per kg fresh wt. in peas, cabbage lettuce, and beans, resp.  Physcion predominated in all vegetables.  In the herbs grape vine leaves, couch grass root and plantain herb, anthraquinones were above the limit of detection.  Contents ranged below 1 mg/kg (dry wt.).  All three anthraquinones were also found in seven of 11 herbal-flavored liquors, in a range of 0.05 mg/kg to 7.6 mg/kg.  The genotoxicity of the analyzed anthraquinones was investigated in the comet assay, the micronucleus test and the mutation assay in mouse lymphoma L5178Ytk+/- cells.  Emodin was genotoxic, whereas chrysophanol and physcion showed no effects.  Complete vegetable ext. on its own did not show any effect in the micronucleus test.  A lettuce ext. completely abolished the induction of micronuclei by the genotoxic anthraquinone danthron.  Taking into consideration the measured concns. of anthraquinones, estd. daily intakes, the genotoxic potency, as well as protective effects of the food matrix, the analyzed constituents do not represent a high priority genotoxic risk in a balanced human diet.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwesuX1dAslrVg90H21EOLACvtfcHk0lgLZBYp7SZXZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVChu7s%253D&md5=35ba83255c87c03f942d834f3344f426</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2FS0278-6915%2899%2900027-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0278-6915%252899%252900027-7%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DS.%2BO.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DDekant%26aufirst%3DW.%26aulast%3DStopper%26aufirst%3DH.%26aulast%3DSchlatter%26aufirst%3DJ.%26aulast%3DSchreier%26aufirst%3DP.%26aulast%3DLutz%26aufirst%3DW.%2BK.%26atitle%3DOccurrence%2520of%2520emodin%252C%2520chrysophanol%2520and%2520physcion%2520in%2520vegetables%252C%2520herbs%2520and%2520liquors.%2520Genotoxicity%2520and%2520anti-genotoxicity%2520of%2520the%2520anthraquinones%2520and%2520of%2520the%2520whole%2520plants%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D1999%26volume%3D37%26spage%3D481%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. R.</span><span> </span><span class="NLM_article-title">Molecular pharmacology of the interaction of anthracyclines with iron</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=261-271&author=X.+Xuauthor=H.+L.+Perssonauthor=D.+R.+Richardson&title=Molecular+pharmacology+of+the+interaction+of+anthracyclines+with+iron"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DPersson%26aufirst%3DH.%2BL.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DMolecular%2520pharmacology%2520of%2520the%2520interaction%2520of%2520anthracyclines%2520with%2520iron%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D261%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Patani, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVoie, E. J.</span><span> </span><span class="NLM_article-title">Bioisosterism: a rational approach in drug design</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3147</span><span class="NLM_x">–</span> <span class="NLM_lpage">3176</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr950066q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1996&pages=3147-3176&author=G.+A.+Pataniauthor=E.+J.+LaVoie&title=Bioisosterism%3A+a+rational+approach+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosterism: A rational approach in drug design</span></div><div class="casAuthors">Patani, George A.; LaVoie, Edmond J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3147-3176</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with 191 refs., on bioisosteres that incorporates sufficient detail to enable the reader to understand the concepts being delineated.  Classical bioisosteres, such as monovalent atoms and groups, divalent isosteres, trivalent atoms and groups, tetra substituted atoms, and ring equiv., and non-classical bioisosteres, such as cyclic vs. non-cyclic non-classical bioisosteric replacements and non-classical bioisosteric replacements of functional groups, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrADeNoRGbU9LVg90H21EOLACvtfcHk0li2koH2mQeROg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D&md5=4b3ec55087feabc53e0490ebd5a3ddcd</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fcr950066q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr950066q%26sid%3Dliteratum%253Aachs%26aulast%3DPatani%26aufirst%3DG.%2BA.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26atitle%3DBioisosterism%253A%2520a%2520rational%2520approach%2520in%2520drug%2520design%26jtitle%3DChem.%2520Rev.%26date%3D1996%26volume%3D96%26spage%3D3147%26epage%3D3176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Waters, M. L.</span><span> </span><span class="NLM_article-title">Aromatic interactions in model systems</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2FS1367-5931%2802%2900359-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=12470725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD38XptFequ74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=736-741&author=M.+L.+Waters&title=Aromatic+interactions+in+model+systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatic interactions in model systems</span></div><div class="casAuthors">Waters, Marcey L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">736-741</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  A thorough knowledge of noncovalent interactions is crucial to the understanding of biol. complexity.  One of the less well understood but significant weak interactions in nature is the arom. interaction.  Recent studies have provided new insight into the driving force, stability and selectivity of these interactions.  The contribution of solvophobic and electrostatic interactions have been shown to be inextricably linked.  Moreover, the influence of electrostatic and solvophobic components on the selectivity of arom. interactions has been demonstrated.  Recent studies of arom. interactions have provided new insight into the nature of these biol. important noncovalent interactions in terms of their driving force, stability, and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxRG8RP5BTlLVg90H21EOLACvtfcHk0li2koH2mQeROg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptFequ74%253D&md5=41ce2df6f1baa0cbf508bfab6cbe9083</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2FS1367-5931%2802%2900359-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1367-5931%252802%252900359-9%26sid%3Dliteratum%253Aachs%26aulast%3DWaters%26aufirst%3DM.%2BL.%26atitle%3DAromatic%2520interactions%2520in%2520model%2520systems%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2002%26volume%3D6%26spage%3D736%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. K.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2996</span><span class="NLM_x">–</span> <span class="NLM_lpage">2999</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2996-2999&author=J.+H.+Ahnauthor=S.+J.+Kimauthor=W.+S.+Parkauthor=S.+Y.+Choauthor=J.+D.+Haauthor=S.+S.+Kimauthor=S.+K.+Kangauthor=D.+G.+Jeongauthor=S.+K.+Jungauthor=S.+H.+Leeauthor=H.+M.+Kimauthor=S.+K.+Parkauthor=K.+H.+Leeauthor=C.+W.+Leeauthor=S.+E.+Ryuauthor=J.+K.+Choi&title=Synthesis+and+biological+evaluation+of+rhodanine+derivatives+as+PRL-3+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DPark%26aufirst%3DW.%2BS.%26aulast%3DCho%26aufirst%3DS.%2BY.%26aulast%3DHa%26aufirst%3DJ.%2BD.%26aulast%3DKim%26aufirst%3DS.%2BS.%26aulast%3DKang%26aufirst%3DS.%2BK.%26aulast%3DJeong%26aufirst%3DD.%2BG.%26aulast%3DJung%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DRyu%26aufirst%3DS.%2BE.%26aulast%3DChoi%26aufirst%3DJ.%2BK.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520rhodanine%2520derivatives%2520as%2520PRL-3%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2996%26epage%3D2999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Cutshall, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Day, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezhdo, M.</span><span> </span><span class="NLM_article-title">Rhodanine derivatives as inhibitors of JSP-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3374</span><span class="NLM_x">–</span> <span class="NLM_lpage">3379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3374-3379&author=N.+S.+Cutshallauthor=C.+O%E2%80%99Dayauthor=M.+Prezhdo&title=Rhodanine+derivatives+as+inhibitors+of+JSP-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCutshall%26aufirst%3DN.%2BS.%26aulast%3DO%25E2%2580%2599Day%26aufirst%3DC.%26aulast%3DPrezhdo%26aufirst%3DM.%26atitle%3DRhodanine%2520derivatives%2520as%2520inhibitors%2520of%2520JSP-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3374%26epage%3D3379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Gualtieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastide, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villain-Guillot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaux-Charachon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latouche, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, J. P.</span><span> </span><span class="NLM_article-title">In vitro activity of a new antibacterial rhodanine derivative against <i>Staphylococcus epidermidis</i> biofilms</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1093%2Fjac%2Fdkl314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16880176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1yjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=778-783&author=M.+Gualtieriauthor=L.+Bastideauthor=P.+Villain-Guillotauthor=S.+Michaux-Charachonauthor=J.+Latoucheauthor=J.+P.+Leonetti&title=In+vitro+activity+of+a+new+antibacterial+rhodanine+derivative+against+Staphylococcus+epidermidis+biofilms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms</span></div><div class="casAuthors">Gualtieri, Maxime; Bastide, Lionel; Villain-Guillot, Philippe; Michaux-Charachon, Sylvie; Latouche, Jaqueline; Leonetti, Jean-Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">778-783</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Staphylococcus epidermidis biofilms form at the surface of implants and prostheses and are responsible for the failure of many antibiotic therapies.  Only a few antibiotics are relatively active against biofilms, and rifampicin, a transcription inhibitor, is among the most effective mols. for treating biofilm-related infections.  Having recently selected a new potential transcription inhibitor, the authors attempted to evaluate its efficacy against S. epidermidis biofilms.  Biofilm-forming S. epidermidis strains were grown planktonically or as biofilms and their susceptibility to this transcription inhibitor was compared with ref. antibiotics with different mechanisms of action.  These results demonstrate that this new mol. is active; its effects are fast and kinetically related to those of rifampicin, but unlike rifampicin it does not select for resistant bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTpWNPN_05S7Vg90H21EOLACvtfcHk0li2koH2mQeROg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1yjsb4%253D&md5=40e13bdcf90673171a4dd6cf38ee1976</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkl314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkl314%26sid%3Dliteratum%253Aachs%26aulast%3DGualtieri%26aufirst%3DM.%26aulast%3DBastide%26aufirst%3DL.%26aulast%3DVillain-Guillot%26aufirst%3DP.%26aulast%3DMichaux-Charachon%26aufirst%3DS.%26aulast%3DLatouche%26aufirst%3DJ.%26aulast%3DLeonetti%26aufirst%3DJ.%2BP.%26atitle%3DIn%2520vitro%2520activity%2520of%2520a%2520new%2520antibacterial%2520rhodanine%2520derivative%2520against%2520Staphylococcus%2520epidermidis%2520biofilms%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2006%26volume%3D58%26spage%3D778%26epage%3D783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Hu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S. Q.</span><span> </span><span class="NLM_article-title">In situ “click” assembly of small molecule matrix metalloprotease inhibitors containing zinc-chelating groups</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">5529</span><span class="NLM_x">–</span> <span class="NLM_lpage">5531</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol802286g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=5529-5531&author=M.+Huauthor=J.+Liauthor=S.+Q.+Yao&title=In+situ+%E2%80%9Cclick%E2%80%9D+assembly+of+small+molecule+matrix+metalloprotease+inhibitors+containing+zinc-chelating+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fol802286g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol802286g%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DS.%2BQ.%26atitle%3DIn%2520situ%2520%25E2%2580%259Cclick%25E2%2580%259D%2520assembly%2520of%2520small%2520molecule%2520matrix%2520metalloprotease%2520inhibitors%2520containing%2520zinc-chelating%2520groups%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D5529%26epage%3D5531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Irvine, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kewney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastings, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKenzie, S. J.</span><span> </span><span class="NLM_article-title">Rhodanine derivatives as novel inhibitors of PDE4</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2032</span><span class="NLM_x">–</span> <span class="NLM_lpage">2037</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2032-2037&author=M.+W.+Irvineauthor=G.+L.+Patrickauthor=J.+Kewneyauthor=S.+F.+Hastingsauthor=S.+J.+MacKenzie&title=Rhodanine+derivatives+as+novel+inhibitors+of+PDE4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DPatrick%26aufirst%3DG.%2BL.%26aulast%3DKewney%26aufirst%3DJ.%26aulast%3DHastings%26aufirst%3DS.%2BF.%26aulast%3DMacKenzie%26aufirst%3DS.%2BJ.%26atitle%3DRhodanine%2520derivatives%2520as%2520novel%2520inhibitors%2520of%2520PDE4%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2032%26epage%3D2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Johnson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbach, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savinov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strongin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiney, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellecchia, M.</span><span> </span><span class="NLM_article-title">Rhodanine derivatives as selective protease inhibitors against bacterial toxins</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1747-0285.2007.00617.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18221310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFSntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=131-139&author=S.+L.+Johnsonauthor=L.+H.+Chenauthor=R.+Harbachauthor=M.+Sabetauthor=A.+Savinovauthor=N.+J.+Cottonauthor=A.+Stronginauthor=D.+Guineyauthor=M.+Pellecchia&title=Rhodanine+derivatives+as+selective+protease+inhibitors+against+bacterial+toxins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodanine derivatives as selective protease inhibitors against bacterial toxins</span></div><div class="casAuthors">Johnson, Sherida L.; Chen, Li-Hsing; Harbach, Rebecca; Sabet, Mojgan; Savinov, Alexei; Cotton, Naomi J. H.; Strongin, Alex; Guiney, Donald; Pellecchia, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-139</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A series of rhodanine derivs. were analyzed as potential inhibitors of bacterial toxins, namely the proteases anthrax lethal factor and the botulinum neurotoxin type A.  An extensive structure-activity relation study on rhodanine derivs. was conducted and selectivity was profiled against the two bacterial toxins and two related human metalloproteases using in vitro assays.  In addn., initial in vitro ADME-Tox properties of selected compds. and their ability to protect lethal factor-induced cell death of macrophages were examd.  These data allowed the selection of one addnl. drug candidate for which preliminary in vivo efficacy studies against anthrax spores were conducted.  Integration of these results with structure-activity relation studies provides a framework for the development of potential drug candidates against anthrax and botulinum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozA5v4ZIgxNbVg90H21EOLACvtfcHk0lgiEvPwdsJ32A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFSntbc%253D&md5=a067d72fa74e517cfbd9f7220a68f5ee</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00617.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00617.x%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DL.%2BH.%26aulast%3DHarbach%26aufirst%3DR.%26aulast%3DSabet%26aufirst%3DM.%26aulast%3DSavinov%26aufirst%3DA.%26aulast%3DCotton%26aufirst%3DN.%2BJ.%26aulast%3DStrongin%26aufirst%3DA.%26aulast%3DGuiney%26aufirst%3DD.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DRhodanine%2520derivatives%2520as%2520selective%2520protease%2520inhibitors%2520against%2520bacterial%2520toxins%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2008%26volume%3D71%26spage%3D131%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Kumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parasuraman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karmodiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surolia, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surolia, A.</span><span> </span><span class="NLM_article-title">Discovery of a rhodanine class of compounds as inhibitors of <i>Plasmodium falciparum</i> enoyl-acyl carrier protein reductase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2665</span><span class="NLM_x">–</span> <span class="NLM_lpage">2675</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061257w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2665-2675&author=G.+Kumarauthor=P.+Parasuramanauthor=S.+K.+Sharmaauthor=T.+Banerjeeauthor=K.+Karmodiyaauthor=N.+Suroliaauthor=A.+Surolia&title=Discovery+of+a+rhodanine+class+of+compounds+as+inhibitors+of+Plasmodium+falciparum+enoyl-acyl+carrier+protein+reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fjm061257w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061257w%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DG.%26aulast%3DParasuraman%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DBanerjee%26aufirst%3DT.%26aulast%3DKarmodiya%26aufirst%3DK.%26aulast%3DSurolia%26aufirst%3DN.%26aulast%3DSurolia%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520rhodanine%2520class%2520of%2520compounds%2520as%2520inhibitors%2520of%2520Plasmodium%2520falciparum%2520enoyl-acyl%2520carrier%2520protein%2520reductase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2665%26epage%3D2675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorronsoro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelpi, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. J.</span><span> </span><span class="NLM_article-title">SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7103</span><span class="NLM_x">–</span> <span class="NLM_lpage">7112</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040895g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyjt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7103-7112&author=A.+Martinezauthor=M.+Alonsoauthor=A.+Castroauthor=I.+Dorronsoroauthor=J.+L.+Gelpiauthor=F.+J.+Luqueauthor=C.+Perezauthor=F.+J.+Moreno&title=SAR+and+3D-QSAR+studies+on+thiadiazolidinone+derivatives%3A+exploration+of+structural+requirements+for+glycogen+synthase+kinase+3+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">SAR and 3D-QSAR Studies on Thiadiazolidinone Derivatives: Exploration of Structural Requirements for Glycogen Synthase Kinase 3 Inhibitors</span></div><div class="casAuthors">Martinez, Ana; Alonso, Mercedes; Castro, Ana; Dorronsoro, Isabel; Gelpi, J. Luis; Luque, F. Javier; Perez, Concepcion; Moreno, Francisco J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7103-7112</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 2,4-disubstituted thiadiazolidinones (TDZD) are described as the first ATP-noncompetitive GSK-3 inhibitors.  Following an SAR study about TDZD, different structural modifications in the heterocyclic ring aimed to test the influence of each heteroatom on the biol. study are here reported here.  Various compds. such as hydantoins, dithiazolidindiones, rhodanines, maleimides, and triazoles were synthesized and screened as GSK-3 inhibitors.  After an extensive SAR study among these different heterocyclic families, TDZDs have been revealed as a privileged scaffold for the selective inhibition of GSK-3.  A Co-MFA anal. was also performed highlighting the mol. electrostatic field interaction in the interaction of TDZDs with GSK-3.  Moreover, first mapping studies indicate two binding modes which in turn might imply relevant differences in the mechanism that underly the inhibitory activity of TDZDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUQ6m_G-n_WLVg90H21EOLACvtfcHk0lh4pkmUs8jQWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyjt73O&md5=35b315178d5e518a64b7a2670d41d27b</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fjm040895g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040895g%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DDorronsoro%26aufirst%3DI.%26aulast%3DGelpi%26aufirst%3DJ.%2BL.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMoreno%26aufirst%3DF.%2BJ.%26atitle%3DSAR%2520and%25203D-QSAR%2520studies%2520on%2520thiadiazolidinone%2520derivatives%253A%2520exploration%2520of%2520structural%2520requirements%2520for%2520glycogen%2520synthase%2520kinase%25203%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7103%26epage%3D7112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Russell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redfield, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurieri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, E.</span><span> </span><span class="NLM_article-title">Selective small molecule inhibitors of the potential breast cancer marker, human arylamine <i>N</i>-acetyltransferase 1, and its murine homologue, mouse arylamine <i>N</i>-acetyltransferase 2</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=905-918&author=A.+J.+Russellauthor=I.+M.+Westwoodauthor=M.+H.+Crawfordauthor=J.+Robinsonauthor=A.+Kawamuraauthor=C.+Redfieldauthor=N.+Laurieriauthor=E.+D.+Loweauthor=S.+G.+Daviesauthor=E.+Sim&title=Selective+small+molecule+inhibitors+of+the+potential+breast+cancer+marker%2C+human+arylamine+N-acetyltransferase+1%2C+and+its+murine+homologue%2C+mouse+arylamine+N-acetyltransferase+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DCrawford%26aufirst%3DM.%2BH.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DRedfield%26aufirst%3DC.%26aulast%3DLaurieri%26aufirst%3DN.%26aulast%3DLowe%26aufirst%3DE.%2BD.%26aulast%3DDavies%26aufirst%3DS.%2BG.%26aulast%3DSim%26aufirst%3DE.%26atitle%3DSelective%2520small%2520molecule%2520inhibitors%2520of%2520the%2520potential%2520breast%2520cancer%2520marker%252C%2520human%2520arylamine%2520N-acetyltransferase%25201%252C%2520and%2520its%2520murine%2520homologue%252C%2520mouse%2520arylamine%2520N-acetyltransferase%25202%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D905%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Villain-Guillot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualtieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastide, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roquet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amblard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pugniere, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, J. P.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4195</span><span class="NLM_x">–</span> <span class="NLM_lpage">4204</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0703183" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4195-4204&author=P.+Villain-Guillotauthor=M.+Gualtieriauthor=L.+Bastideauthor=F.+Roquetauthor=J.+Martinezauthor=M.+Amblardauthor=M.+Pugniereauthor=J.+P.+Leonetti&title=Structure%E2%80%93activity+relationships+of+phenyl-furanyl-rhodanines+as+inhibitors+of+RNA+polymerase+with+antibacterial+activity+on+biofilms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1021%2Fjm0703183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703183%26sid%3Dliteratum%253Aachs%26aulast%3DVillain-Guillot%26aufirst%3DP.%26aulast%3DGualtieri%26aufirst%3DM.%26aulast%3DBastide%26aufirst%3DL.%26aulast%3DRoquet%26aufirst%3DF.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DAmblard%26aufirst%3DM.%26aulast%3DPugniere%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DJ.%2BP.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520phenyl-furanyl-rhodanines%2520as%2520inhibitors%2520of%2520RNA%2520polymerase%2520with%2520antibacterial%2520activity%2520on%2520biofilms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4195%26epage%3D4204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Zervosen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, T. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frere, J. M.</span><span> </span><span class="NLM_article-title">Interactions between penicillin-binding proteins (PBPs) and two novel classes of PBP inhibitors, arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-ones</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1128%2FAAC.48.3.961-969.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=14982790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitVGhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=961-969&author=A.+Zervosenauthor=W.+P.+Luauthor=Z.+Chenauthor=R.+E.+Whiteauthor=T.+P.+Demuthauthor=J.+M.+Frere&title=Interactions+between+penicillin-binding+proteins+%28PBPs%29+and+two+novel+classes+of+PBP+inhibitors%2C+arylalkylidene+rhodanines+and+arylalkylidene+iminothiazolidin-4-ones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions between penicillin-binding proteins (PBPs) and two novel classes of PBP inhibitors, arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-ones</span></div><div class="casAuthors">Zervosen, Astrid; Lu, Wei-Ping; Chen, Zhouliang; White, Ronald E.; Demuth, Thomas P., Jr.; Frere, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">961-969</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Several non-β-lactam compds. were active against various gram-pos. and gram-neg. bacterial strains.  The MICs of arylalkylidene rhodanines, e.g. I and II, and arylalkylidene iminothiazolidin-4-ones, e.g. III and IV, were lower than those of ampicillin and cefotaxime for methicillin-resistant Staphylococcus aureus MI339 and vancomycin-resistant Enterococcus faecium EF12.  Several compds. were found to inhibit the cell wall synthesis of S. aureus and the last two steps of peptidoglycan biosynthesis catalyzed by ether-treated cells of Escherichia coli or cell wall membrane prepns. of Bacillus megaterium.  The effects of the arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-one derivs. on E. coli PBP 3 and PBP 5, Streptococcus pneumoniae PBP 2xS (PBP 2x from a penicillin-sensitive strain) and PBP 2xR (PBP 2x from a penicillin-resistant strain), low-affinity PBP 2a of S. aureus, and the Actinomadura sp. strain R39 and Streptomyces sp. strain R61 DD-peptidases were studied.  Some of the compds. exhibited inhibitory activities in the 10 to 100 μM concn. range.  The inhibition of PBP 2xS by several of them appeared to be noncompetitive.  The dissocn. const. for the best inhibitor (Ki = 10 μM) was not influenced by the presence of the substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY1OMwCnBRtrVg90H21EOLACvtfcHk0lh4pkmUs8jQWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitVGhtL0%253D&md5=28a82402adeeb97c9e56fd92625d457e</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.3.961-969.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.3.961-969.2004%26sid%3Dliteratum%253Aachs%26aulast%3DZervosen%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DW.%2BP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWhite%26aufirst%3DR.%2BE.%26aulast%3DDemuth%26aufirst%3DT.%2BP.%26aulast%3DFrere%26aufirst%3DJ.%2BM.%26atitle%3DInteractions%2520between%2520penicillin-binding%2520proteins%2520%2528PBPs%2529%2520and%2520two%2520novel%2520classes%2520of%2520PBP%2520inhibitors%252C%2520arylalkylidene%2520rhodanines%2520and%2520arylalkylidene%2520iminothiazolidin-4-ones%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D961%26epage%3D969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Carlson, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiessling, L. L.</span><span> </span><span class="NLM_article-title">Chemical probes of UDP-galactopyranose mutase</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.chembiol.2006.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16931332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD28XoslOhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=825-837&author=E.+E.+Carlsonauthor=J.+F.+Mayauthor=L.+L.+Kiessling&title=Chemical+probes+of+UDP-galactopyranose+mutase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Probes of UDP-Galactopyranose Mutase</span></div><div class="casAuthors">Carlson, Erin E.; May, John F.; Kiessling, Laura L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">825-837</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Many pathogenic prokaryotes and eukaryotes possess the machinery required to assemble galactofuranose (Galf)-contg. glycoconjugates; these glycoconjugates can be crit. for virulence or viability.  Accordingly, compds. that block Galf incorporation may serve as therapeutic leads or as probes of the function of Galf-contg. glycoconjugates.  The enzyme UDP-galactopyranose mutase (UGM) is the only known generator of UDP-galactofuranose, the precursor to Galf residues.  We previously employed a high-throughput fluorescence polarization assay to investigate the Klebsiella pneumoniae UGM.  We demonstrate the generality of this assay by extending it to UGM from Mycobacterium tuberculosis.  To identify factors influencing binding, we synthesized a directed library contg. a 5-arylidene-2-thioxo-4-thiazolidinone core, a structure possessing features common to ligands for both homologs.  Our studies offer a blueprint for identifying inhibitors of the growing family of UGM homologs and provide insight into UGM inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8RQO7mDu8VrVg90H21EOLACvtfcHk0lj5EihHpDwtNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XoslOhurc%253D&md5=e2bcbf65928d3d4ddaa15975a6d7639c</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2006.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2006.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26aulast%3DMay%26aufirst%3DJ.%2BF.%26aulast%3DKiessling%26aufirst%3DL.%2BL.%26atitle%3DChemical%2520probes%2520of%2520UDP-galactopyranose%2520mutase%26jtitle%3DChem.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D825%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Hotta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akanuma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shichiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeta, Y.</span><span> </span><span class="NLM_article-title">Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative aldose reductase inhibitor-diabetes complications trial</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1538</span><span class="NLM_x">–</span> <span class="NLM_lpage">1544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=1538-1544&author=N.+Hottaauthor=Y.+Akanumaauthor=R.+Kawamoriauthor=K.+Matsuokaauthor=Y.+Okaauthor=M.+Shichiriauthor=T.+Toyotaauthor=M.+Nakashimaauthor=I.+Yoshimuraauthor=N.+Sakamotoauthor=Y.+Shigeta&title=Long-term+clinical+effects+of+epalrestat%2C+an+aldose+reductase+inhibitor%2C+on+diabetic+peripheral+neuropathy%3A+the+3-year%2C+multicenter%2C+comparative+aldose+reductase+inhibitor-diabetes+complications+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHotta%26aufirst%3DN.%26aulast%3DAkanuma%26aufirst%3DY.%26aulast%3DKawamori%26aufirst%3DR.%26aulast%3DMatsuoka%26aufirst%3DK.%26aulast%3DOka%26aufirst%3DY.%26aulast%3DShichiri%26aufirst%3DM.%26aulast%3DToyota%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DM.%26aulast%3DYoshimura%26aufirst%3DI.%26aulast%3DSakamoto%26aufirst%3DN.%26aulast%3DShigeta%26aufirst%3DY.%26atitle%3DLong-term%2520clinical%2520effects%2520of%2520epalrestat%252C%2520an%2520aldose%2520reductase%2520inhibitor%252C%2520on%2520diabetic%2520peripheral%2520neuropathy%253A%2520the%25203-year%252C%2520multicenter%252C%2520comparative%2520aldose%2520reductase%2520inhibitor-diabetes%2520complications%2520trial%26jtitle%3DDiabetes%2520Care%26date%3D2006%26volume%3D29%26spage%3D1538%26epage%3D1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Sturm, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levstik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristl, A.</span><span> </span><span class="NLM_article-title">Permeability characteristics of novel aldose reductase inhibitors using rat jejunum in vitro</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.ejps.2006.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16497491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ChtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2006&pages=128-133&author=K.+Sturmauthor=L.+Levstikauthor=V.+J.+Demopoulosauthor=A.+Kristl&title=Permeability+characteristics+of+novel+aldose+reductase+inhibitors+using+rat+jejunum+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Permeability characteristics of novel aldose reductase inhibitors using rat jejunum in vitro</span></div><div class="casAuthors">Sturm, Katja; Levstik, Lea; Demopoulos, Vassilis J.; Kristl, Albin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">128-133</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The aim of this study was to est. in vivo permeability and bioavailability of epalrestat and newly synthesized compds. with possible therapeutic activity as aldose enzyme inhibitors (ARIs).  For this purpose permeability in vitro using rat jejunum mounted in side-by-side diffusion cells was detd.  Tested substances were found to be low and moderately permeable and some of them were also substrates for efflux transporters.  It was shown, that the higher efflux for some derivs. was due to MRP-2, but not Pgp involvement.  Tested ARIs do not share the same efflux transporter with epalrestat, the only ARI currently on the market in Japan.  The most permeable compd., a 2,6-difluoro-4-pyrrol-1ylphenol deriv., is not a substrate for efflux transporters and would therefore be the most promising lead compd. for further investigation of potent ARIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3QgzqMrZmXbVg90H21EOLACvtfcHk0lj5EihHpDwtNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ChtLo%253D&md5=7feaf11b668fb9877d7aa6419cb25c42</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2006.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2006.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DSturm%26aufirst%3DK.%26aulast%3DLevstik%26aufirst%3DL.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26aulast%3DKristl%26aufirst%3DA.%26atitle%3DPermeability%2520characteristics%2520of%2520novel%2520aldose%2520reductase%2520inhibitors%2520using%2520rat%2520jejunum%2520in%2520vitro%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D28%26spage%3D128%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Necula, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C. G.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">10311</span><span class="NLM_x">–</span> <span class="NLM_lpage">10324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1074%2Fjbc.M608207200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17284452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs1Sitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=10311-10324&author=M.+Neculaauthor=R.+Kayedauthor=S.+Miltonauthor=C.+G.+Glabe&title=Small+molecule+inhibitors+of+aggregation+indicate+that+amyloid+beta+oligomerization+and+fibrillization+pathways+are+independent+and+distinct"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct</span></div><div class="casAuthors">Necula, Mihaela; Kayed, Rakez; Milton, Saskia; Glabe, Charles G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">10311-10324</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Alzheimer disease is characterized by the abnormal aggregation of amyloid β peptide into extracellular fibrillar deposits known as amyloid plaques.  Sol. oligomers have been obsd. at early time points preceding fibril formation, and these oligomers have been implicated as the primary pathol. species rather than the mature fibrils.  A significant issue that remains to be resolved is whether amyloid oligomers are an obligate intermediate on the pathway to fibril formation or represent an alternate assembly pathway that may or may not lead to fiber formation.  To det. whether amyloid β oligomers are obligate intermediates in the fibrillization pathway, we characterized the mechanism of action of amyloid β aggregation inhibitors in terms of oligomer and fibril formation.  Based on their effects, the small mols. segregated into three distinct classes: compds. that inhibit oligomerization but not fibrillization, compds. that inhibit fibrillization but not oligomerization, and compds. that inhibit both.  Several compds. selectively inhibited oligomerization at substoichiometric concns. relative to amyloid β monomer, with some active in the low nanomolar range.  These results indicate that oligomers are not an obligate intermediate in the fibril formation pathway.  In addn., these data suggest that small mol. inhibitors are useful for clarifying the mechanisms underlying protein aggregation and may represent potential therapeutic agents that target fundamental disease mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1wCvf_-f5QLVg90H21EOLACvtfcHk0lj5EihHpDwtNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs1Sitb4%253D&md5=094771ea07dedf90832f09fce28cca7d</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M608207200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M608207200%26sid%3Dliteratum%253Aachs%26aulast%3DNecula%26aufirst%3DM.%26aulast%3DKayed%26aufirst%3DR.%26aulast%3DMilton%26aufirst%3DS.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520aggregation%2520indicate%2520that%2520amyloid%2520beta%2520oligomerization%2520and%2520fibrillization%2520pathways%2520are%2520independent%2520and%2520distinct%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D10311%26epage%3D10324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larbig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khlistunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coksezen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">10016</span><span class="NLM_x">–</span> <span class="NLM_lpage">10023</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi700878g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=10016-10023&author=M.+Pickhardtauthor=G.+Larbigauthor=I.+Khlistunovaauthor=A.+Coksezenauthor=B.+Meyerauthor=E.+M.+Mandelkowauthor=B.+Schmidtauthor=E.+Mandelkow&title=Phenylthiazolyl-hydrazide+and+its+derivatives+are+potent+inhibitors+of+tau+aggregation+and+toxicity+in+vitro+and+in+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fbi700878g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi700878g%26sid%3Dliteratum%253Aachs%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DLarbig%26aufirst%3DG.%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DCoksezen%26aufirst%3DA.%26aulast%3DMeyer%26aufirst%3DB.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DPhenylthiazolyl-hydrazide%2520and%2520its%2520derivatives%2520are%2520potent%2520inhibitors%2520of%2520tau%2520aggregation%2520and%2520toxicity%2520in%2520vitro%2520and%2520in%2520cells%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D10016%26epage%3D10023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Taghavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyny-von Haussen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title"><i>N</i>′-Benzylidene-benzohydrazides as novel and selective tau-PHF ligands</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=21891864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Sls7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2011&pages=835-843&author=A.+Taghaviauthor=S.+Nasirauthor=M.+Pickhardtauthor=R.+Heyny-von+Haussenauthor=G.+Mallauthor=E.+Mandelkowauthor=E.+M.+Mandelkowauthor=B.+Schmidt&title=N%E2%80%B2-Benzylidene-benzohydrazides+as+novel+and+selective+tau-PHF+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">N'-Benzylidene-Benzohydrazides as Novel and Selective Tau-PHF Ligands</span></div><div class="casAuthors">Taghavi, Ali; Nasir, Samir; Pickhardt, Marcus; Heyny-von Haussen, Roland; Mall, Gerhard; Mandelkow, Eckhard; Mandelkow, Eva-Maria; Schmidt, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">835-843</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The structure activity relationship of N'-benzylidene-benzohydrazide (NBB) binding to tau and paired helical filament (PHF) proteins as well as amyloid-β1-42 fibrils indicate differential selectivity for these protein aggregates.  The ability of the compds. to stain neurofibrillary tangles and senile plaques isolated from human AD brain was investigated histochem.  These studies resulted in several tau-PHF and amyloid-β1-42 fibril selective ligands resp.  Supported by these results, we rationalized a model for the design of selective ligands for tau, PHF, and amyloid-β1-42 fibrils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmUckFrrYIfbVg90H21EOLACvtfcHk0lilSPUssWNMaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Sls7bF&md5=6a91548633b7d72a0c439f32bcc3af5a</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaghavi%26aufirst%3DA.%26aulast%3DNasir%26aufirst%3DS.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DHeyny-von%2BHaussen%26aufirst%3DR.%26aulast%3DMall%26aufirst%3DG.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DN%25E2%2580%25B2-Benzylidene-benzohydrazides%2520as%2520novel%2520and%2520selective%2520tau-PHF%2520ligands%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D27%26spage%3D835%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Vijaya Raj, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayana, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashalatha, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchetha Kumari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarojini, B. K.</span><span> </span><span class="NLM_article-title">Synthesis of some bioactive 2-bromo-5-methoxy-<i>N</i>′-[4-(aryl)-1,3-thiazol-2-yl]benzohydrazide derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=425-429&author=K.+K.+Vijaya+Rajauthor=B.+Narayanaauthor=B.+V.+Ashalathaauthor=N.+Suchetha+Kumariauthor=B.+K.+Sarojini&title=Synthesis+of+some+bioactive+2-bromo-5-methoxy-N%E2%80%B2-%5B4-%28aryl%29-1%2C3-thiazol-2-yl%5Dbenzohydrazide+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVijaya%2BRaj%26aufirst%3DK.%2BK.%26aulast%3DNarayana%26aufirst%3DB.%26aulast%3DAshalatha%26aufirst%3DB.%2BV.%26aulast%3DSuchetha%2BKumari%26aufirst%3DN.%26aulast%3DSarojini%26aufirst%3DB.%2BK.%26atitle%3DSynthesis%2520of%2520some%2520bioactive%25202-bromo-5-methoxy-N%25E2%2580%25B2-%255B4-%2528aryl%2529-1%252C3-thiazol-2-yl%255Dbenzohydrazide%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D425%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Sonar, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P. A.</span><span> </span><span class="NLM_article-title">Synthesis and antitubercular activity of a series of hydrazone and nitrovinyl analogs derived from heterocyclic aldehydes</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1080%2F14756360801915526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18629678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=117-124&author=V.+N.+Sonarauthor=P.+A.+Crooks&title=Synthesis+and+antitubercular+activity+of+a+series+of+hydrazone+and+nitrovinyl+analogs+derived+from+heterocyclic+aldehydes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antitubercular activity of a series of hydrazone and nitrovinyl analogs derived from heterocyclic aldehydes</span></div><div class="casAuthors">Sonar, Vijayakumar N.; Crooks, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A series of hydrazone and 3-nitrovinyl analogs of indole-3-carboxaldehydes and related compds. were synthesized and screened for antitubercular activity against Mycobacterium tuberculosis H37RV in BACTEC 12B medium using the Microplate Alamar Blue Assay (MABA).  Several compds. showed inhibitory activity against M. tuberculosis in primary screening assays at a concn. of 6.25 μg/mL; subsequent dose-response studies indicated that the most active compds., 3d, 3e & 8b, had IC50 values of 5.96, 5.4 & 1.6 μg/mL, resp.  These compds. represent potential leads for the further development of novel antitubercular agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyruFNE4xxHbVg90H21EOLACvtfcHk0lilSPUssWNMaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSqu74%253D&md5=ce808ff81ae509ba5e18c86f9bd70818</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1080%2F14756360801915526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756360801915526%26sid%3Dliteratum%253Aachs%26aulast%3DSonar%26aufirst%3DV.%2BN.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26atitle%3DSynthesis%2520and%2520antitubercular%2520activity%2520of%2520a%2520series%2520of%2520hydrazone%2520and%2520nitrovinyl%2520analogs%2520derived%2520from%2520heterocyclic%2520aldehydes%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2009%26volume%3D24%26spage%3D117%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Hafez, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Gazzar, A. B.</span><span> </span><span class="NLM_article-title">Design and synthesis of 3-pyrazolyl-thiophene, thieno[2,3-<i>d</i>]pyrimidines as new bioactive and pharmacological activities</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5222</span><span class="NLM_x">–</span> <span class="NLM_lpage">5227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5222-5227&author=H.+N.+Hafezauthor=A.+B.+El-Gazzar&title=Design+and+synthesis+of+3-pyrazolyl-thiophene%2C+thieno%5B2%2C3-d%5Dpyrimidines+as+new+bioactive+and+pharmacological+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHafez%26aufirst%3DH.%2BN.%26aulast%3DEl-Gazzar%26aufirst%3DA.%2BB.%26atitle%3DDesign%2520and%2520synthesis%2520of%25203-pyrazolyl-thiophene%252C%2520thieno%255B2%252C3-d%255Dpyrimidines%2520as%2520new%2520bioactive%2520and%2520pharmacological%2520activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5222%26epage%3D5227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. S.</span><span> </span><span class="NLM_article-title">In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1890</span><span class="NLM_x">–</span> <span class="NLM_lpage">1899</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800185b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvFSls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1890-1899&author=R.+S.+Obachauthor=A.+S.+Kalgutkarauthor=T.+F.+Ryderauthor=G.+S.+Walker&title=In+vitro+metabolism+and+covalent+binding+of+enol-carboxamide+derivatives+and+anti-inflammatory+agents+sudoxicam+and+meloxicam%3A+insights+into+the+hepatotoxicity+of+sudoxicam"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Metabolism and Covalent Binding of Enol-Carboxamide Derivatives and Anti-Inflammatory Agents Sudoxicam and Meloxicam: Insights into the Hepatotoxicity of Sudoxicam</span></div><div class="casAuthors">Obach, R. Scott; Kalgutkar, Amit S.; Ryder, Tim F.; Walker, Gregory S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1890-1899</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sudoxicam and meloxicam are nonsteroidal anti-inflammatory drugs (NSAIDs) from the enol-carboxamide class.  While the only structural difference between the two NSAIDs is the presence of a Me group on the C5-position of the 2-carboxamidothiazole motif in meloxicam, a marked difference in their toxicol. profile in humans has been discerned.  In clin. trials, sudoxicam was assocd. with several cases of severe hepatotoxicity that led to its discontinuation, while meloxicam has been in the market for over a decade and is devoid of hepatotoxicity.  In an attempt to understand the biochem. basis for the differences in safety profile, an in vitro investigation of the metabolic pathways and covalent binding of the two NSAIDs was conducted in NADPH-supplemented human liver microsomes.  Both compds. demonstrated NADPH-dependent covalent binding to human liver microsomes; however, the extent of binding of [14C]-meloxicam was ∼2-fold greater than that of [14C]-sudoxicam.  While inclusion of glutathione (GSH) in microsomal incubations resulted in a decrease in covalent binding for both NSAIDs, the redn. in binding was more pronounced for meloxicam.  Metabolite identification studies on [14C]-sudoxicam in NADPH-supplemented human liver microsomes indicated that the primary route of metab. involved a P 450-mediated thiazole ring scission to the corresponding acylthiourea metabolite (S3), a well-established pro-toxin.  The mechanism of formation of S3 presumably proceeds via (a) epoxidn. of the C4-C5-thiazole ring double bond, (b) epoxide hydrolysis to the corresponding thiazole-4,5-dihydrodiol deriv., which was obsd. as a stable metabolite (S2), (c) ring opening of the thiazole-4,5-dihydrodiol to an 2-oxoethylidene thiourea intermediate, and (d) hydrolysis of the imine bond within this intermediate to yield S3.  In the case of meloxicam, the corresponding acylthiourea metabolite M3 was also obsd., but to a lesser extent; the main route of meloxicam metab. involved hydroxylation of the 5'-Me group, a finding that is consistent with the known metabolic fate of this NSAID.  Inclusion of GSH led to a decrease in the formation of M3 with the concomitant formation of an unusual two-electron redn. product (metabolite M7).  The formation of M7 is proposed to arise via redn. of the imine bond in 2-oxopropylidene thiourea, an intermediate in the thiazole ring scission pathway in meloxicam.  In conclusion, the results of our anal. suggest that if the covalent binding of the two NSAIDs is important to the overall hepatotoxicity risk, the differences in metab. (differential preponderance of formation of the acylthiourea relative to total metab.), differential effects of GSH on covalent binding, and finally differences in daily doses of the two NSAIDs may serve as a plausible explanation for the marked differences in toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr41ErheTuDvLVg90H21EOLACvtfcHk0ljj4_bWRib2rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvFSls7o%253D&md5=af142bb2df6107277dcbbb82b0907c21</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1021%2Ftx800185b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800185b%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DRyder%26aufirst%3DT.%2BF.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26atitle%3DIn%2520vitro%2520metabolism%2520and%2520covalent%2520binding%2520of%2520enol-carboxamide%2520derivatives%2520and%2520anti-inflammatory%2520agents%2520sudoxicam%2520and%2520meloxicam%253A%2520insights%2520into%2520the%2520hepatotoxicity%2520of%2520sudoxicam%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1890%26epage%3D1899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Preziosi, P.</span><span> </span><span class="NLM_article-title">Isoniazid: metabolic aspects and toxicological correlates</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.2174%2F138920007782798216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18220565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVahtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=839-851&author=P.+Preziosi&title=Isoniazid%3A+metabolic+aspects+and+toxicological+correlates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Isoniazid: metabolic aspects and toxicological correlates</span></div><div class="casAuthors">Preziosi, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">839-851</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For over half a century, pyridine-4-carboxy hydrazide (isonicotinyl hydrazide; isoniazid - INH) has been a front-line weapon in the battle against tuberculosis.  Its metab. has been the subject of important research, much of which has focused on the pharmacodynamic and toxicol. aspects of certain INH metabolites.  Since 1952, when the drug was first introduced, multiple INH metabolites have been identified, including hydrazine (HZ), isonicotinic acid (INA), ammonia, the acetylated deriv. N1-acetyl-N2-isonicotinylhydrazide (AcINH), hydrazones with pyruvic and ketoglutaric acids (INH-PA and INH-KA, resp.), monoacetylhydrazine (AcHZ), diacetylhydrazine (DiAcHZ), and oxidizing free radicals.  Their formation is the result of hydrolysis (INA, HZ), cytochrome P 450 (CYP)-dependent oxidn. (HZ, NH3, oxidizing free radicals), and N-acetyltransferase (NAT) activity (AcINH, AcHZ, DiAcHZ).  Doubts remain about isonicotinamide (INAAM) as an INH metabolite in mammals.  Quant. speaking, one of the major metabolites is AcINH, which is produced by the enzyme NAT.  It has virtually no antitubercular activity and is far less toxic than INH.  Its formation and elimination are genetically controlled, and its elimination profile is trimodal (rapid, intermediate, and slow acetylation).  Slow acetylation, which is transmitted as an autosomal recessive trait, increases the risk for peripheral neurotoxicity and hepatotoxicity in INH users.  Thus far, there is no conclusive pharmacogenetic evidence that the formation of HZ and oxidizing radicals are linked to CYP polymorphisms.  This article examines INH, HZ and its mono- and diacetylated metabolites, and ammonia (which in vitro and in vivo studies indicate as another deriv. of HZ) in terms of their potential to cause neurotoxic and hepatotoxic effects (the two major forms of INH toxicity obsd. in animals and humans).  INH hepatotoxicity seems to be related mainly to HZ, AcHZ, and other HZ metabolites that are capable of generating free radicals.  The pathol. aspects of slow INH acetylation will be discussed in relation to the drug's hepato- and neurotoxic effects.  The mechanism underlying INH neurotoxicity has yet to be fully defined.  The metabolite(s) involved in this phenomenon remain obscure although a major role is clearly played by HZ (and possibly also by the ammonia it releases).  There is some evidence of the involvement of γ-glutamyl HZ and of a chem. analog of a Schiff base formed by INH and pyridoxal-phosphate.  Recent findings have also revealed important interactions between INH and the various isoforms of CYP, and these may play a role in clin. relevant interactions between INH and several other drugs.  All of these aspects of INH will be covered in the review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPwlruMxT4sbVg90H21EOLACvtfcHk0ljj4_bWRib2rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVahtrrJ&md5=e567918ae0ed2b1f527a243c87883f37</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.2174%2F138920007782798216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920007782798216%26sid%3Dliteratum%253Aachs%26aulast%3DPreziosi%26aufirst%3DP.%26atitle%3DIsoniazid%253A%2520metabolic%2520aspects%2520and%2520toxicological%2520correlates%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2007%26volume%3D8%26spage%3D839%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Timmins, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deretic, V.</span><span> </span><span class="NLM_article-title">Mechanisms of action of isoniazid</span> <span class="citation_source-journal">Mol. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1220</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1365-2958.2006.05467.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17074073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlenu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=1220-1227&author=G.+S.+Timminsauthor=V.+Deretic&title=Mechanisms+of+action+of+isoniazid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of action of isoniazid</span></div><div class="casAuthors">Timmins, Graham S.; Deretic, Vojo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1220-1227</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  For decades after its introduction, the mechanisms of action of the front-line antituberculosis therapeutic agent isoniazid (INH) remained unclear.  Recent developments have shown that peroxidative activation of isoniazid by the mycobacterial enzyme KatG generates reactive species that form adducts with NAD+ and NADP+ that are potent inhibitors of lipid and nucleic acid biosynthetic enzymes.  A direct role for some isoniazid-derived reactive species, such as nitric oxide, in inhibiting mycobacterial metabolic enzymes has also been shown.  The concerted effects of these activities - inhibition of cell wall lipid synthesis, depletion of nucleic acid pools and metabolic depression - drive the exquisite potency and selectivity of this agent.  To understand INH action and resistance fully, a synthesis of knowledge is required from multiple sep. lines of research - including mol. genetic approaches, in vitro biochem. studies and free radical chem. - which is the intent of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq9OybVddk-rVg90H21EOLACvtfcHk0ljj4_bWRib2rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlenu7jE&md5=fbc095f0f79cd443b55d54c19b36f932</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2006.05467.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2006.05467.x%26sid%3Dliteratum%253Aachs%26aulast%3DTimmins%26aufirst%3DG.%2BS.%26aulast%3DDeretic%26aufirst%3DV.%26atitle%3DMechanisms%2520of%2520action%2520of%2520isoniazid%26jtitle%3DMol.%2520Microbiol.%26date%3D2006%26volume%3D62%26spage%3D1220%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Pessayre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Saint-Louvent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degott, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernuau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueff, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, J. P.</span><span> </span><span class="NLM_article-title">Iproclozide fulminant hepatitis. Possible role of enzyme induction</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1978&pages=492-496&author=D.+Pessayreauthor=P.+de+Saint-Louventauthor=C.+Degottauthor=J.+Bernuauauthor=B.+Rueffauthor=J.+P.+Benhamou&title=Iproclozide+fulminant+hepatitis.+Possible+role+of+enzyme+induction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPessayre%26aufirst%3DD.%26aulast%3Dde%2BSaint-Louvent%26aufirst%3DP.%26aulast%3DDegott%26aufirst%3DC.%26aulast%3DBernuau%26aufirst%3DJ.%26aulast%3DRueff%26aufirst%3DB.%26aulast%3DBenhamou%26aufirst%3DJ.%2BP.%26atitle%3DIproclozide%2520fulminant%2520hepatitis.%2520Possible%2520role%2520of%2520enzyme%2520induction%26jtitle%3DGastroenterology%26date%3D1978%26volume%3D75%26spage%3D492%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Fagervall, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S. B.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1986&pages=1381-1387&author=I.+Fagervallauthor=S.+B.+Ross&title=Inhibition+of+monoamine+oxidase+in+monoaminergic+neurones+in+the+rat+brain+by+irreversible+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFagervall%26aufirst%3DI.%26aulast%3DRoss%26aufirst%3DS.%2BB.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520in%2520monoaminergic%2520neurones%2520in%2520the%2520rat%2520brain%2520by%2520irreversible%2520inhibitors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1986%26volume%3D35%26spage%3D1381%26epage%3D1387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">Park, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitteringham, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirmohamed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. P.</span><span> </span><span class="NLM_article-title">The role of metabolic activation in drug-induced hepatotoxicity</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1146%2Fannurev.pharmtox.45.120403.100058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15822174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVWjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=177-202&author=B.+K.+Parkauthor=N.+R.+Kitteringhamauthor=J.+L.+Maggsauthor=M.+Pirmohamedauthor=D.+P.+Williams&title=The+role+of+metabolic+activation+in+drug-induced+hepatotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">The role of metabolic activation in drug-induced hepatotoxicity</span></div><div class="casAuthors">Park, B. Kevin; Kitteringham, Neil R.; Maggs, James L.; Pirmohamed, Munir; Williams, Dominic P.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">177-202</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The importance of reactive metabolites in the pathogenesis of drug-induced toxicity was a focus of research interest since pioneering investigations in the 1950s revealed the link between toxic metabolites and chem. carcinogenesis.  There is now a great deal of evidence that shows that reactive metabolites are formed from drugs known to cause hepatotoxicity, but how these toxic species initiate and propagate tissue damage is still poorly understood.  This review summarizes the evidence for reactive metabolite formation from hepatotoxic drugs, such as acetaminophen, tamoxifen, diclofenac, and troglitazone, and the current hypotheses of how this leads to liver injury.  Several hepatic proteins can be modified by reactive metabolites, but this in general equates poorly with the extent of toxicity.  Much more important may be the identification of the crit. proteins modified by these toxic species and how this alters their function.  It is also important to note that the toxicity of reactive metabolites may be mediated by noncovalent binding mechanisms, which may also have profound effects on normal liver physiol.  Technol. developments in the wake of the genomic revolution now provide unprecedented power to characterize and quantify covalent modification of individual target proteins and their functional consequences; such information should dramatically improve the authors' understanding of drug-induced hepatotoxic reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNxj1QZaR8MbVg90H21EOLACvtfcHk0ljQbcXkbTTSIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVWjt78%253D&md5=0e7f16ec0deb3e1da4be3f7f2a68df5b</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.45.120403.100058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.45.120403.100058%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DB.%2BK.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DMaggs%26aufirst%3DJ.%2BL.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26atitle%3DThe%2520role%2520of%2520metabolic%2520activation%2520in%2520drug-induced%2520hepatotoxicity%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2005%26volume%3D45%26spage%3D177%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group">Koechlin, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberhaensli, W. E.</span><span> </span><span class="NLM_article-title">Metabolism of C-14-iproniazid and C-14-isocarboxazid in man</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=14034092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaF3sXhs1KqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1962&pages=11-20&author=B.+A.+Koechlinauthor=M.+A.+Schwartzauthor=W.+E.+Oberhaensli&title=Metabolism+of+C-14-iproniazid+and+C-14-isocarboxazid+in+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of C14-iproniazid and C14-isocarboxazid in man</span></div><div class="casAuthors">Koechlin, , Bernard A.; Schwartz, , Morton A.; Oberhaensli, Wilhelm E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1962</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-20</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">cf. CA 56, 10846e.  The metabolic fate of iproniazid (I), labeled in the iso-Pr group, and isocarboxazid (II), labeled in the benzyl group, was investigated in humans and compared with results previously obtained in rats.  Both drugs were rapidly absorbed after ingestion.  I was metabolized by oxidn. of the labeled iso-Pr substituent with elimination of 50-60% of the radioactivity as pulmonary CO2 within 24 hrs.  The oxidn. rates differed markedly with the individual subjects as did the patterns of the radioactive urinary excretion products.  II was metabolized in an analogous manner by oxidn. of the labeled benzyl moiety to C14-benzoic acid which was excreted as urinary hippurate and accounted for 56% of the dose in 24 hrs.  The pathways of oxidative degradation of both drugs was the same in man and rat but with differences in the rates of degradation.  In both species II seemed to be oxidized faster than I, and both I and II were oxidized faster in rats than in man</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrozI3SD1fXQbVg90H21EOLACvtfcHk0ljQbcXkbTTSIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3sXhs1KqtA%253D%253D&md5=a3688b760222f1fb01e1e826f8ed258b</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoechlin%26aufirst%3DB.%2BA.%26aulast%3DSchwartz%26aufirst%3DM.%2BA.%26aulast%3DOberhaensli%26aufirst%3DW.%2BE.%26atitle%3DMetabolism%2520of%2520C-14-iproniazid%2520and%2520C-14-isocarboxazid%2520in%2520man%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1962%26volume%3D138%26spage%3D11%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group">Shimada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, H.</span><span> </span><span class="NLM_article-title">Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans</span> <span class="citation_source-journal">Arch. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1007%2Fs002040050403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=9195021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK2sXjsVCnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1997&pages=401-408&author=T.+Shimadaauthor=M.+Mimuraauthor=K.+Inoueauthor=S.+Nakamuraauthor=H.+Odaauthor=S.+Ohmoriauthor=H.+Yamazaki&title=Cytochrome+P450-dependent+drug+oxidation+activities+in+liver+microsomes+of+various+animal+species+including+rats%2C+guinea+pigs%2C+dogs%2C+monkeys%2C+and+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans</span></div><div class="casAuthors">Shimada, Tsutomu; Mimura, Mayumi; Inoue, Kiyoshi; Nakamura, Seiichi; Oda, Hajime; Ohmori, Shigeru; Yamazaki, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-408</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Levels of cytochrome P 450 (P 450 or CYP) proteins immunoreactive to antibodies raised against human CYP1A2, 2A6, 2C9, 2E1, and 3A4, monkey CYP2B17, and rat CYP2D1 were detd. in liver microsomes of rats, guinea pigs, dogs, monkeys, and humans.  Several drug oxidn. activities were also examd. catalyzed by liver microsomes of these animal species using eleven P 450 substrates such as phenacetin, coumarin, pentoxyresorufin, phenytoin, S-mephenytoin, bufuralol, aniline, benzphetamine, ethylmorphine, erythromycin, and nifedipine; the activities were compared with the levels of individual P 450 enzymes.  Monkey liver P 450 proteins had relatively similar immunochem. properties by immunoblotting anal. to the human enzymes, which belong to the same P 450 gene families.  Mean catalytic activities (on basis of mg microsomal protein) of P 450-dependent drug oxidns. with eleven substrates were higher in liver microsomes of monkeys than of humans, except that humans showed much higher activities for aniline p-hydroxylation than those catalyzed by monkeys.  When the catalytic activities of liver microsomes of monkeys and humans were compared on the basis of nmol of P 450, both species gave relatively similar rates towards the oxidn. of phenacetin, coumarin, pentoxyresorufin, phenytoin, mephenytoin, benzphetamine, ethylmorphine, erythromycin, and nifedipine, while the aniline p-hydroxylation was higher and bufuralol 1°-hydroxylation was lower in humans than monkeys.  The immunochem. properties of P 450 proteins and the activities of P 450-dependent drug oxidn. reactions in dogs, guinea pigs, and rats were somewhat different from those of monkeys and humans; the differences in these animal species varied with the P 450 enzymes examd. and the substrates used.  The results provide useful information towards species-related differences in susceptibilities of various animal species regarding actions and toxicities of drugs and xenobiotic chems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfEheVlvaHFLVg90H21EOLACvtfcHk0ljQbcXkbTTSIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsVCnsr0%253D&md5=0837537dd86ce2c75a5f22971366697a</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1007%2Fs002040050403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002040050403%26sid%3Dliteratum%253Aachs%26aulast%3DShimada%26aufirst%3DT.%26aulast%3DMimura%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DOda%26aufirst%3DH.%26aulast%3DOhmori%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DH.%26atitle%3DCytochrome%2520P450-dependent%2520drug%2520oxidation%2520activities%2520in%2520liver%2520microsomes%2520of%2520various%2520animal%2520species%2520including%2520rats%252C%2520guinea%2520pigs%252C%2520dogs%252C%2520monkeys%252C%2520and%2520humans%26jtitle%3DArch.%2520Toxicol.%26date%3D1997%26volume%3D71%26spage%3D401%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span> </span><span class="NLM_article-title">Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1471</span><span class="NLM_x">–</span> <span class="NLM_lpage">1484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2FS0024-3205%2801%2901232-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=11554609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtFantrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=1471-1484&author=W.+E.+Klunkauthor=Y.+Wangauthor=G.+F.+Huangauthor=M.+L.+Debnathauthor=D.+P.+Holtauthor=C.+A.+Mathis&title=Uncharged+thioflavin-T+derivatives+bind+to+amyloid-beta+protein+with+high+affinity+and+readily+enter+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain</span></div><div class="casAuthors">Klunk, William E.; Wang, Yanming; Huang, Guo-Feng; Debnath, Manik L.; Holt, Daniel P.; Mathis, Chester A.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1471-1484</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">In vivo assessment of the beta-sheet proteins deposited in amyloid plaques (Aβ peptide) or neurofibrillary tangles (tau protein) presents a target for the development of biol. markers for Alzheimer's disease (AD).  In an effort to develop in vivo beta-sheet imaging probes, derivs. of thioflavin-T (ThT) were synthesized and evaluated.  These compds. lack the pos. charged quaternary heterocyclic nitrogen of ThT and are therefore uncharged at physiol. pH.  They are 600-fold more lipophilic than ThT.  These ThT derivs. bind to Aβ(1-40) fibrils with higher affinity (Ki = 20.2 nM) than ThT (Ki = 890 nM).  The uncharged ThT derivs. stained both plaques and neurofibrillary tangles in post-mortem AD brain, showing some preference for plaque staining.  A carbon-11 labeled compd., [N-methyl-11C]6-Me-BTA-1, was prepd., and its brain entry and clearance were studied in Swiss-Webster mice.  This compd. entered the brain at levels comparable to commonly used neuroreceptor imaging agents (0.223% ID-kg/g or 7.61% ID/g at 2 min post-injection) and showed good clearance of free and non-specifically bound radioactivity in normal rodent brain tissue (brain clearance t1/2 = 20 min).  The combination of relatively high affinity for amyloid, specificity for staining plaques and neurofibrillary tangles in post-mortem AD brain, and good brain entry and clearance makes [N-methyl-11C]6-Me-BTA-1 a promising candidate as an in vivo positron emission tomog. (PET) beta-sheet imaging agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5mxuurQ9YN7Vg90H21EOLACvtfcHk0lhzgM8NAFe2Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtFantrc%253D&md5=13015aac9a380b4827c8bd205a4846ec</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1016%2FS0024-3205%2801%2901232-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0024-3205%252801%252901232-2%26sid%3Dliteratum%253Aachs%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DG.%2BF.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26atitle%3DUncharged%2520thioflavin-T%2520derivatives%2520bind%2520to%2520amyloid-beta%2520protein%2520with%2520high%2520affinity%2520and%2520readily%2520enter%2520the%2520brain%26jtitle%3DLife%2520Sci.%26date%3D2001%26volume%3D69%26spage%3D1471%26epage%3D1484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group">Necula, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirita, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuret, J.</span><span> </span><span class="NLM_article-title">Cyanine dye N744 inhibits tau fibrillization by blocking filament extension: implications for the treatment of tauopathic neurodegenerative diseases</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">10227</span><span class="NLM_x">–</span> <span class="NLM_lpage">10237</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi050387o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=10227-10237&author=M.+Neculaauthor=C.+N.+Chiritaauthor=J.+Kuret&title=Cyanine+dye+N744+inhibits+tau+fibrillization+by+blocking+filament+extension%3A+implications+for+the+treatment+of+tauopathic+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1021%2Fbi050387o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi050387o%26sid%3Dliteratum%253Aachs%26aulast%3DNecula%26aufirst%3DM.%26aulast%3DChirita%26aufirst%3DC.%2BN.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DCyanine%2520dye%2520N744%2520inhibits%2520tau%2520fibrillization%2520by%2520blocking%2520filament%2520extension%253A%2520implications%2520for%2520the%2520treatment%2520of%2520tauopathic%2520neurodegenerative%2520diseases%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D10227%26epage%3D10237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikonomovic, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefterov, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koldamova, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamson, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span> </span><span class="NLM_article-title">Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer’s disease brain but not in transgenic mouse brain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">10598</span><span class="NLM_x">–</span> <span class="NLM_lpage">10606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1523%2FJNEUROSCI.2990-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=16291932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Kqsb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10598-10606&author=W.+E.+Klunkauthor=B.+J.+Loprestiauthor=M.+D.+Ikonomovicauthor=I.+M.+Lefterovauthor=R.+P.+Koldamovaauthor=E.+E.+Abrahamsonauthor=M.+L.+Debnathauthor=D.+P.+Holtauthor=G.+F.+Huangauthor=L.+Shaoauthor=S.+T.+DeKoskyauthor=J.+C.+Priceauthor=C.+A.+Mathis&title=Binding+of+the+positron+emission+tomography+tracer+Pittsburgh+compound-B+reflects+the+amount+of+amyloid-beta+in+Alzheimer%E2%80%99s+disease+brain+but+not+in+transgenic+mouse+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of the positron emission tomography tracer pittsburgh compound-B reflects the amount of amyloid-β in Alzheimer's disease brain but not in transgenic mouse brain</span></div><div class="casAuthors">Klunk, William E.; Lopresti, Brian J.; Ikonomovic, Milos D.; Lefterov, Iliya M.; Koldamova, Radosveta P.; Abrahamson, Eric E.; Debnath, Manik L.; Holt, Daniel P.; Huang, Guo-feng; Shao, Li; DeKosky, Steven T.; Price, Julie C.; Mathis, Chester A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">10598-10606</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">During the development of in vivo amyloid imaging agents, an effort was made to use micro-positron emission tomog. (PET) imaging in the presenilin-1 (PS1)/amyloid precursor protein (APP) transgenic mouse model of CNS amyloid deposition to screen new compds. and further study Pittsburgh Compd.-B (PIB), a PET tracer that has been shown to be retained well in amyloid-contg. areas of Alzheimer's disease (AD) brain.  Unexpectedly, we saw no significant retention of PIB in this model even at 12 mo of age when amyloid deposition in the PS1/APP mouse typically exceeds that seen in AD.  This study describes a series of ex vivo and postmortem in vitro studies designed to explain this low retention.  Ex vivo brain pharmacokinetic studies confirmed the low in vivo PIB retention obsd. in micro-PET expts.  In vitro binding studies showed that PS1/APP brain tissue contained less than one high-affinity (Kd = 1-2 nM) PIB binding site per 1000 mols. of amyloid-β (Aβ), whereas AD brain contained >500 PIB binding sites per 1000 mols. of Aβ.  Synthetic Aβ closely resembled PS1/APP brain in having less than one high-affinity PIB binding site per 1000 mols. of Aβ, although the characteristics of the few high-affinity PIB binding sites found on synthetic Aβ were very similar to those found in AD brain.  We hypothesize that differences in the time course of deposition or tissue factors present during deposition lead to differences in secondary structure between Aβ deposited in AD brain and either synthetic Aβ or Aβ deposited in PS1/APP brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwwhX6rXFA5LVg90H21EOLACvtfcHk0lhzgM8NAFe2Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Kqsb%252FP&md5=55732aca5ee5b47d4ce985edf014c6a9</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2990-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2990-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DIkonomovic%26aufirst%3DM.%2BD.%26aulast%3DLefterov%26aufirst%3DI.%2BM.%26aulast%3DKoldamova%26aufirst%3DR.%2BP.%26aulast%3DAbrahamson%26aufirst%3DE.%2BE.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DHuang%26aufirst%3DG.%2BF.%26aulast%3DShao%26aufirst%3DL.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DPrice%26aufirst%3DJ.%2BC.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26atitle%3DBinding%2520of%2520the%2520positron%2520emission%2520tomography%2520tracer%2520Pittsburgh%2520compound-B%2520reflects%2520the%2520amount%2520of%2520amyloid-beta%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain%2520but%2520not%2520in%2520transgenic%2520mouse%2520brain%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D10598%26epage%3D10606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacskai, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajdasz, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLellan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frosch, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2FS0960-894X%2801%2900734-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=11814781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslKmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=295-298&author=C.+A.+Mathisauthor=B.+J.+Bacskaiauthor=S.+T.+Kajdaszauthor=M.+E.+McLellanauthor=M.+P.+Froschauthor=B.+T.+Hymanauthor=D.+P.+Holtauthor=Y.+Wangauthor=G.+F.+Huangauthor=M.+L.+Debnathauthor=W.+E.+Klunk&title=A+lipophilic+thioflavin-T+derivative+for+positron+emission+tomography+%28PET%29+imaging+of+amyloid+in+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain</span></div><div class="casAuthors">Mathis, Chester A.; Bacskai, Brian J.; Kajdasz, Stephen T.; McLellan, Megan E.; Frosch, Matthew P.; Hyman, Bradley T.; Holt, Daniel P.; Wang, Yanming; Huang, Guo-Feng; Debnath, Manik L.; Klunk, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">295-298</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The synthesis of a new lipophilic thioflavin-T analog, 2-[4-(methylamino)phenyl]benzothiazole (I), with high affinity for amyloid is reported.  I.v. injection of [11C]-labeled I into control mice resulted in high brain uptake.  Amyloid deposits were imaged with multiphoton microscopy in the brains of living transgenic mice following the systemic injection of unlabeled I.  [11C]-I is a promising amyloid imaging agent for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsNt35PExWgrVg90H21EOLACvtfcHk0lhzgM8NAFe2Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslKmtQ%253D%253D&md5=c761b7a60b9ec39bdf615c28983a89e0</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900734-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900734-X%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DBacskai%26aufirst%3DB.%2BJ.%26aulast%3DKajdasz%26aufirst%3DS.%2BT.%26aulast%3DMcLellan%26aufirst%3DM.%2BE.%26aulast%3DFrosch%26aufirst%3DM.%2BP.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DG.%2BF.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DA%2520lipophilic%2520thioflavin-T%2520derivative%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%2520of%2520amyloid%2520in%2520brain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D295%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Impact of amyloid imaging on drug development in Alzheimer’s disease</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">822</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.nucmedbio.2007.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17921032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFeiu7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=809-822&author=C.+A.+Mathisauthor=B.+J.+Loprestiauthor=W.+E.+Klunk&title=Impact+of+amyloid+imaging+on+drug+development+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of amyloid imaging on drug development in Alzheimer's disease</span></div><div class="casAuthors">Mathis, Chester A.; Lopresti, Brian J.; Klunk, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">809-822</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Imaging agents capable of assessing amyloid-beta (Aβ) content in vivo in the brains of Alzheimer's disease (AD) subjects likely will be important as diagnostic agents to detect Aβ plaques in the brain as well as to help test the amyloid cascade hypothesis of AD and as an aid to assess the efficacy of anti-amyloid therapeutics currently under development and in clin. trials.  Positron emission tomog. (PET) imaging studies of amyloid deposition in human subjects with several Aβ imaging agents are currently underway.  We reported the first PET studies of the carbon 11-labeled thioflavin-T deriv. Pittsburgh Compd. B in 2004, and this work has subsequently been extended to include a variety of subject groups, including AD patients, mild cognitive impairment patients and healthy controls.  The ability to quantify regional Aβ plaque load in the brains of living human subjects has provided a means to begin to apply this technol. as a diagnostic agent to detect regional concns. of Aβ plaques and as a surrogate marker of therapeutic efficacy in anti-amyloid drug trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCxDzRikl-aLVg90H21EOLACvtfcHk0lhv-mdkRgVK_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFeiu7%252FM&md5=48130f4a7b66e7fc0ffa34a8460b5749</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2007.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2007.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DImpact%2520of%2520amyloid%2520imaging%2520on%2520drug%2520development%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2007%26volume%3D34%26spage%3D809%26epage%3D822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group">Ikonomovic, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamson, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsopelas, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziolko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paljug, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hope, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isanski, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S. T.</span><span> </span><span class="NLM_article-title">Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1645</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2008&pages=1630-1645&author=M.+D.+Ikonomovicauthor=W.+E.+Klunkauthor=E.+E.+Abrahamsonauthor=C.+A.+Mathisauthor=J.+C.+Priceauthor=N.+D.+Tsopelasauthor=B.+J.+Loprestiauthor=S.+Ziolkoauthor=W.+Biauthor=W.+R.+Paljugauthor=M.+L.+Debnathauthor=C.+E.+Hopeauthor=B.+A.+Isanskiauthor=R.+L.+Hamiltonauthor=S.+T.+DeKosky&title=Post-mortem+correlates+of+in+vivo+PiB-PET+amyloid+imaging+in+a+typical+case+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIkonomovic%26aufirst%3DM.%2BD.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DAbrahamson%26aufirst%3DE.%2BE.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DPrice%26aufirst%3DJ.%2BC.%26aulast%3DTsopelas%26aufirst%3DN.%2BD.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DZiolko%26aufirst%3DS.%26aulast%3DBi%26aufirst%3DW.%26aulast%3DPaljug%26aufirst%3DW.%2BR.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DHope%26aufirst%3DC.%2BE.%26aulast%3DIsanski%26aufirst%3DB.%2BA.%26aulast%3DHamilton%26aufirst%3DR.%2BL.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26atitle%3DPost-mortem%2520correlates%2520of%2520in%2520vivo%2520PiB-PET%2520amyloid%2520imaging%2520in%2520a%2520typical%2520case%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2008%26volume%3D131%26spage%3D1630%26epage%3D1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group">Chang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congdon, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honson, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duff, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuret, J.</span><span> </span><span class="NLM_article-title">Structure–activity relationship of cyanine tau aggregation inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3539</span><span class="NLM_x">–</span> <span class="NLM_lpage">3547</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900116d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3539-3547&author=E.+Changauthor=E.+E.+Congdonauthor=N.+S.+Honsonauthor=K.+E.+Duffauthor=J.+Kuret&title=Structure%E2%80%93activity+relationship+of+cyanine+tau+aggregation+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Fjm900116d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900116d%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DE.%26aulast%3DCongdon%26aufirst%3DE.%2BE.%26aulast%3DHonson%26aufirst%3DN.%2BS.%26aulast%3DDuff%26aufirst%3DK.%2BE.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520of%2520cyanine%2520tau%2520aggregation%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3539%26epage%3D3547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group">Schafer, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murale, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cisek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuret, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, D. G.</span><span> </span><span class="NLM_article-title">Structure–activity relationship of cyclic thiacarbocyanine tau aggregation inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3273</span><span class="NLM_x">–</span> <span class="NLM_lpage">3276</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3273-3276&author=K.+N.+Schaferauthor=D.+P.+Muraleauthor=K.+Kimauthor=K.+Cisekauthor=J.+Kuretauthor=D.+G.+Churchill&title=Structure%E2%80%93activity+relationship+of+cyclic+thiacarbocyanine+tau+aggregation+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchafer%26aufirst%3DK.%2BN.%26aulast%3DMurale%26aufirst%3DD.%2BP.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DCisek%26aufirst%3DK.%26aulast%3DKuret%26aufirst%3DJ.%26aulast%3DChurchill%26aufirst%3DD.%2BG.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520of%2520cyclic%2520thiacarbocyanine%2520tau%2520aggregation%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3273%26epage%3D3276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group">van Kan, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groeneveld, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalmijn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spieksma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Berg, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guchelaar, H. J.</span><span> </span><span class="NLM_article-title">Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1365-2125.2004.02233.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15752377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtVOgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2005&pages=310-313&author=H.+J.+van+Kanauthor=G.+J.+Groeneveldauthor=S.+Kalmijnauthor=M.+Spieksmaauthor=L.+H.+van+den+Bergauthor=H.+J.+Guchelaar&title=Association+between+CYP1A2+activity+and+riluzole+clearance+in+patients+with+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis</span></div><div class="casAuthors">van Kan, H. J. M.; Groeneveld, G. J.; Kalmijn, S.; Spieksma, M.; van den Berg, L. H.; Guchelaar, H. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">310-313</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Riluzole is used in a fixed dosing schedule of 50 mg twice daily to treat patients with amyotropic lateral sclerosis (ALS), one form of motor neuron disease.  The large variability in the pharmacokinetics of riluzole may be a factor contributing to its limited therapeutic benefit.  Riluzole is assumed to be mainly metabolized by the cytochrome P 450 enzyme 1A2 (CYP1A2).  The aim of the study was to investigate the relationship between CYP1A2 activity and riluzole clearance with a view to optimize drug treatment.  A group of 30 ALS patients participated in the study.  In each patient the CYP1A2 activity was detd. using caffeine as a metabolic probe.  Riluzole clearance was estd. from serum drug concn. measurements followed by Bayesian fitting.  Riluzole clearance and the serum paraxanthine : caffeine (P/C) ratio showed a pos. correlation (r=0.693; P=0.0002).  Linear regression anal. identified the P/C ratio (beta: 1.16) and height (beta: 0.027) as independent predictors of riluzole clearance (adjusted r2 = 0.369).  The P/C ratio, used as measure of CYP1A2 activity, significantly correlated with the riluzole clearance, although only 37% of the obsd. variability could be explained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlVb82AN0ZuLVg90H21EOLACvtfcHk0liPAwTvLhKwQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtVOgu7c%253D&md5=7f565cd36addbad20483911f2b18a644</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2004.02233.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2004.02233.x%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BKan%26aufirst%3DH.%2BJ.%26aulast%3DGroeneveld%26aufirst%3DG.%2BJ.%26aulast%3DKalmijn%26aufirst%3DS.%26aulast%3DSpieksma%26aufirst%3DM.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DL.%2BH.%26aulast%3DGuchelaar%26aufirst%3DH.%2BJ.%26atitle%3DAssociation%2520between%2520CYP1A2%2520activity%2520and%2520riluzole%2520clearance%2520in%2520patients%2520with%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2005%26volume%3D59%26spage%3D310%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group">Milane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vautier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensimon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meininger, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farinotti, R.</span><span> </span><span class="NLM_article-title">Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood–brain barrier</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17635670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2qu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2007&pages=164-173&author=A.+Milaneauthor=C.+Fernandezauthor=S.+Vautierauthor=G.+Bensimonauthor=V.+Meiningerauthor=R.+Farinotti&title=Minocycline+and+riluzole+brain+disposition%3A+interactions+with+p-glycoprotein+at+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier</span></div><div class="casAuthors">Milane, Aline; Fernandez, Christine; Vautier, Sarah; Bensimon, Gilbert; Meininger, Vincent; Farinotti, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">164-173</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis is a neurodegenerative fatal disease.  The only drug recognized to increase the survival time is riluzole (RLZ).  In animal models, minocycline (MNC) delayed the onset of the disease and increased the survival time (in combination with RLZ).  The objective of our work was to study the interactions between RLZ, MNC and the efflux pump p-glycoprotein (p-gp) at the blood-brain barrier.  We investigated these two drugs as:.  (i) p-gp substrates by comparing their brain uptake in CF1 mdr1a (-/-) and mdr1a (+/+) mice,.  (ii) p-gp modulators by studying their effect on the cerebral uptake of digoxin.  Mdr1a (-/-) mice showed higher brain uptake of MNC and RLZ than mdr1a (+/+) (in a 1.6- and 1.4-fold, resp.); and in mdr1a (+/+) mice pre-treated with repeated doses of MNC, brain uptake of digoxin was increased.  When both drugs were administered to mdr1a (+/+) mice, MNC increased the brain uptake of RLZ in a 2.1-fold.  In conclusion, MNC and RLZ are both p-gp substrates.  MNC is also a p-gp inhibitor and increases the brain diffusion of RLZ.  In vitro expts. with the GPNT cell line confirmed these results.  These interactions should be taken into account in the design of future clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobRSJaLIIDDLVg90H21EOLACvtfcHk0liPAwTvLhKwQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2qu7bP&md5=7044004383a0848d24edbd65491a0dce</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMilane%26aufirst%3DA.%26aulast%3DFernandez%26aufirst%3DC.%26aulast%3DVautier%26aufirst%3DS.%26aulast%3DBensimon%26aufirst%3DG.%26aulast%3DMeininger%26aufirst%3DV.%26aulast%3DFarinotti%26aufirst%3DR.%26atitle%3DMinocycline%2520and%2520riluzole%2520brain%2520disposition%253A%2520interactions%2520with%2520p-glycoprotein%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D103%26spage%3D164%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group">Hilal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. A.</span><span> </span><span class="NLM_article-title">Cyanine dyes for the detection of double stranded DNA</span> <span class="citation_source-journal">J. Biochem. Biophys. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.jprot.2007.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=18304645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVOgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2008&pages=1104-1108&author=H.+Hilalauthor=J.+A.+Taylor&title=Cyanine+dyes+for+the+detection+of+double+stranded+DNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Cyanine dyes for the detection of double stranded DNA</span></div><div class="casAuthors">Hilal, H.; Taylor, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemical and Biophysical Methods</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1104-1108</span>CODEN:
                <span class="NLM_cas:coden">JBBMDG</span>;
        ISSN:<span class="NLM_cas:issn">0165-022X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Twenty three novel cyanine dyes have been applied as fluorescent stains for the detection of nucleic acids in agarose gel electrophoresis.  Significant fluorescence enhancement of these dyes in the presence of double stranded DNA was obsd.  Five dyes offered superior sensitivity in the detection and quantification of DNA, over Ethidium Bromide, the most commonly used nucleic acid stain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVc0Yp_0rdurVg90H21EOLACvtfcHk0liPAwTvLhKwQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVOgtro%253D&md5=ae0e889fca1568962bb2020ae0f8b18d</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2Fj.jprot.2007.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jprot.2007.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DHilal%26aufirst%3DH.%26aulast%3DTaylor%26aufirst%3DJ.%2BA.%26atitle%3DCyanine%2520dyes%2520for%2520the%2520detection%2520of%2520double%2520stranded%2520DNA%26jtitle%3DJ.%2520Biochem.%2520Biophys.%2520Methods%26date%3D2008%26volume%3D70%26spage%3D1104%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group">Clifton, J.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leikin, J. B.</span><span> </span><span class="NLM_article-title">Methylene blue</span> <span class="citation_source-journal">Am. J. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1097%2F00045391-200307000-00009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=12845393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A280%3ADC%252BD3szhsFeqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=289-291&author=J.+Cliftonauthor=J.+B.+Leikin&title=Methylene+blue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Methylene blue</span></div><div class="casAuthors">Clifton Jack 2nd; Leikin Jerrold B</div><div class="citationInfo"><span class="NLM_cas:title">American journal of therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">289-91</span>
        ISSN:<span class="NLM_cas:issn">1075-2765</span>.
    </div><div class="casAbstract">Methylene blue finds its major utilization in toxicology in the treatment of methemoglobinemia at a dose of 1 to 2 mg/kg intravenously.  By interacting with methemoglobin and the erythrocyte's enzyme systems to reduce back to hemoglobin, methylene blue is a generally safe drug with dose-related hemolytic effects.  People with G-6-PD deficiency, along with patients exposed to aniline dyes and dapsone, may present with special risks in the treatment of methemoglobinemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTsV_YxfWgvkny-c-E1v-fmfW6udTcc2eaL9fgcdjapebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szhsFeqtA%253D%253D&md5=d1a99d86f55a591ec32273ef6b7dafb2</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1097%2F00045391-200307000-00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00045391-200307000-00009%26sid%3Dliteratum%253Aachs%26aulast%3DClifton%26aufirst%3DJ.%26aulast%3DLeikin%26aufirst%3DJ.%2BB.%26atitle%3DMethylene%2520blue%26jtitle%3DAm.%2520J.%2520Ther.%26date%3D2003%26volume%3D10%26spage%3D289%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group">Johnson, I. D.</span><span> </span><span class="NLM_article-title">Cellular Function Probes</span>. In  <span class="citation_source-book">Current Protocols in Cytometry</span>; <span class="NLM_publisher-name">Wiley Online Library</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">; </span>Chapter 4, Unit 4 4.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=I.+D.+Johnson&title=Current+Protocols+in+Cytometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DI.%2BD.%26atitle%3DCellular%2520Function%2520Probes%26btitle%3DCurrent%2520Protocols%2520in%2520Cytometry%26pub%3DWiley%2520Online%2520Library%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group">Hassan, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridovich, I.</span><span> </span><span class="NLM_article-title">Intracellular production of superoxide radical and of hydrogen peroxide by redox active compounds</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=1979&pages=385-395&author=H.+M.+Hassanauthor=I.+Fridovich&title=Intracellular+production+of+superoxide+radical+and+of+hydrogen+peroxide+by+redox+active+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHassan%26aufirst%3DH.%2BM.%26aulast%3DFridovich%26aufirst%3DI.%26atitle%3DIntracellular%2520production%2520of%2520superoxide%2520radical%2520and%2520of%2520hydrogen%2520peroxide%2520by%2520redox%2520active%2520compounds%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1979%26volume%3D196%26spage%3D385%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group">Zigman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilman, P.,  Jr.</span><span> </span><span class="NLM_article-title">Inhibition of cell division and growth by a redox series of cyanine dyes</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">208</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=208&publication_year=1980&pages=188-191&author=S.+Zigmanauthor=P.+Gilman&title=Inhibition+of+cell+division+and+growth+by+a+redox+series+of+cyanine+dyes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZigman%26aufirst%3DS.%26aulast%3DGilman%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520cell%2520division%2520and%2520growth%2520by%2520a%2520redox%2520series%2520of%2520cyanine%2520dyes%26jtitle%3DScience%26date%3D1980%26volume%3D208%26spage%3D188%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd.</span><span> </span><span class="NLM_article-title">Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3739</span><span class="NLM_x">–</span> <span class="NLM_lpage">3747</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100138f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3739-3747&author=C.+Ballatoreauthor=K.+R.+Brundenauthor=F.+Piscitelliauthor=M.+J.+Jamesauthor=A.+Croweauthor=Y.+Yaoauthor=E.+Hydeauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=A.+B.+Smith&title=Discovery+of+brain-penetrant%2C+orally+bioavailable+aminothienopyridazine+inhibitors+of+tau+aggregation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1021%2Fjm100138f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100138f%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DPiscitelli%26aufirst%3DF.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DHyde%26aufirst%3DE.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DDiscovery%2520of%2520brain-penetrant%252C%2520orally%2520bioavailable%2520aminothienopyridazine%2520inhibitors%2520of%2520tau%2520aggregation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3739%26epage%3D3747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossidivito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd.</span><span> </span><span class="NLM_article-title">Aminothienopyridazine inhibitors of tau aggregation: evaluation of structure–activity relationship leads to selection of candidates with desirable in vivo properties</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4451</span><span class="NLM_x">–</span> <span class="NLM_lpage">4461</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=4451-4461&author=C.+Ballatoreauthor=A.+Croweauthor=F.+Piscitelliauthor=M.+Jamesauthor=K.+Louauthor=G.+Rossidivitoauthor=Y.+Yaoauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=K.+R.+Brundenauthor=A.+B.+Smith&title=Aminothienopyridazine+inhibitors+of+tau+aggregation%3A+evaluation+of+structure%E2%80%93activity+relationship+leads+to+selection+of+candidates+with+desirable+in+vivo+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DPiscitelli%26aufirst%3DF.%26aulast%3DJames%26aufirst%3DM.%26aulast%3DLou%26aufirst%3DK.%26aulast%3DRossidivito%26aufirst%3DG.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DAminothienopyridazine%2520inhibitors%2520of%2520tau%2520aggregation%253A%2520evaluation%2520of%2520structure%25E2%2580%2593activity%2520relationship%2520leads%2520to%2520selection%2520of%2520candidates%2520with%2520desirable%2520in%2520vivo%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D4451%26epage%3D4461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group">Buchwald, P.</span><span> </span><span class="NLM_article-title">Small-molecule protein–protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations</span> <span class="citation_source-journal">IUBMB Life</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">724</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=724-731&author=P.+Buchwald&title=Small-molecule+protein%E2%80%93protein+interaction+inhibitors%3A+therapeutic+potential+in+light+of+molecular+size%2C+chemical+space%2C+and+ligand+binding+efficiency+considerations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuchwald%26aufirst%3DP.%26atitle%3DSmall-molecule%2520protein%25E2%2580%2593protein%2520interaction%2520inhibitors%253A%2520therapeutic%2520potential%2520in%2520light%2520of%2520molecular%2520size%252C%2520chemical%2520space%252C%2520and%2520ligand%2520binding%2520efficiency%2520considerations%26jtitle%3DIUBMB%2520Life%26date%3D2010%26volume%3D62%26spage%3D724%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group">Arkin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. A.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of protein–protein interactions: progressing towards the dream</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=301-317&author=M.+R.+Arkinauthor=J.+A.+Wells&title=Small-molecule+inhibitors+of+protein%E2%80%93protein+interactions%3A+progressing+towards+the+dream"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520protein%25E2%2580%2593protein%2520interactions%253A%2520progressing%2520towards%2520the%2520dream%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D301%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group">Thiel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottmann, C.</span><span> </span><span class="NLM_article-title">Small-molecule stabilization of protein–protein interactions: an underestimated concept in drug discovery?</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2012</span><span class="NLM_x">–</span> <span class="NLM_lpage">2018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=2012-2018&author=P.+Thielauthor=M.+Kaiserauthor=C.+Ottmann&title=Small-molecule+stabilization+of+protein%E2%80%93protein+interactions%3A+an+underestimated+concept+in+drug+discovery%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThiel%26aufirst%3DP.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DOttmann%26aufirst%3DC.%26atitle%3DSmall-molecule%2520stabilization%2520of%2520protein%25E2%2580%2593protein%2520interactions%253A%2520an%2520underestimated%2520concept%2520in%2520drug%2520discovery%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D2012%26epage%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shively, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald-Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toleikis, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.0406361102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15615853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtlemtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=227-231&author=B.+Zhangauthor=A.+Maitiauthor=S.+Shivelyauthor=F.+Lakhaniauthor=G.+McDonald-Jonesauthor=J.+Bruceauthor=E.+B.+Leeauthor=S.+X.+Xieauthor=S.+Joyceauthor=C.+Liauthor=P.+M.+Toleikisauthor=V.+M.+Leeauthor=J.+Q.+Trojanowski&title=Microtubule-binding+drugs+offset+tau+sequestration+by+stabilizing+microtubules+and+reversing+fast+axonal+transport+deficits+in+a+tauopathy+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model</span></div><div class="casAuthors">Zhang, Bin; Maiti, Arpita; Shively, Sharon; Lakhani, Fara; McDonald-Jones, Gaye; Bruce, Jennifer; Lee, Edward B.; Xie, Sharon X.; Joyce, Sonali; Li, Chi; Toleikis, Philip M.; Lee, Virginia M.-Y.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">227-231</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We tested the hypothesis that microtubule (MT)-binding drugs could be therapeutically beneficial in tauopathies by functionally substituting for the MT-binding protein tau, which is sequestered into inclusions of human tauopathies and transgenic mouse models thereof.  Transgenic mice were treated for 12 wk with weekly i.p. injections of 10 or 25 mg/m2 paclitaxel (Paxceed).  Both doses restored fast axonal transport in spinal axons, wherein MT nos. and stable (detyrosinated) tubulins were increased, compared with sham treatment, and only Paxceed ameliorated motor impairments in tau transgenic mice.  Thus, MT-stabilizing drugs could have therapeutic potential for treating neurodegenerative tauopathies by offsetting losses of tau function that result from the sequestration of this MT-stabilizing protein into filamentous inclusions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Xfh_fgcZrLVg90H21EOLACvtfcHk0lgxgfVbxIwBCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtlemtA%253D%253D&md5=bf2746acbdcf115ac7fc9042232c9c36</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0406361102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0406361102%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DMaiti%26aufirst%3DA.%26aulast%3DShively%26aufirst%3DS.%26aulast%3DLakhani%26aufirst%3DF.%26aulast%3DMcDonald-Jones%26aufirst%3DG.%26aulast%3DBruce%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DE.%2BB.%26aulast%3DXie%26aufirst%3DS.%2BX.%26aulast%3DJoyce%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DToleikis%26aufirst%3DP.%2BM.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DMicrotubule-binding%2520drugs%2520offset%2520tau%2520sequestration%2520by%2520stabilizing%2520microtubules%2520and%2520reversing%2520fast%2520axonal%2520transport%2520deficits%2520in%2520a%2520tauopathy%2520model%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D227%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group">Lo Conte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chothia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janin, J.</span><span> </span><span class="NLM_article-title">The atomic structure of protein–protein recognition sites</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=2177-2198&author=L.+Lo+Conteauthor=C.+Chothiaauthor=J.+Janin&title=The+atomic+structure+of+protein%E2%80%93protein+recognition+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLo%2BConte%26aufirst%3DL.%26aulast%3DChothia%26aufirst%3DC.%26aulast%3DJanin%26aufirst%3DJ.%26atitle%3DThe%2520atomic%2520structure%2520of%2520protein%25E2%2580%2593protein%2520recognition%2520sites%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D285%26spage%3D2177%26epage%3D2198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group">LeVine, H.,  3rd.</span><span> </span><span class="NLM_article-title">Thioflavine T interaction with synthetic Alzheimer’s disease beta-amyloid peptides: detection of amyloid aggregation in solution</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">404</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1002%2Fpro.5560020312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=8453378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK3sXksVCntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1993&pages=404-410&author=H.+LeVine&title=Thioflavine+T+interaction+with+synthetic+Alzheimer%E2%80%99s+disease+beta-amyloid+peptides%3A+detection+of+amyloid+aggregation+in+solution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Thioflavin T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution</span></div><div class="casAuthors">LeVine, Harry, III</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">404-10</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    </div><div class="casAbstract">Thioflavine T (ThT) assocs. rapidly with aggregated fibrils of the synthetic β/A4-derived peptides β(1-28) and β(1-40), giving rise to a new excitation (ex) (absorption) max. at 450 nm and enhanced emission (em) at 482 nm, as opposed to the 385 nm (ex) and 445 nm (em) of the free dye.  This change is dependent on the aggregated state as monomeric or dimeric peptides do not react, and guanidine dissocn. of aggregates destroys the signal.  There was no effect of high salt concns.  Binding to the β(1-40) is of lower affinity, Kd 2 μM, while it sats. with a Kd of 0.54 μM for β(1-28).  Insulin fibrils converted to a β-sheet conformation fluoresce intensely with ThT.  A variety of polyhydroxy, polyanionic, or polycationic materials fail to interact or impede interaction with the amyloid peptides.  This fluorometric technique should allow the kinetic elucidation of the amyloid fibril assembly process as well as the testing of agents that might modulate their assembly or disassembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGqSauseHbKrVg90H21EOLACvtfcHk0lgxgfVbxIwBCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVCntLo%253D&md5=d4bfff1cedf68a3c9379a87d88c3f97a</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560020312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560020312%26sid%3Dliteratum%253Aachs%26aulast%3DLeVine%26aufirst%3DH.%26atitle%3DThioflavine%2520T%2520interaction%2520with%2520synthetic%2520Alzheimer%25E2%2580%2599s%2520disease%2520beta-amyloid%2520peptides%253A%2520detection%2520of%2520amyloid%2520aggregation%2520in%2520solution%26jtitle%3DProtein%2520Sci.%26date%3D1993%26volume%3D2%26spage%3D404%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettegrew, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, D. J.</span><span> </span><span class="NLM_article-title">Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1273</span><span class="NLM_x">–</span> <span class="NLM_lpage">1281</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1177%2F37.8.2666510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=2666510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaL1MXlt12ht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1989&pages=1273-1281&author=W.+E.+Klunkauthor=J.+W.+Pettegrewauthor=D.+J.+Abraham&title=Quantitative+evaluation+of+Congo+red+binding+to+amyloid-like+proteins+with+a+beta-pleated+sheet+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation</span></div><div class="casAuthors">Klunk, William E.; Pettegrew, Jay W.; Abraham, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1273-81</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    </div><div class="casAbstract">The binding of Congo Red to several purified amyloid-like peptides having a β-pleated sheet conformation was quant. examd.  Congo Red binds preferentially to the β-pleated sheet conformation of both insulin fibrils and poly-L-lysine.  Congo Red does not bind nearly so well to poly-L-serine or polyglycine, despite the fact that these peptides also have a β-pleated sheet conformation.  Binding to insulin fibrils was saturable with an apparent Bmax of 2 mol Congo Red/mol insulin fibrils and an apparent KD of 1.75 × 10-7M.  Binding to β-poly-L-lysine was similar but had a much higher apparent Bmax of 43.  Binding of Congo Red to β-poly-L-lysine was pH dependent and appeared to be detd. by the no. of protonated lysine residues in the 250 amino acid peptide.  A new hypothesis is presented in which Congo Red binds to amyloid-like proteins via bonds between the 2 neg. charged sulfonic acid groups of Congo Red and 2 pos. charged amino acid residues of 2 sep. protein mols. which are properly oriented by virtue of the β-pleated sheet conformation of the peptide backbone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqB2vRbQvcVLVg90H21EOLACvtfcHk0lgxgfVbxIwBCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlt12ht7k%253D&md5=dbf3a9182aa87171b7a13a0e1dd529fd</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1177%2F37.8.2666510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F37.8.2666510%26sid%3Dliteratum%253Aachs%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DPettegrew%26aufirst%3DJ.%2BW.%26aulast%3DAbraham%26aufirst%3DD.%2BJ.%26atitle%3DQuantitative%2520evaluation%2520of%2520Congo%2520red%2520binding%2520to%2520amyloid-like%2520proteins%2520with%2520a%2520beta-pleated%2520sheet%2520conformation%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D1989%26volume%3D37%26spage%3D1273%26epage%3D1281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group">Petric, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golobic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agdeppa, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timbol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keum, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyamurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houk, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span> </span><span class="NLM_article-title">Dicyanovinylnaphthalenes for neuroimaging of amyloids and relationships of electronic structures and geometries to binding affinities</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">16492</span><span class="NLM_x">–</span> <span class="NLM_lpage">16497</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.1214134109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=23012452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKltrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=16492-16497&author=A.+Petricauthor=S.+A.+Johnsonauthor=H.+V.+Phamauthor=Y.+Liauthor=S.+Cehauthor=A.+Golobicauthor=E.+D.+Agdeppaauthor=G.+Timbolauthor=J.+Liuauthor=G.+Keumauthor=N.+Satyamurthyauthor=V.+Kepeauthor=K.+N.+Houkauthor=J.+R.+Barrio&title=Dicyanovinylnaphthalenes+for+neuroimaging+of+amyloids+and+relationships+of+electronic+structures+and+geometries+to+binding+affinities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Dicyanovinylnaphthalenes for neuroimaging of amyloids and relationships of electronic structures and geometries to binding affinities</span></div><div class="casAuthors">Petric, Andrej; Johnson, Scott A.; Pham, Hung V.; Li, Ying; Ceh, Simon; Golobic, Amalija; Agdeppa, Eric D.; Timbol, Gerald; Liu, Jie; Keum, Gyochang; Satyamurthy, Nagichettiar; Kepe, Vladimir; Houk, Kendall N.; Barrio, Jorge R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">16492-16497, S16492/1-S16492/47</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The positron-emission tomog. (PET) probe 2-(1-[6-[(2-fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene) (FDDNP) is used for the noninvasive brain imaging of amyloid-β (Aβ) and other amyloid aggregates present in Alzheimer's disease and other neurodegenerative diseases.  A series of FDDNP analogs has been synthesized and characterized using spectroscopic and computational methods.  The binding affinities of these mols. have been measured exptl. and explained through the use of a computational model.  The analogs were created by systematically modifying the donor and the acceptor sides of FDDNP to learn the structural requirements for optimal binding to Aβ aggregates.  FDDNP and its analogs are neutral, environmentally sensitive, fluorescent mols. with high dipole moments, as evidenced by their spectroscopic properties and dipole moment calcns.  The preferred soln.-state conformation of these compds. is directly related to the binding affinities.  The extreme cases were a nonplanar analog t-butyl-FDDNP, which shows low binding affinity for Aβ aggregates (520 nM Ki) in vitro and a nearly planar tricyclic analog cDDNP, which displayed the highest binding affinity (10 pM Ki).  Using a previously published x-ray crystallog. model of 1,1-dicyano-2-[6-(dimethylamino)naphthalen-2-yl]propene (DDNP) bound to an amyloidogenic Aβ peptide model, the binding affinity is inversely related to the distortion energy necessary to avoid steric clashes along the internal surface of the binding channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPwwHtPvSJpbVg90H21EOLACvtfcHk0ljJAOhAJyBWlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKltrrK&md5=a2d4875f1ad3219e50d3c205c8fd5cfb</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1214134109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1214134109%26sid%3Dliteratum%253Aachs%26aulast%3DPetric%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DS.%2BA.%26aulast%3DPham%26aufirst%3DH.%2BV.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCeh%26aufirst%3DS.%26aulast%3DGolobic%26aufirst%3DA.%26aulast%3DAgdeppa%26aufirst%3DE.%2BD.%26aulast%3DTimbol%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DKeum%26aufirst%3DG.%26aulast%3DSatyamurthy%26aufirst%3DN.%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26atitle%3DDicyanovinylnaphthalenes%2520for%2520neuroimaging%2520of%2520amyloids%2520and%2520relationships%2520of%2520electronic%2520structures%2520and%2520geometries%2520to%2520binding%2520affinities%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D16492%26epage%3D16497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group">Reinke, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gestwicki, J. E.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1111%2Fj.1747-0285.2007.00557.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=17718715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVels7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=206-215&author=A.+A.+Reinkeauthor=J.+E.+Gestwicki&title=Structure%E2%80%93activity+relationships+of+amyloid+beta-aggregation+inhibitors+based+on+curcumin%3A+influence+of+linker+length+and+flexibility"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility</span></div><div class="casAuthors">Reinke, Ashley A.; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-215</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Self-assembly of amyloid beta into fibrillar plaques is characteristic of Alzheimer's disease, and oligomers of this peptide are believed to be involved in neurodegeneration.  Natural org. dyes, such as congo red and curcumin, bind tightly to amyloid beta and, at higher concns., block its self-assembly.  The ability of these mols. to prevent amyloid accumulation has generated interest in understanding which of their structural features contribute to inhibitory potency.  In general, amyloid beta ligands tend to be flat, planar mols. with substituted arom. end groups; however, a comprehensive structure-activity study has not been reported.  To better understand these ligands, the authors surveyed the effect of three prominent features on inhibition of amyloid aggregation: the presence of two arom. end groups, the substitution pattern of these aroms., and the length and flexibility of the linker region.  The authors found that modification of any one of the modules has profound effects on activity.  Further, the authors report that the optimal length of the linker lies within a surprisingly narrow regime (6-19 Å).  These results offer insight into the key chem. features required for inhibiting amyloid beta aggregation.  In turn, these findings help define the nature of the docking site for small mols. on the amyloid beta surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK9vZhehk5I7Vg90H21EOLACvtfcHk0ljJAOhAJyBWlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVels7rO&md5=9fb830c8d1dda285aa6d50c88a03ff27</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00557.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00557.x%26sid%3Dliteratum%253Aachs%26aulast%3DReinke%26aufirst%3DA.%2BA.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520amyloid%2520beta-aggregation%2520inhibitors%2520based%2520on%2520curcumin%253A%2520influence%2520of%2520linker%2520length%2520and%2520flexibility%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2007%26volume%3D70%26spage%3D206%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group">Wolfe, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaho, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranker, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span> </span><span class="NLM_article-title">Protein-induced photophysical changes to the amyloid indicator dye thioflavin T</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">16863</span><span class="NLM_x">–</span> <span class="NLM_lpage">16868</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1073%2Fpnas.1002867107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=20826442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1OlsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=16863-16868&author=L.+S.+Wolfeauthor=M.+F.+Calabreseauthor=A.+Nathauthor=D.+V.+Blahoauthor=A.+D.+Mirankerauthor=Y.+Xiong&title=Protein-induced+photophysical+changes+to+the+amyloid+indicator+dye+thioflavin+T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-induced photophysical changes to the amyloid indicator dye thioflavin T</span></div><div class="casAuthors">Wolfe, Leslie S.; Calabrese, Matthew F.; Nath, Abhinav; Blaho, Dorottya V.; Miranker, Andrew D.; Xiong, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">16863-16868, S16863/1-S16863/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The small mol. thioflavin T (ThT) is a defining probe for the identification and mechanistic study of amyloid fiber formation.  As such, ThT is fundamental to investigations of serious diseases such as Alzheimer's disease, Parkinson disease, and type II diabetes.  For each disease, a different protein undergoes conformational conversion to a β-sheet rich fiber.  The fluorescence of ThT exhibits an increase in quantum yield upon binding these fibers.  Despite its widespread use, the structural basis for binding specificity and for the changes to the photophys. properties of ThT remain poorly understood.  Here, we report the co-crystal structures of ThT with two alternative states of β-2 microglobulin (β2m); one monomeric, the other an amyloid-like oligomer.  In the latter, the dye intercalates between β-sheets orthogonal to the β-strands.  Importantly, the fluorophore is bound in such a manner that a photophys. relevant torsion is limited to a range of angles generally assocd. with low, not high, quantum yield.  Quantum mech. assessment of the fluorophore shows the electronic distribution to be strongly stabilized by arom. interactions with the protein.  Monomeric β2m gives little increase in ThT fluorescence despite showing three fluorophores, at two binding sites, in configurations generally assocd. with high quantum yield.  Our efforts fundamentally extend existing understanding about the origins of amyloid-induced photophys. changes.  Specifically, the β-sheet interface that characterizes amyloid acts both sterically and electronically to stabilize the fluorophore's ground state electronic distribution.  By preventing the fluorophore from adopting its preferred excited state configuration, nonradiative relaxation pathways are minimized and quantum yield is increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppmHF0DIrtwbVg90H21EOLACvtfcHk0ljJAOhAJyBWlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1OlsLfJ&md5=cee6125bc69a3965da8db55138c002fa</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1002867107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1002867107%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DL.%2BS.%26aulast%3DCalabrese%26aufirst%3DM.%2BF.%26aulast%3DNath%26aufirst%3DA.%26aulast%3DBlaho%26aufirst%3DD.%2BV.%26aulast%3DMiranker%26aufirst%3DA.%2BD.%26aulast%3DXiong%26aufirst%3DY.%26atitle%3DProtein-induced%2520photophysical%2520changes%2520to%2520the%2520amyloid%2520indicator%2520dye%2520thioflavin%2520T%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D16863%26epage%3D16868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group">Krebs, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromley, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donald, A. M.</span><span> </span><span class="NLM_article-title">The binding of thioflavin-T to amyloid fibrils: localisation and implications</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2Fj.jsb.2004.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15629655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFGj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2005&pages=30-37&author=M.+R.+Krebsauthor=E.+H.+Bromleyauthor=A.+M.+Donald&title=The+binding+of+thioflavin-T+to+amyloid+fibrils%3A+localisation+and+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">The binding of thioflavin-T to amyloid fibrils: localisation and implications</span></div><div class="casAuthors">Krebs, M. R. H.; Bromley, E. H. C.; Donald, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Structural Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-37</span>CODEN:
                <span class="NLM_cas:coden">JSBIEM</span>;
        ISSN:<span class="NLM_cas:issn">1047-8477</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Amyloid fibrils are a polymeric form of protein, involving a continuous β-sheet with the strands perpendicular to the long axis of the fibril.  Although typically implicated in diseases such as Alzheimer's disease and the transmissible spongiform encephalopathies, non disease-assocd. protein can also be converted into amyloid fibrils.  Traditionally, amyloid fibrils are identified via the use of specific dyes such as Congo red and thioflavin-T, although their specificity is ill understood.  Recently, solns. of bovine insulin and bovine β-lactoglobulin have been found to form spherulites, micron-sized spherical structures contg. radially arranged amyloid fibrils.  When studied by confocal microscopy using polarized laser light and thioflavin-T, a consistent pattern of emission, rather than a uniform disk, was obsd.  This suggests the dye binds in a specific, regular fashion to amyloid fibrils.  Confocal microscopy studies of thioflavin-T aligned in stretched poly-vinyl alc. films showed that the dye dipole excitation axis lies parallel to the long mol. axis.  Therefore, thioflavin-T binds to amyloid fibrils such that their long axes are parallel.  We propose binding occurs in channels' that run along the length of the β-sheet.  Steric interactions between dye mols. and side chains indicate why thioflavin-T fluoresces more intensely when bound to amyloid fibrils and can explain why this interaction with amyloid fibrils is specific, but with varying efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqly9uW7UlHI7Vg90H21EOLACvtfcHk0litjxzZgHwKKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFGj&md5=c3110e632f450a1e2287df4fbc014c3e</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1016%2Fj.jsb.2004.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsb.2004.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DKrebs%26aufirst%3DM.%2BR.%26aulast%3DBromley%26aufirst%3DE.%2BH.%26aulast%3DDonald%26aufirst%3DA.%2BM.%26atitle%3DThe%2520binding%2520of%2520thioflavin-T%2520to%2520amyloid%2520fibrils%253A%2520localisation%2520and%2520implications%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2005%26volume%3D149%26spage%3D30%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettegrew, J. W.</span><span> </span><span class="NLM_article-title">Development of small molecule probes for the beta-amyloid protein of Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1016%2F0197-4580%2894%2990050-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=7891823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADyaK2MXis1Crur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1994&pages=691-698&author=W.+E.+Klunkauthor=M.+L.+Debnathauthor=J.+W.+Pettegrew&title=Development+of+small+molecule+probes+for+the+beta-amyloid+protein+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Development of small molecule probes for the beta-amyloid protein of Alzheimer's disease</span></div><div class="casAuthors">Klunk, William E.; Debnath, Manik L.; Pettegrew, Jay W.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">691-8</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    </div><div class="casAbstract">This study describes the synthesis and in vitro testing of small mol. probes that may eventually prove useful as markers of amyloid deposition in living patients.  The prototype agent, Chrysamine G (CG), is a deriv. of Congo red.  CG binds synthetic beta-amyloid well in vitro, as does a fluorinated deriv.  The mechanism of binding appears to be the same as Congo red-through a bidentate attachment spanning several amyloid peptide chains.  CG is much more lipophilic than Congo red and crosses the blood-brain barrier in normal mice, achieving a brain/blood ratio over 10/1.  There was no acute toxicity in mice at doses 10 times those used in the distribution studies.  CG appears to be a relatively high affinity probe for beta-amyloid that appears to have low toxicity and can cross the blood-brain barrier.  These characteristics are promising for development of in vivo amyloid probes similar to CG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph72RMRngsGLVg90H21EOLACvtfcHk0litjxzZgHwKKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXis1Crur0%253D&md5=39b76e039c4831218445956e2eee3c9e</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1016%2F0197-4580%2894%2990050-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0197-4580%252894%252990050-7%26sid%3Dliteratum%253Aachs%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DPettegrew%26aufirst%3DJ.%2BW.%26atitle%3DDevelopment%2520of%2520small%2520molecule%2520probes%2520for%2520the%2520beta-amyloid%2520protein%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D1994%26volume%3D15%26spage%3D691%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group">Inouye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschner, D. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s beta-amyloid: insights into fibril formation and structure from Congo red binding</span> <span class="citation_source-journal">Subcell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Fjm3017317&amp;key=10.1007%2F0-387-23226-5_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Fjm3017317&amp;key=15709480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Fjm3017317&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotFaktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2005&pages=203-224&author=H.+Inouyeauthor=D.+A.+Kirschner&title=Alzheimer%E2%80%99s+beta-amyloid%3A+insights+into+fibril+formation+and+structure+from+Congo+red+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's β-amyloid: Insights into fibril formation and structure from congo red binding</span></div><div class="casAuthors">Inouye, Hideyo; Kirschner, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Subcellular Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid β</span>),
    <span class="NLM_cas:pages">203-224</span>CODEN:
                <span class="NLM_cas:coden">SBCBAG</span>;
        ISSN:<span class="NLM_cas:issn">0306-0225</span>.
    
            (<span class="NLM_cas:orgname">Springer Science+Business Media, Inc.</span>)
        </div><div class="casAbstract">A review.  We consider here the chem. of Congo red (CR), its binding equil. to Alzheimer's β-amyloid, and the kinetics of β-amyloid formation.  Spectroscopic UV/Vis measurements for the pH- and time-dependence binding of CR to Aβ analogs are analyzed by Scatchard binding and the theory of nucleation-dependent fibril formation.  CR likely binds electrostatically to the imidazolium sidechains of histidine residues that are exposed at the surface of amyloid fibrils.  As revealed by at. models of the Aβ protofilament, such as the nanotube β-helix and parallel β-sheet, the regular arrangement of histidines likely acts as a template for the end-to-end J-aggregation of CR mols., which produces a red shift in UV/Vis absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA60Stf-PA6bVg90H21EOLACvtfcHk0litjxzZgHwKKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotFaktrs%253D&md5=09488750b42cdd5a496c599433b1a391</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1007%2F0-387-23226-5_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F0-387-23226-5_10%26sid%3Dliteratum%253Aachs%26aulast%3DInouye%26aufirst%3DH.%26aulast%3DKirschner%26aufirst%3DD.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520beta-amyloid%253A%2520insights%2520into%2520fibril%2520formation%2520and%2520structure%2520from%2520Congo%2520red%2520binding%26jtitle%3DSubcell.%2520Biochem.%26date%3D2005%26volume%3D38%26spage%3D203%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group">Mukrasch, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweckstetter, M.</span><span> </span><span class="NLM_article-title">Sites of tau important for aggregation populate {beta}-structure and bind to microtubules and polyanions</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">24978</span><span class="NLM_x">–</span> <span class="NLM_lpage">24986</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=24978-24986&author=M.+D.+Mukraschauthor=J.+Biernatauthor=M.+von+Bergenauthor=C.+Griesingerauthor=E.+Mandelkowauthor=M.+Zweckstetter&title=Sites+of+tau+important+for+aggregation+populate+%7Bbeta%7D-structure+and+bind+to+microtubules+and+polyanions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukrasch%26aufirst%3DM.%2BD.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DGriesinger%26aufirst%3DC.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DZweckstetter%26aufirst%3DM.%26atitle%3DSites%2520of%2520tau%2520important%2520for%2520aggregation%2520populate%2520%257Bbeta%257D-structure%2520and%2520bind%2520to%2520microtubules%2520and%2520polyanions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D24978%26epage%3D24986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group">Akoury, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soraya, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweckstetter, M.</span><span> </span><span class="NLM_article-title">Inhibition of tau filament formation by conformational modulation</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">2853</span><span class="NLM_x">–</span> <span class="NLM_lpage">2862</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja312471h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=2853-2862&author=E.+Akouryauthor=M.+Gajdaauthor=M.+Pickhardtauthor=J.+Biernatauthor=P.+Sorayaauthor=C.+Griesingerauthor=E.+Mandelkowauthor=M.+Zweckstetter&title=Inhibition+of+tau+filament+formation+by+conformational+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1021%2Fja312471h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja312471h%26sid%3Dliteratum%253Aachs%26aulast%3DAkoury%26aufirst%3DE.%26aulast%3DGajda%26aufirst%3DM.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DSoraya%26aufirst%3DP.%26aulast%3DGriesinger%26aufirst%3DC.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DZweckstetter%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520tau%2520filament%2520formation%2520by%2520conformational%2520modulation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D2853%26epage%3D2862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3017317&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-11%3Barticle%3Aarticle%3A10.1021%2Fjm3017317%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3017317" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799af301eabd96e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
